ࡱ> y  ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x a  1 bjbj / hGbhGb22N@d@x@x@x@@@@8@L J @gSiiiiv+4 ̬fffffff$:mo^f9x@hu|vhhfx@x@ii g>hx@ix@isf6hfFqEiA>l_fFg<gYNpbNpEE&Npx@6H0hhhhhhhffhhhghhhhNphhhhhhhhh2B ?:    CONNECTICUT PROVIDER MANUAL July 1, 2019 Contents  TOC \o "1-2" \h \z \u  HYPERLINK \l "_Toc11930046" Introduction and Guide to Manual  PAGEREF _Toc11930046 \h 5  HYPERLINK \l "_Toc11930047" Purpose and Introduction  PAGEREF _Toc11930047 \h 5  HYPERLINK \l "_Toc11930048" Information Sources  PAGEREF _Toc11930048 \h 6  HYPERLINK \l "_Toc11930049" Legal and Administrative Requirements Overview  PAGEREF _Toc11930049 \h 6  HYPERLINK \l "_Toc11930050" Dispute Resolution and Arbitration  PAGEREF _Toc11930050 \h 7  HYPERLINK \l "_Toc11930051" Financial Institution/Merchant Fees  PAGEREF _Toc11930051 \h 8  HYPERLINK \l "_Toc11930052" Insurance Requirements  PAGEREF _Toc11930052 \h 8  HYPERLINK \l "_Toc11930053" Misrouted Protected Health Information (PHI)  PAGEREF _Toc11930053 \h 9  HYPERLINK \l "_Toc11930054" Risk Adjustments  PAGEREF _Toc11930054 \h 9  HYPERLINK \l "_Toc11930055" Directory of Services  PAGEREF _Toc11930055 \h 11  HYPERLINK \l "_Toc11930056" Online Provider Directories and Demographic Data Integrity  PAGEREF _Toc11930056 \h 12  HYPERLINK \l "_Toc11930057" Provider Web Sites  PAGEREF _Toc11930057 \h 14  HYPERLINK \l "_Toc11930058" Anthem Provider Website - www.anthem.com  PAGEREF _Toc11930058 \h 14  HYPERLINK \l "_Toc11930059" Availity Portal  PAGEREF _Toc11930059 \h 14  HYPERLINK \l "_Toc11930060" Eligibility  PAGEREF _Toc11930060 \h 16  HYPERLINK \l "_Toc11930061" Member Identification Card  PAGEREF _Toc11930061 \h 17  HYPERLINK \l "_Toc11930062" Claims Submission  PAGEREF _Toc11930062 \h 18  HYPERLINK \l "_Toc11930063" Claim Submission Filing Tips  PAGEREF _Toc11930063 \h 18 Medical Records Submission. 36  HYPERLINK \l "_Toc11930064" Electronic Data Interchange (EDI) Overview  PAGEREF _Toc11930064 \h 36 Medical Records Submission... 38  HYPERLINK \l "_Toc11930065" Medicare Crossover  PAGEREF _Toc11930065 \h 39  HYPERLINK \l "_Toc11930066" Administrative, Reimbursement and Billing Policies  PAGEREF _Toc11930066 \h 42  HYPERLINK \l "_Toc11930067" Medical Policies and Clinical Utilization Management (UM) Guidelines  PAGEREF _Toc11930067 \h 44  HYPERLINK \l "_Toc11930068" Utilization Management  PAGEREF _Toc11930068 \h 45  HYPERLINK \l "_Toc11930069" Utilization Management Program  PAGEREF _Toc11930069 \h 45  HYPERLINK \l "_Toc11930070" Pre-service Review & Continued Stay Review  PAGEREF _Toc11930070 \h 46  HYPERLINK \l "_Toc11930071" Medical Policies and Clinical UM Guidelines  PAGEREF _Toc11930071 \h 47  HYPERLINK \l "_Toc11930072" On-Site Review  PAGEREF _Toc11930072 \h 47  HYPERLINK \l "_Toc11930073" Discharge Planning  PAGEREF _Toc11930073 \h 47  HYPERLINK \l "_Toc11930074" Observation Bed Policy  PAGEREF _Toc11930074 \h 47  HYPERLINK \l "_Toc11930076" Retrospective Utilization Management  PAGEREF _Toc11930076 \h 47  HYPERLINK \l "_Toc11930077" Failure to Comply With Utilization Management Program  PAGEREF _Toc11930077 \h 47  HYPERLINK \l "_Toc11930079" Utilization Statistics Information  PAGEREF _Toc11930079 \h 48  HYPERLINK \l "_Toc11930080" Electronic Data Exchange  PAGEREF _Toc11930080 \h 48  HYPERLINK \l "_Toc11930081" Interactive Care Reviewer (ICR)  PAGEREF _Toc11930081 \h 48  HYPERLINK \l "_Toc11930082" Peer to Peer Review Process  PAGEREF _Toc11930082 \h 49  HYPERLINK \l "_Toc11930083" Quality of Care Incident  PAGEREF _Toc11930083 \h 49  HYPERLINK \l "_Toc11930084" Audits/Records Requests  PAGEREF _Toc11930084 \h 49  HYPERLINK \l "_Toc11930085" Case Management  PAGEREF _Toc11930085 \h 49  HYPERLINK \l "_Toc11930086" MCG (formerly known as Milliman Care Guidelines)  PAGEREF _Toc11930086 \h 49  HYPERLINK \l "_Toc11930087" Prior Authorization Guidelines  PAGEREF _Toc11930087 \h 49  HYPERLINK \l "_Toc11930088" Responsibility for Prior Authorization  PAGEREF _Toc11930088 \h 50  HYPERLINK \l "_Toc11930089" Balance Billing for Services Considered Not Medically Necessary  PAGEREF _Toc11930089 \h 50  HYPERLINK \l "_Toc11930090" Emergency Admissions Authorization  PAGEREF _Toc11930090 \h 50  HYPERLINK \l "_Toc11930091" Urgent Care  PAGEREF _Toc11930091 \h 51  HYPERLINK \l "_Toc11930092" Behavioral Health/Substance Abuse Services  PAGEREF _Toc11930092 \h 51  HYPERLINK \l "_Toc11930093" Mental Health Parity Legislation  PAGEREF _Toc11930093 \h 52  HYPERLINK \l "_Toc11930094" UM Decisions Appropriateness of Care and Services  PAGEREF _Toc11930094 \h 52  HYPERLINK \l "aim" AIM Specialty Health................................................................................................................... 54  HYPERLINK \l "_Toc11930095" Physician/Provider Participation Requirements  PAGEREF _Toc11930095 \h 54  HYPERLINK \l "_Toc11930096" Credentialing  PAGEREF _Toc11930096 \h 59  HYPERLINK \l "_Toc11930097" Credentials Committee  PAGEREF _Toc11930097 \h 61  HYPERLINK \l "_Toc11930098" Nondiscrimination Policy  PAGEREF _Toc11930098 \h 62  HYPERLINK \l "_Toc11930099" Initial Credentialing  PAGEREF _Toc11930099 \h 62  HYPERLINK \l "_Toc11930100" Recredentialing  PAGEREF _Toc11930100 \h 63  HYPERLINK \l "_Toc11930101" Ongoing Sanction Monitoring  PAGEREF _Toc11930101 \h 63  HYPERLINK \l "_Toc11930102" Appeals Process  PAGEREF _Toc11930102 \h 64  HYPERLINK \l "_Toc11930103" Reporting Requirements  PAGEREF _Toc11930103 \h 64  HYPERLINK \l "_Toc11930104" Anthem Credentialing Program Standards  PAGEREF _Toc11930104 \h 64  HYPERLINK \l "_Toc11930105" Quality Improvement Program  PAGEREF _Toc11930105 \h 74  HYPERLINK \l "_Toc11930108" Member Rights and Responsibilities  PAGEREF _Toc11930108 \h 76  HYPERLINK \l "_Toc11930109" Continuity and Coordination of Care  PAGEREF _Toc11930109 \h 76  HYPERLINK \l "_Toc11930110" Continuity of Care/Transition of Care Program  PAGEREF _Toc11930110 \h 76  HYPERLINK \l "_Toc11930111" Quality In Sights : Hospital Incentive Program (Q-HIP)  PAGEREF _Toc11930111 \h 77  HYPERLINK \l "_Toc11930112" Anthem Quality-In-Sights Incentive Program (AQI)  PAGEREF _Toc11930112 \h 77  HYPERLINK \l "_Toc11930113" Performance Data  PAGEREF _Toc11930113 \h 78  HYPERLINK \l "_Toc11930114" Overview of HEDIS  PAGEREF _Toc11930114 \h 78  HYPERLINK \l "_Toc11930115" Overview of CAHPS  PAGEREF _Toc11930115 \h 79  HYPERLINK \l "_Toc11930116" Clinical Practice Guidelines  PAGEREF _Toc11930116 \h 79  HYPERLINK \l "_Toc11930117" Preventive Health Guidelines  PAGEREF _Toc11930117 \h 79  HYPERLINK \l "_Toc11930118" Medical Record Standards  PAGEREF _Toc11930118 \h 80  HYPERLINK \l "_Toc11930119" Multicultural Health  PAGEREF _Toc11930119 \h 80  HYPERLINK \l "_Toc11930120" Centers of Medical Excellence  PAGEREF _Toc11930120 \h 83  HYPERLINK \l "_Toc11930121" Member Quality of Care (QOC)/Quality of Service (QOS) Investigations  PAGEREF _Toc11930121 \h 87  HYPERLINK \l "_Toc11930122" Overview  PAGEREF _Toc11930122 \h 87  HYPERLINK \l "_Toc11930123" Corrective Action Plans (CAP)  PAGEREF _Toc11930123 \h 88  HYPERLINK \l "_Toc11930124" Reporting  PAGEREF _Toc11930124 \h 88  HYPERLINK \l "_Toc11930125" Severity Levels for Quality Assurance  PAGEREF _Toc11930125 \h 88  HYPERLINK \l "_Toc11930126" Trend Thresholdfor Analysis  PAGEREF _Toc11930126 \h 88  HYPERLINK \l "_Toc11930127" Provider Complaint and Appeals Process  PAGEREF _Toc11930127 \h 89  HYPERLINK \l "_Toc11930128" Guidelines and Timeframes for Submitting Clinical Appeals  PAGEREF _Toc11930128 \h 90  HYPERLINK \l "_Toc11930129" BlueCard Members  PAGEREF _Toc11930129 \h 90  HYPERLINK \l "_Toc11930130" Product Summary  PAGEREF _Toc11930130 \h 91  HYPERLINK \l "_Toc11930131" Plans and Benefits  PAGEREF _Toc11930131 \h 91  HYPERLINK \l "_Toc11930132" Federal Employee Program (FEP or FEHBP)  PAGEREF _Toc11930132 \h 92  HYPERLINK \l "_Toc11930133" The BlueCard Program  PAGEREF _Toc11930133 \h 92  HYPERLINK \l "_Toc11930134" Medicare Advantage  PAGEREF _Toc11930134 \h 92  HYPERLINK \l "_Toc11930135" Medicare Supplemental  PAGEREF _Toc11930135 \h 92  HYPERLINK \l "_Toc11930136" Lumenos Consumer Driven Health Plans  PAGEREF _Toc11930136 \h 92  HYPERLINK \l "_Toc11930137" Empire Blue Cross and Blue Shield HMO/POS  PAGEREF _Toc11930137 \h 93  HYPERLINK \l "_Toc11930138" New England Health Plans  PAGEREF _Toc11930138 \h 94  HYPERLINK \l "_Toc11930139" Taft Hartley  PAGEREF _Toc11930139 \h 95  HYPERLINK \l "_Toc11930140" Federal Employees Health Benefits Program  PAGEREF _Toc11930140 \h 96  HYPERLINK \l "_Toc11930141" Health Insurance Marketplace (exchanges)  PAGEREF _Toc11930141 \h 98  HYPERLINK \l "_Toc11930142" Audit  PAGEREF _Toc11930142 \h 99  HYPERLINK \l "_Toc11930143" Fraud, Waste and Abuse Detection  PAGEREF _Toc11930143 \h 104  HYPERLINK \l "_Toc11930144" Laboratory Services  PAGEREF _Toc11930144 \h 106  HYPERLINK \l "pharmacyhome" Pharmacy Home Program.........................................................................................................106  HYPERLINK \l "_Toc11930145" Useful Links  PAGEREF _Toc11930145 \h 107   HYPERLINK \l "Introduction"Introduction and Guide to Manual Purpose and Introduction The Anthem Blue Cross and Blue Shield (Anthem) Provider Manual presents an overview of the most current policies and procedures as a reference for participating facilities and professional providers. In keeping with the transition to an increasingly paperless environment, this provider manual contains many references to information that will be found, and maintained, on our website at  HYPERLINK "http://www.anthem.com" www.anthem.com. More information on accessing our website can be found in this manual under the heading Information Sources. Anthem is redesigning the providerwebsite to make it easier and more useful for Providers and Facilities, and working hard to move resources into the new redesigned website promptly for an enhanced Provider experience. In the meantime, Providers and Facilities can still access most ofour resources on our legacy site. It is possible that links or navigation instructions within this Manual may not work during this transition time; but every effort will be made to minimize any disruption in the availability of information resources. This Manual is intended to support all entities and individuals that have contracted with Anthem. The use of Provider within this manual refers to entities and individuals contracted with Anthem that bill on a CMS 1500. They may also be referred to as Professional Providers in some instances. The use of Facility within this manual refers to entities contracted with Anthem that bill on a UB 04, such as Acute General Hospitals and Ambulatory Surgery Centers. General references to Provider Inquiry, Provider Website, Provider Network Manager and similar terms apply to both Providers and Facilities. Any changes to the information contained herein will be communicated via notice posted to  HYPERLINK "http://www.anthem.com" www.anthem.com, direct mailings to providers, Rapid E-mail service, and/or Anthems monthly Network Update until such time as the provider manual is next updated. In those instances where Anthem determines that information in the manual differs from that of the Anthem Facility or Participating Provider Agreement (the Agreement,) the Agreement will take precedence over the manual. Anthem Blue Cross and Blue Shield is committed to providing Providers and Facilities with an accurate and current manual; however, there may be instances in which changes occur between manual revision dates. The information contained in this provider manual will be reviewed and updated on an annual basis. Information Sources Anthem Web Site An internet site that is available to providers at  HYPERLINK "http://www.anthem.com" www.anthem.com. The site provides information on: Anthem products Contact phone numbers Provider services Health information Network/Participating Provider directories ANTHEMNetwork Update - Our provider newsletter, Network Update, is our primary source for providing important information to Providers and Facilities. The Network Update is available twelve (12) times a year on www.anthem.com and via email distribution. You can easily locate the monthly online edition by logging onto www.anthem.com, then selecting Providers at the top of the Anthem home page, selecting Provider Overview, state of CT, and selecting Enter. From the Communications tab on the top of the provider home page, select Publications, then Provider Newsletters. You may also access by selecting this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003096.htm&state=ct&rootLevel=4&label=Provider%20Newsletters" Provider Newsletters We encourage you to sign up for the email delivery of a link to the newsletter directly in your email inbox. Registration for this service is available by accessing an online registration form through the link to Network eUpdate on the Provider home page of anthem.com You may also access via this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f1/s0/t0/pw_040291.htm&label=Network%20eUPDATE&state=ct&rootLevel=0" Network eUpdate Registration  Legal and Administrative Requirements Overview Coordination of Benefits If a Member or eligible dependent is covered by more than one Health Benefit Plan, the carriers involved work together to prevent duplicate payments for any services. This cooperative effort is called Coordination of Benefits (COB), a provision in most Health Benefit Plans. If a Plan is other than the primary payor, any further compensation to Provider or Facility from Plan or the Member be determined in accordance with the Agreement, the applicable Health Benefit Plan and any applicable Plan written policies and procedures for coordinating benefits. Such compensation from Plan as a secondary payer plus the amounts owed by all other sources, including the Member, shall add up to one hundred percent (100%) of the Plan rate. Notwithstanding the foregoing, in no event shall Plan or the Member be required to pay more than they would have paid had the Plan been the primary payor. Providers and Facilities will not collect any amount from the Member if such amount, when added to the amounts collected from the primary and secondary payors, would cause total reimbursement to the Provider or Facility for the Covered Service to exceed the amount allowed for the Covered Service under the Agreement. Further, this provision shall not be construed to require Providers or Facilities to waive Cost Share in contravention of any Medicare rule or regulation, nor shall this provision be construed to supersede any other Medicare rule or regulation. If, under this Section, Providers and Facilities are permitted to seek payment from other sources by reason of the existence of other group coverage in addition to Plans Health Benefit Plan. Providers and Facilities may seek payment from the other sources on a basis other than the Plan rate. When filing Coordination of Benefits Claims on paper submission Include Explanation of Benefit. (EOB) from primary insurance carrier with coordination of benefits (COB) Claims submitted for secondary payment. . Dispute Resolution and Arbitration The substantive rights and obligations of Anthem, Providers and Facilities with respect to resolving disputes are set forth in the Anthem Provider Agreement (the Agreement) or the Anthem Facility Agreement (the "Agreement"). All administrative procedures set forth in the Agreement and this provider manual shall be exhausted prior to filing an arbitration demand. The following provisions set forth some of the procedures and processes that must be followed during the exercise of the Dispute Resolution and Arbitration Provisions in the Agreement. Attorneys Fees and Costs The shared fees and costs of the non-binding mediation and arbitration (e.g. fee of the mediator, fee of the independent arbitrator, etc.) will be shared equally between the parties. Each party shall be responsible for the payment of that partys specific fees and costs (e.g. the partys own attorneys fees, the fees of the party selected arbitrator, etc.) and any costs associated with conducting the non-binding mediation or arbitration that the party chooses to incur (e.g. expert witness fees, depositions, etc.). Notwithstanding this provision, the arbitrator may issue an order in accordance with Federal Rule of Civil Procedure Rule 11. Location of the Arbitration The arbitration hearing will be held in the city and state in which the Anthem office, identified in the address block on the signature page to the Agreement, is located except that if there is no address block on the signature page, then the arbitration hearing will be held in the city and state in which the Anthem Plan has its principal place of business. Notwithstanding the foregoing, both parties can agree in writing to hold the arbitration hearing in some other location. C. Selection and Replacement of Arbitrator(s) For disputes equal to or greater than (exclusive of interests, costs or attorneys fees) the dollar thresholds set forth in the Dispute Resolution and Arbitration Article of the Agreement the panel shall be selected in the following manner. The arbitration panel shall consist of one (1) arbitrator selected by Provider/Facility, one (1) arbitrator selected by Anthem, and one (1) independent arbitrator to be selected and agreed upon by the first two (2) arbitrators. If the arbitrators selected by Provider/Facility and Anthem cannot agree in thirty (30) calendar days on who will serve as the independent arbitrator, then the arbitration administrator identified in the Dispute Resolution and Arbitration Article of the Agreement shall appoint the independent arbitrator. In the event that any arbitrator withdraws from or is unable to continue with the arbitration for any reason, a replacement arbitrator shall be selected in the same manner in which the arbitrator who is being replaced was selected. D. Discovery The parties recognize that litigation in state and federal courts is costly and burdensome. One of the parties goals in providing for disputes to be arbitrated instead of litigated is to reduce the costs and burdens associated with resolving disputes. Accordingly, the parties expressly agree that discovery shall be conducted with strict adherence to the rules and procedures established by the mediation or arbitration administrator identified in the Dispute Resolution and Arbitration Article of the Agreement, except that the parties will be entitled to serve requests for production of documents and data, which shall be governed by Federal Rules of Civil Procedure 26 and 34. E. Decision of Arbitrator(s) The decision of the arbitrator, if a single arbitrator is used, or the majority decision of the arbitrators, if a panel is used, shall be binding. The arbitrator(s) may construe or interpret, but shall not vary or ignore, the provisions of the Agreement and shall be bound by and follow controlling law including, but not limited to, any applicable statute of limitations, which shall not be tolled or modified by the Agreement. If there is a dispute regarding the applicability or enforcement of the class waiver provisions found in the Dispute Resolution and Arbitration Article of the Agreement, that dispute shall only be decided by a court of competent jurisdiction and shall not be decided by the arbitrator(s). Either party may request a reasoned award or decision, and if either party makes such a request, the arbitrator(s) shall issue a reasoned award or decision setting forth the factual and legal basis for the decision. The arbitrator(s) may consider and decide the merits of the dispute or any issue in the dispute on a motion for summary disposition. In ruling on a motion for summary disposition, the arbitrator(s) shall apply the standards applicable to motions for summary judgment under Federal Rule of Civil Procedure 56.\ Judgment upon the award rendered by the arbitrator(s) may be confirmed and enforced in any court of competent jurisdiction. Without limiting the foregoing, the parties hereby consent to the jurisdiction of the courts in the State(s) in which Anthem is located and of the United States District Courts sitting in the State(s) in which Anthem is located for confirmation and injunctive, specific enforcement, or other relief in furtherance of the arbitration proceedings or to enforce judgment of the award in such arbitration proceeding. A decision that has been appealed shall not be enforceable while the appeal is pending. Confidentiality Subject to any disclosures that may be required or requested under state or federal law, all statements made, materials generated or exchanged, and conduct occurring during the arbitration process including, but not limited to, materials produced during discovery, arbitration statements filed with the arbitrator(s), and the decision of the arbitrator(s), are confidential and shall not be disclosed in any manner to any person who is not a director, officer, or employee of a party or an arbitrator or used for any purpose outside the arbitration. If either party files an action in federal or state court arising from or relating to a mediation or arbitration, all documents must be filed under seal to ensure that confidentiality is maintained. Nothing in this provision, however, shall preclude Anthem or its parent company from disclosing any such details regarding the arbitration to its accountants, auditors, brokers, insurers, reinsurers or retrocessionaires. Financial Institution/Merchant Fees Providers and Facilities are responsible for any fees or expenses charged to it by their own financial institution or payment service provider. Insurance Requirements Providers and Facilities shall, during the term of this Agreement, keep in force with insurers having an A.M. Best rating of A minus or better, or self-insure, the following coverage: Professional liability/medical malpractice liability insurance which limits shall comply with all applicable state laws and/or regulations, and shall provide coverage for claims arising out of acts, errors or omissions in the rendering or failure to render those services addressed by this Agreement. In states where there is an applicable statutory cap on malpractice awards, Providers and Facilities shall maintain coverage with limits of not less than the statutory cap. If this insurance policy is written on a claims-made basis, and said policy terminates and is not replaced with a policy containing a prior acts endorsement, Providers and Facilitiesagree to furnish and maintain an extended period reporting endorsement ("tail policy") for the term of not less than three (3) years. Workers Compensation coverage with statutory limits and Employers Liability insurance. Commercial general liability insurance for Providers and Facilities for bodily injury and property damage, including personal injury and contractual liability coverage, which limits shall apply with applicable state laws. For Ambulance/Medical Transportation Providers Only, in addition to the above: Auto Liability insurance which complies with applicable state laws and/or regulations, and shall provide coverage for claims arising out of acts, errors or omissions in rendering or failing to render services. For Air Ambulance Providers Only, in addition to the above: Aviation Liability insurance with limits of not less than $1,000,000 per occurrence and $2,000,000 in the aggregate. Acceptable self-insurance can be in the form of a captive or self-management of a large retention through a Trust. A self-insured Provider or Facility shall maintain and provide evidence of a valid self-insurance program consisting of at least one of the following upon request: Actuarially validated reserve adequacy for incurred Claims, incurred but not reported Claims, and future Claims based on past experience; Designated claim third party administrator or appropriately licensed and employed claims professional or attorney; Evidence of surety bond, reserve or line of credit as collateral for the self-insured limit. B. Providers and Facilities shall notify Anthem of a reduction in, cancellation of, or lapse in coverage within ten (10) days of such a change.A certificate of insurance shall be provided to Anthem upon execution of this Agreement and upon request during the Agreement period. Misrouted Protected Health Information (PHI) Providers and Facilities are required to review all Member information received from Anthem to ensure no misrouted PHI is included. Misrouted PHI includes information about Members that a Provider or Facility is not currently treating. PHI can be misrouted to Providers and Facilities by mail, fax, email, or electronic remittance. Providers and Facilities are required to immediately destroy any misrouted PHI or safeguard the PHI for as long as it is retained. In no event are Providers or Facilities permitted to misuse or re-disclose misrouted PHI. If Providers or Facilities cannot destroy or safeguard misrouted PHI, Providers and Facilities must contact Provider Services to report receipt of misrouted PHI. Risk Adjustments Compliance with Federal Laws, Audits and Record Retention Requirements Medical records and other health and enrollment information of Members must be handled under established procedures that: Safeguard the privacy of any information that identifies a particular Member; Maintain such records and information in a manner that is accurate and timely; and Identify when and to whom Member information may be disclosed. In addition to the obligation to safeguard the privacy of any information that identifies a Member, Anthem, Providers and Facilities areobligated to abide by all Federal and state laws regarding confidentiality and disclosure for medical health records (including mental health records) and enrollee information. Encounter Data for Risk Adjustment Purposes Commercial Risk Adjustment and Data Submission: Risk adjustment is the process used by Health and Human Services (HHS) to adjust the payment made to health plans under the Affordable Care Act (ACA) based on the health status of Members who are insured under small group or individual health benefit plans compliant with the ACA (aka ACA Compliant Plans). Risk adjustment was implemented to pay health plans more accurately for the predicted health cost expenditures of Members by adjusting payments based on demographics (age and gender) as well as health status. Anthem, as a qualifying health plan, is required to submit diagnosis data collected from encounter and claim data to HHS for purposes of risk adjustment. Because HHS requires that health plans submit all ICD10 codes for each beneficiary, Anthem also collects diagnosis data from the Members medical records created and maintained by the Provider or Facility. Under the HHS risk adjustment model, the health plan is permitted to submit diagnosis data from inpatient hospital, outpatient hospital and physician/qualified non-physician e.g. nurse practitioner encounters only. Maintaining documentation of Members visits and of Members diagnoses and chronic conditions helps Anthem fulfill its requirements under the Affordable Care Act. Those requirements relate to the risk adjustment, reinsurance and risk corridor, or 3Rs provision in the ACA. To ensure that Anthem is reporting current and accurate Member diagnoses, Providers and Facilities may be asked to complete an Encounter Facilitation Form (also known as a SOAP note) for Members insured under small group or individual health benefit plans suspected of having unreported or out of date condition information in their records. Anthems goal is to have this information confirmed and/or updated no less than annually. As a condition of the Facility or Providers Agreement with Anthem, the Provider or Facility shall comply with Anthems requests to submit complete and accurate medical records, Encounter Facilitation Forms or other similar encounter or risk adjustment data in a timely manner to Anthem, Plan or designee upon request. In addition to the above ACA related commercial risk adjustment requirements, Providers and Facilities also may be required to produce certain documentation for Members enrolled in Medicare Advantage or Medicaid. RADV Audits As part of the risk adjustment process, HHS will perform a risk adjustment data validation (RADV) audit in order to validate the Members diagnosis data that was previously submitted by health plans. These audits are typically performed once a year. If the health plan is selected by HHS to participate in a RADV audit, the health plan and the Providers or Facilities that treated the Members included in the audit will be required to submit medical records to validate the diagnosis data previously submitted. ICD-10 CM Codes HHS requires that physicians use the ICD-10 CM Codes (ICD-10 Codes) or successor codes and coding practices services under ACA Compliant Plans. In all cases, the medical record documentation must support the ICD-10 Codes or successor codes selected and substantiate that proper coding guidelines were followed by the Provider or Facility. For example, in accordance with the guidelines, it is important for Providers and Facilities to code all conditions that co-exist at the time of an encounter and that require or affect patient care, treatment or management. In addition, coding guidelines require that the Provider or Facility code to the highest level of specificity which includes fully documenting the patients diagnosis. Medical Record Documentation Requirements Medical records significantly impact risk adjustment because: They are a valuable source of diagnosis data; They dictate what ICD-10 Code or successor code is assigned; and They are used to validate diagnosis data that was previously provided to HHS by the health plans. Because of this, the Provider and Facility play an extremely important role in ensuring that the best documentation practices are established. HHS record documentation requirements include: Patients name and date of birth should appear on all pages of record. Patients condition(s) should be clearly documented in record. The documentation must show that the condition was monitored, evaluated, assessed/addressed or treated (MEAT), or there is evidence of treatment, assessment, monitoring or medicate, plan, evaluate, referral (TAMPER). The documentation describing the condition and MEAT or TAMPER must be legible. The documentation must be clear, concise, complete and specific. When using abbreviations, use standard and appropriate abbreviations. Because some abbreviations have different meanings, use the abbreviation that is appropriate for the context in which it is being used. Physicians/Qualified Non-Physicians signature, credentials and date must appear on record and must be legible.  Directory of Services A listing of phone numbers for our Provider Service Centers, Electronic Data Interchange (EDI) and Anthem Online Provider Services (AOPS) Help Desks, Utilization Management (UM) and Other Provider Call Centers may be found on our website. For the most comprehensive and current listings, please refer to  HYPERLINK "http://www.anthem.com" www.anthem.com, select the Providers link under Other Anthem Websites, select state of CT, and Enter. Select the Contact Us button at the top of the provider home page. You may also access by selecting this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&label=Contact%20Us" Contact Us  The contact information on our website also includes the Member identification prefixes associated with each product, in the even that you require a cross reference to determine the appropriate provider service center for your inquiries. The website also includes contact information for the Institutional and Professional Network Relations Consultants who are assigned by geographic location or by facility. Secure E-Mail Secure E-mail is a service that allows providers to communicate directly with Utilization Management (UM) and several of our Provider Call Centers directly via e-mail for quick, convenient, and documented responses to your inquiries. You will find references to electronic medical records submission, electronic prior authorization reviews, and Provider Call Center e-mail mailboxes throughout our website; each of which will require that you are registered for secure e-mail service in order to protect the health information of Members that is being transmitted. If you are interested in signing up for a Secure E-mail account, please visit our registration website at  HYPERLINK "https://messages.anthemsecureemail.com" https://messages.anthemsecureemail.com and follow the directions contained therein. If you should require any assistance in using Secure E-Mail service, please access our  HYPERLINK "http://userawareness.zixcorp.com/wellpoint/" \t "_blank" online help at:  HYPERLINK "http://userawareness.zixcorp.com/wellpoint/%20%20%20" http://userawareness.zixcorp.com/wellpoint/  or call 1-866-755-2680 Network Update and Network eUPDATE Services Network Update is our monthly newsletter containing articles of interest as well as news on significant policy changes. You may receive the Network Update via email or read it on www.anthem.com. Select Providers under Other Anthem Websites, select state of CT, then select Enter. On the provider home page, select Communications, then Publications, then Provider Newsletters. Here you will find all editions archived since 2005 in addition to the current edition. Should you wish to receive a paper copy of the Network Update, you may request one by calling the Provider Service Center. You may also access by selecting the link below:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003096.htm&state=ct&rootLevel=4&label=Provider%20Newsletters" Provider Newsletters By signing up for Network eUPDATE services, you will receive the current Network Update via e-mail and will also receive the most prompt notification of significant policy changes and other important information. You may register for Network eUPDATE service via the link found on the provider home page of  HYPERLINK "http://www.anthem.com" www.anthem.com titled Network eUPDATE; under this link you will find information on the service and online registration form. You may also access by selecting the link below:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f1/s0/t0/pw_ad076835.htm&rootLevel=0&state=ct&label=Provider%20Home" Network eUpdate Registration Quick Reference Guides Please visit  HYPERLINK "http://www.anthem.com" www.anthem.com for our most current Quick Reference Guides (QRGs).On www.anthem.com, select Providers under Other Anthem websites, select state of CT, select Enter. From the Communications tab, select Publications, then Quick Reference Guides. You may also access by via the link below:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&state=ct&rootLevel=4&label=Quick%20Reference%20Guides" Quick Reference Guides The following guides are available to assist you:  HYPERLINK "http://www.anthem.com/provider/noapplication/f4/s0/t0/pw_b153377.pdf?refer=ahpprovider&state=ct" \t "_blank" Medical Management IVR Quick Reference Guide  HYPERLINK "http://www.anthem.com/provider/ct/f4/s0/t0/pw_a035022.pdf?refer=ahpprovider&state=ct" \t "_blank" Behavioral Health Quick Reference Guide -HMO, PPO, FEP & NEHP  HYPERLINK "http://www.anthem.com/provider/ct/f4/s6/t0/pw_a031254.pdf?refer=ahpprovider&state=ct" \t "_blank" Physician/Provider Interactive Voice Response System (IVR) Quick Reference Guide  HYPERLINK "http://www.anthem.com/provider/ct/f4/s0/t0/pw_a034840.pdf?refer=ahpprovider&state=ct" \t "_blank" Taft-Hartley Quick Reference Guide  HYPERLINK "http://www.anthem.com/provider/ct/f4/s0/t0/pw_a034841.pdf?refer=ahpprovider&state=ct" \t "_blank" HMO, PPO, FEP & NEHP Quick Reference Guide  HYPERLINK "http://www.anthem.com/provider/ct/f4/s0/t0/pw_a034842.pdf?refer=ahpprovider&state=ct" \t "_blank" Medicare Advantage Quick Reference Guide  HYPERLINK "http://www.anthem.com/provider/noapplication/f4/s0/t0/pw_e184315.pdf?refer=ahpprovider&state=ct" \t "_blank" Medicare Advantage Interactive Voice Response (IVR) Guide for Facility Providers  HYPERLINK "http://www.anthem.com/provider/noapplication/f4/s0/t0/pw_e184316.pdf?refer=ahpprovider&state=ct" \t "_blank" Medicare Advantage Interactive Voice Response (IVR) Guide for Professional Providers Who is here for you? Provider Service Representatives and Network Relations Consultants are here at Anthem to assist you. The provider service center is your first point of contact for claims questions. Provider Service Representatives Contact a Provider Service Representative in one of our call centers using the product-specific phone number provided in the manuals Directory of Services section, or on our provider website under Contact Us for questions/comments concerning: Claims status Eligibility Claims reviews Complaints Claims coding and or submission Network Relations Consultants Network Relations Consultants generally serve as Provider liaisons and are responsible for physician recruitment, education and communication, contracting, and provider demographic information. They are your first point of contact for adding or terminating providers from your practice, new contracts, and address changes.  Online Provider Directories and Demographic Data Integrity Providers and Facilities are able to confirm their Network participation status by using the Find a Doctor tool. You are able to search by a specific provider name, or view a list of local in-network Providers and Facilities using search features such as provider specialty, zip code, and plan type. Online Provider Directory Providers and Facilities who have questions on their participation status are encouraged to contact Provider Services at 1-800-922-3242 Accessing the Online Provider Directory: Go to  HYPERLINK "http://anthem.com" anthem.com, and from the menu select Providers then Connecticut. Select Menu, and then under the Care heading select the Find a Doctor link. Select your state. To search our online Provider Directory either enter your member information or enter as guest. If you are directing a Member to another Provider or Facility, please verify that the Provider or Facility is participating in the Members specific network. To help ensure you are directing a Member to stay within his/her specific Network, utilize the Online Provider Directory one of the following ways: Search as a Member: Search by entering the Members ID number (including the three-character prefix), or simply enter the three-character prefix by itself. Search as a Guest: Search by Selecting a Plan or Network. Note: You can usually find the Members Network Name on the lower right corner of the front of the Members ID card. Updating your Demographic Data with Anthem It is critical that your patients receive accurate and current data related to provider availability.Please notify Anthem of any changes to your Provider and Facility information. All requests must be received 30 days prior to change/update. Any requests received within less than 30 days notice may be assigned a future effective date. Contractual terms may supersede effective date request. Notes: Tax ID changes must be accompanied by a W-9 to be valid. For notices of termination from our network, refer to the termination clause in your Agreement for specific notification requirements. Please allow the number of days notice of termination from our network as required by your Agreement. Types of demographic data updates can include, but are not limited to: Accepting New Patients Address Additions, Terminations, Updates (including physical and billing locations) Areas of Expertise (Behavioral Health Only) Email Address Handicapped Accessibility Hospital Affiliation and Admitting Privileges Languages Spoken License Number Name change (Provider/Organization or Practice) National Provider Identifier (NPI) Network Participation Office Hours/Days of Operation Patient Age/Gender Preference Phone/Fax Number Provider Leaving Group, Retiring, or Joining another Practice* Specialty Tax Identification Number (TIN) Termination of Provider Participation Agreement Web Address Please send us this information using our online Provider Maintenance Form:  HYPERLINK "https://central.provider.anthem.com/mwpmf/entpmf/landingpage?brand=ctabcbs:" Online Provider Maintenance Form * Note: To request participation for a new provider or practitioner, even if joining an existing practice, providers or practitioners must first begin the Application process. Go to anthem.com. Select Providers, then select Providers Overview. On the following screen, select Begin Application, and pick Your State.  Provider Web Sites There are many resources available to Facilities and Providers on Anthems website. An overview of these resources is listed below. Anthem Provider Website -  HYPERLINK "http://www.anthem.com" www.anthem.com Anthem.com is the Anthem web portal. Access the provider home page of  HYPERLINK "http://www.anthem.com" www.anthem.com by selecting Providers from the anthem.com home page menu, then selecting state of CT and Enter. The website contains reference materials addressing our policies, guidelines, products and resources for Facilities and Providers, as well as information on joining our networks and contacting our Provider Service Centers, and a library of the downloadable forms providers may need. On the provider home page of  HYPERLINK "http://www.anthem.com" www.anthem.com, you will find posted bulletins concerning significant policy changes or other important information that we want to communicate to you quickly, such as new programs or legislative updates. In addition, you will find across the top of the home page screen several drop-down boxes covering the topics of: Health and Wellness Quality Programs, Practice Guidelines, Tools and Resources, and more H&W tools Plans and Benefits Information on our plans including Health, Individual Health, Medicare Eligible, Vision, Dental, Life, Behavioral Health, and Prescription Answers@Anthem Additional links to services available to registered AOPS users, as well as provider directory, library of downloadable forms, and web claims submission information Communications Publications, general information and FAQs. On the left side of the provider home page, you will find a link to medical policies and prior authorization guidelines for plans in all BCBS states, and a link to our online provider directory. You will also find a link to the Availity portal further described below. Availity Portal Anthem is offering an array of online tools through the Availity Portal, a secure multi-health plan portal. Engage and obtain the information you need instantly with the following tools: Care Reminders Receive clinical alerts on members care gaps and medication compliance indicators, when available. Claim Status Inquiry See details and payment information including Claim line-level details/processing. Medical Attachments Submit your medical records electronically when requested to support a pended or denied claim. Includes the ability to submit an itemized bill electronically. Member Certificate Booklet View a local plan Members certificate of coverage, when available Member eligibility and benefits inquiry Get real-time patient eligibility, benefits, and accumulative data, including current and historical coverage information, plus detailed co-insurance, co-payment and deductible information for ALL members, including BlueCard and FEP. Member ID Card Viewer View the front and back of a members ID card when available. Secure Messaging Send a question to clarify the status of a claim or to get additional information on claims. Payer Spaces: View Anthem specific tools by selecting Payer Spaces, then the Anthem icon to view the following tools: Clear Claim Connection Research procedure code edits and receive edit rationale. Education and Reference Center Locate important policies, forms and educational resources. Fee Schedule Retrieves professional office-based contracted price information for patient services performed. Remittance Inquiry View an imaged copy of the paper Anthem remits up to 15 months in the past. Patient360 Real time, robust picture of your patients health and treatment history. Plus, links to other Anthem pages, tool overview documents and more, such as: AIM Specialty Health (AIM) link to precertification requests and inquiries through AIM OptiNet Survey on AIM link to the survey via AIM Specialty Health. Take advantage of these Availity benefits No charge Anthem transactions are available at no charge to providers. Accessibility Availity functions are available 24 hours a day from any computer with Internet access. Standard responses Responses from multiple payers returned in the same format and screen layout, providing users with a consistent look and feel. Access to both commercial and government payers Users can access data from Anthem, Medicare, Medicaid and other commercial insurers (See  HYPERLINK "http://www.availity.com" www.availity.com for a full list of payers.) Compliance Availity is compliant with all Health Insurance Portability and Accountability Act (HIPAA) regulations. How to get started To register for access to Availity, go to  HYPERLINK "http://www.availity.com/providers/registration-details/" www.availity.com/providers/registration-details/. It's that simple! If you need further assistance getting registered, please contact Availity Client Services at 1-800-AVAILITY (282-4548). Availity Training Once you log into Availity, you'll have access to many resources to help jumpstart your learning, including free and on-demand training, frequently asked questions, comprehensive help topics and other resources to help ensure you get the most out of your Availity experience. Availity also offers onboarding modules for new Administrators and Users. If you would like more information on navigating in Availity, select Help & Training (from the top navigation menu on the Availity home page) | Get Trained, and type onboarding in the search catalog field. Or, go to Help & Training | My Learning Plan, and plot your learning journey. Availity Training for Anthem specific tools For more information on Anthem features and navigation, select Payer Spaces| Applications | Education and Reference Center to find presentations and reference guides that can be used to educate provider staff on Anthem proprietary tools. Organization Maintenance To change/update an Administrator or Organization information: To replace theAdministratorcurrently on record with Availity, please call Availity Client Services at 1-800-AVAILITY (282-4548). AnAdministrator can use the Maintain Organization feature to maintain the organization's demographic information, including address, phone number, tax ID, and NPI. Any changes made to this information automatically apply to all Users associated to the organization and affects only the registration information on the Availity Portal. .  Eligibility Facilities and Providers may identify and verify benefits for Members by using the following resources: Availity Portal (see description above) Provider Service Centers-Contact the appropriate service center using the information provided on the back of the Members ID card or by referring to the appropriate service center listed under Contact Us on www.anthem.coms provider home page. You may also access by selecting this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&label=Contact%20Us" Contact Us  270/271 Health Care Eligibility Benefit Inquiry and Response through EDI Electronic Data Interchange- Eligibility benefit inquiry/response is a real time transaction that provides information on patient eligibility, coverage verification, and Member liability (deductible, co-payment, and coinsurance) Getting Connected with EDI Batch or Real time Inquires Clearinghouses and EDI vendors often have easy-to-use web and automated solutions to verify information for multiple payors simultaneously through one portal in a consistent format. Contact your EDI software vendor or clearinghouse to learn more about options available. For connectivity options and file specifications, our Health Insurance Portability and Accountability Act of 1996 (HIPAA) Companion Guide is available at anthem.com/edi. For more information on benefit inquiry and other electronic transactions, visit  HYPERLINK "http://www.anthem.com/edi" www.anthem.com/edi; or you may call the EDI help desk at 1-800-334-8262, or email them at  HYPERLINK "mailto:edihelpdesk-ne@wellpoint.com" edihelpdesk-ne@wellpoint.com  Member Identification Card Member Identification (ID) Card Ask patients for the most current ID card at every visit Submit Claims with ID numbers exactly as they appear on a Members ID card including alpha prefixes Identification Card Front  Identification Card Back Anthem Logo is included for easy reference when only ID card back is copied All contact information is in the upper right corner PCP text appears on HMO and POS ID cards  CT Insurance Exchange Plans (Pathway Network) Member ID Cards Health benefits for Anthem plans purchased on and off the Connecticut Insurance Exchange (Pathway plans) were effective beginning on January 1, 2014. Members purchasing these plans receive new member ID cards. The Pathway ID cards have a similar format to commercial Anthem member ID cards, but some information on the card may look slightly different. This information is critical, as it provides details about member benefits and the provider network supporting the members health plan. For example, some new plans have limited or no out-of-area benefits Select this link for further details about the CT Insurance Exchange and member ID cards:  HYPERLINK "https://www11.anthem.com/provider/noapplication/f1/s0/t0/pw_g279544.pdf?refer=ahpprovider&state=ct" Insurance Exchange Quick Reference Guide and Sample ID Card  Claims Submission Claim Submission Filing Tips Eliminate processing delays and unnecessary correspondence with these Claim filing tips: CPT Coding The current version of the CPT Professional Edition manual is considered by Anthem as the industry standard for accurate CPT and modifier coding. Electronic Claims Submissions Please submit Claims electronically whenever possible. If Providers or Facilities have questions about electronic submissions, or if Providers or Facilities want to learn more about how EDI can work for Providers or Facilities, please review the EDI Submissions section in this manual or call 1-800-470-9630. Please refer to the subsection titled Recommended Fields for Electronic 837 Professional (837P) and Institutional (837I) Health Care Claims for more information on EDI submissions. Paper Claims Submissions If Providers or Facilities must file Claims on paper, failure to submit them on the most current CMS-1500 (Form 1500 (02-12)) or CMS-1450 (UB04) will cause Claims to be rejected and returned to the Provider or Facility. More information and the most current forms can be found at  HYPERLINK "http://www.cms.gov" www.cms.gov. Submit all paper Claims using the current standard RED CMS Form 1500 (02-12) for professional Claims and the UB-04 (CMS-1450) for Facility Claims. If Providers or Facilities are submitting a multiple page Claim, the word continued should be noted in the total charge field, with the total charge submitted on the last page of the Claim. When submitting a multiple page document, do not staple over pertinent information. Complete all mandatory fields. Do not highlight any fields. Check the printing of Claims from time to time to help ensure proper alignment and that characters are legible. Ensure all characters are inside the appropriate fields and do not overlap. Change the printer cartridge regularly and do not use a DOT matrix printer. Submit a valid member identification number including three digit prefix or R+8 numeric for Federal Employee Program (FEP) members on all pages. Claims must be submitted with complete provider information, including referring, rendering and billing NPI; tax identification number; name; and servicing and billing addresses on all pages. Please refer to the subsection titled Recommended Fields for Paper CMS Form 1500 (02-12) and UB-04 (CMS-1450) Claims for more information on paper submissions. Ambulatory Surgical Centers When billing revenue codes, always include the CPT or HCPCS code for the surgery being performed. This code is required to determine the procedure, and including it on the Claim helps us process the Claim correctly and more quickly. Ambulatory surgical Claims must be billed on a CMS-1500 (Form 1500 (02-12)) or CMS-1450 (UB04), as indicated in your Agreement. Ancillary Filing Guidelines Ambulance Claims Include the Point of Pickup (POP) ZIP Code for all ambulance (including air ambulance) Claims, both institutional outpatient and professional. File the Claims to the plan whose service area the Point of Pickup (POP) ZIP Code is located. The POP (Point of Pick-up) ZIP Code should be submitted as follows: Professional Claims for CMS-1500 submitters: the POP ZIP code is reported in field 23 Institutional outpatient Claims for UB submitters: the Value Code of A0 (zero), and the related ZIP Code of the geographic location from which the beneficiary was placed on board the ambulance, should be reported in the Value Code Amount field and billed with the appropriate revenue 54x codes. Durable/Home Medical Equipment and Supplies Durable/Home Medical Equipment and Supplies (D/HME) is determined by the provider specialty code in the provider file, not by CPT codes. Delivered to patients home File the Claim to the plan in the service area where the item was sent/delivered. Purchased at retail store File the Claim to the plan in the service area where the retail store is located. Home Infusion Therapy - Services and Supplies File the Claim with the plan in the service area where the services are rendered or the supply was delivered. Examples: If services are rendered in a members home, Claims should be sent to the plan in the members state. If Supplies are delivered to the members home, Claims should be sent to the plan in the members state. Laboratory Claims File the Claim to the plan in the service area where the specimen was drawn, as determined by the referring providers location (based on NPI) Independent lab Claims are determined by the provider specialty code in the provider file, not by CPT codes. Specialty Pharmacy Claims File the Claim to the plan in the service area where the referring provider is located (based on NPI). Specialty pharmacy Claims are determined by the provider specialty code in the provider file, not by CPT codes. Duplicate Claims (aka Tracers) Providers and Facilities should refrain from submitting a Claim multiple times to avoid potential duplicate denials. Providers or Facilities can check the status of Claims via Availity. Itemized Bill Providers and Facilities are required to submit a complete itemized bill for all Inpatient Acute and Childrens Facilities with charges over $40,000. Late Charges Late charges for Claims previously filed can be submitted electronically. You must reference the original Claim number in the re-billed electronic Claim. If attachments are required, please submit them using the PWK attachment face sheet. (See Electronic Data Interchange website for instructions as  HYPERLINK "http://www.anthem.com/edi" www.anthem.com/edi). Late charges for Claims previously filed can be submitted via paper. Type of bill should contain a 5 in the 3rd position of the TOB (ex: 135). A late billing should contain ONLY the additional late charges. The Provider should also advise the original claim# to which the late charges should be added. Maternity Delivery Claims Delivery procedure codes reported on a professional Claim (procedure codes: 59612, 59620, 59400, 59410, 59515, 59614, 59622, 59510, 59610, or 59618) are required to submit with the appropriate Z3A diagnosis code indicating the babies gestational age. National Drug Codes (NDC) See separate subsection titled National Drug Codes. Negative Charges When filing Claims for procedures with negative charges, please dont include these lines on the Claim. Negative charges often result in an out-of-balance Claim that must be returned to the provider for additional clarification. Not Otherwise Classified (NOC) Codes When submitting Not Otherwise Classified (NOC) codes please follow these guidelines to avoid possible Claim processing delays. Anthem must have a clear description of the item/service billed with a NOC code for review. If the NOC is for a drug, include the drugs name, dosage NDC number and number of units. If the NOC is not a drug, include a specific description of the procedure, service or item. If the item is durable medical equipment, include the manufactures description, model number and purchase price if rental equipment. If the service is a medical or surgical procedure, include a description on the Claim and submit medical record/and the operative report (if surgical) that support the use of an NOC and medical necessity for the procedure. If the NOC is for a laboratory test, include the specific name of the laboratory test(s) and/or a short descriptor of the test(s) NOTE: NOC codes should only be used if there are no appropriate listed codes available for the item or service. Descriptions should be included in the shaded area for item 24 on professional Claim forms, or locator 43 on facility Claim forms. Occurrence Dates When billing facility Claims, please make sure the surgery date is within the service from and to dates on the Claim. Claims that include a surgical procedure date that falls outside the service from and to dates will be returned to the provider. Other Insurance Coverage When filing Claims with other insurance coverage, please ensure the following fields are completed and that a legible copy of the Explanation of Benefits (EOB) from the other insurance coverage is attached to the Claim: CMS-1500 Fields: Field 9: Other insureds name Field 9a: Other insureds policy or group number Field 9b: Other insureds date of birth Field 9c: Employers name or school name (not required in EDI) Field 9d: Insurance plan name or program name (not required in EDI) UB-04 CMS-1450 Fields: Field 50a-c: Payer Name Field 54a-c: Prior payments (if applicable) Including Explanation of Medicare Benefits (EOMB) or other payer Explanation of Benefits (EOB): When submitting a CMS Form 1500 (02-12) or CMS-1450 (UB04) Claim form with an Explanation of Medicare Benefits (EOMB) attached, the EOMB should indicate Medicares Assignment. When submitting a CMS Form 1500 (02-12) or CMS-1450 (UB04) Claim form with an Explanation of Medicare Benefits (EOMB) or other payer Explanation of Benefits (EOB) attached, the EOMB or EOB should match each service line and each service line charge submitted on the CMS Form 1500 (02-12) or CMS-1450 (UB04). Preventive Colonoscopy correct coding Anthem allows for preventive colonoscopy in accordance with state mandates. Colonoscopies which are undertaken as a SCREENING colonoscopy, during which a polyp/tumor or other procedure due to an abnormality are discovered, should be covered under benefits for Preventive Services. This has been an area of much confusion in billing by Providers or Facilities of services. Frequently the Provider or Facility will bill for the CPT code with an ICD-10 diagnosis code corresponding to the pathology found rather than the Special screening for malignant neoplasms, of the colon, diagnosis code V76.51. CMS has issued guidance on correct coding for this situation and states that the ICD-10 diagnosis code Z12.11 (Encounter for screening for malignant neoplasm of colon) should be entered as the primary diagnosis and that the ICD-10 diagnosis code for any discovered pathology should be entered as the secondary diagnosis on all subsequent Claim lines. Anthem endorses this solution for this coding issue as the appropriate method of coding to ensure that the Provider or Facility receives the correct reimbursement for services rendered and that our members receive the correct benefit coverage for this important service. Type of Billing Codes When billing facility Claims, please make sure the type of bill coincides with the revenue code(s) billed on the Claim. For example, if billing an outpatient revenue code, the type of bill must be for outpatient services. Frequency Codes When submitting frequency codes (third digit of type of bill (TOB) on a UB-04 electronic Claims (837I), please keep in mind the following guidelines: Frequency 5 (TOB example 135) is used to resubmit late charges. Claim(s) received in the 837 HIPPA Claim format with a 5 as the third digit in the TOB field will be identified as a Claim with added lines or late charges. Frequency 7 (TOB example 117) is used to replace a prior submitted Claim. This frequency code is used as a full replacement of a prior submitted Claim. Frequency 8 (TOB example 138) is used to void/cancel a prior Claim. Frequency code 8 is to be used when a void (void/cancel of a prior Claim) is being requested. Be sure to send the original claim number when available for all types of frequency codes. Urgent Care Step Down Process Claims that meet all of the following criteria will be processed as urgent care (type of service OUC) Billed with a revenue code 450 Billed with a Evaluation & Management (E&M) codes 99281, 99282 or 99283; and All diagnoses on the Claim are listed in the Anthem Urgent Care Table. (A listing of the Anthem Urgent Care Table is available upon request) This adjudication process applies to all Anthem Blue Cross and Blue Shield programs and plans, including the FEP, BlueCard POS and PPO BlueCard. Facility Charge updates during an Inpatient Stay When a Facilitys charges are updated during an inpatient stay the Facility should bill each set of days using the appropriate revenue code on the UB 04. One line should indicate the days prior to the Facility Charge Update and a second line should be billed indicating those charges from the date of update and after. Emergency Room Services with Next Day Admission Emergency Room resulting in next day inpatient admissions requiring the Facilities to bill separate Claims for Emergency Room and Inpatient charges. Emergency Room Billing Guidelines Occasionally, a Covered Individual may require two (2) visits to the emergency room on the same day at the same Facility. Even though both Claims would have different patient control numbers, one Claim will automatically deny as duplicate to the other Claim. To help us identify Claims that are not duplicates, please include the admit hour (form locator 13) and the discharge hour (form locator 16). Claim Inquiry/Adjustment Filing Tips The different types of Claim inquiries should be handled in separate ways depending on what is being requested. Here are some examples: Claim Inquiry: A question about a Claim or Claim payment is called an inquiry. Claim Inquiries do not result in changes to Claim payments, but the outcome of the Claim Inquiry may result in the initiation of the Claim Payment Dispute. In other words, once the Provider or Facility receives the answer to the Claim Inquiry, the Provider or Facility may opt to begin the Claim Payment Dispute process. Providers and Facilities can send a Secure Message through the Availity Portal, or call the Provider Services number on the back of the Member ID Card and select the Claims prompt. Please reference the Availity Portal section for further details on Secure Messaging. Claim Correspondence: Claim Correspondence is when Anthem requires more information to finalize a Claim. Typically, Anthem makes the request for this information through the Explanation of Payment (EOP) The Claim or part of the Claim maybe denied, but it is only because more information is required to process the Claim. Once the information is received, Anthem will use it to finalize the Claim. Clinical / Medical Necessity Appeals: An appeal regarding a clinical decision denial, such as an authorization or Claim that has been denied as not medically necessary, experimental/investigational. For more information on Clinical / Medical Necessity Appeals, please refer to the Clinical Appeals section within the Provider Manual. . Precertification Disputes: Precertification disputes should be handled via the process detailed in the letter received from our precertification department. If Providers or Facilities disagree with a clinical decision, please follow the directions detailed on our letter. Sending precertification/predetermination requests or appeals to the provider correspondence address may delay responses. Corrected Claims: Submitting corrected Claims should only be utilized to update information on the Claim form. If the inquiry is about the way the Claim processed, please refer to the prior sections. If Providers or Facilities have corrections to be made to the Claim, please submit according to the Corrected Claim Guidance below. Corrected Claim Guidance When submitting a correction to a previously submitted Claim, submit the entire Claim as a replacement Claim if Providers or Facilities have omitted charges or changed Claim information (i.e., diagnosis codes, procedure codes, dates of service, etc.) including all previous information and any corrected or additional information. To correct a Claim that was billed to Anthem in error, submit the entire Claim as a void/cancel of prior Claim. TypeProfessional ClaimInstitutional ClaimEDITo indicate the Claim is a replacement Claim: In element CLM05-3 Claim Frequency Type Code Use Claim Frequency Type 7To indicate the Claim is a replacement Claim: In element CLM05-3 Claim Frequency Type Code Use Claim Frequency Type 7To confirm the Claim which is being replaced: In Segment REF Payer Claim Control Number Use F8 in REF)! and list the original payer Claim number is REF02To confirm the Claim which is being replaced: In Segment REF Payer Claim Control Number Use F8 in REF)! and list the original payer Claim number is REF02To indicate the Claim was billed in error (Void/Cancel): In element CLM05-3 Claim Frequency Type Code Use Claim Frequency Type 8To indicate the Claim was billed in error (Void/Cancel): In element CLM05-3 Claim Frequency Type Code Use Claim Frequency Type 8To confirm the Claim which is being void/cancelled: In Segment REF Payer Claim Control Number Use F8 in REF)! and list the original payer Claim number is REF02To confirm the Claim which is being void/cancelled: In Segment REF Payer Claim Control Number Use F8 in REF)! and list the original payer Claim number is REF02PaperTo indicate the Claim is a replacement Claim: In Item Number 22: Resubmission and/or Original Reference Number Use Claim Frequency Type 7 under Resubmission CodeTo indicate the Claim is a replacement Claim: In Form Locator 04: Type of Bill Use Claim Frequency Type 7To confirm the Claim which is being replaced: In the right-hand side of Item Number 22 under Original Ref. No. list the original payer Claim number for the resubmitted Claim.To confirm the Claim which is being replaced: In Form Locator 64: Document Control Number (DCN) list the original payer Claim number for the resubmitted Claim.To indicate the Claim is a void/cancel of a prior Claim: In Item Number 22: Resubmission and/or Original Reference Number Use Claim Frequency Type 8 under Resubmission CodeTo indicate the Claim is a void/cancel of a prior Claim: In Form Locator 04: Type of Bill Use Claim Frequency Type 8To confirm the Claim which is being void/cancelled: In the right-hand side of Item Number 22 under Original Ref. No. list the original payer Claim number for the void/cancelled Claim.To confirm the Claim which is being void/cancelled: In Form Locator 64: Document Control Number (DCN) list the original payer Claim number for the void/cancelled Claim. For additional information on provider complaints and appeals, please refer to the Provider Complaint and Appeals section. National Drug Codes (NDC) All practitioners and providers should supply the 11-digit NDC when billing for injections and other drug items on the CMS1500 and UB04 Claim forms as well as on the 837 electronic transactions. Note: These billing requirements will apply to Local Plan and BlueCard member Claims only, and will exclude Federal Employee Program (FEP) and Coordination of Benefits/ Secondary Claims. Line items on a claim regarding drugsadministered in a physician office or outpatient facility setting for all drug categoriesshould include the following: Applicable HCPCS code or CPT code Number of HCPCS code or CPT code units The valid 11-digit NDC,including the N4 qualifier Unit of measure qualifier(F2, GR, ML, UN, MG) NDC Units dispensed (must be greater than 0) Unit of Measurement Requirements The unit of measurement codes are also required to be submitted. The codes to be used for all Claim forms are: F2 International unit GR Gram ML Milliliter UN Unit MG - Milligram Location of the NDC The NDC is found on the label of a prescription drug item and must be included on the CMS-1500 or UB04 Claim form or in 837 electronic transactions. The NDC is a universal number that identifies a drug or related drug item.  NDC Number Section Description 1 (five digits) Vendor/distributor identification 2 (four digits) Generic entity, strength and dosage information 3 (two digits) Package code indicating the package size  Correcting Omission of a Leading Zero Providers and Facilities may encounter NDCs with fewer than 11-digits. In order to submit a Claim, Providers and Facilities will need to convert the NDC to an 11-digit number.Sometimes the NDC is printed on a drug item and a leading zero has been omitted in one of the segments. Instead of the digits and hyphens being in a 5-4-2 format, the NDC might be printed in a 4-4-1 format (example, 1234-1234-1), a 5-3-2 format (example, 12345-123-12), or a 5-4-1 format (example, 12345-1234-1). If this occurs, when entering the NDC on the Claim form, it will be required to add a leading zero to the beginning of the segment(s) that is missing the zero. Do not enter any of the hyphens on Claim forms. See the examples that follow: If the NDC appears asThen the NDCAnd it is reported as NDC 12345-1234-12 (5-4-2 format)Is complete12345123412NDC 1234-1234-1 (4-4-1 format)Needs a leading zero placed at the beginning of the first segment and the last segment01234123401NDC 12345-123-12 (5-3-2 format)Needs a leading zero placed at the beginning of the second segment12345012312NDC 12345-1234-1 (5-4-1 format)Needs a leading zero placed at the beginning of the third segment12345123401 Process for Multiple NDC numbers for Single HCPC Codes If there is more than one NDC within the HCPCs code, you must submit each applicable NDC as a separate Claim line. Each drug code submitted must have a corresponding NDC on each Claim line. If the drug administered is comprised of more than one ingredient (i.e. compound or same drug with different strength, etc.), you must represent each NDC on a Claim line using the same drug code. Standard HCPCs billing accepts the use of modifiers to determine when more than one NDC is billed for a service code. They are: KO Single drug unit dose formulation KP First drug of a multiple drug unit dose formulation KQ Second or subsequent drug of a multiple drug unit dose formulation JW Drug amount discarded /not administered to the patient How/Where to Place the NDC on a Claim Form CMS 1500 Claim Form: Reporting the NDC requires using the upper and lower rows on a Claim line. Be certain to line up information accurately so all characters fall within the proper box and row. DO NOT bill more than one NDC per Claim line. Even though an NDC is entered, a valid HCPCS or CPT code must also be entered in the Claim form. If the NDC you bill does not have a specific HCPCS or CPT code assigned, please assign the appropriate miscellaneous code per Correct Coding Guidelines. The unit of service for the HCPCS or CPT code is very important. Units for injections must be billed consistent with the HCPCS or CPT description of the code. The following table provides elements of a proper NDC entry on a CMS-1500 Claim form. All elements are requested: HowExampleWhereEnter a valid NDC code including the N4 qualifierNDC 00054352763 is entered as N400054352763Beginning at left edge, enter NDC in the shaded area of box 24AEnter one of five (5) units of measure qualifiers; F2 International Unit GR Gram ML Milliliter UN Units MG Milligrams and quantity, including a decimal point for correct reportingGR0.045 ML1.0 UN1.000In the shaded area immediately following the 11-digit NDC, enter 3 spaces, followed by one of five (5) units of measure qualifiers, followed immediately by the quantityEnter a valid HCPCS or CPT codeJ0610 Injection Calcium Gluconate, per 10 ml is billed as 1 unit for each 10 ml ampul usedNon-shaded area of box 24D UB04 Claim Form: Even though an NDC is entered, a valid HCPCS or CPT code must also be entered in the Claim form. If the NDC you bill does not have a specific HCPCS or CPT code assigned, please assign the appropriate miscellaneous code per Correct Coding Guidelines. DO NOT bill more than one NDC per Claim line. The unit of service for the HCPCS or CPT code is very important. Units for injections must be billed consistent with the HCPCS or CPT description of the code. The following table provides elements of a proper NDC entry on a UB04 Claim form. All elements are requested: HowExampleWhereEnter a valid revenue codePharmacy Revenue Code 0252Form locator (box) 42Enter 11- digit NDC, including the N4 qualifierNDC 00054352763 is entered as N400054352763Beginning at left edge, enter NDC In locator (box) 43 currently labeled as Description Enter one of five (5) units of measure qualifiers; F2 International Unit GR - Gram ML - Milliliter UN Units MG - Milligrams and quantity, including a decimal point for correct reportingGR0.045 ML1.0 UN1.000Immediately following the 11 digit NDC, enter 3 spaces followed by one of five (5) units of measure qualifiers, followed immediately by the quantity. Enter a valid HCPCS or CPT CodeJ0610 injection Calcium, per 10ML is billed as 1 unit for each 10ML ampul usedForm locator (box 44) Sample Images of the UB04 Claim Form 837 P And 837 I Reporting Fields Billing or Software Vendor: You will need to notify your billing or software vendor that the NDC is to be reported in the following fields in the 837 format: Tips for Using NDCs When Submitting Electronic Claims Loop SegmentElement NameInformationSample2410LIN02Product or Service ID QualifierEnter product or NDC qualifier N4LIN**N4*01234567891~2410LIN03Product or Service IDEnter the NDCLIN**N4*01234567891~2410CTP04QuantityEnter quantity billedCTP****2*UN~2410CTP05-1Unit of Basis for Measurement CodeEnter the NDC unit of measurement code: F2: International unit GR: Gram ML: Milliliter UN: Unit MG: MilligramCTP****2*UN~2410REF01Reference ID Qualifier (used to report Prescription # or Link Sequence Number when reporting components for a Compound Drug) VY: Link Sequence Number XZ : Prescription NumberREF01*XZ*123456~2410REF02Reference IdentificationPrescription Number or Link Sequence Number REF01*XZ*123456~ Recommended Fields for Electronic 837 Professional (837P) and Institutional (837I) Health Care Claims Please reference our Transaction Specific Companion Documents available on our EDI webpage. Go to  HYPERLINK "http://www.anthem.com/edi" www.anthem.com/edi. Select your state from the dropdown list and enter. Under the Documents tab, select Companion Guide, then see the appropriate link under the Section B Transaction Specific Companion Documents heading. Recommended Fields for Paper CMS Form 1500 (02-12) Claims If these are not completed, Claims may be delayed or returned to the Provider or Facility for additional information. Field 1a: Insureds ID Number from Member ID card, including any prefix Field 2: Patients Name do not use nicknames or middle names Field 3: Patients Birth Date date of birth should be 8-digit (MM|DD|YYYY) format and Sex Field 4: Insureds Name same is acceptable if the insured is the patient Field 5: Patients Address submitted when the patients address is different than the insureds address. If its the same, this field does not need to be populated. Field 6: Patient Relationship to Insured Field 7: Insureds Address Field 10: Is Patients Condition Related to: Field 10A: Employment? Field 10B: Auto Accident? Field 10C: Other Accident? Field 12: Patient Authorization Signature If patient signature is on file, Signature on file is acceptable Important information about Fields 14 and 15: CMS Form 1500 (02-12) gives Providers and Facilities two fields (14 and 15) to enter a date with a Qualifier that tells payers what the date is for. Field 14 is titled Date of Current Illness, Injury, or Pregnancy and field 15 is titled Other Date. If the visit is due to an accident, Qualifier 439 must be entered in field 15 along with the appropriate date. This information is consistent with the form instruction manual available on the NUCC website. For more guidance, please see information available on the NUCC website at www.nucc.org. Field 14: Date of Current Illness, Injury or Pregnancy (LMP) (if applicable) Enter the 8-digit (MM|DD|YYYY) date of the present illness, injury, or pregnancy. For pregnancy, use the date of the last menstrual period (LMP) as the first date. Enter the applicable qualifier to identify which date is being reported: 431 Onset of current symptoms or illness 484 Last Menstrual Period Field 15: Other Date Enter another date related to the patients condition or treatment. Enter the date in the 8-digit (MM|DD|YYYY) format. Enter the applicable qualifier to identify which date is being reported: 454 Initial treatment 304 Latest visit or consultation 453 Acute manifestation or a chronic condition 439 Accident 455 Last X-ray 471 Prescription 090 Report start (assumed care date) 091 Report end (relinquished care date) 444 First visit or consultation Field 16: Dates Patient Unable to Work in Current Occupation This is the time span a patient is or was unable to work Field 17: Referring physician name Enter the name of the referring or ordering provider. Enter the applicable qualifier to the left of the vertical, dotted line: DN Referring provider DK Ordering provider DQ Supervising provider Field 17b: Referring physician NPI Field 21: Diagnosis or Nature of Illness or Injury enter the appropriate diagnosis code/nomenclature Relate A-L to Field 24E Field 21: ICD Ind - ICD Indicator must be submitted between the vertical, dotted lines in the upper right-hand portion of the field or Claim may be rejected. Enter 9 for Code Set ICD-9-CM diagnosis for dates of service prior to 10/01/2015 or "0 for Code Set ICD-10 diagnosis for dates of service 10/01/2015 and later. Field 22: Resubmission and/or Original Reference Number This field is not intended for original Claim submissions. When resubmitting a Claim, enter the original Anthem Claim number and the appropriate bill frequency code (7=Replacement of prior Claim; 8=Void/Cancel of prior Claim) left justified in the left-hand side of the field. Field 23: Attention Ambulance Providers: Consistent with guidance from the Centers for Medicare and Medicaid Services (CMS), please include the zip code for the point of pick up. Providers or Facilities can report the physical pick up and drop off addresses in field 32. Field 24: NDC - When submitting an NDC the NDC should be submitted in the shaded area and should be preceded with the qualifier N4, followed immediately by the 11 digit NDC code. The NDC quantity should be submitted in positions 17-24 of the same line. The Quantity should be preceded by the appropriate Qualifier. UN (units), F2 (international units), GR (gram), MG (milligram) or ML (milliliter) number. The total dosage administered in mgs or mls can be reported in box 24 (the shaded section) and should not be reported in the Units field. The Units field on the CMS-Form 1500 (02-12) box 24G represents the number of units based on the NDC number. Field 24A: Date(s) of Service Field 24B: Place of Service Field 24D: Procedures, Services or Supplies Enter the appropriate CPT, HCPCS code/nomenclature; include a narrative description for Non Specific (NOC) codes. Do not use NOC codes when a specific CPT code is available. Anthem must have a clear description of the item/service billed with a NOC code to review. Descriptions should be included in the shaded area for item 24 on professional Claim forms. Please indicate appropriate modifier when applicable. Field 24E: Diagnosis Pointer refer to field 21 - Be sure to enter the diagnosis code reference (pointer) from Field 21 to relate the date of service and the procedures performed to the primary diagnosis. When multiple services are performed, the primary reference number for each service should be listed first, other applicable services should follow. The references were changed from numeric to alpha characters on the updated 02/12 form version. Be sure to use alpha characters (A-L) and not numerical characters in this field. Field 24F: $ Charges line item charge. Field 24G: Days or Units When providing anesthesia submit time in minutes. When providing pain management, drugs, etc. it should be submitted in units. Field 24J: Lower: National Provider Identification number (NPI) Field 25: Federal Tax ID Number (9-digit) Field 28: Total Charge total of line item charges. Field 31: Full name and title of Physician or Supplier actual signature or typed/printed designation is acceptable. Field 32: Service Facility Location Information Address where services were rendered Field 32a: Service Facilitys National Provider Identification number (NPI) Service location NPI Field 33: Billing Provider Information and Phone # Complete name, address, city, state and zip code Reminder: If submitting Claims electronic, this field must hold a physical address and should not contain any of the following: "Post Office Box", "P.O. Box", "PO Box", "Lock Box", "Lock Bin", "PO Box" Field 33a: Billing Providers National Provider Identification number (NPI) Billing Provider NPI Note: To help improve payment accuracy and timeliness, please remember that when filing Claims, the Tax Identification Number (TIN) and National Provider Identifier (NPI) numbers are required. Additionally, bill Claims using the taxonomy codes as applicable.  Recommended Fields for Paper UB-04 (CMS-1450) Claims If these fields are not completed, Claims may be delayed or returned to the Provider or Facility for additional information. For Inpatient and outpatient UB-04 Claim Forms these fields must be completed: Field 1: Provider name and complete address Field 2: Providers designated billing name and remittance address Field 4: Type of Bill Field 5: Federal Tax Identification Number Field 6: Statement Covers Period (From-Through) Field 8: Patient Name Field 9: Patient Address Field 10: Birth Date (8-digit (MM|DD|YYYY) format) Field 11: Sex Field 12: Admission Date Field 13: Admission Hour Field 14: Admission Type Priority (Type) of Admission or Visit [Inpatient only] Field 15: Admission SRC Point of Origin for Admission or Visit [Inpatient only] Field 16: Discharge Hour [Inpatient only] Field 17: Patient Discharge Status [Inpatient only] Fields 31-34: Occurrence Codes and Dates Fields 39-41: Value Code(s) and Amounts If there is a Combined Deductible + Coinsurance + Copayamount on the EOMB greater than zero, there must be a corresponding Value code of A1, B1, C1, 08, 09, 11, A2, B2, C2 A7, B7 or C7 and amount on the UB04. If there is a Value Code present and not equal to 02 there must be a Value Code amount. The Value Codes to be submitted when billing Private Room Revenue codes according to the UB-04 Data Specifications Manual 2014 and CMS Manual Transmittal 1104 are: 01 (semi-private room facility) must be accompanied by the semi-private room rate when the facility offers semi-private rooms and the patients stay is in a private room 02 indicating private room only facility with $0.00 when the facility is private room only Common errors in Fields 39-41: The following is a quick overview of the most common errors we are seeing on fields 39, 40 and 41, when Medicare is primary and Anthem is secondary: Value codes are missing. Value codes A1, B1, C1 are deductibles. Value codes 09, 11, A2, B2 and C2 are coinsurance. Value codes A7, B7 and C7 are copay. Value code 06 is blood deductible. The member deductible is missing or does not match the EOMB (Explanation of Medicare Benefits). If there is a deductible amount indicated on the primary payers remittance advice, the UB04 must include the member deductible (A1, B1 or C1 value code) and amount. The coinsurance amount is missing. If there is coinsurance on the primary payers remittance advice, the UB04 must include the coinsurance amount (09, 11, A2, B2 or C2 value code). The copay amount is missing. If there is copayment on the primary payers remittance advice, the UB04 must include the copay amount (A7, B7, or C7 value code). Blood deductible is not noted. If there is blood deductible on the payers remittance advice, the value code 06 must be on the Claim, along with the amount. There are errors in listing multiple value codes. If more than one value code is submitted on lines a d, please fill in fields 39a, 40a or 41a before populating 39b, 40b, or 41b. The value code and remittance advice amounts are different. In all cases, the value code and remittance advice amounts must match. Field 42: Revenue Code(s) When submitting Revenue Code 011X or 11X and/or 014X or 14X, (X = numeric value) a value code of 01 with an amount greater than zero OR a value code of 02 with zero charges or blank must also be submitted. Field 43: Description NDC: When submitting an unlisted drug HCPCS code, please submit the National Drug Code (NDC) in the shaded area above the drug code. Submit qualifier N4 followed immediately by the 11 digit NDC code. The NDC quantity should be submitted in positions 17-24 of the same line. The Quantity should be preceded by the appropriate Qualifier. UN (units), F2 (international units), GR (gram), MG (milligram) or ML (milliliter). The total dosage administered in mgs or mls can be reported in the shaded section and should not be reported in the Units field. The Service Units Field (46) represents the number of units based on the NDC number. Field 44: HCPCS/Accommodation Rates/HIPPS Rate Codes Field 45: Service Date Field 46: Service Units Field 47: Total Charges Field 56: Providers National Provider Identification number (NPI) Field 58: Insureds Name Field 59: Patients Relationship Field 60: Insured Unique ID from Member ID card, including any prefix/suffix Field 66: Diagnosis and Procedure Code Qualifier (ICD Version Indicator) The qualifier that denotes the version of International Classification of Diseases (ICD) reported. The following qualifier codes reflect the edition portion of the ICD: 9 -Ninth Revision for dates of service prior to 10/01/2015 or 0 -Tenth Revision for dates of service 10/01/2015 and later. Field 67: Principal Diagnosis Code and Present on Admission (POA) Indicator Fields 67A-Q: Other Diagnosis Code(s) and Present on Admission (POA) Indicator(s) Field 74: Principal Procedure Code and Date  Medical Records Submission (Solicited and Unsolicited) Solicited Medical Records Submission When additional medical records are being submitted in response to Anthems request or to support an appeal, please submit them via mail or fax to the appropriate department as directed in the letter received from Anthem to ensure a fast, accurate response. Always include the Anthem letter requesting records on the top of the records. A copy of the Claim is not needed. Please do not place copy of Claim on top of the records. If Providers or Facilities are submitting X-Rays, pictures or dental molds, remember to include a valid and complete member identification number on page one of the material sent with these items. Medical Records requested (solicited) by Anthem needed for Claim processing can be submitted electronically using the Medical Attachments feature on the Availity Portal. The solicited Medical Attachments feature supports.tiff, .jpg and .pdf attachment file types. To access the solicited Medical Attachments tool, a provider organizations Availity administrator should complete the following steps: From My Account Dashboard, select Enrollments Center > Medical Attachments Setup, follow the prompts and complete the following sections: Select Application > Choose Medical Attachments Registration Provider Management > Select Organization from the drop-down. Add NPIs and/or Tax IDs. Multiples can be added separated by spaces or semi-colons. Assign user access by checking the box in front of the users name. Users may be removed by unchecking their name. To use the solicited Medical Attachments tool, Availity users should complete the following steps: Log in to  HYPERLINK "http://www.availity.com/" www.availity.com. Select Claims and Payments > Medical Attachments > Send Attachment tab. Complete all required fields on the form. Attach supporting documentation. Unsolicited Medical Records Submission Anthem will send a request when medical records are required. However, if a Provider or Facility wishes to send medical records with the Claim submission, below are helpful tips to follow. To determine what medical records or portion of the medical records may be required, refer to the applicable Anthem Medical Policy, Anthem Clinical Guideline at  HYPERLINK "http://www.anthem.com" www.anthem.com or the applicable AIM Clinical Guideline at  HYPERLINK "http://aimspecialtyhealth.com/ClinicalGuidelines.html" http://aimspecialtyhealth.com/ClinicalGuidelines.html. Review the Position Statement section in the Anthem Medical Policies, or Clinical Indications section in the applicable Anthem Clinical Guidelines or the appropriate AIM Clinical Guideline, to determine what medical records are needed. Refer the Medical Policies, Clinical Guidelines, and/or AIM Specialty Health sections of the Provider Manual for details on accessing this information. When submitting medical records that are not requested by Anthem, include a clear description of the billed code submitted with the Claim to help ensure prompt processing of the Claim for all miscellaneous, not otherwise classified (NOC), not otherwise specified (NOS), and unlisted HCPCS and CPT codes. Types of Medical Records Required Medical records needed to determine the medical necessity of a billed code include, depending on the service or procedure, some or all of the following examples: History & Physical, Office Notes, Treatment Records & Response Chemotherapy Regimens, Chemotherapy Drugs, and Records Medications List (current and prior) Radiology, Diagnostic Imaging, or Diagnostic Testing Reports Therapy/Rehabilitation Records Laboratory reports, Pathology reports Exact description of NOC/NOS code Operative/Procedure Report Inpatient Admission Summary, Daily Records, Discharge Summary Anthem May Request Additional Records Some situations may require additional medical records in addition to what was submitted with the Claim. Although these situations may not have specific rules and guidelines, Anthem will make every attempt to make these requests explicit and limited to the minimal requests necessary to render a decision. Examples include, but are not limited to, the following situations: Medical records requested by a members Blue Cross and/or Blue Shield home plan Federal Employee Plan requirements Review and investigation of Claims (e.g., pre-existing conditions [for grandfathered policies of the Affordable Care Act], lifetime benefit exclusions) Medical review and evaluation Requests for retro authorizations Medical management review (utilization review) and evaluation Underwriting review and evaluation Adjustments Appeals Quality management (quality of care concerns) Records documenting prolonged services Provider audits Pre-pay review program Fraud, waste and abuse HIPAA Privacy Rule Minimum Necessary Anthem complies with HIPAA Privacy Rules and will request the minimum necessary information needed to determine benefits and/or coverage associated with Claim processing. Providers and Facilities are also required under the Minimum Necessary rule to submit only those records requested. Electronic Data Interchange (EDI) Overview Anthem recommends using Electronic Data Interchange (EDI) for Claims submission. Electronic Claims submissions can help reduce administrative and operating costs, expedite the Claim process, and reduce errors. Providers and Facilities who use EDI can electronically submit Claims and receive acknowledgements 24 hours a day, 7 days a week. Anthem has designated Availity to operate and serve as the electronic data interchange (EDI) Gateway. As a mandatory requirement, all trading partners who currently submit directly to the Anthem EDI Gateway must transition to the Availity EDI Gateway. If Providers and Facilities wish to become a direct trading partner with Availity, the setup is easy. Use the  HYPERLINK "https://apps.availity.com/web/welcome/" \l "/edi" Availity Welcome Application to begin the process of connecting to the Availity EDI Gateway for Anthem EDI transmissions. If Providers or Facilities prefer to use their clearinghouse or billing company, they must work with them to ensure connectivity through the Availity EDI Gateway. Submitting via EDI may require additional hardware and software needed to automate other tasks in your office. No matter what method you choose to submit your transactions (direct or through a clearinghouse/billing company), Anthem does not charge a fee to submit electronically. Providers and Facilities engaging in electronic transactions should familiarize themselves with the HIPAA transaction requirements. Electronic Funds Transfer (EFT) Providers or Facilities seeking to register or manage account changes for EFT will need to use the Council for Affordable Quality Health Care(CAQH) Enrollment Tool called  HYPERLINK "https://solutions.caqh.org/" EnrollHub (at  HYPERLINK "https://solutions.caqh.org/" https://solutions.caqh.org/), a secure electronic EFT registration platform. This tool will help eliminate the need for paper registration and reduce administrative time and costs and allow you to register with multiple payers at one time. Electronic Remittance Advice (ERA) Effective June 1, 2018, Providers and Facilities must use Availity to manage all account changes and new registrations for ERA transactions. Additional Information For additional information concerning electronic Claims submission and other electronic transactions, you can visit the Electronic Data Interchange (EDI) website at  HYPERLINK "http://www.anthem.com/edi%20and" www.anthem.com/edi and select Connecticut, then enter. You may also use this link: HYPERLINK "https://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f1/s0/t0/pw_038000.htm&na=edi_ct&rootLevel=0&label=EDI"EDI Connecticut. Overpayments Anthem s Cost Containment Overpayment Avoidance Division reviews Claims for accuracy and requests refunds if Claims are overpaid or paid in error. Some common reasons for overpayment are: Paid wrong provider / Member % Coordination of Benefits Allowance overpayments % Late credits Billed in error % Duplicate Non-covered services % Claims editing Terminated Members % Total charge overpaid Paid wrong Member/ provider number Anthem s Cost Containment Overpayment Avoidance Division also requests refunds for overpayments identified by other Divisions of Anthem, such as Provider Audit or the Special Investigations Unit. Anthem Identified Overpayment (aka Solicited) When refunding Anthem on a Claim overpayment that Anthem has requested, please use the payment coupon included on the request letter and the following information with your check: The payment coupon Member ID number Members name Claim number Date of service Reason for the refund as indicated in our refund request letter As indicated in the Anthem refund request letter and in accordance with provider contractual language, provider overpayment refunds not received and applied within the timeframe indicated will result in Claim recoupment from any Claim Provider or Facility submits to Anthem. Providers and Facilities may direct disputes of amounts indicated on an Anthem refund request letter to the address indicated on the letter. Provider and Facility Identified Overpayments (aka voluntary or unsolicited) If Anthem is due a refund as a result of an overpayment discovered by a Provider or Facility, refunds can be made in one of the following ways: Submit a refund check with supporting documentation outlined below, or Submit the Overpayment Adjustment Request Form with supporting documentation to have claim adjustment/recoupment done off a future remittance advice When voluntarily refunding Anthem on a Claim overpayment, please include the following information: Overpayment Adjustment Request Form (see directions below for how to access online)) All documents supporting the overpayment including EOBs from Anthem and other carriers as appropriate Member ID number Members name Claim number Date of service Reason for the refund as indicated in the list above of common overpayment reasons Please be sure the copy of the provider remittance advice is legible and the Member information that relates to the refund is circled. By providing this critical information, Anthem will be able to expedite the process, resulting in improved service and timeliness to Providers and Facilities. Important Note: If a Provider or Facility is refunding Anthem due to coordination of benefits and the Provider or Facility believes Anthem is the secondary payer, please refund the full amount paid. Upon receipt and insurance primacy verification, the Claim will be reprocessed and paid appropriately. How to access the Overpayment Adjustment Request Form online: To download the Provider Overpayment Adjustment Request Form directly from anthem.com, Select Providers from the anthem.com home page, then select Providers Overview. Choose CT as the applicable state, scroll down to Find Resources for Connecticut and press enter. On the provider home page, select Answers@Anthem on the menu bar. On the Answers@Anthem page, select Forms and Overpayment Adjustment Request Form. Please utilize the proper address noted in the grid below to return payment: Line of Business (Blue Branded)Type of RefundMake Check Payable To:Regular Mailing Address: Overnight Delivery Address:  All Voluntary Anthem Blue Cross and Blue Shield Central Region CCOA Lockbox PO Box 73651 Cleveland, OH 44193-1177 Anthem Central Lockbox 73651 4100 West 150th Street Cleveland, Ohio 44135 All Solicited Refund with Coupon Letter Anthem Blue Cross and Blue Shield Anthem Blue Cross and Blue Shield PO Box 5281 Carol Stream, IL 60197 N/A Medicare Crossover Duplicate Claims Handling for Medicare Crossover Since January 1, 2006, all Blue Plans have been required to process Medicare crossover Claims for services covered under Medigap and Medicare Supplemental products through Centers for Medicare & Medicaid Services (CMS). This has resulted in automatic submission of Medicare Claims to the Blue secondary payer to eliminate the need for Provider or Facilities or his/her/its billing service to submit an additional Claim to the secondary carrier.Additionally, this has also allowed Medicare crossover Claims to be processed in the same manner nationwide. Effective October 13, 2013 when a Medicare Claim has crossed over, Providers and Facilities are to wait 30 calendar days from the Medicare remittance date before submitting the Claim to the local Plan if the charges have still not been considered by the Members Blue Plan. To avoid the submissions of duplicate Claims, use the 276/277 Health care Claims status inquiries to verify Claim and adjudication status prior to re-submission of electronic Claims. If Provider or Facility provides Members Blue Plan ID numbers (including three-character prefix) when submitting Claims to the Medicare intermediary, they will be crossed over to the Blue Plan only after they have been processed by the Medicare intermediary. This process will take a minimum of 14 days to occur. This means that the Medicare intermediary will be releasing the Claim to the Blue Plan for processing about the same time Provider or Facility receives the Medicare remittance advice. As a result, upon receipt of the remittance advice from Medicare, it may take up to 30 additional calendar days for Provider or Facility to receive payment or instructions from the Blue Plan. Providers and Facilities should continue to submit services that are covered by Medicare directly to Medicare.Even if Medicare may exhaust or has exhausted, continue to submit Claims to Medicare to allow for the crossover process to occur and for the Members benefit policy to be applied. Medicare primary Claims, including those with Medicare exhaust services, that have crossed over and are received within 30 calendar days of the Medicare remittance date or with no Medicare remittance date, will be rejected by the local Plan. Effective October 13, 2013, we will reject Medicare primary provider submitted Claims with the following conditions: Medicare remittance advice remark codes MA18 or N89 that Medicare crossover has occurred MA18 Alert: The Claim information is also being forwarded to the patient's supplemental insurer. Send any questions regarding supplemental benefits to them. N89Alert: Payment information for this Claim has been forwarded to more than one other payer, but format limitations permit only one of the secondary payers to be identified in this remittance advice. Received by Provider or Facilitys local Plan within 30 calendar days of Medicare remittance date Received by Provider or Facilitys local Plan with no Medicare remittance date Received with GY modifier on some lines but not all A GY modifier is used by Providers and outpatient Facilities when billing to indicate that an item or service is statutorily excluded and is not covered by Medicare. Examples of statutorily excluded services include hearing aids and home infusion therapy. When these types of Claims are rejected, Anthem will also remind the Provider or Facility to allow 30 days for the crossover process to occur or instruct the Provider or Facility to submit the Claim with only GY modifier service lines indicating the Claim only contains statutorily excluded services. Medicare statutorily excluded services just file once to your local Plan There are certain types of services that Medicare never or seldom covers, but a secondary payer such as Anthem may cover all or a portion of those services. These are statutorily excluded services. For services that Medicare does not allow, such as home infusion, Providers and outpatient Facilities need only file statutorily excluded services directly to their local Plan using the GY modifier and will no longer have to submit to Medicare for consideration. These services must be billed with only statutorily excluded services on the Claim and will not be accepted with some lines containing the GY modifier and some lines without. For Claims submitted directly to Medicare with a crossover arrangement where Medicare makes no allowance, Providers and Facilities can expect the Members benefit plan to reject the Claim advising the Provider or Facility to submit to their local Plan when the services rendered are considered eligible for benefit. These Claims should be resubmitted as a fresh Claim to a Provider or Facilitys local Plan with the Explanation of Medicare Benefits (EOMB) to take advantage of Provider or Facility contracts. Since the services are not statutorily excluded as defined by CMS, no GY modifier is required. However, the submission of the Medicare EOMB is required. This will help ensure the Claims process consistent with the Providers or Facilitys contractual agreement. Effective October 13, 2013: Providers or outpatient Facilities who render statutorily excluded services should indicate these services by using GY modifier at the service line level of the Claim. Providers or Facilities will be required to submit only statutorily excluded service lines on a Claim (cannot combine with other services like Medicare exhaust services or other Medicare covered services) The Provider or outpatient Facilitys local Plan will not require Medicare EOMB for statutorily excluded services submitted with a GY Modifier. If Providers or outpatient Facilities submit combined line Claims (some lines with GY, some without) to their local Plan, the Provider or outpatient Facilitys s local Plan will deny the Claims, instructing the Provider or outpatient Facility to split the Claim and resubmit. Original Medicare The GY modifier should be used when service is being rendered to a Medicare primary Member for statutorily excluded service and the Member has Blue secondary coverage, such as an Anthem Medicare Supplement plan. The value in the SBR01 field should not be P to denote primary. Medicare Advantage Please ensure SBR01 denotes P for primary payer within the 837 electronic Claim file. This helps ensure accurate processing on Claims submitted with a GY modifier. The GY modifier should not be used when submitting: Federal Employee Program Claims Inpatient institutional Claims. Please use the appropriate condition code to denote statutorily excluded services. These processes align Blue Cross and/or Blue Shield plans with industry standards and will result in less administrative work, accurate payments and fewer rejected Claims. Because the Claim will process with a consistent application of pricing, our Members will also see a decrease in health care costs as the new crossover process eliminates or reduces balance billing to the Member. Medicare Crossover Claims FAQs How do I handle traditional Medicare-related Claims? When Medicare is primary payer, submit Claims to your local Medicare intermediary. All Blue Claims are set up to automatically cross over (or forward) to the Members Blue Plan after being adjudicated by the Medicare intermediary. How do I submit Medicare primary / Blue Plan secondary Claims? For Members with Medicare primary coverage and Blue Plan secondary coverage, submit Claims to your Medicare intermediary and/or Medicare carrier. When submitting the Claim, it is essential that you enter the correct Blue Plan name as the secondary carrier. This may be different from the local Blue Plan. Check the Members ID card for additional verification. Be certain to include the three-character prefix as part of the Member identification number. The Members ID will include the three-character prefix in the first three positions. The three-character prefix is critical for confirming membership and coverage, and key to facilitating prompt payments. When you receive the remittance advice from the Medicare intermediary, look to see if the Claim has been automatically forwarded (crossed over) to the Blue Plan: If the remittance advice indicates that the Claim was crossed over, Medicare has forwarded the Claim on your behalf to the appropriate Blue Plan and the Claim is in process. DO NOT resubmit that Claim to Anthem; duplicate Claims will result in processing and payment delays. If the remittance advice indicates that the Claim was not crossed over, submit the Claim to your local Anthem Plan with the Medicare remittance advice. In some cases, the Member identification card may contain a COBA ID number. If so, be certain to include that number on your Claim. For Claim status inquiries, please contact your local Anthem Plan. Who do I contact with Claims questions? Your local Anthem Plan. How do I handle calls from Members and others with Claims questions? If Members contact you, tell them to contact their Blue Plan. Refer them to the front or back of their ID card for a customer service number. A Members Blue Plan should not contact you directly, unless you filed a paper Claim directly with that Blue Plan. If the Members Blue Plan contacts you to send another copy of the Members Claim, refer the Blue Plan to your local Anthem Plan. Where can I find more information? For more information: Visit Anthems Web site at HYPERLINK "C:\\Users\\AD43469\\AppData\\Local\\Microsoft\\Windows\\Temporary Internet Files\\Content.Outlook\\02UATIHE\\www.anthem.com"www.anthem.com, or contact your local Anthem plan.  Administrative, Reimbursement and Billing Policies Anthem is committed to sharing reimbursement policies with our Provider network. The core reimbursement policies for professional Providers may be found by selecting Answers@Anthem on the provider home page of anthem.com, and then selecting Reimbursement Policies Professional.  HYPERLINK "https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_g328372.htm&state=ct&rootLevel=3&label=Reimbursement%20Policies%20%20Professional" Reimbursement Policies - Professional The administrative, billing and reimbursement facility policies are also updated periodically, and are located directly on the provider home page of anthem.com.  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_b142511.htm&label=Administrative,%20Billing%20and%20Reimbursement%20Policies&state=ct&rootLevel=0" Administrative, Billing and Reimbursement Policies When significant changes are made to reimbursement policies, a notification will be published in Network Update, our monthly newsletter, and/or posted to anthem.com, alerting you to the updates and directing you to access administrative, billing and reimbursement policies link so that you may review the changes. In addition, please review the following reimbursement and billing policies for facility/emergency room: Emergency Room Services with Next Day Admission Emergency Room services resulting in next day inpatient admissions require the Facilities to bill separate Claims for Emergency Room and Inpatient charges. Emergency Room Same Day Visits Occasionally, a Covered Individual may require two (2) visits to the emergency room on the same day at the same Facility. Even though both Claims would have different patient control numbers, one Claim will automatically deny as duplicate to the other Claim. To help us identify Claims that are not duplicates, please include the admit hour (form locator 13) and the discharge hour (form locator 16). Preventable Adverse Events Acute Care General Hospitals (Inpatient) Three (3) Major Surgical Never Events When any of the Preventable Adverse Events (PAEs) set forth in the grid below occur with respect to a Member, the acute care general hospital shall neither bill, nor seek to collect from, nor accept any payment from the Plan or the Member for such events. If acute care general hospital receives any payment from the Plan or the Member for such events, it shall refund such payment within ten (10) business days of becoming aware of such receipt. Further, acute care general hospital shall cooperate with Anthem in any Anthem initiative designed to help analyze or reduce such PAEs. Whenever any of the events described in the grid below occur with respect to a Member, acute care general hospital is encouraged to report the PAE to the appropriate state agency, The Joint Commission (TJC), or a patient safety organization (PSO) certified and listed by the Agency for Healthcare Research and Quality. Preventable Adverse EventDefinition / DetailsSurgery Performed on the Wrong Body PartAny surgery performed on a body part that is not consistent with the documented informed consent for that patient. Excludes emergent situations that occur in the course of surgery and/or whose exigency precludes obtaining informed consent. Surgery includes endoscopies and other invasive procedures.Surgery Performed on the Wrong PatientAny surgery on a patient that is not consistent with the documented informed consent for that patient. Surgery includes endoscopies and other invasive procedures.Wrong surgical procedure performed on a patientAny procedure performed on a patient that is not consistent with the documented informed consent for that patient. Excludes emergent situations that occur in the course of surgery and/or whose exigency precludes obtaining informed consent. Surgery includes endoscopies and other invasive procedures. CMS Hospital Acquired Conditions (HAC) Anthem follows CMS current and future recognition of HACs. Current and valid Present on Admission (POA) indicators (as defined by CMS) must be populated on all inpatient acute care Facility Claims. When a HAC does occur, all inpatient acute care Facilities shall identify the charges and/or days which are the direct result of the HAC. Such charges and/or days shall be removed from the Claim prior to submitting to the Plan for payment. In no event shall the charges or days associated with the HAC be billed to either the Plan or the Member. Providers and Facilities (excluding Inpatient Acute Care General Hospitals) Four (4) Major Surgical Never Events When any of the Preventable Adverse Events (PAEs) set forth in the grid below occur with respect to a Member, the Provider or Facility shall neither bill, nor seek to collect from, nor accept any payment from the Plan or the Member for such events. If Provider or Facility receives any payment from the Plan or the Member for such events, it shall refund such payment within ten (10) business days of becoming aware of such receipt. Further, Providers and Facilities shall cooperate with Anthem in any Anthem initiative designed to help analyze or reduce such PAEs. Whenever any of the events described in the grid below occur with respect to a Member, Providers and Facilities are encouraged to report the PAE to the appropriate state agency, The Joint Commission (TJC), or a patient safety organization (PSO) certified and listed by the Agency for Healthcare Research and Quality. Preventable Adverse EventDefinition / DetailsSurgery Performed on the Wrong Body PartAny surgery performed on a body part that is not consistent with the documented informed consent for that patient. Excludes emergent situations that occur in the course of surgery and/or whose exigency precludes obtaining informed consent. Surgery includes endoscopies and other invasive procedures.Surgery Performed on the Wrong PatientAny surgery on a patient that is not consistent with the documented informed consent for that patient. Surgery includes endoscopies and other invasive procedures.Wrong surgical procedure performed on a patientAny procedure performed on a patient that is not consistent with the documented informed consent for that patient. Excludes emergent situations that occur in the course of surgery and/or whose exigency precludes obtaining informed consent. Surgery includes endoscopies and other invasive procedures.Retention of a foreign object in a patient after surgery or other procedureExcludes objects intentionally implanted as part of a planned intervention and objects present prior to surgery that were intentionally retained. Medical Care Provided to or by Family Member Services for any type of medical care rendered by a Provider to him/herself or to an immediate family member (as defined below), who is a Member, are not eligible for coverage and should not be billed to Anthem. In addition, a Provider may not be selected as a Primary Care Physician (PCP) by his/her immediate family member. Unless otherwise set forth in a Members Health Benefit Plan, an immediate family member includes: father, mother, children, spouse, domestic partner, legal guardian, grandparent, grandchild, sibling, step-father, step-mother, step-children, step-grandparent, step-grandchild, and/or step-sibling.  Medical Policies and Clinical Utilization Management (UM) Guidelines The Office of Medical Policy & Technology Assessment (OMPTA) develops medical policy and clinical UM guidelines (collectively, Medical Policy) for Anthem. The principal component of the process is the review for development of Medical Necessity and/or investigational policy position statements or clinical indications that are objective and based on clinical evidence for certain new medical services and/or procedures or for new uses of existing services and/or procedures. The services consisting of medical, surgical, and behavioral health treatments include, but are not limited to devices, biologics and specialty pharmaceuticals, and professional health services. The Medical Policy & Technology Assessment Committee (MPTAC) is a multiple disciplinary group including physicians from various medical and behavioral health specialties, clinical practice environments and geographic areas. Voting membership may include external physicians in clinical practices and participating in networks, external physicians in academic practices and participating in networks, internal medical directors and Chairs of MPTAC Subcommittees. Non-voting members may include internal legal counsel and internal medical directors. Additional details regarding the Medical Policy development process, including information about MPTAC and its Subcommittees, is provided in HYPERLINK "CT%202019%20Provider%20Manual-Final.doc"http://www.anthem.com/medicalpolicies/policies/mp_pw_a044135.htm. Medical Policy and Clinical Utilization Management (UM) Guidelines Distinction  Medical Policy and clinical UM guidelines differ in the type of determination being made. Both set forth position statements or clinical indications regarding the medical necessity of individual services and/or procedures. In general, Medical Policy may be developed to address experimental or investigational technologies (including a novel application of an existing technology) and services where there is a significant concern regarding Member safety. clinical UM guidelines address Medical Necessity criteria for technologies or services where sufficient clinical evidence exists to evaluate the clinical appropriateness of the request, goal length of stay (GLOS), place of service and level of care. In addition, Medical Policies are implemented by all Anthem Plans while clinical UM guidelines are adopted and implemented at the local Anthem Plan or line of business discretion. Medical Policies and Clinical UM Guidelines are posted online at anthem.com All Anthem Medical Policy is publicly available on our website, which provides transparency for Providers and Facilities, Members and the public in general. Some vendor guidelines used to make coverage determinations are proprietary and are not publicly available on the Anthem website, but are available upon request. To locate Medical Policy online, go to anthem.com. Select Providers, and then under the Provider Resources heading select the Policies and Guidelines link. Select Connecticut as your state. Choose View Medical Policies and UM Guidelines, then select one of the following links:  HYPERLINK "https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003150.htm&label=Medical%20Policies%20and%20Clinical%20UM%20Guidelines&cnslocale=en_US_ct&state=ct" Medical Policies and Clinical UM Guidelines for Local Plan Members  HYPERLINK "https://www11.anthem.com/vaprovider/router/" Medical Policy and Clinical UM Guidelines (for BlueCard/Out-of-area members) Clinical UM Guidelines for Local Plan members The clinical UM guidelines published on our website represent the clinical UM guidelines currently available to all Plans for adoption throughout our organization. Because local practice patterns, claims systems and benefit designs vary, a local Plan or line of business may choose whether to implement a particular clinical UM guideline. The link below can be used to confirm whether the local Plan or line of business has adopted the clinical UM guideline(s) in question. Adoption lists are created and maintained solely by each local Plan or line of business. To view the list of specific clinical UM guidelines adopted by Connecticut, navigate to the Disclaimer page by following the instructions above for Medical Policy and Clinical UM Guidelines (for Local Plan members); scroll to the bottom of the page. Above the Continue button, select the link titled Specific Clinical UM Guidelines adopted by Anthem Blue Cross and Blue Shield of Connecticut.  Utilization Management Utilization Management Program Providers and Facilities agree to abide by the following Utilization Management (UM) Program requirements in accordance with the terms of the Agreement and the Members Health Benefit Plan. Providers and Facilities agree to cooperate with Anthem in the development and implementation of action plans arising under these programs. Provider or Facility shall comply with all requests for medical information required to complete Anthems UM review. Providers and Facilities agree to adhere to the following provisions and provide the information as outlined within this section. . UM Definitions Adverse Determination: means a denial, reduction or failure to make payment (in whole or in part) for a benefit based on a determination that a benefit is experimental, investigational, or not medically necessary or appropriate as defined in the applicable health benefit plan. This may apply to prospective, continued stay, and retrospective reviews. Business Day: Monday through Friday, excluding designated company holidays. Continued Stay Review: (continuation of services). Continued Stay Review means utilization review that is conducted during a Members ongoing stay in a facility or course of treatment. Continued Stay Review includes continuation of services (Urgent Care & Extensions). Notification: The telephonic and/or written/electronic communication to the applicable Providers, Facility and the Member documenting the determination, and informing the Member, Providers, and Facility of their rights if they disagree with the determination. Pre-certification/Pre-authorization Requirement: List of procedures that require Pre-service Review by Anthem UM prior to service delivery. For Anthem UM team to perform Pre-service Review, the provider submits the pertinent information as soon as possible to Anthem UM prior to service delivery. Pre-Service (Prospective) Review: Review for Medical Necessity that is conducted on a health care service or supply prior to its delivery to the Member. Post Service (Retrospective) review: means a utilization review that is conducted after the health care service (or supply) has been provided to the Member. Urgent Care Review:means review of health care services which in the opinion of the treatingProvideror anyhealth care providerwith knowledge of theMembersmedical condition or based on aprudent laypersonsjudgment which, in the absence ofurgent care reviewtime frames could: Seriously jeopardize the life or health of theMemberor the ability of theMemberto regain maximum function or; Would subject theMemberto severe pain that cannot be adequately managed without the health care service or treatment that is the subject of the request. Program Overview Utilization Management (UM) may be required for Pre-certification/Pre-authorization, Pre-service (Prospective) Review, Continued Stay Review, or Post-service (Retrospective) Review. The determination that services are medically necessary is based on the information provided, and is not a guarantee that benefits will be paid. Payments are based on the Members coverage at the time of service. These terms typically include certain exclusions, limitations and other conditions. Benefit payment could be limited, for example, when: The information submitted with the claim, or on the medical record, differs from that given by telephone, fax or electronic communication. The service is excluded from coverage. The Member is not eligible for coverage when the service is provided. The review may consider such factors as the Medical Necessity of services provided, and whether the service involves cosmetic or experimental/investigative procedures. UM may be conducted via multiple communication paths. Inpatient medical admissions require UM review. UM for inpatient medical services may include but is not limited to: acute hospitalizations, units described as sub-acute, step-down and skilled nursing facility; designated skilled nursing beds/units; comprehensive outpatient rehabilitation facilities; rehabilitation units; inpatient hospice; and sub-acute rehabilitation facilities or transitional living centers. These services are subject to admission review for determination of Medical Necessity and appropriateness, site of service and level of care. Non-inpatient medical services may require Pre-Service Review. The list of Pre-certification/Pre-authorization Requirements can be accessed online at anthem.com. UM for behavioral health inpatient and non-inpatient services, including but not limited to Residential, Partial Hospitalization and intensive outpatient services, require Pre-Service Review or Continued Stay Review. Pre-service Review & Continued Stay Review Provider or Facility shall ensure both requirements (1) and (2) are met: (1) that non-emergency admissions and outpatient procedures that require Pre-certification/Pre-authorization as specified by Anthem are submitted for review and have a decision rendered before the service occurs. Information provided to Anthem UM shall include demographic and clinical information including, but not limited to, primary diagnosis. For information on applicable penalties for non-compliance see Failure to Comply with Utilization Management Program section. (2) For non-emergency admissions, Provider or Facility shall also provide confirmation to Anthem UM of the necessary demographic information and primary diagnosis within twenty-four (24) hours or next Business Day following the Members admission. If an Emergency admission has occurred, Provider or Facility shall notify Anthem UM within forty-eight (48) hours or the first Business Day following admission. If the forty-eight (48) hours expires on a day that is not a Business Day the timeframe will be extended to include the next Business Day. Information provided to Anthem UM shall include demographic and clinical information including, but not limited to, primary diagnosis. For information on applicable penalties for non-compliance see Failure to Comply with Utilization Management Program section. Provider or Facility shall verify that the Members primary care physician has provided a referral as required by certain Health Benefit Plans. Provider or Facility shall comply with all requests for medical information required to complete Anthems UM review up to and including discharge planning coordination. To facilitate the review process, Provider or Facility shall make best efforts to supply requested information within twenty-four (24) hours of request. Anthem specific Pre-certification/Pre-authorization Requirements may be confirmed on the Anthem web site or by contacting customer service. When the review is completed, the physician, hospital, facility, or other health care professional(s) and the Member receive notification of the UM determination. UM Review Timeframes follow State, Federal and accreditation requirements as may be applicable to the review. Medical Policies and Clinical UM Guidelines Please refer to the Medical Policies and Clinical Utilization Management (UM) Guidelines section of this manual for additional information about Medical Policy and Clinical UM Guidelines. On-Site Review If Anthem maintains an on-site Initial Request/Continued Stay Review program, the Facilitys UM program staff is responsible for following the Members stay and documenting the prescribed plan of treatment, promoting the efficient use of services and resources, and facilitating available alternative outpatient treatment options. Facility agrees to cooperate with Anthem and provide Anthem with access to Members medical records, as well as, access to the Members in performing on-site Initial Request/Continued Stay Review and discharge planning related to, but not limited to, the following: ( Emergency and/or maternity admissions ( Ambulatory surgery ( Case management ( Pre-admission testing (PAT) ( Inpatient Services, including Neonatal Intensive Care Unit (NICU) ( Focused procedure review Certain services may be excluded from on-site review including but not limited to Transplant. Discharge Planning Discharge planning includes the coordination of medical services and supplies, medical personnel and family to facilitate the Members timely discharge to a more appropriate level of care following an inpatient admission. Observation Bed Policy Please refer to the Reimbursement Guidelines section of the Manual. Retrospective Utilization Management Medical records and pertinent information regarding the Member's care may be reviewed to make a claim determination. Failure to Comply With Utilization Management Program Provider and Facility acknowledge that Anthem may apply monetary penalties, such as a reduction in payment, as a result of Provider's or Facilitys failure to provide notice of admission or obtain Pre-service Review on specified outpatient procedures, as required under this Agreement or for Provider's or Facilitys failure to fully comply with and participate in any cost management programs and/or UM programs. Members may not be balance billed for penalty amounts. Penalties include but are not limited to the following: If non-emergency outpatient procedures that require Pre-certification/Pre-authorization as specified by Anthem are not submitted for review and a decision rendered before the service occurs, payment may be subject to a 50% penalty (for outpatient services managed by Anthem) or a 100% penalty/Claim denial (for high-cost radiology, sleep therapy and cardiology cases managed by AIM). Providers and Facilities must present evidence of extenuating circumstances in the event that a provider or facility elects to dispute these reimbursement penalties. If non-emergency admissions that require Pre-certification/Pre-authorization as specified by Anthem are not submitted for review and a decision rendered before the service occurs, payment may be subject to a 50% penalty. Providers and Facilities must present evidence of extenuating circumstances in the event that a provider or facility elects to dispute these reimbursement penalties. Payment for emergency inpatient admissions may be subject to a 50% penalty if the notification is not provided within 48 hours of admission. If the 48 hours expires on a day that is not a Business Day, the time frame will be extended to include the next Business Day. Providers and Facilities must present evidence of extenuating circumstances in the event that a provider or facility elects to dispute these reimbursement penalties. Utilization Statistics Information On occasion, Anthem may request utilization statistics for disease management purposes using Coded Services Identifiers. These may include, but are not limited to: Member name Member identification number Date of service or date specimen collected Physician name and/or identification number Value of test requested or any other pertinent information Anthem deems necessary This information will be provided by Provider or Facility to Anthem at no charge to Anthem. Electronic Data Exchange Facility will support Anthem by providing electronic data exchange including, but not limited to, ADT (Admissions, Discharge and Transfer), daily census, confirmed discharge date and other relevant clinical data. Interactive Care Reviewer (ICR) Anthems Interactive Care Reviewer (ICR) is an online tool and the preferred method for the submission of pre-authorization requests offering a streamlined and efficient experience for providers requesting inpatient and outpatient medical or behavioral health services for Members covered by Anthem plans. Additionally, providers can use this tool to make inquiries on previously submitted requests regardless of how they were sent (phone, fax, ICR or other online tool). Initiate pre-authorization requests online, eliminates the need to fax. Allows detailed text, photo images and attachments to be submitted along with your request. Make inquiries on previously submitted requests via phone, fax, ICR or other online tool. Instant accessibility from almost anywhere including after business hours. Update clinical information when the case is still active. Update the case with extension of services or discharge information. View, download or print all provider letters associated to the case. Utilize the dashboard to provide a complete view of all ICR submitted UM and behavioral health requests with real time status updates. Email notifications if requested using a valid email address to notify activity on the case. Real time decisions for some common procedures. Access ICR under Authorizations and Referrals via the Availity Portal. Request clinical Appeals. Check appeals status. Please visit our ICR Help Page on anthem.com to access on demand training demos and to sign up for monthly live training webinars. For an optimal experience with Anthems Interactive Care Reviewer (ICR) online tool, use a browser that supports 128-bit encryption. This includes Internet Explorer, Chrome, Firefox or Safari. Anthems Interactive Care Reviewer (ICR) online tool is not currently available for the following: FEP Members Non Anthem BlueCard Some National Account Members Transplant services Services administered by venders such as AIM Specialty Health (For these requests, follow the same precertification process that you use today). Peer to Peer Review Process Upon the providers request, from an attending physician or treating provider, Anthem provides a clinical peer-to-peer conversation when an adverse medical necessity determination will be made or has been made regarding health care services for Members. The attending physician or treating provider may offer additional information and/or further discuss his/her cases with a physician or other appropriate reviewer. In compliance with accreditation standards, a provider or his/her designee may request the peer-to-peer review. Others such as hospital representatives, employers and vendors are not permitted to do so. In compliance with accreditation standards, a provider or his/her designee may request the peer-to-peer review. Others such as hospital representatives, employers and vendors are not permitted to do so. Quality of Care Incident Providers and Facilities will notify Anthem in the event there is a quality of care incident that involves a Member. Audits/Records Requests At any time Anthem may request on-site, electronic or hard copy medical records, utilization review sheets and/or itemized bills related to Claims for the purposes of conducting audits and reviews to determine Medical Necessity, diagnosis and other coding and documentation of services rendered. Case Management Case Management assists Members to optimize the use of their benefits and available community resources to gain access to quality health care in all settings. The Case Management programs help coordinate services for Members with health care needs due to serious, complex, and/or chronic health conditions. The programs coordinate benefits and educate Members who agree to take part in the Case Management program to help meet their health-related needs. Case Management programs are confidential and voluntary and are made available at no extra cost. These programs are provided by, or on behalf of and at the request of, health plan case management staff. These Case Management programs are separate from any Covered Services. If the Member meets program criteria and agrees to take part, we will help the Member meet identified health care needs. This is reached through contact and team work with the Member and/or the Members chosen authorized representative, treating Physician(s), and other providers. In addition, assistance may be provided in coordinating care with existing community-based programs and services. This may include giving information about external agencies and community-based programs and services. MCG (formerly known as Milliman Care Guidelines) The company licenses and utilizes MCG (formerly known as Milliman Care Guidelines) and may also license and/or utilize the guidelines of other entities. Prior Authorization Guidelines To view Anthem Blue Cross and Blue Shield of Connecticut Precertification Guidelines, go to anthem.com, click on Providers, enter Connecticut, and on the Provider Home Page click on Precertification (Prior Authorization) Guidelines, or use this direct link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_ad078024.htm&label=Precertification%20(Prior%20Authorization)%20Guidelines&state=ct&rootLevel=0" Precertification (Prior Authorization) Guidelines From this page you will have the option to select guidelines for products issued and delivered by Anthem in Connecticut, as well as for members of National Accounts and other products. To verify member eligibility, benefits and account information please call the telephone number listed on the back of the members identification card Responsibility for Prior Authorization For HMO type health plans: Under our HMO plans and products: It is the participating physicians or providers responsibility to contact Anthems Utilization Management Department at (800) 238-2227, or such other number indicated below for specific services, to obtain prior authorization. The request must come from the provider or facility rendering the service, not the referring physician, except where described below for specific services. If prior authorization is not obtained, the claim payment may be reduced or denied by the Plan and the member must be held harmless. For PPO type health plans: Under our PPO plans and products: Services provided by a network provider: The provider is responsible for prior authorization. Services provided by a BlueCard or non-participating provider: The member is responsible for prior authorization. The member is financially responsible for services and/or settings that are not covered under the certificate based on an adverse determinationof medical necessity or experimental or investigational services. Balance Billing for Services Considered Not Medically Necessary Please be aware that if you render services that are not Medically Necessary or are considered experimental/investigational to an AnthemMember, you may only bill the Member for such services if you obtain a signed/written, dated, waiver from the Member prior to the services being performed. The waiver should specify the following: the specific Health Services and date they are to be performed, confirmation that the services are likely to be deemed not Medically Necessary or experimental/investigational, the approximate cost of the Health Service, and the date of the Members signature. Emergency Admissions Authorization Certification is required within forty-eight (48) hours or two (2) business days when a Member of our HMO plans or PPO programs with Managed Benefits is admitted on an emergent basis. See below for plan specific guidelines. BlueCare Health Plan and New England Health Plans In an emergency situation, Members are directed to go immediately to the nearest emergency room and, if possible, to contact their PCP before going. Emergency admissions must be reported to the UM Department within forty-eight (48) hours or two (2) business days. Members are generally responsible for an emergency room co-payment for each visit that does not result in the patient being admitted as an inpatient directly from the emergency room. Emergency Treatment from a Non-Participating Provider If a Member requires Emergency Services from a non-participating provider, no prior authorization from Anthem or the PCP is required. The Member must contact their PCP to arrange any Medically Necessary follow up care as soon as he she is able. If the Member is admitted: The Member or admitting physician must report all inpatient admissions to the UM Department within forty-eight (48) hours or two (2) business days of admission. Century Preferred, Century Preferred Comp and State Preferred Hospital admissions resulting from covered Emergency Services are subject to the Managed Benefits guidelines. Coverage is provided for the initial emergency room visit for emergency medical care, emergency accident care, serious and sudden illness care and accidental ingestion or consumption of a controlled drug, if the services commence within seventy-two (72) hours of the accident or injury. Compensation will only be provided for Covered Services for Medically Necessary care. Century Preferred: there is a co-payment for the use of the emergency room. The co-payment is waived if the Members visit to the emergency room results in immediate admission to the hospital. State Preferred: There is a copayment of $35 for the use of the emergency room for State Preferred insured active employees and retirees whose retirement became effective October 1, 2011 or later. For retirees with retirement dates prior to October 1, 2011, there is no copayment. Urgent Care BlueCare Health Plan, State BlueCare, Century Preferred (including Century Preferred comp) State Preferred, BlueCard POS, FEP Standard Option and Basic Option Members have access to a comprehensive, hospital-based urgent care Network for urgent care twenty-four (24) hours a day, seven (7) days a week, when the Members physician may not be available. Urgent care Facilities provide: Triage service- Medical professionals determine if the Member requires Emergency Services or urgent care. Access to the emergency room is available when Medically Necessary. Extended hours of service- available to Members at any time. Shorter wait times- 90% of Members must be treated within sixty (60) minutes. Access to hospital facilities- available to hospital equipment, technologies, and other onsite ancillary services including x-ray, laboratory and pharmacy. Quality Monitoring- via provider auditing and satisfaction surveys. Urgent care criteria: No referral is required for urgent care. However, Members are encouraged to contact their PCP in an urgent situation. Members may self-refer to a participating urgent care facility at any time. The urgent care facility must be participating to be eligible for in Network coverage. If the Member is admitted to the hospital as a result of the visit to an urgent care facility, the UM department must be notified within forty-eight (48) hours or two (2) business days of the admission at 1-800-238-2227 Members are responsible for applicable urgent care visit co-payments. Members are also responsible for a co-payment for each covered emergency room visit that does not result in an inpatient admission. Services rendered must meet urgent care criteria in order to be eligible for coverage. Urgent care refers to services that can be provided for an injury or illness that isnt an emergency, but does not require immediate attention. Routine primary care (physical exams), preventative care (routine immunizations), and occupational health care (PT exams for employment) will be ineligible for coverage as urgent care. Urgent care facilities may not be used as a back-up for the PCP. PCPs who act as care coordinators may not sign out to a walk in center for covering purposes. Behavioral Health/Substance Abuse Services Anthems behavioral health and substance abuse benefits in Connecticut are administered by professionals who are specially trained to handle referrals and coordinate care. Call (800) 934-0331 for Inpatient behavioral health and substance abuse admissions. Prior authorization is also required for the following outpatient and residential services: Residential Care Partial hospital program (PHP) Intensive outpatient programs (IOP) Transcranial Magnetic Stimulatin (TMS) Behavioral Health In-Home programs ABA Applied Behavioral Analysis is not a standard benefit. If ABA is covered for a client, prior authorization is recommended. If prior authorization is selected, the Autism Spectrum Disorder (ASD) program must be purchased. Prior authorization for psychological testing and outpatient services varies by products and plan; please contact the customer service number for requirements or when verifying eligibility. Professionals are available 24 hours a day, seven days a week. For benefits to be paid, the member must be eligible on the date of service and the service must be a covered benefit under the policy. Mental Health Parity Legislation State of Connecticut and Federal legislation mandating parity for mental health services affects the benefits for Members of many groups covered under Century Preferred and Century Preferred Comp. Under state law, policies are required to provide coverage of the diagnosis and treatment of mental or nervous conditions (including treatment for substance abuse) on the same basis as other Health Services covered under the Health Benefit Plan. The Plan cannot place a greater financial burden on a Member for access to this type of service than for the diagnosis or treatment of medical, surgical or other physical health conditions. Excluded from this requirement is treatment related to: Mental retardation Learning disorders Motor skills disorders Communication disorders Caffeine-related disorders Relational problems Also excluded are additional conditions that may be a focus of clinical attention, but are not otherwise defined as mental disorders in the most recent edition of the American Psychiatric Associations Diagnostic and Statistical Manual of Mental Disorders. This eliminates the benefit distinction between biologically and non-biologically based diagnoses as well as the hospitalization limitations specific to behavioral health services. UM Decisions Appropriateness of Care and Services As part of our goal to improve the health of the members we serve, we are committed to promoting appropriate utilization of medical services. Please note the following: Individuals who make utilization management decisions do not receive compensation or incentives to deny care. This also applies to individuals who supervise them, including management, medical directors, utilization management managers and licensed staff. Utilization management decisions are based only on appropriateness of care and services and existence of coverage. UM Criteria is Available to Physicians/Providers: Physicians and health care providers may request that we provider the specific criteria utilized to render a medical necessity determination. If a treating physician or provider would like to request a copy of specific UM criteria, they may call the Utilization Management Department at (800) 437-7162. Our physician reviewers are involved in utilization management determinations that result in a denial of benefits and are available to discuss the determinations by calling (800) 437-7162.  AIM Specialty Health(AIM) AIM Specialty Health provides clinical solutions that drive appropriate, safe, and affordable care. Serving more than 50 million members across 50 states, D.C. and U.S. territories, AIM promotes optimal care through use of evidence-based clinical guidelines and real-time decision support for both providers and their patients. The AIM platform delivers significant cost-of-care savings across an expanding set of clinical domains, including radiology, cardiology, oncology, specialty drugs, sleep medicine, musculoskeletal care, and genetic testing. Visit AIMs program websites to find program information, clinical guidelines, interactive tutorials, worksheets & checklists, FAQs, and access to AIM ProviderPortalSM Radiology:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_radiology&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=GtHgD0w8hhDFhG0V6Eh1_4U0UobZykFoT8dO-tWI3Lk&e=" www.aimprovider.com/radiology Cardiology:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_cardiology&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=HzSY0MjsKCiU2RePm2xJQkZ6FrBvOugXrZ-12bXU_dY&e=" www.aimprovider.com/cardiology Medical Oncology:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.cancercarequalityprogram.com&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=5oV7aK5iynovoZm3r_3UAIAQWz4yge5_TPbCTdKiuT4&e=" www.cancercarequalityprogram.com Radiation Oncology:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_radoncology&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=Ycr8WDlpD1-9fgXwbv3ELmuX7vn8eFIzsNV8IxoZcUI&e=" www.aimprovider.com/radoncology Genetic Testing:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_genetictesting&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=ZZnnHJYURIdOBlJW5N0E6gpEadhw5I8PtaDyOnwDTd4&e=" www.aimprovider.com/genetictesting Sleep:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimspecialtyhealth.com_gowebsleep&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=1DHpJRhJYuVJZ3siYFYXW6nU6DdvQO1dId_Pny7GX5M&e=" www.aimspecialtyhealth.com/gowebsleep Specialty Drugs:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_specialtyrx&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=T-yEdBwsSk6dL4FpuZeDJbQfjTcg9dm0IwbUKOEON9A&e=" www.aimprovider.com/specialtyrx Musculoskeletal:  HYPERLINK "https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_msk&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=EkSgHW1NQslQ9wvcvlamIxH27SunJ636fzwTVZ_9UNk&e=" www.aimprovider.com/msk Surgical Procedures: HYPERLINK "http://www.aimproviders.com/surgicalprocedures"www.aimproviders.com/surgicalprocedures Rehabilitation: HYPERLINK "http://www.aimproviders.com/rehabilitation"www.aimproviders.com/rehabilitation Submit Pre-certification/Pre-authorization requests to AIM Ordering and servicing Providers may submit Pre-certification/Pre-authorizaztion requests to AIM in one of the following ways: Access AIM ProviderPortalSM directly at  HYPERLINK "http://www.providerportal.com/" providerportal.com. Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization. Access AIM via the Availity Portal at  HYPERLINK "http://www.availity.com/" availity.com Call the AIM Contact Center toll-free number: 866-714-1107, MondayFriday, 8:00 a.m.5:00 p.m. ET.. OptiNet Registration The OptiNet Registration is an important tool that assists ordering providers in real-time decision support information to enable ordering providers to choose a high quality, low cost imaging providers for their patients. Servicing providers need to complete the OptiNet Registration online. To access the OptiNet Registration: Access AIM ProviderPortal directly at  HYPERLINK "http://www.providerportal.com/" providerportal.com. You may also access AIM via the Availity Portal at  HYPERLINK "http://www.availity.com/" availity.com Once logged into AIM, from the My Homepage screen, choose Access Your OptiNet Registration. Select the Registration Type, and choose the Access Your OptiNet Registration button. Complete requested information. The registration does not need to be completed in one sitting. Data can be saved as you proceed through the registration. Once the registration has been submitted, a score card will be produced. The score for the Facility will be presented to the ordering Provider when the particular Facility is selected as a place of service which drives Ordering Provider Decision Support. For technical questions, contact AIM ProviderPortal Web Support at 800-252-2021. For any other questions, contact the Anthem Provider Service Center.  Physician/Provider Participation Requirements Participating Physician, Provider, and Group Agreements Your participation with Anthem is determined by your completion and Anthems formal acceptance of your Participating Provider Agreement (group or solo practice) and credentialing application. To avoid delays in compensation and gaps in participation, it is important that you contact Anthem whenever there is a change of any kind in your practice information, including name, address, tax ID or other. Participation Confirmation and Effective Dates Physicians or Providers who have applied for participation should not agree to provide services as Network/Participating Providers to Members under any Anthem plan or program until such time as they receive a formal notification from Anthem that they are accepted as participating Providers. This notification will specify the effective date of participation and which programs and/or products are included in the participation. Any services provided to Members before the effective date will be considered out of network services. Defining Solo vs. Group Practices Determinations on whether a practice receives a solo or group agreement are based on the following criteria: Solo providers are identified as those who provide us with a Social Security or Tax ID number (TIN) that is tied to their name alone. Group providers are identified as those who provide us with a TIN that is tied to either their name as a PC, LLC, or partnership; or to a group business name. If you practice both as a member of a group and under a separate practice as a solo practitioner, and you are submitting the Anthem agreement, you must sign an individual agreement in addition to the group agreement in order to be participating in both arrangements. A separate agreement is required for each tax ID number under which you are billing. Moving to A New Group Practice If a Provider, or group of providers, leaves a participating group practice and joins or forms another group practice, participation does not automatically continue for those providers. Depending on the situation, a new Group Agreement and/or Signature Sheet may need to be completed and submitted in order to continue participation in Anthems networks with a new group, for example if there is a different TIN associated with the new group. Services to Members are not eligible for in-network reimbursement until such time as the physician or provider receives a formal notification from Anthem of his/her participation under the new Group Agreement, and the effective date of same, as noted under Participation Confirmation and Effective Dates above. Notifying Members of Participation Status Each provider is responsible for informing Members about his/her participation status with Anthem so that Members may maximize their benefits and make informed decisions about the providers they are choosing for their care. Open Practice Provider shall give Plan sixty (60) days prior written notice when Provider no longer accepts new patients, so that we may maintain current information on provider availability in our online Provider Finder and directories. Adding New Providers to Group Practices It is important that new individual providers joining group practices promptly apply for participation in order to maintain participation consistency within the practice and ensure that Members see Providers to maximize the value of their Health Benefit Plan. Important note: a new provider in a participating Anthem group is not considered a Provider until such time as he/she is credentialed and/or contracted with Anthem and receives formal written notification of participation and effective date. Participation In a Provider Sponsored Organization In circumstances where Anthem contracts with an IPA, PHO, or other provider-sponsored organization, you may be required to execute an individual or group agreement with Anthem in addition to your agreement with the contracting organization Joining Our Network You may obtain Group and Solo Agreements and credentialing applications, as well as helpful information on the contracting and credentialing process, by visiting anthem.com. Select Providers, then select Providers Overview. Choose Connecticut as State, and then select Find Resources for Connecticut. Finally, select Join Our Networks from the menu bar.  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f6/s0/t0/pw_e229315.htm&rootLevel=5&state=ct&label=Join%20Our%20Networks" Join Our Networks An overview of the contracting requirements and process follows: When to Submit an Agreement An Agreement may be submitted to Provider Solutions Department When a physician, health care professional, or provider group chooses to apply for participation in any Anthem network. When a physician or provider in a group practice that is participating in any Anthem network wishes to also maintain a solo practice and retain membership in that network under the solo practice as well as the group practice. When a physician who has a solo practice or is a member of a group practice wishes to join an IPA, PHO, or other provider-sponsored organization that has an agreement with Anthem (this may not be required for membership in all such arrangements.) NOTE: When a physician or health care provider joins a group practice that is already participating in any Anthem network, that physician or provider must sign a Represented Provider Certification and Authorization signature sheet, but does not need to submit an Agreement. How to Complete an Agreement When completing an Anthem Agreement and associated credentialing form, please be sure to follow the instructions carefully and complete all required information, keeping the following in mind: Sign on the appropriate line for physician or health care provider Provide original signature on document returned to Anthem for processing; signature stamps are not acceptable but the document may be scanned and emailed Include the street address of the primary office location where appropriate (post office boxes without the physical address are not acceptable) Groups: Include a signed Represented Provider Certification and Authorization Signature Sheet for each individual provider when completing a Group Agreement Do not white out or cross out information on the Agreement; doing so will render the Agreement void. Do not complete any sections that are marked as being for Anthem use only. Notification of Changes In accordance with your Participating Provider Agreement (group or solo), Network/Participating Providers are required to notify Anthem within ten days of any of the following: Any change of business address, including relocation, addition or closing of a location Any action taken to restrict, suspend or revoke the providers or groups license, accreditation or certification Any action to restrict, suspend or revoke the providers medical staff privileges Any action brought against the group or provider for malpractice and the final disposition of such action by settlement or adjudication The termination, reduction or cancellation of the insurance coverage required under the Agreement Any criminal action against the group or individual provider Any action to suspend, sanction, expel, or disbar the group or individual provider under Title XVIII or Title XIX of the Social Security Act Any situation which might materially affect the groups or solo providers ability to carry out the duties under the terms of the Agreement, or to meet any credentialing/recredentialing criteria For Group Agreements only: any material changes in the groups ownership to the extent that the ownership or control of the group changes by 20 percent or more. Professional Providers wishing to submit changes to practice address, billing address, or other demographic information including termination without cause (see Provider Termination Without Cause below) should do so online using our Online Provider Maintenance Form on anthem.com. Select Menu, then select Providers from the Support Column. Choose Connecticut as State, and then select Find Resources for Connecticut. Select Contact Us, then Provider Maintenance Form, or you may use this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&label=Contact%20Us" Contact Us To notify us of other changes not related to your practice demographics, as outlined in the Notification of Changes requirements above, please contact your network relations representative. The Provider Maintenance Form is for the use of professional (CMS-1500 billing) providers only. Facility providers should contact their network relations representative for instructions on submitting a demographic change in writing. Physician/Provider Access Goals and Calendar Requirements One of our goals is to make accessing medical care easy for Members by assuring a comprehensive network of physicians and providers close to their homes. As a result, we have implemented the following plan-wide geographic access goals as guidelines for our HMO network. It is our goal to provide Members with access to the following within our defined service areas: Two PCPs within five miles of each Member Two OB/GYNs within eight miles of each Member Full range of specialists (including non-MD allied providers) within 15 miles of each Member Calendar Access Requirements Primary Care Providers: Preventive care - members scheduling periodic routine exams (well care/preventive visits), appointments should be available within 45 calendar days of a members call. Care provided to prevent illness or injury; examples include, but are not limited to, routine physical examinations, immunizations, mammograms and pap smears. Urgent care appointment with acute symptoms - appointments should be available within 24 hours of the members call. Care provided for a non-emergent illness or injury with acute symptoms that require immediate care; examples include, but are not limited to, sprains, flu symptoms, minor cuts and wounds, sudden onset of stomach pain and severe, non-resolving headache. Routine Care with symptoms must have access to care within 5 days of the members call. Routine check-up must have access to care within 10 business days of the members call. This consists of care provided for non-symptomatic visits or follow-up.. Though it is important for members to have the continuity of receiving care from their PCPs, there are occasions when you may not be available at a time that meets their scheduling needs. As a reminder, we now contract with walk-in centers and urgent care facilities which are listed in our directory. Specialists: Urgent care appointment with acute symptoms - appointments should be available within 24 hours of the members call. Care provided for a non-emergent illness or injury with acute symptoms that require immediate care; examples include, but are not limited to, sprains, flu symptoms, minor cuts and wounds, sudden onset of stomach pain and severe, non-resolving headache. Routine check-up must have access to care within 15 calendar days of the members call. Care provided for non-symptomatic visits for health check. Behavioral Health Providers: Non-life threatening emergency needs - must be seen, or have appropriate coverage directing the member, within six (6) hours. Emergent behavioral health care provided when a member is in crisis, experiencing acute distress and/or other symptoms and needs immediate attention; no risk of loss of life. Urgent needs - must be seen, or have appropriate coverage directing the member, within 48 hours. Non-emergent behavioral health illness that requires immediate care; member is experiencing significant psychological distress with symptoms that impairs daily functioning; no risk of loss of life. Initial routine office visit - must be seen within 10 business days. New patient non-urgent appointment scheduled after intake assessment or a direct referral from a treating practitioner. Follow-up Routine visit must be seen within 30 calendar days. Non-urgent behavioral health care; member has been scheduled for a non-urgent consultation or requires services including, but not limited to, follow-up and existing medication management. After-Hours Coverage After-hours coverage, which is required by the Provider Agreement, consists of an attendant or recording assisting the member in accessing urgent services outside of regular office hours. Note that telephone answering machines and voice mail are not acceptable means of providing access for Members if the answering machine or voice mail message only refers Members to the Emergency Room or to call 911. The recording or live person must refer the patient to Urgent Care Center, 911, or Emergency Room, and also provide the option to contact a live health care practitioner (via cell, pager, beeper, transfer system) , get a call back for urgent instructions, or the live person transfers patient directly to the available practitioner or on-call practitioner. Timely access to physicians is a major priority of our Members and employer groups. The requirements adopted reflect not only their expectations, but market norms. We will be assessing physicians against these requirements through our customer satisfaction surveys and provider surveys as well as follow-up on any Members complaints received. However, we are sensitive to problems related to seasonal services, the varying nature of practice specialties, and the challenges faced by busy practices. If your office routinely exceeds these targets, it is important that you document and we understand the reasons that the requirements are not met. 24/7 Coverage Required for Network/Participating Providers Anthem requires that Network/Participating Provider practices must afford physical or verbal provider accessibility 24/7. Anthem recognizes that individual providers may not be available under all circumstances for coverage of their own practices. However, when they are unavailable or when out of the office for an extended period of time, provider(s) of a similar specialty must be covering for their patients. Hospitalist Programs Anthem has developed a network of contracted hospital-based hospitalist programs. The goal of these programs is to promote continuity of medical care (24/7) in the inpatient and outpatient settings for Members who elect to support the decision of their primary care physician (PCP) to have acute inpatients medical care provided to their patients through such a program. Information to be supplied by a requesting facility: An entity requesting participation for a hospitalist program must provide a detailed description of its program to Anthem This description must include an established communication process with primary care physicians about their patients on the hospitalist inpatient service A list of all current hospital-based physicians who provide clinical care through the hospitalist program, with curriculum vitae Name of the contracting entity and its business relationship to the hospitalists Identification of the billing entity for professional services rendered by the hospitalists Requirements for participation in an Anthem Contracted Hospitalist Program: Hospitalists must be credentialed by the hospitals as full-time hospital employees with no community-based practices. They are not selected by Anthem Members as PCPs and are not listed in Anthem provider directories. Hospitalists must have current American Board of Medical Specialty (ABMS) or American Osteopathic Association (AOA) board certification in internal medicine or family practice, or must be eligible to take the applicable certifying examination and achieve full board certification within the time period required by the applicable hospital medical staff bylaws. Locum Tenens Locum Tenens will be allowed to provide services to Anthem Members when they meet Anthems administrative guidelines. A Locum Tenens is a substitute physician who takes over a physicians professional practice when the physician is absent for reasons such as illness, pregnancy, extended vacation or continuing medical education. The substitute physician generally has no practice of his/her own. Locum Tenens will be required to submit information to Anthem. Administrative Guidelines for Locum Tenens The participating physician or provider who will be absent must make a request to Anthem in writing prior to the Locum Tenens providing medical services to a Member. The request should include: Dates of absence (the request should not exceed a six month substitution period, but unusual absence circumstances may be reviewed on a case-by-case basis) The absent physicians tax identification and Anthem provider number The Locum Tenens will be requested to submit the following: An Anthem modified credentialing application An Anthem agreement statement A confirmation of liability insurance with the participating physician Anthem will review the completed application and send back approval or denial of the Network/Participating Providers request for substitute physician. After the six month covering period, the substitute physician must apply to become a Network/Participating Provider, either as a member of that group or as an individual provider, in order to continue providing in-network medical services to Members, except as otherwise approved by Anthem. Provider Termination Without Cause Anthems participation agreements set forth a required notification period for termination of the contract without cause on the part of Anthem or the Network/Participating Provider. In no case is the notice period less than sixty (60) days. : We recognize that there are situations in which you do not know far in advance of a pending termination but ask that you notify us immediately as soon as this determination has been made. These situations may include: Moving out of state Leaving your group to accept a position with another practice Illness, injury or other emergency Retirement: in the case of retirement, we will be firm that the Network/Participating Provider comply with the required notice period per the terms of the contract The advance notice is required by Connecticut law and is for the benefit of our Members. In order to satisfy our internal quality standards, as well as maintain our accreditation with the National Committee on Quality Assurance (NCQA) we are required under accreditation standards to notify Members at least 30 days in advance of provider termination date, upon termination of: Primary care physician selected by the Member under his/her plan with Anthem Specialist who has provided services to the Member within the past twelve months (based on history of claims submitted by the provider) When a network provider is terminated from a network, Anthem will make a good faith effort to notify Members no later than thirty (30) calendar days following receipt of the written termination notice. Members who are attributed to or have received services from the affected provider will be notified. If a provider notifies Anthem of termination less than 30 calendar days prior to the effective date, Anthem notifies the affected Members as soon as possible and as required by law; as noted above, Anthem will make a good faith effort to provide written notice no later than 30 calendar days after receipt of the notification. The Member may then call Member Services to obtain assistance in selecting a new provider. To notify us of your intent to terminate your participation in our network, complete an online Provider Maintenance Form and include the reason for the termination under section B Briefly describe the reason for submitting this form. The online form can be found under Contact Us on the  HYPERLINK "http://www.anthem.com/" www.anthem.com provider home page. The termination will result in an automatic update to the online Provider Directory. Termination With or Without Cause - List of Participating Providers Patients Each participating provider terminating from our network with or without cause, as determined by the terms of the contract, will be required to provide a list of the participating provider's patients who are members under a network plan of Anthem within 30 days of their notification to Anthem.  Credentialing Anthems Discretion The credentialing summary, criteria, standards, and requirements set forth herein are not intended to limit Anthems discretion in any way to amend, change or suspend any aspect of its credentialing program nor is it intended to create rights on the part of practitioners who seek to provide healthcare services to our Members. Anthem further retains the right to approve, suspend, or terminate individual physicians and health care professional, and sites in those instances where it has delegated credentialing decision making. Credentialing Scope Anthem credentials the following licensed/state certified independent health care practitioners: Medical Doctors (MD) Doctors of Osteopathic Medicine (DO) Doctors of Podiatry Chiropractor Optometrists providing Health Services covered under the Health Benefit Plan Doctors of dentistry providing Health Services covered under the Health Benefit Plan including oral and maxillofacial surgeons Psychologists who have doctoral or masters level training Clinical social workers who have masters level training Psychiatric or behavioral health nurse practitioners who have masters level training Other behavioral health care specialists who provide treatment services under the Health Benefit Plan Telemedicine practitioners who provide treatment services under the Health Benefit Plan Medical therapists (e.g., physical therapists, speech therapists, and occupational therapists) Genetic Counselors Audiologists Acupuncturists (non-MD/DO) Nurse practitioners Certified nurse midwives Physician assistants (as required locally) Registered Dieticians The following behavioral health practitioners are not subject to professional conduct and competence review under Anthems credentialing program, but are subject to a certification requirement process including verification of licensure by the applicable state licensing board to independently provide behavioral health services and/or compliance with regulatory or state/federal contract requirements for the provision of services: Certified Behavioral Analysts Certified Addiction Counselors Substance Abuse Practitioners Anthem credentials the following Health Delivery Organizations (HDOs): Hospitals Home Health Agencies Skilled Nursing Facilities (Nursing Homes) Ambulatory Surgical Centers Behavioral Health Facilities providing mental health and/or substance abuse treatment in inpatient, residential or ambulatory settings, including: Adult Family Care/Foster Care Homes Ambulatory Detox Community Mental Health Centers (CMHC) Crisis Stabilization Units Intensive Family Intervention Services Intensive Outpatient Mental Health and/or Substance Abuse Methadone Maintenance Clinics Outpatient Mental Health Clinics Outpatient Substance Abuse Clinics Partial Hospitalization Mental Health and/or Substance Abuse Residential Treatment Centers (RTC) Psychiatric and/or Substance Abuse Birthing Centers Home Infusion Therapy when not associated with another currently credentialed HDO The following Health Delivery Organizations are not subject to professional conduct and competence review under Anthems credentialing program, but are subject to a certification requirement process including verification of licensure by the applicable state licensing agency and/or compliance with regulatory or state/federal contract requirements for the provision of services: Clinical laboratories (CLIA Certification of Accreditation or CLIA Certificate of Compliance) End Stage Renal Disease (ESRD) service providers (dialysis facilities) (CMS Certification) Portable x-ray Suppliers (FDA Certification) Home Infusion Therapy when associated with another currently credentialed HDO (CMS Certification) Hospice (CMS Certification) Federally Qualified Health Centers (FQHC) (CMS Certification) Rural Health Clinics (CMS Certification) Credentials Committee The decision to accept, retain, deny or terminate a practitioners participation in a Network or Plan Program is conducted by a peer review body, known as Anthems Credentials Committee (CC). The CC will meet at least once every forty-five (45) calendar days. The presence of a majority of voting CC members constitutes a quorum. The chief medical officer, or a designee appointed in consultation with the vice president of Medical and Credentialing Policy, will designate a chair of the CC, as well as a vice-chair in states or regions where both Commercial and Medicaid contracts exist. The chair must be a state or regional lead medical director, or an Anthem medical director designee and the vice-chair must be a lead medical officer or an Anthem medical director designee, for that line of business not represented by the chair. In states or regions where only one line of business is represented, the chair of the CC will designate a vice-chair for that line of business also represented by the chair. The CC will include at least five, but no more than ten external physicians representing multiple medical specialties (in general, the following specialties or practice-types should be represented: pediatrics, obstetrics/gynecology, adult medicine (family medicine or internal medicine); surgery; behavioral health, with the option of using other specialties when needed as determined by the chair/vice-chair). CC membership may also include one to two other types of credentialed health providers (e.g. nurse practitioner, chiropractor, social worker, podiatrist) to meet priorities of the geographic region as per chair/vice-chairs discretion. At least two of the physician committee members must be credentialed for each line of business (e.g. Commercial, Medicare, and Medicaid) offered within the geographic purview of the CC. The chair/vice-chair will serve as a voting member(s) and provide support to the credentialing/re-credentialing process as needed. The CC will access various specialists for consultation, as needed to complete the review of a practitioners credentials. A committee member will disclose and abstain from voting on a practitioner if the committee member (i)believes there is a conflict of interest, such as direct economic competition with the practitioner; or (ii)feels his or her judgment might otherwise be compromised. A committee member will also disclose if he or she has been professionally involved with the practitioner. Determinations to deny an applicants participation, or terminate a practitioner from participation in one or more Networks or Plan Programs, require a majority vote of the voting members of the CC in attendance, the majority of whom are Network practitioners. During the credentialing process, all information that is obtained is confidential and not subject to review by third parties except to the extent permitted by law. Access to information will be restricted to those individuals who are deemed necessary to attain the objectives of Anthems credentialing program. In particular, information supplied by the Practitioner or HDO in the application, as well as other non-publicly available information will be treated as confidential. Confidential written records regarding deficiencies found, the actions taken, and the recommended follow-up will be kept in a secure fashion. Security mechanisms include secured office facilities and locked filing cabinets, a protected computer infrastructure with password controls and systematic monitoring, and staff ethics and compliance training programs. The procedures and minutes of the CC will be open to review by state and federal regulating agencies and accrediting bodies to the extent permitted by law. Practitioners and HDOs are notified that they have the right to review information submitted to support their credentialing applications. In the event that credentialing information cannot be verified, or if there is a discrepancy in the credentialing information obtained, the Credentialing staff will contact the practitioner or HDO within thirty (30) calendar days of the identification of the issue. This communication will notify the practitioner or HDO of the right to correct erroneous information or provide additional details regarding the issue in question. This notification will also include the process for submission of this additional information, including where it should be sent. Depending on the nature of the issue in question, this communication may occur verbally or in writing. If the communication is verbal, written confirmation will be sent at a later date. All communication on the issue(s) in question, including copies of the correspondence or a detailed record of phone calls, will be documented in the practitioners credentials file. The practitioner or HDO will be given no less than fourteen (14) calendar days in which to provide additional information. On request, the practitioner will be provided with the status of their credentialing or recredentialing application. Anthem may request and will accept additional information from the applicant to correct or explain incomplete, inaccurate, or conflicting credentialing information. The CC will review the information and rationale presented by the applicant to determine if a material omission has occurred or if other credentialing criteria are met. Nondiscrimination Policy Anthem will not discriminate against any applicant for participation in its programs or provider network(s) on the basis of race, gender, color, creed, religion, national origin, ancestry, sexual orientation, age, veteran, or marital status or any unlawful basis not specifically mentioned herein. Additionally, Anthem will not discriminate against any applicant on the basis of the risk of population they serve or against those who specialize in the treatment of costly conditions. Other than gender and language capabilities which are provided to the members to meet their needs and preferences, this information is not required in the credentialing and re-credentialing process. Determinations as to which practitioners and providers require additional individual review by the Credentials Committee are made according to predetermined criteria related to professional conduct and competence. Credentials Committee decisions are based on issues of professional conduct and competence as reported and verified through the credentialing process. Anthem will audit credentialing files annually to identify discriminatory practices, if any, in the selection of practitioners. Should discriminatory practices be identified through audit or through other means, Anthem will take appropriate action(s) to track and eliminate those practices. Initial Credentialing Each practitioner or HDO must complete a standard application form deemed acceptable by Anthem when applying for initial participation in one or more of Anthems Networks or Plan Programs. For practitioners, the Council for Affordable Quality Healthcare (CAQH) ProView system is utilized. To learn more about CAQH, visit their web site at  HYPERLINK "javascript:openWin('http://www.CAQH.org',%20'mainWin',%201,%201,%201,%201,%20700,%20500);" www.CAQH.org. Anthem will verify those elements related to an applicants legal authority to practice, relevant training, experience and competency from the primary source, where applicable, during the credentialing process. All verifications must be current and verified within the one hundred eighty (180) calendar day period prior to the CC making its credentialing recommendation or as otherwise required by applicable accreditation standards. During the credentialing process, Anthem will review, among other things, verification of the credentialing data as described in the following tables unless otherwise required by regulatory or accrediting bodies. These tables represent minimum requirements. Practitioners Verification ElementLicense to practice in the state(s) in which the practitioner will be treating Members.Hospital admitting privileges at a TJC, NIAHO or AOA accredited hospital, or a Network hospital previously approved by the committee.DEA/CDS and state controlled substance registrations The DEA/CDS registration must be valid in the state(s) in which practitioner will be treating Members. Practitioners who see Members in more than one state must have a DEA/CDS registration for each state.Malpractice insuranceMalpractice claims historyBoard certification or highest level of medical training or educationWork historyState or Federal license sanctions or limitationsMedicare, Medicaid or FEHBP sanctionsNational Practitioner Data Bank reportState Medicaid Exclusion Listing, if applicable B. HDOs Verification ElementAccreditation, if applicableLicense to practice, if applicableMalpractice insuranceMedicare certification, if applicableDepartment of Health Survey Results or recognized accrediting organization certificationLicense sanctions or limitations, if applicableMedicare, Medicaid or FEHBP sanctions Recredentialing The recredentialing process incorporates re-verification and the identification of changes in the practitioners or HDOs licensure, sanctions, certification, health status and/or performance information (including, but not limited to, malpractice experience, hospital privilege or other actions) that may reflect on the practitioners or HDOs professional conduct and competence. This information is reviewed in order to assess whether practitioners and HDOs continue to meet Anthem credentialing standards. All applicable practitioners and HDOs in the Network within the scope of Anthem Credentialing Program are required to be recredentialed every three (3) years unless otherwise required by contract or state regulations. Health Delivery Organizations New HDO applicants will submit a standardized application to Anthem for review. If the candidate meets Anthem screening criteria, the credentialing process will commence. To assess whether Network HDOs, within the scope of the Credentialing Program, meet appropriate standards of professional conduct and competence, they are subject to credentialing and recredentialing programs. In addition to the licensure and other eligibility criteria for HDOs, as described in detail in Anthem Credentialing Program Standards, all Network HDOs are required to maintain accreditation by an appropriate, recognized accrediting body or, in the absence of such accreditation, Anthem may evaluate the most recent site survey by Medicare, the appropriate state oversight agency, or a site survey performed by a designated independent external entity within the past 36 months for that HDO. Recredentialing of HDOs occurs every three (3) years unless otherwise required by regulatory or accrediting bodies. Each HDO applying for continuing participation in Networks or Plan Programs must submit all required supporting documentation. On request, HDOs will be provided with the status of their credentialing application. Anthem may request, and will accept, additional information from the HDO to correct incomplete, inaccurate, or conflicting credentialing information. The CC will review this information and the rationale behind it, as presented by the HDO, and determine if a material omission has occurred or if other credentialing criteria are met. Ongoing Sanction Monitoring To support certain credentialing standards between the recredentialing cycles, Anthem has established an ongoing monitoring program. Credentialing performs ongoing monitoring to help ensure continued compliance with credentialing standards and to assess for occurrences that may reflect issues of substandard professional conduct and competence. To achieve this, the credentialing department will review periodic listings/reports within thirty (30) calendar days of the time they are made available from the various sources including, but not limited to, the following: Office of the Inspector General (OIG) Federal Medicare/Medicaid Reports Office of Personnel Management (OPM) State licensing Boards/Agencies Member/Customer Services Departments Clinical Quality Management Department (including data regarding complaints of both a clinical and non-clinical nature, reports of adverse clinical events and outcomes, and satisfaction data, as available) Other internal Anthem Departments Any other information received from sources deemed reliable by Anthem. When a practitioner or HDO within the scope of credentialing has been identified by these sources, criteria will be used to assess the appropriate response. Appeals Process Anthem has established policies for monitoring and re-credentialing practitioners and HDOs who seek continued participation in one or more of Anthems Networks or Plan Programs. Information reviewed during this activity may indicate that the professional conduct and competence standards are no longer being met, and Anthem may wish to terminate practitioners or HDOs. Anthem also seeks to treat Network practitioners and HDOs, as well as those applying for participation, fairly and thus provides practitioners and HDOs with a process to appeal determinations terminating/denying participation in Anthem's Networks for professional competence and conduct reasons, or which would otherwise result in a report to the National Practitioner Data Bank (NPDB). Additionally, Anthem will permit practitioners and HDOs who have been refused initial participation the opportunity to correct any errors or omissions which may have led to such denial (informal/reconsideration only). It is the intent of Anthem to give practitioners and HDOs the opportunity to contest a termination of the practitioners or HDOs participation in one or more of Anthems Networks or Plan Programs and those denials of request for initial participation which are reported to the NPDB that were based on professional competence and conduct considerations. Immediate terminations may be imposed due to the practitioners or HDOs license suspension, probation or revocation, or if a practitioner or HDO has been sanctioned, debarred or excluded from the Medicare, Medicaid or FEHB programs, or has a criminal conviction, or Anthems determination that the practitioners or HDOs continued participation poses an imminent risk of harm to Members. Participating practitioners and HDOs whose network participation has been terminated due to the practitioners suspension or loss of licensure or due to criminal conviction are not eligible for Informal Review/Reconsideration or Formal Appeal. Participating practitioners and HDOs whose network participation has been terminated due to sanction, debarment or exclusion from the Medicare, Medicaid or FEHB are not eligible for Informal Review/Reconsideration or Formal Appeal. Reporting Requirements When Anthem takes a professional review action with respect to a practitioners or HDOs participation in one or more of its Networks or Plan Programs, Anthem may have an obligation to report such to the NPDB, state licensing board and legally designated agencies. . In the event that the procedures set forth for reporting reportable adverse actions conflict with the process set forth in the current NPDB Guidebook, the process set forth in the NPDB Guidebook will govern. Anthem Credentialing Program Standards I. Eligibility Criteria Health care practitioners: Initial applicants must meet the following criteria in order to be considered for participation: Must not be currently federally sanctioned, debarred or excluded from participation in any of the following programs: Medicare, Medicaid or FEHBP; and Possess a current, valid, unencumbered, unrestricted, and non-probationary license in the state(s) where he/she provides services to Members; and Possess a current, valid, and unrestricted Drug Enforcement Agency (DEA) and/or Controlled Dangerous Substances (CDS) registration for prescribing controlled substances, if applicable to his/her specialty in which he/she will treat Members; the DEA/CDS registration must be valid in the state(s) in which the practitioner will be treating Members. Practitioners who see Members in more than one state must have a DEA/CDS registration for each state. Initial applications should meet the following criteria in order to be considered for participation, with exceptions reviewed and approved by the CC: For MDs, DOs, DPMs, and DMDs/DDSs practicing oral and maxillofacial surgery, the applicant must have current, in force board certification (as defined by the American Board of Medical Specialties (ABMS), American Osteopathic Association (AOA), Royal College of Physicians and Surgeons of Canada (RCPSC), College of Family Physicians of Canada (CFPC), American Board of Foot and Ankle Surgery (ABFAS), American Board of Podiatric Medicine (ABPM), or American Board of Oral and Maxillofacial Surgery (ABOMS)) in the clinical discipline for which they are applying. If not certified, MDs and DOs will be granted five years or a period of time consistent with ABMS or AOA board eligibility time limits, whatever is greater, after completion of their residency or fellowship training program to meet the board certification requirement. If not certified, DPMs will be granted five years after the completion of their residency to meet this requirement for the ABPM. Non-certified DPMs will be granted seven years after completion of their residency to meet this requirement for ABFAS Individuals no longer eligible for board certification are not eligible for continued exception to this requirement. As alternatives, MDs and DOs meeting any one of the following criteria will be viewed as meeting the education, training and certification requirement: a. Previous board certification (as defined by one of the following: ABMS, AOA, RCPSC, CFPC, ABFAS, ABPM, or ABOMS) in the clinical specialty or subspecialty for which they are applying which has now expired AND a minimum of ten (10) consecutive years of clinical practice. OR b. Training which met the requirements in place at the time it was completed in a specialty field prior to the availability of board certifications in that clinical specialty or subspecialty. OR c. Specialized practice expertise as evidenced by publication in nationally accepted peer review literature and/or recognized as a leader in the science of their specialty AND a faculty appointment of Assistant Professor or higher at an academic medical center and teaching Facility in Anthems Network AND the applicants professional activities are spent at that institution at least fifty percent (50%) of the time. 2. Practitioners meeting one of these three (3) alternative criteria (a, b, c) will be viewed as meeting all Anthem education, training and certification criteria and will not be required to undergo additional review or individual presentation to the CC. These alternatives are subject to Anthem review and approval. Reports submitted by delegate to Anthem must contain sufficient documentation to support the above alternatives, as determined by Anthem. B. For MDs and DOs, the applicant must have unrestricted hospital privileges at a The Joint Commission (TJC), National Integrated Accreditation for Healthcare Organizations (NIAHO), Center for Improvement in Healthcare Quality (CIHQ), a Healthcare Facilities Accreditation Program (HFAP) accredited hospital, or a Network hospital previously approved by the committee. Some clinical disciplines may function exclusively in the outpatient setting, and the CC may at its discretion deem hospital privileges not relevant to these specialties. Also, the organization of an increasing number of physician practice settings in selected fields is such that individual physicians may practice solely in either an outpatient or an inpatient setting. The CC will evaluate applications from practitioners in such practices without regard to hospital privileges. The expectation of these physicians would be that there is an appropriate referral arrangement with a Network practitioner to provide inpatient care. II. Criteria for Selecting Practitioners New Applicants (Credentialing) Submission of a complete application and required attachments that must not contain intentional misrepresentations or omissions; Application attestation signed date within one hundred eighty (180) calendar days of the date of submission to the CC for a vote; Primary source verifications within acceptable timeframes of the date of submission to the CC for a vote, as deemed by appropriate accrediting agencies; No evidence of potential material omission(s) on application; Current, valid, unrestricted license to practice in each state in which the practitioner would provide care to Members; No current license action; No history of licensing board action in any state; No current federal sanction and no history of federal sanctions (per System for Award Management (SAM), OIG and OPM report nor on NPDB report); Possess a current, valid, and unrestricted DEA/CDS registration for prescribing controlled substances, if applicable to his/her specialty in which he/she will treat Members. The DEA/CDS registration must be valid in the state(s) in which the practitioner will be treating Members. Practitioners who treat Members in more than one state must have a valid DEA/CDS registration for each applicable state. Initial applicants who have NO DEA/CDS registration will be viewed as not meeting criteria and the credentialing process will not proceed. However, if the applicant can provide evidence that he/she has applied for a DEA/CDS registration, the credentialing process may proceed if all of the following are met: It can be verified that this application is pending. The applicant has made an arrangement for an alternative practitioner to prescribe controlled substances until the additional DEA/CDS registration is obtained. The applicant agrees to notify Anthem upon receipt of the required DEA/CDS registration. Anthem will verify the appropriate DEA/CDS registration via standard sources. The applicant agrees that failure to provide the appropriate DEA/CDS registration within a ninety (90) calendar day timeframe will result in termination from the Network. Initial applicants who possess a DEA certificate in a state other than the state in which they will be seeing Anthems members will be notified of the need to obtain the additional DEA, unless the practitioner is delivering services in a telemedicine environment only and does not require a DEA or CDS registration in the additional location(s) where such telemedicine services may be rendered under federal or state law. If the applicant has applied for an additional DEA registration the credentialing process may proceed if all the following criteria are met: It can be verified that the applicants application is pending; and The applicant has made an arrangement for an alternative provider to prescribe controlled substances until the additional DEA registration is obtained; and The applicant agrees to notify Anthem upon receipt of the required DEA registration; and Anthem will verify the appropriate DEA/CDS registration via standard sources; and The applicant agrees that failure to provide the appropriate DEA registration within a 90 day timeframe will result in termination from the network. Office-based practitioners who voluntarily choose to have a DEA/CDS registration that does not include all Controlled Substance Schedules (for example, Schedule, II, III or IV), if that practitioner certifies the following: controlled substances from these Schedules are not prescribed within his/her scope of practice; and he/she must provide documentation that an arrangement exists for an alternative provider to prescribe controlled substances from these Schedules should it be clinically appropriate; and DEA/CDS registration is or was not suspended, revoked, surrendered or encumbered for reasons other than those aforementioned. No current hospital membership or privilege restrictions and no history of hospital membership or privileges restrictions; No history of or current use of illegal drugs or history of or current alcoholism; No impairment or other condition which would negatively impact the ability to perform the essential functions in their professional field. No gap in work history greater than six (6) months in the past five (5) years with the exception of those gaps related to parental leave or immigration where twelve (12) month gaps will be acceptable. No convictions, or pleadings of guilty or no contest to, or open indictments of, a felony or any offense involving moral turpitude or fraud. In addition, no other criminal or civil litigation history that together with any other relevant facts, raises a reasonable suspicion of future substandard professional conduct and/or competence. A minimum of the past ten (10) years of malpractice case history is reviewed. Meets Credentialing Standards for education/training for the specialty(ies) in which practitioner wants to be listed in Anthems Network directory as designated on the application. This includes board certification requirements or alternative criteria for MDs and DOs and board certification criteria for DPMs, and oral and maxillofacial surgeons; No involuntary terminations from an HMO or PPO; No "yes" answers to attestation/disclosure questions on the application form with the exception of the following: investment or business interest in ancillary services, equipment or supplies; voluntary resignation from a hospital or organization related to practice relocation or facility utilization; voluntary surrender of state license related to relocation or nonuse of said license; a NPDB report of a malpractice settlement or any report of a malpractice settlement that does not meet the threshold criteria. non-renewal of malpractice coverage or change in malpractice carrier related to changes in the carriers business practices (no longer offering coverage in a state or no longer in business); previous failure of a certification exam by a practitioner who is currently board certified or who remains in the five (5) year post residency training window; actions taken by a hospital against a practitioners privileges related solely to the failure to complete medical records in a timely fashion; history of a licensing board, hospital or other professional entity investigation that was closed without any action or sanction. Note: the CC will individually review any practitioner that does not meet one or more of the criteria required for initial applicants. Additional Participation Criteria and Exceptions for Behavioral Health practitioners (Non Physician) Credentialing. 1. Licensed Clinical Social Workers (LCSW) or other master level social work license type: Master or doctoral degree in social work with emphasis in clinical social work from a program accredited by the Council on Social Work Education (CSWE) or the Canadian Association on Social Work Education (CASWE). Program must have been accredited within three (3) years of the time the practitioner graduated. Full accreditation is required, candidacy programs will not be considered. If masters level degree does not meet criteria and practitioner obtained PhD degree as a clinical psychologist, but is not licensed as such, the practitioner can be reviewed. To meet the criteria, the doctoral program must be accredited by the American Psychological Association (APA) or be regionally accredited by the Council for Higher Education Accreditation (CHEA). In addition, a doctor of social work from an institution with at least regional accreditation from the CHEA will be viewed as acceptable. 2. Licensed professional counselor (LPC) and marriage and family therapist (MFT) or other master level license type: Masters or doctoral degree in counseling, marital and family therapy, psychology, counseling psychology, counseling with an emphasis in marriage, family and child counseling or an allied mental field. Master or doctoral degrees in education are acceptable with one of the fields of study above. b. Master or doctoral degrees in divinity do not meet criteria as a related field of study. c. Graduate school must be accredited by one of the Regional Institutional Accrediting Bodies and may be verified from the Accredited Institutions of Post-Secondary Education, APA, Council for Accreditation of Counseling and Related Educational Programs (CACREP), or Commission on Accreditation for Marriage and Family Therapy Education (COAMFTE) listings. The institution must have been accredited within three (3) years of the time the practitioner graduated. d. Practitioners with PhD training as a clinical psychologist can be reviewed. To meet criteria this doctoral program must either be accredited by the APA or be regionally accredited by the CHEA. A Practitioner with a doctoral degree in one of the fields of study noted will be viewed as acceptable if the institution granting the degree has regional accreditation from the CHEA and; e. Licensure to practice independently. 3. Clinical nurse specialist/psychiatric and mental health nurse practitioner: Masters degree in nursing with specialization in adult or child/adolescent psychiatric and mental health nursing. Graduate school must be accredited from an institution accredited by one of the Regional Institutional Accrediting Bodies within three (3) years of the time of the practitioners graduation. Registered Nurse license and any additional licensure as an Advanced Practice Nurse/Certified Nurse Specialist/Adult Psychiatric Nursing or other license or certification as dictated by the appropriate State(s) Board of Registered Nursing, if applicable. Certification by the American Nurses Association (ANA) in psychiatric nursing. This may be any of the following types: Clinical Nurse Specialist in Child or Adult Psychiatric Nursing, Psychiatric and Mental Health Nurse Practitioner, or Family Psychiatric and Mental Health Nurse Practitioner. Valid, current, unrestricted DEA/CDS registration, where applicable with appropriate supervision/consultation by a Network practitioner as applicable by the state licensing board. For those who possess a DEA registration, the appropriate CDS registration is required. The DEA/CDS registration must be valid in the state(s) in which the practitioner will be treating Members. 4. Clinical Psychologists: Valid state clinical psychologist license. Doctoral degree in clinical or counseling, psychology or other applicable field of study from an institution accredited by the APA within three (3) years of the time of the practitioners graduation. Education/Training considered as eligible for an exception is a practitioner whose doctoral degree is not from an APA accredited institution, but who is listed in the National Register of Health Service Providers in Psychology or is a Diplomat of the American Board of Professional Psychology. Masters level therapists in good standing in the Network, who upgrade their license to clinical psychologist as a result of further training, will be allowed to continue in the Network and will not be subject to the above education criteria. 5. Clinical Neuropsychologist: Must meet all the criteria for a clinical psychologist listed in C.4 above and be Board certified by either the American Board of Professional Neuropsychology (ABPN) or American Board of Clinical Neuropsychology (ABCN). A practitioner credentialed by the National Register of Health Service Providers in Psychology with an area of expertise in neuropsychology may be considered. Clinical neuropsychologists who are not Board certified, nor listed in the National Register, will require CC review. These practitioners must have appropriate training and/or experience in neuropsychology as evidenced by one or more of the following: Transcript of applicable pre-doctoral training, OR Documentation of applicable formal one (1) year post-doctoral training (participation in CEU training alone would not be considered adequate), OR Letters from supervisors in clinical neuropsychology (including number of hours per week), OR Minimum of five (5) years experience practicing neuropsychology at least ten (10) hours per week. 6. Licensed Psychoanalysts: Applies only to Practitioners in states that license psychoanalysts. Practitioners will be credentialed as a licensed psychoanalyst if they are not otherwise credentialed as a practitioner type detailed in Credentialing Policy (e.g. psychiatrist, clinical psychologist, licensed clinical social worker). Practitioner must possess a valid psychoanalysis state license. Practitioner shall possess a masters or higher degree from a program accredited by one of the Regional Institutional Accrediting Bodies and may be verified from the Accredited Institutions of Post-Secondary Education, APA, CACREP, or the COAMFTE listings. The institution must have been accredited within 3 years of the time the Practitioner graduates. Completion of a program in psychoanalysis that is registered by the licensing state as licensure qualifying; or accredited by the American Board for Accreditation in Psychoanalysis (ABAP) or another acceptable accrediting agency; or determined by the licensing state to be the substantial equivalent of such a registered or accredited program. A program located outside the United States and its territories may be used to satisfy the psychoanalytic study requirement if the licensing state determines the following: it prepares individuals for the professional practice of psychoanalysis; and is recognized by the appropriate civil authorities of that jurisdiction; and can be appropriately verified; and is determined by the licensing state to be the substantial equivalent of an acceptable registered licensure qualifying or accredited program. Meet minimum supervised experience requirement for licensure as a psychoanalyst as determined by the licensing state. Meet examination requirements for licensure as determined by the licensing state. C.. Additional Participation Criteria and Exceptions for Nurse Practitioners, Certified Nurse Midwives, Physicians Assistants (Non Physician) Credentialing. Process, requirements and Verification Nurse Practitioners: The nurse practitioner applicant will submit the appropriate application and supporting documents as required of any other Practitioners with the exception of differing information regarding education/training and board certification. The required education/training will be, at a minimum, the completion of an education program leading to licensure as a Registered Nurse, and subsequent additional education leading to licensure as a NP. Verification of this will occur either via verification of the licensure status from the state licensing agency provided that that agency verifies the education or from the certification board if that board provides documentation that it performs primary verification of the professional education and training If the licensing agency or certification board does not verify highest level of education, the education will be primary source verified in accordance with policy. The license status must be that of NP as verified via primary source from the appropriate state licensing agency. Additionally, this license must be active, unencumbered, unrestricted and not subject to probation, terms or conditions. Any applicants whose licensure status does not meet these criteria, or who have in force adverse actions regarding Medicare or Medicaid will be notified of this and the applicant will be administratively denied. If the NP has prescriptive authority, which allows the prescription of scheduled drugs, their DEA and/or state certificate of prescriptive authority information will be requested and primary source verified via normal Anthem procedures. If there are in force adverse actions against the DEA, the applicant will be notified of this and the applicant will be administratively denied. All NP applicants will be certified in the area which reflects their scope of practice by any one of the following: Certification program of the American Nurse Credentialing Center ( HYPERLINK "http://www.nursecredentialing.org" www.nursecredentialing.org), a subsidiary of the American Nursing Association ( HYPERLINK "http://www.nursingcertification.org/exam_programs.htm" http://www.nursingcertification.org/exam_programs.htm); or American Academy of Nurse Practitioners Certification Program ( HYPERLINK "http://www.aanpcertification.org" www.aanpcertification.org); or National Certification Corporation ( HYPERLINK "http://www.nccwebsite.org" http://www.nccwebsite.org); or Pediatric Nurse Certification Board (PNCB) Certified Pediatric Nurse Practitioner (note: CPN certified pediatric nurse is not a nurse practitioner) ( HYPERLINK "http://www.pncb.org/ptistore/control/exams/ac/progs" http://www.pncb.org/ptistore/control/exams/ac/progs); OR Oncology Nursing Certification Corporation (ONCC) Advanced Oncology Certified Nurse Practitioner (AOCNP) ONLY ( HYPERLINK "http://oncc.org" http://oncc.org); American Association of Critical Care Nurses ( HYPERLINK "https://www.aacn.org/certification/verify-certification" https://www.aacn.org/certification/verify-certification) ACNPC Adult Care Nurse Practitioner; ACNPC-AG Adult Gerontology Acute Care. This certification must be active and primary source verified. This certification must be active and primary source verified. If the state licensing board primary sources verifies this certification as a requirement for licensure, additional verification by Anthem is not required. If the applicant is not certified or if his/her certification has expired, the application will be submitted for individual review. If the NP has hospital privileges, they must have hospital privileges at a CIHQ, TJC, NIAHO, or HFAP accredited hospital, or a network hospital previously approved by the committee. Information regarding history of any actions taken against any hospital privileges held by the NP will be obtained. Any adverse action against any hospital privileges will trigger a level II review. The NP applicant will undergo the standard credentialing processes outlined in Anthems Credentialing Policies. NPs are subject to all the requirements outlined in these Credentialing Policies including (but not limited to): the requirement for Committee review of Level II files for failure to meet predetermined criteria, re-credentialing every three years, and continuous sanction and performance monitoring upon participation in the network. Upon completion of the credentialing process, the NP may be listed in Anthems provider directories. As with all providers, this listing will accurately reflect their specific licensure designation and these providers will be subject to the audit process. NPs will be clearly identified as such: On the credentialing file; At presentation to the Credentialing Committee; and On notification to Network Services and to the provider database. Process, Requirements and Verifications Certified Nurse Midwives: The Certified Nurse Midwife (CNM) applicant will submit the appropriate application and supporting documents as required of any other Practitioner with the exception of differing information regarding education, training and board certification. The required educational/training will be at a minimum that required for licensure as a Registered Nurse with subsequent additional training for licensure as a Certified Nurse Midwife by the appropriate licensing body. Verification of this education and training will occur either via primary source verification of the license, provided that state licensing agency performs verification of the education, or from the certification board if that board provides documentation that it performs primary verification of the professional education and training. If the state licensing agency or the certification board does not verify education, the education will be primary source verified in accordance with policy. The license status must be that of CNM as verified via primary source from the appropriate state licensing agency. Additionally, this license must be active, unencumbered, unrestricted and not subject to probation, terms or conditions. Any applicant whose licensure status does not meet these criteria, or who have in force adverse actions regarding Medicare or Medicaid will be notified of this and the applicant will be administratively denied. If the CNM has prescriptive authority, which allows the prescription of scheduled drugs, their DEA and/or state certificate of prescriptive authority information will be requested and primary source verified via normal Anthem procedures. If there are in force adverse actions against the DEA, the applicant will be notified and the applicant will be administratively denied. All CNM applicants will be certified by either: The National Certification Corporation for Ob/Gyn and Neonatal Nursing; or The American Midwifery Certification Board, previously known as the American College of Nurse Midwifes. This certification must be active and primary source verified. If the state licensing board primary source verifies one of these certifications as a requirement for licensure, additional verification by Anthem is not required. If the applicant is not certified or if their certification has expired, the application will be submitted for individual review by the geographic Credentialing Committee. If the CNM has hospital privileges, they must have unrestricted hospital privileges at a CIHQ, TJC, NIAHO, or HFAP accredited hospital, or a network hospital previously approved by the committee or in the absence of such privileges, must not raise a reasonable suspicion of future substandard professional conduct or competence. Information regarding history of any actions taken against any hospital privileges held by the CNM will be obtained. Any history of any adverse action taken by any hospital will trigger a Level II review. Should the CNM provide only outpatient care, an acceptable admitting arrangement via the collaborative practice agreement must be in place with a participating OB/Gyn. The CNM applicant will undergo the standard credentialing process outlined in Anthems Credentialing Policies. CNMs are subject to all the requirements of these Credentialing Policies including (but not limited to): the requirement for Committee review for Level II applicants, re-credentialing every three years, and continuous sanction and performance monitoring upon participation in the network. Upon completion of the credentialing process, the CNM may be listed in Anthems provider directories. As with all providers, this listing will accurately reflect their specific licensure designation and these providers will be subject to the audit process. CNMs will be clearly identified as such: On the credentialing file; At presentation to the Credentialing Committee; and On notification to Network Services and to the provider database. Process, Requirements and Verifications Physicians Assistants (PA): The PA applicant will submit the appropriate application and supporting documents as required of any other Practitioners with the exception of differing information regarding education/training and board certification. The required education/training will be, at a minimum, the completion of an education program leading to licensure as a PA. Verification of this will occur via verification of the licensure status from the state licensing agency provided that that agency verifies the education. If the state licensing agency does not verify education, the education will be primary source verified in accordance with policy. The license status must be that of PA as verified via primary source from the appropriate state licensing agency. Additionally, this license must be active, unencumbered, unrestricted and not subject to probation, terms or conditions. Any applicants whose licensure status does not meet these criteria, or who have in force adverse actions regarding Medicare or Medicaid will be notified of this and the applicant will be administratively denied. If the PA has prescriptive authority, which allows the prescription of scheduled drugs, their DEA and/or state certificate of prescriptive authority information will be requested and primary source verified via normal Anthem procedures. If there are in force adverse actions against the DEA, the applicant will be notified and the applicant will be administratively denied. All PA applicants will be certified by the National Commission on Certification of Physicians Assistants. This certification must be active and primary source verified. If the state licensing board primary sources verifies this certification as a requirement for licensure, additional verification by Anthem is not required. If the applicant is not certified or if their certification has expired, the application will be classified as a Level II according to geographic Credentialing Policy #8 and submitted for individual review by the Credentialing Committee. If the PA has hospital privileges, they must have hospital privileges at a CIHQ, TJC, NIAHO, or HFAP accredited hospital, or a network hospital previously approved by the committee. Information regarding history of any actions taken against any hospital privileges held by the PA will be obtained. Any adverse action against any hospital privileges will trigger a level II review. The PA applicant will undergo the standard credentialing process outlined in Anthems Credentialing Policies. PAs are subject to all the requirements described in these Credentialing Policies including (but not limited to): Committee review of Level II files failing to meet predetermined criteria, re-credentialing every three years, and continuous sanction and performance monitoring upon participation in the network. Upon completion of the credentialing process, the PA may be listed in Anthem provider directories. As with all providers, this listing will accurately reflect their specific licensure designation and these providers will be subject to the audit process. PAs will be clearly identified such: On the credentialing file; At presentation to the Credentialing Committee; and On notification to Network Services and to the provider database. Currently Participating Applicants (Recredentialing) Submission of complete re-credentialing application and required attachments that must not contain intentional misrepresentations; Re-credentialing application signed date within one hundred eighty (180) calendar days of the date of submission to the CC for a vote; Must not be currently federally sanctioned, debarred or excluded from participation in any of the following programs; Medicare, Medicaid or FEHBP. If, once a Practitioner participates in Anthems programs or provider Network(s), federal sanction, debarment or exclusion from the Medicare, Medicaid or FEHBP programs occurs, at the time of identification, the Practitioner will become immediately ineligible for participation in the applicable government programs or provider Network(s) as well as Anthems other credentialed provider Network(s). Current, valid, unrestricted, unencumbered, unprobated license to practice in each state in which the practitioner provides care to Members; No new history of licensing board reprimand since prior credentialing review; *No current federal sanction and no new (since prior credentialing review) history of federal sanctions (per SAM, OIG and OPM Reports or on NPDB report); Current DEA/CDS registration and/or state controlled substance certification without new (since prior credentialing review) history of or current restrictions; No current hospital membership or privilege restrictions and no new (since prior credentialing review) history of hospital membership or privilege restrictions; OR for practitioners in a specialty defined as requiring hospital privileges who practice solely in the outpatient setting there exists a defined referral relationship with a Network practitioner of similar specialty at a Network HDO who provides inpatient care to Members needing hospitalization; No new (since previous credentialing review) history of or current use of illegal drugs or alcoholism; No impairment or other condition which would negatively impact the ability to perform the essential functions in their professional field; No new (since previous credentialing review) history of criminal/felony convictions, including a plea of no contest; Malpractice case history reviewed since the last CC review. If no new cases are identified since last review, malpractice history will be reviewed as meeting criteria. If new malpractice history is present, then a minimum of last five (5) years of malpractice history is evaluated and criteria consistent with initial credentialing is used. No new (since previous credentialing review) involuntary terminations from an HMO or PPO; No new (since previous credentialing review) "yes" answers on attestation/disclosure questions with exceptions of the following: voluntary resignation from a hospital or organization related to practice relocation or facility utilization; voluntary surrender of state license related to relocation or nonuse of said license; an NPDB report of a malpractice settlement or any report of a malpractice settlement that does not meet the threshold criteria; nonrenewal of malpractice coverage or change in malpractice carrier related to changes in the carriers business practices (no longer offering coverage in a state or no longer in business); previous failure of a certification exam by a practitioner who is currently board certified or who remains in the five (5) year post residency training window; actions taken by a hospital against a practitioners privileges related solely to the failure to complete medical records in a timely fashion; history of a licensing board, hospital or other professional entity investigation that was closed without any action or sanction. No QI data or other performance data including complaints above the set threshold. Recredentialed at least every three (3) years to assess the practitioners continued compliance with Anthem standards. *It is expected that these findings will be discovered for currently credentialed Network practitioners and HDOs through ongoing sanction monitoring. Network practitioners and HDOs with such findings will be individually reviewed and considered by the CC at the time the findings are identified. Note: the CC will individually review any credentialed Network practitioners and HDOs that do not meet one or more of the criteria for recredentialing. HDO Eligibility Criteria All HDOs must be accredited by an appropriate, recognized accrediting body or in the absence of such accreditation, Anthem may evaluate the most recent site survey by Medicare, the appropriate state oversight agency, or site survey performed by a designated independent external entity within the past 36 months. If a HDO has satellite facilities that follow the same policy and procedures, Anthem may limit site visits to the main facility. Non-accredited HDOs are subject to individual review by the CC and will be considered for Member access need only when the CC review indicates compliance with Anthem standards and there are no deficiencies noted on the Medicare or state oversight review which would adversely affect quality or care or patient safety. HDOs are recredentialed at least every three (3) years to assess the HDOs continued compliance with Anthem standards. General Criteria for HDOs: Valid, current and unrestricted license to operate in the state(s) in which it will provide services to Members. The license must be in good standing with no sanctions. Valid and current Medicare certification. Must not be currently federally sanctioned, debarred or excluded from participation in any of the following programs; Medicare, Medicaid or the FEHBP. Note: If, once an HDO participates in Anthems programs or provider Network(s), exclusion from Medicare, Medicaid or FEHBP occurs, at the time of identification, the HDO will become immediately ineligible for participation in the applicable government programs or provider Network(s) as well as Anthems other credentialed provider Network(s). Liability insurance acceptable to Anthem. If not appropriately accredited, HDO must submit a copy of its CMS, state site or a designated independent external entity survey for review by the CC to determine if Anthems quality and certification criteria standards have been met. Additional Participation Criteria for HDO by Provider Type: HDO Type and Anthem Approved Accrediting Agent(s) Medical Facilities Facility Type (Medical Care)Acceptable Accrediting AgenciesAcute Care HospitalCIQH, CTEAM, DNV/NIAHO, HFAP, TJCAmbulatory Surgical CentersAAAASF, AAAHC, AAPSF, HFAP, IMQ, TJCBirthing CenterAAAHC, CABC, TJCClinical LaboratoriesCLIA, COLADialysis CenterCMS Certification, TJCHome Health Care Agencies (HHA)ACHC, CHAP, CTEAM , DNV/NIAHO, TJCHome Infusion Therapy (HIT)ACHC, CHAP, CTEAM, HQAA, TJCPortable Xray ServicesFDA CertificationSkilled Nursing Facilities/Nursing HomesBOC INT'L, CARF, TJC Behavioral Health Facility Type (Behavioral Health Care)Acceptable Accrediting AgenciesAcute Care HospitalPsychiatric Disorders CTEAM, DNV/NIAHO, TJC, HFAPAdult Family Care Homes (AFCH)ACHC, TJCAdult Foster CareACHC, TJCCommunity Mental Health Centers (CMHC) AAAHC, CARF, CHAP, COA,TJCCrisis Stabilization UnitTJCIntensive Family Intervention ServicesCARFIntensive Outpatient Mental Health and/or Substance AbuseACHC, CARF, COA, DNV/NIAHO, TJC Outpatient Mental Health ClinicCARF, CHAP, COA, HFAP, TJCPartial Hospitalization/Day TreatmentPsychiatric Disorders and/or Substance AbuseCARF, DNV/NIAHO, HFAP, TJCResidential Treatment Centers (RTC) Psychiatric Disorders and/or Substance AbuseCARF, COA, DNV/NIAHO, HFAP, TJC Rehabilitation Facility Type (Behavioral Health Care)Acceptable Accrediting AgenciesAcute Inpatient Hospital Detoxification Only FacilitiesDNV/NIAHO, HFAP, TJC, CTEAMBehavioral Health Ambulatory DetoxCARF, TJCMethadone Maintenance ClinicCARF, COA, TJCOutpatient Substance Abuse ClinicsCARF, TJC  Quality Improvement Program Quality Improvement Program Overview Together, we are transforming health care with trusted and caring solutions. We believe health care is local and Anthem has the strong local presence required to understand and meet Member needs. Anthem is well positioned to deliver what Members want: innovative, choice-based products; distinctive service; simplified transactions; and better access to information for quality care. Our local presence and broad expertise create opportunities for collaborative programs that reward Providers and Facilities for clinical quality and excellence. Providers and Facilities are expected to cooperate with Quality Improvement activities. Our commitment to health improvement and care management provides added value to Members and health care professionals helping improve both health and health care costs. Anthem takes a leadership role to improve the health of communities and is helping to address some of health cares most pressing issues. The Quality Improvement (QI) Program Description defines the quality infrastructure that supports Anthems QI strategies. The QI Program Description establishes QI Program governance, scope, goals, objectives, structure, and responsibilities encompassing the quality of medical and behavioral health care and services provided to Members. The QI Work Plan is developed and implemented which reflects ongoing progress made on QI activities during the year. The QI Work Plan includes Anthems approach to patient safety for Members and improving medical and behavioral health care: quality of clinical care, safety of clinical care, quality of service and Members experience. The QI Evaluation assesses outcomes of Anthems medical and behavioral health care programs, processes, activities and performance in the quality and safety of clinical care and service. The QI Evaluation also evaluates how the QI Program goals and objectives were met. Goals and Objectives The following QI Program goals and objectives support Anthems vision and values, promote continuous improvement in quality care, patient safety for Members and quality of service to Members, Providers and Facilities: To develop and maintain a well-integrated system to continuously identify, measure, assess, and improve clinical and service quality outcomes through standardized and collaborative activities. To respond to the needs and expectations of internal and external customers by evaluating performance and taking action relative to meeting those needs and expectations, including compliance with regulatory and accreditation requirements, policies and procedures. To promote processes that helps reduce medical errors and improves patient safety for Members by implementing member-focused, provider and safety initiatives. To identify and promote educational opportunities for Members, medical and behavioral health care providers and other health care professionals. For multicultural health strategies to improve the health and health care of Anthems multicultural Members. To help maximize health status, improve health outcomes and reduce health care costs of Members through effective Case Management (CM) and Disease Management (DM) programs addressing complex care needs.  TC "V. OBJECTIVES" \f C \l "1" As part of the QI Program, initiatives in these major areas include, but are not limited to: Quality and Safety of Clinical Care Chronic Disease and Prevention: Anthem focuses on Member and/or Provider/Facility outreach for chronic conditions like asthma, heart disease, diabetes, and Chronic Obstructive Pulmonary Disease (COPD) and for preventive health services such as immunizations and cancer screenings. Improvements in these areas result in improved clinical measures such as HEDIS (Healthcare Effectiveness Data and Information Set)1. Behavioral Health Case Management: A program designed to provide a comprehensive and integrated approach to early identification, treatment, intensive case management and individualized recovery support for Members with complex behavioral health conditions who are at risk for negative outcomes and high costs. Community Health: Anthem has committed resources and worked with key entities to co-create community-based health initiatives to address public health concerns and societal problems including behavioral health/substance abuse disorder, cancer, diabetes and maternal and child health. Disease Management: The ConditionCare program is designed to help maximize health status, improve health outcomes, and reduce health care costs of Members diagnosed with Asthma (Pediatric and Adult), Diabetes (Type 1 and Type 2, Pediatric and Adult), Coronary Artery Disease (CAD), Heart Failure (HF) and COPD. The DM program was created and developed based on recent versions of nationally accepted evidence-based Clinical Practice Guidelines (CPGs). These guidelines are reviewed at least every two years, and program interventions and protocols are updated accordingly. Health and Wellness: Programs offer a seamless integration of preventive care, wellness, care management coordination services and online and mobile tools. The programs are clinically driven and designed to help Members better manage individual health and make more informed health care decisions. Programs include: MyHealth Coach (MHC), MyHealth Advantage (MHA), Neonatal Intensive Care Unit (NICU) program, Worksite Wellness, Healthy Lifestyles (HL), and Healthwise Knowledge Base (HWKB). Service Quality Anthem periodically surveys its Members, monitors the quality of care and service of network providers and strives to provide excellent service to Members, Providers and Facilities. Anthem actively analyzes business processes, trends, identifies and takes action on opportunities to improve the Member, Provider and Facility experience, recommending appropriate activities to address root causes. Patient Safety for Members The strategic vision is to establish and maintain goals in advancing patient safety for Members. This program is structured to align with the overall mission and national patient safety for Members strategy. The goals are to work with physicians, hospitals in the network and other health care partners to reduce adverse drug events, health care associated conditions, hospital readmissions and avoidable cost of care, as well as develop innovative programs to accelerate improvements in quality and safety. Priority areas include medication safety, radiation safety, surgical safety, infection control, protection, engagement, care management and payment innovation. Patient safety for member initiatives are managed by various business units within the enterprise, but tracked by a single unit. These member- and provider-facing initiatives/activities are designed to meet regulatory and accreditation requirements and consumer needs. Whenever possible, nationally endorsed clinical metrics are used to evaluate progress. 1 HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA). Member Rights and Responsibilities The delivery of quality health care requires cooperation between Members, their Providers and Facilities and their health care benefit plans. One of the first steps is for Members, Providers and Facilities to understand member rights and responsibilities. Therefore, Anthem has adopted a Members Rights and Responsibilities statement which can be accessed on anthem.com. Select the Provider link at the top of the landing page, then select Providers Overview and Connecticut as your state. From the provider home page, select the Health & Wellness tab, then Quality Improvement and Standards, and finally Member Rights and Responsibilities. Members or Providers who do not have access to the website can request copies by contacting Anthem. Members can call the Member Services number, and Providers can call the Provider Services number on the back of the Member ID card. Continuity and Coordination of Care Anthem encourages communication between all physicians, including primary care physicians (PCPs) and medical specialists, as well as other health care professionals who are involved in providing care to Anthem Members. Please discuss the importance of this communication with each Member and make every reasonable attempt to elicit permission to coordinate care at the time treatment begins. HIPAA allows the exchange of information between Covered Entities for the purposes of Treatment, Payment and Health Care Operations. The Anthem QI Program is an ongoing and integrative program, which features a number of evaluative surveys and improvement activities designed to help ensure the continuity and coordination of care across physician and other health care professional sites, enhancing the quality, safety, and appropriateness of medical and behavioral health care services offered by Providers. Continuity of Care/Transition of Care Program This program is for Members when their Provider or Facility terminates from the network and new Members (meeting certain criteria) who have been participating in active treatment with a provider not within Anthems network. Anthem makes reasonable efforts to notify Members affected by the termination of a Provider or Facility according to contractual, regulatory and accreditation requirements andprior to the effective termination date. Anthem also helps them select a new Provider or Facility. Anthem will work to facilitate the Continuity of Care/Transition of Care (COC/TOC) when Members, or their covered dependents with qualifying conditions, need assistance in transitioning to in-network Providers or Facilities. The goal of this process is to minimize service interruption and to assist in coordinating a safe transition of care. Completion of Covered Services may be allowed at an in-network benefit and reimbursement level with an out-of-network provider for a period of time, according to contractual, regulatory and accreditation requirements, when necessary to complete a course of treatment and to arrange for a safe transfer to an in-network Provider or Facility. Completion of Covered Services by a Provider or Facility whose contract has been terminated or not renewed for reasons relating to medical disciplinary cause or reason, fraud or other criminal activity will not be facilitated. Members may contact Customer Care to get information on Continuity of Care/Transition of Care. Quality In Sights : Hospital Incentive Program (Q-HIP) The Quality-In-Sights: Hospital Incentive Program (Q-HIP) is our performance-based reimbursement program for hospitals. The mission of Q-HIP is to help improve patient outcomes in a hospital setting and promote health care value by financially rewarding hospitals for practicing evidence-based medicine and implementing best practices. Q-HIP strives to promote improvement in health care quality and to raise the bar by moving the bell shaped quality curve to the right towards high performance. Q-HIP measures are credible, valid, and reliable because they are based on measures developed and endorsed by national organizations which may include: American College of Cardiology (ACC) Center for Medicare and Medicaid Services (CMS) Institute for Healthcare Improvement (IHI) National Quality Forum (NQF) The Joint Commission (JC) The Society of Thoracic Surgeons (STS) In order to align Q-HIP goals with national performance thresholds, the Q-HIP benchmarks and targets are based on national datasets such as the Centers for Medicare and Medicaid Services Hospital Compare database. The measures can be tracked and compared within and among hospital[s] for all patient data regardless of health plan carrier. Annual meetings are held with participating hospitals from across the country, offering participants an opportunity to share feedback regarding new metrics and initiatives. Additionally, a National Advisory Panel on Value Solutions (NAPVS) was established in 2009 to provide input during the scorecard development process. The NAPVS is made up of patient safety and quality leaders from health systems and academic medical centers from across the country and offers valuable advice and guidance as new measures are evaluated for inclusion in the program. Participating hospitals are required to provide Anthem with data on measures outlined in the Q-HIP Manual. Q-HIP measures are based on commonly accepted indicators of their quality of care. Participating hospitals will receive a copy of their individual scorecard which shows their performance on the Q-HIP measures. Anthem Quality-In-Sights Incentive Program (AQI) Anthem evaluates and financially rewards eligible Primary Physicians and some specialties for achieving measures related to preventive care, quality of care and patient safety. The Anthem Quality- In-Sights Incentive Program (AQI) represents an initiative with eligible participating physicians. This program is the physician component to a suite of quality initiatives and health improvement programs with emphasis on some of the most pervasive and costly health concerns of our times. This program rewards performance for physicians based on nationally endorsed industry standard measures of quality as well as technology adoption, applicable external recognition and resource measures aimed at improving quality and cost-effectiveness of patient care. Anthem offers POIT (Provider Online Interactive Tool) a web-based interactive tool which may be accessed through Availity. Your Availity access will give you automatic access to POIT. The AQI POIT Web Portal is a secure website, you will find details about components of the program such as the Clinical Quality Measures Composite and the External Physician Recognition Composite, as well as the program measures and the method of reward for those who meet or exceed the targets. In addition, you will find the annual provider survey, an on line application, that needs to be completed and submitted annually no later than February 28th following the measurement year. If you are not a registered Availity user, please refer to the section on Availity in this manual for information on registering for access. Performance Data Provider/Facility Performance Data means compliance rates, reports and other information related to the appropriateness, cost, efficiency and/or quality of care delivered by an individual healthcare practitioner, such as a physician, or a healthcare organization, such as a hospital. Common examples of performance data would include the Healthcare Effectiveness Data and Information Set (HEDIS) quality of care measures maintained by the National Committee for Quality Assurance (NCQA) and the comprehensive set of measures maintained by the National Quality Forum (NQF). Provider/Facility Performance Data may be used for multiple Plan programs and initiatives, including but not limited to: Reward Programs Pay for performance (P4P), pay for value (PFV) and other results-based reimbursement programs that tie Provider or Facility reimbursement to performance against a defined set of compliance metrics. Reimbursement models include but are not limited to total cost of care shared savings/risk programs, enhanced fee schedules and episode bundled payment arrangements. Recognition Programs Programs designed to transparently identify high value Providers and Facilities and make that information available to consumers, employers, peer practitioners and other healthcare stakeholders. Additional Information on Anthem Quality Improvement Programs Please refer to  HYPERLINK "https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f2/s4/t0/pw_003178.htm&label=QUALITY%20IMPROVEMENT%20AND%20STANDARDS&rootLevel=1&state=ct&label=Quality%20Improvement%20and%20Standards%20" CT Quality Improvements and Standards for additional information on Anthems Quality Improvement programs.  Overview of HEDIS HEDIS (Healthcare Effectiveness Data and Information Set) is a set of standardized performance measures used to compare the performance of managed care plans and physicians based on value rather than cost. HEDIS is coordinated and administered by NCQA and is one of the most widely used sets of health care performance measures in the United States. Anthems HEDIS Quality Team is responsible for collecting clinical information from Provider offices in accordance with HEDIS specifications. Record requests to Provider offices begin in early February and Anthem requests that the records be returned within 5 business days to allow time to abstract the records and request additional information from other Providers, if needed. Health plans use HEDIS data to encourage their contracted providers to make improvements in the quality of care and service they provide. Employers and consumers use HEDIS data to help them select the best health plan for their needs. More information on HEDIS can be found online at anthem.com. Select Providers, then Providers Overview. From the provider home page, select the Health and Wellness tab on the top menu bar, then select Quality Improvement and Standards from the drop-down menu. Scroll down to the section titled HEDIS Information You may also follow this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f2/s4/t0/pw_003178.htm&state=ct&rootLevel=1&label=Quality%20Improvement%20and%20Standards.%20" HEDIS Information HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).  Overview of CAHPS CAHPS (Consumer Assessment of Healthcare Providers and Systems) surveys represent an effort to accurately and reliably capture key information from Anthems Members about their experiences with Anthems Health Plans in the past year. This includes the Members access to medical care and the quality of the services provided by Anthems network of Providers. Anthem analyzes this feedback to identify issues causing Members dissatisfaction and works to develop effective interventions to address them. Anthem takes this survey feedback very seriously. Health Plans report survey results to National Committee for Quality Assurance (NCQA), which uses these survey results for the annual accreditation status determinations and to create National benchmarks for care and service. Health Plans also use CAHPS survey data for internal quality improvement purposes. Results of these surveys are shared with Providers annually via our provider newsletter, so they have an opportunity to learn how Anthem Members feel about the services provided. Anthem encourages Providers to assess their own practice to identify opportunities to improve patients access to care and improve interpersonal skills to make the patient care experience a more positive one. Our Provider newsletters can be found online at:  HYPERLINK "https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003096.htm&state=ct&rootLevel=4&label=Provider%20Newsletters" Network Updates CAHPS is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).  Clinical Practice Guidelines Anthem considers clinical practice guidelines to be an important component of health care. Anthem adopts nationally recognized clinical practice guidelines, and encourages physicians to utilize these guidelines to improve the health of our Members. Several national organizations such as, National Heart, Lung and Blood Institute, American Diabetes Association and the American Heart Association, produce guidelines for asthma, diabetes, hypertension, and other conditions. The guidelines, which Anthem uses for quality and disease management programs, are based on reasonable medical evidence. We review the guidelines at least every two years or when changes are made to national guidelines for content accuracy, current primary sources, new technological advances and recent medical research. Providers can access the up-to-date listing of the medical, preventive and behavioral health guidelines through the Internet.To access the guidelines, go to anthem.com>Providers>CT. On the Provider Home page, click to open the Health and Wellness tab (which can be found on the blue toolbar across the top of the screen) and from the drop down menu, select the link titled Practice Guidelines and from this screen select Clinical Practice Guidelines. You may also use the link below:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_003161.htm&label=Clinical%20Practice,%20Preventive%20Health,%20and%20Behavioral%20Health%20Guidelines&rootLevel=1&state=ct&label=Practice%20Guidelines%20" Clinical Practice Guidelines. With respect to the issue of coverage, each Member should review his/her Certificate of Coverage and Schedule of Benefits for details concerning benefits, procedures and exclusions prior to receiving treatment. The Certificate of Coverage and/or Schedule of Benefits supersede the clinical practice guidelines.  Preventive Health Guidelines Anthem considers prevention an important component of health care. Anthem develops preventive health guidelines in accordance with recommendations made by nationally recognized organizations and societies such as the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), the Advisory Committee on Immunizations Practices (ACIP), the American College of Obstetrics and Gynecology (ACOG) and the United States Preventive Services Task Force (USPSTF). The above organizations make recommendations based on reasonable medical evidence. We review the guidelines annually for content accuracy, current primary sources, new technological advances and recent medical research and make appropriate changes based on this review of the recommendations and/or preventive health mandates. We encourage physicians to utilize these guidelines to improve the health of our Members. The current guidelines are available on our website. In order to access these guidelines, go to anthem.com>Providers Overview>CT. On the Provider Home page, click to open the Health and Wellness tab (which can be found on the blue toolbar across the top of the screen) and from the drop down menu, select the link titled Practice Guidelines, or use the link below. On this screen, select Preventive Health Guidelines.  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_003161.htm&label=Clinical%20Practice,%20Preventive%20Health,%20and%20Behavioral%20Health%20Guidelines&rootLevel=1&state=ct&label=Practice%20Guidelines%20" Preventive Health Guidelines. With respect to the issue of coverage, each Member should review his/her Certificate of Coverage and Schedule of Benefits for details concerning benefits, procedures and exclusions prior to receiving treatment. The Certificate of Coverage and/or Schedule of Benefits supersede the preventive health guidelines.  Medical Record Standards Anthem recognizes the importance of medical record documentation in the delivery and coordination of quality care. Anthem has medical record standards that require Providers and Facilities to maintain medical records in a manner that is current, organized, and facilitates effective and confidential medical record review for quality purposes. For more information on Medical Record standards, please go to the Provider home page at anthem.com. by selecting the Provider link at the top of the home page of  HYPERLINK "http://www.anthem.com" www.anthem.com (under the Other Anthem Websites section).Select your state and click enter. On the Provider home page under the Health and Wellness tab (on the blue toolbar), choose Quality Improvement and Standards, and then scroll down to Medical Record Review.  Multicultural Health Multicultural Health Overview Anthem identifies and addresses health and healthcare disparities among Members based on key clinical quality metrics, evidence-based research, and member experience metrics. We aim to help eliminate these disparities and promote health equity. Our core strategies for helping to mitigate disparities and achieve equity include the following: Monitor the quality of health care to identify actionable health and health care disparities trends Identify clinical and geographic areas exhibiting health and health care disparities and design appropriate interventions to help close those gaps Establish baseline data and measures/evaluates the results of program interventions Support Member access to equitable treatment, standards of care and services based on their Plan benefits Promote Culturally and Linguistically Appropriate Services (CLAS) Offer education, tools and subject matter expertise to Providers and Facilities that may help them achieve the shared goal of providing quality care and service equally to their patients Facilitate cultural competency of Anthem associates to help meet the Members needs for access to culturally sensitive, linguistically appropriate care and service Offer education, tools and subject matter expertise to Members that may help them improve their health literacy, allowing better communication with their doctors and Anthem about their health care and service Promote the Department of Health and Human Services Office of Minority Healths National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care (the National CLAS standards).  HYPERLINK "https://www.thinkculturalhealth.hhs.gov/clas/standards" https://www.thinkculturalhealth.hhs.gov/clas/standards Develop programs to help improve health status and outcomes Promote consumer-centered care that addresses the Members values, needs and preferences in reaching optimal health care and outcomes standards Support communities in which Anthem does business with cultural and linguistic programs and services Collaborate with other industry and government efforts to help reduce and eliminate health disparities Anthem Innovation HYPERLINK "http://www.mydiversepatients.com/"MyDiversePatients.com: An online resource to support your diverse patient panel Anthem strives to meet the needs of our diverse membership and promotes access to consistently high quality standards across our networks. We believe that by offering our Providers and Facilities the types of learning experiences described above, we can help keep all our Members healthy. In addition, these online experiences reinforce our commitment to promoting health equity for our diverse Members as referenced in our Provider and Facility contractual non-discrimination provisions. All learning experiences can be found on HYPERLINK "http://www.mydiversepatients.com/"MyDiversePatients.com, a website that features robust resources for Providers to help support addressing racial and ethnic disparities in health and health care: CME learning experiences about disparities, potential contributing factors, and opportunities for Providers to enhance care. Real-life stories about diverse patients and the unique challenges they face. Tips and techniques for working with your diverse patients to promote improvement in health outcomes. While theres no single easy answer to the issue of health care disparities, the vision of HYPERLINK "http://www.mydiversepatients.com/"MyDiversePatients.com is to start reversing these trendsone patient at a time. Embrace the knowledge, skills, ideals, strategies, and techniques to accelerate your journey to becoming your patients trusted health care partner by visiting HYPERLINK "http://www.mydiversepatients.com/"MyDiversePatients.com today. Descriptions of the learning experiences and tools are listed below. Moving Toward Equity in Asthma Care Built upon extensive research and data analytics, the Moving Toward Equity in Asthma Care online CME experience offers 1 hour of Continuing Medical Education (CME) credit through the American Academy of Family Physicians, and includes scenarios that fulfill the following learning objectives: Describe common racial and ethnic asthma disparities and their effects on diverse patients ability to successfully control their asthma. Describe ways Providers may unknowingly contribute to poor asthma care for diverse populations. Explain ways Providers can improve the quality of asthma care to enhance outcomes among African Americans, Hispanic and Asian patients. Explain the importance of using spirometry to assess the severity of asthma accurately. Explain the concept of unconscious bias. A Resources section contains additional information on asthma disparities. The experience was developed in an effort to address the substantial gaps in asthma care and outcomes for diverse populations and can be accessed at  HYPERLINK "http://www.mydiversepatients.com/le-asthma.html" www.mydiversepatients.com/le-asthma.html. Primary Audiences include: Physicians (Family Practice, Pediatrician, Pulmonologist, Allergist Immunologist), Nurse Practitioners, Registered Nurse (RN), Licensed Vocational Nurse (LVN), and Licensed Practical Nurse (LPN). Asthma & Me App Are you looking for innovative ways to educate and engage your patients with asthma? The Asthma & Me app is an interactive and fun way to show patients the physiology of their asthma. The app is a free support tool that uses face detection technology along with augmented reality to simulate a diseased airway. When the camera on the mobile device is aimed at the patients face, an animation of the lungs is overlaid and a short video illustrating the physiology of an asthma attack is produced and recorded. The video can be used to facilitate discussion with the patient about what occurs during an asthma attack airway inflammation, bronchiole constriction, and mucus production. The video can be saved and shared via social media or email. The app is currently available in three languages: English, Spanish, and Tagalog. The language is selected based on the patients smartphone or tablet settings. The Asthma & Me app can be accessed at  HYPERLINK "http://www.MyDiversePatients.com" MyDiversePatients.com using your smartphone, tablet, or computer. The app supplements the Moving Toward Equity in Asthma Care online provider CME experience, which is also available on the site as well as  HYPERLINK "http://www.mydiversepatients.com/le-asthma.html" www.mydiversepatients.com/le-asthma.html Creating an LGBT-Friendly Practice What you may not know about your Lesbian, Gay, Bisexual, or Transgender (LGBT) patients may be putting their health at risk. Studies have shown that many LGBT patients fear they will be treated differently in health care settings and that this fear of discrimination prevents them from seeking primary care. Anthem joins you in striving for the best clinical outcomes for everyone, including LGBT populations. Thats why Anthem has created an online experience that provides strategies, tools, and resources to Providers and Facilities interested in attracting or maintaining an LGBT patient panel. Hopefully, as a result of increasing LGBT-friendly practices, we will see an increase in primary care and prevention among LGBT patients. Like you, Anthem strives to meet the needs of our diverse membership and promotes access to consistently high quality standards across our networks. We believe that by offering our Providers and Facilities these types of experiences, we can help keep all our Members healthy. In addition, this online experience reinforces our commitment to equality for our LGBT Members as referenced in our Provider and Facility contractual non-discrimination provisions. Visit www.mydiversepatients.com/le-lgbt.html for free 24/7 access to the experience either via computer, tablet or smartphone. The course has been approved for 1 AAFP Prescribed credit, which is equivalent to AMA PRA Category 1 Credit. Reducing Health Care Stereotype Threat (HCST): Assuring your diverse patients they are not being judged due to their race/ethnicity Your diverse patients may feel threatened about being personally reduced to group stereotypes. Their fear of being prejudged or stigmatized based on phenotype may be omnipresent throughout their life journeys and may be present during health care interactions with you or your team. A perceived health care stereotype threat is not the same as discrimination. Instead, it is a situational, psychosocial phenomenon that may contribute to disparities. As a trusted health care Provider, you can make a difference. Find out how to recognize when your patients may be experiencing this threat. Then explore how to foster a threat-safe environment with practical shifts you can make today. Visit the Provider pages online at www.mydiversepatients.com/le-hcst.html for free 24/7 access to the experience-either via your computer, tablet or smartphone. You will better understand Health Care Stereotype Threat (HCST) and its implications for multicultural patient groups and also learn how to recognize when your patients may be experiencing HCST. In addition, you will learn the benefits of reducing HCST to both your patients and your practice. The course is approved for 1 AAFP Prescribed credit, which is the equivalent to AMA PRA Category 1 Credit. Medication Adherence You want whats best for your patients health. So, it's challenging when a patient doesn't follow your prescribed treatment plan. Why do approximately 50% of patients with chronic illness stop taking their medications within one year of being prescribed1? Wheres the disconnect? What can be done differently? As a health care provider, you care about your patients. However, you may only be seeing and hearing the tip of the icebergthe observable portion of the thoughts and emotions your patient is experiencing. The barriers that exist under the waterline -- the Titanic-sized, often invisible, patient self-talk that may not get discussed -- can create a misalignment between patient and provider. So weve created an online learning experience for the skills and techniques that may help you navigate these uncharted patient waters. After completing the learning experience youll know how to see the barriers, use each appointment as an opportunity to build trust, and bring to light the concerns that may be occurring beneath the surface of your patient interactions. Understanding and addressing these concerns may help improve medication adherenceand youll earn CME credit along the way. The course is approved for 1 AAFP Prescribed credit, which is the equivalent to AMA PRA Category 1 Credit. Take the next step. Go to  HYPERLINK "https://mydiversepatients.com/" MyDiversePatients.com > The Medication Adherence Iceberg: How to navigate what you cant see to enhance your skills. 1 Center for Disease Control and Prevention. (2017, February 1). Overcoming Barriers to Medication Adherence for Chronic Conditions. Retrieved from  HYPERLINK "https://www.cdc.gov/cdcgrandrounds/archives/2017/february2017.htm" https:// HYPERLINK "https://www.cdc.gov/cdcgrandrounds/archives/2017/february2017.htm" www.cdc.gov/cdcgrandrounds/archives/2017/february2017.htm  Centers of Medical Excellence Anthem currently offers access to Centers of Medical Excellence (CME) programs in solid organ and blood/marrow transplants, bariatric surgery, cancer care, cardiac care, maternity, spine surgery, and knee/hip replacement surgery. As much of the demand for CME programs has come from National Accounts, most of our programs are developed in partnership with the Blue Cross and Blue Shield Association (BCBSA) and other Blue plans to ensure adequate geographic coverage. The BCBSA refers to its designated CME providers as Blue Distinction Centers for Specialty Care (BDC). Using objective information and input from the medical community, the BCBSA has designated hospitals as Blue Distinction Centers that are proven to outperform their peers in the areas that matter to you quality, safety and, in the case of Blue Distinction Centers+ (BDC+), cost efficiency. For transplants and ventricular assist devices (VAD), Members also have access to the Anthem Centers of Medical Excellence Transplant and VAD Network. The CME designation is awarded to qualified programs by a panel of national experts currently practicing in the fields of solid organ, marrow transplantation, and cardiac surgery representing centers across the country. EachCenter must meet Anthems CME participation requirements and is selected through a rigorous evaluation of clinical data that provides insight into the Facility's structures, processes, and outcomes of care. Current transplant designations include the following transplants: autologous/allogeneic bone marrow/stem cell, heart, lung, combination heart/lung, liver, kidney, simultaneous kidney/pancreas and pancreas. For both the BDC and Anthem CME programs, selection criteria are designed to evaluate overall quality, providing a comprehensive view of how the Facility delivers specialty care. More information on our programs can be accessed  HYPERLINK "http://www.anthem.com/wps/portal/ahpmember?content_path=provider/noapplication/f2/s3/t0/pw_ad094863.htm&label=Centers%20of%20Medical%20Excellence&state=oh&rootLevel=1" online at  HYPERLINK "http://www.anthem.com" anthem.com. Select Menu, and then under the Support heading, select the Providers link. Select Find Resources in Your State, and pick Connecticut. Select the Health & Wellness tab at the top of the page, and select.  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/noapplication/f2/s3/t0/pw_ad094863.htm&rootLevel=1&state=ct&label=Centers%20of%20Medical%20Excellence" Centers of Medical Excellence Connecticut Transplant Blue Distinction Centers for Transplant (BDCT) launched in 2006. More than 115,082 people in the United States were waiting for a lifesaving organ transplant from one of the nation's more than 140transplant centers in 2017. There were nearly 34,800 organ transplants in 2017. This was the fifth consecutive record-breaking year. Blue Distinction Centers and Blue Distinction Centers+ for Transplants have demonstrated their commitment to quality care, resulting in better overall outcomes for transplant patients. Each Facility meets stringent clinical criteria, established in collaboration with expert physicians' and medical organizations' recommendations**, including the Center for International Blood and Marrow Transplant Research (CIBMTR), the Scientific Registry of Transplant Recipients (SRTR), and the Foundation for the Accreditation of Cellular Therapy (FACT), and is subject to periodic re-evaluation as criteria continue to evolve. Both Blue Distinction Centers and Blue Distinction Centers+ for Transplants help simplify the administrative process involved in this complex careso that patients, their families, and physicians can focus on the medical issues. Hospitals receiving the Blue Distinction Center+ for Transplants designation have met the Blue Distinction Centers' standards for quality while also demonstrating better cost-efficiency relative to their peers. The Anthem CME Transplant Network is a wrap-around network to the BDCT program and offers Members access to an additional 60 transplant facilities. When BDCT and Anthem CME are combined, Members have access to 200 transplant specific programs for heart, lung, combined heart/lung, liver, pancreas, kidney, combined kidney/pancreas, and bone marrow/stem cell transplant. Cardiac Care Blue Distinction Centers for Cardiac Care launched in January 2006. According to the Centers for Disease Control and Prevention, the number of adults with a diagnosis of heart disease is 27.6 million, and the percent of adults with diagnosed heart disease is 11.5%. Heart Disease is the #1 Cause of death in the United States. Research shows that Blue Distinction Centers and Blue Distinction Centers+ demonstrate better quality and improved outcomes for patients, with lower rates of complications following certain cardiac procedures and lower rates of healthcare associated infections compared with their peers. Blue Distinction Centers+ are also 20 percent more cost-efficient than non-designated hospitals for those same cardiac procedures. Blue Distinction Centers and Blue Distinction Centers+ for Cardiac Care provide a full range of cardiac care services, including inpatient cardiac care, cardiac rehabilitation, cardiac catheterization and cardiac surgery (including coronary artery bypass graft surgery). Bariatric Surgery Blue Distinction Centers for Bariatric Surgery launched in 2008 According to the National Center for Health Statistics report released in November 2015: Prevalence of Obesity among Adults and Youth has grown to more than one-third (36.5%) of U.S. adults which have been diagnosed with obesity, and 32.3% for young adults aged 20-39. Obesity-related conditions include heart disease, stroke, type 2 diabetes and certain types of cancer, which are some of the leading causes of preventable death. Blue Distinction Centers for Bariatric Surgery have demonstrated their commitment to quality care, resulting in better overall outcomes for bariatric patients. Each facility meets stringent clinical criteria, developed in collaboration with expert physicians and medical organizations, including the American Society for Metabolic and Bariatric Surgery (ASMBS) and the American College of Surgeons (ACS), and is subject to periodic re-evaluation as criteria continue to evolve The 2017 Blue Distinction Centers for Bariatric Surgery program uses updated Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) accreditation levels, which focus on site of service. With this design change, each facility can apply to achieve the BDC or BDC+ designation, as either a Comprehensive Center (including outpatient capability) or an Ambulatory Surgery Center (ASC). Cancer Care Blue Distinction Centers for Cancer Care is a new national designation program that recognizes physicians, physician practices, cancer centers, and hospitals for their efforts in coordinating all types of cancer care. This program incorporates patient-centered and data-driven practices, to coordinate care better and to improve quality of care and safety, as well as affordability. Providers in this Program are paid under a provider agreement with their local BCBS Plan that has value-based reimbursement, rather than traditional fee-for-service, so they must perform against both quality and cost outcome targets in order to receive incentives and rewards for better health outcomes. Designations will be awarded on an ongoing basis, and the program will continue to expand in the future. Spine Surgery Blue Distinction Centers forSpine Surgery launched in November 2009. Studies confirm that as many as eight out of 10 Americans suffer from some sort of back pain. Many ways to treat back pain are available, and your doctor can guide you toward the most appropriate recommendation for your situation. For those with severe and/or chronic back pain, spine surgery may be a treatment option. Research confirms that hospitals designated as Blue Distinction Centers and Blue Distinction Centers+ for Spine Surgery have fewer complications and fewer hospital readmissions than non-designated hospitals.Blue Distinction Centers+ for Spine Surgery also deliver care more efficiently than their peers. Blue Distinction Centers and Blue Distinction Centers+ for Spine Surgery provide comprehensive inpatient spine surgery services, including discectomy, fusion and decompression procedures. To date, wehave designatedhospitals in the majority of states across the U.S. Knee and Hip Replacement Blue Distinction Centers for Knee and Hip Replacement launched in November 2009. Blue Distinction Centers and Blue Distinction Centers+ for Knee and Hip Replacementprovide comprehensive inpatient knee and hip replacement services, including total knee replacement and total hip replacement surgeries. Maternity Care Blue Distinction Centers and Blue Distinction Centers+ for Maternity Care launched in 2016 and offers access to healthcare facilities with demonstrated expertise and a commitment to quality care during the delivery episode of care, which includes both vaginal and cesarean section delivery. The Maternity Care designation uses publicly available data from Hospital Compare data which includes the Early Elective Delivery (PC-01) and elected patient experience measures at the facility level from Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS). Ventricular Assist Devices Anthems Center of Medical Excellence Ventricular Assist Device (VAD), small implantable pumps that assist the heart by pumping blood in the circulatory system of individuals with end-stage heart failure, launched in 2017. According to the Centers for Disease Control and Prevention Heart failure reports that about5.7 millionadults in the United States have heart failures a major public health problem associated with significant hospital admission rates, mortality, and costly health care services. Based on registry data, >15,000 left ventricular assist devices (LVADs) were implanted from June 2006 to December 2014. An estimated 3000+ VADs will be implanted worldwide this year, but the volume is expected to increase as newer, smaller devices receive regulatory approval, clinical indications slowly expand and the continued increase in centers certified to place these devices. Chimeric Antigen Receptor Therapy (CAR-T) The FDA has approved a new product Chimeric Antigen Receptor T-cell (CAR-T), a CD19-directed genetically modified autologous T cell immunotherapy which brings new treatment options for cancer patients. Two (2) Chimeric Antigen Receptor T cell therapies (CAR-T) have been recently approved by the FDA to treat certain patients with leukemia and lymphoma: Yescarta for treatment in Adult Patients Kymriah for treatment in Pediatric and Adult Patients These procedures can be performed in the Inpatient (IP) or Outpatient (OP) setting and Care and follow-up continues over the first year. These Members are managed by the transplant Case Managers and Anthem Medical Policy requires the procedure be performed at a Certified CAR-T center. Currently there is not a designation or contract for CAR-T therapy and each case requires a Letter of Agreement. In 2019 Anthem Centers of Medical Excellence will have a designation and contract for CAR-T The Blue Cross Blue Shield Association will also have a designation, but not a contract requirement for CAR-T Providers in 2019.  Member Quality of Care (QOC)/Quality of Service (QOS) Investigations Overview The Grievances and Appeals department develops, maintains and implements policies and procedures for identifying, reporting and evaluating potential quality of care/service (QOC/QOS) concerns or sentinel events involving Anthem Members. This includes cases reviewed as the result of a grievance submitted by a Member and potential quality issues (PQI) reviewed as the result of a referral received from an Anthem clinical associate. All Anthem associates who may encounter clinical care/service concerns or sentinel events are informed of these policies. Quality of care grievances and PQIs are processed by clinical associates. Medical records and a response from the Provider and/or Facility are requested. If the clinical associate determines the case is a non-issue with no identifiable quality issue, the clinical associate may assign a severity level C-0. A clinical associate may also assign a severity level rating of C-1 if the case meets the criteria for a known complication. A clinical associate may issue a C-3 rating for a Providers or Facilitys failure to submit requested information. Otherwise, the clinical associate will send a case summary to the Medical Director for review (i.e., First Level Peer Review). The case summary will include a list of previous severity levels assigned to the involved Provider and/or Facility on a rolling 12-month basis. If there are no previous severity levels, this will be documented. The Medical Director will select a specialty matched reviewer to evaluate the case, as appropriate. Upon completion of the review, the Medical Director makes a final determination and assigns a severity level for tracking and trending purposes. Upon completion of First Level Peer Review, if the case is a Member grievance, the Member is sent a resolution letter within thirty (30) calendar days of Anthems receipt of the grievance. The Member is informed that peer review statutes do not permit disclosure of the details and outcome of the quality investigation. In addition, the clinical associate will send a letter to the Provider and/or Facility explaining the outcome of the review and the severity level assigned. Significant quality of care issues may be elevated to the regional Peer Review Committee for Second Level Peer Review. This may result in a subsequent referral to the appropriate Credentials Committee. Trends/patterns of all assigned severity levels are reviewed with the Medical Director for intervention and corrective action planning. Providers and Facilities have a contractual obligation to actively cooperate with any investigation. When a Member alerts Anthem to a quality concern regarding the care they received, Anthem has an obligation to thoroughly investigate that allegation by reviewing all relevant materials including any internal investigation and their outcomes done by the impacted Providers and/or Facility. This requirement is in the Provider and Facility Agreements and, as a business associate, Anthem has a right to that information. Corrective Action Plans (CAP) When corrective action is required, the Medical Director or the applicable local Peer Review Committee will determine appropriate follow-up interventions which can include one or more of the following: a CAP from the Provider and/or Facility, CME, chart reviews, on-site audits, tracking and trending, Provider and/or Facility counseling, and/or referral to the appropriate committee. Reporting G&A leadership reports grievance and PQI rates, categories, and trends; to the appropriate Quality Improvement Committee on a bi-annual basis or more often as appropriate. Quality improvement or educational opportunities are reported, and corrective measures implemented, as applicable. Results of corrective actions are reported to the Committee. The Quality Council reviews these trends annually during the process of prioritizing quality improvement activities for the subsequent year. Severity Levels for Quality Assurance Quality of CareLevelPoints AssignedDescriptionC-00No quality of care issue found to exist.C-10Predictable/unpredictable occurrence within the standard of care. Recognized medical or surgical complication that may occur in the absence of negligence and without a QOC concern.C-25Communication, administrative, or documentation issue that adversely affected the care rendered.C-35Failure of a practitioner/provider to respond to a member grievance regarding a clinical issue despite two requests per internal guidelines.C-410Mild deviation from the standard of care. A clinical issue that would be judged by a prudent professional to be mildly beneath the standard of care.C-515Moderate deviation from the standard of care. A clinical issue that would be judged by a prudent professional to be moderately beneath the standard of care.C-625Significant deviation from the standard of care. A clinical issue that would be judged by a prudent professional to be significantly beneath the standard of care. Quality of ServiceLevelPoints AssignedDescriptionS-00No quality of service or administrative issue found to exist.S-10Member grievances regarding practitioners office: physical accessibility, physical appearance, and adequacy of the waiting-room and examining-room space.S-25Communication, administrative, or documentation issue with no adverse medical effect on member.S-35Failure of a practitioner/provider to respond to a member grievance despite two requests per internal guidelines.S-410Confirmed discrimination, confirmed HIPAA violation, confirmed confidentiality and/or privacy issue. Trend Thresholdfor Analysis Quality of Care and Service Trend Parameters The following accumulation of QOC and QOS cases with severity levels and points, or any combination of cases totaling 20 points or more during a rolling 12 months will be subject to trend analysis: 8 cases with a leveling of C-0 and S-0 4 cases with a leveling of C-1 4 cases with a leveling of C-2 and S-2 4 cases with a leveling of C-3 and S-3 2 cases with a leveling of C-4 2 cases with a leveling of C-5 1 case with a leveling of C-6 (automatic referral to the applicable Peer Review Committee) 3 cases with a leveling of S-1 (for a specific office location in a 6 month period); refer for site visit 4 cases with a leveling of S-4 (automatic referral to the applicable Provider Review Committee) A rolling 12 month cumulative level report is generated monthly and reviewed by a G&A clinical associate for trend identification. (Four similar complaints constitute a trend). An analysis is completed by the G&A clinical associate and forwarded to the Medical Director to determine if there is a pattern among the cases. For example, a provider who repeatedly fails to return phone calls to postoperative patients resulting in the potential for or an actual adverse outcome. The Medical Director will determine if further action is warranted, such as the need for a corrective action plan, or referral to the appropriate committee for further review and action, as appropriate. Corrective action plans received for QOC issues are reviewed by the Medical Director and may be forwarded to the applicable local Peer Review Committee for further review and follow up, as appropriate. A provider who does not submit the corrective action plan by the deadline or who does not comply with the terms of the corrective action plan will be referred to the Credentialing Committee for further action, which may include termination from the network.  Provider Complaint and Appeals Process (also known as the Grievance Process) Clinical Appeals Clinical appeals refer to a situation in which an authorization or Claim for a service was denied as not medically necessary or experimental/investigational. . Medical necessity appeals/prior authorization appeals are different than complaints or grievances related to the adjudication of claims, and should be submitted in accordance with the Clinical appeal process. Examples of non-clinical items that are considered complaints or grievances include: Contractual payment issues Disagreements over reduced or zero-paid Claims Claim code editing issues Duplicate Claim issues Retro-eligibility issues Claim data issues Claims that are denied for no authorization when an authorization was obtained, a claim dispute may be submitted as long as the authorized services match the claim details. Timely filing issues Clinical Appeals can be used if Providers or Facilities disagree with a clinical decisions. Clinical Appeals are requests to change decisions based on whether services or supplies are Medically Necessary or experimental/ investigative. UM program Clinical Appeals involve certification decisions, Claims, or predetermination decisions evaluated on these bases. Clinical Appeals can be made verbally, in writing, or by using Interactive Care Reviewer for appeals regarding prior authorization adverse decisions. Anthem Members may designate a representative to exercise their complaint and appeal rights. When a Provider or Facility is acting on behalf of a Member as the designated representative, the complaint or appeal may be directed to the Provider Service Center, using the phone number on the back of the Member ID card. These types of issues are reviewed according to Anthems Member Complaint and Appeal Procedures, for each applicable state. Provider Service Center representatives will help Providers and Facilities determine what action must be taken and if a Designate of Representative (DOR) form completed by the member is needed. Guidelines and Timeframes for Submitting Clinical Appeals Providers and Facilities have one hundred and eighty (180) calendar days to file a clinical appeal from the date they receive notice of Anthem's initial decision. All standard post-service clinical appeals will be resolved within a reasonable period of time appropriate to the medical circumstances, generally within 60 calendar days from the receipt of the appeal request by Anthem. For clinical appeals, there are two (2) types of review: expedited and standard. Expedited Appeal: Anthem offers an expedited appeal for decisions meeting the expedited criteria. Please note: Requests to handle a review as expedited are always handled as a Member appeal. Both standard and expedited appeals are reviewed by a person who did not make the initial decision. Unless the Member, on his or her own behalf, or another Provider or Facility has already filed an expedited appeal on the service at issue in the appeal, a Provider or Facility that requests an expedited appeal will be deemed to be the Members designated representative for the limited purpose of filing the expedited appeal. As a result, the expedited appeal will be handled pursuant to the Anthem Member Appeal Procedures exclusively. Standard Appeal: A standard appeal is available following the reconsideration, or initially, if it is formally requested. UM decisions are communicated in writing to the Provider or Facility and Member. These letters provide details on appeal rights and the address to use when sending additional information. Please note: Requests for appeal of Pre-Service requests will always be handled as a Member appeal. An expedited appeal is available for cases meeting the expedited criteria. Please see the instructions detailed in the UM decision letter. Appeals should be submitted to Anthem, along with a copy of our response to the original complaint. Send the appeal request to: Anthem Attention: Grievances and Appeals P.O. Box 1038 North Haven, CT 06473-4201 BlueCard Members Appeals involving clinical decisions related to Medical Necessity, experimental/investigative and/or Utilization Management (UM) decisions involving Pre-certification/Pre-authorization are the responsibility of the Blue Plan insuring or administering benefits for non-Anthem Members (the Members Home Plan). Technically the Member, not the Provider or Facility, is responsible for obtaining the necessary authorization prior to the delivery of non-inpatient admission services. Anthem understands that many providers obtain Pre-certification/Pre-authorization or may wish to dispute these types of denials on behalf of, and as a service to, their patients. If the appeal relates to Pre-certification/Pre-authorization, the Provider or Facility may have received information directly from the Members Home Plan regarding appeal rights and processes. Please - follow the directions provided by the Members Home Plan. If the appeal relates to Claim denial, and the Provider or Facility did not receive this information from the Members Home Plan and wishes to appeal a Medical Necessity or experimental/investigational Claim denial, the local Anthem Plan is the point of contact. When a Provider or Facility expresses dissatisfaction and wishes to file an appeal as indicated in the description above, a Claim Payment Dispute should be submitted, along with attached supporting documentation, to the local Anthem Plan. Please reference the Claim Payment Dispute section for further details. Member Rights If the Members Health Benefit Plan is subject to the Employee Retirement Income Security Act of 1974 (ERISA), and the Member has exhausted all mandatory Appeal rights, the Member has the right to bring a civil action in federal court under section 502(a)(1)(B) of ERISA. The Member can ask us for copies of the specific rule, guideline, protocol or other similar criterion on which a decision was based. A Member can also ask us for reasonable access to and copies of all documents, records, communications and other information and evidence relied upon to make a decision. All this information will be provided upon request and free of charge. If an adverse determination is based on a Medical Necessity, or experimental treatment, or other similar exclusion or limit, an explanation of the scientific or clinical judgment for the determination applying the terms of the Plan to the Members medical circumstances will be provided free of charge upon request. If a consultants advice was obtained in connection with a Members adverse determination, without regard to whether the advice was relied upon in making the benefit determination, the consultant will be identified upon request.  Fully-insured Plans issued in the State of Connecticut and State of Connecticut Employees After completion of the Appeals process for an adverse utilization review determination or an adverse non-utilization review determination based on Medical Necessity, a Member, the provider or the duly authorized representative of the Member or provider will receive information (including the application) regarding an external appeal process administered by the Insurance Department. The Member must first exhaust all of the utilization review companys internal appeal mechanisms UNLESS it is determined that the time frame for completion of an expedited internal appeal may cause or exacerbate an emergency or life threatening situation. In an emergency or life threatening situation, the Member, or provider acting on behalf of the Member with the Members consent, would not need to exhaust all internal appeals in this situation in order to file for an external appeal. The expedited appeal application must be filed with the Insurance Department immediately following receipt of the utilization review companys initial adverse determination or at any level of adverse appeal determination.If the expedited external appeal is not accepted on an expedited basis, and the Member has not previously exhausted all internal appeals, the Member may resume the internal appeal process until all internal appeals are exhausted and then may file for a standard external appeal within 120 days following receipt of the final denial letter   The Member, the provider, or the duly authorized representative of the Member or provider may, at any time, seek further review of an adverse determination by writing to the Insurance Commissioner at State of Connecticut, Insurance Department, Consumer Affairs, P.O. Box 816, Hartford, Connecticut 06142, or by calling (860) 297-3910.   Product Summary Plans and Benefits Please visit  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f3/s0/t0/pw_ad076839.htm&label=Plans%20and%20Benefits&rootLevel=2&state=ct&label=Plans%20%5e%20Benefits" www.anthem.com>Providers> CT. Choose the Plans & Benefits Tab at the top of the screen. Select the plan from the drop down menu. You may also access our  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&label=Quick%20Reference%20Guides&state=ct&rootLevel=0" Quick Reference Guides by visiting our website. You will find a listing of prefix codes and Claim submission guidelines for our products along with prior authorization information. HYPERLINK "http://www.anthem.com" www.anthem.com> Providers > CT Communications >Provider Reference Materials>Quick Reference Guides Federal Employee Program (FEP or FEHBP) Visit the Blue Cross Blue Shield  HYPERLINK "http://www.anthem.com/wps/portal/disclaimerlink?uri=http://www.fepblue.org/" \t "_blank" Federal Employee Program web site at  HYPERLINK "http://www.fepblue.org" www.fepblue.org to find valuable information about the Service Benefit Plan, which provides quality, affordable insurance coverage for federal employees and retirees. The BlueCard Program BlueCard is a national program that enables Members of one Blue Plan to obtain healthcare service benefits while traveling or living in another Blue Plans service area. The program links participating healthcare Providers and Facilities with the independent Blue Plans across the country and in more than 200 countries and territories worldwide through a single electronic network for Claims processing and reimbursement. The program allows Providers and Facilities to submit Claims for Members from other Blue Plans, domestic and international, to Anthem. Anthem is the sole contact for Claims payment, adjustments and issue resolution. For more information about the BlueCard Program, Providers and Facilities can access the BlueCard Provider Manual, online at  HYPERLINK www.anthem.com> Providers> CT> Communications> Publications> Provider Manuals> Bluecard manual, or by selecting this link:  HYPERLINK "https://www.anthem.com/provider/me/f5/s2/t0/pw_036843.pdf?refer=ahpprovider&state=ct" BlueCard Provider Manual Medicare Advantage Please refer to the Medicare Eligible website online for additional information at  HYPERLINK "http://www.anthem.com/medicareprovider" www.anthem.com/medicareprovider The Medicare Advantage Provider Manual is also available on the Medicare Eligible website referenced above, or via this link:  HYPERLINK "http://www.anthem.com/shared/noapplication/f0/s0/t0/pw_ad094474.pdf?refer=ahpmedicare" Medicare Advantage HMO and PPO Provider Guidebook Medicare Supplemental  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=shared/ct/f3/s2/t0/pw_002632.htm&state=ct&rootLevel=2&label=Medicare%20Supplemental" \t "_top" Medicare Supplemental plans are additional insurance sold by private insurance companies such as Anthem. These plans, when combined with payments made by Medicare, are designed to reduce your out-of-pocket costs for most Medicare-covered services. They are sometimes referred to as Medigap insurance. Anthem offers several Medicare Supplemental plans each with different sets of benefits and premiums. Lumenos Consumer Driven Health Plans Lumenos is the name of Anthem Blue Cross and Blue Shields Consumer Driven Health Plans (CDHP). Through our Lumenos products, we are offering our members a new set of options including a Health Reimbursement Account (HRA) Plan, a Health Savings Account (HSA) Plan, Health Incentive Account (HIA) Plan, and an HIA Plus Plan. We are singularly focused on maintaining and improving consumers' health by offering an approach that engages and provides incentives for consumers to make better personal choices about their health and health care dollars. Lumenos is an Anthem product, not a network, and since the Lumenos product uses the PPO network, your PPO contract with Anthem Blue Cross and Blue Shield means that you are a participating provider for these members. Just as with other PPO members, you will file claims for the Lumenos product through the local Anthem Blue Cross and Blue Shield plan. Members with our Lumenos products will have a health account. When a member needs services, the provider may be paid from this account, in many cases directly by Anthem, based upon the providers PPO contract for covered services. In addition, nationally recognized recommended preventive services are paid at 100% of the allowed amount for covered services, in most cases, without deductions from the account or added out-of-pocket costs for the member. For more information on the Lumenos Consumer Driven Health Plans, including a sample ID card and list of preventive services covered under these plans, please select this link  HYPERLINK "http://www.anthem.com/provider/ct/f3/s10/t0/pw_003460.pdf?refer=ahpprovider&state=ct" Lumenos Consumer Driven Health Plans. You will find the information under  HYPERLINK "http://www.anthem.com" www.anthem.com, select Providers>select state CT>Click the Plans and Benefits tab at the top of the screen>Select Lumenos. Empire Blue Cross and Blue Shield HMO/POS Anthem participating providers in Connecticut may expand their participation under the participation agreement with Anthem to include Empire Blue Cross and Blue Shield of New York (Empire) HMO/POS Members. The following plans are available to Empire Members with an expanded local network that includes Anthem Network/Participating Providers: Empire Direct POS Empire Direct HMO Empire DirectShare SM POS These Members can be identified through the prefixes of their identification cards, which are YLL, YLF, YLQ, POS, or POP. The State of New York requires the selection of a Primary Care Physician (PCP) for Empire HMO/POS Members, but none require referrals. The Empire Direct HMO does not offer out-of-network services, while the other plans do offer out-of-network services subject to Member Cost Shares. While a referral from the PCP is not required to obtain services from a network specialist, some services require prior authorization. Eligibility and Claims Status Inquiries For Member eligibility, call: 1-800676-BLUE (2583) For Claims status, call: 1-800-992-2583 Prior Authorization Empire Blue Cross and Blue Shield is the primary source for prior authorizations to Empire HMO/POS plans. Empire refers to prior authorization as pre-certification, and you will note the use of this term in their communications. The medical management contact information for services to an Empire HMO/POS Member is located on the back of the Members ID card. If the Member is admitted to the hospital as a result of a visit to an urgent care facility, the emergency room, or the physicians office, the Empire Medical Management Department must be notified by the physician or the hospital within 48 hours of the admission at: (800) 441-2411 Hours 8:00 AM to 5:00 PM For additional plan information on Empire HMO/POS, select this link:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_ad085407.htm&label=Empire%20Blue%20Cross%20and%20Blue%20Shield%20Plan%20Information&state=ct&rootLevel=0" Empire Blue Cross and Blue Shield Plan Information Or go to  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_036845.htm&state=ct&rootLevel=4&label=The%20BlueCard%20Program" www.anthem.com>select Providers> select state CT>Scroll down the Provider Home Page to Empire Blue Cross and Blue Shield Plan Information. New England Health Plans Anthem participates in a regional managed care program, New England Health Plans, in cooperation with four other New England Blue Cross and Blue Shield plans in Maine, New Hampshire, Massachusetts and Rhode Island. In Connecticut, Members of the New England Health Plans access care from health care professionals participating in our BlueCare Health Plan Network. Anthem Blue Cross and Blue Shields participation is twofold: As a Home Plan When the employer groups headquarters is located in the service area, this areas plan has the primary responsibility for selling and servicing the account. As a Host Plan- The area in which a Member from a Home Plan account selects a PCP is responsible for provider and medical management services for the Member. Membership/Benefits/ Eligibility Inquires 1-800-676-BLUE Claims Inquires 1-800-238-2465 Anthem Behavioral Health 1-800-228-5975 New England Health Plans - Utilization Management When a New England Health Plans Member selects from the Connecticut Network, the Members care will be coordinated in accordance with the BlueCare Health Plans UM guidelines. To coordinate appropriate approval for one of these Members, use the numbers listed below. If the Members PCP is located outside of Connecticut, call 1-800-676-BLUE to contact the Plan in the state where the PCP is located for UM requirements. Please refer to the UM section of this manual for more information on Urgent Care and Emergency Admissions Authorization. Prior Authorization- 1-800-238-2227 Elective Admission Emergency Admissions Certification Urgent Care/Emergency Treatment Case Management 1-800-231-8254 Benefit Programs HMO Blue New England: Requires Members to select a PCP from the Network directory in the state where the Member will be accessing Health Services. In Connecticut, Members select their PCP from the BlueCare Health Plan Network. Requires Members to obtain all routine care or obtain a referral from their designated PCP for Covered Services from a participating specialist. Allows Members to change their PCP at anytime. This change will be effective the first day of the following month. No out of Network benefits. Blue Choice New England Point Of- Service (POS) program: Requires Members to select a PCP from the Network directory in the state where the Member will be accessing Health Services. In Connecticut ,Members select their PCP from the BlueCare Health Plan Network. Encourages Members to obtain all routine care or obtain a referral from their PCP for Covered Services from a participating specialist. By doing so, Members will pay only a small co-payment for Covered Services. Allows Members to self-refer to participating or non-participating specialists and still be eligible for coverage with additional cost shares and deductibles. Allows Members to change their PCP at any time. This change will be effective the first day of the following month. Access Blue New England: Requires Members to select a PCP from the Network directory in the state where the Member will be accessing Health Services. In Connecticut, Members select their PCP from the BlueCare Health Plan Network. Referrals are not required for all in Network New England Access Blue participating providers. Allows Members to change their PCP at any time. This change will be effective the first day of the following month. No out of Network benefits. Important Networking Note on New England Health Plans: Members who have selected a PCP from another states Network must obtain out-of-Network referrals in order to receive care from a BlueCare Health Plan participating provider. For example, Members who have selected a PCP from the Blue Cross and Blue Shield of Massachusetts Network will access in-Network services from participating specialty physicians or providers in the Massachusetts Network. Likewise, Members with a BlueCare Health Plan PCP will access in-Network services from participating BlueCare Health Plan specialty physicians or providers. If you participate in more than one (1) state you should submit Claims to the state where services are rendered. Prefix Codes Home Plan StateHMO PrefixPOS PrefixAccess Blue PrefixConnecticutCTNCTPEHFMaineMENMEPEHGMassachusettsMTNMTPEHJNew HampshireNHNNHPEHH Behavioral Health Care If a New England Health Plans Member requires behavioral Health Services, you or the Member must call the number on the back of the identification card to locate a participating behavioral health physician or provider. Behavioral health services for a New England Health Plans Members do not require a referral from the PCP. The Home Plan is responsible for coordinating behavioral health benefits. You will be able to distinguish the Cover Individuals home plan by referring to the Prefix Codes listed above. Always send behavioral health Claims to the home plan for processing, unless and outside vendor is responsible for the behavioral health Claims. Connecticut Home Plan Members (CTN CTP) will access Anthem Behavioral Health Network, which they may do without a referral. Prior Authorization 1-800-238-2227 Elective Admissions Emergency Admissions Certification Urgent Care/Emergency Treatment Please refer to the Utilization Management section of this manual for more information on: Urgent Care Emergency Admissions Authorization Taft Hartley Anthem currently participates in a Taft Hartley Jointly Administrated Arrangement (JAA) with Taft Hartley Funds in Connecticut. Anthem is responsible for provider servicing only, and all Member service is handled by the individual Taft Hartley Funds. All eligibility and benefits determination for Claims adjudication is done at the Fund level. Anthem is responsible for coordinating all payments to Network/Participating Providers and all out of state Blue Cross and Blue Shield plans. All Claim payments are finalized through a shared Claims processing interface between Anthem and the Funds. Visit the website for the Taft Hartley Quick Reference Guide. Go  HYPERLINK "http://www.anthem.com/provider/ct/f4/s6/t0/pw_e225397.pdf?refer=ahpprovider&state=ct" to www.anthem.com >select Providers> select state CT>Provider reference Materials>Quick Reference Guides> Taft Hartley  You will find the following information on the Quick Reference Guide: Prefix Codes Fund Names Timely Filing Authorization and Vendor phone numbers  Federal Employees Health Benefits Program FEHBP Requirements Providers and Facilities acknowledge and understand that Anthem participates in the Federal Employees Health Benefits Program (FEHBP). The Anthem FEHBP encompasses the Blue Cross Blue Shield Association Service Benefit Plan, otherwise known as Federal Employee Program or FEP, the health insurance Plan for federal employees.Providers and Facilities further understand and acknowledge that the FEHBP is a federal government program and the requirements of the program are subject to change at the sole direction and discretion of the United States Office of Personnel Management. Providers and Facilities agree to abide by the rules, regulations, and other requirements of the FEHBP as they exist and as they may be amended or changed from time to time, with or without prior notice. Providers and Facilities further agree that, in the event of a conflict between the Provider or Facility agreement or this Provider Manual and the rules, regulations, or other requirements of the FEHBP, the terms of the rules, regulations, and other requirements of the FEHBP shall control. When a conflict arises between federal and state laws and regulations, the federal laws and regulations supersede and preempt the state or local law (Public Law 105-266). In those instances, FEHBP is exempt from implementing the requirements of state legislation. Submission of Claims under the Federal Employees Health Benefits Program All Claims under the FEHBP must be submitted to Plan for payment within the timeframe listed in the Provider or Facility Agreement. This timeframe applies from the date of discharge or from the date of the primary payers explanation of benefits. Providers and Facilities agree to provide to Plan, at no cost to Anthem or Member, all information necessary for Plan to determine its liability, including, without limitation, accurate and complete Claims for Covered Services, utilizing forms consistent with industry standards and approved by Plan or, if available, electronically through a medium approved by Plan. If Plan is the secondary payer, the timeframe will not begin to run until Provider or Facility receives notification of primary payer's responsibility. Plan is not obligated to pay Claims received after the timeframe indicated in the Agreement.. Except where the Member did not provide Plan identification, Provider and Facility shall not bill, collect, or attempt to collect from Member for Claims Plan receives after the applicable period regardless of whether Plan pays such Claims. Erroneous or duplicate Claim payments under the FEHBP For erroneous or duplicate Claim payments under the FEHBP, either party shall refund or adjust, as applicable, all such duplicate or erroneous Claim payments regardless of the cause. Such refund or adjustment may be made within five (5) years from the end of the calendar year in which the erroneous or duplicate Claim was submitted. In lieu of a refund, Plan may offset future Claim payments. Coordination of Benefits for FEHBP In certain circumstances when the FEHBP is the secondary payer and there is no adverse effect on the Member, the FEHBP pays the local Plan allowable minus the Primary payment. The combined payments, from both the primary payer and FEHBP as the secondary payer, might not equal the entire amount billed by the Provider or Facility for covered services. FEHBP Waiver requirements Notice must identify the proposed services. Inform the Member that services may be deemed not medically necessary or experimental/investigational, by the Plan Provide an estimate of the cost for services Member must agree in writing to be financially responsible in advance of receiving the services; otherwise, the Provider or Facility will be responsible for the cost of services denied FEHBP Member Reconsiderations and Appeals There are specific procedures for reviewing disputed Claims under the Federal Employees Health Benefits Program. The process has two steps, starting with a review by the local Plan (reconsideration), which may lead to a review by the Office of Personnel Management (OPM). The review procedures are designed to provide Members with a way to resolve Claim disputes as an alternative to legal actions. The review procedures are intended to serve both contract holders and Members. The local Plan and OPM do not accept requests for review from Providers or Facilities, except on behalf of, and with the written consent of, the contract holder or Member. Providers and Facilities are required to demonstrate that the contract holder or Member has assigned all rights to the Provider or Facility for that particular Claim or Claims. When a Claim or request for Health Services, drugs or supplies including a request for precertification or prior approval is denied, whether in full or partially, the local Plan that denied the Claim reviews the benefit determination upon receiving a written request for review. This request must come from the Member, contract holder or their authorized representative. The request for review must be received within six months of the date of the Plans final decision. If the request for review is on a specific Claim(s), the Member must be financially liable in order to be eligible for the disputed Claims process. The local Plan must respond to the request in writing, affirming the benefits denial, paying the Claim, or requesting the additional information necessary to make a benefit determination, within 30 calendar days of receiving the request for review. If not previously requested, the local Plan is required to obtain all necessary medical information, such as operative reports, medical records and nurses notes, related to the Claim. If the additional information is not received within 60 calendar days, the Plan will make its decision based on the information available. Appropriate medical review will also be done at this time. If the Plan does not completely satisfy the Members request, the Plan will advise the Member of his/her right to appeal to OPM. Providers or Facilities may not submit appeals to the OPM. Only the Member or contract holder may do so, as outlined in the Blue Cross and Blue Shield Service Benefit Plan brochure. FEHBP Formal Provider and Facility Appeals Providers and Facilities are entitled to pursue disputes of their preservice request (this includes pre-certification or prior approval) or their postservice claim (represents a request for reimbursement of benefits for medical services that have already been performed), by following a formal dispute resolution process. A formal Provider or Facility appeal is a written request from the rendering Provider or Facility, to his/her local Plan, to have the local Plan re-evaluate its contractual benefit determination of their post-service Claim; or to reconsider an adverse benefit determination of a pre-service request. The request must be from a Provider or Facility and must be submitted in writing within 180 days of the denial or benefit limitation. In most cases, this will be the date appearing on the Explanation of Benefits/Remittance sent by the Plan. For pre-service request denials, the date will be the date appearing on the Plans notification letter. The request for review may involve the Provider or Facilitys disagreement with the local Plans decision about any of the clinical issues listed below where the Providers or Facilities are not held harmless. Local Plans should note that this list is not all-inclusive. not medically necessary (NMN); experimental/investigational (E/I); denial of benefits, in total or in part, based on clinical rationale (NMN or E/I); precertification of hospital admissions; and, prior approval (for a service requiring prior approval under FEHBP). Not all benefit decisions made by local Plans are subject to the formal Provider and Facility appeal process. The formal Provider and Facility appeal process does not apply to any non-clinical case. When a Claim or request for services, drugs or supplies including a request for precertification or prior approval is denied, whether in full or partially, the local Plan that denied the Claim reviews the benefit determination upon receiving a written request for review. This request must come from the rendering/requesting Provider or Facility. The request for review must be received within six months of the date of the local Plans final decision. If the request for review is on a specific Claim(s), the Provider or Facility must be financially liable in order to be eligible for the formal Provider and Facility appeal process. The local Plans must respond to the request in writing, affirming the benefits denial, paying the Claim, or requesting the additional information necessary to make a benefit determination, within 30 calendar days of receiving the request for review. If not previously requested, the local Plan is required to obtain all necessary medical information, such as operative reports, medical records and nurses notes, related to the Claim. If the additional information is not received within 60 calendar days, the local Plan will make its decision based on the information available. Appropriate medical review will also be done at this time. Even if the local Plan does not completely satisfy the Provider or Facilitys request, the formal Provider and Facility appeal process is complete; no additional appeal rights are available. FEHBP Inpatient Skilled Nursing Facility Care Effective January 1, 2018 benefits are available for up to 30 days of inpatient skilled nursing facility (SNF) care per benefit year for Standard Option Members who are not enrolled in Medicare Part A. Hospitals and Plan staff must be proactive in identifying Members for whom a SNF stay is an appropriate level of care in the continuum toward transition home. The Member must be enrolled in case management (CM) and the signed consent for CM must be received by the case manager prior to precertification approval of the SNF admission. This will require that the hospital discharge planning staff collaborate with the Plan case manager, and in some cases, will necessitate the hospital case manager/discharge planners assistance in delivering the consent to the Member and having it returned to the Plan after the Member/proxy signs the document. The transferring facility must submit a detailed description of the Members clinical status and the proposed treatment plan for the Plans review of the proposed admission. Once the Member is admitted and subsequently within the timeframes established by the Plan, the SNF representative must provide specific information regarding the Members status, progress towards goals, changes to the treatment plan and/or discharge plan (if applicable) and documentation of any obstacles preventing the Member from achieving the goals. The attending physician in the SNF must write admission orders and review the preliminary treatment plan within 24 hours of the Members admission. Members admitting on a ventilator must be seen by a pulmonologist within 12 hours of admission and respiratory therapy be available in the facility 24 hours/day. Members admitted for rehabilitation must receive an evaluation by a physical therapist and a physical therapy treatment plan must be in place within 16 hours of admission. Members admitted primarily for rehabilitation must receive at least 2 hours of physical therapy and occupational therapy combined at least 5 days per week (logs must be provided to the Plan to document therapy time)  Health Insurance Marketplace (exchanges) Health Insurance Marketplace The Affordable Care Act (ACA) authorized the creation of Health Insurance Marketplaces (commonly referred to as exchanges) to help individuals and small employers shop for, select, and enroll in high quality, affordable private health plans. Anthem offers qualified health plans on the Individual or Small Business Health Options Program (SHOP) Exchange in many states, as well as health plans not purchased on public exchanges. Qualified health plans on the Individual and SHOP Exchange follow the same policies and protocols within this Provider Manual, unless otherwise stated in the Provider or Facility Agreement. Updates about Anthems ACA compliant health plans and the networks supporting these plans are published in Anthems provider newsletter, and sent via Anthems email service. To sign up for Provider Communications for Connecticut, go to  HYPERLINK "https://messageinsite.com/networkeupdate" https://messageinsite.com/networkeupdate. Additional information and current communications about Health Insurance Exchanges can be found from the provider homepage at anthem.com. Important reminder: Providers and Facilities are able to confirm their participation status in our different networks by using the Find a Doctor tool. Please see the Online Provider Directories and Demographic Data Integrity section for more details.  Audit Anthem Audit Policy This Anthem Audit Policy applies to Providers and Facilities. If there is conflict between this Policy and the terms of the applicable Provider or Facility Agreement, the terms of the Agreement will prevail. If there is a conflict in provisions between this Policy and applicable state law that is not addressed in the Provider or Facility Agreement the state law will apply. All capitalized terms used in this Policy shall have the meaning as set forth in the Provider or Facility Agreement between Anthem and Provider or Facility. Coverage is subject to the terms, conditions, and limitations of a Members Health Benefit Plan and in accordance with this Policy. There may be times when Anthem conducts claim reviews or audits either on a prepayment or post payment basis. Claim reviews and audits are conducted in order to confirm that healthcare services or supplies were delivered in compliance with the Members plan of treatment or to confirm that charges were accurately reported in compliance with Anthems policies and procedures as well as general industry standard guidelines and regulations. In order to conduct such reviews and audits, Anthem or its designee may request documentation, most commonly in the form of patient medical records. Anthem may accept additional documentation from Provider or Facility that typically might not be included in medical records such as other documents substantiating the treatment or health service or delivery of supplies, Providers or Facilitys established internal policies, professional licensure standards that reference standards of care, or business practices justifying the healthcare service or supply. The Provider or Facility must review, approve and document all such internal policies and procedures as required by The Joint Commission (TJC) or other applicable accreditation bodies and such policies shall be made available for review by the auditor. This policy documents Anthems guidelines for claims requiring additional documentation and the Providers or Facilitys compliance for the provision of requested documentation. Definition: The following definitions shall apply to this Audit section only: Agreement means the written contract between Anthem and Provider or Facility that describes the duties and obligations of Anthem and the Provider or Facility, and which contains the terms and conditions upon which Anthem will reimburse Provider or Facility for Health Services rendered by Provider or Facility to Member(s). Appeal means Anthems or its designees review of the disputed portions of the Audit Report, conducted at the written request of a Provider or Facility and pursuant to this Policy. Appeal Response means Anthems or its designees written response to the Appeal after reviewing all Supporting Documentation provided by Provider or Facility. Audit means a qualitative or quantitative review of Health Services or documents relating to such Health Services rendered by Provider or Facility, and conducted for the purpose of determining whether such Health Services have been appropriately reimbursed under the terms of the Agreement. Audit Report and Notice of Overpayment ("Audit Report") means a document that constitutes notice to the Provider or Facility that Anthem or its designee believes an overpayment has been made by Anthem and identified as the result of an Audit. The Audit Report shall contain administrative data relating to the Audit, including the amount of overpayment and findings of the Audit, that constitute the basis for Anthems or its designees belief that the overpayment exists. Unless otherwise stated in the Agreement between the Provider or Facility and Anthem, Audit Reports shall be sent to Provider or Facility in accordance with the Notice section of the Agreement. Business Associate or designee means a third party designated by Anthem to perform an Audit or any related Audit function on behalf of Anthem pursuant to a written agreement with Anthem. Provider or Facility means an entity with which Anthem has a written Agreement. Provider Manual means the proprietary Anthem document available to the Provider and Facility, which outlines certain Anthem Policies. Recoupment means the recovery of an amount paid to Provider or Facility which Anthem has determined constitutes an overpayment not supported by an Agreement between the Provider or Facility and Anthem. A Recoupment is generally performed against a separate payment Anthem makes to the Provider or Facility which is unrelated to the services which were the subject of the overpayment, unless an Agreement expressly states otherwise or is prohibited by law. Recoupments shall be conducted in accordance with applicable laws and regulations. Supporting Documentation means the written material contained in a Members medical records or other Provider or Facility documentation that supports the Providers or Facilitys claim or position that no overpayment has been made by Anthem. Policy Upon request from Anthem or its designee, facilities are required to submit additional documentation for claims identified for pre-payment review or post payment audit. Applicable types of claims include, but are not limited to: Claims being reviewed to validate the correct diagnosis related group (DRG) assignment/payment (DRG validation audits) Claims being reviewed to validate items and services billed are documented in the medical record for hospital bill audits (also known as hospital charge audits) Claims with unlisted or miscellaneous codes Claims for services requiring clinical review Claims for services found to possibly conflict with covered benefits for Members after validity review of the Members medical records Claims for services found to possibly conflict with Medical Necessity of covered benefits for Members Claims requesting an extension of benefits Claims being reviewed for potential fraud, abuse or demonstrated patterns of billing/coding inconsistent with peer benchmarks Claims for services that require an invoice Claims for services that require an itemized bill Claims for beneficiaries where other health insurance (OHI) is indicated with the claim submission Claims requiring documentation of the receipt of an informed consent form Claims requiring a certificate of Medical Necessity Appealed claims where supporting documentation may be necessary for determination of payment Other documentation required by other entities such as the Centers for Medicare and Medicaid Services (CMS), and state or federal regulation Documentation for such services as the provision of durable medical equipment, prosthetics, orthotics, and supplies, rehabilitation services, and home health care Anthem or its designee will use the following guidelines for records requests and the adjudication of claims identified for prepayment review or post payment audit: Upon confirmation of Providers or Facilitys address, an original letter of request for supporting documentation will be sent. When a response is not received within 30 days of the date of the initial request, a second request letter will be sent. When a response is not received within 15 days of date of the second request, a final request letter will be sent. When a response is not received within 15 days of the date of the final request (60 days total): Anthem or its designee will initiate claim denial for claims identified as pre-payment review claims as Provider or Facility failed to submit the required documentation. The Member shall be held harmless for such payment denials. or Anthem or its designee will initiate claim retractions for claims identified as post payment audit claims as Provider or Facility failed to submit the required documentation. The Member shall be held harmless for such payment retractions. Anthem or its designee will not be liable for interest or penalties when payment is denied or recouped when Provider or Facility fails to submit required or requested documentation for claims identified for prepayment or post payment audit. [This policy will not supersede any individual Provider or Facility contract provisions or state or federal guidelines.] Procedure: 1. Review of Documents. Anthem or its designee will request in writing or verbally, final and complete itemized bills and/or complete medical records for all Claims under review. The Provider or Facility will supply the requested documentation in the format requested by Anthem or its designee within the time frame outlined above. 2. Scheduling of Audit. After review of the documents submitted, if Anthem or its designee determines an Audit is required, Anthem or its designee will call the Provider or Facility to request a mutually satisfactory time for Anthem or its designee to conduct an Audit; however, the Audit must occur within forty-five (45) calendar days of the request. 3. Rescheduling of Audit. Should Provider or Facility desire to reschedule an Audit, Provider or Facility must submit its request with a suggested new date to Anthem or its designee in writing at least seven (7) calendar days in advance of the day of the Audit. Providers or Facilitys new date for the Audit must occur within thirty (30) calendar days of the date of the original Audit. Provider or Facility may be responsible for cancellation fees incurred by Anthem or its designee due to Providers or Facilitys rescheduling. 4. Under-billed and Late-billed Claims. During the scheduling of the Audit, Provider or Facility may identify Claims for which Provider or Facility under-billed or failed to bill for review by Anthem during the Audit. Under-billed or late-billed Claims not identified by Provider or Facility before the Audit commences will not be evaluated in the Audit. These Claims may, however, be submitted (or resubmitted for under-billed Claims) to Anthem for adjudication. 5. Scheduling Conflicts. Should the Provider or Facility fail to work with Anthem, or its designee in scheduling or rescheduling the Audit, Anthem or its designee retains the right to conduct the Audit with a seventy-two (72) hour advance written notice, which Anthem or its designee may invoke at any time. While Anthem or its designee prefers to work with the Provider or Facility in finding a mutually convenient time, there may be instances when Anthem or its designee must respond quickly to requests by regulators or its clients. In those circumstances, Anthem or its designee will send a notice to the Provider or Facility to schedule an Audit within the seventy-two (72) hour timeframe. 6. On-Site and Desk Audits. Anthem or its designee may conduct Audits from its offices or on-site at the Providers or Facilitys location. If Anthem or its designee conducts an Audit at a Providers or Facilitys location, Provider or Facility will make available suitable work space for Anthems or its designees on-site Audit activities. During the Audit, Anthem or its designee will have complete access to the applicable health records including ancillary department records and/or invoice detail without producing a signed Member authorization. When conducting credit balance reviews, Provider or Facility will give Anthem or its designee a complete list of credit balances for primary, secondary and tertiary coverage, when applicable. In addition, Anthem or its designee will have access to Providers or Facilitys patient accounting system to review payment history, notes, Explanation of Benefits and insurance information to determine validity of credit balances. If the Provider or Facility refuses to allow Anthem or its designee access to the items requested to complete the Audit, Anthem or its designee may opt to complete the Audit based on the information available. All Audits (to include medical chart audits and diagnosis related group reviews) shall be conducted free of charge despite any Provider or Facility policy to the contrary. 7. Completion of Audit. Upon completion of the Audit, Anthem or its designee will generate and give to Provider or Facility a final Audit Report. This Audit Report may be provided on the day the Audit is completed or it may be generated after further research is performed. If further research is needed, the final Audit Report will be generated at any time after the completion of the Audit, but generally within ninety (90) days. Occasionally, the final audit report will be generated at the conclusion of the exit interview which is performed on the last day of the Audit. During the exit interview, Anthem or its designee will discuss with Provider or Facility its Audit findings found in the final Audit Report. This Audit Report may list items such as charges unsupported by adequate documentation, under-billed items, late billed items and charges requiring additional supporting documentation. If the Provider or Facility agrees with the Audit findings, and has no further information to provide to Anthem or its designee, then Provider or Facility may sign the final Audit Report acknowledging agreement with the findings. At that point, Provider or Facility has thirty (30) calendar days to reimburse Anthem the amount indicated in the final Audit Report. Should the Provider or Facility disagree with the final Audit Report generated during the exit interview, then Provider or Facility may either supply the requested documentation or Appeal the Audit findings. 8. Provider or Facility Appeals. See Audit Appeal Policy. 9. No Appeal. If the Provider or Facility does not formally Appeal the findings in the final Audit Report and submit supporting documentation within the (thirty) 30 calendar day timeframe, the initial determination will stand and Anthem or its designee will process adjustments to recover the amount identified in the final Audit Report. Documents Reviewed During an Audit: The following is a description of the documents that may be reviewed by the Anthem or its designee along with a short explanation of the importance of each of the documents in the Audit process. It is important to note that Providers and Facilities must comply with applicable state and federal record keeping requirements. A. Confirm that Health Services were delivered by the Provider or Facility in compliance with the plan of treatment. Auditors will verify that Providers or Facilitys plan of treatment reflected the Health Services delivered by the Provider or Facility. The services are generally documented in the Members health or medical records. In situations where such documentation is not found in the Members medical record, the Provider or Facility may present other documents substantiating the treatment or Health Service, such as established institutional policies, professional licensure standards that reference standards of care, or business practices justifying the Health Service or supply. The Provider or Facility must review, approve and document all such policies and procedures as required by The Joint Commission (TJC) or other applicable accreditation bodies. Policies shall be made available for review by the auditor. B. Confirm that charges were accurately reported on the Claim in compliance with Anthems Policies as well as general industry standard guidelines and regulations. The auditor will verify that the billing is free of keystroke errors. Auditors may also review the Members health record documents. The health record records the clinical data on diagnoses, treatments, and outcomes. A health record generally records pertinent information related to care and in some cases, the health record may lack the documented support for each charge on the Members Claim. Other appropriate documentation for Health Services provided to the Member may exist within the Providers or Facilitys ancillary departments in the form of department treatment logs, daily charge records, individual service/order tickets, and other documents. Anthem or its designee may have to review a number of documents in addition to the health record to determine if documentation exists to support the Charges on the Members Claim. The Provider or Facility should make these records available for review and must ensure that Policies exist to specify appropriate documentation for health records and ancillary department records and/or logs. Audit Appeal Policy Purpose: To establish a timeline for issuing Audits and responding to Provider or Facility Appeals of such Audits. Procedure: 1. Unless otherwise expressly set forth in an Agreement, Provider or Facility shall have the right to Appeal the Audit Report. An Appeal of the Audit Report must be in writing and received by Anthem or its designee within thirty (30) calendar days of the date of the Audit Report unless State Statute expressly indicates otherwise. The request for Appeal must specifically detail the findings from the Audit Report that Provider or Facility disputes, as well as the basis for the Providers or Facilitys belief that such finding(s) are not accurate. All findings disputed by the Provider or Facility in the Appeal must be accompanied by relevant Supporting Documentation. Retraction will begin at the expiration of the thirty (30) calendar days unless expressly prohibited by contractual obligations or State Statute. 2. A Providers or Facilitys written request for an extension to submit an Appeal complete with Supporting Documentation or payment will be reviewed by Anthem or its designee on a case-by-case basis. If the Provider or Facility chooses to request an Appeal extension, the request should be submitted in writing within thirty (30) calendar days of receipt of the Audit Report. One Appeal extension may be granted during the Appeal process at Anthems or it designees sole discretion, for up to thirty (30) calendar days from the date the Appeal would otherwise have been due. Any extension of the Appeal timeframes contained in this Policy shall be expressly conditioned upon the Providers or Facilitys agreement to waive the requirements of any applicable state prompt pay statute and/or provision in an Agreement which limits the timeframe by which a Recoupment must be completed. It is recognized that governmental regulators are not obligated to the waiver. 3. Upon receipt of a timely Appeal, complete with Supporting Documentation as required under this Policy, Anthem or its designee shall issue an Appeal Response to the Provider or Facility. Anthems or its designees response shall address each matter contained in the Providers or Facilitys Appeal. If appropriate, Anthems or its designees Appeal Response will indicate what adjustments, if any, shall be made to the overpayment amounts outlined in the Audit Report. Anthems or its designees response shall be sent via certified mail to the Provider or Facility within thirty (30) calendar days of the date Anthem or its designee received the Providers or Facilitys Appeal and Supporting Documentation. Revisions to the Audit data will be included in this mailing if applicable. 4. The Provider or Facility shall have fifteen (15) calendar days from the date of Anthems or its designees Appeal Response to respond with additional documentation or, if appropriate in the State, a remittance check to Anthem or its designee. If no Provider or Facility response or remittance check (if applicable) is received within the fifteen (15) calendar day timeframe, Anthem or its designee shall begin recoupment of the amount contained in Anthems or its designees response, and a confirming recoupment notification will be sent to the Provider or Facility. 5. Upon receipt of a timely Provider or Facility response, complete with Supporting Documentation as required under this Policy, Anthem or its designee shall formulate a final Appeal Response. Anthems or its designees final Appeal Response shall address each matter contained in the Providers or Facilitys response. If appropriate, Anthems or its designees final Appeal Response will indicate what adjustments, if any, shall be made to the overpayment amounts outlined in the Audit Report or final Appeal Response. Anthems or its designees final Appeal Response shall be sent via certified mail to the Provider or Facility within fifteen (15) calendar days of the date Anthem or its designee received the Provider or Facility response and Supporting Documentation. Revisions to the Audit Report will be included in this mailing if applicable. 6. If applicable in the state, the Provider or Facility shall have fifteen (15) calendar days from the date of Anthems or its designees final Appeal Response to send a remittance check to Anthem or its designee. If no remittance check is received within the fifteen (15) calendar day timeframe, Anthem or its designee shall recoup the amount contained in Anthems or its designees final Appeal Response, and a confirming Recoupment notification will be sent to the Provider or Facility. If Provider or Facility still disagrees with Anthems or its designees position after receipt of the final Appeal Response, Provider or Facility may invoke the dispute resolution mechanisms under the Agreement.  Fraud, Waste and Abuse Detection We are committed to protecting the integrity of our health care programs and the effectiveness of our operations by preventing, detecting and investigating fraud, waste and abuse (FWA). Combating FWA begins with knowledge and awareness. Fraud intentionally falsifying information and knowing that deception will result in improper payment and/or unauthorized benefit. This includes, knowingly soliciting, receiving, and/or offering compensation to encourage or reward referrals for items or services and/or making prohibited referrals for certain designated health services. Waste includes overusing services, or other practices that, directly or indirectly, result in unnecessary costs. Waste is generally not considered to be driven by intentional actions, but rather occurs when resources are misused. Abuse when health care providers or suppliers do not follow appropriate medical billing/documentation practices or medical practices resulting in unnecessary or excessive costs, incorrect payment, misuse of codes, or services that are not medically necessary. Investigation Process The Special Investigations Unit (SIU) investigates suspected incidents of FWA for all types of services. We may take corrective action with a Provider or Facility, which may include, but is not limited to: Written warning and/or education: We send letters to the Provider or Facility advising the Provider or Facility of the issues and the need for improvement. Letters may include education or requests for repayment, or may advise of further action. Medical record review: We review medical records to investigate allegations or validate the appropriateness of Claims submissions. Edits: A certified professional coder or investigator evaluates Claims and places payment or system edits in Anthems Claims processing system. This type of review prevents automatic Claims payments in specific situations. Recoveries: We recover overpayments directly from the Provider or Facility. Failure of the Provider or Facility to return the overpayment may result in reduced payment for future Claims, termination from our network, or legal action. Prepayment Review One method Anthem uses to detect FWA is through prepayment Claim review. Through a variety of means, certain Providers or Facilities, or certain Claims submitted by Providers or Facilities, may come to Anthems attention for behavior that might be identified as unusual for coding, documentation and/or billing issues, or Claims activity that indicates the Provider or Facility is an outlier compared to his/her/its peers. Once a Claim, or a Provider or Facility, is identified as an outlier or has otherwise come to Anthems attention for reasons mentioned above, further investigation is conducted by the SIU to determine the reason(s) for the outlier status or any appropriate explanation for unusual coding, documentation, and/or billing practices. If the investigation results in a determination that the Providers or Facilitys actions may involve FWA, the Provider or Facility is notified and given an opportunity to respond. If, despite the Providers or Facilitys response, Anthem continues to believe the Providers or Facilitys actions involve FWA, or some other inappropriate activity, the Provider or Facility may be placed on prepayment review. If that occurs, the Provider or Facility will receive written notice of being placed on prepayment review. This means that the Provider or Facility will be required to submit medical records and any other supporting documentation with each Claim so Anthem can review the appropriateness of the services billed, including the accuracy of billing and coding, as well as the sufficiency of the medical records and supporting documentation submitted. Failure to submit medical records and supporting documentation to Anthem in accordance with this requirement will result in a denial of the Claim under review. The Provider or Facility will be given the opportunity to request a discussion of his/her/its prepayment review status. Under the prepayment review program, Anthem may review coding, documentation, and other billing issues. In addition, we may use one or more clinical utilization management guidelines in the review of Claims submitted by the Provider or Facility, even if those guidelines are not used for all Providers or Facilities delivering services to Plan Members. The Provider or Facility will remain subject to the prepayment review process until Anthem is satisfied that all inappropriate billing, coding, or documentation activity has been corrected. If the inappropriate activity is not corrected, the Provider or Facility could face corrective measures, up to and including termination from our network. Finally, Providers and Facilities are prohibited from billing a Member for services we have determined are not payable as a result of the prepayment review process, whether due to FWA, any other coding or billing issue or for failure to submit medical records as set forth above. Providers or Facilities whose Claims are determined to be not payable may make appropriate corrections and resubmit such Claims in accordance with the terms of their Provider and Facility Agreement, proper billing procedures and state law. Providers or Facilities also may appeal such a determination in accordance with applicable grievance and appeal procedures. Acting on Investigative Findings In addition to the previously mentioned actions, we may refer suspected criminal activity committed by a Member, Provider or Facility to the appropriate regulatory and/or law enforcement agencies Recoupment/Offset/Adjustment for Overpayments Anthem shall be entitled to offset and recoup an amount equal to any overpayments or improper payments made by Anthem to Provider or Facility (Overpayment Amount) against any payments due and payable by Anthem or any Affiliate to Provider or Facility with respect to any Health Benefit Plan under this Agreement or under any provider agreement between Provider and an Affiliate regardless of the cause. Provider or Facility shall voluntarily refund the Overpayment Amount regardless of the cause, including, but not limited to, payments for Claims where the Claim was miscoded, non-compliant with industry standards, or otherwise billed in error, whether or not the billing error was fraudulent, abusive or wasteful.Upon determination by Anthem that an Overpayment Amount is due from Provider or Facility, Provider or Facility must refund the Overpayment Amount to Anthem within thirty (30) calendar days of the date of the overpayment refund notice from Anthem to the Provider or Facility. If the Overpayment Amount is not received by Anthem within the thirty (30) calendar days following the date of such notice letter, Anthem shall be entitled to offset the unpaid portion of the Overpayment Amount against other Claims payments due and payable by Anthem or an Affiliate to Provider or Facility under any Health Benefit Plan in accordance with Regulatory Requirements.In such event, Provider or Facility agrees that all future Claim payments, including Affiliate Claim payments, applied to satisfy Providers or Facilitys repayment obligation shall be deemed to have been legally paid to Provider or Facility in full for all purposes, including Affiliates and/or Regulatory Requirements as defined by the Provider or Facility Agreement. Should Provider or Facility disagree with any determination by Anthem or a Plan that Provider or Facility has received an overpayment or improper payment, Provider or Facility shall have the right to appeal such determination under Anthems procedures set forth in the Provider Manual,provided that such appeal shall not suspend Anthems right to recoup the Overpayment Amount during the appeal process unless required by Regulatory Requirements. Anthem reserves the right to employ a third party collection agency in the event of non-payment.  Laboratory Services Laboratory Network The Provider agreement requires referrals to in-network providers, and using an in-network laboratory helps your patients maximize their laboratory benefits and minimize their out-of-pocket expenses. A complete and current list of in-network participating laboratories may be obtained on our website at anthem.com. From the menu, select Providers, then select Connecticut and from the provider home page select Find a Doctor on the left menu bar. The directory may also be accessed via this link:  HYPERLINK "https://www.anthem.com/health-insurance/provider-directory/searchcriteria" Online Provider Directory  Pharmacy Home Program The availability and access to opioid medications used for the treatment of acute and chronic health conditions is at an all-time high. This access to healthcare is helping patients live longer and healthier lives. However, it can also lead to safety concerns when Members are on multiple controlled medications that are prescribed by multiple healthcare providers. To address the growing opioid epidemic, Anthem implemented the Pharmacy Home Program in April 2016 to allow for better administration of drug benefits through increased communication and coordination amongst prescribing physicians and pharmacies. The information in this section applies to Anthem Members with our prescription drug coverage. The Pharmacy Home program helps reduce potential overutilization of prescription medications. If a Member is believed to be at an increased safety risk due to the overutilization of multiple medications, providers and/or pharmacies; and meets enrollment criteria they may be included in this program. Anthem is able to increase communication and coordination amongst prescribing physicians for Members that have been identified and restricted to a single pharmacy. The pharmacy is selected by the Member and/or is assigned based on the retrospective Drug Utilization Review (DUR) of their prescription claims history. Following the selection of the Members new Pharmacy Home, all prescribing physicians receive notification of the Members enrollment into the program, the assigned pharmacy information and a 3-month prescription profile containing a list of all prescribers, medications, dosages, and quantities received by the Member during that timeframe. The program is designed to limit a qualifying Member to the use of one specific participating pharmacy for a period of no less than 12 consecutive months. This assigned pharmacy, or Pharmacy Home, will fill all of the Members prescribed medications throughout the term of their enrollment in this program. The Pharmacy Home program includes: Reimbursement of Claims when filled at the Members Pharmacy Home. All pharmacy Claims are denied if filled at any pharmacy other than the Members assigned Pharmacy Home. Temporary overrides for urgent prescriptions. Access to Mail Order and Specialty pharmacies, in addition to the Pharmacy Home. Criteria A Member whose prescription Claims history shows they meet the below inclusion criteria may be enrolled in the Pharmacy Home program if: The Member received five or more controlled substance prescriptions (government-regulated drugs) in a 90-day period. The Member received controlled substance prescriptions from three or more prescribers in a 90-day period. The Member visited three or more pharmacies to fill controlled substance prescriptions in a 90-day period. Communications to Members meeting criteria Members who meet criteria are sent a notification at least 60 days prior to potential inclusion in the program. After a 60-day monitoring period, if the Member continues to meet the program criteria during that timeframe, he/she is contacted in writing of the decision to place him/her into the Pharmacy Home program and will be given 30 additional days to select a Pharmacy Home and/or to file an appeal of the decision. In the event the Member does not select a Pharmacy Home within the allotted timeframe, one will be chosen for the Member on the 31st day based off of their pharmacy Claims. Anthem will ensure both the Member and their Provider will be notified of their new Pharmacy Home in writing. Once they have chosen a Pharmacy Home, a request to change pharmacies will be considered only for good cause situations. Anthem is more committed than ever to equipping Providers with the tools and support necessary to help curb these trends and save more lives than are lost. If you have any questions or comments regarding enrollment, please contact the Member Services number located on the back of the Members ID.  Useful Links Anthems Web Site for Members and Providers  HYPERLINK "http://www.anthem.com/" www.anthem.com  Contact Us Phone Numbers:  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&rootLevel=4&label=Phone%20Numbers" http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&rootLevel=4&label=Phone%20Numbers Quick Reference Guides  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&state=ct&rootLevel=0&label=Quick%20Reference%20Guides" http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&state=ct&rootLevel=0&label=Quick%20Reference%20Guides BlueCard  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_036846.htm&state=ct&rootLevel=4&label=What%20is%20the%20BlueCard%20Program" http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_036846.htm&state=ct&rootLevel=4&label=What%20is%20the%20BlueCard%20Program? Blue Cross and Blue Shield Association  HYPERLINK "http://www.bcbs.com" www.bcbs.com Federal Employee Program  HYPERLINK "http://www.fepblue.org/index.html" http://www.fepblue.org/index.html Availity Portal  HYPERLINK "http://www.availity.com" www.availity.com National Uniform Billing Committee (NUBC)  HYPERLINK "http://www.nubc.org" www.nubc.org Electronic Data Interchange (EDI)  HYPERLINK "http://www.anthem.com/edi" www.anthem.com/edi EDI Register link  HYPERLINK "http://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f2/s2/t0/pw_039731.htm&na=edi_ct&rootLevel=1&label=EDI%20Registration%20Forms" http://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f2/s2/t0/pw_039731.htm&na=edi_ct&rootLevel=1&label=EDI%20Registration%20Forms) Anthem HIPAA Companion Guide  HYPERLINK "http://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f3/s1/t0/pw_038045.htm&na=edi_ct&rootLevel=2&label=HIPAA%20Companion%20Guide" http://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f3/s1/t0/pw_038045.htm&na=edi_ct&rootLevel=2&label=HIPAA%20Companion%20Guide) Anthems Medical Policies and Clinical Guidelines  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003150.htm&state=ct&rootLevel=0&label=Medical%20Policies%20and%20Clinical%20UM%20Guidelines" http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003150.htm&state=ct&rootLevel=0&label=Medical%20Policies%20and%20Clinical%20UM%20Guidelines Anthem Blue Cross and Blue Shield Appeal Process  HYPERLINK "http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a084753.htm&state=ct&rootLevel=3&label=Provider%20Appeals%20and%20Billing%20Disputes" http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a084753.htm&state=ct&rootLevel=3&label=Provider%20Appeals%20and%20Billing%20Disputes Medicare Eligible  HYPERLINK "http://www.anthem.com/wps/portal/ahpmedicare?content_path=shared/noapplication/f2/s2/t4/pw_ad090993.htm&label=Anthem%20Provider%20Services" http://www.anthem.com/wps/portal/ahpmedicare?content_path=shared/noapplication/f2/s2/t4/pw_ad090993.htm&label=Anthem%20Provider%20Services  Both controlled and non-controlled medications must be filled at the designated Pharmacy Home.  A Member may change the designated pharmacy only if the request meets good cause criteria.  Exemption of members with a diagnosis of Cancer, HIV, Multiple Sclerosis, Sickle-cell Anemia or those that are in Hospice Care. (Note: Exemptions are determined by both pharmacy claim history and medical diagnosis.)     July 1, 2019 Confidential i Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc., an independent licensee of the Blue Cross Blue Shield Association.   %&.123789:ADEɴzrɐg\gQFQh7Vh8^JaJh7Vh)^JaJh7VhVP^JaJh7Vhg^JaJh 5^JaJh7Vh 5^JaJh7Vh?@gd)$a$gdF$a$$a$gd>F@ABCDEFGHIJKLMNOPQRSTUVWXYZ $dha$gdYjgdV F$dha$gdYjgd)EFXYZcd{|}~ʹup_L$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJ h Pj.h Ujh U h hB_h 0J^JjhB_h 0JUh hB_h 0JjhB_h 0JUh jh UhagDh7Vh'^JaJ hVhVhV&h*B*CJOJQJ^JaJphZc6 \  , f `U ]Ygdgd H ! Ggdm@F   0 1 2 3 4 5 6 7 8 S T U V i j k ҿx`J*jhB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#j$h UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*jhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu ~sndnWdRdA h@b9h CJOJQJ^JaJ h Pjh Ujh U h hB_h 0J^JjhB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jh UmHnHu     ; < = V W X Y Z [ \ ] ^ y z { | ҿx`J*jhB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*jhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu          4 5 {k``N#jh UmHnHuh mHnHuhB_h 0J^JmHnHu*jwhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jh UmHnHu5 6 7 c d e ~  ǼxjajKǼ*jchB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*jmhB_h 0JUmHnHu % & ' ) * + , - . I ~sndnWdRdA h@b9h CJOJQJ^JaJ h Pjh Ujh U h hB_h 0J^JjYhB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jh UmHnHuI J K L  ʳڝ|ڝi[Rh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHujh UjEhB_h 0JUh h@b9h CJOJQJ^JaJ h Pjh Ujh U h hB_h 0J^JjhB_h 0JUjOhB_h 0JUhB_h 0J     D E F _ ` a c d e f g h ȸi`Jȸ*j1hB_h 0JUmHnHuh mHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*j;hB_h 0JUmHnHuhB_h 0JmHnHu !~sndnWdRdA h@b9h CJOJQJ^JaJ h Pjh Ujh U h hB_h 0J^Jj'hB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jh UmHnHu!"#$>?@YZ[]^_`ab}~ʳڝ|ڝi[Rh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHujh UjhB_h 0JUh h@b9h CJOJQJ^JaJ h Pjh Ujh U h hB_h 0J^JjhB_h 0JUjhB_h 0JUhB_h 0J    2PRUVWrsȸvj\NjEh mHnHuh@b9h5mHnHuh@b9h 5mHnHuh@b9h mHnHuh 0JmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*j hB_h 0JUmHnHuhB_h 0JmHnHustu   &'();<=Ǽׅyky]T]>Ǽ*jhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHuh@b9h5mHnHuh@b9hmHnHuh 0JmHnHuh PmHnHu#jzh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*jhB_h 0JUmHnHu=VWXZ[\]^_z{|}ԶtidZdMZHZ h Pjf h Ujh U h hB_h 0J^Jj hB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jp h UmHnHuh mHnHu789RSTVWXYZ[vwxy⺵ى⺵|i[hB_h 0JmHnHu$jhB_h 0JUmHnHujR h Uj hB_h 0JU h Pj\ h Ujh U h hB_h 0J^Jj hB_h 0JUh hB_h 0JjhB_h 0JU h@b9h CJOJQJ^JaJ#   ./01[ҿ败pcZVZFc;hB_h 0J^Jj hB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jH h UmHnHujh UmHnHuh mHnHu$jhB_h 0JUmHnHu*j hB_h 0JUmHnHuhB_h 0JmHnHuh mHnHu[\]vwxz{|}~ufuTfIfh PmHnHu#j4h UmHnHujh UmHnHuh mHnHu*jhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJjhB_h 0JU h Pj>h Ujh U h }:L'?CdVH ! H ! ^gdGgdm@  345789:;<WXYZlmnҾ۳ہq۳dہj h UjhB_h 0JU h@b9h CJOJQJ^JaJ h Pj*h Ujh U h hB_h 0J^JjhB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHu%*+,EFGIJKLMNijklһȶ✘{ȶ✘kjhB_h 0JUj h UjhB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJ h Pjh Ujh U h hB_h 0J^JjhB_h 0JUjhB_h 0JU& !"$%&Ƴ{l{ZlOlh PmHnHu#jh UmHnHujh UmHnHuh mHnHu*j}hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJjhB_h 0JU h Pjh Ujh U&'()DEFG_`az{|~ǾǨǝ|qd[W[Gd[B h jihB_h 0JUh hB_h 0JjhB_h 0JUh PmHnHu#jh UmHnHujh UmHnHuh mHnHu*jshB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHu89:<=>vgvUgJgh PmHnHu#jh UmHnHujh UmHnHuh mHnHu*j_hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJjhB_h 0JU h Pjh U h jh U>?@A\]^_wxyǾǨǝ|qǾ[ǝI#jh UmHnHu*jKhB_h 0JUmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHu*jUhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHu!"#<=>@ABCDE`abcҺҬҬpҺҬZҬ*j7hB_h 0JUmHnHu#jh UmHnHuh mHnHu*jAhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu4567{pp^H*j#hB_h 0JUmHnHu#jh UmHnHuh mHnHu*j-hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jh UmHnHu7]^_xyz|}~׺קp^׺ק#jh UmHnHu*jhB_h 0JUmHnHuh mHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHuhB_h 0JmHnHu BCD]^_abcdefɾzq[ɾIz#j h UmHnHu*j hB_h 0JUmHnHuh mHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jh UmHnHujh UmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu*jhB_h 0JUmHnHu:;<=]^_xyzߵq[ߵI#jl"h UmHnHu*j!hB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jv!h UmHnHujh UmHnHuh mHnHu*j hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHuz|}~   ӻӭӭqӻaUBa%j#h0J>*B*Uphh0J>*B*phjh0J>*B*Uph#jb#h UmHnHuh mHnHu*j"hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHujh UmHnHuh PmHnHu  ! $%&'456O̿{veUj<%hB_h 0JU h@b9h CJOJQJ^JaJ h Pj$h Ujh U h hB_h 0J^JjF$hB_h 0JUh hB_h 0JjhB_h 0JUhh0J>*B*phh0J>*B*phjh0J>*B*Uphhh0JOPQSTUVWXstuv $%׽כ閉׽yכl׽j'h Uj('hB_h 0JUj&h U h hB_h 0J\]^Jj2&hB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJjhB_h 0JU h Pjh Uj%h U*V^ ^{D 1!!!J"""Z## $i$$=%%%P&&H ! Ggdm@%&'<=>WXY[\]^_`{|}~ϸų♕xų♕hj *hB_h 0JUj)h Uj)hB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJ h Pj(h Ujh U h hB_h 0J\]^JjhB_h 0JUj(hB_h 0JU&     )*+,;<=>WXY[\]^_`{|}~׽כ~׽nכajq,h Uj+hB_h 0JUj{+h U h h P0J\]^JhB_h 0J\]^Jj+hB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJjhB_h 0JU h Pjh Uj*h U& ;<=>YZ[tuvxyz{|ⷲن{n[$jhB_h 0JUmHnHuj].h UhB_h 0J^Jj-hB_h 0JU h Pjg-h Ujh U h hB_h 0J\]^Jj,hB_h 0JUh hB_h 0JjhB_h 0JU h@b9h CJOJQJ^JaJ"|}" # $ = ҿx`J*j/hB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jS/h UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*j.hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu= > ? A B C D E F a b c d {k``N#j?1h UmHnHuh mHnHuhB_h 0J^JmHnHu*j0hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jI0h UmHnHu !!!!!*!+!,!.!/!0!1!2!3!N!O!P!Q!ǵǵǪ~fXOX9*j2hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#j52h UmHnHujh UmHnHuh mHnHu"hB_h 0JH*^JmHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*j1hB_h 0JUmHnHuQ!!!!!!!!!!!!!!!!!!!!!!!!!!!ֹ֦waOֹ֦#j!4h UmHnHu*j3hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHu#j+3h UmHnHujh UmHnHuh mHnHuhB_h 0J\mHnHu!!!""""(")"*"C"D"E"G"H"I"J"K"L"g"h"i"j"{"|"}"~""""""""""""ĺĭ|pĺcj 6h UhB_h 0JH*^JhB_h 0J^Jj5hB_h 0JU h@b9h CJOJQJ^JaJ h Pj5h Ujh U h hB_h 0J\^Jj4hB_h 0JUh hB_h 0JjhB_h 0JU%"""""""""""""""####8#9#:#S#T#U#W#X#Y#Z#[#\#w#x#y#z#####һȶ✘{ȶ✘kjt8hB_h 0JUj7h Uj~7hB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJ h Pj7h Ujh U h hB_h 0J^JjhB_h 0JUj6hB_h 0JU&################$$$$$ $ $ $ $'$($)$*$G$H$I$b$c$d$f$g$h$i$j$k$$$׽מ陌׽|׽o׽j:h Uj`:hB_h 0JUj9h U h hB_h 0J^Jjj9hB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJjhB_h 0JU h Pjh Uj8h U*$$$$$$$$$$$$$$$%%%%%%%6%һȶ⥒{eZKZjh UmHnHuh mHnHu*jL<hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJ h Pj;h Ujh U h hB_h 0J^JjhB_h 0JUjV;hB_h 0JU6%7%8%:%;%<%=%>%?%Z%[%\%]%|%}%~%%%%%%%%%%%%%%{pp^H*j8>hB_h 0JUmHnHu#j=h UmHnHuh mHnHu*jB=hB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#j<h UmHnHu%%%%%%%%%%%%%&&& &.&/&0&I&J&K&M&N&O&P&Q&R&m&n&׺קp^׺ק#j?h UmHnHu*j.?hB_h 0JUmHnHuh mHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHu#j>h UmHnHujh UmHnHuh mHnHuhB_h 0JmHnHun&o&p&&&&&&&&&&&&&&&&&&&ɾzmd`dPmE@ h hB_h 0J^JjAhB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#j@h UmHnHujh UmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu*j$@hB_h 0JUmHnHu&&'''''''''3'4'5'6'o'p'q'''''''vgvUgJgh PmHnHu#jBh UmHnHujh UmHnHuh mHnHu*jBhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJjhB_h 0JU h PjAh U h jh U&'''5(((M)))^**#+q++F,,,F--9.;.<.=.>.?.@.A.gdcH ! Ggdm@''''''''''''''''''''((((ǾǨǝ|qd[W[GdjChB_h 0JUh hB_h 0JjhB_h 0JUh PmHnHu#jCh UmHnHujh UmHnHuh mHnHu*jChB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu.h@b9h 5CJOJQJ^JaJmHnHu((((.(/(0(2(3(4(5(6(7(R(S(T(U(g(h(i((((Ƕvf[L[:L#jmEh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu*jDhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu$jhB_h 0JUmHnHu h@b9h CJOJQJ^JaJjhB_h 0JU h PjwDh Ujh U h hB_h 0J^J((((((((((((((((((((((())))+),)-)ӻӭ~ssaӻӭK~s*jFhB_h 0JUmHnHu#jcFh UmHnHuh mHnHuhB_h 0J^JmHnHu*jEhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHujh UmHnHuh PmHnHu-)F)G)H)J)K)L)M)N)O)j)k)l)m)))))))))))))))ԶqaOԶ#jOHh UmHnHuhB_h 0J^JmHnHu*jGhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jYGh UmHnHuh mHnHu)))))))))))))))****<*=*>*W*ǼxjajKǼ*jIhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#jEIh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*jHhB_h 0JUmHnHuW*X*Y*[*\*]*^*_*`*{*|*}*~***************{k``N#j1Kh UmHnHuh mHnHuhB_h 0J^JmHnHu*jJhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#j;Jh UmHnHu***++++++ +!+"+#+$+%+@+A+B+C+O+P+Q+j+ǼxjajKǼ*jLhB_h 0JUmHnHuh mHnHuhB_h 0JmHnHu.h@b9h 5CJOJQJ^JaJmHnHuh PmHnHu#j'Lh UmHnHujh UmHnHuh mHnHuhB_h 0J^JmHnHu$jhB_h 0JUmHnHu*jKhB_h 0JUmHnHuj+k+l+n+o+p+q+r+s++++++++++++++++++~sndnWdRdA h@b9h CJOJQJ^JaJ h PjNh Ujh U h hB_h 0J^JjMhB_h 0JUh hB_h 0JjhB_h 0JU.h@b9h 5CJOJQJ^JaJmHnHu$jhB_h 0JUmHnHuh PmHnHujh UmHnHu#jMh UmHnHu++++$,%,&,?,@,A,C,D,E,F,G,H,c,d,e,f,k,l,m,,,,,,,,,,,,,,,,ɿɲڜ}ɿpڜ`}jzPhB_h 0JUjOh UhB_h 0J^JjOhB_h 0JUh h@b9h CJOJQJ^JaJ h Pj Oh Ujh U h hB_h 0J\^JjhB_h 0JUjNhB_h 0JUhB_h 0J%,,,,,,,,,,, ----#-$-%->-?-@-C-D-E-F-G-e-f-g-|-}-Ҹҙ|p]|T|hBchm@0J%jfRhBc0J>*B*UphhBc0J>*B*phjhBc0J>*B*UphjQh UhB_h 0J^JjpQhB_h 0JUh hB_h 0J h@b9h CJOJQJ^JaJjhB_h 0JU h PjPh U h jh U}----.. . ....1.2.3.6.7.8.9.:.;.<.d.e.f.g.伷䊂~shZL@h7VhvX]^JaJjShU]^JaJh[h 5]^JaJh 5]^JaJh15]^JaJhagDjh U h@b9h CJOJQJ^JaJ h Pj\Sh Ujh U h hB_h 0J^JjRhB_h 0JUh hB_h 0JjhB_h 0JUhm@hm@0J>*B*phA.B.C.D.E.F.G.H.I.J.K.L.M.N.O.P.Q.R.S.T.U.V.W.X.Y.Z.[.\.].^.gdc^._.`.a.b.c.d.e.g.h.....3n5p78888Z9 $xa$gd  0*$gd>F  0*$gdjagdU$ @&a$gd>%gd!egdYegdcg.h.i............./ /c/~/G0H0k0l0ŭufWuLufuD@DhzjhzUh7VhN^JaJh7VhWB*^JaJphh7VhWB*^JaJphh7Vh=S[^JaJ/h7VhNH5>*B*CJOJQJ^JaJph)h|5>*B*CJOJQJ^JaJph/h7Vh|5>*B*CJOJQJ^JaJphh7Vh!e^JaJh7Vhq 3^JaJh7Vh[T^JaJjh7Vh/|iU^JaJh7Vh^JaJl0z0{0001133n5555555%6B666666777(7n7̷ڤژڍwl]Nwh7VhWB*^JaJphh7VhEB*^JaJphh7VhW^JaJh7Vhi^JaJh7VhW^JaJh7Vh&^JaJh^^JaJhzjhzUh7Vhh7Vh|H0J^JaJhzjhzUh7Vh^JaJh7Vh|^JaJh7Vh>F5^JaJh7Vh|5^JaJh7Vh+Z5^JaJ/h7Vh$C5>*B*CJOJQJ^JaJph)h>%5>*B*CJOJQJ^JaJphh7VhZ^JaJh7VhFSs^JaJh7Vh=S[^JaJh7Vh3^JaJh7Vh^JaJh7VhaS1^JaJ495969Y9i9j9999999999999999::R:Z:[:j:תtbSDh7VhB*^JaJphh7Vh(tB*^JaJph#h7Vh|6B*]^JaJphh7VhWB*^JaJphh7Vh|B*^JaJphh7Vho!:5^JaJh7Vh|5^JaJh7Vh|<^JaJh7Vh(t^JaJh7VhoN^JaJh7Vho!:^JaJh7Vh|^JaJh7Vh|B*^JaJphjhz0JU^JaJZ9j999999<<B<<<>>)>>>>>>gdYe $ a$gd)$a$gd>F$a$gd $h^ha$gd>F$ & F 8^a$gdo$ & F 8^a$gdoj:::::::::;;;;;;;;*;3;l;;;;;;;<<-<6<B<C<<<ʿ𰥚xiia]ahzjhzUh7VhuB*^JaJphh7VhFHB*^JaJphh7Vhny^JaJhNH^JaJh7VhN^JaJh7Vhu^JaJh7VhNB*^JaJphh7Vh|^JaJh7Vh<^JaJh7VhB*^JaJphhNHB*^JaJphh7Vh|B*^JaJph!<<<<]=_=e===>>>(>)>*>>>>>>>>>ǸǸ֩֋ufT@&jUhCJOJQJU]^JaJ#h7VhnyCJOJQJ]^JaJh7VhCgB*^JaJphhu0J^JaJhzjhzUh7VhB*^JaJphh7VhNB*^JaJphh7VhnyB*^JaJphh7VhaS1B*^JaJphh7Vh|B*^JaJphh7VhuB*^JaJphjhz0JU^JaJh7Vhu0J^JaJ>>>??-?BFEFFFFG-IGIHIII°~f[I=[h7Vhx>*^JaJ#h7Vhx>*B*\^JaJphh7Vhx^JaJ/h>%hx5>*B*CJOJQJ^JaJphh7VhxB*^JaJphh 45B*\^JaJphh 4B*^JaJphh 4^JaJ#h>%hx5>*B*^JaJph h7Vhx>*B*^JaJphh7Vhq 3^JaJh7Vh!e^JaJ,h7Vh)>*B*CJOJQJ^JaJph>??C@D@BBFFEFFFFGG,I-IHI$ & F( ha$gdo$a$gdx$ @&a$gd>%$ r7$8$H$a$gdxgd 4$ r7$8$H$a$gd1gdYeHIIIKKKKMMNNQQ R Rv $ 0*$a$gdx$ 0h*$^h`a$gdx$ 0hh*$^ha$gdx $^a$gdx$ 0hh*$^h`a$gdx$ & F( ha$gdo $h^ha$gdx$ hh^h`a$gdx IIKKKMNNNPPQQQ R RTTTkUV/WWWX]Z[3\4\5\E\``8`˽䰢䰢䕋zb/h,Mhx5>*B*CJOJQJ^JaJph h7Vhx>*B*^JaJphh80J?^JaJh7Vhx0J?^JaJh7Vhx>*@^JaJh7Vhx@^JaJh7Vhx0J>>*^JaJh7Vhx0J>^JaJh7Vhx>*^JaJh7Vhx^JaJ h7VhxB*\^JaJph RTTTTXXYY[[4\5\E\F\$ hh^h`a$gdx$ & F) hh^ha$gdo$ 0hh*$^h`a$gdx$ 0hh*$^h`a$gdx$ 0h*$^h`a$gdx$ hh^h`a$gdxF\``8`9`````aayczc|wgd1Jgdy3u$ r^`a$gd1$ & F, ha$gdo $ ra$gd1gdx$ r7$8$H$a$gdx$ @&a$gd>%$ r7$8$H$a$gd1$ 0hh*$^h`a$gdx 8`9`````wcxczcdddeeKeUeeecffggghCjDj[kȰxxxxmxcxxUh7Vh1@]^JaJh8@^JaJh7Vhy{^JaJh7Vh1^JaJh7Vh1B* ^JaJphI}!h7Vh1@B*^JaJphh7Vh1@^JaJ/h>%h15>*B*CJOJQJ^JaJph h7Vhx>*B*^JaJphh7Vhx^JaJh7Vhx\^JaJh7VhxB* ^JaJphzcddeeeeCfDfggUgVgggJ$ & F. 8a$gdoJgd1J$ & F- 8a$gdo $ ha$gd1 $ 8a$gd1 $ ra$gd1$ 8^a$gdy3u$ 8^8a$gd1^gd1ghhqiiCjDj\k]kkk[n\nmnr$ 0h h*$^h`a$gd)gdI$ @&a$gd>%$ rh7$8$H$^ha$gd]_$ r^a$gd1$ & F/ ^a$gdo$ rh^h`a$gd1$ hh^h`a$gd1 [k\k]kkkk%n6n[n\nmnnnnɴ{cN42h7Vh)5B*CJOJQJ\]^JaJph)h7Vhqv2B*CJOJQJ^JaJph/h>%hqv25>*B*CJOJQJ^JaJphh7Vh)^JaJh,MhI^JaJh7VhI^JaJ/h7Vh85>*B*CJOJQJ^JaJph)h"Z5>*B*CJOJQJ^JaJph/h7Vh"Z5>*B*CJOJQJ^JaJphh7Vh]_5>*^JaJ h7Vh1>*B*^JaJph mnnnnn2oooppOqPq}q~q#u$uuuzzzzzzgd)gd)  & F@7$8$H$gdo & F@x7$8$H$gdoxgd)$a$gd)gdqv2nOqPq{q|q}q~q#uuzz|| "#$ؾةꞆ{m`UJ>h7Vh4J5^JaJh7Vh}^JaJh7Vhq 3^JaJh7Vh2@^JaJjSWhU]^JaJh7Vh8^JaJ/h7Vh)5B*CJOJQJ\^JaJphh7Vh)^JaJ)h7VhNHB*CJOJQJ^JaJph2h7Vh)5B*CJOJQJ\]^JaJph#h)B*CJOJQJ^JaJph)h7Vh)B*CJOJQJ^JaJphz||||Bqց^7Ƀ & FBx7$8$H$gdo & FA7$8$H$^gdo & FAx7$8$H$^gdoxgd)gd) #$%)*Vҋnj$-DM a$gd $-DM a$ $ ,a$$a$gd}gdQ $a$gdYegd,M$ 0*$-DM a$gd>Fgd)J & FBgdo$%QYUXY|}()AJVWއ߇%+ɗɗߗrrrg_h,M^JaJh7VhTB^JaJjh7Vh/|iU^JaJh7VhQ ^JaJh7Vh^JaJh7Vh5&^JaJjhz0JU^JaJh7Vh5&0J^JaJhzjhzUh7VhO^JaJh7Vh)Ba^JaJh7VhN^JaJh7Vh=S[^JaJh7Vhd^JaJ#dfыҋoZE0E)h7VhPB*CJOJQJ^JaJph)h7Vh"uB*CJOJQJ^JaJph)h7Vh4JB*CJOJQJ^JaJph#h,MB*CJOJQJ^JaJph)h7Vh%B*CJOJQJ^JaJph)h7Vh#4B*CJOJQJ^JaJph)h7VhB*CJOJQJ^JaJphh7VhyZ5^JaJ#h7Vhtc5>*B*^JaJph#h7Vh<5>*B*^JaJphh7Vh}B*^JaJph  <=qrƌnjʌΌ ոxfQ*B*CJOJQJU^JaJph0h7VhTr0J>*B*CJOJQJ^JaJphhzjhzU h7VhTrCJOJQJ^JaJnj,}b9j!89cdKL~* $IfgdN;$If$a$gd>F $-DM a$$-DM a$gd"+,ю8>bh|}Ϸ}l[l[l[lJl9l h7VhNCJOJQJ^JaJ h7Vh4JCJOJQJ^JaJ h7Vh-$CJOJQJ^JaJ h7VhxCJOJQJ^JaJ h7VhenCJOJQJ^JaJ h7Vh=S[CJOJQJ^JaJ/h7Vh4J5>*B*CJOJQJ^JaJph/h7Vh95>*B*CJOJQJ^JaJph/h7Vhen5>*B*CJOJQJ^JaJph/h7Vh=S[5>*B*CJOJQJ^JaJphKL`abtM]Ȓɒ89PYjk !89E̻̻w̻eYNh7Vh|^JaJh7Vh|5^JaJ#h7Vh|5>*B*^JaJph h7VhNCJOJQJ^JaJ h7Vh4JCJOJQJ^JaJ h7VhenCJOJQJ^JaJ h7Vh=S[CJOJQJ^JaJ h7VhxCJOJQJ^JaJ'jhz0JCJOJQJU^JaJ$h7Vhx0JCJOJQJ^JaJhzjhzUEFGjkyzÔɔʔӔ +178DKc{~23IJKLZ[ø΢ujh7Vhk!^JaJh7Vh|5^JaJh7Vhd%^JaJh7Vh#4^JaJh7Vh=S[^JaJh7Vhx^JaJh7Vh/^JaJh7Vh2C^JaJh7Vh|^JaJjhz0JU^JaJh7Vhx0J^JaJhzjhzUh7VhN^JaJ(()*+,-./Ǘȗܗݗޗt_Tth7VhH+^JaJ(jz[hhU^JaJmHnHuh7VhoN<^JaJ h7Vh*T'jhz0J>*B*U^JaJph$h7Vh00J>*B*^JaJph$h7VhN;0J>*B*^JaJph$h7Vh=S[0J>*B*^JaJphhzjhzUh7Vh*T^JaJ(jYhhU^JaJmHnHu*+,.ݗޗߗ>Ukd]$$If0VBB t634Bayt*T $IfgdH+$IfJ & FgdvNUkd[$$If0[BB t634BayttcQR:;<=>?@AڙۙܙݙޙߙOPচচpচ[(j"ehhU^JaJmHnHu(jbhhU^JaJmHnHu(jL`hhU^JaJmHnHuh7VhoN<^JaJ h7Vh*T'jhz0J>*B*U^JaJph$h7Vh=S[0J>*B*^JaJphhzjhzUh7Vh*T^JaJ(j]hhU^JaJmHnHu#<=>GUkdWb$$If0 BB t634Bayt*TJ & FgdvNUkd_$$If08BB t634Bayt*T$If>@ܙݙޙz{EUkd-g$$If0BB t634Bayt*TJ & FgdvNWkdd$$IfP0[BB t634BaytH+$IfPxyz{|}~IJKLMNOPɛʛ !"78XǻΞǻΞzh\Qh7VhPE^JaJh7VhPE5^JaJ#h7VhPE5>*B*^JaJphh7Vh4J^JaJ(jihhU^JaJmHnHuhzjhzU(jghhU^JaJmHnHuh7VhoN<^JaJ h7Vh*Th7Vh*T^JaJ'jhz0J>*B*U^JaJph$h7Vh=S[0J>*B*^JaJph{|~KLMO Ukdi$$If0pBB t634Bayt*T$IfJ & FgdvN !"78"1<\]| $^a$gd>F$a$gd>F$^a$Wkdk$$Ifg0NBF tN634Bayt0X]eo;Vgh]{|}>Ÿßğş갧zrjbTjilh@U^JaJh8^JaJhT ^JaJhPE^JaJh7Vh4^JaJh7VhG5^JaJh7Vh=S[^JaJh7VhNH5^JaJh/5^JaJh7Vh=S[5^JaJh7Vh*T^JaJh7Vh-$^JaJh7Vh-$5^JaJh7VhPE5^JaJh7VhPE^JaJh7Vh^JaJ|}ŸßşƟ01KMա֡iɢ* J & F+7$8$gdom$J & F+x7$8$gdom$ x7$8$gdPegdPe7$8$gdPe $ a$gd>F$a$gd,Mgd,M$a$gd>FşƟ/01JKLMơԡա&'12hpʻ軧~vrvbQIhgg^JaJ!jhz0J5U\^JaJh,MhPe0J5\^JaJhzjhzU.hgg5B*\^JaJfHphq h,MhPe>*B*^JaJph&h,MhPe>*B*\]^JaJphh,MhPeB*^JaJph$h7Vh-$@CJOJQJ^JaJh7Vh/^JaJh,MhPe^JaJh7Vh|5^JaJptƢ,ˣ_q ٥fjr糜wbwN<#h,MhPeCJOJQJ\^JaJ&h,MhPe5CJOJQJ\^JaJ)h,MhPe5>*CJOJQJ\^JaJ&h,MhPe>*CJOJQJ\^JaJ h,MhPeCJOJQJ^JaJ,h,MhPe>*B*CJOJQJ^JaJph2h,MhPe>*B*CJOJQJ\]^JaJphh,MhPe5^JaJh,MhPe6]^JaJh,MhPe^JaJh,MhPe5\^JaJ*,ˣ_٥ۥijrY  & FkH$^gdo  & FjH$gdogdPegdPe J & Figdom$ J & Fixgdom$ J & Fixgdom$ x7$8$gdPe7$8$gdPerfgh|箝s_G84h,MhggCJOJQJ]^JaJ/h,MhPe6B*CJOJQJ]^JaJph&h,MhPe6CJOJQJ]^JaJ/h,MhPe5B*CJOJQJ]^JaJph#h,MhPeCJOJQJ]^JaJ h,MhPeCJOJQJ^JaJ)h,MhPeB*CJOJQJ^JaJph#h7Vhg CJOJQJ\^JaJ#h,MhPeCJOJQJ\^JaJ/h,MhPeB*CJOJQJ\]^JaJphߩ2Ul)Zgh45vwx $ a$gd>FgdPegd,MgdPe  & FkH$^gdo01358 *-DM^dsuvxyɾtaM'j'nh@CJOJQJU^JaJ$h7Vh-$@CJOJQJ^JaJh,MhPe6^JaJh,MhPe5^JaJh[}^JaJh[}5\^JaJh,MhPe5\^JaJ h,MhPe5B*^JaJphh,MhPe^JaJh,MhPe]^JaJjhz0JU]^JaJh,MhGE0J]^JaJhzjhzUxz{deBCbcLMgdNd$ @&a$gd?/gdgdYe $ a$gd>Fyz{ĭ˭ͭέ/0STǼ}rfNFBFhzjhzU/h?/h4>5>*B*CJOJQJ^JaJphh7Vh5^JaJh7Vh^JaJh7Vh??^JaJh7Vh-^JaJh7VhZ.^JaJh7Vh4^JaJh,M^JaJh7Vh#x^JaJh7Vh)^JaJh7Vh}6^JaJh7Vh=S[^JaJ *h7Vh^Z^JaJ,h7Vh3>*B*CJOJQJ^JaJphTbcdewЮѮ߮AB_cͿwlallVVwVh7VhNd^JaJh7VhN^JaJh7Vh4>^JaJjhz0JU^JaJh7Vh?f0J^JaJhzjhzUh7VhPe^JaJh7Vh=S[^JaJh7Vh4J^JaJh7Vh4J5>*^JaJ2jhz5>*B*CJOJQJU^JaJph/h?/h=S[5>*B*CJOJQJ^JaJph 7KLM_%& qҜwl^M h[Dth~CJOJQJ^JaJh~CJOJQJ^JaJh7Vh^JaJ/h?/h5>*B*CJOJQJ^JaJphh7Vh@^JaJ/h7Vh05>*B*CJOJQJ^JaJphh,M^JaJh7Vh^JaJh7VhNd^JaJh7Vh4J^JaJh7VhE^JaJh7Vh=S[^JaJh7Vh=S[>*^JaJpq6V͸#  & FeH$gd~  & FdH$gd~  & FbH$gdCg  & FbH$gd~ H$^gd~gd~$a$gd$ @&a$gd?/$a$gd $ a$gdj-qе+67LUVʶlllZH3)hYG}h~B*CJOJQJ^JaJph!#hDNih~CJOJQJ\^JaJ#hOnh~CJOJQJ\^JaJ&hOnh~5CJOJQJ\^JaJ&hOnhCg5CJOJQJ\^JaJ hOnh~CJOJQJ^JaJ hkh~CJOJQJ^JaJ&hkh~5CJOJQJ\^JaJ hf5h~CJOJQJ^JaJ&h[Dth~5CJOJQJ\^JaJ h~5CJOJQJ\^JaJVq޷¸ɸʸ̸͸"#4۬hVEV1E&h2h~5CJOJQJ\^JaJ h~5CJOJQJ\^JaJ#h~B*CJOJQJ^JaJph!,hh~B*CJH*OJQJ^JaJph!)hh~B*CJOJQJ^JaJph!/hh~5B*CJOJQJ\^JaJph!2hh~5B*CJH*OJQJ\^JaJph!)h4"h~B*CJOJQJ^JaJph! hh~CJOJQJ^JaJ&hh~5CJOJQJ\^JaJ `-3ӼԼJF'  & FgH$gd~  & FH$^gd~  & FbH$gd~gd~H$gd~H$gd~̹ع $^`ɺʺͺ,-27ɸ~`E`4 hCh~CJOJQJ^JaJ4h~B*CJOJQJ^JaJfHphq :hCh~B*CJOJQJ^JaJfHphq )hCh~B*CJOJQJ^JaJph h~5CJOJQJ\^JaJ&hMh~5CJOJQJ\^JaJ hMh~CJOJQJ^JaJ hh~CJOJQJ^JaJ#hh~CJOJQJ\^JaJ&hh~5CJOJQJ\^JaJ7@3GHNOQӼͼͼsaLa)hMh~5CJH*OJQJ\^JaJ#hMh~CJOJQJ\^JaJ)hMh~5CJH*OJQJ\^JaJ hh~CJOJQJ^JaJ hfmh~CJOJQJ^JaJ#hfmh~CJOJQJ\^JaJ h~5CJOJQJ\^JaJh~CJOJQJ^JaJ hMh~CJOJQJ^JaJ&hMh~5CJOJQJ\^JaJ IJWZĽǽDFuxѾҾﻧraJ-jh~0J5CJOJQJU\^JaJ hMxh~CJOJQJ^JaJ#h=h~CJOJQJ\^JaJ hdh~CJOJQJ^JaJ#hdh~CJOJQJ\^JaJ&hdh~5CJOJQJ\^JaJh~CJOJQJ^JaJ#hf5h~CJOJQJ\^JaJ&h[Dth~5CJOJQJ\^JaJ h[Dth~CJOJQJ^JaJҾ #&'14֨lWlWI7#hf5h~CJOJQJ\^JaJh~CJOJQJ^JaJ)h[Dth~B*CJOJQJ^JaJph,h[Dth~B*CJOJQJ\^JaJph&h[Dth~5CJOJQJ\^JaJ h[Dth~CJOJQJ^JaJ/h[Dth~5B*CJOJQJ\^JaJph*h[Dth~0J5CJOJQJ\^JaJ-jh~0J5CJOJQJU\^JaJ$h~0J5CJOJQJ\^JaJӿۿܿ!"RS ɸxgUFUg8gh~CJOJQJ^JaJh~5CJOJQJ^JaJ#hf5h~5CJOJQJ^JaJ h[Dth~CJOJQJ^JaJ*hi,h~0J5CJOJQJ\^JaJ$h~0J5CJOJQJ\^JaJ-jh~0J5CJOJQJU\^JaJ hi,h~CJOJQJ^JaJ#hi,h~CJOJQJ\^JaJ&h[Dth~5CJOJQJ\^JaJ h~5CJOJQJ\^JaJhTUvwp$a$gd>F<xgdT J & Fhd^gd~J & Fh^gd~m$gd~gd~ 9:LMSU$0?BRXuvwx~Ϭᡕxxxh_0ch~5^JaJh~^JaJh~5^JaJhf5h~5^JaJh4h~^JaJ hCh~CJOJQJ^JaJ#h5bsh~6CJOJQJ^JaJ#hCh~5CJOJQJ^JaJh~CJOJQJ^JaJ h4h~CJOJQJ^JaJ/UnopstUVպծՖ}h]RD9h7Vh{A^JaJjoh@U^JaJh7Vh ^JaJh7Vh^JaJ(h~B*^JaJfHphq 1h_0ch~6B*^JaJfHphq .h_0ch~B*^JaJfHphq h_0ch~5^JaJh_0ch~^JaJh~^JaJfHq %h_0ch~^JaJfHq h.:h~^JaJh.:h~5^JaJ<=ef[\MN $1$a$gdol $1$a$gdt $7$8$H$a$gd $a$gd\gd\$a$gd $a$gd|h$a$gdol$a$gdt$ !@ 1$a$gd>FgdYe$ ^a$gd>F<=ef}~ȼȰtbSD6h7Vh.5\^JaJh7Vh5>*\^JaJh7Vh.5>*\^JaJ#h7Vh)>*B*\^JaJphh7Vh J>5>*\^JaJh7Vh J>\^JaJh,M\^JaJh7VhWDx\^JaJh7Vh.\^JaJh7Vh=S[\^JaJh7VhG5\^JaJh7VhWR\^JaJh7Vh-&^JaJh7Vhq 3^JaJ)h7Vh3B*CJOJQJ^JaJphLZ[s|[ƺugYKh7Vh 5>*^JaJh7Vhq5>*^JaJh7Vh#P5>*^JaJh7Vh\0J^JaJjh7Vh/|iU^JaJh7Vh x^JaJh\^JaJh7VhN^JaJh7Vh\^JaJh7Vh#P\^JaJh7Vh\\^JaJh7Vh \^JaJh,M\^JaJh7Vh.\^JaJh7VhY\^JaJ<KLMN`dstABW}q}ia]aOh7VhQ`0J\^JaJhzjhzUh x^JaJh7Vh8Y\^JaJh7Vhi^JaJh7Vhq^JaJh7Vh^JaJh7Vhs^JaJh7VhV^JaJh7VhOta5^JaJh7Vh=S[5^JaJh7Vh^JaJh7Vh/r^JaJh7VhOta^JaJh,M^JaJh7Vh=S[^JaJABhijlmK $^a$gd|h$a$ $`a$gd|h $8^8a$gdY$a$gd|hgd?/$ ^a$gdV$a$gdV $^a$gdt$a$gdol $1$^a$ $1$a$gdolIJfghijkl͵٭teVH=h7VhV^JaJjqh@U^JaJh7Vh8B*^JaJph33h7Vh9B*^JaJph33!h7Vh.0JB*^JaJph33$jhz0JB*U^JaJph33!h7Vhi0JB*^JaJph33hzjhzUh7Vhs\^JaJh7Vh.\^JaJh7Vh8Y\^JaJh7VhL\^JaJh7Vhs^JaJjhz0JU\^JaJlm!'JK˷{ocWKc?c6cWh,M\^JaJh7Vhn\^JaJh7Vh/r\^JaJh7Vh)\^JaJh7Vh.\^JaJh7VhY\^JaJ&h7Vh)5>*B*\^JaJph&h7Vh85>*B*\^JaJph&h7Vh.5>*B*\^JaJph&h7Vh95>*B*\^JaJph&h7VhV5>*B*\^JaJphh?/hV^JaJ)h7VhVB*CJOJQJ^JaJphKLfh+,/01qr $ a$gd $ a$gd0 $ a$gd>F$a$gd>F $^a$gd2C$a$gd>F $h^ha$gd2C $h^ha$gd!e$h^ha$KLMZ[`fgh,-./01LֽxcWC/'h7Vh0 5@CJOJQJ^JaJ'h7Vhh>*@CJOJQJ^JaJh7VhcG]^JaJ(jchhU^JaJmHnHujhUmHnHuh7Vhs^JaJh7Vh.5^JaJh7Vh.^JaJ(jashhU^JaJmHnHuh7Vh!e5\^JaJh85\^JaJh7Vh.5\^JaJh7Vhs5\^JaJh7Vh/r5\^JaJL^_prs'.HOr|\jɵyyyydOd<$h7Vhh@CJOJQJ^JaJ)h7Vh\B*CJOJQJ^JaJph)h7Vh[B*CJOJQJ^JaJph#h xB*CJOJQJ^JaJph)h7Vh0 B*CJOJQJ^JaJph)h7Vhy*B*CJOJQJ^JaJph'h7Vh 5@CJOJQJ^JaJ'h7Vh0 5@CJOJQJ^JaJ!h85@CJOJQJ^JaJ!h x5@CJOJQJ^JaJmnǴǴǬn[G2)h7VhcGB*CJOJQJ^JaJph'jh@CJOJQJU^JaJ$h7Vh~`P@CJOJQJ^JaJ$h7VhA@CJOJQJ^JaJ'jhz0JCJOJQJU^JaJ$h7Vh[0JCJOJQJ^JaJhzjhzU$h7Vhs5@CJOJQJ^JaJ$h7Vh @CJOJQJ^JaJ$h7VhN@CJOJQJ^JaJ$h7VhO@CJOJQJ^JaJ:;FG01gd 7$8$H$gd gd X*$ @&a$gdjagdmgdm $`a$gd>F $ a$gd>F9;GJaҺhTh@h'h B*OJQJ^JaJmH ph!%)sH 'hCTB*OJQJ^JaJmH ph!%)sH -hyQh B*OJQJ^JaJmH ph!%)sH h 5B*^JaJphh B*^JaJphhh B*^JaJph# *hh X*>*B*^JaJph/hjah X*5>*B*CJOJQJ^JaJphh2x^JaJh7Vhz^JaJh7Vh*XZ^JaJh7VhcGB*^JaJph/01EHVWƵƘxfxO7O/h G&h 6>*B*CJOJQJ^JaJph,hh >*B*CJOJQJ^JaJph#h B*CJOJQJ^JaJph)hh B*CJOJQJ^JaJphhh B*phh B*^JaJph hh 5B*^JaJph h7ih 5B*^JaJphhh B*^JaJph hyQh 5B*^JaJph1hyQh B*CJOJQJ^JaJmH ph!%)sH <=HIJKMNʻykakTkyHy7H hh 5B*^JaJphh B*^JaJphh8h 0J^JaJh 0J^JaJjh 0JU^JaJh7ih B*^JaJph h7ih >*B*^JaJph h7ih 5B*^JaJph hh >*B*^JaJphhh B*^JaJph,hh >*B*CJOJQJ^JaJphh CJOJQJ^JaJ hh CJOJQJ^JaJKMN78BCJ`gd J & FE7$8$H$gd 7$8$H$^`gd  & FD 87$8$H$^gd 7$8$H$gd 9:VW&~  & FUdgd  & FUdgd dgd J^gd gd gd Jgd  & FD 87$8$H$^gd J`gd  679:VW>pҰ䡒|qiqiq^O>^i hGh >*B*^JaJphh5`h B*^JaJphhGh ^JaJh ^JaJh-8h ^JaJhh ^JaJh-8h CJaJhh B*^JaJphhe!h B*^JaJph hh >*B*^JaJph h G&h 6B*^JaJph#h G&h 6>*B*^JaJphh B*^JaJphhh B*^JaJphHI&34<}~`aǹǧNjǀui]PDh-8h 5^JaJhh PJ^JaJhh >*^JaJh-8h >*^JaJhch ^JaJh>w h ^JaJhGh CJ^JaJh 6CJOJQJ^JaJ#hGh 6CJOJQJ^JaJh CJOJQJ^JaJ hGh CJOJQJ^JaJ#hGh >*CJOJQJ^JaJhch 5^JaJh 5^JaJ`?@no\Ngd 7$8$H$^gd & FT7$8$H$gd J7$8$H$gd m$ J & FVgd m$J & FVgd Jgd 7$8$H$gd a{|}~?@moCDRcݸНЬЌugZOh G&h CJaJh G&h CJ^JaJh G&h 5CJ^JaJh G&h ^JaJh G&h 5^JaJ hh 5B*^JaJphhh B*^JaJphhh >*^JaJh-8h >*^JaJh-8h 5^JaJhh PJ^JaJhh ^JaJh-8h ^JaJhh 5^JaJCDQR %&Z[lTU|}J^gd 9gd gd 7$8$H$gd cdCd &*EXYZ[ԽrfUfr h5`h 6B*^JaJphh B*^JaJphh5`h B*^JaJphh 5B*^JaJphh G&h CJaJ h G&h 5B*^JaJphhO#h ^JaJ hO#h hb+h 0J^JaJh 0J^JaJjh 0JU^JaJh`h ^JaJh-8h ^JaJh ^JaJ [kmSTU|}VXYȺ{p_WKWD9h-8h CJaJ h3h h3h 6^JaJh3h 6 hh 6B*^JaJphh G&h ^JaJh G&h 5^JaJh ^JaJhh ^JaJhh B*^JaJph h7ih 5B*^JaJphh 5B*^JaJphh7ih ^JaJhGh ^JaJ h`h 5B*^JaJph h5%Ih 5B*^JaJph}Yv $xa$gd $a$gd gd gd Jgd J & FD gd J & FD 7$8$H$gd  & FD 87$8$H$^gd novUVeǽǮǝǽԏ|q|qeqT h7ih >*B*^JaJphh7ih >*^JaJh7ih ^JaJ$h7ih @CJOJQJ^JaJh7ih >*@^JaJ!h7ih @B*^JaJphhh B*^JaJphh @^JaJh7ih @^JaJh7ih 5@^JaJh 5@^JaJh ^JaJh-8h ^JaJNv)UV gd 7$8$H$gd Jx^gd J^gd xgd gd w $gd ef#pwƸқ~l~YNC8hh ^JaJh7ih CJaJhO#h CJaJ$hO#h @CJOJQJ^JaJ#hO#h 56>*\]^JaJhO#h 6>*]^JaJhO#h 6]^JaJhO#h ^JaJ#hO#h >*B*\^JaJphhO#h 5\^JaJhO#h 5^JaJhO#h B*^JaJphhh B*^JaJphhh B* ^JaJphI}/ F%D !Q$ & F ha$gd$ & F a$gd$ & F a$gd$a$gdJ$ & Fdd[$\$a$gd$dd[$\$a$gd dd[$\$gdgd 0/Fcikв}e}eS#hwhCJOJQJ\^JaJ/h7,h5>*B*CJOJQJ^JaJph2h7,h5>*B*CJOJQJ\^JaJphh~m[hB*^JaJphhB*^JaJphhthB*^JaJphh5>*B*^JaJph#h7,h5>*B*^JaJphhK8h ^JaJh ^JaJh7ih ^JaJklop%,!PQ!*/:?x !&IJޞĆu hGh >*B*^JaJph/h^Pph5B*CJOJQJ\^JaJph&h7,h>*CJOJQJ\^JaJ#hJhCJOJQJ\^JaJ2h7,h5>*B*CJOJQJ\^JaJph#hwhCJOJQJ\^JaJhCJOJQJ\^JaJ-QIJv    T U |}~Jgd ^gd gdo & FFgd J & FFx7$8$gd m$ & FFxgd m$gd $a$gdHIJX   u v          ּu``΂TIhyh ^JaJh5 \h 6^JaJ)h5 \h B*CJOJQJ^JaJphh5 \h OJQJaJh5 \h ^JaJhyh >*^JaJ#h5 \h 6CJOJQJ^JaJ h5 \h CJOJQJ^JaJ#hyh >*CJOJQJ^JaJh ^JaJhh ^JaJ hGh >*B*^JaJphh >*B*^JaJph  f T U e h bcr{~'U?mb/06d HIhK'h ^JaJhK'h 5^JaJh hK'h 5B*^JaJphhbh ^JaJ#hOh 5>*B* ^JaJph?hGh >*^JaJhm`h ^JaJhh ^JaJh ^JaJ7~?kdѿ$$Ifl4 FaM," @@@ tNyNyNy06    44 lapNyNyNyytK' $IfgdK' 'U J & FO$IfgdK' $IfgdK' J & FM$IfgdK'?H??22 J & FN$IfgdK' $IfgdK'kd$$Ifl4 FaM," ` t.t06    44 lap.tytK'?m2kd$$Ifl4 FaM,"  ` t.t06    44 lap.tytK' J & FP$IfgdK' $IfgdK'Gb J & FM$IfgdK' $IfgdK'IH??22 J & FN$IfgdK' $IfgdK'kd$$Ifl4 FaM,"  ` t.t06    44 lap.tytK'/062kdr$$Ifl4 FaM,"  ` t.t06    44 lap.tytK' J & FN$IfgdK' $IfgdK'6d -H J & FS$IfgdK' J & FQ$IfgdK' $IfgdK'HIJx)H??2? J & FR$IfgdK' $IfgdK'kdZ$$Ifl4 FaM," ` t.t06    44 lap.tytK'IJx)P-./pUVLvvvk_hO#h 6^JaJhO#h ^JaJhGh ^JaJhGh 5^JaJhGh >*^JaJ hGh >*B*^JaJphh >*B*^JaJphh-6^JaJh ^JaJhh ^JaJh hK'h ^JaJhK'h 5^JaJ hK'h 5B*^JaJph%);22 $IfgdK'kdH$$Ifl4 FaM,"  ` t.t06    44 lap.tytK' J & F^$IfgdK'P J & FS$IfgdK' $IfgdK' J & FQ$IfgdK'H??2? J & F]$IfgdK' $IfgdK'kd0$$Ifl4 FaM,"  ` t.t06    44 lap.tytK'./03;6666gd kd$$Ifl4 FaM,"  ` t.t06    44 lap.tytK' J & F]$IfgdK'MNH & FXx^gd xgd gd ((7$8$^`gd ((7$8$^`gd d((7$8$^`gd ((7$8$gd 7$8$H$gd gd LNwxTUtiiTi(jh h U^JaJmHnHuhGh ^JaJhGh 5\^JaJhGh \^JaJh CJOJQJ\^JaJ#hGh CJOJQJ\^JaJ hGh CJOJQJ^JaJ&hGh 5CJOJQJ\^JaJh CJOJQJaJh ^JaJh !h ^JaJhGh 6^JaJH<<$If^HgdK' <<$IfgdK' 7$8$H$gd  & FXx^gd ( ) k l       ,!-!3!K!!!"""#######$$$$$$$$үyymm^m^m *hGh 5\^JaJhGh \^JaJh >*^JaJhGh >*^JaJhGh ^JaJh ^JaJhGh 5\^JaJ#hGh CJOJQJ\^JaJ hGh CJOJQJ^JaJ hK8h &hGh 5CJOJQJ\^JaJ#hGh 5CJOJQJ^JaJ$ ( yhH<<$If^HgdK' <<$IfgdK'xkd$$Iflp0" V044 laJytK'( ) : k yhH<<$If^HgdK' <<$IfgdK'xkd$$Iflh0" V044 laJytK'k l |  yhH<<$If^HgdK' <<$IfgdK'xkd$$Iflh0" V044 laJytK'     "\###}ttiZMt & FY7$8$H$gd  & FYx7$8$H$gd x7$8$H$gd 7$8$H$gd ^gd xkd $$Iflh0" V044 laJytK'#####`<<$7$8$H$If^`gdK'0<<$7$8$H$If^0gdK'<<$7$8$H$IfgdK' x7$8$H$gd ### $$#$kYYC-`<<$7$8$H$If^`gdK'0<<$7$8$H$If^0gdK'<<$7$8$H$IfgdK'kd$$IfTlF ,"x x x t06    44 laytK'T#$$$4$C$$$kYYC-`<<$7$8$H$If^`gdK'0<<$7$8$H$If^0gdK'<<$7$8$H$IfgdK'kd$$IfTlF ,"x x x t06    44 laytK'T$$$$ %%kYYC-`<<$7$8$H$If^`gdK'0<<$7$8$H$If^0gdK'<<$7$8$H$IfgdK'kd$$IfTlF ,"x x x t06    44 laytK'T$$%%%%%%%%%%&&'&s&t&' '''s(((((())+),)))tdtZtdh PJ^JaJhGh 5PJ\^JaJhGh PJ^JaJ!hGh 56PJ\^JaJhGh 56\^JaJhK8h ^JaJh \^JaJhK8h \^JaJhGh 5\^JaJhGh h]%\^JaJ *hGh 5\^JaJhGh \^JaJ hK8h %%(%7%y%%kYYC-`<<$7$8$H$If^`gdK'0<<$7$8$H$If^0gdK'<<$7$8$H$IfgdK'kd)$$IfTlF ,"x x x t06    44 laytK'T%%%%%&E''kbbbRRBJ & FW<7$8$H$gd m$J & FWx7$8$H$gd m$ 7$8$H$gd kd$$IfTlF ,"x x x t06    44 laytK'T''&(n(((((()),**f+g+++++<<$7$8$H$IfgdK' & F[7$8$H$gd  & F[x7$8$H$gd x7$8$H$gd 7$8$H$gd J & FW<7$8$H$gd m$)))* **+++++++++++!,L,M,v,,,,,---M-N-c-d-k-v- . ..-........ս㽇}ㇽo㽥hGh 5PJ^JaJhu;PJ^JaJhGh \^JaJ hK8h h 5\^JaJhGh 5\^JaJh PJ^JaJhGh PJ^JaJh PJ\^JaJhGh PJ\^JaJhGh 5PJ\^JaJh 5PJ\^JaJ+++++!,=+<<$7$8$H$IfgdK'kd;$$IfTl4F $ ^ t0e%6    44 laytK'Te<<$7$8$H$If^egdK'Y<<$7$8$H$If^YgdK'!,M,,,,A/<<$7$8$H$IfgdK'kdח$$IfTlF $ ^ t0e%6    44 laytK'Te<<$7$8$H$If^egdK'Y<<$7$8$H$If^YgdK',,,,--N-V-\-d- .e<<$7$8$H$If^egdK'Y<<$7$8$H$If^YgdK'<<$7$8$H$IfgdK' & FZ<<$7$8$H$If^gd ......m[E/e<<$7$8$H$If^egdK'Y<<$7$8$H$If^YgdK'<<$7$8$H$IfgdK'kdl$$IfTlF $ ^ t0e%6    44 laytK'T............kbbbbbbbbbb 7$8$H$gd kd$$IfTl)F $ ^ t0e%6    44 laytK'T ......//(/)//////0000001112131M1N1c1d1e111222¶ݏݏmݶ``hGh PJ^JaJ"hGh 5\^JaJmH sH hGh \^JaJmH sH h 5\^JaJh ^JaJhGh ^JaJh \^JaJhGh \^JaJhGh 56\^JaJh 56\^JaJhGh 5\^JaJjh UmHnHu hK8h #......)///00001 11F<<$7$8$H$If^FgdK'<<$7$8$H$IfgdK' x7$8$H$gd & F\7$8$H$gd  & F\<7$8$H$gd <7$8$H$gd 7$8$H$gd 11131N1d1UC-F<<$7$8$H$If^FgdK'<<$7$8$H$IfgdK'kd$$IfTl F ,"  t06    44 laytK'Tb<<$7$8$H$If^bgdK'd1e1112kYC-b<<$7$8$H$If^bgdK'F<<$7$8$H$If^FgdK'<<$7$8$H$IfgdK'kd3$$IfTl F ,"  t06    44 laytK'T22O2h2r2222kY@@@@@ & FZ<<$7$8$H$If^gd <<$7$8$H$IfgdK'kd̚$$IfTl F ,"  t06    44 laytK'T22223333444:4;4\4y4425358595@5A5M5N5Y5Z5`5a5b5f5g5l5m555555555555555Ƹv٪٪٪٪ƅم酪ƅمhGh B*^JaJphhGh ^JaJhGh 56\^JaJh 5\^JaJhGh 5\^JaJjh UmHnHu hK8h hGh \^JaJhGh 5PJ\^JaJhGh PJ^JaJhu;PJ^JaJ.222223b<<$7$8$H$If^bgdK'F<<$7$8$H$If^FgdK'<<$7$8$H$IfgdK'33334kYC-b<<$7$8$H$If^bgdK'F<<$7$8$H$If^FgdK'<<$7$8$H$IfgdK'kde$$IfTl F ,"  t06    44 laytK'T44:4;4\4]4y44kbWNNCN x7$8$H$gd 7$8$H$gd 7$8$H$gd gd kd$$IfTl F ,"  t06    44 laytK'T44253595A5N5Z5a5<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK'+<<$If^+gdK' <<$IfgdK' $$(a$gd ((gd 7$8$H$gd a5b5g5, <<$IfgdK'kd$$If4rc>!BBBBB t062-4Bap2ytK'g5m5555<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK'+<<$If^+gdK'5555H;*+<<$If^+gdK' <<$IfgdK'kd$$Ifrc>!BBBBB t062-4BaytK'555 6<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK'5555566 6 66666663646;6<6@6A6B6F6G6N6O6l6m6q6r6666666666666666/727v7w777777777777777777888 8!8"8#8hu;^JaJhGh 5PJ\^JaJ hK8h hGh 5\^JaJhGh ^JaJhGh PJ^JaJH 6 666H;*+<<$If^+gdK' <<$IfgdK'kd{$$Ifrc>!BBB t062-4BaytK'6646A6<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK'A6B6G6O6H;*+<<$If^+gdK' <<$IfgdK'kd<$$Ifrc>!BBBBB t062-4BaytK'O6m6r66666666<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK' 6666H;*+<<$If^+gdK' <<$IfgdK'kd$$Ifrc>!BBBBB t062-4BaytK'6w7777<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK'7777H;*+<<$If^+gdK' <<$IfgdK'kd$$Ifrc>!BBBBB t062-4BaytK'778"8<<$If^gdK'O<<$If^OgdK'B<<$If^BgdK'"8#8$888996:HCCCC>>gd gd kd$$Ifrc>!BBBBB t062-4BaytK'#8$8E8F8V8v888888899)9*9-9>9Z9_9k9x999999հsaaRh 5CJOJQJ^JaJ#hQh 6CJOJQJ^JaJ'hQh 0J5CJOJQJ^JaJ#hQh 5CJOJQJ^JaJ,jhQh 5CJOJQJU^JaJh CJOJQJ^JaJ,hFh >*B*CJOJQJ^JaJph,hQh >*B*CJOJQJ^JaJph&h >*B*CJOJQJ^JaJph99999::.:/:5:6:7:;;B;C;;;;;;;;<<<<±±~ococoTCococococ hh B*]^JaJphh 6B*]^JaJphh B*^JaJphhh B*^JaJph hh 5B*^JaJph hGh >*B*^JaJph hyh >*B*^JaJph hGh >*B*^JaJphh >*B*^JaJph h|h >*B*^JaJphh CJOJQJ^JaJ hQh CJOJQJ^JaJ6:7:::::9;:;;;;;<<<<<<== =!=<===Y=Z== gd |^`|gd gd <<<==+=,=G=H=c=d====>->>>%@A@B@J@K@T@U@AAAcAdA>BBDDoDDDD·p’ahvh B* ^JaJphI} hvh >*B*^JaJph hh 5B*^JaJphh7ih B*^JaJphhh 5\^JaJh ^JaJhh ^JaJ h7ih >*B*^JaJph hOh >*B*^JaJphGh B*^JaJphhh B*^JaJph%====&@'@fAAAABBBBCC&CMCwCC & FI hT^Tgd & FIT^Tgd & FHT^Tgd |^`|gd  gd gd CCDDDDDDEE(E)EEEF?H@HRISIKK hh^hgd & FJT^Tgd  gd |^`|gd  h^h`gd DDD)GbGJHgHSI\I]I`IJJUKXKYKK%LLMZMMMMMOOоовpeYeMepОh !h 6^JaJh !h 5^JaJh !h ^JaJh !h B*^JaJphhGh ^JaJhh >*^JaJhu;^JaJhh ^JaJh \^JaJhGh \^JaJ#hh 56B*^JaJphhh B*^JaJph hh 5B*^JaJphhh B* ^JaJphI}KLL$L%LMM P P4P5PPPQQ>Q?QuQvQQQERFRRRS |^`|gd  |^`|gd OOOPMPPPQRcRRRSSSSSATGUIUJUKULUMURUخ؝y]F,hh 5B*CJOJQJ^JaJph7h7ih 5B*CJOJQJ^JaJmHnHphu1jNh h B*U^JaJmHnHphuhh ^JaJ hh CJOJQJ^JaJ#hh 6CJOJQJ^JaJh B*^JaJphhmh \^JaJhh B*^JaJphhO56^JaJhh 56^JaJSSS@TATEUFUGUHUIUKUMUNUOUPUQURUUVVYVZV$a$gd ugd gd gd  |^`|gd |^`|gd m |^`|gd RUiUoUUUUVV VVV$V5V8VXVYVVV/X0X龭{i{Z{Z{I@4h B*^JaJphh 6^JaJ hh 5B*^JaJphh 5B*\^JaJph#ha]h 5B*\^JaJph#hh 5B*\^JaJphhh B*^JaJph hh B*\^JaJph hFh B*\^JaJph,hGh >*B*CJOJQJ^JaJph&h >*B*CJOJQJ^JaJph,hGh >*B*CJOJQJ^JaJphZVVVVVVVWWAWBWYWZWtWuWWWWWWWWWAXBXXXXX |^`|gd 0X@XXXXXXXXXGYHYiYjYZZuZvZ[[[[[[*\I\J\\\\\ಧllZZ#hGh >*CJOJQJ^JaJ&hh 5CJOJQJ\^JaJ hh CJOJQJ^JaJh CJOJQJ^JaJh ^JaJhh ^JaJ h7ih CJOJQJ^JaJ h5bsh 6B*^JaJphh B*^JaJphhh B*^JaJph hGh 6B*^JaJphXXXYYGYHYZuZvZ[[[)\*\I\J\\  & FG gd  & FG xgd h^hgd ^`gd  & FKgd & FKxgd gd  |^`|gd |^`|gd \\]^[__`Paaabbeefeeeeeeee |^`|gd |^`|gd  hh^h`gd  & FG8^8gd  & FG8<^8gd h^hgd \\]]^^[_v__```Paaaabbbbbb@cKcldmdddcedeeeeeg*hh޽pdh B*^JaJph h/Mh 6B*^JaJphhh >*^JaJhu;^JaJh 5^JaJhh 5^JaJh ^JaJhh ^JaJhh B*^JaJph#hGh >*CJOJQJ^JaJ hh CJOJQJ^JaJ ha]h CJOJQJ^JaJ#ee,f-fFfGfifjfff*h,hxhyhhhhhhh4i5igd,\gd X* |^`|gd X* |^`|gd  |^`|gd |^`|gd hhhh3i4i5iOiZi[ikisijjjjjjjjkkkllнykk[k[yN>hh,\6CJ]^JaJh?h,\CJ^JaJhh,\5>*CJ^JaJhh,\5CJ^JaJh,\CJ^JaJhh,\CJ^JaJh,\5CJ\^JaJhh,\5CJ\^JaJh,\>*B*CJ^JaJph$hh,\>*B*CJ^JaJphhh X*^JaJ(jK hhU^JaJmHnHuhh X*B*^JaJph5iZi[i k kkkbmcmmm-nlnnn6o7oooo+p  & FH$gdo  & FH$^gdo  & FH$gdo  & FH$gdo^gd,\ & FFgdo & FFgdo^gd,\gd,\llllm m m m"m$mambmcmhm|m~mmmmmmmmmmmnnnn n+n@nAnBnCnJnWnknlnnn>oBoLo³³³³³³³³p hh,\6B*CJaJphh,\5B*CJ\aJph hh,\B*CJ\aJph#hh,\5B*CJ\aJphhh,\B*CJaJphh,\B*CJaJphhh,\CJaJhh,\6CJ]^JaJh,\CJ^JaJhh,\CJ^JaJ,Lo_odooooooooooooooppp%pypppppppppp=q>qrrǽǰtjtjtjtjtZjh,\0JCJU^JaJh,\CJ^JaJhh,\CJ^JaJh,\5CJ\^JaJhh,\5CJ\^JaJ#hh,\5B*CJ\aJphh=Kh,\0JCJaJh,\0JCJaJjh,\0JCJUaJh=Kh,\B*CJaJphh,\B*CJaJphhh,\B*CJaJph!+pVpxpyppp_q`qdtetuuuuuu^v_vvvv7wVw}www J & Fgdom$7$8$gd,\gd,\gd,\  & FH$gdor&r'r5r6r7r=r>rbrcrdrrrrrrrssssssttbtctdtլ{ndnVnVnVndE hh,\CJOJQJ^JaJhh,\6CJ^JaJh,\CJ^JaJhh,\CJ^JaJh,\CJOJQJ^JaJ$h*h,\0JCJOJQJ^JaJh,\0JCJOJQJ^JaJ'jh,\0JCJOJQJU^JaJ(hOh,\0J>*B*CJ^JaJphhh,\0JCJ^JaJjh,\0JCJU^JaJh,\0JCJ^JaJdtttuuuuuu5v6v]v^v_vvvUwVw{w}wwxx xWxfxyyy{||2}3}4}5}ɼټټٱt*h,\>*@B*CJOJQJ^JaJph!hh,\B*CJ^JaJphhh,\5CJ^JaJh,\@CJhh,\@CJh,\5CJ\^JaJhh,\6CJ]^JaJhh,\5CJ\^JaJh,\CJ^JaJhh,\CJ^JaJ#wwwx xyyy zzzz!{D{P{X{{{{{{{||7$8$gd,\^gd,\ & Fgdo $a$gd,\gd,\ J & Fgdom$|4}5}b}c}~~$%GIMNOtuGgdO -DM gddgddgd X*h@&gdM,d7$8$gd,\5}b}c}'(fg%FG׃ )*/оМ~n~^NBNN~hd0JCJ^JaJjhd0JCJU^JaJhd5B*CJ^JaJphhdB*CJ\^JaJphhdB*CJ^JaJphhd5B*CJ^JaJphhd5CJ^JaJhd0JCJaJhd0JCJ\^JaJ"jhd0JCJU\^JaJhdCJ^JaJhU h X*CJ^JaJ0hM,dh X*>*@B*CJOJQJ^JaJph/0YZuvOstuÆĆGHׇ؇هɾɤ~z~n~~zc~]~ hd0Jj hdUhd0JCJ^JaJhdjhdU!hdhdB*CJ^JaJphhd5>*CJ^JaJhdCJ^JaJhd5B*CJ^JaJphhd5CJ^JaJhdB*CJ^JaJphhd0JCJaJhd0J5CJ^JaJ"jhd0J5CJU^JaJprJVČŌz{J & F: h7$8$H$^gdU 7$8$H$gdU & F: h7$8$H$^gdU & F7$8$H$gdUgdUgd X*gdOnplxŌ{!wff_[ShUB*phhU hhU h*YhU5B*^JaJphhU5B*^JaJphh8_hUB*^JaJphhUB*^JaJph h*YhU>*B*^JaJphh*YhUB*^JaJphh*Yh X*5>*^JaJ#h h X*5>*B*^JaJph33#h h 5>*B*^JaJph33h >*B*^JaJph΍"#$ސstّڑ/J & F;7$8$H$gdUm$ 7$8$H$gdUgdU 7$8$H$gdU & F: h7$8$H$^gdU!"${ sבّڑ./v|Pͯܞ̀raSaGGGhUB*^JaJphh*YhU5\^JaJ h*YhU5B*^JaJphhX5B*^JaJphh*YhUB*^JaJphhX5B*\^JaJph h])hUB*\^JaJph#h*YhU5B*\^JaJphh*YhU5^JaJh*YhUB*^JaJph h*YhUB*\^JaJph#hUB* CJOJQJ^JaJphI}ĒՒ()OP~dfg՗2 $Ifgdg7$8$gdU 7$8$H$gdU & F: h7$8$H$^gdUP_}~ceܼ{pd[dOG<1hXhU^JaJhohX^JaJhU^JaJhUB*^JaJphhX\^JaJh*YhU\^JaJhX5\^JaJ h*YhUB*\^JaJphhX5B*\^JaJph#h*YhU5B*\^JaJphh*YhUB*^JaJphh*YhU6^JaJ&h*YhU56B*\^JaJph h*YhU6B*^JaJph#h*YhU56B*^JaJphefgmodf23489CDfgƘǘݘޘ BCdepq÷÷ttttltlttltltttttltlh(^JaJh*Yh(^JaJhO^JaJ h*Yh(h*Yh(5\^JaJh*YhU5^JaJh*YhU57\^JaJh*YhU\^JaJhX\^JaJh2hX\^JaJh2hU\^JaJhA^hU\^JaJhXhUB*^JaJph*2348*!! $Ifgdgkd $$IflXrL$ x#F8ffTf~ f t0$44 lBap2yto89CDfgǘޘ $Ifgdg *!! $Ifgdgkd $$IflrL$ x#f8fFTF~ F t0$44 lBap2yto BCeq $Ifgdg qәՙ֙&fȯqfOfGf4$h)hf@CJOJPJQJaJhf^JaJ-h)hf56@CJOJQJ]^JaJh)hf^JaJ-h)hf@B*CJOJQJ^JaJph$h)hf@CJOJQJ^JaJ'h[hf>*@CJOJQJ^JaJ0h[hf>*@B*CJOJQJ^JaJph*hO>*@B*CJOJQJ^JaJph h*Yh(h(^JaJhO^JaJh*Yh(^JaJ-''h@&gd[kd $$IflrL$ x#&8&T~  t0$44 lap2ytoՙ̝֙͝ gΤ0j & F"gdoi & F2gdogdfhgdffΤ/0~ĥ-gͭ'ѲŲѪr]L h)hfCJOJQJ^JaJ)h)hf56>*@CJOJQJaJ&h)hf56@CJOJQJaJ#h)hf6@CJOJQJaJ#h)hf5@CJOJQJaJh"^JaJ$h)hf@CJOJQJ^JaJh)hf5^JaJh)hf^JaJ$h)hf@CJOJPJQJaJ h)hf@CJOJQJaJ,-̭ͭuBԯկвѲ% J & F3dgdo i & Fdgdfi & F2gdogdfhgdf dgdf:oµV',Ϲ|Dl J & F7^gdoq & F6 ^gdos^gdfq & F5 ^gdo$ & F d(^gdoq & F4 ^gdor & F ^gdogdf:gho˵̵V;<)Ǹ,Ϲ.3hm}ǿǿǮǿǿǿǿǿǀuǿǿǿdǿǀ h)hf56CJ\]aJhf5CJ\aJh)hf5CJ\aJ#h)hf6CJOJQJ^JaJhfCJOJQJ^JaJ h)hfCJOJQJ^JaJhfCJaJh)hfCJaJhfB*CJaJphh)hfB*CJaJph#hM,dhf5CJOJQJ^JaJ'5: DZ_lɼMp)*+9:^_`Ǹޯwogh X*^JaJh]CJaJjhz0JCJUaJh)hf0JCJaJj h"Uh"jhzU hfaJh)hfaJh)hfB*^JaJphh)hf^JaJhfB*CJaJphh)hfB*CJaJphhfCJaJh)hfCJaJ$ɼXMp_`abde2 $7$8$H$a$gdW)gd"$a$gdW)gdmq & F9 ^gdo^gdf$ & F8 0dx*$1$a$gdor & F ^gdo`bcdv3@AHIfg/012ȽȲ}pbWWKh7Vh)5^JaJh7Vh=^JaJjhz0JU^JaJh7VhN m0J^JaJhzjhzUh7Vh8^JaJh"^JaJh7VhN m^JaJh7Vhi^JaJh7Vh7<^JaJh7VhZxX^JaJh7Vh{^JaJh^^JaJh7Vh2\@^JaJj h@U^JaJh^@^JaJ23*+efMijPQRl H$If^HgdtgdHc$a$gdX $7$8$H$a$gdN m $7$8$H$a$gdW)234()* Ade+INXjo*2FKûûóvvvvevvvvvv h6-5CJOJQJ\^JaJhXCJOJQJ\^JaJ#hwhXCJOJQJ\^JaJ&hXhX5CJOJQJ\^JaJhX^JaJhN m^JaJh?^JaJh7VhN m^JaJjhz0JU^JaJh7Vh2\0J^JaJhzjhzUh7Vh4^JaJ'LMghijPR./0Z[̵̽wwwnhHc5^JaJh &hHc^JaJ h &hHchbhHc^JaJhHc6^JaJh &hHc6^JaJh &hHc5^JaJhHc^JaJhHc>*B*\^JaJph#hbhHc>*B*\^JaJphhXCJOJQJ\^JaJ#hwhXCJOJQJ\^JaJ&lh[M $7$8$H$Ifgdt & F$IfgdHckdM $$IfTl4 0( x&   P    t0&644 lapyttT $Ifgdt~qc $7$8$H$Ifgdt & F$IfgdHckd* $$IfTl 0( x&  P   t0&644 layttT~qh $Ifgdt & F$IfgdHckd $$IfTl 0( x&  P  t0&644 layttT/0Z[  ~yyyyyyyyyyyyygdHckd! $$IfTl 0( x&   P   t0&644 layttT[  LMN}~Mİxm`h7Vh8@^JaJhOhX^JaJh7Vh6-^JaJh7Vh6-5\]^JaJhoh6-5\]^JaJh7Vh6-B*^JaJphhHc5^JaJh#GhHc^JaJ h#GhHchbhHc^JaJhHc6^JaJh#GhHc6^JaJhHc^JaJh#GhHc5^JaJ! MNh}~_N & F<<$IfgdHckds" $$IfTl4 0 $   P    t0D%644 lapyttT <<$IfgdtgdHcl[ & F<<$IfgdHckdP# $$IfTl 0 $  P   t0D%644 layttT<<$7$8$H$Ifgdt~m` <<$Ifgdt & F<<$IfgdHckd$ $$IfTl 0 $  P  t0D%644 layttTM~m` <<$Ifgdt & F<<$IfgdHckd$ $$IfTl 0 $  P  t0D%644 layttTXY~phcc[[[O $7$8$H$a$gdX7$8$gd6-gd6-$a$gd6- $7$8$@&H$a$gdXkd% $$IfTl 0 $   P   t0D%644 layttT yzuv3Jyzgd7< -DM gdBgdB$a$gd7<$a$gd8gd?/$a$gdW)7?./bcd?ʿtg^R^RF^F^F^FhwhB\^JaJhwhB\^JaJhB\^JaJh^hB0J^JaJ!j( h^0JU^JaJh^0J^JaJjh^0JU^JaJhzghB^JaJhwhB^JaJh7Vh7<>*^JaJh7Vh8^JaJh?/h8^JaJh7Vh#+*B*^JaJphh7Vhp@^JaJj\& h@U^JaJuv3Zdnw Jyz{|?@WX¶߶߶߶ߪ߶ߢ߶ߖrhrZjhz0JU^JaJhM,d0J^JaJhM,dh7<0J^JaJhzjhzUh7Vh7<^JaJh7Vh7<5^JaJhB^JaJhwhB6^JaJhwhB5^JaJhwhB>*^JaJ hwhB>*B*^JaJphhwhB^JaJhwhB\^JaJhB\^JaJ#z=>tu=> 0*$gdXm gdXm  gdXm $ a$gd/wgd?/ $h^ha$gd mgdW)J^gd:gd7<J^gd"J^gd"  =>12ꫢseRCh7Vh{eB*^JaJph$h7Vh{e>*@B*^JaJphj( h@U^JaJh7Vh:@^JaJhE5\^JaJh7Vh7<5\^JaJhE\^JaJhB\^JaJh7Vh7<\^JaJh7Vh7<5^JaJjhz0JU^JaJh7Vh7<0J^JaJhzjhzUh7Vh7<^JaJhM,dh7<^JaJ=l~l[M[hXmCJOJQJ^JaJ h0hXmCJOJQJ^JaJ#h-BhXm5CJOJQJ^JaJ#h0hXm5CJOJQJ^JaJhXm5CJOJQJ^JaJ h|h3Q>*B*^JaJphh3Q^JaJhXm^JaJh hXm^JaJ&h hXm56>*B*CJaJphh7Vh/w^JaJh?/h)^JaJh?/hi^JaJBOS}FGf & F^gd3Q f & Fgd3Qf & F7$8$^gd3Q f & Fgd3Qf & Fgd3Q, & FG$]gd3Q, & FG$]gdXmgd3Q 0*$gd3Q 0*$gdXm%78BKLPQXstm[J[J2/h0h3Q5B*CJOJQJ\^JaJph h0h3QCJOJQJ^JaJ#h0h3Q5CJOJQJ^JaJ)h0h3QB*CJOJQJ^JaJph,h0h3Q5B*CJOJQJ^JaJph#h3QB*CJOJQJ^JaJph)h>ch3QB*CJOJQJ^JaJph)h h3QB*CJOJQJ^JaJph)h3Q5B*CJOJQJ\^JaJph)h0hXmB*CJOJQJ^JaJph tu4?MNO[\] CQRS곞wwwwwcRA hGh3QCJOJQJ^JaJ hU h3QCJOJQJ^JaJ&hU h3Q5CJOJQJ\^JaJ#h3QB*CJOJQJ^JaJph)h h3QB*CJOJQJ^JaJph)h3Q5B*CJOJQJ\^JaJph/h h3Q5B*CJOJQJ\^JaJphh3QCJOJQJ^JaJ h!eh3QCJOJQJ^JaJ)h!eh3QB*CJOJQJ^JaJph}#%ƱƱƱuaP8/h0h3Q5B*CJOJQJ\^JaJph h h3QCJOJQJ^JaJ&h3QB*CJOJQJ\^JaJph)h$h3QB*CJOJQJ^JaJph#h3QB*CJOJQJ^JaJph)h h3QB*CJOJQJ^JaJph)h3Q5B*CJOJQJ\^JaJph/h h3Q5B*CJOJQJ\^JaJph hGh3QCJOJQJ^JaJ hwxh3QCJOJQJ^JaJ%'23:; #7ԿԿr^M<*<*#hwxh3QCJOJQJ\^JaJ hwxh3QCJOJQJ^JaJ h-Bh3QCJOJQJ^JaJ&h-Bh3Q5CJOJQJ\^JaJ hmRh3QCJOJQJ^JaJ)hmRh3QB*CJOJQJ^JaJph#h3QB*CJOJQJ^JaJph)h0h3QB*CJOJQJ^JaJph)h3Q5B*CJOJQJ\^JaJph/h0h3Q5B*CJOJQJ\^JaJph&h^h^5CJOJQJ\^JaJ7<NVw  &Y_IJV޷qYqD)hU h3QB*CJOJQJ^JaJph/hh3Qh!SB*CJOJQJ^JaJph)hh3QB*CJOJQJ^JaJphhe]h3Q5KH^JaJh3Q>*B*KH^JaJph$h-Bh3Q>*B*KH^JaJph)h3Q5B*CJOJQJ\^JaJph#h-Bh3QCJOJQJ\^JaJ h-Bh3QCJOJQJ^JaJ hwxh3QCJOJQJ^JaJG   7$8$H$gd3Q & F D^`gd3Q & F D^`gd3Qgd3Q,]^gd3Q1$gd3Q,]^gd3Q f & Fgd3Q34MNJKNOVW_`lŷŬŬŬŬŬšsjd h3Q0J8hGh3QaJhGh3Q5\aJ h3QaJhh3QhG^JaJhh3Q5\^JaJhh3Q^JaJh0h3Q^JaJh0h3Qh[E^JaJh3Q^JaJhMh3Q^JaJ)he]h3QB*CJOJQJ^JaJph#h3QB*CJOJQJ^JaJph#_`!" & F*$]gdoh-DM ]^h`gdo-DM ]gdo & F-DM ]gdo 0*$@&gd3Q 0*$gd3Q 7$8$H$gd3Q .EJ^ruv}~Oo䧙zk`U``h_}h3Q^JaJh~h3Q^JaJh h3QB*^JaJph h h3Q>*B*^JaJphh3Q>*B*^JaJphh^>*B*^JaJphh h3Q^JaJh0h3QB*^JaJphh3QB*^JaJphh^h3QB*^JaJphh3Q^JaJh0h3Q^JaJ h0h3QB* \^JaJph `! qG]^akw1:wx!"*7MS ':  + , q ȸ楅zzzzzzzzzzh h3Q^JaJ1h h3Q5B*^JaJfHphq hNU*h3Q%h h3Q^JaJfHq h3Q^JaJfHq %hBv7h3Q^JaJfHq hBv7h3Q^JaJ h 2Bh3Qh3Q^JaJh~h3Q^JaJ0  ' ( )       $ a$gd$ 0*$a$gd$ a$gd1J & Fgd$]a$gdoJ]gdoh]^h`gdo & F*$]gdoh*$]^h`gdo q          & ( )              ſ{p_QChp>*B*^JaJphhp>*B*^JaJph h h>*B*^JaJphh h^JaJhoh^JaJh^JaJh h5^JaJ&h1h56>*B*CJaJph h^56>*B*CJaJph haJhh3QaJhoh3QaJh3Q56CJaJh#h3Q^JaJhX/h3Q^JaJh3Q^JaJ      '9Y-.   Vd^gdp 0*$gdp 0vh*$`hgdp 0*$gdpgdp 0*$@&gdp$ 0*$@&a$gd            $ * + 2 C D O P _ e }            '(9:>?YZ[.@ö䞕h^hpCJhp>*B*^JaJphhpCJ^JaJhchpCJ^JaJhKehp^JaJ jh hp^JaJhp^JaJh hp^JaJ h hp>*B*^JaJph8@J  #&HRijk >@Ƕ҆}wl[M< h hM>*B*^JaJphhM>*B*^JaJph h*B*^JaJphh hV^JaJ haJh*B*^JaJphh,yhp^JaJhfhp^JaJ hd!hpB*]^JaJphhd!hp^JaJ h hp>*B*^JaJphhp>*B*^JaJphh^hpCJ hpCJ $&jk ?@NOvw$ 0*$@&a$gd 0*$@&gdXm7$8$gdXmgdXm 0*$@&gdM$ 0*$a$gd 0*$@&gdp@MO  (t)*;<^_wx~*IKyӿӣӣӣӘӣӣh>*B*^JaJphh|Sh^JaJh h^JaJh*B*^JaJph&h1h56>*B*CJaJphh^JaJ h@/hXmhXm hJhXmhXm^JaJhJhXm^JaJ1xJKgdM$a$gdM $ a$gd$ 0v*$a$gd$ & FC 80hvh*$^ha$gdogd1$ 0*$@&a$gd$ a$gd1"#u~  ȶvvh]]QIh^^JaJhMB* ^JaJphI}hF*B*^JaJph#hL4hM5>*B*^JaJphhL4hM5>*B*aJphhM^JaJh^JaJh*^JaJ<d 8   !(!>!?!!!""h^hgdMgdM^gd^ & FC^gdM7$8$gdM >!^!l!!!!!! """""""""#######$8$@$wiXiG h(PhMCJOJQJ^JaJ hhMCJOJQJ^JaJhMCJOJQJ^JaJh>*B*^JaJph&h1h56>*B*CJaJph hh56>*B*CJaJphhrhMH*\^JaJhh^JaJhMhM5B*\^JaJphhMB*^JaJphhF*B*^JaJphh hF>*B*aJph&h1hF56>*B*CJaJphhF^JaJh h^JaJh^JaJh*B*^JaJph&h1h56>*B*CJaJph h,yh>*B*^JaJph))))))----".#.....00(2gdl h$a$gdA$a$gdl hgdW)$ a$gd1gdF$ 0*$@&a$gdF$ a$gdF$ 0*$a$gd/w, ------- .!.".....///00̸{gWLD<8<hzjhzUhA^JaJh7Vhl h^JaJh7Vhl h5>*B* aJph.&h1hl h56>*B*CJaJphh7Vhl hPJ^JaJh7VhPJ^JaJ#h7Vh5>*B* PJaJph. h7Vh>*B* PJaJph.&h1h56>*B*CJaJphh7VhF^JaJhFCJaJhFCJaJhFCJOJQJ^JaJhF hhF00000'2(2)2O2P2Q2k222s3t3334ڷp_PAPAP0P h7Vhi>*B*^JaJphh7VhYB*^JaJphh7VhiB*^JaJph h7Vhi5B*^JaJph#h7VhY5B*\^JaJph&h1hY56>*B*CJaJph&h1hi56>*B*CJaJphh7Vhl hPJ^JaJ&h7Vhl h5>*B*\^JaJphh7Vhl hB*^JaJphh7Vhl h^JaJjhz0JU^JaJh7Vhl h0J^JaJ(2)2P2Q22t3444445566678 dd[$\$gd{ |$dd[$\$a$gd{ | $h^ha$gd m & F gdo & Fgdo & F 0gdo & F gdo$ a$gd1gdW)4444444444555T5U55566666J7п𰥚xfR>&h1hOA56>*B*CJaJph&h1hi56>*B*CJaJph#h7Vh{ |5>*B*^JaJphh7Vh)^JaJh7Vh.^JaJh7VhiH*^JaJh7Vhl h^JaJh7Vhi^JaJh7Vh~.B*^JaJph h7Vhi5B*^JaJph h7VhY5B*^JaJphh7VhiB*^JaJphh7VhYB*^JaJphJ7P7h7n7777788P8Q888889 999;9<9=9999: :R:S:T:o:u:::$;U;\;];ӸĤsbӸ h7VhOA5B*^JaJph h7Vhi5B*^JaJphh7VhOA5^JaJ&h1hOA56>*B*CJaJph&h1hi56>*B*CJaJphh,MB*^JaJphh7VhOAB*^JaJphh7VhiB*^JaJphh7VhOA^JaJh7Vhi^JaJh,M^JaJ&8Q8889<9=9: :S:T::];<<K<L<$ & F 8^8a$gdo $h^ha$gd m$a$gd{ |$ a$gd1 & F dd[$\$gdo & F 0dd[$\$gdo];c;<<J<K<L<Q<W<<<<<@=A=H=N=`=f===<>>>>>>$@%@@@@@ABB BBBBBGCMCijijijբzi h7Vh05B*^JaJph&h1h56>*B*CJaJph&h1hi56>*B*CJaJph h7Vh>*B*^JaJph h7VhOA5B*^JaJph h7Vhi5B*^JaJphh7VhOAB*^JaJphh7VhiB*^JaJphh,MB*^JaJph)L<<A====>>>>%@@BBBBqCrCC@D}D $h^ha$gd~`P$a$gd~`P$ a$gd1$ & F 8^8a$gdo $h^ha$gd m $^a$gd m$ & F 8^8a$gdoMCpCqCrCCCCCCC?D@DZDhDnD|D}DDDDDDD#E)EfEgEzEEEEEEEEE;FAFLFFFFFFFGGGGzhhB*^JaJph h7Vh5B*^JaJphh7Vh"}B*^JaJphh7VhoNB*^JaJphh,MB*^JaJph h7Vhi5B*^JaJphh7Vh8B*^JaJphh7VhB*^JaJphh7VhiB*^JaJph0}DDgEEEEEFFGH&JJJJ$ a$gd1$ & F 8a$gdo $ & Fa$gdo$ & F ha$gdo$ & F a$gdo$ & F a$gdo$ & F 0a$gdo$a$gd~`P $h^ha$gd~`PGHHHH%J&JJJJJJJJKULVLgLLMeOOOİwh\P\h\h@h7Vh5>*B*aJphhhB*^JaJphhMEB*^JaJphh7Vh&B*^JaJph h7Vh(5B*^JaJph&h1h56>*B*CJaJph&h1h&56>*B*CJaJph&h1hi56>*B*CJaJph h7Vho5B*^JaJphh7VhoNB*^JaJphh,MB*^JaJphh7VhiB*^JaJphJJKULVLgLLLLLMMNNdOeOOO*B*CJaJphh7Vh*B*^JaJphh7VhB*^JaJphhhB*^JaJphhoNB*^JaJphh7VhoNB*^JaJphh7VhhB*^JaJphhB*^JaJphh,MB*^JaJphh7VhiB*^JaJph h7Vh5B*^JaJphRRRRSS{T|TTT[U\UVXXXXXXYY?[gd&8$a$gd&8$ a$gd1$a$gd~`P$a$gdh $^a$gdh$ & F 8a$gdoTTXXXXXXXXXYYYY[[๪l\I8 hrh&856\]^JaJ%hrh&8^JaJfHq hh^JaJfHq /hrh&80J}5H*^JaJfHq (hrh&85^JaJfHq j* hB*U^JaJphh7VhH@B*^JaJphhhB*^JaJphhB*^JaJphh7VhB*^JaJphh7Vh2wB*^JaJph h7Vh2w5B*^JaJph?[@[[[&]d^_`?bcdf{fff&g'gghhViWi & F`d]gd&8 & F`dx]gd&8xgd&8 J & F_^gd&8m$J & F_x^gd&8m$gd&8[[[[[[[]]"]#]%]&]3]4]C^D^b^c^d^u^v^w^x^______`````aabb*B*\^JaJph#hrh&8>*B*\^JaJph hrh&8>*B*^JaJphchGh&80J^JaJjh&8U^JaJh&8^JaJ h&h&8>*B*^JaJphchrh&8^JaJhrh&8B*^JaJphchrh&80J^JaJjh&80JU^JaJh&80J^JaJ#g&g'gSghgwggggggggghhhhhhhh iTiViWi԰Ԉ~qԈ~qhP.hrh&8B*^JaJfHphwwwq hf]h&8^Jhrh&80J^JaJh&80J^JaJjh&80JU^JaJhrh&8H*^JaJhrh&86]^JaJ hrh&856\]^JaJh&8^JaJhDDh&8^JaJhrh&8^JaJhrh&85\^JaJ#hrh&8>*B*\^JaJphWi[i^i_iminiriviyiujyj|jjjjjjȬzoWAoWAoWAo0 hrh&856\]^JaJ+hrh&86>*^JaJfHq .hrh&856>*^JaJfHq hrh&8^JaJ1hrh&8>*B*^JaJfHphq 1hrh&8>*B*^JaJfHphq 7hrh&86>*B*H*^JaJfHphq 4hrh&86>*B*^JaJfHphq 7hrh&856>*B*^JaJfHphq Wiminijjjj"kkk?l`lalmmrnsntnvnwnnn$a$gd~`Pgd?/h^hgd mgd8:gdH@ J & Fagd&8m$ J & Faxgd&8m$ J & Faxgd&8m$gd&8jjjj k kk k"kUkVk|k}kkkkkkkkkkkll!l(l5lnnnNnqn綦¦wwf^h&8^JaJ hrh&856\]^JaJ.hrh&856>*^JaJfHq hrh&85^JaJh&80J6^JaJjh&80J6U^JaJhrh&86^JaJhrh&80J^JaJh&80J^JaJjh&80JU^JaJhrh&8^JaJhrh&86]^JaJ qnrnsntnunvnwnnnnnnn>ouoijq_N?0h7VhiB*^JaJphh7Vh=S[B*^JaJph h7Vh&0G5B*^JaJph3#h7Vh05>*B*^JaJph3#h7Vhi5>*B*^JaJphh?/h4J^JaJh?/h=S[^JaJh7Vh&0G^JaJh7Vh&0GB*^JaJph jA, hB*U^JaJphhAB*^JaJph.h7VhoB*^JaJfHphwwwq .hrh&8B*^JaJfHphwwwq nnnrpsppprrrrKssptqtuuuuxxyyyy J$ & F a$gdo$a$gd~`Puo~oqprpspppppp*q0qqqrlrrrrrrrrrJsǵwwhYGYw#h7VhG/5>*B*^JaJphh7VhG/B*^JaJphh7Vh&0GB*^JaJphh7Vh=S[B*^JaJphh,MB*^JaJph h7Vh>_5B*^JaJph#h7Vh>_5>*B*^JaJph#h7Vhi5>*B*^JaJphh7Vh@Y^JaJh7Vh@YB*^JaJphh7VhiB*^JaJphh7VhkiB*^JaJphJsKsssotptqtttuuuuuuufwwwwxxxxxᥓo``T`C h7Vh7>*B*^JaJphh,MB*^JaJphh7VhiB*^JaJph#h7Vh75>*B*^JaJph#h7Vhi5>*B*^JaJph#h7Vh35>*B*^JaJphh7Vh7B*^JaJphh7VhkiB*^JaJphh7VhR%B*^JaJphh7VhoNB*^JaJphh7Vh=S[B*^JaJphh7Vh>_B*^JaJphxxyyy>yDy}yyyyyzzzPzzzz {udYNC4h7VhB*^JaJphh7Vh^JaJh7Vhki^JaJh7Vhi^JaJ h7Vh5B*^JaJph#h7Vh8]H5>*B*^JaJphhh5>*B*^JaJphh7Vh7B*^JaJphh,MB*^JaJphh7VhiB*^JaJphhT^B*^JaJph#h7Vhki5>*B*^JaJph#h7Vhi5>*B*^JaJphh,M5>*B*^JaJphyyyzzzz{{}}:};}+~,~@~A~XY$a$$a$gd~`P$ 0h *$a$gd~`P$ 0h h*$^h`a$gd~`P {{{{{|%||||}}}}}9}:};}*~,~A~~ϴϴϥޔp_M>h7VhyB*^JaJph#h7Vhy5>*B*^JaJph *h7Vh7B*^JaJph#h7Vh5>*B*^JaJph#h7Vhi5>*B*^JaJph h7Vh7>*B*^JaJphh7Vh=S[B*^JaJphh7VhB*^JaJphh,MB*^JaJphh7VhiB*^JaJphh7Vh7B*^JaJph#h7Vh75>*B*^JaJph~~ *5PnDEVWX\𶮪rfUFh7VhB*^JaJph h7Vhy5B*^JaJphh7Vhy5^JaJ#h7Vhy5>*B*^JaJphh7Vhy^JaJjhz0JU^JaJh7Vh0J^JaJhzjhzUh7VhyB*^JaJphhhB*^JaJph hoh495B*^JaJphhh5B*^JaJphh7Vh49B*^JaJphoQH[\z{<GĈň J$ & Fa$gdo J$ & Fa$gdo J$ & F a$gdo$a$gd~`P\z{ه]{ÈĈӵqbSbDb5h7VhLB*^JaJphh7VhB*^JaJphh7Vh(tB*^JaJphh7Vh=S[B*^JaJph h7VhL5B*^JaJph#h7VhL5>*B*^JaJph#h7Vhi5>*B*^JaJphhh5>*B*^JaJphh7Vh&B*^JaJphh7VhB*^JaJphh7VhyB*^JaJph h7Vhy5B*^JaJphh7Vhy5^JaJĈňjk̊͊  YZ:tǍȍ"09CJ[fôôô{j{j{j{j{j{ h7Vh495B*^JaJphh7Vh49B*^JaJphh@B*^JaJphh7VhB*^JaJphh7Vh3B*^JaJphh7Vh3LB*^JaJphh7VhvRB*^JaJphh7VhoNB*^JaJphh7Vh=S[B*^JaJphh7VhhB*^JaJph&k͊ ZEF01klݒޒ6J$a$gd~`P J$ & Fa$gdo$a$gd~`P $^a$gd~`P J$ & Fa$gdoԎyzc/01jkl̻sbP>- h7VhL>*B*^JaJph3#h7VhL5>*B*^JaJph#h7Vhi5>*B*^JaJph *h7VhvRB*^JaJph *h7VhLB*^JaJphh7VhvRB*^JaJphh7Vh3LB*^JaJphh7Vh^JaJjhz0JU^JaJh7Vh0J^JaJhzjhzUhT^B*^JaJphh7Vh49B*^JaJph hoh495B*^JaJphlܒݒޒ/56ړ䨙vdSEhY:CJOJQJ^JaJ h7VhY:CJOJQJ^JaJ#h7VhY:5CJOJQJ^JaJh7Vh/B*^JaJph&h7Vh/5>*B*\^JaJphh7Vh4JB*^JaJphh7VhoNB*^JaJphh7VhvRB*^JaJphh7VhhB*^JaJphh7VhLB*^JaJphh,MB*^JaJphh7Vh=S[B*^JaJphʓ˓ŘƘ9:КњFGgdY:$a$gdo 7$8$H$gdf$a$gdY:$a$gd~`P?>Pw̾}}hSH=h7VhY:^JaJh7Vh]k^JaJ)h7Vh]kB*CJOJQJ^JaJph)h7VhY:B*CJOJQJ^JaJph h7Vh]kCJOJQJ^JaJhfhfCJPJ\^JaJ"hfhf5CJPJ\^JaJhfCJOJQJ^JaJhY:CJOJQJ^JaJ h7VhY:CJOJQJ^JaJ#h7VhY:5CJOJQJ^JaJ h7VhoCJOJQJ^JaJƘݘޘ9JmoК*Gcloڟ=AGx|ϭym\m h7Vh/>*B*^JaJphh,MB*^JaJphh7VhY:^JaJh7Vh/^JaJh7Vh/B* ^JaJphI}h7Vh/B*^JaJph&h7Vh/5>*B*\^JaJph@$hfCJOJQJ^JaJ h7VhY:CJOJQJ^JaJ#h7VhY:5CJOJQJ^JaJh7VhY:5\^JaJ!G CDX٩J & FgdogdD$a$gd~`Pgd~`P$a$gdY:PVU[zhVGh7Vh4B*^JaJph#h7Vh45>*B*^JaJph#h7Vhi5>*B*^JaJphhh5>*B*^JaJphho5>*B*^JaJphh7Vh6^B*^JaJph&h7Vh/5>*B*\^JaJphh7Vh/^JaJh,MB*^JaJphh7Vh/B* ^JaJphI}h7Vh/B*^JaJphh7Vh/B*^JaJphdj BDWXة٩)*ҪӪԪkq$%&agƦssdh7VhLB*^JaJphh7Vh,}B*^JaJph#h7Vh,}5>*B*^JaJph#h7Vhi5>*B*^JaJph *h7Vh,}B*^JaJphh7VhB*^JaJphh7VhoNB*^JaJphh7Vh4B*^JaJphh,MB*^JaJphh7Vh=S[B*^JaJph#٩*ӪԪ%&!"ưǰ0NSJ & FgdoJ & FgdoJ & Fgdoh`hgdDgdDJ & Fgdo !"ƯŰưǰ/0MN "(RSTivuc#h7Vhi5>*B*^JaJph#h7VhY:5>*B*^JaJphhT^5>*B*^JaJphh7Vh(tB*^JaJphh7VhoNB*^JaJphh,MB*^JaJphh7Vh=S[B*^JaJph *h7Vh9UB*^JaJphh7Vh9UB*^JaJph h7Vh=S[5B*^JaJph STwxjlG[bc޷+IJ  gdDJ^gd.^gd. & F&gdo^gd^gd & F%gdoJ & F$gdogdDvwxijklǴFGZ[ǵʵ)6Uȷzzk\K h7Vh(tB*\^JaJphh7VhB*^JaJphhhoNB*^JaJphh7VhoNB*^JaJph h7Vh8]HB*\^JaJphhB*\^JaJphh7Vh4JB*^JaJph h7Vh=S[B*\^JaJphhB*CJ^JaJphhB*phh7Vh8]HB*^JaJph#h7Vh8]H5>*B*^JaJphUYabcv_}ݷ޷ *+W]^ntòﲤﲖﲇvҲeWh^ =B*\^JaJph h7VhY:B*\^JaJph h7Vh&B*\^JaJphh7Vh4JB*^JaJphhC_B*\^JaJphh,MB*\^JaJph h7Vh=S[B*\^JaJphh7Vh8]HB*^JaJphh7VhoNB*^JaJphhT^B*\^JaJph h7VhB*\^JaJph}ѹHN5=ݻ~ϼм޼߼ĭzvz]C3jhz0JB*CJOJQJU\^JaJph0h7Vh=S[0JB*CJOJQJ\^JaJphhzjhzU&hM,dB*CJOJQJ\^JaJph,h7Vh&B*CJOJQJ\^JaJph,h7Vh=S[B*CJOJQJ\^JaJph#h.B*CJOJQJ^JaJphh.CJOJQJ^JaJhhm5h.hP5hoNB*^JaJphHIJԽԨ}iU=,% hP5hC_ h.hC_CJOJQJ^JaJ/h.hC_5>*B*CJOJQJ^JaJph33&hC_B*CJOJQJ\^JaJph&hB*CJOJQJ\^JaJph,h7VhB*CJOJQJ\^JaJph&hM,dB*CJOJQJ\^JaJph)h7VhY:B*CJOJQJ^JaJph,h7Vh=S[B*CJOJQJ\^JaJph)h7VhiB*CJOJQJ^JaJph,h7VhY:B*CJOJQJ\^JaJph J¾ľžӾԾuvJ & F7$8$H$gd`m$ 7$8$H$gd`gd`gdt $ 8^8a$gd mgd8: $ a$gd~`P  gdDJgdC_J^gdC_1;?ip¾þľžӾԾϺzo[M>[h!Gh`>*\]^JaJh!Gh`\]^JaJ&h!Gh`>*B*\]^JaJphh!Gh`^JaJh?/ht ^JaJ)h7Vh>B*CJOJQJ^JaJphh7Vh{eB*^JaJph j- hB*U^JaJph)h7Vh4JB*CJOJQJ^JaJph h7Vh4JCJOJQJ^JaJ h6hC_CJOJQJ^JaJh hP5hC_hC_ ~%13?x{v*BCat}Ǻ衕o-h!Gh`5>*@B*\]^JaJphh!Gh`B*^JaJphh!Gh`^JaJhh`h`PJ^JaJh!Gh`>*^JaJh!Gh`@^JaJh!Gh`@^JaJhh`^JaJhh`^JaJh!Gh`^JaJh!Gh`5^JaJ&h&12$ & F 0a$gd`$ 0a$gd` $a$gd`J & F7$8$H$gd`m$!?@$`~L] & Fgd` & Fgd` ^gd` gd`$ & F 0a$gd`,u $ a$gd` ,^gd`gd`$a$gd` gd` & F ^gd` & F^gd` & F^gd`m$xgd` ^gd`n%=>?{|ɾɾ|eN|9)h!Gh`B*CJOJQJ^JaJph,h!Gh`B*CJOJQJ^JaJhph-h`h`B*CJOJPJQJ^JaJph$h!Gh`5>*@\]^JaJ-h!Gh`5>*@B*\]^JaJph/h!Gh`B*CJOJQJ]^JaJhphh!Gh`^JaJh`h`PJ^JaJh!Gh`^JaJhh!Gh`@^JaJ h!Gh`CJOJQJ^JaJ$%>?{|ab-.2 & F P^`Pgd`gd`$a$gd`-gd` 8gd`gd` $ a$gd`QR^_`-.CD#$&'=>YZ 01abnҾҧꒁvb[[[[[[[[[[[[ h!Gh`&h!Gh`5CJOJQJ\^JaJh!Gh`^JaJ h!Gh`CJOJQJ^JaJ)h!Gh`B*CJOJQJ^JaJph,hh`>*B*CJOJQJ^JaJph&h`>*B*CJOJQJ^JaJph/jh`>*B*CJOJQJU^JaJph)hh`B*CJOJQJ^JaJph#.CDikd/ $$IfTl4U044 layt`T .$Ifgd`#$Y$gkd0 $$IfTlU044 layt`T .$Ifgd`ikd00 $$IfTlU044 layt`TY&'= .$Ifgd`gkd1 $$IfTlU044 layt`T . & F$Ifgd`=>YZ&gkd1 $$IfTlU044 layt`T .$Ifgd`gkd1 $$IfTlU044 layt`T&gkd2 $$IfTlU044 layt`T .$Ifgd`gkdd2 $$IfTlU044 layt`T 0&gkd3 $$IfTlU044 layt`T .$Ifgd`gkdD3 $$IfTlU044 layt`T01ab&gkd4 $$IfTlU044 layt`T .$Ifgd`gkd$4 $$IfTlU044 layt`TbcmnoZ. %$If^`%gd`gkd5 $$IfTl044 layt`T . $Ifgd` .  ` gd`. gd`2gd`n]^ t\Dt/h!Gh`>*B*CJOJQJ^JaJhph/h!Gh`>*B*CJOJQJ^JaJhph,h!Gh`B*CJOJQJ^JaJhphh!Gh`^JaJ$h!Gh`5>*@\]^JaJ-h!Gh`5>*@B*\]^JaJph)h!Gh`B*CJOJQJ^JaJph h!Gh`CJOJQJ^JaJ h!Gh`#h!Gh`5CJOJQJ^JaJ. %$If^`%gd`gkdt5 $$IfTl044 layt`T. %$If^`%gd`gkd5 $$IfTl044 layt`T. %$If^`%gd`gkdT6 $$IfTl044 layt`T]^&gkd47 $$IfTl044 layt`T .$Ifgd`gkd6 $$IfTl044 layt`T. %$If^`%gd`gkd7 $$IfTl044 layt`T+,www1^gd`-gd`gd`$a$gd`3gd`gkd8 $$IfTl044 layt`T  Gi  WJ^gd`/^gd`/ & Fugd`/^gd`0gd`gd`$a$gd`-gd`1^gd`  I5/5yWXnopL r s {{ooooob{Q!h!Gh`>*@\]^JaJh`h`PJ^JaJh!Gh`^JaJh,h!Gh`B*CJOJQJ^JaJhph#h!Gh`CJOJQJ^JaJh h!Gh`CJOJQJ^JaJh!Gh`^JaJ$h!Gh`5>*@\]^JaJ-h!Gh`5>*@B*\]^JaJph)h!Gh`B*CJOJQJ^JaJphWXopK L s t        7   J & F ^`gd`m$ 8gd` gd`gd` gd`/^gd`gd`$a$gd`-gd`s t     4bK"c#g#%%''z,../G666yhT&h!Gh`CJOJQJ\]^JaJ hbh`CJOJQJ^JaJh`CJOJQJ^JaJ!h`h`B*PJ^JaJph$h`h`>*B*PJ^JaJphh!Gh`\^JaJ)h!Gh`B*CJOJQJ^JaJphh!Gh`>*^JaJh!Gh`]^JaJ h!Gh`CJOJQJ^JaJh!Gh`^JaJYZ uv>?3 ^`gd`^gd` ^`gd`  p^p`gd` p^p`gd` J 8^8gd` J & F gd` h^h`gd` & F7$8$H$gd` & Fgd`34_b[#  K"L"## 87$8$H$^8gd` 7$8$H$^gd`7$8$H$^`gd`1 & Fx ^gd` & Fw !gd` hgd`^gd`##W$$$%'!(()h))*B++z,J & F N @ 7$8$H$^@ gd`m$J & F 7$8$H$^gd`J & F@ 7$8$H$^@ gd`J & F N @ 7$8$H$^@ gd`J & F ~ p7$8$H$^p`gd`z,,I--.B011B222T334455F6G66 1 ^gd`1^gd`1 & Fx p^pgd`1 & Fx  p^pgd`1 & Fx ^gd`1 & Fx ^gd`666E7F77~88*9-;/;;<.=?@@@@p1$^p`gd`J & Fy p1$^pgd`1 & F| p^pgd` 1^`gd` 1 & Fw gd`1gd`1^gd`6E7J774;;<=@@@EEHIT!T#TTTT,[2[\\\\\\]]K]L]]]]]]]^^=^>^e^f^^^_ _Ѯћ|ћ|ћ|ћ|ћ!h!Gh`0JB*^JaJphh`0JB*^JaJph$jh`0JB*U^JaJphh`^JaJh`CJOJQJ\^JaJh!Gh`\^JaJh!Gh`^JaJ h!Gh`CJOJQJ^JaJ#h!Gh`CJOJQJ\^JaJ0@,B+CTDEEEFFHHHIIJKKXLL1 & Fz  @ ^@ `gd`1 & F p^pgd`1gd`1 & F~ p^pgd` 1^`gd`1p^pgd`1 & F} p^pgd`LMM5MzMeNNP_QWSS T!TTTT J & Fw gd` 1^`gd`1 ^ gd` 1 & F^gd`1 & F@ ^@ `gd` 1 & Fp^pgd` 1^`gd`1@ ^@ gd`1 & Fz  @ ^@ `gd`TUXRZ[D\]^^_B`ab_dfgGgbggghikmo J & Fw gd`Jp^pgd` J & Fw @ gd` J & Fw pgd` _a_b___``.`/`>`?`p`q`````xn~n||ׅ̈́/0  (R}ٕM¶¶®®®wwccw&h!Gh`CJOJQJ\]^JaJ#h!Gh`CJOJQJ\^JaJ&h!Gh`h;YCJOJQJ^JaJ h!Gh`CJOJQJ^JaJh`^JaJjh`U^JaJh!Gh`^JaJ!h!Gh`0JB*^JaJph$jh`0JB*U^JaJphh`0JB*^JaJph&oDoooqFtuvwwPwwwxNz|}:߃ T J & Fw gd`Jp^pgd` J & Fw @ gd` J & Fw pgd`̄̈́PׅوtGҌGy1 & Fy 8^gd`J & Fy ^gd`m$1 & Fy ^gd` !^gd` & F !gd`J@ ^@ gd`y?1'(ڕەL 1 ^gd`1 & Fv h`gd`1gd`1^gd` 1 ^gd` 1 & Fy^gd`1 & Fy ^gd`1 & Fy p^pgd`LMh;-WCDǝȝ $Ifgd`gd`$^`a$gd`1$ 8h`ha$gd`1 & F{ 8^`gd`1 & F{ 8^gd`1$ & F{ ^a$gd`1 & Fgd`1^gd`MfԚ-Dȝ<=~žÞ./hiџҟ-.uv LMUVɢʢۢ"#yzԣգܾh1rh`^JaJ h!Gh`h1rh`5^JaJh!Gh`5^JaJ#h!Gh`>*CJOJQJ^JaJ h!Gh`CJOJQJ^JaJ#h!Gh`CJOJQJ\^JaJ<<okd8 $$Ifl0J! t0644 lapyt1r $Ifgd`<=Y~xoo $Ifgd`kd9 $$Ifl0J! t0644 lapyt1r~xoo $Ifgd`kd9 $$Ifl0J! t0644 lapyt1ržxoo $Ifgd`kdR: $$Ifl0J! t0644 lapyt1ržÞӞxoo $Ifgd`kd: $$Ifl0J! t0644 lapyt1r .xoo $Ifgd`kd; $$Ifl0J! t0644 lapyt1r./Khxoo $Ifgd`kd < $$Ifl0J! t0644 lapyt1rhixoo $Ifgd`kd< $$Ifl0J! t0644 lapyt1rџxoo $Ifgd`kdT= $$Ifl0J! t0644 lapyt1rџҟӟ -xsssjj $Ifgd`gd`kd= $$Ifl0J! t0644 lapyt1r-.Yuxoo $Ifgd`kd> $$Ifl0J!2 t0644 lapyt1ruvxoo $Ifgd`kd"? $$Ifl0J!2 t0644 lapyt1rxoo $Ifgd`kd? $$Ifl0J!2 t0644 lapyt1rxoo $Ifgd`kdV@ $$Ifl0J!2 t0644 lapyt1rxoo $Ifgd`kd@ $$Ifl0J!2 t0644 lapyt1r GLxoo $Ifgd`kdA $$Ifl0J!2 t0644 lapyt1rLMxoo $Ifgd`kd$B $$Ifl0J!2 t0644 lapyt1rˡxoo $Ifgd`kdB $$Ifl0J!2 t0644 lapyt1r:Uxoo $Ifgd`kdXC $$Ifl0J!2 t0644 lapyt1rUVɢxoo $Ifgd`kdC $$Ifl0J!2 t0644 lapyt1rɢʢˢڢۢ"xkb]TT $Ifgd`gd`h^hgd` ^`gd`kdD $$Ifl0J!2 t0644 lapyt1r"#]yxoo $Ifgd`kd&E $$Ifl0,"KM t0644 lapyt1ryzxoo $Ifgd`kdE $$Ifl0,"KM t0644 lapyt1rţԣxoo $Ifgd`kdZF $$Ifl0,"KM t0644 lapyt1rԣգxoo $Ifgd`kdF $$Ifl0,"KM t0644 lapyt1r#$%IJKmxqcXI=X=XhhU5^JaJhhUB* ^JaJphPhhU^JaJhhU56^JaJ h2 h2 h_[,h%Kn5aJh_[,h?/5aJ h?/h?/h%Kn^JaJh?/h%Kn^JaJh7VhCo]^JaJh7Vh{eB*^JaJphj(H h@U^JaJh!Gh`^JaJ h!Gh`CJOJQJ^JaJ h!Gh`h1rh`hW(^JaJ$%Jxje]XSNIgd@gd?/gd?/gdS~f$a$gdS~fgd`1 8h`hgd`kdG $$Ifl0,"KM t0644 lapyt1rJK}~WͫΫmnvwJgdU J & F*dgdU$ & F H*$1$a$gdU gdUgdU $ & Fa$gdU$a$gdUgd2   i,-0Sfghzɷ߷йѹ_`wkk_SSShhU5^JaJh hU5^JaJhhU^JaJhhhU6^JaJhhhUh 1^JaJ hhUB*H*^JaJphhhUH*^JaJhhU6^JaJh_[,hU5^JaJhhU^JaJ&jhhU5>*U^JaJhhU^JaJhhU7^JaJ hi0hɷйѹ`ab}~ $ ha$gdUJ$ & F  ^`a$gdUm$$ & F  ^`a$gdU hgdUgdU J & F*dgdUJgdU`b}~۽޿߿\lnoɸجؤp_J_<_h2<CJOJQJ^JaJ)h7Vh2!OB*CJOJQJ^JaJph h7Vh2!OCJOJQJ^JaJ h7Vh7VCJOJQJ^JaJ/h*qh2!O5>*B*CJOJQJ^JaJphhh{^JaJhU^JaJhhUH*^JaJ hUhU5B*^JaJphhUhUB*^JaJphhhU^JaJh hU5^JaJ hhU5B* ^JaJphI}~߿su"P2FG9;gdS~f x7$8$gdmxgdmgdmxgdygdEMagdBd$a$gd7V@&gd*qgdU ($da$gdooy,7Xfqrstulr!"PܹΫwlwlwdL/h*qhTBc5>*B*CJOJQJ^JaJphhEMa^JaJh7Vht ^JaJh7VhBd^JaJ/h*qh>5>*B*CJOJQJ^JaJph h7Vh7VCJOJQJ^JaJhoCJOJQJ^JaJ)h7Vh2!OB*CJOJQJ^JaJphh2<CJOJQJ^JaJ h7Vh2!OCJOJQJ^JaJ#h7Vh2!O5CJOJQJ^JaJPQdj\bF:;PSuvwxyץss[J?h7Vh!CJaJ h7VhI&CJOJQJ^JaJ/h7Vhz5>*B* CJOJQJ^JaJphp2h7Vhi5>*B*CJH*OJQJ^JaJph/h7Vhi5>*B*CJOJQJ^JaJphh7VhR~5^JaJh7VhmB*^JaJphh7Vhm7^JaJh7Vht ^JaJh7Vhm^JaJhyht ^JaJhyhm^JaJh2<^JaJ;xyo,\=j7$8$gdS~f Vd@&^gd[ X & F#dgdo X & F#dgdo Vd<^gdS~f Vd^gdS~fgdS~f@&gd[&*,jy)6 5r|O辪wwfS$h7VhLqB*PJ\^JaJph!h7VhS~fB*PJ^JaJph!h7Vhy!B*PJ^JaJph!h7Vh}}B*PJ^JaJph!h7VhLqB*PJ^JaJph&h7Vh}}5>*B*CJ\aJph&h7VhY[5>*B*CJ\aJphh7VhsCJaJh7VhxNCJaJh7Vh!CJaJh7Vh!CJH*aJ OQr4J^&evwVW|ܺwwweZRNRAh7Vhg]A0J^JaJhzjhzUh7VhI&^JaJ#hohI&5>*B*^JaJph;h7Vh]^JaJh7Vh5\]^JaJ&h*qhz5>*B*CJ\aJph&h*qh%k5>*B*CJ\aJph!h7Vhy!B*PJ^JaJph!h7Vh}}B*PJ^JaJph!h7VhLqB*PJ^JaJph$h7VhLqB*H*PJ^JaJphJ&ef$a$gd05xgdy3uxgdoh^hgd m $h@&^ha$gd[ $h^ha$gd mgdxN$a$gd'DgdS~fJ & Fdgdom$gd Vd@&^gd*q|}~Ƚۊvjva[PBP9h5^JaJh7Vh055\^JaJh7Vh05^JaJ h^Jh%h^Jh,/h6]^Jh,/h^Jh7Vhwv^JaJ&h7Vhwv5CJOJQJ\^JaJjI h@U^JaJ h7Vh'DCJOJQJ^JaJh7Vhkn^JaJhI&^JaJh7Vhi^JaJh7VhI&^JaJh7Vhg]A^JaJjhz0JU^JaJ !"#46Ǽ{o{aVNC7h*qhI&H*^JaJh*qhI&^JaJhI^JaJh7VhAX^JaJjK h@U^JaJh7VhwvH*^JaJh7Vhwv^JaJh7VhwvB*^JaJphOjhz0JU^JaJh7Vh0J^JaJhzjhzUh7Vh?u^JaJh7Vh^JaJh^JaJh7Vh^JaJh7Vh05^JaJh7Vh05B*^JaJph[ "#67`aTcdfg $$xgd}}gd}}7$8$gdUgdU$a$gdS~fgd[ $$$xa$gdS~fgdS~f$a$gdS~fxgdS~f67<=abSTUbcdefgѿ٘zlaYN@h7VhI&5>*^JaJh*qhI&^JaJhI^JaJh7Vh%k^JaJjbM h@U^JaJh7VhI@^JaJ h7VhBkc56\]^JaJh7VhBkc^JaJhIhB;5^JaJjhz0J5U^JaJhIhB;0J5^JaJhzjhzUh7VhB;^JaJhUH*^JaJhU^JaJh7VhI&^JaJu{CM123mnzȽȲ}uj\Qh7VhI&^JaJjO h@U^JaJh7VhI^JaJhV*^JaJjhz0J5U^JaJhIhz0J5^JaJhzjhzUh7Vhz^JaJh7Vhq^JaJh7VhI:^JaJh7Vha5^JaJh7VhxN^JaJh7VhZ5^JaJh7VhM!^JaJh7VhZ^JaJmn23NO $$xgdz$a$gdS~fgd[gdz$a$gdS~fgd}} <O1234-.HJK{ϼϼϰϨϰϰϠ{n`Uh7VhI&^JaJjhz0JU^JaJhIhz0J^JaJhIhz0J5^JaJhzjhzUh7VhEMa^JaJhq^JaJh ^JaJh7Vhq5^JaJh7Vh^JaJh,M^JaJh7Vhq^JaJh7VhI&5>*^JaJh*qhI&^JaJh*qh%k5^JaJjsŹqi^PE:h*qhDF^JaJh7Vh%k^JaJjR h@U^JaJh7Vh ^JaJh^JaJjhz0JU^JaJh7Vhtk0J^JaJhzjhzUh7VhN^JaJh7VhxN^JaJh7Vhtk^JaJh7Vhwv5^JaJh*qhwv^JaJh7Vh5^JaJh7Vhwv^JaJjP h@U^JaJh7VhI^JaJklc! $ & Fa$gd $ & Fa$gdgd 7$8$H$gd 7$8$H$gdDF $$$xa$gdS~f$a$gdS~fgdtkgd[$a$gdS~fklij       vvg]I:Ih0J5>*B*^Jph&jh0J5>*B*U^Jphhuh5^Jhuh>*B*^Jphhuh0JCJ^JaJ%jhuh0JCJU^JaJhuhCJ^JaJhuh5B* \^JphI|huhPJ^JhuhB*^Jphhuh>*B*\^Jphhuh>*B*\^Jph#h7VhDF>*B*\^JaJph!e #             x, J & Fgdm$gd 7$8$H$gd $ & Fa$gd J & Fgdm$ $ & Fa$gd $ & Fa$gd         % ( ) V W l m o p  ,ùêq`qUqOBhuhCJ^JaJ h^JhF h0J^J hF h0J>*B*^Jph)jhF h0J>*B*U^JphhF h^Jhuh^J"huhhWT>*B*^Jphhuh5B*^Jphhuh5^JhuhhWT5^J#huh0J5>*B*^Jph&jh0J5>*B*U^Jphh0J5^J,- ;<`awWgd p & Fgdogdgd,;`ghҹҦҹҦteXA-jhuh>*B*OJQJU^JphhF hOJQJ^JhuhB*OJQJphhB*OJQJ^Jph!huhB*OJQJ^Jph$huh5B*OJQJ^Jph$hF h0JCJOJQJ^JaJ0hF h0J>*B*CJOJQJ^JaJph9jhF h0J>*B*CJOJQJU^JaJph huhCJOJQJ^JaJh45Sfz{ֺqfq]SqAq]2jhuh0JU^J#huhCJ^JaJmHnHuhuh5^Jhuh^Jh^JmHnHuhuh^JmHnHu!huh5\^JmHnHuhuh\^JmHnHuh\^JmHnHuhuhOJQJ^JhRZ|hOJQJ^Jhuh0JOJQJ^J-jhuh>*B*OJQJU^Jph$huh>*B*OJQJ^JphsRS    !!1"2"##$$''.'/'j(k(gdogdgdJgdm$ J & Fgdm${*{|   !!1"2"%*%''ݺ݂vfYJYhuh0J^JmH sH huh^JmH sH huh5B*\^Jphyhuh5\^J'huh5B*OJQJ\^Jphyhuh0J^JmHnHu'huh>*B*^JmHnHphu0jhuh>*B*U^JmHnHphuhuh5^Jhuh^Jjhuh0JU^Jhuh0J^J'.'/'/(0()+T,W,r,s,,,,,,,,--X---ֻ֕o[I=huh6]^J#huh6CJOJQJ^JaJ&huh56CJOJQJ^JaJ#huh5CJOJQJ^JaJ'huh0J5CJOJQJ^JaJ0jhuh0J5CJOJQJU^JaJhuh^JmH sH huh^J#huhCJH*OJQJ^JaJ huhCJOJQJ^JaJhuhH*^Jhuh>*B*^Jphk())W,X,--.........#2$2%2B5C5[d^gdo!Ygd Y$@&a$gd?d Y$a$gdgd6^gdDFgdgd----..V.W.............0ɻubL8'hho!0J\5B*CJ\aJph*h7Vh0JZ5>*B*CJ\aJph$h?dhg.0JZ5B*CJaJphh0JZ5B*CJaJph$h?dh?d0JZ5B*CJaJph$h7Vhz0JZ5B*CJaJphh7Vh%k0JZ5CJ\aJjNT h@U^JaJh7Vh~`^JaJhDF^JaJhuh^Jhuh0J^Jjhuh0JU^J0$2'6(6666666 7 777"7&7;7B7W7`7h7n777ןrdrSrdrG??@ABC & Fo<9D[$\$gdo! & Fn-DM gdo!] & Fngdo! [^gdo! & Fnx9D[$\$gdo! ] & Fndgdo! [^gdo!gdk[d^gd):~==Q>????@ACCC DDD D1D^DxDyDD±žzzaP>P>#ho!ho!CJOJQJ\^JaJ ho!ho!CJOJQJ^JaJ1hho!B*CJOJQJ^JaJmH phsH $hho!0J\5B*CJaJph!hho!B*CJ^JaJph$ho!ho!0J\B*CJH*aJph!hho!0J\B*CJaJph'hho!0J\5B*CJ\aJph(h7ho!CJOJQJ^JaJmH sH (hho!CJOJQJ^JaJmH sH CCC DEGRISI_I`ILLyL{LL[d^gdo![ & Fsdgdo![d^gdo![ & Frdgdo!  & Frx1$gdo!  & Fpx1$gdo! [ & Fpdgdo! [^gdo! [^gdo!DEGQIRI_I`ILLxLyLzLLLLLLLMPePfPPPͿyl^lN9ylN(hho!CJOJQJ^JaJmH sH hho!0J\5CJ\aJhho!0J\CJH*aJhho!0J\CJaJ'hho!0J\5B*CJ\aJph#hho!5B*CJ\aJph!hho!0J\B*CJaJphhho!B*CJaJphhho!5CJ\aJ1hho!B*CJOJQJ^JaJmH phsH 1hho!CJOJQJ^JaJfHq LLNAOOMPfPPQQQRRSSTT J & Ft7$8$H$gdo! x7$8$H$gdo! J & Fq7$8$H$gdo!h^hgdo!J & Fqgdo! ]^`gdo! & Fn9D[$\$gdo! [^gdo! & Fnx9D[$\$gdo!PQQQQRSTTT>UIUUU{W|WWȴeIe;,hho!B*^JaJphho!B*CJ^JaJph6hho!0JB*CJ^JaJfHphq 2hho!B*CJ^JaJfHphq $hho!5B*CJ^JaJph!hho!B*CJ^JaJph hho!CJ^JaJmH sH 'hho!0J\5B*CJ\aJph$hho!0J\B*CJ\aJphh 0J\B*CJ\aJph(hho!CJOJQJ^JaJmH sH TTUU|W}WWtX Y7YnYYZ\[$ & F 0d,x*$1$a$gdo$ & F 0d,x*$1$a$gdo!$ & F 0d,x*$1$a$gdo!$ & F 0d,x*$1$a$gdo!Jgdo! J & Ft7$8$H$gdo! 7$8$H$gdo! WWWWWWWtXYYZZZZX[Y[Z[\[[[[[[[\\)\ygRg)hyhpyih; n5CJOJQJ^JaJ#hyhpyi5CJOJQJ^JaJ#hyhy5CJOJQJ^JaJh7Vhy^JaJj V hU^JaJ%h5@B*CJPJ\aJphhh^JaJhho!aJh^JaJhho!^JaJho!^JaJhho!B*^JaJphho!B*^JaJph\[[[[[*\+\4\5\g^h^ddee f fhhh8hgdA^ggdA^gdA^gdpyi m$@&a$gdygd8: [^gdo!$ & F 0d,x*$1$a$gd)\*\+\4\5\9\O\\\\]$]o]u]]]]]]]h^^^_ziTIAIhA^^JaJhYhA^^JaJ)hYhA^B* CJOJQJ^JaJph hhA^CJOJQJ^JaJ hL;hA^CJOJQJ^JaJhA^CJOJQJ^JaJ hYhA^CJOJQJ^JaJ,hvmhA^56>*B*CJ\]aJph&hA^56>*B*CJ\]aJph,h7Vhpyi56>*B*CJ\]aJph&h7Vhpyi6B*CJ\]aJph_____``L`d`p````gaacc)c/ccc$d%dTdlddeeee f fhhh/h8h9hi*igihioi˺k&hA^56>*B*CJ\]aJph,hvmhA^56>*B*CJ\]aJphhOhA^^JaJh3hA^^JaJhA^CJOJQJ^JaJ hYhA^CJOJQJ^JaJhYhA^^JaJhA^B*^JaJphhr4hA^^JaJhA^^JaJhr hA^^JaJ*8h9hiiiikkkkkkkplkdW $$IfTl    ,"$ t0    644 laytgTJ$$If^a$gdggdA^ggdA^gdA^ oiiiiii jjkkkkkkkk l l;l*B*CJ\]aJph,hvmhA^56>*B*CJ\]aJph hYhA^CJOJQJ^JaJhA^CJOJQJ^JaJ kk l lll;l]P J$If^gdgkdQX $$IfTl    FE ,"  h  t0    6    44 laytgTJ$$If^a$gdg;l*B*\]ph$hvmhA^56>*B*\]ph,hvmhA^56>*B*CJ\]aJph hYhA^B*\^JaJph hthA^hA^hA^5PJ^JaJ hMhA^hA^hA^PJ^JaJooo ppJ$$If^a$gdglkd#] $$IfTl    ,"$ t0    644 laytgTpppp]pm]]P J$If^gdgJ$$If^a$gdgkd] $$IfTl    FK ,"  m  t0    6    44 laytgT]p^pbpdpqm]]P J$If^gdgJ$$If^a$gdgkd[^ $$IfTl    FK ,"  m  t0    6    44 laytgTqqqqgqm]]P J$If^gdgJ$$If^a$gdgkd^ $$IfTl    FK ,"m t0    6    44 laytgTgqhqlqnqqm]]P J$If^gdgJ$$If^a$gdgkd_ $$IfTl    FK ,"m t0    6    44 laytgTqqqqMrm]]P J$If^gdgJ$$If^a$gdgkd(` $$IfTl    FK ,"m t0    6    44 laytgTMrNrOrmrnrrrbscsmaXXPPPP$a$gdA^gdA^ $^a$gdA^kd` $$IfTl    FK ,"m t0    6    44 laytgTcssssst6ttt[uvvxxxxyyyyy zgdYe$a$gdt ^gd mggdA^$ 8a$gdA^$a$gdA^J$ & F xa$gdA^m$/xxyyyyyyyyy z0z1z2zCzDzzz˽ﭟzog_QF;3h,^JaJheh,^JaJh7Vh-8^JaJhK9hK95>*^JaJhK9^JaJh!;^JaJh7Vh!;^JaJh7Vhfu^JaJh7Vhq 3^JaJh7VhtB*^JaJphjRa h@U^JaJh3@CJOJQJ^JaJhYhA^5CJ\aJhYhA^0J8CJaJ,hYhA^56CJOJQJ\]^JaJ hYhA^CJOJQJ^JaJ z1z2zCzDz{{ |&|U|o||||^}s}t}t-gd, dgd,7$8$gd,d7$8$H$gd, & Fd^gd,m$gd,gd-8gdK9$a$gd1zzzzzz{-{l{q{{{{{ |N|O|y|z|||]}^}t}}}},~-~6~7~@~C~^~k~l~t~u~~~~~~ݱ𗋗zlzzzh,B*\^JaJph heh,B*\^JaJphh,B*^JaJphheh,B*^JaJphhPh,^JaJhi:h,^JaJheh,^JaJsH'heh,heE^JaJcHdhs{rh,^JaJheh,^JaJh,h,B*^JaJph*~~~pqZu+Uρ-.Lirw\lmno~ +^_ɸխ󥭥խխvheh,h:D^JaJhnh,6^JaJh,6^JaJh:Dh,6^JaJh,^JaJheh,^JaJ h,h,5B*CJaJphh7`h,6CJaJh,h,B*^JaJphheh,B*^JaJphh,B*^JaJph.-.҂ӂ^_  7$8$H$gd,d7$8$H$^gd,m$ & Fd7$8$H$^gd,m$d7$8$H$^gd,m$ & Fd7$8$H$^gd,m$d7$8$^gd, & Fd7$8$^gd,gd,ABEFrs̈ Éljȉ)*12:<W^z  ,?@OPWcɺyhG}h,^JaJh,\^JaJheh,\^JaJ hnh,h7`h,6CJ\aJh7`h,6CJaJh,>*B*CJ\aJphh,h,5\^JaJh,h,^JaJhgHh,^JaJheh,^JaJh,^JaJ/ ȉ/яҏ  gd!; J  dgd7`d7$8$H$^gd7`d7$8$H$gd,7$8$gd,gd,gd, 7$8$H$^gd,d7$8$H$^gd,m$ & Fd7$8$H$^gd,m$cًߋ+Ɍˌ'UWv}~Ս֍*+23<?\]jm*qtϏЏяҏ؏h,M5B*\^JaJphh7Vh!;5^JaJh7Vh!;B*^JaJphh7Vh!;^JaJh7`^JaJh,\^JaJheh,\^JaJhG}h,^JaJh,^JaJheh,^JaJ5؏ߏX^yZ`֕ܕqw̗җܗęʙȱ~rh7VhO8<^JaJ h7VhO8h7VhI5^JaJhO85^JaJh7VhO85^JaJh7VhO8^JaJh7Vh!;B*^JaJphh,M^JaJh7Vh!;^JaJh7VhI^JaJh!;5B*\^JaJph#h7Vh!;5B*\^JaJph,ҏ@jkSkdc $$IfT0!L'634aytSAT $IfgdSAgdO8 7$8$H$gdO8gd!;  gd!;ޛߛxsa$1$@&[$\$a$gdQ>gde$a$gd>F $ a$gd>F$ ^a$gd>FSkdnc $$IfT0!634aytSAT $IfgdSAgdO8 ՚ۚޛߛќҜϻqf[PHDH7hyhhr0J^JaJhzjhzUhyh(8$^JaJhyh!x ^JaJh7Vh=7^JaJ/heh=75>*B*CJOJQJ^JaJphh7Vh(8$^JaJ#h7Vhq 35CJOJQJ^JaJ)h7Vh{eB*CJOJQJ^JaJph'jc h@CJOJQJU^JaJ,h7VhXA5B*CJOJQJ^JaJph h7VhO8h,M^JaJh7VhO8^JaJVWQRSTgd 5gd 5$1$@&[$\$a$gd 5gd$1$@&[$\$a$gdQ>$a$gd$a$gd$1$[$\$a$gde$a$gdaB&gdaB&gdygd=7*-OTVWop()5DkpuȞɞ潲papRh7Vh'B*^JaJphh7VhnB*^JaJphh7Vh B*^JaJphh7VhaB&B*^JaJphh7VhF^JaJh7Vhi0J^JaJhzjhzUh7Vhi^JaJh7VhaB&^JaJhyh ^JaJhyhF^JaJhI^JaJhyh(8$^JaJjhz0JU^JaJ PQRST !ĸڠ}eZRNR:'h7Vh0J5>*B*^JaJphhzjhzUh7Vh^JaJ/heh5>*B*CJOJQJ^JaJph h7Vh>*B*^JaJph#h7Vh5>*B*^JaJph/hehM5>*B*CJOJQJ^JaJphh7VhaB&\^JaJh7VhF^JaJh7VhUf^JaJh7VhaB&^JaJjhz0JU^JaJh7VhF0J^JaJ!"/0TUde"#hiƸ߰}y}fR}y}?$heh 50JCJOJQJ^JaJ'jh 50J>*B*U^JaJph$h7Vh 50J>*B*^JaJphh 5jh 5Uh7Vh 5^JaJ/heh 55>*B*CJOJQJ^JaJphh 5^JaJh^JaJjhz0JU^JaJh7Vh0J^JaJhzjhzUh7Vh^JaJ*jhz0J5>*B*U^JaJph !456ޥߥ  K^bcƦǦѹ}s}f}s^^V^NJNhzjhzUhd^JaJhkU^JaJhhd0J^JaJhd0J^JaJjhd0JU^JaJhhd^JaJh7VhF^JaJ/hehM5>*B*CJOJQJ^JaJph/hehi5>*B*CJOJQJ^JaJphh7Vh 5^JaJheh 50JCJOJQJ'jh 50JCJOJQJU^JaJ !56abMNOtu$a$gd>F$a$gd[ogdoh^gdUf$1$[$\$a$gdegdd$a$gdF$1$@&[$\$a$gdQ>gd 5$1$[$\$a$gd 5ǦϧЧѧʼ|kc_cL8-h7VhK -^JaJ'jhz0J>*B*U^JaJph$h7Vho0J>*B*^JaJphhzjhzU h7Vho>*B*^JaJph,heho>*B*CJOJQJ^JaJph/hehi5>*B*CJOJQJ^JaJph h7Vho>*B*^JaJphhUfCJOJQJ^JaJhQ>hF0JCJOJQJ'jhz0JCJOJQJU^JaJ$hQ>hF0JCJOJQJ^JaJѧ*+MNOstuîbhrst}l`R`F`:2jhzUh7Vhd\^JaJh7VhN\^JaJh7VhC 5\^JaJh7VhC \^JaJ h7Vh(8$>*B*^JaJph/heho5>*B*CJOJQJ^JaJph/hehi5>*B*CJOJQJ^JaJph&he>*B*CJOJQJ^JaJph h7Vh>*B*^JaJphh7Vh=S[B*^JaJphh7VhB*^JaJphh7VhoB*^JaJphuͩ.CIWq®îsưǰȰ$a$gd>F$a$gd[o$a$gdC t֯ׯ%&IJXYưǰȰɰ+INʻg\QIQIQ>Qh7Vh(t^JaJh,M^JaJh7Vh=S[^JaJh7VhF^JaJ/heh4J5>*B*CJOJQJ^JaJph/hehi5>*B*CJOJQJ^JaJph)hkn5>*B*CJOJQJ^JaJphh7VhD*_B*^JaJphh7Vh(8$B*^JaJphh7VhC B*^JaJphjhz0JU^JaJh7VhC 0J^JaJjhzUhzȰɰOPbt  شٴ %456JK$a$$a$gd,$1$@&[$\$a$gdQ>NOPabst   ms״شٴݴ  $%3޿Ǵ޿޿Ǩzzzodzdoh7Vhq#w^JaJh7Vh*^JaJh7Vhi>*^JaJ *h7VhA^JaJh7VhxN^JaJh,M^JaJh7Vh,^JaJh7Vh=S[H*^JaJh7Vh=S[^JaJ *h7Vh4J^JaJh7Vh4J^JaJ$3456IJKĶ·÷ѷҷ%12-ɽ~~skgkZh7Vh120J^JaJhzjhzUh7VhN^JaJh7Vh)^JaJh7VhxN^JaJh7Vh7^JaJh7Vh12^JaJh,M^JaJh7Vh=S[^JaJ *h7VhT}^JaJh7VhLt>*^JaJh7Vhi>*^JaJh?:>*^JaJh7Vh= ^JaJh7VhLt^JaJ÷ҷ1/0efgh01޽ gd_$1$@&[$\$a$gdQ>$a$gdv$a$gd&gdv$a$gd,-./09:عٹdefhij̢lTG:0h?:@^JaJh7Vhw}@^JaJh7Vh}bf@^JaJ/heh)5>*B*CJOJQJ^JaJph/hehi5>*B*CJOJQJ^JaJph h7Vh{,>*B*^JaJphh7Vh&@^JaJ h7Vh&<B*^JaJph"""h7Vh{,0J^JaJhzjhzUh7Vh{,B*^JaJphh7Vh{,^JaJh7Vh12^JaJjhz0JU^JaJ $XYkqr /2w}  ;<󎁎n^Nh7Vh}bf5>*@^JaJh7Vhi5>*@^JaJ$h7Vhq#w>*@B*^JaJphh7Vhq@^JaJh7Vh&@^JaJh7Vh[o@^JaJh7Vh@@^JaJh7Vhn@^JaJh7Vh'@^JaJh,M@^JaJh7Vh;@^JaJh7Vhw}@^JaJh7Vh}bf@^JaJ  <=]^'( $^a$gd6 $ & F a$gdogdv$a$gdS #$a$gd}bf<=]cghݾ߾!'(PVW]޺ԭޠԭԭޓކyk[h7Vhi5>*@^JaJh7VhxN5@^JaJh7VhS #@^JaJh7VhVAM@^JaJh7Vh[o@^JaJh7Vhz@^JaJh7VhEF@^JaJh7Vhn@^JaJh7VhxN@^JaJh,M@^JaJh7Vh}bf@^JaJ'h7VhdJ5>*@B*^JaJph%'017RZ{Ud 㹯㹯{{nh7Vh6@^JaJh7Vhn@^JaJh7VhoN@^JaJh7VhxN@^JaJh7Vh[o@^JaJh,M@^JaJh?:@^JaJ$h7VhS #>*@B*^JaJphh7Vhi@^JaJh7VhS #@^JaJh7Vh)5>*@^JaJ$RS! "#PEF$a$gd2C $ & F a$gdo$a$gd]a $h^ha$gd]a $ & F a$gdo$a$gdS #PQR[\b} !,2w ǽǦdzǙǙǽdznjdzrrerrrrh7Vh'@^JaJh7Vh]a@^JaJh7Vhn@^JaJh7VhoN@^JaJh7VhxN@^JaJh7Vh[o@^JaJh,M@^JaJh?:@^JaJh7VhS #@^JaJh7VhS #5@^JaJh7Vhi5@^JaJh7Vhi5>*@^JaJ$  *7  !"#+,2@AMUv|曎{qdWh7Vh[o@^JaJh7Vhn@^JaJh?:@^JaJ$h7VhXE>*@B*^JaJphh7Vhi@^JaJh7Vhi5>*@^JaJhh@^JaJh,M@^JaJh7VhoN@^JaJh7Vh'@^JaJh7Vh{?@^JaJh7Vh]a@^JaJh7Vh{,@^JaJ+17DOPW]yz ,œueWh7Vh]a>*@^JaJh7Vh~ 5>*@^JaJh7Vh]a5>*@^JaJh7VhXE5@^JaJh7Vh]a5@^JaJhh@^JaJh7Vh'@^JaJh7Vhn@^JaJh7VhoN@^JaJh,M@^JaJh?:@^JaJh7Vh]a@^JaJh7VhxN@^JaJ",-GNOVjq,3CJq{,6DEFjnžžٞžžٞ摆{ph7Vhn^JaJh7Vh>^JaJh7Vh^JaJh7Vh@^JaJh7VhD@^JaJh7Vh]Cx@^JaJh,M@^JaJh7Vhn@^JaJh?:@^JaJh7Vh'@^JaJh7Vh]a@^JaJh7VhxN@^JaJ& $$Ifa$gdr$a$gd]a$a$gdD/0JKefgjȺȳzj\REEh7Vh>@^JaJh,M@^JaJh7Vh]a5@^JaJhVh}5>*@^JaJhVhi5>*@^JaJh7VhD*_>*@^JaJh7Vhd5@^JaJh7Vh}@^JaJ h7Vh}h7Vh'5@^JaJh7Vh}5@^JaJh7Vh]a@^JaJh7VhD5@^JaJh7VhdJ5@^JaJ^RRRR $$Ifa$gdrkde $$Ifl\:," t0644 laytr#'+/^RRRR $$Ifa$gdrkde $$Ifl\:," t0644 laytr/0>BFJ^RRRR $$Ifa$gdrkdlf $$Ifl\:," t0644 laytrJKY]ae^RRRR $$Ifa$gdrkdf $$Ifl\:," t0644 laytrefghij]^^VVVVVVQVgdX~$a$gd]akdVg $$Ifl\:," t0644 laytr 67\]89>?@AB-3dk¨ܨܛ騎}kZ h7Vh}bf<B*^JaJph"""#h7Vh}bf5<B*^JaJph""" h7Vh{,<B*^JaJph"""h7Vhn@^JaJh7Vh2C@^JaJh7VhVAM@^JaJh7VhEF@^JaJh7Vh#s@^JaJh7Vh]a@^JaJh7Vhd@^JaJh,M@^JaJh7Vh}@^JaJ^r~  ')op} & F gdo$1$@&[$\$a$gdQ>gdX~  )36PQimquj_j_jTIj>jIjh7Vh[o^JaJh7Vhl/^JaJh7Vh}^JaJh7Vh2C^JaJh7Vh]Cx^JaJh7Vh]Cx@^JaJ/heh)5>*B*CJOJQJ^JaJph/hehi5>*B*CJOJQJ^JaJphh7Vh&>*@^JaJh7Vh&@^JaJ h7Vh}bf<B*^JaJph""" h7Vh&<B*^JaJph""" h7Vh <B*^JaJph"""qwxFd =>LM&'()n埔zm\Mh7Vh]CxB*^JaJph h7Vh]Cx5B*^JaJphh7Vhi0J^JaJh7VhM 0J^JaJh7Vh]Cx0J^JaJh7Vhm!^JaJjh7Vh/|iU^JaJh7Vh2C^JaJh7Vh&^JaJh7Vhn^JaJh7Vh(t^JaJh7VhMk^JaJh7Vh]Cx^JaJhh^JaJh,M^JaJnop|}˿vgUC#hyhk5CJOJQJ^JaJ#h7Vhk5CJOJQJ^JaJhI5CJOJQJ^JaJh7Vh*]^JaJh7VhGB*^JaJphjg h@U^JaJ h7Vh;m<B*^JaJph"""h7VhIB*^JaJph"""h;mB*^JaJph"""h7VhoN^JaJh7Vh]Cx^JaJh7Vh]CxB*^JaJphh7Vh&B*^JaJphCLM$$ 0*$1$a$gd 4 $1$a$gd 41$gd 4$1$[$\$a$gd 4 m$@&a$gdygd*$a$gd>F & F gdoLM34ɵxqxqcxUG9h2h 4@\^JaJhA^h 4@\^JaJhUh 4@\^JaJh ,h ,@\^JaJ h ,h ,h ,h 4@\^JaJh 4h 4@\^JaJh"h 4@\^JaJ$h"h 4@B*\^JaJph'h"h 4>*@B*\^JaJphh"h 4B*^JaJph h"h 4CJOJQJ^JaJ,h"h 4>*B*CJOJQJ^JaJph&/"%9:Uʼ漝zcPzcAh 4h 4B*^JaJph$h"h 4@CJOJQJ^JaJ,h"h 4>*B*CJOJQJ^JaJphh"h 4B*^JaJph'h"h 4@CJOJQJ\^JaJ'h"h 4>*@B*\^JaJphh 4@\^JaJh"h 4@\^JaJhUh 4@\^JaJh 4h 4@\^JaJh@\^JaJhdh 4@\^JaJ$%9:TU! & F1$gd 4 $1$a$gd 4$1$[$\$a$gd 41$gd 4$ 1$a$gd 4 $1$a$gd 4k+>"&E45_`abcdѮўމthYM>h7VhYB*^JaJphji hU^JaJh7Vhq7B*^JaJphh0B*^JaJphhq7B*^JaJphh"h 4aJ)h"h 4B*CJOJQJ^JaJphh 4h 46PJ]^JaJ$h 4h 456PJ\]^JaJh 4h 45PJ\^JaJh 4h 4PJ^JaJ,h"h 4>*B*CJOJQJ^JaJphh"h 4^JaJIJklcdrs 7|}DEJ & F1$7$8$H$gd 4m$ 1$7$8$H$gd 4$1$[$\$a$gd 41$gd 4E45@`abdefgde$a$gd<"Ggdm!$a$gd^gd" & Fx7$8$H$]^gd 4$1$[$\$a$gd 41$gd 4def QR  CDlm̺~rjrj_PjB8B8Bh20J^JaJjh20JU^JaJhoh2B*^JaJphh2h2^JaJh2^JaJh2B*^JaJphh2B*CJOJQJaJph#h2B*CJOJQJ^JaJphh7Vh<"G>*^JaJh7Vh<"G>*\^JaJ#h7Vh<"G>*B*\^JaJph#heh<"G>*B*\^JaJphheh<"G\^JaJh@5\^JaJh7Vh)^JaJ op 7$8$H$gdX~ m$@&a$gdygdYegd8:J^gdX~ 7$8$H$gd2gd2 [$\$gd2gd<"GmoõêyncQ?#h7VhbI5>*B*^JaJph#hyhKp5CJOJQJ^JaJh7Vh%k^JaJh7Vh)^JaJjAk hU^JaJh7Vh0^JaJh7Vh:^JaJh7Vh<"GB*^JaJphh26]^JaJh25B*^JaJphh2B*^JaJphh25]^JaJh256>*]^JaJh2B*CJOJQJaJphh2^JaJu {   p q \j ˴˨˙˨ˁˁt˨˙˙_)h7VhbIB*CJOJQJ^JaJphh7VhbI@^JaJh7VhbI]^JaJh7VhbI\^JaJh7VhbIB*^JaJphh7VhbI5^JaJh7VhbI>*^JaJh7Vh Ps^JaJh7VhbI^JaJ1h7VhX~5B* ^JaJfHphq h7VhbI5B*^JaJph 1 2   q r [\ijJKop  & F<gdo ,p@ P !$*$gdX~gdX~ 7$8$H$gdX~  2 & F=gdogdX~ 7$8$H$gdX~J^gdX~ & F<gdogdX~`f!`$$$$Y%%%%%&&&O'P'\'_'r'((*&*),L,-.0022 66;; <<t<x<<<÷÷ë}uh?:^JaJh7Vh Ps^JaJh7VhbI>*^JaJh7VhbI5^JaJh7VhbI^JaJh7VhbI\^JaJh7Vh Ps]^JaJh7VhbI]^JaJh7VhbIB*^JaJph h7Vh PsCJOJQJ^JaJ h7VhbICJOJQJ^JaJ.uS  !!,""&###$$%%&&O'gd0$a$gdbIgdX~ 87$8$H$^8gdX~ & F?7$8$H$gdo & F>7$8$H$gdo 7$8$H$gdX~^gdX~ & F=gdoO'P'['\'( **%,&,--0066;; < <]=^===>h7$8$H$^h`gd0 7$8$H$^gd0 7$8$H$gd0 hh^h`gd0<^==>@???W@]@uBCCC{CCDDDDPFVF1G2G3G4GHGIGSGGGGGRRTTYYZY.Z0Zʿ铇{lldhV^JaJh7VhbIB*^JaJphh7VhbI]^JaJh7Vh05^JaJhbI5^JaJ h7VhbI>*B*^JaJph#h0hbI5>*B*^JaJphh7Vh?:^JaJhbI^JaJh7Vh Ps^JaJh7VhbI>*^JaJh7VhbI5^JaJh7VhbI^JaJ'>>@?A?qBrBCC2G3G4GHGIGRGSGGGGGgd0 7$8$H$^gdX~ 87$8$H$^8gdX~ 7$8$H$^gd0h7$8$H$^h`gd07$8$H$^`gd0 h7$8$H$^hgd0GJJNNQQTToWpWZY[Y/Z0Z2Z5ZVZXZxgd+8 m$@&a$gdygdV^gdV & FgdV hh^h`gd0gd0 ^`gd0v^vgd0 h^h`gd00Z1Z4Z5ZUZVZXZF[]]^^^^ _ _p__f`{``Ͷ~mZLB44hh+86CJ^JaJh+8CJ^JaJhh+8>*CJ^JaJ$hh+8>*B*CJ^JaJph hh+8CJOJQJ^JaJh+86CJOJQJ^JaJ#hh+86CJOJQJ^JaJhh+8CJ^JaJhVCJ^JaJ,h7Vhbg5B*CJOJQJ^JaJph#h7Vhbg5CJOJQJ^JaJhe5^JaJh7VhK$^JaJjl hU^JaJXZF[\]^^^^p_f``abbbbbpdqdpfqf/j0jkJ & Fgd+8 J & Fxgd+8m$gd+8mgd+8m & Fgd+8 m & Fxgd+8xgd+8````aaaaaabbbbbccccccdddeeeeeeeeqf1ggh*CJOJQJ^JaJ,hh+8>*B*CJOJQJ^JaJph&h+8>*B*CJOJQJ^JaJphhh+86CJ^JaJh+86CJ^JaJhh+8CJ^JaJh+8CJ^JaJ-iijj:jDjmj}jkkkkl2lvmmnnnn!o#opoqooooVpWpXpppĶĶĶĶĶĶĶĶr^' *h0h+8>*B* CJ^JaJphI}$hVh+8>*B*CJ^JaJphhh+8>*CJ^JaJh+8>*B*CJ^JaJph$hh+8>*B*CJ^JaJphh+8CJOJQJ^JaJ hh+8CJOJQJ^JaJ'hh+85B* CJ\^JaJphI}hh+8CJ^JaJh+8CJ^JaJkkllpoqoooWpXpppyyzy{y|y~yyyyyy{|7$8$gdSA $$$xa$gdSA$ @&a$gdSAgdm!gd+8mgd+8ppwyxyzy{y|y}y~yyyyyyyz{{{i^L;^3^3hSA^JaJ h7VhSA5B* ^JaJph#h7VhSA5>*B*^JaJphh7VhSA^JaJ,h7VhSA5B*CJOJQJ^JaJph&h_65B*CJOJQJ^JaJphh7Vhz-^JaJh7Vhg ^JaJjn hU^JaJh7Vh_6^JaJh)^JaJh+8CJ^JaJh+8h+8CJ^JaJhoh+8CJ^JaJ$ *h0h+8B* CJ^JaJphI}{{{{||||||||*|+|,|5}=}}}}}~~~V­vk]RJRJRJRJR?hh`^JaJh`^JaJhdh`^JaJhdhV5>*^JaJh`5>*^JaJhdh`5>*^JaJhSA5CJOJQJ^JaJh7Vhg 5^JaJj{p h@U^JaJ)h7Vh0B*CJOJQJ^JaJphhSAB*^JaJphhSA0J^JaJjhz0JU^JaJh7VhSA0J^JaJhzjhzU|||||+|,|~ 89BCͅgd`v & Fgd`v & Flgd` v & Flxgd`gd`gd`m$gd`$a$gd` m$@&a$gd?:$a$gdSA$ ^a$gdSA7$8$gdVۀ >]^ 67[\abx89ABC_`ʅ˅'*0BDEއmøhV5CJaJh`5CJaJ!jhdh`0JCJUaJhdh`5CJaJh`CJaJhdh`CJaJh5*h`B*^JaJphh`h`B*^JaJphh`B*^JaJphhh`^JaJh`^JaJ.ͅBDE!;<^_gd*gd. m$@&a$gdygdm! xHgd`gd`gd`v & Fmgd` v & Fmxgd`mos&+ɾucXLh7VhX~5^JaJh7Vh'1^JaJ#hyh)5CJOJQJ^JaJ#hyh'15CJOJQJ^JaJh7Vh)^JaJj9r hU^JaJh7Vh^JaJhFs8h`CJ^JaJh`^JaJhFs8h`^JaJhdh`^JaJhdh`]^JaJh`CJaJhdh`CJaJhdh`CJH*aJԋڋ !;<=ӌԌ\]^_vijĥĖskgkWsF h7VhUq5B*^JaJphjhz0J5U^JaJhzjhzU#h7Vh.5>*B*^JaJph h7Vh.5B*^JaJphh7Vh.B*^JaJphh7Vh.0J5^JaJ h7VhdGX5B*^JaJph)jh7Vh/|i5B*U^JaJphh7Vh.5>*^JaJh7Vh Ps5^JaJh7Vh.5^JaJ_vw._`y͐ΐސDuvבؑ/0M 7$8$H$gd*gdygd*vwxef./PQ]^_yzː̐͐ΐò|qfUòò h7VhUq5B*^JaJphh7Vh7_^JaJh7Vhz^JaJjhz0JU^JaJh7Vh7_0J^JaJh7VhUq5^JaJh7VhUqB*^JaJph h7VhUq5B*^JaJphjhz0J5U^JaJh7VhUq0J5^JaJhzjhzU#h7VhUq5>*B*^JaJph ΐސߐ<=ABDEfgstv‘ÑŶxcSCSCSh7Vhn5^JaJmHsHh7VhUq5^JaJmHsH(h7VhUq5B*^JaJmHphsH&jhz0J5U^JaJmHsH#h7VhUq0J5^JaJmHsHh7Vhn5^JaJh7VhUq5^JaJh7VhRnB*^JaJphjhz0J5U^JaJh7VhRn0J5^JaJhzjhzU h7VhRn5B*^JaJphÑՑ֑בؑ,-/08<MNyhyXG!jhz0J5U\^JaJh7VhUq0J5\^JaJ h7Vh'5B*^JaJph h7VhUq5B*^JaJphhzjhzU+h7VhUq5B*\^JaJmHphsH(h7VhUqB*\^JaJmHphsH+h7VhUq5B*\^JaJmHphsH)jhz0J5U\^JaJmHsH&h7VhUq0J5\^JaJmHsH”ÔĔ-./0abؿwk]M< h7VhUq5B*^JaJphjhz0J5U^JaJh7VhUq0J5^JaJh7VhUq5^JaJ h7VhUqB*\^JaJph#h7VhUq5B*\^JaJph!jhz0J5U\^JaJh7VhUq0J5\^JaJhzjhzU h7VhUq5B*^JaJph&h7VhUq5>*B*\^JaJph&h7VhUq5>*B*\^JaJphÔ/0a[&gd`v & FZx^Z`gd`mgd`m$$a$gd>F  gd*gd*җӗkl*Z[\]_eѹ|rncXPnrnXPXn?n!jhy$h 0JCJUaJh CJaJh]dh CJaJhh CJaJh jh 0JUh7Vhz-^JaJh7Vh A^JaJ h7VhUqCJOJQJ^JaJ*jhz0J5CJOJQJU^JaJ'h7VhUq0J5CJOJQJ^JaJhzjhzU,h7VhUq5B*CJOJQJ^JaJphh7VhUqB*^JaJph;@ǚȚʚ`a0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 ηίΛΛvodh7Vhz-^JaJ h>%h hh CJaJjh!gUh!gh h`h CJOJQJaJh`h 5CJOJQJaJh`h CJOJQJaJ$ƚǚɚʚ0 0 1 1 1 1 1 $a$gd>F;gd>%;$a$gd4;$$dNa$gd%/ =!"#$% @=5s:x/%gN zx}UՕ&Y=̟7Ҋa0H';BǕ6KHdE!%8Ơ$fzQʪ#Zeq"tF$ HK`t@TY{~~{=޽wֺu=>չ?>2eʔ;&2e@˾˔)r5S|d D?6/T>jʛa_?r*/ɔ%CsT|Am[jMyisd4nUmw'W٨߿z譑l0> -y.# 6\;| L4 -?4}Ek](ڻku(_]h6~ɱjmG-~q{sC@l&9=a;>hUͿBoU&V!ܷݽ49~9 v8_ğ9Gjtb@hZ>|x>j?ޙ$z|`y?=v%?~y l\ECP⪬,6`ćbw[_|>(@w!Cv9ܰ\s :{>SPb΋/O\:.yY637[}|lF027?$Ǎ}r3.PQo"st?(Bƍ=ly|7ӺOu˯М73Щ1mrzo.\⧬g&B[Bc;_Z|c"WreoUߡy$Շ6Le؇ 'd̳jcoy#O]eΡ6~[S:8~fm:G#l1oiV|u<$fQ(k')yVA" >#yq0c[9[-tLZ>#Sr_Oy~I\V޾5c#Sr>~yj%S״գU*^JbnoS/Vߓ}Vw$iu܇P ]"+gAb`?CdԄϳ(͢i}8[^|%y6?CCGE*w:Y鶮'\Jw\9μt<ФOꃲFjsq>V81Fb,uOpU_k:& -)v |/o{{Iozo٦^:{S_`<~w;(vsI3Ne퍀dU=h PtU>ƩIbߓO>eH?|с@˶n1QhLt[ȭq|۷K5mlM_J];&W=Ҏճ;n^4H<;I3|~+jﭟG^x!Il(fh)P-G?꾟=_^|?%Α@!b`?dԄϳ(͢i}8[^|%y66󿫧.T Ot#Z!`QmQ+<<::rpz00=4muij?~Y7 ?KvoVe_;,րEPsK7,#L">a5Y-PZLfMMh<",6kkcX)|/&{]-\9 7Z|戢{&Zx؛+~ SǕN?;R ΐ+?!(+Y-.2 moD}з|>[^3xkc9|/&{M}b>ڼC-ýQ}uob;)RL҆ Oҡ奄E;Ds^DotU. ߞ7"9(+͞ aEСsX#޾g^y2]tD?wnQ=w[g* ENk\AQTbZw;^e> nC Pz=7l1pB$e'[h 8mG׷}ˋؽ$O]e6~0ߋ|ϦNSϦ~ZfrUrR.$fio짏:p=y  Pz[ g9tLZ>#Sr>_?-/>cR1. @=-:& -)v |/o{{I9 Cwm"@Zcj%?C~^=M+hG?AS/mZŨGZ뾯-q]-c#?h >9O-Y߂jdoVE x0IIֆOIZc#[fIfs Ư~]?zAeo.՚_5W-.o:yWc<{@4K{_|^-uŌm[.YZhF1NCˇcḇ]#]<o+6>ڇw$6w{N~wK"B{zqDoO  -|^z4I(F0Cl|8 zhU2΁&N$Ը?Iش}c:F{ (ݯQE0>Wh>0et?Kw]usC[VLs=thk5l@hZ>|͟b]zoý4ڕ5Fՠ:%g]ّm-sT3ܴvq_ƚ_mxEkk>(_|Gk'Ǩ{iޒuVyߧ};ۿ{pPtDm3=Y}Rߞ\ԩZ__\ػ@[ZByٚ%h{G{fobI;+$~iz ?qL _ÿߵBއWҁ=ջO}>/+>(_!z-0*OЊcu{3Lo%*a4qE" Xkp;`nv+veݯ_iUҴZ qB!Xq#]} 4 -]?=a.xTqށAZxz A7m/sQ#Xg+ >hB7M?=MFq,p?x@8k;Ƃ+|V~(&c~wwضo4z"&_^@XFv_w&ӿ5z"" _=@XZ8By eΝסߗj6ֵ4}4qjO$7Y<7{ށE\@%lksvO@hZ>̏Ճ]/NWoSpݤy>cfhOųm=~`k gyVCh1I{n~OP{B_B/݋|"GX&둖\uݲeKE X\|y =-yxR/1s-~3}ͱplGT^!.+kcX?|/QV1࣏>Z}E$g~tY>VR onR cyfb~pcGeLn#c텻a?R0!R蘤1QmoܑS״7ZJ4>Xy~s44:6 SlpͶ}ӕY}:%k.!_د9.Z_u( I$N)#N0蚴'I낢GRμO41IjR&m{~,=O31(oyH[k&߃Ok?Gn}/n&dU~wf5'W_KGa:pdIӦ_K};iPD"}%X2oSDĪLfte%twކd2zFR˜]s'z8H]R.r?$m}(o]. A6sGѷ}sG"2O]A{h賴k[͟5[}f WΫϸ Q⎀^SwuM7u D E$&R_ݐUֱF[:ncDV.\dX&ԕu~2)4ɜ]s;Sk2?iǾ{)-&[g|CcQmoܑS״S-Kzoct. wCQ\`|fq' e#`?)MQT4Id]l:*cp!:]RY8\lgdj4J˺M^.kn8DLIWI˹=R6RZLe ޾#oic3lRz4qvyv Q∀|FZ1cZO!?"BM7><'%\"MFRq޵<ɪՎkmiP_{LZ9Ie!v)KJʀC;`W\Om%S״]=u) 2dxjf?}IDK9T vWf3n|C˒+q@s`II}IB-LGJ|RF_;[;yKBˏkϢg~x ||(-iŦs،|ߍsZ<6[ȰMM)h[":&)|d(oyH[kcg/ -?JB#XϬ> =z=]<_?Cԡd-+two|w>pd߳bʕ'Ӥqs9~zs$][:N:4-W:9w&S`]R.IfR{净FYK ]>34Y;[;yKBˏk㎟S|nR7*OETnD}W}6Cs#r>V\ ߧdMs}]:S-[Vl' mQ\棍DNnb[ӦϣԱm]K/S{K%i%=iޑg+ҞaMKlS;'G%xę_r|ebtv`-.&Vym9orOxc rb!6g)+iOeWhWviŎ4/H3g6(GT{z"_-s˞SBj_w1O-ӽ*}z%5گ^9yUkld?q83;胷wq{hݧ:~;PGOƂ#?'hE}}%> {$#ZkN ?.si<\K'x=}] >o.x*W󜝉tݭ 81 V$sZ\q34c~Oe3_\/.\Pڷ*F#)],!LrmCm[6]%_ß&_F'+&!cuN?CsoLͺ\N]c$[ss@Yd\ku<?x5Aw,D0]]n6_WI#GQpL$0a&)u;XoS?K @C/0 (_6Wotc, ]@_ij _aA>P>ͿBˇCZ1_WP@^O@| 4 ->_<+M8O"[ 8`9~'H!qyh_9|%E +vdWhl(K;, Ѳ;裏֮а z6ѡXo%6Q??ùp3]X |5| 4 -~Zl(_'&Td6k#wu9e[L^|V$xTA=϶{+b_k=a+@| 4 ->Y<4 ?͋;=oЦC>5*Hlr^-:ywm@>_z16GuK}3'iҷ젃mzX} J_~G{>B{|φ9b9mAi{A:x Jc@ 'IbV} .|N㾓v&9ࡓIzmt =}H,>y K>h1iXYiӦj Ж-[9>|RDzvj>tڵkW/f]=$Z֌ NOAεQtOFpa` |(>p}k?hDoI}1 I:b5ۧΧ$f'3ǐy+mxsձ>re$\f㹍4uf0e6S("v+(o j@mtHT%/SOw7*uڕhMd@^{9ZɁ a~4\e}?^JJ̑g2}?>L#܅y:m="mI0ԌL#)o+̣޹kKPE+I.,|︜gBv޾5c_Ofdmmt8?[4^:&)|\h  =mF޾<5ϱ]Zhz?qH=y͏XkJi$ bb)$=[Z}y͐Ǭ75#F11e5:ftc?@#%$tLRvl${F}u+W9=Cwm"`Z9pl^,}MdsDQZ}o[2-6l;2#yyۦTM8\g%%Mj'e+ؖbdIkN2dy%$y!>n;n%S״7Z^8Xys44:6 SlemIސ&?z +Bke. 䶷?rkJҬmA/Inb@iR%'2\ƕrl]ɒz< 1GmW ]>54Y;[;y6]9@U JArhb4DVOE6RQ{<-$Χ& zenT焺,Y%ɔxIܗJ~Ȕ1\rW x2Dg,iߜ٦̾8gJc]~0(yܑS״Mw'~_L(պSx-=9@:,udE[̗9_=IR/ǮyR?y>HZw0$)c4'acI+k/:;WscTdc>UKix7ʓ1?$ں {;iѢ:;ҁlS%:5$:sz_'IO +nNW*𾬅:,=Oei)L؍`O&cI:͵l+{9۪SZL޾#oyI$F( /ꠣޅj={?Ej$ͼ|lk=u-slz9ݢʐC#ߞa "B2 F`B$e6A~玢o{De9v|&$4&;Z?~..\C7MNCU/ozUowUGՁU74'o̩*u!Z}P8!PDBB(>R蘤ơ1QmoܑS<ǎ$^Z~\#FϰfWL3=T7'HCk3#wF:şϪ^ԃ` "PDBBfq (>R蘤ơ1QmoܑS<ǎ$^Z~\#Fy}Z:~:szLl}>|gw/Sq{_BȬX _)tLRvldk(oyH[kcg/ -?JB#`?y'm=tVf!mS7+0ZϬuﶮ."no)"~!t !9ˡw?^mǿ1͎LoVE x0fYdFۘc%6QHȧ|Ⱥk]p…e?Yܬ8mlR3tN:f Dݼ+N& 2D'630>.xx"`BиsȬ}⋔{j=g{$MhU! 4 ~[(Se ph/uV䆎B׎iB7g=6I7tKi94yTY cOW qz>>_TY/1 ;Fϫ{:'N4﨣/lEу=պ}!a@ #7|`;@hZ~;۶Uf򿼾7Eݯ|N[Z.պ2~޺Wu  ![5V+VQt4y|Ⱦwcs|R}OWϧWM|z}R\?zvp?e{0_oͿB7䥟&üHfL oo9OWWJT?bO9Y";i..>=L'd_m|qcֵNzdR /eb, p?o7|>/ߛOb~\ %;/.ނ6@ԃ_~#&+|u3szO'?;H (}5|>/&r5٢+u_a#@@hZ>|x Wо>.o&T`Q~H#oriTAYvuBzs髗zm-_zH'׳_OQsn&eHK\b\2Kn+wvEy~ .o0lBqz"zC$>fYz)?|9du͏y^k_(ct,.2kze˖*vI o16m";^1g[_6Bszb2V1뱭϶Y`6Vμ_ْ1mL8fkl}lL>f&6s`/il/I"c+viҮh9& |<>_/wO0Gbd-&FAdkz[9s:\'j3Xp+L[M^ >$kz.O GMg[JvEY\?1Vְu+@HxEFunHM,pMVo+u0εmc׹>S[[.ܗg"u&kCquMg[.۴Jb]Z$ssCX>VU iv'3twoeA^ئaO+\O/{r.V.r}OO/v>MRK?[n3m(ɒzmN͎5;fBgCv_Oy~I\V޾5ct+mkotrq3dїdqd͍6>l!ך}۷ficGhìD*T;|OՆq}E"(("E@1Ckx?\CYJ\ae"%( ŀ 9s:{ғLw̜|fΩs]}]iz.]ɷ:FflUC;~S![[ BE>/ܖ#wT6TVZ7{ZcUBFt]l;N:oǘWS{"yT/m8!DCJ8D[vv-;&-,=lk{-/sԵ;H%wìӐ5 s^)iP9$VFba{i,d{MbQWPt܌1NS'4/\H?5iT/.gͮb2#cG|jt5//ܲ^ky-v㦮]MΫrD2T#O~,`VސNWžmЫXu[ =m-%I؍y3k v@X9CyzqlaѦRƫd#4Guvߖ)qf.^|m,v1pGS[eܒ+^@"YZzo#-gC+V@~Io9^M['b@[ }] 6]q4mi6S`lS}-nDNw@1Iw1.?Vvs=}7ۈ=9dwό ~+_u.zL(6lϼ5GcDS\č7j`ĬBHw<;m\xTwcgZcoߙC%!Q6N܌{ 1~wi?|=Я'>d["+`;ݹeE)vؖK{HL^Yduc@w_[n>iٻƩ ;?#giQRp|nuFX`HmN}l5ujw>&'m 0Vb[ʅ_&b` 0閟>L6 ='iw5,^?VMa\Ie9zgO1_X<=5דf͞[W0  $t/òu7n8C-E!bh>8[4"ZlCy3,6QӞ|,+ cьQuO|"> Ān[Ym3s?Ú@3r[a[}4عg\F 7<X9?nW2l N>YN2\ڮ=1.;N07>`n>3Һw@Ey l)k1!0POl5ch`yq'`@0 / _ ^W3SKɣ ';7\ho 8Ʌ#`~!\?tw/G+K5s1#mQ>6j\WuI"WHS]+O't/l"yz3gwI\[״ 8.Yk'2jsYՑe 8;~Ÿ:* 06OϹc+oi~}Efz9\dnC^5sW=%*> ۢ]. D€n[~$>=㨉¾:~\|n/^x8_4Rxe)s۩rmJLIX@A`[ڡ*v f _!3k`inAU~߰.`w$3Oz'6OMUۙ(>v[@w"Zڦ:+>n|}$fcGk;i2vJeI ~MF\Kw OK|0n8j? w N<r\ ?! ny6uYf w ODǀn[~7g2u?1eDr[4qΪh]X/q!;Fb#` 1閟>{?/F AMS?Q]3rS vVM^`@0Ϳtvm5PPJ܈`<>uCwvSVl+ ŀn[)x=~q 9Bɦɨ ^¤ŶPdć_C! ٻ[c8qXD~cx Y_5E%uX77'z`Ή涩ۄ!CqC~Gk5 _MmoǦ4 6dkߘvKMr'YIb`@0  t/<f/B.br /͛~mSκr=+969kb,q{Z(v}ٓ4m|>։VnNdp}NL2Vt}`kt..l94M]ݬIuwuuu|y~PE\4|Axh w,l{5't:'cUltwr;5h-ϙխl'v:9J|`!g{pydc^7jOR^cky=񖛺Y6DG)^ݷQ}`>꓋|XS)q 릦P }N/ƒ^Ѷ?g?{H+=瑍yݜ:=Jy9[nfNڬ[_ 2eDQ LG^F%C9 sD&o=Y뤦~/;#csN; ̵?g9mOr Gus*嵿ou;inNt2Z.%up8kBc ,- zg@iV.DQ#[ PM :_/wiQt-E=s|K쭨#tr G6usv) NwS׮h(Hwht Dh)4VMBBgWW,(+Ic32cKaӝ)+>,p}\A LTs+;P5ЏyVH#5lz: Dx0h-|+ ~-/:{+s٘ͩטZ^O妮]խ$tĮxTd3 +){B5.C2&z;wr[y=3;(˅*7 ?ݴƃ9FmN<q?{H+38lYUky-'rS׮f׎kŠQ9=qf:x=\ITW}KjuZWh3s|K쭨#tr G6us*5漖okWu3| ,]A9SC77!?{m9?ySSݨ~MuZWh3s|K쭨#tr G6us*5漖okWu[..%~ _;6pus8<ɏ5?2G9`YjJri*7ui]=-m ~-/:{+s٘ͩטZ^O妮]M޹tF?,f]\I_OZ?2I2~[,K1E˶^7.VG ͺM|':Jo-`4<9%p_[EDJ.q8F.TTrӧO;)jB"TfEhgoiOwL _m-ƭ[}nNJN?Ƃ?9!f91I'A,e{Σ9xk{-'pSW7vf(e[yC \:] {NAK`m)w{~T́b=WZRjwhYtǩiۗ,- |M.?q6j?JnժK̶x`Lc=2F1^^U;u bP{xMgmo1eU ņϛdqh!W8mw򽲳qooUG˖WfpI߇1'npp^pUS7W_Ȉsܴ} 9lxGljxn>J665j˭g\V:w6h%$Q5D7`@0  N0FRsX?ufj*8bo`@0  KDi+9~=;}'oE5.2q93-]Sǻ/En `@0 t/#-(N0xZ v4xvxog)VA= xeav,Yx-z7dxX?Tp?\O'`@0  $t/3cF׊dzNU-l(~ {hEPMXp G`@0  nSԎ?hj}³%` c.xf=rwO0? O'`@0  $*t/կ.3;lYI- ~8zZ,̳" 9F,cG\`@0  't/í8|!EbsÜD|" @`@7-?YOf̿)Qŭ?+?Aw10Ow ~ $n&w9N ` 10P2[Ohhi0-z.M{Bq7e $HE6o?ߗU*.[𑨋`_g _nfN[# %.x `ɞzȻ*ͳ?ٙwŹ"5˵?Z%ODƆ?rގÓ/7uuZڳ;nr\Y S[Em:Ϊٮӊ]ƻh k.C.ȫh1L_lA xlh쀂{QPi=NɅmMՀِZS2`rv.<1NV?I~Qn:۰*fo^;o"[Z 7ytd}eLEѼM^m]7WYP5XPԵ#sI_!!s|&܇́i(zF7G{M3>Fc}c{̅|Ceb}c:指OalKEqGqP'I߂WmUA PF5,B^9a0b$xzC_4S3aa,֟m,2q}wW> K W[BٽWm& qܺ7js@XzG?6[ S,,ԇ \]7KaлMru(\n\9:Uy<_ϫEIu3|&|:D, KrV"WgS]E#a_:D}y5+_ 5B;n/?M;HA2+_c:y =vp8Ђ׹L+rk2%uxjztno'i d hh}؛va3s`,ho9qH5ۀur[<|.`TтYG-Bڒ;VA` h8;̕:yLV=^ ˎ@;06 Sf X+:ڥ%"}eGZ`sa֣+)cT5,F9 *(bq#lOI`q0q؞7~,vJWd f7<]_p.katiO[G3`Xuph: +2ϟc&_q>< DZg킗* !gh.g ᳚`쥪`'_-պ]b? qz{,_>OhXoAŌjO},Օ/c/%vz h?=شʤ5F}wI<ŕv\6^5x~5px9,E}f#t cGgZs"cPT{qt8 AM>֌¾|𚉐'U⋤J}~F.e2ohգdZk?W+r u-yZfn1ȳvo M? ^fE.qZe=y'|zpq|vڃeZ|珔}C g&EvƏ^ eAfy%a\"28ymâ˰鎁~ U MFw¶{ ɒ} laZem÷[1ºcY?lkTca:Eii܁XzkӤ +,=:6/pK pg;oj?q7_7תc vl YD#jֶc'_k-_ʼnuyn`bU.gurq6Oo_ם=xKٛC0<E*:~_16zhb|4 }#dϜi"m!QJ YkP_>/C my첾,SP_EJ+` Ecvo __](<ʧ`1O`;`ͫ<¥jW/\RiJW^ͅPx}s!xYWBcӑur1I+a w%8w aVQ߈2Tj%_z>r|د_S?8p2Ab?PGû.Kp''~Ԙ없5;|H?;BC{e#!\xC.DŽo; 4X >_h'igAF˄/6rRi! /3x y?nuEUK><3aw5Wπk@4R6]9ť#E8?VC Y(jܴj+{9`RfCznɘ 9v[0NOq{ ]''+܁c';WI ܑx/47:wE53p̪y?CBıe h [㓙7mA' VV;;_XU5.M ߼.'?J^9_KWC! Hݔ79'Зj[a9Ы׵yۦ{oE!1v[J¤o@?yz&[V u Z#?Qܠ34 :Q=7ii;N/Jy-!<}QQ'x/f>}T.8e>SbuԶH뎓ںؼax4T̜S{y}|HFj17/1fsقwx^Ϝ WeAR|Z^׎=,SU0T;^vVsע]}pg!jFѴ;K4o@|빺l1ٖDܷ<2xS@sXJ$Ձ^L LX7L 3*t|/⤙9my khU7W [6a.s 5/&Lٍ9JXW{jR[W_x/M 8jc#fmG??|4> z,8FPV!}xGT#yŊbp?T1߰!ÌgH= :i~C&}/V7퓷0EuVc>\Hq4_pቀGq.NV)6nNORwwυݲr/x3R0.?8g)bcܪ+:\Ye%pT(vƔߢ/:r4 ߁8uZ8x]M#,a 7. <&h#CƼ)hO3g0Tt:y'zy2y.uqyq_(yTg\Thgt#SH_1|.+8?g> ~ԘtӲv#P;Oi?YdqGa^lJG9xP}cA79*͑^wAm:S2x|{oH~??ҍ;Y1b)Ε|DU3f`M,;0? ;!Lf>g'A:ڞ;ŚiiǛai4/auֹzs`k0ָ7z)[w[c͆\lysOpkuQ5" W[=\sF9];`1j,}^?0)p~nwq#6}8z' ӌq?-+w«?4>dz[Δap`\K7%L}zr|<}>>y1]MkfyvzP\n`)*ͅ”!HGuqgnqؗ?osH)aG}cU^09x_#ţXG;d+Tup^U B1Â|1 _fd+7ҳpr1osX<?yjM.| ˦e5Pl9ϵҕ0I?S~JfCNAtiU7ww5~QOIE0Exy5E@MG_7|M4I@E {gTb!!},w/ ;|ؽ;w3s=gɍib G؀'c ;Jdd);3o}v#?ϰO)32j=:} OWjPqzՅ7Tyߋ$ObC>wḰ~m P i3UdRpԔ胴8kWǣ P;Olý9&jW6z؍f^ ·̛jyc>D[+O|i@ؽlSi9Ý4u e.-B#d{T<^d=S첣cw !n?f wLe1ߦ?&]<#Iz{a{<5v ]: 7p@DmF"{܇ ?F7?c#N?Ѧ'a繢r~~X@AhpbbMߕ.C?'_F] _);P^Gҥ̩d#-:Xe'jsw?yp/5?ߍ1;N})kmA)Nz\-޸ 6lQ\*[OGw}k],{bq2*NoO*=R,Ӈi O h d6O%c, ûjug?LUGTvY0/4sPLJ*i4̤I+Űmn2&cD[`#XjZ3}]r]i+BO-ד7˽`bS[bg'#8O|H)yQ'p?}]a_A*By*a+,{(__=.S]Ӓ,p0^$p }3WXw,FPgsXGWΥMu))#W"֗7ݶJ#o.ݵ{ﾮZʛjW*mH9Ki/ +,{X_tRY8`ယ/\}{wwK>o8s̊ih.='u`w+~ iJ0Ν1܇jEΤq%z #i߽v-u5c{b쿯t+K ?,u {Aܠ'o4XXm47dWD;es/\(e~?Hݝ_j]4Ÿ^lVF#^E$S*_]Oj}v}@Y BKal %E?Lw~\d{:% ~yƹ/rLa"%XEW)cF쇐u)3F*_J ڗK">Lc Oq$mf= @'Ƃ>{aS _qf" /e>/|~GgI)*}!Oy)8?~PӜXJ˴2*J qaXZʟ>Y9x =VG.<]ivW=|I?ANͅgR`q)גkMt ;IDd^Oi"P( (ub2u|ìpܦc2Dn~=6MM7=~zTE MS Msau,gsdZH/n?R2g&ϊuWϷGRJFr!U.׵F0ʽLEIeѻuk'`EF׭ɂ[09KħX 8HYy?:r~p!+253vܦqT'_sBJ:Lǚ8}o)ͶLM GŹYQ.0r@eV74TT,ε-SwblnU:qn L;n!VaOZ ?(RZIRm$o7fnH]tb1l@鰜J\[HKz/[pg.m`Fa(0kh=zE6[KYg1Z&h=h}xBߡ#&vY/b>(_e:ЏM4q7y7i]!\J Hħҕk㓊MnTcsCh "o1WyBVz ]km׵hkP|aV$|v8/o8~ـ ?YQ3cq$~m`<7kKסf+=O)방c:p%2VBN,Xꈣ{?>Pί4nK<@<9sQgdדl+SQR$!Jڝ2&:_rqO'S<-ɼW?|^(y*c5(ϳX_F- ?%-)'^Ӓmd/)i)jLP7g_GS뭃5쳇>TUq >`nяU(1 xsCկ͂r~|ރ> <|2/-4yʽ{KJads4rQ̏\J%Sm)#GO/0R2/OKڟuXxGGױ>}rhXj'ٽ]<!돉}+#i^k=E^c~j77fE' b5r|AL#FpGry͚MSz o#lqK k%JKu%gWAm3W&Ҭw 1d\r)RKJߝ !{H*+7G")?q/#vgoԓxٍ0[XQCT`:rS1+J?#}SOdZ>zRf+H~ko|/ !%v(N|G~d)djܳ%%%^k$ J ˟x} Qr/QYXA){vtSZIZWg-TQ-uPGYW_k淋2'YQrn]z^E'ccU?IxO1__=|'Fx!?r$i75et6#iZJ?aL 65Pt_P&:p,]:`%s"~ډEtk~zf@ FgxE\s8S_wש_vAgZKێO^8-G|S_in*q$XйknqEv$?I ܟ8C8s>Ȋ # ӵl"9zͥaX#$n[놬ݖ싕cζJ;⠴?֫&2r0U RNʃb}esʋ7ĺ?ƩcʸO uCܷmJrZ<5*6T]/ZR?^GZ"s*NY`F5]1ܽ) ?6(<(9B×PJUWiIr@Wa߀!ݭty=;Lx0: [8)|6?zSNPc,9KIІ.r M' .a?Y㱟ayh0eKeM?? >4k;iMM -Ϗ.:%.m4n:NnV*C#coe/+'C.ﰠ9Q7F_L0cqu&'iq_ʞ?N^Z۶5Ko6E}羦QQ:~6/ӷg;эht~~JClM ysʩlh,ͷ$ ^o\*e#gߊ)TV[xM!ޡt$dX`]gGKe *U !}yʢ+ٺ8*_UBڙTsJb>\]ևҵ#{^#+?zsPk9nr~?b:j\ZJA)}n<-ʿqbRp!z] ˫ji ɸHKޠO6xWWd >mR:-"}oƻC~O?v65\ۥ[_O]Ɏ;u5MoSJATR/&;@"ϰhI,΍9ٹ,y+9m? ?Rh[Dƃ]16 xH8&S}RO0/࿮F\d I[Ʈ5R'uWSYwŌtlˉ}gCVӟBKr;dz2Q1+=ƥRGس0kx_*zn(mu볤Pίg(qch`or(=,nȠB'|]f.5CdTptwhW:{.V dZ .]0?|]W*'+5} ?ao` 9ß/Ex_0*HĚc)iݽK}كB#}?[`|ђ5J=4۹ݎ{K|vFལL ?6GQT3Xy=OEd=ߔAn_$AvaιP#XJ6lo?ϔvw(Omg"1cfS40XN@N< Y^"*=N'^m{2Y[s4Xv,9HsNUuYprȅ].e_WxטC}[;neK noR_z"A pВzoþXr3*!D@?{ה`E=\O,z_577+4X%,N;eŸ-/^i+ebKk,0/^f2ϼ3gMe~bƫ' P= ڧOOcSҗE,IP?r~#b6/ܠ͍z?=v ]}U#>L0HВiVX_+{ey~Gs-K/ll_6_2Wuf_l9iwfδRw9ը~$b\1sOo Wi縳r7{Q#V:=8'FAY݃6XDmQP̤Yxd=CJ:b,}/9Dԓ{_'͌4]éAG_Kt_ W{D Ia}f:\Z%Sg X xWc)}>]kWKv^\y sg* _/S5_BgxnLHWK?<vd;܁46CD sz~i\e"~d{ Z|/k;[[g{Ѹ"YR_Yۉs;@)ި6AR+n`;P?m١ogx4o? 'nGRT%}YR.&Xs/~fֆP<]򎿏o}ωE{hI#ɱe2/E|vNtGgЇCSkTѤ+_\J>2gh4M]IL8L}kx<[}'{?o#3kc]~6Yxp ӎ.卍1N7{t1tcP1c3cnc;1%P”x رeWWOu wckcs%cϫ{fo 7eJpJOЪX_Z,dQ晐ݰG;VR3v-ǬSZvwom_kDxI_R*N/|PS8/<.P/3JQ\zvDIW񽶼.L{0AT1HmLm GN q~`뷌50GGި $JGtr jAO); ic:~?D|,;,GYi+= Y.5{#S)q,ϲ2_?azDwO/5@6}YV=q;#KWF_&IpM2+jp!s牻*maeGM~vz~)1Kp=sz:@B菭v9QI}r%F I,w5oOp#G5'cD&r߯ Z\B\yq=aqc5p{\]QLU%_gU|VDP(q,>@Fo[t6?֍~#lʵzmq8e*E;K>C闪-9Sos黌 wJ7)E]!Lm2JOu;e{wWs*l&vWs!VV/gJݚynKQ_ZF'nVsQk *uDLw:*1%+۬\2֑z|MVh%UTOA~}[to2fh;YSɛslʲ\^UҕZuj!$~j`y`uZg*Ub-9I; s\Awʝ4'rwTcW~itREb9Ov%cTwvV/݁xi486;,pr 38ȏͿ.37c}7vwymdyEOo$9zC,{oK#6_lєuzQ[YQ`KV1ToG ]# |$u;wRQK{dmg*i{ sb‰Rӌ2ZSonPVBVԑ wʱ[nlF9{rH .2'7 Ɏxg]g=yô91K\q=7j16ڙTs\( 1|oE%l0]Ru\%MV+q+6R=*CtJ3Zch(xfrL:6;ӄNF*3nY]_R{Xgߵ7my*}}gM:6~8cO}6+q7FQe_D7 b 6} L?G(Q؂ wBR{eeҖm?mCĜn)l@|Rw<\x8w>lQx '^W;c r˴*E^r*=V 16t^`ǺKg"Wȏ]|Nkq`lMecadyeto쟺~OhYNPg?Q[Q7mHo=6t9ѝe;^o8,2jwK{ PI׫7U!3G4-QEuU =۱Ewg㴕RD<s|ouu`y|P=4@83=YN֒])ߎ4n=_叩./}=TgK&7'z\Vgәvc,I(Y5 wyѮ6,nb_Y}F_?7 ~Ժco!1 shA*+-Ymso$uU?Ʈ|!ksEd}2>jaiGud?<Ƶc1WߤՙzX}m(bc@x%k=ck25?š$ǹt ]P㾙=^'w]]xGdcwIx{)먭jy b)OOT?ˋS")A2;NH`>ʯS3OGYC\oCsfR+5ylRR/'MEχ)ns.rg;iph =U,JOio Ù֎?i9W_I,~˽OߘN>&]߀ |&zS3erDG6&ͻ4cyLJ#/ 02x.MpEn&7IJ7У wpHX&/ƐW0ܑ]tWۙ8J= #!{ !kq絉 T6P<*"xKUbi@cEؘEDHsы!Ғ⡂z<ԃ!4|ohmȲٝ$߁Ɇ}vf_vX>hs}_"'y{>~=rbV Ivֶei~f[?9AݞoMNIڰ,[ߞR.b`@J`5ZU-+N{zA׃m0EվoI]Gp@ch ڛȺվSp<P @ T*WSP?(`??L.ܳi]oP t2NwY?jJ߿}QSt+ P ?\] ` 0:Is¹` 0` le@X`` 0dvsb=\_#nG>jf[%"QwPNG  IHDRDs|sRGB=IDATx^ \'Zy},'(\5ĮhKj@ZYpWWZ*[^ |AMM 0MD"S3{vawfwf7>̞|ϙ3s93w$۷os6fg m  A@ʘOi2\Vaa,eRaADʲTڕ.+r%CuEI;|Q @@@>G*Q޸q]O7X#`{]_'R~UChO5 \ʱ ^Cv0E$cЖ5SBa1<.h\    n#x}G     (h}E8У`Pxa@@@@Fa_Ux@TRQ٩Q]i p9eUzT%Bg,!14cftiV 5|,:v`>cŇ~Xmgp|RNJ$+ޱ1Nw5rfr?u)mE0cCFƚֺN~θv٧s>6fQrNR^ޖVqo2PBNø{ͮʟ 5ßtU[x(pt0Z^}1&nݒHC1셣؀c44ڵ;m^'V@3%bxz ]8K7TLY00,H~$ (@-K.!>DUYth#ţk4оDd盠bҋzraK7,2߳\sܤ'd\d7T%*Cؘ}_Lsػ3L.v|v+=C|#\VKR|$o%pXwgV_+EШ3 }vV ~®_^lY`"_ђb-gd:0dQo ڕ7Uhn$,Șw]W7ehad֩)݀/ҍN.nb].*q۪:UfZ Bˣ;M|[=_>\?دUg=ngzdtinnf?sT⑫o_=F̵۷YC~0uf۔ v5gWޮe??q|RI٫01XƶBxܠr'/'WUA!o=s*v1/7E`h0V #`CyD~3]°` ^d.m.lЋ懂Y? ߵ]t(࿿,~pz1ؿgF$}VQ~$dCq1JsBq{*JRaSLzPLIiSw9.?.om׬&9Mww6݂7Ve0 {+JuOoy 6ϫm֍ |`—,_?\5(F[G A0a͎9@S\:^QUlӵd:5ź J̟FU(ҥP!+US,_ێNd~KnP7\]v6opl]${&pgӻ~U+[g7݂Vt*?[үw%?_Uumܐz'JO T˺Oˎ{Zz/?t.;2);⣊^,oEvb?UsHn熌SÚ?o͊[&'/ytؕÃs\ ̏h&c9/_e%&+v:9_p]ޓ=7',ynٜ5 -q㌯JqoSSO|;SdUC{e('ߙ0 fqWol68`Fxnhd:U$qgM뜲1SXG1;L׃ܚmҌUe%SUemIڞؑ_ʍrD-}zn(&m 6{XTaPxn@c3yCp' c|.0(`}2W_co̞q;<}H7L,Fϕu?dN~E7WtX~߱etaZ\y߮+ vV]̘^V='щ\O uˣ- Rc%Q+_͡>/{WQk>y[^V\ tr<)_l3U [J֞Sgzvx-6=c7oߘ2ckmB_j=2>ަU @@sƯ_ ң鴸UeGmp~~~Ez1 Fl~o'^"/>\}W8>{JR6>'Ɓ/cCIuE$fe.kH'ݛn<-ͻ? ;.)&'YXBάOG+d:F}\r 7)/3x|)}{(:hegEӍg(G1ؽ0^ٽf#^Zuת]ۍ{loR-乳Y~(CkSӯӪS”hbg=pkS02ދVT F;pe]v:=@O8; dh, 2(AܻA9.|{qb׾pnMgswGouV*杂%ysjG 6 ’JB3yw{83yr<uAFRNј_ ?)9]LkCR k8_GKKW_ҫso,%ߨӸ. n%{w?2`kǼ!~0b%gCm (PMm=]UlE^U]EH?lOuKsı"iSam__H72Sv76]ӥ( x:7 >d4g WWzg>q`P?,YOIY&EgG &g̼3$ A@/\aM+vN-~qW>y H#vxeUғ\]]BwO_}x+?wtJ_m3h4g.ݮ1g~=9N/2*ɧ~;7+k5m7?R(s[C1J=|Eny#y3t5 #SKo)xf0>Xz&oC:_sVy]W|Zq_(zIr΢9͢3~ئ%`ii}muhFJu@D/r7!3WDKiz77o?]]?wƃW>UeK5[VA4vnи/Ӧicٱ}>Ë~e'W>^zj!}v& ^ȝ,(GNNʋ{Ul@~!t[5tCW Gg1q\Tjz l1!2TKՏ}قzы?|Ik/3i~K[qԨkȅɨyqq4F7ϧ%7~k]½ߠnh bݎϯq]Am\O1ïbQhU]^.((qGF})qy÷HHqgc)lк>X`z^ZEEnN>X=%"s?j )֍9D~޼7Wc9f`tZL>X2 Q.W;3%4z,KIi3iitr&}/ͦ;SiOw2BN DndzڽB7LN\p^Cv1E$cЖ[TdŁu}0A &Rܒu^PMܐbi@@@<g/jWc6TD_"0 _SH  IZ;&`[7{߽MA@@@U4pLAbqlR*N8aڶ6jD    =k3x0A-hBۮ*X@@@@[^AL `}lfX;J   j# 陛4 @@ s L4&O jR   m=%i}JǯjOo.S5|z DZczyc @[FL) wA 0MY⢻0~w  ^_A02] &5W8    `> XTڮkg_([x]N뛼uOeyú|Ī:Nr5$Od )2´mJ7\ł,jEƴ0̽)Q=&J80WA.se~(~PkOYQo2+\F⨮EZOR2\_XLs׷MO枦[M7E,/=1]@f.i)qi^VYP䌵EUDΫyE6]2sĂ֯:9#[ݥev`O+߶@VnNϸ+.A71 ^GBkƞiVٓ[cf}y 4n^L9lmW-8qΫb{7#}߼0pcGFЎ ](~w5@UOS1_mnCSlTDK:p3-v^>TP y؎WiF<;~i7/T]D.H(@Pfèw.?{Pynw4k׫W>C]qhJy!*硶Oc|a[󥂛iX˓W_Ɔu./U8ߌK^>ZA"M^Sz2m=Z>h|c\18`Zb(~/0/=:Z@PLLϲxbXp۷8BkfIL$y;VRR"Y~;h`W !=x,  R`oJ-ش= n"5lգ24sOLxvvW+>!!APW6S]4)ҮTpe.vFE͊#iNa>Qb̸8yVe'?c JCFr6'ܕh$/!^^}]|"1Ү,v0xX]+-,<~T[>M@ۉrX;oIl8;c]_5`[ASp;#(DIiܸ+e ȹv{bb"aaa*ԠAqѷv+- Mi7 [u=rleq}׵$}:6R2>WyDZ8R1MCFym>pvRX QfWXP+=3}z-JX$5$) =}4KCa9Ck6>K٢E i۶ŗH   5,,{weB_ nZ; GEEIK^П2"hkWӦM)؆R|2NJ ϒ/\0gk YtNx-j9]0  _[}AOzih-ި%wT7)f׈#=$E>-S=W}?i3>RHS]}ʧmuڕ~ 5kVʵrG ؍=;,4mVjW+'Ѻ_ӫdG>xυ,g\07dYGav$GlQdž縲Sc_㣍q:◱o}co蒓+ a/yz-|Scǎ9M@X$"Ч+5jԁOz)~ ӤIRKM0VX#J o@ xQ75rH~qWy 95^ҏ?[<_R2(Y3ݿк54j OtHF 2-ů Wy+oܧʥT%K(=}EΟ?/K Y$OFkBbaaa%%%)PMV)+b7OF ^N{s<[]P?԰|>򶾙UIj6O.̮rk'=[w4.1vbA)1US\)f/اpGF 4xܕ߅WoQ{DF5Ǖ.,xYvQf[:jmL|Z"G|Pʨx   4kr}+]H̝mW~櫫]7r>wDzY)_Y&WSk>uC>cӞK~ї\'{Ak9:0g׹KozyuWW[jx  &r@ Džw9hnqYD66?>^= /O_8y9 bPXQQ1U^[C⧔/n)TH=%Ix =KJ^^}."0R2}E,]o9@@@@tUįsr7   `z .֜j 9@@@fkˍE`o{$jI{s qP@3k.k)iO)um`G%:3{[{Xm WndL2t%o7TWRCRE. Gk-&_Í ؊>   h}%Ԧw*~͐ݠ 77I    L[|`=QSP@h} W*sٍ`LL}  *!d7JǴjFkt9UUeyFu _sHv^rMhIZٚjq4xův   * pbaSo@n\?v71v 2~>\ƌl+oKj~yG]||6z}WxQy#aT.U1,:q^}ƞ\CV?Ygٟ~S3V52KZ1׮]Xt̟?ǏSAd'OްaCqk#!3}䎎dgw_/}jۿDAXW\8rۡ]n֮oY>_,oȲ6v32sZ6Uc^(by;nw+~s$$j3gGEE9&)iq52K71H7Nd?m4\K^!MBBB(َ;K=I&.\ۼahRAE&/p֫V|/\./p}j(՜<篻_0Wfg+a6݁{#6cci7(~R۷o/))?~ҤI$hŋ1cFNNGOR̙3Jd)(){aV@4 kA˙Aq3 0Sұc(;5j@@@ WBӆ|L{o-9soC+<6-'W_9ӎ11aМAaCoVt/1qp'.VbA~zM֔rv 21H*ΐ47H'+&`)I蛤dr_&Bb"6(an@sVUsrKj/ݾ>vɘ i:3r0`u:j3,/.mٍteű='<<\LE3#7NXÇر#Yn;d޴iSd 4tk۷bY=i,/UOH:D9>fdm{4ڤZiȀNl;pNԌ |^Ł0ٍ%U#'gӃs޽{WR'´nn6]~ڧ+#X3WH)i@@J@OzQ+U?dh'6ۑWJO̘{b͌5񽝞||gsʸEυX;_3\CZ+W9hOWT=A5a5?ܰvIdsh#B+g]H EHYSH6^>V{yFH^J/H-:Xͨ,:?M%zyQ}Y;oYl8Bxhޔ> }zVSW^:t w)uՅ PΧ~^^} >&qm P,gW#Gm̝KS㔋y^v%]ʦMHϛ76R`ԩSik08PYdP3MVt<5)=2߁cں\XXD%KqgJiޏK͢S={v'4g'gϞ-s(%{=cްK(b-#w]Zegk̎R^et$VY%M)vyN=M%y xXշۗ."0R2zXwAkAxNC?mGIfIן2e̬Y(ƆD|&MXJ&XBM e[4`-[FgrYY\E$s#\H7}OřVmV,ӟO޽EYYQR)Pz:CiȸABJG s dY^^}>&4XaY5#Q#G}O-N vɘ@Դ)E!#G}Cu΋\N5cA1=!=5&    Vnům{vhZy%{ܲC #[wJ̮E%'Oqr@Mx斚p!d' `-d/e`^@)=lu Te?ۤDsKc\<#+nkܽ)9?`ْg|]j[70ٳFOP4x̵ꢘqZnhܗg Nlzs^UPY  x(06zO[ 5%5%pzMͭw W|lJh-ktSCF/$x/ltT@@@!؛Xsߛ37] q&/]vmÆ  o_*… Δ   OZTӦM8pȑ#^O'y3qҥyiE?>>o߾8p~'IpUpo. 򀽹搡U .p0"O.]ԧOn7%%$[aV5k(N%Y  JZS[땕UUUO+&~m{={4>3gNMBz/!% j*իV;vV7qՕ><#Ni6N<ټ :i& W)ƌLK,5)InҀ& ^_ͤZ'U4쪎"^(ı5L ּC׮]YԻ ;)xFK=i$*d@^?k,&C^y!dM2EJb! ,[FԖX٠j @@1'@.ܛ%$$ `/*׊*'&oi,TB 6 cǎ999$+WE8I l<<3+l,>--Γ~zq]*..fKKTI2)5UpCv {A/]c di͔m+"h}cق@fő6Nꟾ&vSR͛)@^W䡔vgqr:BK4*$b˫oC]D2&PT触M) ٮG AYH#9={l?x }`'Mv255U,G9QQQyW_tFS)14=Mo&)Rْ4;[~:ZS$ }Lz6 h<TOBT2[ӓ\9FI&|ZoѢE%֗6SNHKiA4nX:=^G "@}@A!'3շ |L) nt>mgw[;߂ KKg5>HI"=M!4>[qă=RC{XHOrr*In* p7O@^RyKZ*gT۠*injS'~'oڴ $֝y&{XLLθ, =K  P&bXCj,//.YN?g~V٣q Z57N A:6RŖRR>e{Sj;:aow{   .So|Zז֯~̴* j{Vc'{žbR^JJ~ŊO/Ȏy<}-I|bYVV  NR  wFMO㋨]BuֿiӦ؍7yf+uƾҥ އeryGKi@򴡖^%36kcYط1cߔsk,RĈR÷؏V Z$y?jsU^-%͵͇sс#V4?QjCmRٓ-$I ϣ<~89itAoߞVП쥼g٤o;3n8V[`^1e9XPѣi!KN KCvWs(D?*ܬ4r#~7lL|xΠ-E%I2e5XTMCx϶'Tɘ=XFUH^ey%3F, .+\CkjC/VdLkdSӦl]Z{WYԂVu!h>5F_A)Iċ5鼍_kc"͈=oDOfF%9/~>vɘ@Q*6(dZ2_ $&)Zk`l0! 9pU0}U5zQ@ꩦ5Ov|"1yOMR2ޥӼnӤ)f]UyWU^}wG D;'@]jJͭ)1Wll,ӎU|ryBWΙη@5@@92sf>M͵V=h} YNAz -/\uۮ5z; "Y-"tP?+ljgn RŴIca%ؕ-Kk<]Uv4E$c'1Lh(dyNƭm3`fx[>.$ln  Mk״5% ?"|3*މ˴apSY^܇B AYpx}g @^)l)1קOƠ]Jl/ >vɘ@PrԴ)E!ۍׇtXRvUhU5k섄0<6E@@@@@'̜90@@@@@< pIENDB`nJɼl/ti@g7ABPNG  IHDR.V7sRGBIDATx^ \ZK IYd -f3inK!3+E??2˝4t;hRTΚYN{9=S|tzy}yޟ>96 ֎_@-:'69/|\nn0 ۳͠F3l! x(VMGQ @Ը:B@ Ըzd P Z/Zjh ^Mւ]Z^mTmA04@ PM@y\U5~L'3!PF|x,n<3UÀB-"LYhFbᬂNlB@ Ըzd P @@' F@ G#c*@ :!`5nË"!@8^TWPzEuqj)zaJX/gx1zaRX/E@ q+z6X^Yag[;n9; kI ϘXήEE6;?P\NRrl}^J$6{Z:[RN=$zvnBB7[MҥAs9ٞ9ǀT0-gK\H兼YZ *|pãęQ{\)L>L[9S sJL dźc{#OUb* :Z+EqRbL }֤ :xP,$fs=w/fF/L; ;V1PVytI>Ҹ_ Hj\?sI47 7"iΜ~g֭& !ՆAX#X$-Cov{5*/`T?rb\yM(5ZHeƠGII}Qhr`髄)k/p6|?phqB|- wqR7 \cp.T6YOhZؐxºT%Ȅ%4إ#tι$gN+WP>#`k 'L^2mBp:{{zɪ!|)8{]Sk?u1a[[9nm?Χ~΂%D|їKr0 )=坫# =xNxs70RBo3*B]kFhڌUrgVn5?װ %IQk|h}瘥/m|#1, N/ΉdD F^aVWp(6HSn}v+ycbwo1h9t*%-gmL+SCe#%s%AуpjxXŎ)z%+"sw*tbօ:#~+cS{( ?7UWۙ)FIΜZ܇gSNo}oVv>%R3#YMU?., 2@ᅯ*o($rkȴ+$֤WNś]\229~̄(s?+%;5#Fӆ 6VK4X9QFœ%*kDc״=* YmTT:a: +3fc`w_bt*ڶQn=>Y'')8 o&Sא\|)[xK՛nqCSap}L8B=H '@.ξcJH>F)UB}xoe_e.sa&5H۟MۓR$]0_27F?w`rI18M5ZuBm:i# z8(&6GWWSרWF=8i7ɱ$/B_6M5=&~3lt}7Ʊ#Y)a, sBK,uc{rDIzǨ Ư]EG; `O5oG*W>6̴@?8a_;-)Ö ?zxX-bգ\~.m7kN<޽LSH-¡qFԹ۹/Wos^7 YSvdZl²_xz/ԮG(eOd'w(ڸ w}\^PVXח><U'QM L( gfr4C'xyQY˻K JPShP;_l0Q](^}\͔Rb˱Uir2+Cױ3qy=}NllV_ M,Ĕ7ޝZ[l&ۇF.4fC-%m+oUR%ĔSm ԭ&IsQ$afKs͎.!ОP/BfKG,IyvdNW^#9%4&A<Ɏq~ o&6G*~,%q?fe쇌IL}].^xʱy6oY*FRLv^=5xArD63ُ޳C/bmsnYӇ`ыjޏ~qofDw~놪oѓ;kf]q.\9 b۾ضͥ `a'Dغ ݻ`afJE Zt:Ηٽ0U=vx\FaYwkGqX!+:v{ZoJo7O] |Kxt_Bʞ1Y13Rnrȡ!tDe9iW0/.߇@[-bmeAEdi˓/@239 o=¡oX8LZ֮{vӖ`e]vUʠ΅8&[/eCw>elXk:vTV{Y񰬛uS#ȥ[ek(:@$E&^mՓW~+Tt8 o3bЙǑZOvJ>O5D%\wW7X: f'<42Hs7ϔvؘxg۸[ RKL+Q3c-qn9$;:۱OFM6>v}Tι5̥g[pndΡl#r+-0EUsj$gkdSuz&aha #B%?woK>Jr]v_aNxk;4r#6ɘXvfR{_6=b_1{*E h)NqhLO"kjaa%[7X3I#pLS񂉿m8|Z6}S!|Vv2cTѷӦbqR13RMߞ.~gMd Gt *Чlqu-2q:ϻs!gыU,0kʗxq丩9fT.?Ph;ik ;]+nӠ)E"cěJςKs~驣{b/[Y||m-uUu:"L滾e=Nِjo~:^U_;yQbʓ{'ۡZaOH.َ N5ޱtc0"wQ;#q]R N=۳תQ]̀Ylĭ[l/SlABzBa%-=| P^[gQϨ*oURu Q$y} ) |D"l5nCŕσw^2h|6œTK`uB5 z4)smڄB L,ʊT惨gTLO22G=ha(Y WA}}SR[|fcPLL+%.ŧc}#R NGOY*bt|,w3c7/Ԁbq(KydGdpjVMNC 66}P̏jAg T`;Ehyۗ\ȿs``_2*W$ ebQ͌ie/1ፄoNw_s˾XP:nN&CeF׸m,2S|Ķ9f,}˰Pʗ̷AYwQvP!d^,Չ D:Iǚ[MPnhVEO@CS7`Wnq~W'BDlAbEN-SRj[cg@5IeIh UFCFdrEvFl, /@ Ҭ͚MZ{^O/XEś\]8Tşϊo5?Cv=|%k\\qmFKtn6FP-Y"2e*|6Ccd^Q8jHh8iìQ`)ET-J#Ǣb oXwxYU[G5^T"VF|?>Dو,saV 5W>"M_}a^}A5` Egp%]$,}p|.c&* >[z8rߪ]R.ZDžk$-XyN@e[-~]ukq8PM@&|Я䏲$,l m&veΣڅd^gOn- 6 tzGl3)xH/1>'ĉgO鑐N j^[W Ը'Yw7ܪ1oOQKOuIPS;zDϺ@n@cb<7>@ HpmϦUQɷ0zĂa>r>I&&$vo]a#~ޡ߭ޛ_߸$Sɔ%BCK `XJ4@`<7uU@ Td jyW'!@ Ըp6@ R*\V7$Z9XxfևKfIZ#lZI>H>nz@l~XaW.@ ԸzaP @@!L@ jW}IENDB`Dd p  s >A?Picture 1""SdaB>/D@='daB>Ǹ?xŵcIInn4^L3WSc-F+)"("vXE齃*EDTioy &!\>3<6e;3]kRUUuÚ]Bj;?nU.UlS+7RlDKT}qUߡu]8O?W<@=*zy]K?QBA P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P( @A P M6EsssK91]oܸ19GpY'ҍHOt̟q<>r.9ȟ=Ҏuqs}:f͚tI;r$N<-uKyǹsr!vui(h~$qp>PSSíW F=R@ f9#65uQHx_|ӳu5X+ H|Xͣf0$nlxߘS=nW$,k~Tӭmux;sy<sI>u%?ϭrG.׺z4ǹs/kXgsNȚ먼np/Osc~t#nڵS뺭y[s^0uS'm\Ґe4mu{I}0%=q~2s,DE+VXre9uIGD>Q~^Nm=V(qwY#]s05F92; 2rl-/ihi6|g9n MMًGԇ ɍ nt>m/_Bz?-婈F^Gbcf$9"F%k$OUNt0/Vzh\ep}NO=u|yZ0GCysu{vLm]1ODcnל;kRfE=WI]/ե!1{"NJo8hRe_z*z]@'Z/&bFX&^bR)G2bUg[ʗ+u[PWR965թm/zܠ6֨k7?~CFqSPz1q֒SCRFӑhU>k֭='9t.5!Zi}G^k7|9N˦| M^:ksDy}\}l-'yZ%뱟Oz|s)ry93% tC6sQokMqh7qkp Qիh>o/ۺI /pHxSDxn{<ϵe}=KwZrN N9ǒ}d!_/G3ːu;#SϝGYNlg<߫Z'f]HGK J|0%QE+ +k'N+PKLV)b566NkJJLBJF۲m\K!zm7X 7| 7c(}h&?ߵ e2Zy*xsՊ-TugK?x,_<Dzeb…{xgcE g^KyS-X f͚^$}6eʔ6lX92|TWz?CO?@ t[ 4iR?xT>suy-QX :4[o5FO=EJm^OC;3 Qg\Gmi3֫VJ3Ϥ1X ±k0Ge ~ӧSi(칦1 -u2n G/ȉDe;;On0h2t/rRҥKS۹G1`\xRȄ>nC/Fx>Ɯ쐙Hߒ[a0v<,7&rnc.kv`Nf+U|RqcY>OBg/j[9Fƛ8>z 9 _Mآʣ5 -S=zU HKRG"= *vm^% dGz~ΟS46SV*7`Q -rGic+M`VgωȈ-: ]s1ğ?CG_*N8t}GO?qt9W7E=é?=~򓟤roE۶m0g.73L|k_ N0!;,=G|;Ѯ]8䓷A>}_җR}j׀ZDsIeSSN9%?nHpgF^.N;-~7w'tRr^q} -?@>;.V袋R·o1=ѣG裏o"yڷo]v/8GSNu,f}/`98R>XM6-qm *=zt*E›qHyDWY8d?SݟgS{&N'/Wd:S)n+_j0n`8;ゲc[nID06O<4?:N;SNc{d1zx})d9~ p 7'^{m R7y饗z d `ƶ\ⷿ!rP_޽{ c~<0ud{79Ce߾} N{[Z//?*_~xqEG]=\ۗbΞOK ]IxѿqŇx忈{.]qT[>C{g4#y7) w =z7lnD]veO}S/~1!-ZOsMe; zK>t >9 L@^t͛~zR"۸|HvK]c;t0Bgt.x}K6Ȍ3(% fO8nñ>(|ePk#wڍEdqӳgԗy{R:+6^;Hc>g,:W`NG_>q#kc"9iaG1i!u2}eh|ȸdppįe> {"k"ԅúK^dc2 馛I3W;"|䡽؅'0acq ߹iu1*S&F_x^1z8)|{'kO 'u|c#-O3ш% @3T>!<#!A QbMձb.6%cc+5"%a39*rP{jbZK .W\&}t,zlL}c~6V<1c%e̺2r\iDcr=q]cc+kOݏE*3k؀`[ӡǙ~ћm>ȸqf Fߡѳt !2 ݀΢||;̹2 K+mc=tQnRؤL&jqEǃէ?O uYԍ>CѶkմ;u9<Ȥ+[2n> 믿E|K@9[5%jyi#i2-/uA`1IYW?-vDFK:Kϣs9/Hm2<ŋ6VKp]Yc0i+-,;˺V-!/cC|;wҥe/Ϛ>lD6(׿s13)=1]v!{ƄoɎ#Fvxc U|Ξ)|{D'7oM)&NPĢkP ӹvVxbЅԐDg#DCcbc}WĆg#mOQ#_Ff=mm?n9qq]_+܍ ~+YCbgh9~#gy1wX1ga`Ή` >!݊%:_o2gux2_O}5vg$akaۺ}o/3dȐ$2hu>ʰޅ_ >|vi3@]֍`>u 7]쿸N|s7.5k}4PKֺs'%~?C,ygu>8 [81 A_Iwa!85ʡ7w/Oyy #9sX+SǙ2G@sq5"}BI'oM:cgۂ>md~ 3hqMغ >5Vf\l$ee9<]$hmg1B<:kUcTŘU1휪xSULX:;#84?*)sʜЭ*_0E, uzDP5nV-}FɘywX?h^00f8_H?ScVGyb^Фk;q$T5ZMKiKgqǠoQw 昩>>w#gQ'Uł|њR:A~@=;u1uvc~lw[o(bI_<=umJ?;4ssb?8 ]9@\;֣N밽Mp壃8Z?Q }=z_G8 zslH^=&;s\ ]i =8P>{MqI[7S@ ׼Һ=Ng`Eg }q 8u&XXi7ܐd諒VLZށoqnF~pmIOQW|yqqN={m}J[:蠴Ol|;vLߌG2åx~Ƿ~bqqxܟ`7X{<k!s S7z75BD6iɿ\n<+^|tL.Zsbbmv~TERF{ϭnYϾ3\xobtux8*p/ޞvZUO{3}4]tH<Н߫_lL bmCŒ'߰2%FP9\.]q}1.|`>='smyG' _1=#~_oHk6]K[86>"kpD6'A'; 6:pCaX9>!=Z\x |#-}bLh|z-& %!˶|9r3nHDf_g> e^1ᗒQ{)~Op+㌀ N~HOIsӇ؃~[7㋲.nE9[K`E[Y$G ]b+=uy[܇f)=z +)Y#As!1}/J|bYo!;27VnjނX<⒈Eǽ!::zK5^VQ"1W'hhDHNsQDNkVW\5QeXu1Kw;Sw~u-fw<"n~FUN5\X5'oRq|Xa';X8*-i }[W%1JkB;(XP> 9;Sȉc:up` ygã!oһ.ڷxqeNLVkr͝\3kY5~(4O&Lh͗Ӛ^fY0o#ͺ J; RvMY~/~"~<_hvIցu`7@[7f݈EVo>}ڋq9o0i߸ )nNt?&qwdg1iXϝ;wnԱSǶҺ@4YoE=|q%GGKG/'Odc쯉ڃ(>^|*NY&Xeˇn܄}#_AϋGiNF]zwe3b(K蘓m? 1{уot1qȓp |10~ {ZgыOnkj-\ FWGY;$]kԉn;9ֿEf] NȂ\Dҳހl֩`zۘjvl#r!σm)Oc0v>򑏤wg8Ưq@b7!/>(b_`˰ûޮ9}k؀m`v^ҳMп/4x"7c>m7X`B;[h+>s{c|#cm>:߿0V;-=>_Ƅ{l~8c=MqxN8A'gwS+㴧;Z264%yAsθcbˣ~fՔxb13c̠0|C;-߀spVW'47wSnr͟뻏QwvsvU_vޛSq5l像SMzPwʛcGI* 5ȡ1Mwh 314D?;Qi91rd#D[Wo7:]nxN:x]wX:s{maot6D9;/ ~p7>~`6x5\w+';OrNzfsׄ_)8CO)@yx[eܸ1w)'5ᦝq{p,}ʓޫwNȖ-&K kݾ$PgbLcB 8MO姳2g=awǬF+5W)JnNGA9.pз7VǠG[(oh]찐Ή93E';a$t 鶗-}Bx~yy.߭GdoA#;K'/kqߏΆ3(on e = YEw[\=i>1Wp ݴ|:mBSf-ߦsgr[`ƬGbwWdg ovL2<owҰ>qԁ5| qA"@[nwr|SaHk!sG8{{IO>d:=ii޳+50d#/{Ȁ  kWzX=WlcNgNgwʣ988V!홲o:L~PqĈsvMq|a$Gtn=q8Iu>r+9 v|zGԲa]{ .g6fI'/3x^QXfëkc#9>r6- kq[.1qSCloڽ!pZW:_n'}'n8]Ye=3W#Ɲ}U8/w_9o_oHc_yT*S/-991ot klywpطCGkw^@Aegݞw##MxC&~p7K0WCS[$dO( ;r] _&/>s_)wa`|Y`,`;y SȀW?u09gk1@~#/o3zȃI;#3ڳ-G֜h'sq}ʡ<#ż!cMy>nX'885^=8Xj-HBLܽ+d#.DD Wh2j%԰0uf\tѯ}ϐ=3KvͼF1]c J+2ŵ4*kXtb8qpf&hbs;O=1Ge1m#&5I|S];0XPĜ%|c ]rmߋ s=~@wޮpʾuk`kֳ^[$}KR!程ȇo;] m^t iбMˉv=k7z)kjD!:fL`p,3c[kSn#2`]m}c|_4;C{p` +%;n'z8/+u"@oG2 |SdJ*_/e zc]p}ä맜[cu)_oH8~E7ش^{8m/LKF],x8^3/R?ZڤsOE=V.O/ŗJ]F7k9Q MRG^n^wA13(j'cM')1`>}rCyGw=8֭)gX21sa^U[ Ox;bϘyx75{_3SqEԮռB^]3P9i =n:Y(5~9c:s[qҹsNsi'cxaۥ~ Lɇ񏌌HۘH;yG0qDg ?cPFI{c#?1\z;-/BWovd]͈ͻ 0==#.[\l~C&č?s'WYg~2ho hwmK, O^G%W׮IgٌcčEo N|K[b|/A4\p,zzNm+[L>q;mg}:s5IHV𝛿V泹5ωzewѧ/tz!"T,@O!_GNYW k'uWF6`t y|9g29'):Ry.=03l$v`gȄNpӸ>YΏ lH>c %8bnaI71ukbP#@\L6 iށ1c3w >[.|sdž1p/֢H.90ve;Ǡd|Ne< +w)e0wAtA?Y?_ç!B)pM֟GDQpvJ=ǂ^QsMybNKMx4Gɕn桎7ۈLK?c00$q qPJ?I,}DhW@+roWn*][̨mK~qtjj&2u/P?Цz ֍$v@ 8Q͓VNGwty[t=r<*{8-1,~|7F9g0W\(=MmW'8* }cLp l>DFc H@?ՙA ڍn4ݔ^ss1{&$1iC R"(һ4f0CD@g(c4N@g^x}=99Wyė/8\) xo tG W3gk\gh߾> m_] qpy=gÍ>~}>g0/>7_=~Es9 ??i/;zyKM?7t;<)kN^e,bY1Nm[lu-ηӍ!l;e}W `6/cV/q3 /o^vzN<Ҡ_nqn䇰/Q7Op~xtNyzYyy Pٌx ~ySP%.iX]mMl-.m7,&f|V2SMb[v wibsXW~MOҲ5.)zb҉]zV:MK﫵H_V:6eS~ۙMjSD裊wc4؇?if #s^6̻G8xW˗?M^y9?#qN} yc<* Bnwp~$~%~_:ny@~7x?"#S,7FP~PE;f͕lk3߇V Ԙ&X*-ք=![a+lle(sC A/ |vCge+3 ~^"*S!?g׬/,t[=c" l0|TBG"5¦F@RAyvHloJlj'H.NE/`X牘dmC>eF:Gk]^^xz^%$kwYfKik"{2>:+m8eYm*bGq~~oh:gf]No zi' nxmva;x.]1H{t[D;ebAX;؇.tBf i8 ץz'vח;>5T}e;56<@I|:9>7_ױpz_by潏1;d̳a]x<>$?{t+uX8yi3La+_Jrqdy衇.ȣxܝ=~p#=n^ySob^?ÿːf1'_'3EcN;dOA^b;>.o9܉pq{TwgAW7t}JkҌ*OpN (.)sVvpz񛶠'l~[}Mx]:O4A,[qX_2G^yz|u',~WMXs~>>g;'sz usb>Wg%!.qz|D>Exq?/»=` &yޭ{ܙb5x|\7'<%N깇zA>#:_xWQ$I-&_*ft sһ7uֹb]lIr˱EP1D|duIqW% .}uMg^ԻUl[үIɇ=]\I ]SN>۳V[O`X F ;lj]m5ｌl܀hҳl.:v^fSZ78{}m2:,v*:Y]=M{ 6͔w9$s 69=*;զ',1_p~Vi%ƃŽ] Pl3'Ǟ]6BOgǯ/59618 =<Ϥog.:N&\. vB_;kpu=Kz~cГ_!mT^yw#vsyiWuiCq|O\i/=s:c7-Nīm_WNw[(vK/ۖtHNӇb .d?V*v3w}SqLJL~}X!qm~+=#<p^s/M_h̘1XJޑ {3~[ ,>n~{y0f/.u:~b́qG#=dȂ^ƶxXo\}'?[}1 8 hq? :d X8]_x1E?…XU>س%|11kzk_3KefxV 4ҙ":Lqv,G맲5޾B[W=jU6KIm!;]"IJ޲5V2ԷՏ7NmgsgwgCoϣoews\kH6>eF~ 7ze5 s&Ig,׏8gٖ={w#۪niunX:bmIl^Ɩ5Pc۲jz":ۗK}K;p^w-R٬7H*|_Ҙ؍x(j՚ ;mL|Ƥ}&1˖'hoNK;axاvuzb-^}X=={Eh P9M ڵk3|1Lf]0drVC|^c._lugY1ɾ[Nvѽa-{~;z Xg2G,@3lnt?Xsnq=Ȗ~QS/>Tq:1'O҃S2X;˜6ߧE>hO}Gi`.%˝ݔyc^2|ڽOxOgpr[8ز4MYVhY4fr7Yi_{w_@ŭ49`P+ߵD|&L1?x ~V7]8QBgVZĶ6ћl~Y>,Y6||/K٦ S3%y}.7z\%smo\\1NeObh0}6 #_/M sxѓ6%f%2pӣ1uO}m6//U?򂬔}99a<8q8KΈBAUbΧL3~9Aeg\n[`Fs>&gqc<0ψ:|k>s77rPwXc:Q7';[4.wgO:{?&L}cny)Ϥ_c.ӆ }`# msfhsFlQV;pa>1cƄr2NQFM:xLW)GX-'Ry7liHʝ @Cw5=c<5#V|X‰4֑+Yj]7ًm L܌ث ٳƩ_ lP8y'Ut|HL {˷lcd^Kfvl`}묷I}edwO/|pl - 5;aHPp\@˱'1;kY.G|>&/XN8[oqvS cS)ti˯_Y)F;mu-tP=Z^T|Ivټ'v o6Y2_M7iAIr\t&B3y![ā߷ld},|o?w7+gRFŽ6եz=ڮ pqһTn_1oEGa/qy:_(a8>߉J9sy}WW'(v<y~Աq&GuiyN1/Յq7Pዼerb.;wSMWo2=ãQu e <#qxمy/;5~ k:^7شMth<Ȩ<@wtq; &Ny4[7'٧q:O=m|ٚNW.ֺnɘ}3?/: DΞTy'l,30 W'`\+25ćtid&PRUâgn+sβ?Y7Z+rFf6} իv}fm,V֪{lڣ,:k珮vb_ s[ѳm1cV is5OpMlyS);V{Ѧݧ+ooߎɱ_Ӿ!oTr+j{ ӗvhl8Ǯh><;.(Ķ5 W(.s w-}Z߳=ꏽx'j\<[shZz^1Bkޞmϴ氏|+v~e +)n)_[~).-:6G6ߝM7?cbLJucyQ֔s,'2&>p{_*Y$q=Ov w~7{=zio,8-T{Aw ?q?խ: 6Yư_*[n}*Fcl~kD:`uD e<)4Gn# mxwf"{y/)W"|-q X( av{gOPq~#N8she2oV/Lه[N῿&vѦvzZoWl?i;|.<̧Ƙԩ)~3Nrr8{uէvHFy>_6~F&6Z>D2֝նӭGs+Lk dgGo6[3ΎnmS'%ݥEADx%ު<Mch+#%>A![JW!J6,+u- V2 wyS~G[l)QY܂d{y*=dYbםO*H^Az1 H6=$3I%dlx<8y-s!M(wqz 'J\τ'"F‚l>`q Ut2mr4_@ m^uüf[fV0"&mbCou;}ֈ=se7o| )ͻ%Ylc7X/U[,m>yVs[()^㕚#,3ۤ3m,JD awE!ee~N;سܤQx7s3;K9K~/>v4#{裪hCOR>'+dZ5C=E}- d<} hbk{5$g=s/ja~|0[4vU9,-\4o#}FKfhy[6_w1{ڴɣsv( 9 Ү}(r^ Xy_>)Lz61't@a7k{Vs HIPUK2jpj;s @Lwx8~Om5Mx^w0|aUuWcY= OBl#` 7,S? E;~;J;]cdK{rxOVm( SEOmtM~z:C<\jlsJⶇ1~SHD7Wsf+XڇuieMck[׳;YRa5/f ssuBSk<i-rHܷ*xF<4<+1N'bhOIt~Gl}tlp0AGuI$@)"wb@X\R&:.K^ryBP2Ca&LWTXY%-@ nUDfhWϊ //x%z?u~|i5ZXh!ӓ۬c4|k̫šu![&& -TQ& 4Wk'i?ԎMlsǩ|aչ:,yR m ;Lk*a2Յ´FV9}.Oa;~ 5e(-#H_qnWZΫ/w6c[gtt]sU#P{]l P"oɃvX f !lv y6T(W#;CFk ӣwیnFHG:uvt.cFľ߭-uh"L6+jch߮yeFRoiLV}@6kMDvTwK7ح#W1mX悡R,O祱kY3'tv+yZ#*)^xplƫpΙ'-Yr\$]&;4)޵ъr'z}^isѺ~r/e)a8gekkg6OS'l;uy:+=pRw71ΩS%m>wPjK"3BRI?ÁĶuӉ0}0N$g7(U;t9Fʚb}GV8ɖ?Oxe",qB8/"N0W/IL%e|=&Ktd>~_g;zvO+<'bK\/p\Tewp!%O%۸/mt|& d=[0ipa}:!8% )H` XDHNK rr#ݪSGweJJ$JU#6CA@PUs2l@zŚ=_6U a|@g$lXޣq/cS߶o/=v<ΙTзJ/rtJps4'1G9&vK#m^YRjy߭qmBO=@.̮W ǏQM@Rߊ^nظGW$V~}j>oY*ճ> JB;7>*O{Ժts6u#Ykn C C` QM>Y7ֶ,|]G?k{[_(iܜ]_q*9=X:C1f6}s2ޙ٠>:#KvS~d^qi6J4s/T1ޡO_{] HNޱFW]xT6dN '[_Q\1,ExB/A4U jas6 .  p!{Z<&L d}9}*!i$㯊/ohz7gEa^:8i ʨ|É;6QX?4&| %n/ L_!.&OT| 6 Ү!yU׋QooJPPX uGm_>e?I y/o^9/*\I?T97 #?EO!?'VU9:LJ~+<؟= ; y{"Pf2LwwE>&gyҮdvRstaew"}e bl΀/+!67-9!Wk.+za !'l"<NzM*BSь ٨Wۂ -4VB~։lJ،(Q?5&9ߡo) ?lWDgaH٣1[vgZoIxj_@e{1Miw%ݴ>L儿|uc X"eU{gtF팱O)AH OiႱ=TsVlvPڳvhl|(_{r4]\ՋYzvnoٴA-4N=+n:z;s,^HԻ W**' Vmk>qeNNw}Gy~/܏ &dy>ͬHXztfj?oH+ =k6ut&{J{7mnw؁yvdأhu?~N=8)љ委?m;mIf`N{ZIb;6OgŮrM8o6EʢA{.ywy~HwBw--an}-|cӱֱ@{g1fRofV=戏ax)=V2~DMsuŏ+?s5*+N&UTY:ͧUW>jK%V74FhI@f5mIÌa2 G<"&ina]2u;,67]۹er$BUGolBnDiU* 1;s$hܦMڦNoozftӸqlcl6Y^` D{ @$yt4z;<'Ny|^9öGW1qrCN'5.sQ h1mD}z':AóMU@>PF_ )Y}oliX}[/& }Vʱwi7M 8M׾B> pcfzz|>խĮH/RyKGAc,.(0Wx%d~6}"7 1c:Kdgu 4o~5 `[?Ƿ&k!gy<>P{{ MLx vt1 0jKC]=\cNB{ P`SxjbͣP3\qT~ MW;}Ulۿߖ;ǟ!b0 I|b>1MǞ)lVJy}X3'}QPOQ hkWQLOl"_ص+Ag}cnz#-vu5_6ڽa {<5&[[w%hZ.Ž`C uh~xmMkia=^kXAٝ15@eW{hf?sކιӇkWmlmWa ;uu)CpNؾ2Hnq{_v,6|nѲ@gK7{3j{e65l.YOK51/܈l hKYa -w nkE[o\l< ^֒msmum | ͏Ȕ̱| ׆Zvx_N[kh[CQ> i:Aka <ƿ{ɋw]0o9Vs:u:ndN澷99𳳞.vWkw:5R&@vT>6[c= 0ޞkبڄfM;~vŮom :"2Gh'J!ȉ"nXbNm9&2dBf:溷W_Mwbba|מg{-?:ޭ`.$)Z~/iM/ٷX(|3id7B+ <7CMRgߕl ~熀OM8w8ʡsk 2M -~-r9> :{9~l%1NfXW.ΣVJ̒qױOj-dEnȿs"QND,B[_G5l#r8b#vf̢бY|n:> '+(/ǟ?|dž*h8Of2u)Z_c tׇ0NMf_]ٷG`QYhUg\G uMYqGoL7=baPІpKmI=Cj{HW Z {Ϣ玷uwXYVzCevƻZf=[s|u`lD_oEQc$F>MYɮPVjAM݋ϢF7#Ff :9-h!{"p>r+Zߗ8 + c/U1J쫆(L['';{1ze@g' .P`LGי=J6vU9X-}j-,aDKXzS*rcv= tTe 3?~S؟r7z}6KۈoJۋgnl6 Z}b {닧h9} ̕6U%Pg+~~ޘe[ٖ;L gك9- o^oZ _fyn̫Wj4݄MN0:_䮒\ڎԑ"oB=Kָ%c/1Ivkg2 4A6@xKƻh탞w,]3]:"gkؙ㭘ssMTXn%Nx/e}݆ϧZ̾EΥ4kǷ`h-OF&=- ƶB 2r -('\hb{{Hmʤ%8ʡU]Kv\렵EVڎ?XG~**,pwl-(9i}=y%aC/KGɟcJ,lk=lTK_oX8!?c VX8M2n;lgkᅭYab p,Y;(^=9\1[efjbQ٣/bǟ߂_m(O P؎o$yC?jy^0nvvDp&\83Xrd)݅siƮ^+mV8 y4g:wSA'g+-vSKmgmڋz~{sqi}yUX؆ة30pcNjK$x&j+g_pUlJ9k[&'c}[ަDވޱ [ Z<\&nI=h?ng"^@um#؂^y7Ͱĵ8hIdSQ*{3q>j+w^D,e3wvq ~9ˡ$ vMm3,eICy̴WSɆd1}:bO w僖! !6/wGyX:~b;U6sm3Q}9⳶yhځaÿEn)Y懑%fg'gigYnt\Pnk)Y<#o`PVWgWYH,uV:V BSYKx&VKEF|Eu$B;oQ{|u0.r`g*7k38\Neekf;NzҢAq~J9#b}͇nPG:A:@ibek?Mշ#Si푯kYs15ǃ-A $X?Şa?n$'sD;4 :|Lvx|[o_#?̖ʹߌGY$},%wZ2L"6lotfUt'h-ilnÏ3N>׾`^==en0"76"^|؝𫻫 kn.Ե}@:G"ПgiCt`8A,ne"zHjS=N7}ka/-ܞYSv1t >ł6/!gg޲d) %H P8&;,X[|ڪ˙ gOkeq,\:fg\A 3'c4bqm[S9b*ZӬb?wQnvp<~N<"OH{|Aa7t22y✹G_S^#^z7ofz/0k=飲jP[Q^E3.9OZKҸ]\E5fEB'[)}bȞeaRb_vVwµw=%٫ؼ~̺Xx[T6-?^p%R~+OI) koSmx'5۹p; 6H؂r7S֒y>/oşh}L-v~}jxB(-ѫ],|׾{Y/MV|!kDO*<Z6_N؂XI?wN_{Vyrvvw+d/vÿEᛈ51z=^vW ::vj{=(*g0ЯfeNN;ӃŬ g:}];}{>60"+\i_E]jѽv=OH.I^sŬQu !d֥aQ#"Zџl!Ѕhj{,djVÐW<p?E{ج*wѮpP`_mϚ*elS}g՞@5(%r7/gy~U)бWnEͩkyExVuЏx,eV'37yۨ?σuLO# :3BW=m4{I#{Բ1ŐSʁ wrec^0؛/}ӪO,xxwmƮoyw(e?Mw:9?1:Ŀt!mcFpXJ<8g:^- ce~S"V};¿es _tՆ&4[Wc\shJv}]0q";T|iզ(ɣ_֚& G{޴"WkN=K;xXJEw+?tA 6/jIA8հ;AH:瞡xN9Lsµm[| e[f;KQTQs\sHr[uGyrfʃ^Orb|&nv5 (|ZG'ѵg#|E<{Vf`2ӭX{v&]߈M!+L^ sEL;+8:{UUI 8QI 4Al!ۑgK6"tQ&Z{Us'Bi{(棣`g0Iu MSs[Y":;jGu¨8cz]Zg"IZA;${;i>X5.tKO&0>_ٜezU9/pv"/|6Z27^}z1 {ea^٭ck?R Ugg?jQzg!~' DA ܵ.gkXԞUt wWI`[ޮF<@1͵]ii?տ8KD ^A+hÿsmr}<[u v6c_'Gp(`5C6St,C+^<{=kz=mj;Oۨ6W< /&G`>c#VLy:4xJOHc,L2A8w-& }ǜ}PK-a 3 =⭯+FmE3[eU1B M0Ѭ p1 Ҕ,[Cѱ3g\RDWd Uuߥm8,,t>G}4baL 񓤮'Rdc|a6⿇g)fb_XgO6&K=-XL?g[!B1G"eSiׇ17'.F2N;{:MC/b%{u_x#=(q4L%sv}l+~$HH|J?41}mi.:ڿ4n+y]Sy6Z/NſSv%>| 9;8;onUE|-מA'bKx>jrUI$ݪ pAJ;M%A|Amg gqBoϲw܈A7h h+u&ߓSw&ЍT䢣uzK#"rJQ+v߳۰jÿ! d٣&nkG7xhYoB$wy /WO9ڒ1az;9-tZFO]½^M@'>^g򷰆BdLtĝ+y o`wn-YgsۈםF[1d٬A4.f 9VOK::߯cwȰZѻrJƯJ6Qg4o~ 6΄Ɗ0ëfҮq{ds ^b38{D<<ȷ 1:{QVbpcxVPq nb9sl#Xs~9w%2-i.6|)+n'f=C%wvZTpiۿ>rӽܕo|2_"'vǿcknG?a1q-s}yO;ȹ VQ`)aߞknk6{C\esvuuo/2cY3@"r^;|gl,=pE̙lK۞n}q\#>3p8ծ}[ 13h#=(:: p+oE쪕[GR CUĀ7qrO<#'(Pt.H ky|}WwŭEG?{_uN  >,&N0t[>- z*~}wxK%;'ɥ(j7 8 oӺx{{|Ĕ'0gH;Qڔ}1۲˴s,򯴋/ -?W4ډ.uVsdn82A(ܖX9tk/:hߘ8 l(C\⌅Xv=e ?zhgr?rHc@s=>.l!rj:|a-X$ƨxf|NcnaCWl5"~ұy7Dvrsw+yw0p$as՛X/ ~gzEk)8Wn﮴7x}F wΟ)cdY{w~&t֯bc|pVrO,i:V0?6Ⱥƻ-"~?O~W'i#wxSgM\йqteFمuyK,ce_Q@;WK'8XT{9|+i Y)rv9n[רؓ93?B=Y'=[Nj(?yQX ᝌ+bttS5tD̍f췎V!GU%Y23c '/>fG_96ع[[݅;p񖻌C K(NN4Wqr uWD1ȸlQc:4ᕉ /v,Gέp:l1h=%ĎRl:+?=t\3qS3*|O^A3,pg3Al>؁iW:H]A瞩ވT)1;m%zP}*u y;Mg|[L෉!V"0]8{|BU#ug9i!#uqnՙUǓo:=,|Mr4N>zz,崃:$[tdR$aGa%1/3S:=Osbo/#߾U]1!V=K+{; {y IRlhq 1 pզYܻ{: T{LZm{g8GG_]ăE^': y v0WC]uXB.1f=gb_ϴ)Nvlu((4L=C _Z"xWOvJLIߎӣ.8ߦ$½ Sb rwcsu頮H^&/;{/҉;xVnYos ʉ|~okrF($[ uҵ?|to#nw8#ǿe稣yBKCL$]. ^&)_W͠_bkwҟcg{$ 'eWv0|u 5Ȧy}f3# \)#R]DG(!(7Wzg&bEb3 ɁjrG'QJB޴k7 6g'Nc Jtx)Vu1PJ]>v_ߝ'0ӿkfU:,LG_  H7d{&qo=[ ϕA 9ojWh*G}HOY]ЏI'5!P:U`oS(BP}}8GA{wȿRr+o]lmş92,bs/F:-?s?eG_gsK'bHxh"u1wթ-M}?yv|!& K@3{'|(bMJ斳v]yid;:GοIX rbc;(rĊŋe%vEs2(]gQ|.{AT#+=5籁Q"g?ع=y]Z>,!sk^ka ۽\z]=@NiԖ [">r v_v۳m$j t _*e*,)i3'WG7х͙fH1ɛ۷ȘtXzO  #?&O|7Z /S[{w5Bb<@.hR- 'gi'b ჋ !2J)Or|C#䫞 GW ın #˜#CloGxrZ) h&kՎᴵ| û3+<&vlW!8VdaFp=[>-ٯ!gnH҇KQcwNjiM,A8{˙~bs8uf69^rB}p6 $wsp/ۼݭ8-2EF~'pij)&fmv9:j_[so)o*-%r+pm< ĸ7gk|'w_Np~G~owXƀ&KV=8??MN Se6ImyVjB)E6jQ 1!± ߽ΡubUG7K|oQ-qf]Z ;~{%#-(ϫ7 QpmUunoĂUю|D$*9lﳊ,jB-Moߪ=&O@Js "fm^2f-9)=qcS6ylrd+IRS߇>Y? F_,?s;Wq/i!!SmʔA6qb ~F_7mآ2hF',/eRT9~sǍ6>f T%=Ut?s3eenm\8i }d=9OLOVtr$g-;;vVUϺ,Pu2J(YS{>mW6&kϿ&9~e;Xʋ4%xFCzDG~[G?ŰGq! L/U!}uCoy=m9q=VK`'[O=|ZluEJ5+f~oo y)Cv,/k׮~|JUj 1^EGl7m 1WMCYV4QsNB" v(yHX`5[X_ >R8|I5#~Qd^#yAB)'Dz|MRȯ+[AKg Q;}BvxvNMB$jo4MQ4q.JV>Oۇ$՘ux,bZ`_l`(r],9VuI m`!`|A<*Ţ=66oBiSyw$~kN~ ){xG}֪J-Ú=5c/~g[Ob.ai+8O Z9DzCZZ Y= V ʊ22WrŮh3^( owՆZw0T{Ps[G^=S ]鿋eˊ-9Ś% vgy}VՈ}y;oJxʷaL3eXپ#VV|CIWrXgQ-/?g.:ꣷo L kOr1|5c'P|R )7p]~kkLSɂv]o'ەb$? ȥw#G_xL6Kr zM9 }l|%F-ŏ]lgN0O8RWV>^O7ɂߪɻr\=5~wQ/o fXbmG/7q1!},׊OgHꈡqvϻh_Qh$K]:rS>uz*reO;v|*uN@$m?]~R~p Nzyj?u>|). yk_4~K&kߪJΪ?4i>oaw2{؊>*hpdA~#ڠ3gj1Vں>SD9uTP9DKn{m~x.wl{PVpЏ`݊f-4ffE#2n*7ٜwowPM&GŽ{f2ᷨM62߂ z*˟",[:~U=E囍T?9levlг<>n !YJ? DGc.o;G[> gF#kET*_(btL>)w H2|h"턠/; ;"^ߵ_ĉY¸;l 1I#'Ny㫭b ^r$F\å[h-V۷iD_Nj@&pێ6qQ?be;OzF_g-eK^@&.|"?]z]= >ɲkeP;Yؽx;X9㽴aퟝ#rKo_a3WȖ1ua<;??뉟1ې!Y̗l0*37nNp>&[ϜJ.ݶs~r/nT Mtv ?ߚwnȦW~ӆ3vbFVIo"̨XxNkbپgK~m}{هzrXQϱ[Y3i[ȻN6-v4}*> y;Bbn(.w/{Tw8(n|wOsMt <.}Φg/9&Ж᯶d@wN[m,Eov%_jX3 O3$7<ܑxs6iWlbWb{8XѬ'p/R]WxyX-}-y-=hAo}f@~%-! \|-{Xz96 ؠ@ooaw/?plzOe>2ewNBC'kJi5yFgۇb|odۧl"my>5vC%6~/WګWO>b!ol5}Alb Vߜ-f@ jL1{w)݄9U4tgռ.s| 1mE(gtL`ɏr[sV8y[;&ƢT=YτB_#僣' {6cTjfzΣ&i'/}x;;ktjG* v+~ܭ+hevOvrFy &-_B1ԉ *ѵ~`|-Ʀ=il(\7ʹ3fb>n?X7OG$wnZT8U`)w;s*o kآ] +RǹSEMAH ֿ%{!_-t.#)5V} n;ZT{D?Q^:5=z ƌy z/ر/RGl#F wiM { v~k#G>7W2ǿo|oʡSj!';Yz7^1P%Iؔ'cP=lɭUd"?|*a@ ލߵnu@Z01d'].|23E\l%IA</q/ggvv/v|/NCσ>K`SNt>NDPb E{/ޢ<<\bBCg. H9ѥEtHDzGn|VY[. g[k&r&wK엸߽[0d@-?JxeX$R~w#1W> x}w1'vJeQkl&nŲ--_:'oҼ3|H~ f|CVV 'SS;~w0x2a|O< !:Ŏm}HH{)B _֏r;9U6ra#k80G.l>{S05d|vOz}?/[a]4v; Y<N `\^ۓ?) =߸X9^,w-VҖdyϠ?z;pşm<`%cXO1&Q/^[0p|;;佮+s|.lS^^1ƜjYqKRhOvң^ӿXj)W.}uNe.Y]%j)H]>x_dHD"JތNRG+xXq2qxt n\UNxMAs'O-߲Y}}rԈ`-^RLul^ SKY غ7;??Mk^Ƹ]WUWJsqN]]-Ԁei}!>uZ\Eegj*Rsn/sb'3ka[K5尜@ q ֯n[6؞P`)[dɖnXwUn_Cٱ4v퍈Atuq<3UO@wd1g3_cOtË|jW֭"y C޶%o_eoאS ?0'`0sMI7khI| N0+?FIwߚ %y,70ކ=49?@1VX|9_-K~ʼn,}@}%J >Y"w GtŭIp[ `4=撤v.]i+˘?bKcF^oqc>r;~I^Zlx>߲si^ou@;8>9\ TesYG!g|+۳Pio >(71fAM;&VŚ#_BHYtH7.M9B|FIU~[݄]|Oֿ.f_/5߲[l'A.wq شV{W( {RS Ùo<~b-z.Sv¤1ovحS0‚^O&o:Y #\ pcxFcL˟=rv`+n:c-ȑבJwB-_uk+͸aAlGJ98m}Z7P/:' s¾N'̈́,rcB6|?z;Hagj tȷ~W-k.lk7RY؁MU{"wbIb)߿]kNՒ7&5@s!-uSO;^o)k4[6<26,Aco>.Yb#hb::# ̔9#˪iɇΣNѬ?iM=HkK1ĄmvUZN&_G Ùv06}Mv$tmN˦#{iMn N!7eĬQ=<#r<9<򽺝.߇>؂ﵒax:JmV\zt.R߫G3)`7^'Γ6}[w7(@ B2SX p3< UT5/~~g6]aDc{Rٯ~2+^>,[Ѷno,1;R'jj}*oO#o V:[;֘<7L\2`|3IXdk0DIۺAK*2  7u"GoXCbwV)V{ȶyoY%¿uv| Xۯwٶyzr:!qxZbjqͅTAk+g ?w{ 9JʞFٸ׉,/XMC5l% 9'K 湫Xhla0B< >ߛܗk;j:ėCH/.`n"e"DrVi!o} |SfGsdG%b2ck;w.w:qЉt Ht{.!CYď~5>e{YGvi['l*{t?s6hG KtӯJV 5p,y0=q6Ge g/`-u|N]>`;sgԆ`)=: P>榼7], L'V>ڏmkm~76q^<xm=6FXqmΆR^O.UgL[UP(ʜNdYw^XٲXC,W^dDSϢ.lGKL&WTcw5(ObȐd|9RهS.('6\ف7:[F䞓CnZa{`s挴eXlwd(\݇[ksq.'6l r޺>ݢ޿Va+@.mCi@1)\Q6M6qf+GGdCދo@cgH/.8=v8 Fځc{`C#b9R[]lIZʶoɣ\w0$c=M8(wMF+;ݶ-v*o_ ##wsH|/\Ǥ`ޛ7Zn49Ϟle)<SeL" >Q5yƓQXZ+`[a\Nyi%J\pU>B8ޱe;;SA7vo]f;チR_>]dy]O,x6́mg3VkX[5ꇾuJqX;w:;g`-,cځ r[i2IdQ8N]8K265Z]fUے 3$>C^ =|g8}mز>ۂei^!~`lRf#/ ?e҆x3>6'ۋ__.xqOO{z#.F~JJSmApkcW4KY-ƆEd c/Hc^;[LG_ꓖt-y36:sbfWkhؑ~oih/7ac8@V()b>m}ۍM=qdAKlufp}ưc1.#54mnB6^xIꃒ:~ؕC|{j>=C԰c'b5R9ƒ ew89Kd' ;':. ԙORJ翦zf3<[[-UғЮ)wR#ޛY'R\z]=ТHƳVcv^Oqzl7cGėWX} %8!3ō?*^WZ̴qs-ZN֦Q`Ѻ2ۺa~6l: vl|߲vPgHӴH蠫њ0jvx 77 <[OmKCm8x͇-j'sukG 7T7RlJfs~%v|Əq2I[/؆qq',''6-i{ϨGCOdn1]=kB~fyyqdF: u}xlOb'o+FHgGN׏}E>dKt@:ZX!ԓG}p$/ARnsW'`K~߈"CY=Pj@Kx r!bXɿBn K'>Ŋ|v/~ΐ=jYCWC[Ւ`ޝVRv1 n'Tq?1\ՏS K=)jc=kem`y_&J5mb%1v7IqIIE]KN!bV"|_P>_EdN] HԀTkֳ2_@M]QzCy(g*?]y~>˖k%nuy?6z]Ia72~v3vmمvxhk.;׍P*SJ{}/=`q!Of0sPlXoan$-#fMv2y음k qcTk,xΐΙ_'ؑ1V0&ZKH;׿#g.G]n5O~unbʼ׻r?Lyv/ ]avS0![sCmF6hj)^դMO3?E3wG1k!v2Y;G!#:>Mt":$nnأbo$v.zOBN#`̕ҹCQl ZS4bm/S?$oB>FkP+DKsLR<2}Njg{kTbH7ʯ[SlD¥4tJromW;iW؇2ӷzCųT1e~8rb+ƈӉؓh=2¿o;=iq{o#u{?:<Q+`)>wa^~1{U?O1:vlomҔնd'l"!7+6^sm.7߮wߑ _ڼմ2t? ߩԡx ]mG-g0|L, O]KuStZAr50:Is5zfXvkV[:3&VMݺ>̙W_x~Ys.!V̇\;(lޢwwM1Ϭ<~~dt!]R4" y[͂Гu);g[4};c>zrri|O>y9_%\lfBfDyD7*&S?W$Yv\]!k9!vYi>;|8;<|Ⱦ}6bcHit.68*?5pV>k lWG:҉){7/Ԋ,3pxx-ZΒy~oB¡B5vMQj1W{{Io:2RoZZ$Y5$Pv#0֛PwD7{Io$==¶lo7Om1b ,YF:Y[>n+Qr.8N5ꡋy俞|7:;ϓl[5[9f1gWVUY؊_{NGOX"i! dafgF3]Iؓ{Ά|Ro/%J:f`55r(ܿ㠝+QsZU[c{Y4:>#+A}L>.[..H^ENNYѱĐ{lpo,?k^$JžEe:x@tUTspoaB`6] ' d]*:P+gOB"8Mnv o P4yՏ/V4f~V웚.C:@-nw kvM%ZF)ښ"X z wXϓM*HB&NuVR"u^u%|7c꡺=.Eu)srN/=^&ԇ[utUCD3g!xm He`kK°I}NoW.קqHp,pV?K~In7n_f{~=D 1ݺK79Ӧ7UVZ!e%i;TT|].VwErCw"Do=JJt#>c&_qW~|.v%!@^$}lo V)4r=V.[+1ts~w.Bsk%HҾ?/F8R~UWR9P$V+f@fy1t]:_}L9`+]JY]k=UKS>^R+a>$ڰ* Y*u蛕C}cg^\!'H[Y>bHWYC\bohu!i[TKk: نD6"З;XT$v.͵o+uV]G8sk?p+Ύ{qYdCBO :gJ1o.}tޥÖ.Y,mY;%d;sI[/;VЛż:Z_LNƎou9`AfNDԭ(i>eQfFڕe\8krOgMMW֨fH#ǚ:h߶z9Ú4b(nAh{~M|gCVَGR!_Z-Nt a Οwܟ$gcBqݥ|8+A0T#<-- =O-/zֺkmr"H@vv3` -;nm[8xrOؒv/88f': d#e/KuSd_?4~y~+֘ş˦NvfI+;mkX:9S%=VXuOOBt.d;z"җݛ9YrW^f17~`.t u5bM!PrL Z^Gz|.1]ӟeHc6F u}[ dyski9>;9w&25tʊx#[wM5_#Q`T>D|.8zԥ{{LRG>'eՊ티v413O_G9Ϸyگ:_ G٤@+l(!j?-"=~8A<G  7HK<+@wJU2襡VPn4p'qz«\ tEʥz'wzm>/|]r&"ONo[|>͗k(o|^}/2 |3 u}*]Uր"WG-q?[k _\qG`D|̼WF+4rTAJt 5@ AoWS-KZaۆmQ OR^ȧfH{/ʧ)Y4NM4kcڹōoa|'Im a rm&4i]K0K70z<_O9}glml oQ$dљ u(coDa< )넂Qyrvv-vt-;IٶG߉iKKI on/97;Xҋ#K[rʟ6?ŏ=fϘBldk4g|-}ۚ`q=_kŧr,;KZ3fVat)ߍLVtG4W5h#.C(!Sk0O >zCFsuYs ~STϧAV7Sr]` >Ficއ_A{ `Xc,zL_=R^eYQ썙&ۊǹ؎sOޮ( O]e%5ˌFaY7@VҁC/ PurFŪ4!] uozFϻ9wg[aQY[7> g_aC3=/ѝPF/qŸu{W"s_#)H +Q >H&9:5RQ,K[w@#7ō/GҽWRUVsf" yx^:?=&y<.mBH|gkd9z woJjwWIq~uV"'ʢC=` *sosæEߙԯSeo\A6<|/͎/gKr?0vӅ '+~" x`@CjV?;Fԟ[T ʠ=j#>:/P1 v&BQ:W&JR<5|{s-coȨ3X(>heٺgjdlEY]0m7 [%K#~rΔ0_@~f3oRYL>q~);ΝwrKx6g mFۥcm4d؟ȫp+/ndyi4xdDNl`HٱB[~-<ΤxiqN`~iKGWd~lݏO aMO􉬳'y~xߨAVyޫDH@#/>/:lTMm[k -?y Sq:7wiZ7 tv~ﶲ\;vrϏ)elj'SIG# ~wϧAV߻uTr\fQWEe 烿Ȃp"2(|x $aq.p1 ]kc~'|oCUmuJRE$vߔI7,GCz1K> sx <"z=ފW28;ɷzh;!Hwz4/$2:D;ȿ.d"?O=[Hx6vS'NN^h|_˅Y;wcvHE⿅ I] ]Hd]bsU[ %~6ѰHe<'M};JbMEޡCxO -)G+afœ:EpH] _Dyp܀On,{W!ݳ O;JrS'9\ C??(J'?A\/snyTvҺBH#OVՊ["c騍wzyLɼeݽ&<WY(}q *%MCݳLzkSk$ -\9rK\ԧ< ur_Cz&@jc[2(GQ`/4\uy둶YNW[K9yAĸ$l,}1_23pejߖ8)Rde/(0=y9%G&"5 4L˸W&U!su~kWV~?H׈ӄG/f`w:FŞN虌ӻ\ԣxviˇ6*Ol5}Y19k6e?A^|QlAWYY_*cGk;FP}UZiySȑx;p ܒcVacm֌mڸ+b?-dT.$ǽ*V9uփ'{Ot|hYz;j$)3C˿;G 8\n͇'֭}RzwJQȈZ{e%s{10_O\A7qSp.bl>v`RR22λE՝ܞI,ax\v3ߒB\yF~M-*+NMUi`Xq/s۱j~'r%΅Ud䓇{ { Kߝ6`}+m_0LW0&0Rބ44@!Ȝ9Cf5H+QZuM'6BAhgM+{1w%O&!9-v/ ?I0sU-[{.(TQ9gya|]VmgOm͡=΢|F'xJLZl'~\s|:t)Ͼ{>W6}@'K83ƣ;`6_Ӑqǔc9>E~JXY[w6TD|t˪Pj"8%+g᝜?PbQL ^d=Ql\|*d`~D7$$Q>a|}bǟ>[D+ 898+ o:?1{5JfA[?˶duk,-%JVعˌQyB2B7j^g𶞳0:3a`1¡ $@GZIW0 *D~U^xӖϿ{ml/?f]i} ݁md]&?|+5[3d766 k[rH{-a W>nJ|m /|־)[5)[5Ӷjlل/Y]Enc|W`p:һT% F;>rjnC3>~dd..(WjWoQ]}>pڵZ;8R۬Z5vg 3tY}#<#3wT>~4P~&ߚla5 8; Xt`%]b+/k Zg9ϡ~M{ 4>`]Ǡ"&4&ݰˬ5e%Lzyt⩧x2bau.W 3K~ GBWluUfwʄb-ߪk_}Vh vv5ԞJ WFSe]l#Gx(Kmß$c^tKKqY\J~YsPi逧Ci%}9:d NA<$bЦ/ YAt>q6;iUZʫ٩*"J6,z Osz s{.Ԁat<;^dsmk;nK}UF΄f0X 4yDi7ȗ%1z^{}L]#?ʼbvr5-jaB+v317]b l<=O/_+ C<5@g7~1rhye[Fcf~FD|0tt)w50N:؊{;Iu$˲B'0tis4. 7X#yu!zpE!#/'HW gσVfQFޔwqb~GaP]$t[ߐ4PEWe9}^MMO#`M{01%BtQᷧTvcC~k CNƸ 7U[1v@]̶Vmأ oFxW)J&o)w;nxe8(J@/? ۮԡ|bgqLl6m?Ȗ,V^,v ;&eG|EE^A]h |v 8db̸ؾsC'c`}zLWQzYegOsY&2M>.Z"i//A: !~x : -J={+YvO |3rl_ Ҕ ﵌ؘF^%}PxX ;Q~;])c? *N[1Br2 .v Y+v|-6g_ISYK˗1  ~xUJuvc'ٛ-9/Gu-q 7j V;8*`L ϭ{U; әX'vU|W|nǣ!)Ƚ. =< ]⽵.*E_o !MzrQۈ;5w>yO:{]?}4 u 3zzDN\y7e!a(|;otحt~OCɏ? i×RE/izZ - "΋l֙F]).N3̋`_}m 75(MVtS^oÐ'/Jy8a97K7jrg4C,;K`96A\!ßG|p۴ifl V\,++˱3@eDYV _n7|Mc76]׈a'-b1 ~;nDW>(Gl2^RBVPFѷXv <v3|]Z>~;YeH![YtC8g[κ,A]=v /d7}1K_y%$+ *=1ʕ ^X6^^‘f al1ϖ@ǠZH憋P=|2\`O ?jQF7GSp#]Ewrv͓m+ȋG'ď>ԟ~ˇڡ͵w*og=$bu4j+{? *"5.ï^]Z(AsSlَ^;N_{2qG`b$oa9){ aWy\9ĐpK +%e^"&Z#AWVw4v5p h&]3%d.ᎎv.A~|mQسx/ "3>˗/݅ŋ>l O ,;~?~s7)ފ>no5'vXln> {Q$u?YC}Q=t ^+kgaOso^7 ow[줏X^ն<2ׁ3J[kqbFD%͐ݩec74R>>ϮDW@I~lbkv(Qq bgt~K7^6# Qw*xEd Xv`6"[?B l!AQuEh(EBdf_&g;w2jȻ}w9|y#i<8(dqNzqט+\Y֣8q|ilsyKsbbРMx'ާV_wjWF6~O&fmIҐIQ,902jޤc;}2<-]9#MؕNM.M eG۴m (Т᫪ {tuϞ|c@D&0"qn%lӻ[3 υhp*po cg/8)]9=~ɓtgWOL zQYpZu|~^z5u΂(f5~+|B>gU`\#ïΣlnum8D2c8ε(7WL,vLz&n!+ӳk1_Bq ~bupt1OU)~> JтCFTY?t(3\3|G kW{G-G;:"w[ҝߘ~b.=4_::B֔7q *xv茊ylX,r2NC(py+&-K=t`YԥBVVHmX~gj%&T/q߅92lwY'}(]8u5h_cnqBnݚV;&3w܋]1<^O.S8J5 ύfw!JE?1T1<uj3WӃ 5MͰSM{M/cOzp:,:rl98qKZ Un>3.f`fY灣b<aN-b{((|%}3I= ;7ƷV۱ $p}n,X~, l[=[Â! m&?6ةa"ڊQ*%׏ݭSdܳ90 Һ|U[rCo_< w:111 ~<*DdP  3 3"(({DyK  _Toc11930046{DyK  _Toc11930046{DyK  _Toc11930047{DyK  _Toc11930047{DyK  _Toc11930048{DyK  _Toc11930048{DyK  _Toc11930049{DyK  _Toc11930049{DyK  _Toc11930050{DyK  _Toc11930050{DyK  _Toc11930051{DyK  _Toc11930051{DyK  _Toc11930052{DyK  _Toc11930052{DyK  _Toc11930053{DyK  _Toc11930053{DyK  _Toc11930054{DyK  _Toc11930054{DyK  _Toc11930055{DyK  _Toc11930055{DyK  _Toc11930056{DyK  _Toc11930056{DyK  _Toc11930057{DyK  _Toc11930057{DyK  _Toc11930058{DyK  _Toc11930058{DyK  _Toc11930059{DyK  _Toc11930059{DyK  _Toc11930060{DyK  _Toc11930060{DyK  _Toc11930061{DyK  _Toc11930061{DyK  _Toc11930062{DyK  _Toc11930062{DyK  _Toc11930063{DyK  _Toc11930063{DyK  _Toc11930064{DyK  _Toc11930064{DyK  _Toc11930065{DyK  _Toc11930065{DyK  _Toc11930066{DyK  _Toc11930066{DyK  _Toc11930067{DyK  _Toc11930067{DyK  _Toc11930068{DyK  _Toc11930068{DyK  _Toc11930069{DyK  _Toc11930069{DyK  _Toc11930070{DyK  _Toc11930070{DyK  _Toc11930071{DyK  _Toc11930071{DyK  _Toc11930072{DyK  _Toc11930072{DyK  _Toc11930073{DyK  _Toc11930073{DyK  _Toc11930074{DyK  _Toc11930074{DyK  _Toc11930076{DyK  _Toc11930076{DyK  _Toc11930077{DyK  _Toc11930077{DyK  _Toc11930079{DyK  _Toc11930079{DyK  _Toc11930080{DyK  _Toc11930080{DyK  _Toc11930081{DyK  _Toc11930081{DyK  _Toc11930082{DyK  _Toc11930082{DyK  _Toc11930083{DyK  _Toc11930083{DyK  _Toc11930084{DyK  _Toc11930084{DyK  _Toc11930085{DyK  _Toc11930085{DyK  _Toc11930086{DyK  _Toc11930086{DyK  _Toc11930087{DyK  _Toc11930087{DyK  _Toc11930088{DyK  _Toc11930088{DyK  _Toc11930089{DyK  _Toc11930089{DyK  _Toc11930090{DyK  _Toc11930090{DyK  _Toc11930091{DyK  _Toc11930091{DyK  _Toc11930092{DyK  _Toc11930092{DyK  _Toc11930093{DyK  _Toc11930093{DyK  _Toc11930094{DyK  _Toc11930094iDyK aim{DyK  _Toc11930095{DyK  _Toc11930095{DyK  _Toc11930096{DyK  _Toc11930096{DyK  _Toc11930097{DyK  _Toc11930097{DyK  _Toc11930098{DyK  _Toc11930098{DyK  _Toc11930099{DyK  _Toc11930099{DyK  _Toc11930100{DyK  _Toc11930100{DyK  _Toc11930101{DyK  _Toc11930101{DyK  _Toc11930102{DyK  _Toc11930102{DyK  _Toc11930103{DyK  _Toc11930103{DyK  _Toc11930104{DyK  _Toc11930104{DyK  _Toc11930105{DyK  _Toc11930105{DyK  _Toc11930108{DyK  _Toc11930108{DyK  _Toc11930109{DyK  _Toc11930109{DyK  _Toc11930110{DyK  _Toc11930110{DyK  _Toc11930111{DyK  _Toc11930111{DyK  _Toc11930112{DyK  _Toc11930112{DyK  _Toc11930113{DyK  _Toc11930113{DyK  _Toc11930114{DyK  _Toc11930114{DyK  _Toc11930115{DyK  _Toc11930115{DyK  _Toc11930116{DyK  _Toc11930116{DyK  _Toc11930117{DyK  _Toc11930117{DyK  _Toc11930118{DyK  _Toc11930118{DyK  _Toc11930119{DyK  _Toc11930119{DyK  _Toc11930120{DyK  _Toc11930120{DyK  _Toc11930121{DyK  _Toc11930121{DyK  _Toc11930122{DyK  _Toc11930122{DyK  _Toc11930123{DyK  _Toc11930123{DyK  _Toc11930124{DyK  _Toc11930124{DyK  _Toc11930125{DyK  _Toc11930125{DyK  _Toc11930126{DyK  _Toc11930126{DyK  _Toc11930127{DyK  _Toc11930127{DyK  _Toc11930128{DyK  _Toc11930128{DyK  _Toc11930129{DyK  _Toc11930129{DyK  _Toc11930130{DyK  _Toc11930130{DyK  _Toc11930131{DyK  _Toc11930131{DyK  _Toc11930132{DyK  _Toc11930132{DyK  _Toc11930133{DyK  _Toc11930133{DyK  _Toc11930134{DyK  _Toc11930134{DyK  _Toc11930135{DyK  _Toc11930135{DyK  _Toc11930136{DyK  _Toc11930136{DyK  _Toc11930137{DyK  _Toc11930137{DyK  _Toc11930138{DyK  _Toc11930138{DyK  _Toc11930139{DyK  _Toc11930139{DyK  _Toc11930140{DyK  _Toc11930140{DyK  _Toc11930141{DyK  _Toc11930141{DyK  _Toc11930142{DyK  _Toc11930142{DyK  _Toc11930143{DyK  _Toc11930143{DyK  _Toc11930144{DyK  _Toc11930144{DyK  pharmacyhome{DyK  _Toc11930145{DyK  _Toc11930145Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy Tnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy Unhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"O\!bhҫ`[ymy Wnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB` Dd  A?\bullet_bodyPicture 126http://www.anthem.com/gimages/bullet_body.gif"b&7}UYn&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`\$$If!vh#v#v:V t6,534 Byttc Dd  A?\bullet_bodyPicture 127http://www.anthem.com/gimages/bullet_body.gif"b&7}[n&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`\$$If!vh#v#v:V t6,534 Byt*T Dd  A?\bullet_bodyPicture 129http://www.anthem.com/gimages/bullet_body.gif"b&7}'^n&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`\$$If!vh#v#vu:V t6,534 Byt*T Dd  A?\bullet_bodyPicture 130http://www.anthem.com/gimages/bullet_body.gif"b&7}`n&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`\$$If!vh#v#v. :V t6,534 Byt*T Dd  A?\bullet_bodyPicture 131http://www.anthem.com/gimages/bullet_body.gif" b&7}bn&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB``$$If!vh#v#v:V P t6,534 BytH+ Dd  A?\bullet_bodyPicture 132http://www.anthem.com/gimages/bullet_body.gif" b&7}fen&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`\$$If!vh#v#v :V t6,534 Byt*T Dd  A?\bullet_bodyPicture 133http://www.anthem.com/gimages/bullet_body.gif" b&7}gn&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`\$$If!vh#v#v:V t6,534 Byt*T Dd  A?\bullet_bodyPicture 134http://www.anthem.com/gimages/bullet_body.gif" b&7}8jn&7}PNG  IHDR |"PLTEfsbKGDH cmPPJCmp0712OmIDATc=pDZSǝIENDB`h$$If!vh#v#v:V g tN6,5534 Byt0Dd $in  3 $A?BD21318_S"a! bhҫ`[ymy lnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy knnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy )pnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in   3 $A?BD21318_S"a!bhҫ`[ymy qnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`JDd ,lSr  s @A?Picture 73"bPIkԚՄu: `snXPIkԚՄu: PNG  IHDR<>sRGB pHYs+IDATx^Eӆ/p9GAA Y*T9YϜ@,$ɒs8݂v۝ͳ57ۡw3{DajZwilNNYE("(@ U\T]A>E9^SR:=QE@P}dѠfgeegff'3s"("()@VNN)..,NiwE@PE@!UbUZ{]|2Q(@"("6Y jSqQ#SE@PZL|?'_PE@Hm2 ,]&;SE@PE >:E@PE JjoE@PE POO@Pmݺ{<CPR rn#e?4E@]Ӧ_嵤"2|}XR}o:D@DdW^G#"uϛb *E lR-Z]P@zu~U| ޚ=PnskE@p=OQQ+YSXyi|Gg"A||_PE@P܅wJ("(F.`X6bO:# Idg..!E@P"G KO ' KcF1ᆏ$kŎ`Inh'95""[N^@qx !Oc<:@VFy vaCz} #|E8$j=pdb*C@_n}'MB,CӘ'є(X?8X<4r֠FԥS:5+^rG dKއ'D<2@#[NZ-t] /ܓB 8DD d͖X?أMIrZ 2OxZo);G2YyҲѸUc4VlCLkyIf^q9o+(D s9lByd#Q SOMKvP)@勰R܋$VҟHK؆ /1yjP }۾ *MHͶ6"fUnEKcRI "Jkpnwwfۋ6~qy=ڣI6>D~TNitE yp.[?v\hj'qjK_:J6Q\!GI0!ŝX"l¡$f3MjqE@w~b+zˡN"@C5}T~x`mK*;q/K1u1e Zl)hZfP"[a akP񄍹)KFj8i-z96N?(G5ｴQ|eCJIڕ"尉4x8ZŴ9\p3BW @VF~dzy-Ob΁^m6{囂vm-|Mo_=h MZW![#ǁBT#5n60i_У,:{D=jcgsCB1x M,ʸZCAؒ QVgvK"ש76G;尉W;Rqͬ(׭OZWXq!'$袛Yc=GOF   ?6{̡?߸}/_A[/\|ŻstcV@}߅4754e=#6hR}E4"nY W Cu4BG,u{ttWm({x &D.]9V!gI- o@Qd{5iRƭ/Fü(h/rބ (}wغ:5""[`uK<*ͣYV,..p5Zڢuj>,nOCضpRʓO~朷k5演"ݜ1s+M >o>A9/9EMkZ0si,1!5*i $4ZUkI%ӣ{?+V̢Le?\kSPC_vռ'Qxi"(QG`i:Zax=ZJPE@PD@OHaSE@PE l5siAE@PE@HBQW("("SE@PdDg=4NeVE@P0aE@PE IPb+"(@(3ՎzEcW"CGtBoC'8{7{xx =bLY,otZE;Ȏ pf"&Zzv5Z"()gZu~䛻?3N/{ ќ[,փe4ð ۜQ |P"P.m9o>Ez̝X5@ݞM╝=CVKh5~{3+FnPOŒgmP{Ďa+t9?o7!TcaηZ՚[(t+ޝt -2 ]|}xoH5+>؉}2"7ʸyHb50377Um/( dE_/5 t_JAc*hT:c h_ipR۠XK/a d:O zFE~#oc֟}J/=.Qa{05w"0ipJ̤E3.@P!aud%@,G%4*ydH7lԆ,bqc/ֲ>/يSGywWn5=%_j$O I \`aRUI[3Q)1r?*RH(§U)(wl:.@a}+2@;5g&XBঝ[vlT-eUo x7ZB,O8E;d`,T_K, ^($պ<}c‡$` P06^"QD` ЮT%q | U`xxn!ӑ";Dq1YwK,@P.NGoEk<*GRI&|N&t`eDI6e`ϐC #2gߥ|0OIkZ.q6*%.,э SIHݹ͟MXj^#U$'yJTp 'M;*f :6cjZw =Ӓ%"@Р0NEW41+B"mV Qm1s!-09̋x,DŽg7" #hVo,r|z)5J[8ߖ3pm4H]6 'yJdK+mHtRSu8#-{D ׳7=ZӠX |ƸV`553bXGQk{M·2p$rZû, :~?3y~;ۼ FQ9uO>\靴p!u}y 3;| 0Z!7 9d<򯸨x!|-ijŗ90gr\^RǽIe۴=''/_yd#$[IRl&J+_hjRvH _Qm]/d>iߗ5pNP0'}~ (xI$HBݒu[OTbK@!ҋ1sVq8JKB'?'89uOs\J"!੒$SCVjzx)xWtwuq!B`aw*ZK%<`$ը5>/L4-_ ܊%X PkG7L dL(")xƻѵ$d..1Ntͭ:uD-,3:uʷao_y\wâP\U6£Ïb6(h("S223]Zڢuj>,@h劀"V| 4缕]Ӧ_Շ(f74"sΣF@~"K*"(@j#cSE@p9,N򸼛+^zN!QE@PE 9k劀"(" qx4ؽ{59FRE@P@ (#{I=6zV{z]KW׵{m,]SwA:#}O=J3)t1AM<_Fc4׵*]zu[wϝMɳhuZ#O_q]=7|03S_m!\5গ"DaÆa\ꪫXV=_sl^"E=_):*E(qlv4ixbEPԧM6U.Z ڡ]݌T̵ŔGܫWvP0):)jJ1$?M6UOB'0hk["PJ7iEZ^PG'Bz"~?9Ik5~%C`̘1T}#~bۀ֮D5~EO-o'@zv_u?9Iz鶯$?MψӡC7 (@@O\?i>Ҷ~v蓵jJ֑S]*~\6 *N\PWm_c5( G;LH['qăy{ 7t}Ȑ!lv _~ﾄJ+Ɋ[hƝذa_;z뭏=;Te?A :ӬY~tҮr,*"d,Z讻瓛ZQuwڕH1Jvu#wm۶VSذÉ0~nT E7ҥb{衇ٔ*q5 k:㺉%MHq9YXjժI&nSeKjn؉ڠA|nJQS　8&d $ߋ'RK۬EEEWQVZjVI0~ !?o9s9lo)l}?WoYPXř8Sv5s_J_r o Yy2۱ig+Xi VUI#9RBzh'Lp }ƹk8ҥK˗+W:7U`ϞrQG95/ꪫqgNKy9r%vWlFaAqͼ:ZzY>-{[v9_g6Ѽnl){-ޯk>߱=ѽiFFhY`r'*믿[n;wNRXN8~!IW]~\>@QʄZjѣP]4PO{V@hwԱ|yHE(ƊwpWaߞ]EYXǂ݅{&S\"|_fزh{?!N~;?_0|?n}v.]옹b60aqt~W\yO]m=.?Nu(}=8(I4i" j|-&r2e˞vz8J*]s.]:#|-_<%攅)ş콗JeyJ^ѷRlvl+3s_oǾ47dC?dqC/'#r`rtv TKi D" O\TXPP`&vadr+W"S|M[SE/S?Pjҷ|[gOwXٿ>_9%2rx,'8v·U41v^>;p7e(,zۗyc9KߚQzc r_޴ST>w]e2rs,'%/g.+x7;-[hѢy _޶m[r~}÷|<{?g337mD\fҏ?W_}A 2?nI k O>Al_LR"h_yڵ+; 饗^b ܲeayx y7nݺ5ӧٳ7*Q#'g^/]6o۶}7i_֯yw?.9',7` /,Uu] lH?_nmy@nɇ-.UQ'tnG{L6U/3;k:3Kd)%Me3`@Ȁl…>2eC]r%Ǐ[.}.]PN: nA\SN9gϞ+WSOP !BJ=sf͚]:u /@ e̙#*.hIA_ sN)*$ /pO 9ɀF|f͚qHO7d/Px<nA($ܼys{챹s׾}{裏p6Oԩӻwo;C]qSX0(I0v}Pv{j̘c7>Ny A[ AYEYX͊_qO#|C^iNm\>rtbhkb~v>C,rwߏ#k:tK*F=K:v+^Ŋ_|aÆ,(]6[oZJ$3cId@ˠV999ؼPɠU2]Bsw93xq_vm($N>TCP'曓&M~ȑ>~" ,IF?_(xazhe?I4X!:jȃnzuVZGS5oya FUVZj,'7"lezeCnlO_>|ӖbM_%E^r-pׇYLNQ=Eύ[ɟo{Nnt |=cS)lĴ=7+O_ɤefxdׯ ֓szwW(s >f\|^ծ=a3Tvqfvaa@6"3JO'6m kG_rcaOغf(شhq`*7>!PT^(`0{qHR{=a?6l89*S~:̉& /<'G}W[A_y_]tćrCg1qC`u6m\y啨Tե^ZlYnȅMe?(KchS:u̫gvk]Ӌ')֙tZ**IOXVd1~$iʕ(Q.w￲9*~aUU\yѴAޭjxHU8ٶ3aRٔͤT⭪BnB4=+YŜ̌RdfB=Aْ`5+dfެW3Vl۝YyRqfYZ,ST!'tR10IQ>G3lF@5X;"L.; JB[c) )+<T8s~CDzÆ M~m 5jN#:T8h̵~zy8:C$#7x0raÎASF $'q-Eŏڢ+ G@O‡ V;vΝ:w'SsTAf& ?߸qS o }\^9B׿[u_1xݽosJI{nm/͠<7ٲu5/V۶Co"`ZUX\t orr*|'&aA,άW<:,u{_k<^tVNikUx+LxԃݛeggiP\kx)̨Wz[OW#aS/LtO?47vn|j|e _a MFPlFA VլYӊ,>BohSwhua] 8CJ fQW^,_$R\0əvPJApƥ+on=3Z1bРA8JGX$/\|9fjժ7kѼ5kn@a@֯][o煒ГN=&{@epdWh0>\P*24^3!6J+נg~GT5y`ƌ^vڝr<ʍǜR9٥KcI| +ϸ>?ؕLXEz]лjժRoY3mժWox{V)|&τo>jq=ż05Wo+Xy؅!͞s߿b媕ϭS!zǿ.ٔ Rl} ^8o MZ==uˎo<L U~anVU.S|.՞_ ^c{n>a2Yzm弃SvG29;ԇLsT7 ,#zYq[6{0M4 ~ JÄFZ!!FԆ1 apj~ꩧbb=.1MܕFw`{\sʹiL:#܀ UPog}|>#ڐy@ﾛHB 4-e?_?yB~"-7kQΣ>ܳgݟ}i* c~W\yE2u*{_y[?oޚիax9x_ 7hݚ5LTʕ ?MWbg?w_A!aC)_<* 6dfeޭۓO=)VLij~zݢ填V5rԌӑēOk⋻ X">V!4~7yO?~hM7'ciٺ;zš˕?jѢch{Ñ?gOQ ej܂ lʪ^>Z܆Y~۽ywoVrꁟ/,ˋǤ~s]̘<S5ddzdד{O悁g6Ѫ3>/eq~v?)˷~0in?xj#aS,/3r.K;3`0j8tAl ܢѬ#ԩeЉZ9hq =m  P3KlLNc<-m&Ř8 b !܆J\ / s Z%6]9NEj=z:56a@aR/ tI%ȼ<:+wX)gT!C5hc[vP<_z9гd|T]ˮW^~"l!EE٨II#]Xbs/p'w͞5 =O_sz8Ql`$=<O[#DY`헨4зyjKb)k' .Ə_j}3>$뮃zȦ!Ͽif=~~ٳLi>~Թg[ R\ /bCn:E"7^w];q{٥WTF9~-xf!W۶mشͷbJաbX]kLct`(#LqG:u4/?"/  a AܯA־%x.7o\e{2;>, YNSqԡ}Ư3y@eZ67'Soռc05ec3݅USTx*W>'bg1M~ СV"'Ǥu4ҿLc#6v~Bǎ<%IUi{DDN>¥ W\y%>VqTT Ă %-k.+pW#8Hw}&^ ZE֪^  TT0:WQ ?J| [{n!n6$:B5kެ[Z:q-Dg-pzv{OV暭.M|B|<ۿMVP͔_m=}^"TZ-o9F9<8=ce9eG=Y 6{EĨ9Aykwl?n*{ysQ}1Gj|tm PO| asI'O삙mb2eN*w^pI*ӞyYld+`| cE׬x4.;w:1ʔ?)mTfwyJZ leQM!d*L3*?c}:., 䬥[זg/vzY%CS^#TزyyYir]jfrݎjꔛtKv|?@ʇبکqedQ:K:??Llu T*YSnкF/Oڬ'֏gBxv9#"sԦG@O">G0'iA:vV߳۔'Rl5G~U]UY3nGM\sZլNKvڬ&f_UvޥGY ccU+̩ !-~~%VKvpzLh@P8ڲh20C93nq7o,#AmAm]f}1FJ %X|tCD:{" C!v瞁wunYrۭ@"ڊЁegeѓy- MVܬCjW8vCj\Z[P5<ۆ8?@h<"b?5g}vmQġ3n5Zԭ@[YjWh\b E>f&- :Y; r:i.UR=5*Cݗ'./޹#Z{u|é6`Gp_g b N*M͞%Ϟx&,KG7 ޺nxԆwud5~c.By^c)RrF񮝻Vּvs.x="*!Sn5&\vji7~ajӣEY 6LY+jYk}߯wa@/h>q o={MVQ'}[L+4ట骶l3#n@tv޻!|R4̪X#2 5˞ټ)+eefc0cUXO|H<)Zކ7|~u {\wuNbΝ+T0 A=őDv_~uO|s)q6(;vHiaVB binv{Ui%y1ENcO$üvo!?-tS!TpTe߳ϞX=^Cd} Iz՘^eKezh xvߖg[M978ԬyM ~8}޺+?{KQ,^>-jW)976_VggquTT|͛Ξ{`g4+#Yc^Xgy>r"׸jU`K-ې Cm^{>Z5>ejy-z޻p -ؾF]Ҫ`O?#P6UhӾJ;)S#FkGt<-ZDw5kţ]:4lh@G~#C !==&0Mf>U(ÃvڿL1"4.]8X3)ɏCoO+k}u+iEm~g<(yyenjc6Qhz"eB,|a0_T 6scΝ7K*oxA8+^]9=OC9r7zb1]X8Z v[v萡սM}yp5r̻lvW^)<ۮUafޓ#@ lNHCVZoyvy5QEm`/GQ/S!wÎBtSaV&wO9W;Qmw/]/GyYrWl̯]67{ +.UW+}(0ӈN.1cؙEi@}p[5kW_}%? (pU# nmP*ώ;8~24T_f;RD#z*lEl(=ּ@N#$Tsdhrs~-6T6| '7e={@4h`-bgmf iBE29ǔ3&MTTN3!f5W*5,<,$RK<ǫړQL_n@78qU[ q׭ m4(럭}赩+k/W5+jx;UcWٻ},~h. cbKMT&3)f#Hjв@I(q+yͫP-wK` ۷/t*u( !79X*TQxw²"(?aW$^g;vDtǝwȳx$)]Z22Z ø`*lɣٵ+۶4wꩧ{?8I&B\pq@x~ }[re9mTܼʕhu:%CHxBǎ߫Tl^eٰqQ?0{yy*Up'"<ݺ_pAŋAڲi&W2лx>"sŜmT˙t:J rՏO&,Ȟf8E`4r1s((jZ V'BN#J\pUo=(~V5SCIJ$e?ԕ@ُ6$%}^]gO*Uo!guQZDgo,4. CKBwo)3$/r/:]^%gnwV&j(~QO&VQDө"VKx4o֌#1>41N UV\v- ލY^.bِ0/Ί {Ng/#2ZAX6Q͜$ b}]PCMDJ!wѰ/' )K(h8;fDVRMcŏ ZIR?,18e6 Z0sӦM ꣗"DHӲC r.@cի(#'r !ФIŋH E(~ѨQ(է(i~RoLG!H*~t2(B@Oz\o*"_T3B.~֖`˾9H/E e@ӹsvDH8~>*@PWR@;thA}E uP:c=3!>|zؘjw eի۾V8Pи*~7rj"'55{t*~RoLGn@@ُFAe&j&޺vMο=+VFf00(~WŏE (:Zam_Q5^V1cƜs9"De?QT+L<jJ#hѢyzפ(e?:'R5~ࠦ_A񓛛~]+1G@O!۾ϟvEE Z'ZHj=_HA򕂃f]Bs)'͆]?km)n`9niC@tXf͌3'jme?:R}qSoڥ4@`ԨQPqU$e?][5k!@ѣGF* Rs\ӠWޥKUPkDm}X"vk͊@,PO,P:_HMCUO/(I@M+jCW}իWКE@P3!5(Wm_9)ګiӦ-S-EE(q`(E@_Sk)(~wVOLA )RvhScIQ>bJX| &dgg7ſLKwzʔ)k׮=ӃgM_Ŋ`EktՕN=yǎ:>_ {=z`z.RJNf @( q~;l0%c֭K.m޼yl,k=w-k*hX 뙫vX,*wargT0e?A! a#'lbU!U)T/. x뭷ROa?#AzӡCThhS^;'4oR!۾jW؟+I=O~zBk,KI QD>|8&» ^W#խ^:98#'΀'9^):׏s" x8{{nnnW "*~t^(qF@OIs?~|aai>of&59Iv=?CP;uXnӦMLJh '5ET:묳.袝;wJy䑖-[{W^y婧zo䫢K.S]s6e@7pCZwq0҉Cq~~"M6yEY|9vRp~4Ȓ彤^x7"<5\3|8WoكG7|{n[:>"5k֌ݴ.Zn}Z?dc֭G@wnfQmViҤ !ƍ׶m[/@>aJ]h {Do߾Ѯ;]۳bʓOlwQu?w.~JBUwGqiU6T"SBurrrOzjC\аaѣGD޲e LE:a>C)JFF޽aR2JgRO*%PDHTq^&57Ggp'G)SW!T׉'xqzkh~h&w ό3:wqT E PjC.J uLT;rv|w8;kS?6ڟG]8;L$+~uy7W:.l/֎[5jɂI-hBɊʭ$h^17|M*UXE Pə_|O?Mq޶m[ٲea?4nﾓ\$>SVHH~(YPB?ҥ*~jTTC@O(;U}7t4't yx`9K;Y?}!={~Ɋʭ$ġ *~aTG@OqzyҥKag ё@eݬY3Vc~);x?8ĞwyG[br+ɀf9"$ (Kl7x?/^`*tbG5o޼ףaӓMf/UVrʡAY~撾 P*o6+h%Q䁰PoRiL%QHmf9UwD4''Y_]v0)]*T OF d%F,!6 ?!.J3S}O +@8$ }dF?p5"$Qdꫯu;6hЀW!׮](ߛ:ȀsN;4\kyc>ꨣx'8F7nG3gKG tJ"BHgL0Nl|Zv-9hWt:5tޝwuy:Z"21VZy8` a mBIQ'\wu&H2b^ƓhPU)EDLT28tH )nH9gtW~: תU  a]^#Hؘ(+o=h)0P0X^Bc$Q $VcCyCsrg!݇Չ *%>$ #BdBIH%c /{Xށ*%DlaHmߞ: uB>8̚5lU|o:NTDwD`8{lXT%ǤP='_n"9q _ Zv#?%Ԃg5jȁ_,ެ*VJaߗ?>( &`L)†008 <רMU &66sA؊/=.`lbIF$5*h#5KY DԀf(Y6H&Z_n )DZ|kgjsq)>(X ^ kU B%/q".w" #391㏸4I qY@XhK'rZ}ˬ߆:fVbKZv` 3(5 " f,L$8\Xw[n}嗳lyP­'䐋 <]yW_}5\6F$* ልI{xv4N,;xGxƎ3cNchu (ldp m91r``5(@B[ý״xhb> ^G;0B,~pӄȾ-=n؟~ݫM(pbo=dS[P#1T.uYqa ' ZB@P@;6@-Ĺ'_vjbdEB WX%H -[bccbA%+7 ?h c ]8Jó²cKd::8@Ye}o߾hm_ a!T8Bn(+B'q"arFlz GS_lmv4)+ 6 /J q/$g#:8xO;1Qz)"(I!fd/ ĹG`*,)ŒB]Aԫ dZN1(&)|X>aEEf h}]Id6%" D4"D9͂IA>JAsb IE(lgösrhl璮 6'qfS)8BùP"6j+Z!v3BHg'9| :*"(@d( ĕ6 x*| ?[$IgUGA}kt'(n= ۗCt>_ 6" D@S<컖D%f7, E }WyB;e41?qz<+ٔ fOlJ"' eM(,/ ~v09R8ڌO;N8l1;<+JHjˊ"(F@Ob{ qqCc`, XO"BJ$, !ؒl_2v÷ 6?c/zHDCY10A`&ތR#ra%71!1xY%#Vħ&174#c 3 -,\脐?x&ߒ-U)"$~nX?xGR+0j#Bg#+)hRF!7\tT>*%{$ 5[% PKH] }j!Ȑx309URL(j5I'KRY0aeB$'芀"(!'2W 2XpdO>ypĕ3#dmhwч{/1.'5 W!1D^8Rz%Ԋ&*s`C$!CNPt)DBR!Ѯ9 Ll{ 8 AGF"i7`Q[VE@H8[$Ymd` ,T$pSё#6YaiInPp+  XP |k8G*B@H$(сmGx 9l"?bMC5vhZD*S%΄00j% < s54V*Z¼EGN/yimbp2 <4AKn26k \_%ܴ#>8"7F?:#ࡴK:TRص洡B@c=nC,;ANBu'_ ~ 7T}Y]֦uT5S, !ɖV5sZ :]5)&Z{@/cAy|Mf*EF}ǖo :֏L)`k"^WE@e?"r~x竾Ѹ8x4Y?}QWλcM*qTE@p-~\;4a 7$Bx`Qd+/?pV^e~[ PHͦ("(Iqa#~x㢊+7K:+=0"2dRD< ${ŹHl² c01Uq̈3$Ra$NKߋ˱q%nDc:|/3apͶ]R5Q;g:QTnE@P$뤀s`Dz{#)i>,vWAP8m۶6Ce2w0 B9}s;_CDv].ȠtA##SX<'ꤰ3Ϥ |A۠*M Ojβ@"2sPٷETB~Nհ lP@8mb\li"tP"3@VE@㴡7.A,hb˃]v#8|(xEUGη"p^G]~ue:_QϳfEQ4nX)ӤY&_Xy o!#HMp8<$"F"7!r# 5𤐎.zʷ#/7g0Nq P|Œӑ%d.G'uQIJR]0ơ"FhB`z)@`_E,:C!r9?;:JVFra"w :# 0}F="R7='VP='gqOg9ϋ{" ͤ{4.%"+vA}DZ|(mq&.!priHNG=Z(5sLIGee#TYI8B yDM$r4!9C懭δ'b5We b*$ 1wIQ<"egP1J^ n윳DԹ D!$  aR[)! hn~{=p:ʛ=zP.nԭ[ c&Y7o!;shSBX_I_I6r*㣃bf„ <&MFD2٤*( 4t0"Ufn(j$j T ǑB"]EˑuZw- 0 tZJ#_K -Xg |Zx2ʯz/X5͒* /{aÆ&'TbeNrΛL?Zhylt؅$Cws'5*?% gedRgݸ]~]TR 8~(&MUD{Etr|nҙ_QgW_~]vk! Ŏbc*ln0rW`R H)rRR8 b#lkyLۂ"a旋"m#KP㒁S x py_ k.y nh,)t)eMb`ycC$< R劾CL "k1Y=a4PcpLWsF$ܨVZ'+XjHΏD1iq&-4+r~p8IFfó 't@M: @Äət~heSL?^B*w2E&\|nR\b= {@ ?[@{Ƒށ9d(Mor\(~+>bgֆFH\9$T.24(s   .oaF5o ۚ=z4 霙SN"@`đ 2`12R!4<vebQ݉ B, lXPX5he 20Ś 4, Tf1Aaӥ)H'Cd@'Q,x"BpP};6$¼T\uU,xb (j\ū"Z8_Aq䑀@+ɭhͣvIP-HYfH<#'_,ElO>6F|di];7=ejfaeBcBsgHLmv{ PLK/(x`X>nsà$3:O<.5lfk3# g I0K4ƿu 1jtM4c `Q>%ܖ NƤ}M>"6B֩S{ IQo 4$" 2å+B w* Z$/4jH ?~i&Dy䧍~gTeLS~H "܈ y!|wO kyPwQ# rٓ:_.~gj-'jsqǚJ] Xix%^:Id\Lx{<V0BԀ&8;ɫ0CwSQ';iD,0,a,{nP`f69fK4p5tH!b5EǸB?H9o$>}A@N geAZ5.(D1BAl]"$B~_̰L >gT2FO'F@چqDïÇV ./i20Cz0pELA2#L3~?,px xZXX?fR,C%傋oq1EIgaDZZ{HLH6!xIGl!'JRl;-M0eIug;/k$.}kT:)h*#2k0!hm{#5@%fP[ea#&mWɔ#Bʍ:LC,[2ֆX+8PqL IBK`& @e=S9I-Zc;>I7Q@>0ASo 7DC [2BQqI x$/H`>FI,!:p,2 ~XDu d0oI z?&ּNEr~?e#~\7CACtĢ7w IT!4KR~Eb,$ld~P2XV$ѰlC_ VxcaˆMIg.(Ǚԓ7r$^fn@"900Zh/PP?p2"PS?áhNǩV0bcT5TAh(4CĠFVt4@,7-HX.̆Z4B@'q7TųE!=K.*q7ֽ"!n%|*0r!9;&%e?aC"dV=g'&J6W6 tS~!jf6焘ۃHxT8`jA1酦l#6#kN`4B&.A,0 09V eطwQo S4%(af0B5[clzG} mMY(yMBpQa_F%qP@0VHw83! @0'Qq }! ʡt \"LB'M 0khlV B1&q!'x S2R3HR|1]h'/02*m.z0~$BDH=Qyoʓꗐz% M_sI?BGNGXCp Ȁ8Xi ,S^.r79ɃJCBe@h9É zv %nE s8Q֪x"'hk[@#E1!:*7 MHCkE@PF@~\7!IoOpVE/\`.((~#FiKoW};ɩ~?N0GE@H2D1pQq(!'J@j5"@/"嚂!7(e?:@{H(H*xAN'9q΂tUofk_yC^K??#mP+W4OIQX|tEr:oW^NPi#$y#-zۺI:'s6$Tp`p9x~znQͺ+5p689܊!Gk֬@=zpFrn>|NLAxQpW֪U+6jݺuz2[n>ydNӧZjd@H>.]Nkܸ1m۶Wsذa+V_^ZF #'|RjU\@$eڴi}g<N?t0(d`37nԨQرcogGΟ?;0ۯ/xGo- ϠuYuԑzͥ˖-=z4bOsޮ]۳=ۑ#Gwq, 9s4i<@fab|l2dd_s%[o# )<|pM7AO^'t0$#%ioyڵ 8 6l֬ԿxbꧧtJRhu~ed]T(!B"WFV(*Fs=a3޹sgD"SN% iwށ3IU C)4vSN9!>fn !쓡O|%Ŏa^z5o˗/g-ٸq/\<%g͚wӦMoE76U}:ktnJ,,Z,!YQYf>lQ Gf$ ⋶~ 8P8WK"SeCWXƸa`aBܹsQp;#FȢ`Mf"R'.LZDi |RRp\VkSO/\tP $Atiy7" Ryg#:#Ӗ|EmdC?I:RJd{&!:Q8"R b!-Af~ ^x`!p8J lë(槟~i1. EO^x!&89 s.Bz W^yyŠ3>^ԬY}^xHvR_);51*ߏI|9ꪻ55tVGbͣdxYPo;>+Y6+(O=7L ]VwqQpqC)Sdg`3h;X2ً Y{n^v0X QC.+,i~c +(aEB}ј?Fp E#,,N#VO?C(yb`u2 E/ݻ7_~9N0| :BaBfYGge,((pn$!5 ϱˬe!3 !ad'Ɍv̘ = nf,zЖ^8|eq-W9 G?V R-|YEH̳>@NDu]s5"!fA edQq[bŊ5Ϟ=fR!9` 0F&h?[9:6H$uQtSjP e-~xYipڀܠAE eQVVe~)/ JcAdC K, Mh/8>h/j iHzDhX!@,L!gUf]`QxTʔmVLNYJ-(~ "$ an3٘H pc8:, ,Q#RA!?Fhk&DEqBVL{P=挐sa䣙?ޚڿ47|~H+wŏIMjF +jB~V>(A!1ּr02^hTRe?I<<axNp ~OYMy!|.BDXhQ6Ȼ5U +1×ԉ?}bBɪ / S7"*/0 9ov~-&4R`=mCZҀ!6:4hP6'1`Y >B-),hPXqQ౼Q@$T“Xe~j_3^<+{?"!Q#32g#>`#R^,b_U1`*b }At6XXůz:lk~D<(}g6 :Lp h1MU+÷ FYh y/&53@9cK$ҙ_y5x"w sw(e4R$RAɰ0b…,+O{1~S m<;DŜWXpx۔⅕Lnb.RD XdaV\( qFljbI:!^G8a` Zj=$/,p@,{ 0,f3٣_d#Tұ1/`^! f˰ z+sFh#2b czpb*\$KE"Yڙ($b#MQojՊE&)Ȑ3_6^V/V}HXD42_Lq,ڂЄƌ4^t@g[KRؘd$V L"?Z:*/,L*C&lb^ ļe 45_B$ * o_ۉxNͯ$ ~erbqiMs- Zq^$5 Q aj^L,ɢ60+:. <^y?ec,۬4aҲ`KͲfXS-OdQ!bUB.`= +M-D«6CMh&b]V8QB{z&(APA1,]CU"GE+QlIWb4aB@ 6B~\Dd&'9%,&*6gJa?.4>4iaK+X1Nr|R(c9DT5(@a# sc-q,,PAf~TȀ`H%A.20QT/ b:@K/Q9E]O|^656,ys4q5 o]fjdAU!5?7OQJ=_ktus$' tc~ YYYD1sKA0beaqف\ʷ0*0;E:+XLd;.|d=#Z&g:/*g(ev4M JW\0d eAqv҃ b! H{)B D*a0D ,)M`3<HBنN' r*fO1 5% Va‡JU_ama`B bG6<ضDR?WܢQ ]L~0mPqM#3))AQt"/M ;]7r g{k<֭Yt,J#iٲ%K|d˃^6I˺|́'NGa?@oR u4oHUcaÅc}вB+7xَNܔڰ;VbDM)ƒ)H0I!h,D{gB#;bP%뺹`EOvV̎wnX{dōļᆦTgE O揤X2TePW_tL)-D<BZV$NCdNJ\@lf7-> rJI 2ͷFX/z$U@B#/>jD ,;0^Q-G]N;dfӖJQJB%=JG*x%aH`Af^ W ~cP<-FIg"`5f4 9i6RlBAYT 30DqYa`aPj))slFVlK@LYķyoV!4$ɃJǹ0ALxe? @O%21.Xð;Tl$;c! >" 9j ^i@Ͳx-V3vS儯ӕ|Q5P虓.j>tGDd}4Mǭ7Flkb:X+4jolj*͊[I(m*8V)qp~ʬdƄb(Lv~ck_:_Ø+q8ߎs'9; λƯ՗Y%蘆2}"ʫ'"p@tWL41Ωcobv]8`1j%# e㷬xT䣕gX'oA.ْ&CH^"IGWC|nEfkiU"k $1t6ߌ%+.49lyB_@p1B3.ВEH iDēePDHm>hO>bJIkWC@z~?9*Q$Nx̸s^x;Ul*hq҇S2ۄ%_{vr4V?lC6~Kf' IS#O,beKk'pfJIQqT'3^HEH ! D)'maUC^9{D̑,ώ0ɏS;8ظ YxI"H*^N5=`"8ᎍ @1ި9hE 8C>GTrJ96.hlac!X%'mZly@$K>٨`l#[I$ {ظN~7,УZ'X P1FB8` {8J+S` trAq:; ^f!p$aZyK wA!M J'6 nBeM$*a a2d"A\klhI%# Nia 1ى$iE YHgξSNT*$ʢϐvB*d'64Tw+֝:m&ykb jIg !cLA$$j#D! F\#7 zgh# !{hql*FJCf=F8C jĖDž=Tl#{'%Z -_x8d> ba> 9kV Q#X{2Aa3h$1+1~N7 2bIZg`]>j1Ղ~"7g7%Zc800?^$A)V\ITeXJ."v2zH 3vѳX8JPD&C:hA6Q`Cw!uDYF}VPvˡP~=㛂^A DZBÅF̷TE& aaNk/@<3O r0`NHAX%$iN-EB<@'D=R&1=# zE CF 9V}H"Q\|ЊT@$(0$DJNcVPEN|vBl.H@A)(qרaRxC7G>z$ޒI%:P FXX!44b5  .1|9ąe Ԙc+`8AbhVHD Y`*TقkCDHΝqx~X Q@42e= E/A] XZװ"vBP&͇k/@ A(f$pKuh`1Y3 *%i I0=zDJiLX=XMN҆  \y_)ǐ E$L4d!u=D6iS TfYAk&LapâEθ; )N=VCTfɏэ yb@;8P!L,?c-BpPk|ΠsF3(.D@ُ %8xKb]dIÝBʳ*ȡQLrQCPdzH4s2MY@f IG iI|ùࣈ!;IHvQDME̲]m8T kH+ CL E#( ?^&$AIYعUfQH t?,-Sx'+n dMAIWâK`=`'ъ~6B:y!+|ۺϜAaFC(1-I9޿4x_@#'srVkfыX{GiA6%at?;썡WR,Ǻt^:dsXCHS%uJmLܪEXs%~BEL;G@u?IS @޳;^+)ºrK!~ϙ7 b'ZEH2jds\JT4^\[` ~E"R8 ,%:rYsGc29}5| ʶ*{ t!hAR(+ Q:k!A ='E4"~I4\ٰCT ~#a 3?|2H/f)rSa-%!bbb{*\dCH &v L-+{OqF1D‹n=CVi5YRhVV_I᯹|NhG.HiˍC @Hu$(~%h)͠~{@Y`_fq^vzZ?YnȃQ߸']$8R˂[oе (Pk#(MJxj@Æ&7pN_F ?-S3>:8|݁7\#[ с\ɶ˹䗐6m0ʴoǎ}ضP4rIwcOoe޲(Dш/4|ԘxA~"?Z+|Ѱ1l J ^j8__9vHx+󪀇4c#ɳ{qBh-J>Zi=0Fwq !y= eNvIGT HǨH%[gDq.k8V3(fBc5v8bqcvqFFs#A'ű~8GE9A(@r!'KU܅>o3|h uZ8p6alb8~`$/E8"j路Xp sm7^&|%L YO .H/C"~Rl@;@l7L9/cq\rfhwHW?Ddd4 Γ*ef  lʖ:4ID"_Gc U 2c:L/[vE@ ~b֪(Ghф̈́^On. CXGTAYp&oE!.B$gl~ز.uR>xœ`KxxI;#\.={* IYуmguaktd$w!^)S!EdP a>}9ص.ZEӵ @ '8vMr?*չK< Cɓ'}0j#"8]b$rL)(H66qQ!5"Ȅxi퐲Nl0!-y37gYt^8(AD`?و@ /g'@AGEi9nfvfU#'+奵͘^̃p8#CP'|q"RD~34  W^5."QdBNI9Sg (L");^A\s m rA?|"ǁJ҉a Qrsh<=4%T4Oi~'S[TX>DO6@8&a}I$9IDb6,g~L:gV?CpB@c9s&AѻHH<ěFaދcPWT_5b$oKoy(YXVe?1ziVy5K `5* آaZf Ňh\'($QrrM΄΅I(``-Y*GtBLi.4p05v+bcUTs$.C8pwrnf=͡lMP⌀8)qEw{h+9>*\^O?{A%(@+1p<-S!4{[4=%} w}՗_~)ŃF6X  i_##c8h&kO6͉4]wn%fo~?PJ06I |M^TueD9;<4MCbk rٳg!22@V!>l1,å^I.ŋKl+C#s4-#E $DfA8BqTxhE gM.){%o%xp 5~^^y'1i1d"pa`y'cںu"%V){3Uj`whdAjժjު~0x_`]# =K/ܼ-7E}̮ODV oس AF!'Dc(L8Qfwx/X".GwÓ!h)jh: b^uКCE $C|^`lZ=`4+B8|X`>mw\\V%Ò%KxSphn'S[ ;(i@7^~ 5P-@WaE;=4XFUC(\΋63<a7JcaX!y(  C + H9qҊQ|P"vOL4jqg ya9?!X%1p B-ۏhҤ ݸ %rјZX14=6+_ɦbGjպu֊X")I2f/Z(*`⽁eRTjsC%S%%`/6/ Cc`6(x≰ab#)k! p(m&l";Xz͑FmC25կ3Rر$ ! #V^{ ' h,_wf"@ʭ0{ʇ:GÖd!NcC/ eE(3~p `ڲϙ@M wT;0;jEʈ&:pK5e3fN9fSD@Orl%p؁U/5B,B9f,IYE0ǓJس KPRjSh\8X7 =D7-&6=>MX#e tM6\t;}IUlH:6|o`1+1cC14+8h&3im혱W`(%h8 ϰ1 r{p91"EY44⦶ @PU8p퀅4JPARMBvBwJ @SERh(wolԆAPso*UnPFyD *4v3(3s~ 4 ^2l&kG ,s%b,|eEhهE6}b`'^)Va p3ـ -Ј5R˗/G]LHj&: 6b(<@,wm)cَV`b$*9 dHQ\0t$lEُ!-dyg6&*'^lLC(]e?zS'e;.\ُ %eDRJ+)iA}KR4rij#8VctFNQVX&q!i&@C$7~RpntJ?KL!Ji1L+V+XgE(WP9Z`=vZJșrK<],(P#͑pIAL{`x0x |R,zBb '!kqBw?!z)!ꪫk@^%ZJP\rpxq Nz IH$p* 97Rҷ=_v md:Yhu(DZ fe?aCQ +!R^s?|HEm'j4 )' DO$ k(q q~\'">/>vh$˜דo!Jlɋ.F"rafW&pZ$͒`U"&.9==l!tX"e?ҌI3Tb=#Wa]Yu|vبX@(( -͛<`PO WHʶ/k[U"GgD "JOJMtIm_~V6ƌөS'I5kd R`( i4)}="Zukt+Lbg}bɅ/68x虦arXjѢ?KR)Oe?y]G[TLVp|돡5۶m#x)jw.N#")"@:]Tn"ǭ#r1~t^Jk!E 8QY&xր953dz6m?ދUA "EآW ѣG뙦3nI\}k_]d 9Mw-[qm=[1PF@OrJoEYT"yԟk׾曈}ѣ>pW_Wo1źSZ"V(IN<.[T">~Xro^zk׮]5jlݺuϞ=.뽊~Ra _7mTf˗/H*U 4hܸo=*T AzZ$ kYE$HƎ۹sv@#AaYv:uvo G999CTe?7f*/zΊ8#'ut?T7r4: 2` s״9E  M\G\ xO0Ǣs0xKCm_W7M$c(~ Ʀ-\Eyφvo[&MDqv/((0UBi"++I&s ?g5!f\pAŊ] 7^CR9{ WV]vwIx 'R@`n( uHxuXX3B-"/D.袷z+yNQQo%PҥK IumF3$6/#SO˔)taɧt9RJ\{ ׭]m^xQ0PhZ!~l~BŚ(wjAe?%Ʊo߾`f7n7QxX>d͐;n' 8 l2O2Oة3> cU{S*7>}4fMC^\Ҽ T-+%NbK.]{WcDH5O2b}z_`-5+v!U%F)-8A@C`Յp(njrФHŪe drDe3^(h@( :-xhďAKk޼y ;ntݛl2Ŝ.1UE@ُ΁$F`ԨQzi_^\ݯ=H|[xƟ~DTVh# cKSڈ"p3q7u.J:e?=I{"VRE4MLk֬Idvu1ùk.<P]rAwrRŋλx˖-)2I|I)ޣYx[IEEK_w/z-;w֮Yۿ_dO:pTOw HTEl$HƱK=wz].Gj|2<wg~3qݻuϬpmOvhT ¡nȪX!E9rABByyCT\'߯Az/z78Ж-x)lqFP#GgH!!N=$;ͪ(|F@5k$GlyU>~7x \F)hLPG@OiɄ Vs9GHڨ_p;w}y=Ͽ׭YaݺnēN膼¥$e?_[ 釃B+X"cB8u_RXXm6}qъ-XV#镖Q(?zE\FB@UQ 1ѠU/cN$O>DjVE (%ZwThѣGcjZ"),_(VF/>k@!C_{:ڵk?hF/E RD<7y&aZԆ4m4;q3zT#{VZ-[z;wqsfSba5G?zE4պ@`Ɵ[n9묳8wy .w=bĈvQeSL7npu7s޽fK/["ͤ e?1V+*ǏZ*ZY@+.JyeΚ57x< & uG}Q뤳>kc9G+nذaYeK~b]Fչs֩)BjACi*ls3b$ ~vZX|ݺu# \M6}脰=E~M7ڊTXzwO=4i6E Fdm;@:z)/ک׻zę>R yKgFROʗԷo_~S;v.>FI#3!^^xı'Fo7oA}p4>(\$9~ᇐhfE!~l~|뮻xՃ7 --)qazm~CQFVVV&n6=3cƌ͛9Cv!£;6DqD*~\7%؆}Ң2Y8 %'1W.]n9.~Is>n8C}ƍ,YxuÎ'EIuc6$fCM]7T!L\cT4?c>-suR%ziR\ ]\9lO_5x$Œ4'f8(+XՋS*n?!yu~)qfK['Aqԣ-`T}v3{l7aXW@P(^8B4ud>tAE@e?aEAx4m(@f͚XisV4u(="1ݺnh@@ُ놉Pk=^znxT E :4%E)9.锲 ĿbT\DHsdqpmXL8BMEһm۶-1e?17;we+8K?1 (;k6ӭQD*Zz5O(VU)Vn>Ը駟vdHv^;H;w0D;"#1xKI-e?mڴA1dNrpq裏>ҭ^qAQ#-ӾL,:+E/zΗ'ƪUX^| hذaR2 Xp*O>OpQP`Z0qʕСC4h0yu9,!'FFZ-3?*UVti~xڵK#D:|B@;k,L "]{}6i$&~\=VqLlw)StZGG_0 a}o߾}ǎ[l=P e?4Z)/:/{Lm{=Q`v7w@"t-~s9':M=NS["DF$ UTB]Z"Pɋ-'T m\PJD@ُNW :kCW 1D*_1Z"+ Y7$8B4 1r>`e?.#/PΣܹRQ 桲 Ҋ@ PCpj!m.͖ǝ&H鉀wwz̘1!Qi"F\rj9⚴E@>~,R)ͬUT´E@O[:>|pbG-@8ϟʴE@&~*7n\x񩧞jAͯt?aR e?9n5[pvVŏ[C*5k֤>=7je@tP0@3zh=" H ?2R*g!'FET.].%G6Z"DD" hN:QV(ɂϺ=YKL+priF\$Dfիo튵>E@e?F`0l`!ܹsH`UH2ӡG!|rvT*"u'nl:Z" Q`?ZVP@vݺ E@P܏@OPHsʴoWaiv_PA :1GWTP܉K)`ur0:zՇHRTlE `ygtFx*T=iК݉iΡ *iE P!Txc +סwMw'ة䊀"("~A-2Ko1yр'ey0y=kt9h"7cXfPE@PBE@OɯfÇyR>WԘle{ICwˇFΒ t~*"(Pbe3o̝ҳK I+]<Н+;5ђgԽ\*(5+]3_TP>vNJ2n7tjVfŲR>( <ٜԖy>aMTn6V&<͜vM0؉6ax)0@sZd͖6 σ=ڔTZltdx\J:P~x7gnOe6IL!=7&O&LqӊM^^(=čN@)Ƀ*+|7-~b8 ,\G7<@rw 4MH ś,ZϬ83,W&Gn6ANk+|I"PfVU1d<xFY-(p-_9pT!Ü"^2H.F oO\hټcw#y:L8p5mb䑧&*Z~`uH:%>hgaT׼38hf͠$/$f*ȨD;*yPCEb fKړ1CbyIR-73wma.MH~<{7:~iމ9F' x9)yC@a gl#! (Ii`AwLOTvb_&f[q M;vPc1ѻPk@!Jb+$%12awgc^@( 4W/:ſ&{ #̚.X!+&0;7<l+`R YH8$v>LY̋$vpTñ&zy-BhAٹ`f/TP5&4V>jm@!i+;5|oMw0ony IH.f??[Mo{keį8ٲSr16Z27")(B(iison)ܘ&7<@ &o a"$017MМUmTx#.FNkmɎ?|qz:XR^NhyQBA CF4o+#v E.-ǹ ހӍv{  V4! |FJ/+/P҅PG<*nH‡4"kdG`|fSHUyh2yEumKU#Xuң(%|P#AgXc4ݓ{I7xA ,/(WqyB!$r( QҿcnJ\RϽYέO(񘳹+ݵ'"PjmHRH[r Ѯs$$dITB߱_Eqe($ 8~YXBZNx_lo#N^*葼r/B^xǓ.[(<~9AG,>ԭl!$S,ݷ60fE?kQ_WyZ@x(A N q2<>rI'I2;e ίj q@I%xDxuv>-4CEDu6B^iP>G7rtmhcq@ECˍ$I F_b GIzJXWv>P2ZSw١_Q3>ԉs򸦵sK_Xm!=v$OQhR-(0F<*FEx}T)#Gu;;(#(,J@0`XBDbg#""b )LBI B(,nu_;oޙ;~K9sΏs=L-TY|^čʦEz dClxN7~Ugգ :qTS+į9(eVRrVnl n 05!AokhܨlFq4qQs&/LRѮ \"U؋"w)$ * &"f[^CN@*lMWt!KZ!i/Oi#CngF3ٱK55w'4OwQUcO׏ӅCуҢ5jSmdYk3j by\K9$RH$d\8l)C挨~V7AQ!}˧v?kڃ wӅC ڟZ<*g9 ~GxYa}߆RhISFO(~؜;1_uv,*䐚kz_M5Jr|UX!yB)| :Ei]z.8V꧛.bvx+G|pTXZZy,óq;fJ<-5b:Zi_:ײ}{.GT*I1k_Cڠv;T7-!AΟbn+7a#Ȯ:j.Ś&!( VUcKT "GfHC:tzB#GI\ !o' >rQ޳Ge4@vޏZJ0ghC6om3PʬP"OEJWC{0 S _;Չ=n *|12 !R@RA٭ (G! 覡yh82Q$]=d+Gg.vJ\NG gNi«uqfoZܠO5 TS%/5PXFLSתJRNjy^2KgaKILm @8x? 9C 'S  7 @(O'C#Sܐc0 @px?@(OqC nZKIENDB`hZDd *"  FA?Picture 74S"bY߁*bFљ`YcnXY߁*bFљPNG  IHDR%^sRGB pHYs+IDATx^%E>pfrÐdD1fQPQ5u]sNkv *f1s$ Ar en;[n[n67 fD-6y3.7_9om3f8n\=h9_:3fܲ،hgs`p&ZkuZIomQꪫ>g͞^Tz҉'tӍkwu%Z. `ʎ]yN=K/1r[]m7>afX%6O;Μ9Ͼ)[۳G->8|D=t=푏zԧ?WX.z|g#;K~u׿u}Ync58 W~-9˃fuܺCO:eOsva?.%XbZqZj%xK.tk>93Xzg,řc}:ks_ߟ^pu[|W^woyg^p]Le5+s`r"U=?]{5Gu"Eoq29yyYf~[qvNy 𦷼n׿z+^WzWfzʜ9s7p?9su,=?Ob q L\z}֙,fv.aC{? 0o .86.}[omUW3ws^~g~xsꫛօ=t,i?SNAO~WρN(׀mC []€!|/kPug_~KΚ2˜x‰gyrw%_LoHimt^aYLț5kM6l]g?类?~YqA_S<+u[ůڿ׃~q}_~k_5W_-͘㊅͖mq]t,1.K=Ѿ|/A /0 jj=)ٯJrr5x뮫g~;4,kVhP2zea#f^{VXiO{Rgqr/7kK/lM7vL?U&FFO|#7`/8=_veilr),q֚3g5MCmj_/3wY3[|VaLWƚk=c6Ϧỵ*~x2wAm:=ykw5~b~;`Gַ>y䑾G%O_}7Ds~q:餓f}#2e} C9]eUX{jkr:wV&oL箽:jۮdk9CP38c{CRJ.uENw?B6X귿o&Խ7h#׌y֜%f-n G刣>'e/@f*kƑ9Rטя}|=mm/| V\ic9k ?-[w?ح;G;H}'g?cjG?Q`׿O뭷QGk/4ќ/뮻J+WB!03;Ӝ|6;!;XO|b5D$@a%zz[~Wțz+e.$ЩeOYkZzsV\iecRK/exMD#K,jfN|;KN e6 }JDjT)H͌k_ zx? WfV_wW;cMowהnfG޺,ԒGy/9k]n%\[o[~UpT|8Ν;Wuބ}CK^Gp ]z?y,( 8K+ݧ}W АOl4Lm|ݽ80zu׳Xc.fc"Xb (CMaJ3<7YFo\r$nؿG#zW..=v:KgIܰOɄjK.a{XAG<{3N;uVi4rUe[n饗nm^` ?#bˣ@ař'6{›Hoկ~IK-3gb 9I_i\dR"f|C6b2XLNQnİ}{o8U)sqKecH2S{q`yug{m%(vIxqd!f:Hy}\Οt@j yFEy H3f^r 9n@3̲˪%1J@R>E;T't>'?a#PEs@W'BCgPdQ駝΀O#)mKo<9So38C~x^+o-_ƱZ_PoUV^}5vy|c"~kϝO!-]B:z 7`ꫬ4E7t'[~1M~\A7~_ͽLy_Ϳc.w$ >8$%Q6OnK&#RBa $e8Ho=`VX񚫮Zj%N>Cy* .[MsH ^v%8lf/U t_b~޼e^Z wi2vW|v:X~yo|o-.CuoSԧTeAWea *WZiדʪRR~14޼oiM6yk^;]v%q2׿~Џ 7}sSY;oVƳF^|E7xr.?o4믝k]k饖={{s=cj r﮸yӞǺCG&Fg?e[~E=%2%&~ '{updٿT0x:K `}`$]P/isVv׿u>淾Dn}e-|ǩTs\(JRJ-2{'o>wEWXaWroӶ{'fO) j~޷v =ﳏxWՏ~cg?=+,oWW2.3:V[=f'n[1Ģ\ HdMc$T"/~z_rŗ< {>{~=c9S[:"x.6߯^g/+.O[mG>:[npp.p{kV`P D{6Ѧn %x]]vE\@D_ seb0u!AO127 -xcw(t[x<詹OxbBrygǾ]^7o}ۜk7wUWZo;%s%7٫l_:I^}#YgK̘> {Kir7h5&rg'C=a 6d5W曛+dmoƚ+-.~0/r'>I _\wu)`YvWrE[׷殳ΜYk 7_+{W`u7\w-63txu=\?y|Bs-=x+k-Ž۱!^rI1 9K01,64~"5o-|Yg=[lf,W.fՎop<{i8S:ēqeɻʫXuGl;[iqkzt\ژw@_]{5WWv(m}?-&3Nw2X9mp G/mg?~c>>|fAYsӟkEx6%y0s+O1#|& ia(MlnĞ旿/ً_ /w8x? 6V~Nӄ;מtܤIo}.[oWON_|I'q8FQwܫ}3mzRNxzby~Os݈ﾇBr=9ꘝ[XwzZQn<s`8t#(4%Aq\w-ɡ0~$bawrbܡҝ4t7tz(2NG.&[gF27PJH RTű{.uf-1j}}G/o}-O|EBl}Moz<mׇ>1sQ& "}U[= G ͘{GM{-0yix8XXW{C3;}9-:l~Ͷۙk0sI'u&6܁ Ld|饗--d}ٻ&JxO{! wݵ4 젃_}.)'>oJ] <=f(nב$? no磊fK?/w|~az>[lg>)soz[w{:o=oH:5_&*j3G2|BL]TC\aALt_vu6_a5Ysꫭ=?Wlxh)n:oK[+Z ,"2N( $ 7tM9ey;5W/w$g<6^y=6dqBK~MIJ-Κ0OWou陸f.i ' 4gKyWpj9L]5r\sWrk͞mCi~m> {_߳8}׿/Iӥu69ca "4R^s)ӺE52Si(;jGhY!L_5ҟԧ?úo|$G^;N<4icxK_l '#{3XNz_ HOO5S^^9u#g:URbsS]N7B2aNP=ǐ!G}+bM69夓Z105;0/%`93tJX([y/r8B,^BG1͞z﨤ol -yU2}xiq>97b W]ePyVr( Gߒ묻UK5W^_Gh׾uֵ$?OPkAQ\{-daȟ=ƛnd]*v59x /ӟ*}b񙋯 DŽ 12Lfvv&hAv2'>[nʫVƒK/dc@2[ۘu|˛di9xmo4 #g ו 6weV!2wz5nx¹N^92yƼICrc?i{S}ccU4s\?9╩N,7u3ؘ_mR5qh5~kN)3=PWU΃u 5Nˠ r)pN YkĩݩMXk z&ji :t ࡜t+&>+DFR #pU9Oy3I>p;%N=p7 hW'Z:;x 쀑%F 'y91aN_iDUJN;EO9dGڢ:0vlY{`z++_駟i̝k,:,;r[lb9C=I_Y} ow>7z4#b# җ.[muq;)~;\u9*n\Hqƙshi\[= O$m'vC6Z-`R뭻6{kbd; .h w {m2o{hFZc)Q!;&GFe+`amꒀ נϚ~c4P b,r?~ߎK+v+vᡳ}>N p1dvۭޚNn)ӟtv!KBU@ wU>4g?*bѾ𡰝u(xbrT}=PV>mq'_"Ǣy(%D04ӹl q5)7B!CA<#˯Aiԇ#0zO 2 f}DMSB&vV'aJhMQ_;z|uFz|wqb 6`7~fezKv&K`-`:am2zm /ۅhv,9GW(<~߳Kz'^}Uŭ򪫯>tPKMzy9ڐEMv JDh8:= " p ^ 8 j ٳ4Q 8KSdKxИ˘Y6<|d\5xs׶\+RZݾ_/:huU%.0vfnyoz-r+ND3gطߐ C46@  $_0 fb+F Cb"rĶB3FHX q -(B V9"0|}3lW yB=%L`IJA ͲWPZڛjV|+.!~/p.lL\EH?Gx\ '/ŠUʀI!3_b~NuJ2 k"!V "ݣ_DX51PAW_|^8^OKuSnQT!{! Yd"SL]Ⱥqd|u]Pc)aPDŽn؉\|DmwlV8FzFi' @ղĐ,; +W'ks͠ mg#~ .KXC4jzB`ʽB6oơϟQߜBK$:JWn!6fA_Y-{;>ʪ ӜRZtZd`b>0cxQȪWȈ99qd1ʁ #W2|;>3|!SyȌdq( #аP*H/~zEYDu@{ ל"2&P&Abkp36G7'SƘbѸJ`O E1C؃~LT` YN @R3QHLz eނj A'MlJ;᯷R׺G ErB+|Z0F@.pPكXvFgݐ=U.8ڊ'jgz~ dz+xkC1εq ߊ4SQb.PbH6w-@3L O$c}{P"#g$bAHƑVWf@,AA'CIQ{-%( |[(k\(a XVJnH,x$d0DHj2Q"3B-qJL1 #$c Zx^$A UYrqP^.evw^kF%hfr5Vȋˢ JJWu\\Nθg_cY:j|BlxA#(* ͽΝk-b8p1z%%pQ-JC=L<->b>QiRoZFŠ`Z.#{r&$ğl *HL08 &D2Vdi;HiAM|΃#0YdgH8fl<_pp EoSA`a)!/"s@v)jRς`[vܨ@+^i.¼ &[ 8͔9`6ȳ8iP+J(^5n8}n6>ܑь '.M=3˶zsCC8.Dȋ11s?}q3fG 'F9? nR6}b] 1b Q/&0gRSf8H4:\cЍmvkNt%g)`w'bRC#a!Bq01 3q@b4YfE4n)|+h: "ȜȠ"2MOBU4OW~lʢ:0 ܰ\R!-%ς@F |R( Z**mCr+9@ВP4%\,|q8 y &dGd @J]Ƞ@=@T L4PT`(c`MGPPF @iU=2x;6 ̍؃Fcȟ10- a8T@<IC` = ᘿt %\P?b)9VT1\M7B1fji,_aԊw]~_-ḱ90iI'pyD6L/)dJB, fJ@IÌG#$,AȖiV{ yd7?C Cc<b2C'`ZռuHVFZ\"_V.`8gTV !l:v-È\W2~,cX"Èua2 iT:UJiclb[- IiwF.kvL3XSd1X m|LNYhzraDZ`"˴TcIS 7XЖ9KRқ`I4=/R\I 1 # -1r{,c ρꧨQJ|8y.( 18ݐD4lW4 r48c,8,ꔓ Y *b@5jbu`883tJMlΒkKdDM+m5h{,aIRTԴqzxMï`)N.QuR LBVxZ"h5o2cfx-rk`sHāAںZVLhz|p@H-n^_2$3D0߼y&$%*2! e,0SDAKR![OڭnQ`=Gյ=U#meSةuFq X`xy|i\Liu3K5, ޽'9gHہpDز6b«LY %{67u{L,Zc ,k- ӺP,LU%n,OW;&< ^@ucid[ J,bJV~NsEc4c:9VH/+FEp!lG3[-sY1^5s SN,u!;G#̩D3  O|8Ԟ,M#,EͶ%g`aK*Mٟ(΅WE-[dCx֙3r1l'.%xb]@!FWl)p 0Jg~6=Lc-:C{*ς軱đ%b7|^d6ZlX3LIJC nmVD @B*J9,*G-!ǍH_6xhSCh,Dӵjl%04ub8%JJ˪ʶMX%MyR2)+0.@m! %|9?2{Z4\1Yˬ6wF+wcuq \$޸Mm4#ۤ<& a)i5[P H#-|C)sΌ$bPiS]^ E?ySj9K_ [Ui[Bě+L"S`YDX UЁWxދqxN] .˨"x 18%IpUPH+48|1PD\ !bf02@0rbɢbH"R$JjP_q9m(ӣfer??Κ34՞ 4\)8ZA\l$Lkiؒ`K9tH|!LЉ)'"GE#Rb`؂KX@LEܙ19K,9C]9])km'Wf"1ʢr@z 2L x嬫~l>sΡHorlLQ$E1;q]IQVMaaXD0]9$R;42qOG?.Ю4Ӽ!AȞ)ಊRQz;V %ޚtSy=*aK_}q{$dޓ+qk$w(|D s'pF С~xh(}z$61isUOwd^/$NՔOac`rrtgQ 1r(XN" jwzsPEefzFp9w㤇79s`"$hbl+:f$>5jl4/ acE[H4ٚS 1'`j+5Pʒ Wg^U#\4q{<&:Ud&QL6 O(Sh\+u"!"`[I87LNq$"9624 'TJ.(hhj RC,U-Lus 5 D0B<딝ғ>p6\I_p!(uA"ȧ|^Ȭ2 1H0G0 =FƉSJX _1pe*laoX dqx*MqNZ[1cʯG KY/k&eWgkdJhsK8'+bᅩ1ncy^92HLE誡NY !4JژB^(:~[I.%䌄ࣟBʑK@߽Ҩ:S;Ia4 a 4\9e Wi@V4bsexd`d̢ڢv 8YC@|puwB:9MHȆxnrq$ ɨXԢk2@;V4g:X^RZ(6.!"+P p@%+\-)ıbgkG5״s-N:aRZ'5΄W@Ss.Dj2H 9ẻ+kCXs!5K:eDjcYFڢ| %: dN v *dU(x"F|='fa1jo) UU&1Q3i_Z`h] MT9IiϤoaPT]_aTKTUF!a 6X) &Y,Y9:۪A=)DtչHqi@~˾҉E h]l,(J=jw_PĬBLgsJBh;ΊliU3 iɎF K0]mӰcxa(s ^ I,y6'-YD|Y6kᴇZYqhY0 0 $֕|+ 9iaxLN8FoNƎ 2QXQ36p ~ [ERcīq-N\SEoO:SS(|9t [fELǒMY"謨^~3XT#KM@cI 1mYeRs,)օ6a021!FBOIYm ؕbF?&WKFΌׅ..I0$ûm.&kwJ9m1a$461Zm[+3GL>0}B MM6;VEЍ/蕠0*vɝ((NĜQ3#RW mꚂe tߛ#D&ĴD  ሷ\t1sL"'og+ ^rA q'**)0;w'MUHOĴ*׺R ragKo[_ٛ-F6qPpR)6m(5 ѹY9Gؐ/Iv72׍Am׃0﬷aYf;W'$ Ӝ$gaExJ'JSr?@"W 2)N*QpMܪ,;3)&cUR3 삌Z7,eG-%;h0׋~E@A-oy*j?8;@p4Sa ȴ:XH>nNa@)T;KZ)Y"X @?h0u %ʁ p@0XkX!jJp@ z.9iؤR隬9 6fK^j:p\z nu?4f]:ufi\ aNm~ SxCӆϲ)O،XnOf(ƲR8Inʐ$PRR'1dof,'cۊ'0>QC)NQBQX&C/%_I1R߅ >5` Ӊ B̞# > BVa{Aj/I>^ZA+iBA.uALvޚ1 _DQ{{LԘEJP/Ih*1Nd` >ShS:Ղ0LDX (SKDrX0ćlS#a*n{L@q_G: q=NtPEx:6#0Ql:[q'HqӈMӛ[a}2coXj8Vʮ,ke#@@.m˲Ek&/H V1iF"Lz aDb8T9IY£kd"X9oG2Y-CcEʋ1 |`9]7G+zغ/ZfXQ%ڋQCZNbdܛ`Kf{h적wPdԑL*FsOf J+"1ba2o(;u̮g"CNB$5 OYd< V"`n( O~{"ól3 ݠD^ CsxN?V^X\404©"FB9Y؁  )1EC/"b*|jF>qo)R(ĸL $D%i~2.C(ڄRoeB_CH!T)(QRLP1UŠFre87ȡAt3R)#ՃB2#${UBBKҤkݣ.n2DiDo}j 4ޖ٭J!-ͤ4G} ɥQFu4\ d!LIip@n&! =K*dx(|j1*K0Tr:&+I_Zq9tI]iC :D(Yf3RH Tt[ eB!Yb PZ6̤f^}<¥@yY+\#Ei4'NeRfQ kX|s^ej\qޙ]ȎJcSsB5^9E[TG Xa袺bFqXQVdrB*\\_01@vRW9YN]CЀ T$M>M1 > ({`g!$b D@NsVNLTL2/WӒQL"\_V J£T8f㤆ǒIa%\eh|Db=(fTf7@mm$8@$j3 @Y=u[WX]ϑxe~)Y?XW#qgô_9a(l0.mTn <RAN#@- ,S&r]L)%XCGB56C[!ABqa6IJj!#OGzLqnJU$;FPd:L9'PX!ý'j YAa1d$K(3ےCw#!HRYp=#"fZot̗;@s@.]z2)IF=-5I1U\` E|$8TC2MaSj(R"&ƑA/^+Pמ#'~yےΒI~-LQEY~Jc nd<)ӥП1kaM|!%12Huê%x +~.ݱ7'@ @C,nsi32pu\pBM'?Apz$i\ql"" D$S\"eC0aJ0?H.?%yDDieP2rc|DR>sY#iN F+]k`h]~R-՛Ѣ(*K{IW䌫#;u N_ g^]AѰΊ<#V|@QRiF~`dԐ镆9;Qa1 BqEy*!/=:IAeL,3,h"qfBD9GLMJvayy[M[%u.a>G rjE֡pJJ z|Q ܚC8KI8,n!t>%`1IY[($oƏW-Vc9L68pu$^ $Ch 5[A 5H9#: !aST%$)K{%'"'[[اq!z/Bp6#U!J F[lhNk$kцgaJ& aʡ~$C TKjFm/&&,"[^c呆 NoqƑdP9 'nkbsHG4 ZA-)0Ξ|VQz57 2D<Wik]qȒ TSĠJwR`ƈ7}R [2I@mYv!b}Ḩ@xtRIi5WeVtFgZfJW8+b%6t4ďl G2KpY@j'؈!XN~.CLzh*I$O"A(Bc)>('|جvByUK YchR(JL A%r`rT 8)^Xڍ\9fq\3:p&)HqkqJI[M%YN"3{D4q@Pqp3!^H1B +DI3,Wz<] M L1K(0!/c}[JرָC'ʐNCE2D2}U!W" 4^'MJW.TiN5A#`EqrڱTQd&$}^&{(`7l(%xvE:De\4iB1U^st:R*ڒ(vkb6[{} ۦ>|[qr@H˼&;%S0I12߯ `h|:E*CNÊbikH$S7cٕE\C^Q"j~dW\dSUAzb#p:CaBT u[N^+M99(v~ÓHCC63a5Dg\9H+{̙!3>CBW<|SuBCePNs)WhP ^-\W"pqɃ|QJ9#H Ɖ$46@,/E.y٠W,%{{amt gj0K)EU0Y3aMcSTTJ IY N+0 16LtG)#*2z>B%C' ? B77@3zU@mVQa)'\b@r_aЊC%BQka60H[٬ď@CRzӗDs9ǂ_)%*GdJXz(Ei˥d%ȲC FF89 Raf%7AJ/2m+ٶjsC4ٳJԫ "L !#PgIsM #3&̗nbg,ı5K2iZBy0cbڧJ0+(S ~ҰbԤI@/}m1ʢ3~Z5@fȊ1$g6HJHRUã6p$nH?F\-P`B*]0]EɋIȖ4eKt.`H\BAե[۽9 =n*Vp:M[ Ҽ5dùl8qS \D]2.YL1e+fЍ@bH%jI@%1&_4M$OBtBІ"V 4Mir L163fӂI$n\-^3z|}U瑳ljϓeMyYѨHX=SkRoPXh K*ڥլ6HLvͱQx`f.YhLiKP1|fSg=X4D@Yd>=%qZ̄S 99Jf-brОuv-8 c)r_Qj\-v WѴՠACj~7y.e(Y@nͫ&7J#@;y!QBQt㍶wwRYo!Թd5hc6.Z5Ii'(7V̈́FP<7SHҬ.lLJpFv㮭qYs %;Kg LsWlNpQ E6X(c9L42eiX EFL{VadG*#@xL-Qx\e9đKzQ.vsh= hBOJD)hO)=@Lwgmf\1$(c`FplwJT E㈩g_`b6<  IqКÑa"dh!U$}kT$c* y pYec%A!H&x= z=,8z+JYN~TmUJi*,|\P^[ɀ5`ј}Qz ( oTT\[#͆,jyߪ"tZua Q9_hk23bn,3CZՄ#z~ '[$q8,ضe-&$oM32&!2G2pY#1J/FI܋HnL_|a % fB q-|C4}-[.!T+bcZ @5rQu3ˋ1ee i}TaO i2.|Bc)i\Jg Kil1&F9f@pa N( B0J]FFجrXM|&43V.Qi83$/-%$ZDͨ=!1Zhaa62C@!OK5CLwSt(hᘁh2NX>bH>UhCC0zp$O\DyJD4ّrbyHH"(H^mWI;l '3@ UYAmĐa|h0L4FMUJS nor*4>Œw QOl΅2iC0WEJgʶ՜b&vܙ N,v m*A, OلO{DV2>%n'&Z#"R02pJ4uQT$ FњEXB(&OqJHYaMb6%AJ9T Ȇ_7i&fUT AzMKNL;7y JCĊCvS|e+~cBO,0Vo9 1N䠅Q(paJ`.z+4cl|fI0愄 ^#M< z;d* r8P(7 E?V&6; ZӤhY _k+X% o9I|7+ 2pHI֌`;-bbRW5HRAnnxR;6BL$Z C R#Y3Qk]ҙ qX"D`NFHXhOfL0#p r!=b&M1t >Uc^O$3]bm4AHBdmE Rf*ˊ #|%YSӎ2SHa6+@g\[:+G)eѮp 3.'d|w4VhzzP(N`^ƣG &"x-H 撹ס-3) `31T6R\%l Ϸ-G2!2ӾBҔfWiO4?f &ɂduXA7QTb$a&-"eHuvj!Wr%#?ĈRsNUpɌTIil+COEA^qD`Y:ơMa;bi4Nb$ɮvtjΔ$Uħ  8N>Sr ~KE8"(vk! oE >̍,^eMFbEPb*.,Xg[!/158KfӈA `%]l g*]&JHHoP`D(6%Yp@ytJbɌ9 <밝יqXQC磂Y&Ę9qe'Rڠ}KڵN',Rx?zWćP_2_Z4)d:S6^Ue֑ukMmr̯RZnUx 0* )G6MR݄~U\N)&['vJ#(^ip @E 8—ll=@!2kw ̜%cV6hUw"-, V{} \M2/!z=dͱTT.ԎHaD|i608ᥱgq.Eތjx;⫣$>iIi9e1nkja2!23e3pIzZ ٬f\t.D'i'slWـF))T*hJj]C;lHSTT o|7?=9dDg6FhX% .RBLҧ!lӍmbp حӞW鴋_ :HWj6w v_MѺbrw Y؊LLر`qŌ$zunz4iΔ,.W 8a<Ӗ8E#g޶PihRv3v@!m$oð[4UT<-C0b} gԃs pJH0$B>am)bs ǴQ䈁 ۙD@ 3"^$hV6A3ĔS]vq39h┠ E!%oIIHy$Sa>=(fO.[$8me:򚈨LJ2Dj6}jocBc bhxs2u]lEs ,&eE4 g!0arnD `bvbP/T&0;gSTzK ri{zݗhH6sk&K,O ?*Dج]%H/#9Kj>0J5xz4n'2-z|dJVx8=t0+-e5H , P(4aVK^̤b x7-jwd:i d":#sr_k"7U1FЄz[ˋrDRg"fnUY^WoIy?q˩i5Ӛl1(ba/g,VbElD\YPbY~bY gBK8I\a5C8N6@:5ޤ K6) V! Y@#%[f1L-[M\*g}Iq.8sCgi8 3g B@8\;a$YR@rU +Pz%d?X* 5ӣOAD[/O*k;(=f!0@+$Jl ˲xa%1 ;TP2N>#r%ݝIHyB Gòykٗ9-Niil?*: L1< a(AgKF,t`vʁVv:]00kĨ 0ДqA踇gq3!PUKIc1=sOs@Lt+JYM52{ZTd kj7Yﮎ,ȅG`s wXMΈD"O`A {S%Zʂ1{W!q,"Ct U.%&9eǍKj od^` sЅ;#萋2_$fi8ɤQBEg{yQb,xցr)m";WY7!=bxHA >vj IV ;u\Xֻ*򿸺JA䚡,EcRغߩa%*2s0/Z',pӺ1l)-jCKl9,e:N&lv E.n9 lzE Bx\(`t-#" MA,&V'{M xf 2&y|E>qi@ TtQ NQ9e@υ`HiQ:BB xL-r'0nsj( 2e'f"9]/1ΔL"GaU+ A*~""1PIĞfkfD\>ylH8YJrܓfH߲ /dx>D(84<~BIeF?Aa%CYbp'sym80U؂=9DؖAbXk%:ʧPʷ@uALY3J`S?/CsZ nr"g ]ϡ0\(C7{ǍPnd;`D82T$p:d~pCQ2JCxzJoB[_2u~1࣒uhS?6X觑 'Pw&=ˊ \8 4Kupdش3tAMT{%I=u wUL8,p!#cxh1q8wxH&to\݂p ^gėr~| 6ΐ]n#0+O40(琂bTtZ bp <** LĻ@ "ҲBl˰Ͷ#n5!J̔i5gx*Zih<L{Ά=@O(6{_M!Ɲ@T0'[\z kC(%cx،dgLY B&U:!aڱӰhJlٯq{0fW(X·`݀rY"QfF! 8 tL8Q$#%VT9@Xfr|o.[̜|/q'rk*% +)Md c# #ࢇrKY%Äe/ncTAp>&gEj#ohwI 臰jSӂbVPm<$pL,i(Rc iNՆ Ĩ_@bݭs ijg9܌p8˘B*]oacYx\H#%* ~3m@`PONdLq+hUԞ34V.V nSUS,/m(~6 6XmYWsJ%ʁ)3ss%}* {9č+j HA\^^!>3 [i~Q&~bWbX=TT+eYI11B]&&dnєvsa1qh I9h|jVHY9cojƪrrPn]T-}]h%kr&uTk~@c Q PHh (fbP6@Kz5r\\J3gj@f-ENb۴_ڂ /7@\ƇēF,b`*PC_@'EЄY\mˀJ9Q(D T0s6s2938U mSn0K,3ߏ\e朾̱ Lx66wFHI jlw _DO,&P,="F9ΔO)ǺPB3%cRxmO@ Q ^[]ZJ!%WvB[7~`Tp* mA-y쉣ijxфl,8Fm`\[*:۵h9iF衸19'= ffże<9C1⧈)/kc07rHE1= rBe~D7dw`Av(DzB6+3_.(|@76m b 1{v nDqخTQzU1c M#XdhOy=eP(0T|1H8&S PhShliMǨNf4<@aURo*UIXuv*̤PA\!͌]l"  AWV+Stpჟp)ػ/#n@`\L'־ bލU#L)B(L7 HgX13gb؈b7M i,쀏D&|\Ì"VH02K:W6:is۱*pMi/0' ,BO'®1͌gm><9 &}\(X \^$PWٕF)^5jC ~1#(jkޚB%@%|^S3Qczkʹ%14T?MQ TjfDc49Ѐ(ālhp?E*JŹ+ګ-B(TOM-rACefU )YKuVHjWi2|Wc&g?'z!ZdYZiQ( GJ]cy*Ƽy㡟)AAL]Dm" *zkO-duz`\{f&œ›f0[kXfaiϢAHhHaޗZsE>S$9?OAg8EEKLT&zsT =',b`KrHR\b&2eeSU[\ڢ^ 4<*_0 U,vK/5B]@Qd| |ulsw`k#u91O =jmدi0`n 0 f.C2y0LjQ2 &3 dFzB,qee*8: J̑˰80V.d!voS%%Щ/RczEv]4[)F XɆQᣞpYƮ16Nzngdփ"E_;Wp@兀 s-DY7TaJA.PhSc2k:ŧ9At B`_U,c 4djIub _'*U{BoڰKqB6E1̥LEIo5=ٲT-]π,4(=昷+Amv_3 K00 DY?)0RQʕ䕟`Kr)}₌p mF$ qBfn9!$,2 P0*vkqQ2>AL9=!$ԮO^;YC=Tv*Vihn?@a)W?)k= `RňcU1y:[qQ')!'L0+ QK,_hЛR7rԎ0z"ⓕJ*Ɵ|H|h+ơa2s Z(3Gb}EɈ qqZJs ݦ""\K pzL/h) Q"Pp[+=-eOޜءuj >ިuf YgZo43B*ėL .eA$Kt?2@Ԍ7C Fd6^4>(39-*Tu˹g '6VrZp' đL %X4(/QE `I4h暀c`\Gx~bde"(/=T$2dB=p#:>ڌ9]ZmF sN #`b1 )=#gl{yo<)@% y(26ug. )^jêqsq  d[eEh]W0U [ULBU!iQīN~YWZL;"zbop8'C1M"M9C3BGY|I1%8J`A7$1Y3a 2@ A`b>p)؃ bp(346ˢC.tzQcZO$[eW7;)!ex.f ̑͠*bb 4Ӿ2EnS{R!G^ݒ7`9w`g4/F/@XQ,X&&r2#'9ny.T-~*h^y~eXEScѢ"DT{FF(sMU]],dqЋ$4*o_cV)©TWJ<޺:hI/KyX)֨N+y M*R5%F*DC(UB{d7gsѸDtYOTQѨâH''A}P 0DdUUQ#d\L։33^  !쩝+Aa9HU6#!#+h>!$~8y|{)W00*M5e[ +=  cE&qD9fN0@l[1Ǯz>*2rp5#Z+xgX0_HUáeLzh"+Q3@K]ZАL 4)7'y(ZXYdhb&(Bf !a q$#La j_0_EWp'p` !j7!"|((Ȕ cWB(ANfBQLd9hia_H0R|3e}ua ƫ|'FQ Qih>R7b /3]Ed R}A'1r(~7AAըbfAؙz˛C< Yʮ ]\ &AfBD-4 dЯ|nh$&D€T}Yմ1N=|xj̷)g\4K%):Hsi2Ԙ!'Oyּrb[njzQV-)MـMႵt>'Ob} N#H &9ZjUenb}4 :,y 2(jiKK0|"[^7LEDP =DH!z&FJңP@>Ȯ'0Z]F Z2 ymN+tQ֝T<0ȁ)uU |N`e31XIO]sxX1E!~àJ&,q2b.x1[ K\`D7b!fǚ&*-(^nwh m ċӡvL˓ QH'%52p$é-kYwbW2eV@߹& 9e^)%KX*" F))_8?e!646HbkL'TM (O6ʤ*ʅ@oe7@s^LMfOަRD-Y|r"%8.N V 2QlkNaC LSLdQɸ$#{c8l+k NJh$4ĖUghVO=:AP"ot++R@|$}NZ=WZΫ%(ϨR5k5˞)}dSe 'Z59ApeHd9K#B Ozh*" ) ߲@<&:-{=[/YCb,YoXxUT̔EN \ BJ}W2 ȟΩ|dIE$CH,3s)pPjwzH UuD IV] Lbfe2Ahc Z71|mO5sdXJ+(q!QREӐ>f*^9,v;Ae*:KPB"8b蘈EL\K6Oekk/P=ؙlدMu}0d8wN ᑫԕdxR1K2 &XFFdj\]`vZם K=pKoFji@ \K=lE6$0fCV.\ uD Ed- aD僆,oƢə$lfndLo)rh\Fom'~_Frp!eo0KfgrƦqF(r)VCRV Q Cc w\Gf'BCJ(1!dtU> rԦW:=,ע!5aPrWY0RoW ;bSx!&KmjSH_LJyݮK)_ܱbi5lxޚ,`\PKȠ B+&&v>_gCq h'i f '62AR P.1]Zr&%0H rR0obf3 S=G$e͉XCgu{ I`Č;VPB)Ġ$o5{cUb18[ ȭ/55Bi|mR0#Yg~-3(9 b1iHR5Np 1=/ggN}z.Qs9~kj'MT-A7"Y]NwVfYi)5V ixϦa 6|zz_Ee0 HmmX HLG?/`uvڎ`lj.zpO-7>WEظEA.`(7;ьsEάTрƢA'^ w?,m[eY5_g le*,s&YMS<Ru;a(X@tvڒ5c,XGcY7>'VV:l %mӞsH4JFUdu8,<&-se}ƜKWXr 2XnWvv(,r(NNhL&M K*Xxoˬ)"Ԫt5"C^e7BjCs$LK:?Xtϕ,4m(+(דOX$&9h`vfk\V2s_seX2qU{`70(G-!W*3˸DقrZS{KmFHmȎE+ e~'1ج769 )0I쉗=dYNJpS QZd)S @3F,-D`NQll"#ڕCf=Z:o+K-\tcu4k^Ji,YdXXͤګ6VeIPȶ1SsE9xb3 BwׄqFks ζOr}8Ng gs;t2S)T Tw#fHl}(_F~H_(04|lp>' nRW{p(m\Z-[[@FpL9@lrX~lffD`$ Err'Q.h*4=ٲ`% X3iw!Hw9;D';9A/7ji&d!!)p;M(@Mmf2p78l. Aq 5f@18ݦiN 6=X @.CLVL3.c/q r0 SNem+vy ̈́V5- ]͚r9 C9 W#dO? ;$u[;jUJ7 _Q]qm|E<="9[7(0xP@Gu`+!8r4fH`Q$,])S~ rv*itH+Yhn4 `A" =U$0`.xnj5vhJ9ϜF'] 52H-<Oq吠|%bi9W'syUȐ p?`TM\,Gn+5Zq O02L1gibjY#rX݅4!$ dj+LfIňV Girli<)~eF<@:iI[Y= +gW©|>* 2:3:I²$AiǓnGy)V2K3lrhPk(16R92e##hYJԙ6{8">牷nWဇ|6-g`)0G7.B6sF2im.3C`}D`њ!>\/91+re7 'pWQr%RRA>F>*uU/iB?Ca>UϞHL[ˌM놔wfkPS$L\M}t$Y]Q'$BD!meHQꇛ+0"B2) {:w$"OYLz3}@ QJ!0̉zTG%h2Ć#<ˠC^ONy~=emq 1h(0.rB=J MȎ)KpGKF9i9+e:J 4+p)5S`z3وF;MzR"n/7o.L45\ vH_#ySr@6PXCO>咃Yy$Gse c 8)"I^cG1匳0T|&G$u,^^6hFU#q;{yRzH`$ (PW;e1^{(I6U LK:1<!YLxZ OEnC4sJ,D X0dZ ku_[ J[dKU ̄ګ2 2yZ!H*3<#싿YRxN.e}nUN1[ cETN䬀J|#'Q|bG_!&A%I4T-R>Z" 4P8)@}$h.ɫ!9U-`@|FbS2'5 KT̊P/`~|>9y^Hj!=9@o%mY>V8_>Ǡ@["d(9:T1` ɱWD4ICrD`NuxͧY_]wOnj ه ,N#y|&ܹHrܨfͱIȧbuqTiiBEm4b`Цp"EP.&H^ :eTs3)r4Md,~? !j 19YV4>";>K ԘH' OנM+G RFpى\mD SS}_ =v[sHN!BhUZ1$B~9&rpQԂQ'4@{"K $N(g6,_4-aJo`–]&.!6& 5꒝ΈE6:s>v7WODY&g,FEBexChaBX@]kiCQ%3onԡVwz6 ~jVaɬd24D!V!r)Js%Xu$ PFE`GT[c &CC?Q(@T<@+= Zl y!"kĹD|pADNq.O mIRqQ*-;y U ^-kDdF/fZPEqL2b&h0Q˨J4&$  ,˘mO'yxeP>]JlÒ3& āpI-Ni.OMt^^p+i89ȴ G'hN£'|Pi}-K ccKgg=sh"WIKAF*aT%,Y6>n8k9.tT]:)lj3ni8!"#wnH4_{s/=?̃#3ܫdGz/PH/Fee|"HCLm[UYmnm IP3_ssi~'N)t\DJ+Ag{&qW< L,B9 Ӆ4M(AiV+B|d+ЃTYCt |V5 pDYڬzȐV@Lj)MU2vh %PF8Sg6%kH &0'5D PZ}p4 .n]<&kC#33U rABN4̜nc1$QMvFP){I$tt%Q+ H v "@Fh-Ul>U~G  իӹ1Dio>aˋvoáA'HOQMp 0aP(XyɰX% F8+ XM#Ȫɐ|Y-2jRTlC)a BrEӃ rPh3ʗ]Ly-/*)3ΒƂX7B'Ap9S%H'4 ;+mhӼ}m2]m]΄PPg. c02rci0 ЩN01aK) )2Kf^C=Xp"ѩw,0H+|M>eB`S2QDsGNv ST%8xJ#Y2N5r)'LV-aK& ՎpGa/[ L>PF CEV;.Ud Jz3Q\|qoY 0o! 廖Z"'<Q Ti k24D:: -% jjDM: }* J4xC \o>~(ibe``7_oY[IF.*A:ݬ$KpO%M+Q3X<ͬJgW p\Gb Jp, EIV#FW`_ba_Vr[=D/4&frh=QNu4 tV[2l*"U}pݰ&"҄`6 J G[UZPqE= B¬RƢ6?(_Sȷ)kCpİ$._8PXJ^Ċ2*N/υ{ƍ"n:*I4[BKe?|ԧ)[~Q*V\I&_ “OCX!U(ap (t乎h|:au5#w{JP?" $Lqʠ e,?384`xq * Of%zeߢ*>Y kVϻ20IJ~X0#aˍ0hbC6{Cd%hfaTFdk\ڛK{I̊0E|N6FӹY)hF:ᶄZtx**! HH@6$EujQ,z* jS(Fy."$2@^%o>Z1Rt4`(-Cbƕj)[!>o~ z4nbpi Ϻ_C|M%zخAL?1ѡZ@ute`i7FT@!a.@.5T'[9Y-Q`FP 0[8b:e&8ե~  qwi;e^j y /4p0r $ώb#U \a 4@TSD8fl7 1GQ& P,3!WACBn nUӻꥁ@^0+`Aψ|ٛ2K d!1]dī :̵/Tp,xK~+ FL1]e"05c) ֥%877)y.FޚdiYӐ[mԈ*`Fgj|Ĺ +V KdK͗JaA@BE"PT w^͆!500ϙBF ]BlID۔oO1큠r@׊,j ̞Ⱥe()SV%`C'Adt`>cGçqfZV8"o(X}M +Y+zm|MaPR mvm'95Hռ-\j $5l,E-19?m̴& ~HBZ1ؤ27S7l": Xs>NJSv4EebYHjc('1:d@qT֯Pr%K*ELPrI\x8/fɪ Jf[>crf}VNCv΄,+-=gs2#B0V6̀ pE9(d 檈5`}6k!\pyWpE煎A~B Wf?4LVA(ypՍzȜC9Fyx;HJ!>ZhJt6;`7As> 7m `Wӟ1 !ΗA #](?f$ e)hL–ԕƀ 1>ۄ5,c&bP! &0ʲ^W`lU>EXad0.D-:, 6GcScU/_3EQlpcS9\W.k >o$4m@̢0<>a+ b-"Pf s \"' 61.J) Aw/n^W19L{u̜ņQMI)Z<1k{Ya0&F̃6íW'5$ƀvz2M lԤ28F -klS`U*s)^L"`|OF C8t KƵ.ƔЧB̥(+ÿ|R* \X7, Z!dKEA E!uA%jd ' PiitB.g7e G܀?\H,QWjҲ@x't21J2mQfȐ>keuJ}'@.&l+ aγzM蠕&)@8m"ymjJL8n\ 0H'ap 4㵋5 H'|׏4JXs p̍\'.bAh)`\ܡ$'hPAQ"d%g?g›|H jT4D^S~2dc,Ď|ɈVh&i%W ~2HY*oI|J@v$hN1y@|0;o0_/ FCbTR#5 Mx^+\Y#s+j10[alvD‹z:F=:8Ab Ds^ cڅg'DڈH:8];eUκ27[!&Jq3 hr "YإSh *q$H0[|idfw$,P|Wث(t .[2+މ5eS*>"0N/Zf%(ҳV µAB$I3G {`DG^7P9Lh%L- N7D@iQeV&7 k+Ψ^}oS jf M_8tȦF~ Y F5I=!`% \h Tc'ή"ddf?Pk eh 6~Q*$~x:oB E_`cd.dw]JoF[_PfWCHaOsDm+A%<9S~@|( 2%f “Qm& ⰌQ& '1q:nBbZw1KȪ'VȃdBTIa7x  @4Beѻ΁ g?*4\H=V z(Hrƃ2= r4JQt6ۀꀑޒ=߲e^!Zѧ8SZU%>J["&Ѳ1Z@OvxꔭvHܪџdJSD)QK43tq¬Z z(h\)*< fF)7 7҅;\b LRz=T\]<|)N1/X+=}fP R n(?+0QIt]11 L@Q7-Š*x`2/%. k%3S҅ vz$,.b =hΌ )6٬ ![E9tB80nH9?p91-4p%+H ~ :m}__EEm]Hu՝+.7,l$,_L(Vؾ,955Ks͛&rƫe32S-I@͚`~40^Ol@;T9[O8GPF^^'23y\H^0XIf127,dRPjQiVFY rl-+LNm7'=3#!Zi4n\I.7 K-T LW;sE RV)x3l`NfI#`'/ Q/dA[DЫ N%W^VFƙ.aL2K=(ź R> $kh5"8@rHIIٞޘ!AFOlOJs;ةpb $< 'u4-RoNW7޷H7 K-@XX0Qt&{Wtϡ@gl"= t?_%*.u +* ПC8{4h [5Y!PB@\ v'6rl-\}IZ Hzj3CUQ?hB׫発Z^i;]%6u}Q?j)DF$k2 ]0=~P*M9h(1?r! %xba?Ә[a9E.uldgMyh ȑ5j!<ԧniMiN)F.*vPXXd8M;b4cːP+q &.rʇ{PX%X.:5H:\*rtbEJ2j D8B n^]oCV:mRk1;x;P+@?<=h}+W?hX!PE q^HJ٧!`Y ݘÁ 9(YwdAr@22##T'Vh'UJMb;0R/ElԘ_c3KٌP=Ln RaXp|=Lh6vzbo1V@,(ÎapKƐgi,TS2c#)f\w\AOU܈dv Ylm))r%PzfLFƹ+{qujr5ZU!O y&?LJ^q:[drBI6ۇ&0s7]" oHY_|ؼBذ#ǎ LB +h/j3A$VXmuJ.߀0q,sr2[䤇妶k0alg2`tكR ^ ,f=KJ* mYjHp mQԀ-`ӴXKf$/BkHm1珓Z2"(4Ó VdHzO<=@aeyXxd($<5Y80'g-h ,P#o$ "2t4GpI &=Ȓo9dC^(#Y74A5j3A2/j,(D?+yGo3F.?XD 50C[1ME C{LJнoh{2@WegV}>'rИF,J.F2H@O #Cq7@([ٗduRi>"9G92 Nj9R{r/-L/@Njؑ#ر55D1 BU_X=)*Q<~7a(%d"IC*kx[jɎB)HHfUa`VODA75jwZt"Ȫ !3RӟnJ# אn%"[(*J4(t#Wpt[7#ޓKC}8 #@$3ؖɢw A;9"ͷUG 4J{*;iJ7liJ&Ȥ@,pW;_H  qe"2&$n@Ki^!E'Puo@nẃ =a.piPN8D0dY9o3&eԛXxȾ̆m.y As\&ĕ#Y[K,RW4 lyr* |a9B5gSp`8t-I֬"zYƃ= Ԝpǡ"vt +2dC, +Qq#G 1aJ841`,){^nN WB`U7NpjD`T%7bld=aȐEaSpW]9 :x:N6 )ޓ80 <>kM``e|R7}R_xLQP^h] ZwE֋'4?eK|pFnsD(J$% pOy=״hoAL)GzmBv$A1H$Nn 2=eLi`vGCLMuȱ)x.[D0nBV:(PRz (8NHh#D\"2A̫|DQ2h$mBm8~2 qYEA2 Y*BwlI(s4hhǼ Kpd_&E+ӠSq!p4(k12,{(=GX[(Av\# EăE˰slddɞ a\$'r5"Y2^-RuT$q z%}0ЖC*`oe3Y1e 5:a>$‰JI6Zx#OYQB4"R-n8f*Voq덀l^=yj0: w+a0Ze$aPa}Nq)FEv>‘'8̳LݏdE"ih'dpz Ka[ a1KaCaCO.IF] iXDU9wuF$I+f$Ց?4+'[XW|(K:g|dZ%NM$'MJefoM6IXrRL  InP̜@U"K%qRlfZ^;pj{ac~,RuoXcPf <̹$H;01 &7!D`yK,fDYr[5Re 4A325BJ4= Dq `+I EQHbXiOϓf|9h$OWv*Fh#cʫ蹿(d KnREE)3+,:P{)֍1Р< љqVeuN"D+gY',K U53dnlӶ|+ ^X&,,E?*!@. 2tq%វAi;PQLϰbÝ8z 1/R.|g#Lϕ30Zg3d!5dpc)D p$[ qpf2'%T0r[D sGdTטM'u!RVgWyTAQLmA{L 9%Y~Ɠqy)]E .]{g흭dۅϊI{រc%*` o Ql%1Ak X~4#@,99$7. Ƽw !xa*bWu"h`e}~2PHMB9ȅd SǬB6 YL&q⒌rd5(+&16s5"eKKLe+4%@N|;ioSgn{^aIMC->غ wݟHÒq:[II-= H S`vdHcwVʢZT3J^i,Ыc5hI^v)!ۀ Cv H&UGlO(GpAfö3Vܤ<ŒqK:0~-릉[k{81_}[$ar'(Lbci`7aG*Anϣ? ЃI;ˠ->+WfQQwOy k"1#gB^iLwz[VL,&: AV.-BMX[^0 6'zA>5Гm}D"'P& S_I$uxAaֱ7UOMDrPQ޸D<ȤϫI'~v&>@!-̠!&ׅ^Z`)7}Tqs0.0(LEkiC%ft9zBIGl6"\%"\&q?ۑԚ6H~yK3 }!E~оE эl*iFpLԅE(~M薒$2<(JmZނxxz-1贲:x/fzUHV&Y; qr5i!\:F3GYr޲` *c:1[mTv%LsMnhGaװMDyk2'[?mZ6tĈRF&V%%zL^n#P}6A4u*.a.3Vp/Ct3y$+DPp No?C`1ً<X uTFP# _ uuR{@=tƯ1r-Jtn)jLLGDp=!<Ʌ^ɑ^KWư3ݘm)PXMPQ]DʩIvz f4*2&& OH|*2ҽҫ۔pʆ8A ôRrܪEy ^t 0یl;bI&FbyکMM5'1~N?A9\k>ZZTJC 9}eRHB&c ZS9$U4vNa̤ ,_^LQ>8FA$2Kc_ >8I@I',E}n~WDٰ _SBpN5  k* b[PƐ#)pcysRcv0ݹēF>"ʇ _ĂK, RRj`OuLˈ]VTMf dGPtɷ6}ng};#%Y;N y{ʁnKaIz[ fGM(lz.Jӿ4-)0*|l_<E)̢LLiv)e<GgmAm>OET4TBBtYCؿQ=` pɗ2Zm\WvA6 l#b4ZWfQAGMxc/Ǩ-,kYLNpMXh1OȰ(2yU'G}sO#M{Qx9)V3پNs`wV($¢&t-1`/u 83ⴅ-[hsL8*OAs;Qf_)&DCUe&XŌF qGP˔,h*)FHQ٩0>{/VK JPCxV 73Y[_YuͽXR1({rXr9 R2ƛBѦ;CI9TDMe:0A@9ȎA*P j͛8]gԐ#/d $&hŚU_@LP$~C2!xґNγ.0&yNe0l$>zLޘs\X#ib $tH~o† L3Ō5@COZ@62+S|FVX"mLdkͨMxM6d0˵4/?"+<ڼ)RJLJ-\]a(E Pgy%vʁ"]nQU>uWO{D@((&@b0l4Ϣ#r$lVYގըXYbUn`%!&brG UP^V6b-b\sFV/Q[%pÛ)( ϠNQm O4”2gO\FDas<}$9M:C8\6uqSd&xߣPSԺ#{دT[2"9rVLE[nqE cVL!`dlyZ;.uOR hb>r*2B@h'"&}n3!kQ27%Th&nBCe!{K8:0`RI&$wyy.!ƒ6/N˘5,FK7ho$۪NLr&DǤ<6^(W,RZs^V-)CICb/">  ;# /_hDDBN) Zk郠&P0TW|]*\Fai``ၛW~ R 6ƘsG LD`u1$^ w%tCKḍ붆^z`̌[;GSddh"&e~7&]i8Eg nS-V>03+fUXaz(Bl4ivc(ăʝl* ]IPb DK%bIp$A+K`*MufB8cK*{-)?sUW,{ y("+ 4Q4R}yG 2B%6`Ғ|, dOh􂴥YM- bWNE`8Qf;x#qZcWpE#)u|L!x#Il.OfsUC^iB OuE:i`d;RƢ ??( áoEH>$b5)?e,qAC3RMF.$R-gufbJ3<%2fQ blʎV[HHm*vS*nAcE)jtrEv"74h?=*gC+w]̏' JR`* Β9g:~nI̥ZofG!@kQk,^ȊdPUMI[^K1ccdMmG ">DXUx`24(ZdJY~_Om98+lCfc5%D`lII&jVSt*gCbb*PՊm64" [i3*:tI 0D$r›aQIRyrnHdT7DG-q%4`k4ᲾiK*iB?CK1X$-8SL%0.50&% |7>=ᷙ4ʎN 9^\cMb*47d75wc19!HaraԻVI/p P`f ,κ`6s[g+$miRiɂbLoٳIX:(& @y",\tDz./a[`-#ĭ׉:"9 ;5`:PJ8N |(6aͅ@8ǿ#ȥwZaq|ir'iPQZG\bCk" $WĜDkb5$<צjMU6Y\r,\S"Sl?p?)2'u+-#FUɯfb" `m.GJLgJLTfVTYC0ƗԢ. VvSˤe,DmS|XhHú&=8DFHZ[y&Rh>o{p`8ǥ; .>"-E!8,^wca^ʯ#V:ԧa^*;%Lmn~$5 m4M6֋_S0KY+IDAT}-~Wp"ewG庹 ޔY/ e_mb3<]۶XYS>R@ }pZTtE7[l5SfmKtѣ%"0T90߭WV *n\Eu9C h üOҧ(V<򊏹O [B`"x6K]X00M(U6ZKIt 8eoT+SY|s%[([x2I%Aцt,vE}];uJxC:G}rVC|h"XJ`KzHE`MP"ɣuC& joĖ6kFHʞ&IJjԉ;n" `_1[}K!$n6EKi쫴`d(.}a:{+r-ܖnM'尠T^mS^ ed&^UOxG{Jz&~$-[ ?^7"nBelmhAxِnZ>o͐)a:Ft3s*/n_#OޛgJ[grkjJ`E@Gԙs]GA.eTzr):ٍI1j&6Œb wiE7?5 λ_ZoLʶ;k2*s8[ smO>YRX$@EyԈKL%Sxg$WjMw}m%_ o]+=KvjO įj!on!.tM*k㜱ֻSH.3;ZhleIs43"%@zݦC.[T_ޝzR!d쫸\4mKO6kK^2)r>qe=UBܖɮ)Y>{ظ]tU_y@>0$Y<ӑw_L_D|H %p|G[Bx˷ґ,=kn^'xwiK;nˇMZ떎<0Vyɾ %8Ş3_3f|ON{sNM1/֭ǴKx ;e#۾sWMU=쐱K΍ <$۫K%Hv238''8Ӌ,wĢ Q2Ε#e`Հ֞[>iq-ܵcK<8|0w`bEv$VώTXB^v~ OS̰tսĪOWd[/gN%yH7V|ueMTT৭ֱ؍0[*{8wzc#S`24qJw_[$M&gR[.S^I9gxCXWxh1i*<_4m{z **Rpٗ# j%\wpυ#|Ga_}^88qGa3g|ǵ0IĨ5<"#a{bDgD&pt}hwbmE-^Xp~m{VLw@߭p@%0RNԯOss"l 4֓zM0l7)ok> H[]zK3#G9PIȩ)&\N훦zsaQ;RxPV@'>CsR qN_?g;ũfOy09h`qC}Q}A+_Xs4wib[ h Q,`@})'jNgx~$}ԇ]wz$IieńoDj&&C `pp fnQQQcڠO_:NTneGWϡ:)l oɘ8B :w_o;mkg Gqa:rRu:lB>\] 0` =ddA2:*z5\ijse*`dɥ^×JҴE1vPr@-mBCyuPY300ZŨlrF1fP723U S9*h(+\;А m&):U ϼp) {jH)Ft}NٚW4 z 9:.ăӊbU`9 H1rnG:T\i\AbH鯦*)2)%FLMSS'Yrh@;P]cAP] ED''o lhqajg#P[hn@P)\7`\ñY>h%;Q<ˆb$|OO|.L{jEF#ʫV qՕ!}#WGÈLnWI*pZi#ʀyVwMM9w=LlUM!W!iy%O5COGąGH;U#uJPsvd^c.kQL@`Ph0 ؃B@>Dt9SU U>;j}69aJtYs~c9zCV!&J OI zύ0H*拓N">qԫmTWr &}鯡2S #87D 2MUh.f_!B׷ZCipCq&15}):Ky}9]>ci\'pDKEiR hk0*d-ҿVinFt&nrȴh#4"WQ d\O@%r+2Ht mf-'4M&Lw,Y.SiQID*ưE ]b8`T5:ؠ8D*tƎY%ZS$cҍ\J6HV4N:ZG(shjY6_ɘ&Nli|] N+kZwHY(L^s))ndЀC 8KRFI̅|JމDeL_#heB/ LEqpʿ4,EN ifw /7IR;:@o^Za2b*2-b^? ~7WXDiꮧnd"9y܊ˆ+fKᄁ,0u}G1t}=? oû` e]Hnѭ胿Fg t l9OFd8ALl+tPOd yܬ C,!fE᝶ DgDF>$& k41 13!ycjt2 ! v5]v,uBKc#&ܕ LyzKzTZE L!Ŷb$1QbD6q }M"Hə`MI)6B])""r`SI0AHm {lo .e~Q =d^ hQq/^ I;=~'2m\PÄp-6IdF}E1IeA KYF9MԠRܖ s\9&5kSBs5:h8RgBu|UuH'2uY0>Vl(bn>bJb( M MmTt1j8Y~ĀIb1vd+mƔvQ3FK#1v IXXq,E*".gWA<t08#d,!b@#3Fo~א@KdXJ| I>$;A@눢\}M>9&j^ۿ_Rſ뿶4ODT 2`^5"FG(c|o0|}WhgD##X7~o+80DL,X$G~6] }JAT06 6Ø6`8?]pqk]ga8D@.h:Ʉ(3sFغl")Lr!Qڨ"ŀ(HkQO5b@`  ?`D- U%uNEQl_F'v O<8z!UhIB7*k^бDKD$\#7REHLM@>Djc;VXći(VTIUqS>e&3TՒ0[ OJ;af_+57e#pգ8y:_M|jhiр MhBC0àva@A"cuʳ¨2qm-*Y &^y.¥̣_soC@Dgc:(kMdՁ"L10\ڒob4~dw鷦QaOKSKT]QIeh9nEO}_Nś;J~hQI\')7BVG j1ž;Ĉ(1^.)Rt)lt1C r2 ](l~s3CR2gBY2ĹZ@|R(\[v ^rAܾ//}g%IV^CODMs> pfSWJ > * |*kp{fu@I& 0iPxdU7f<%X^GIw3:2`b_xDs)%C8fpY}Tji}9jHʏKVw*  [bIOdb@]v(CB{^؊R[Pk*b8nMVK2j($4Kz/D..,em'>H> GVS^` j{I /ۉm.y@%$bu@#xA9xЍ0fnC!r aVDƴ0*SZɢW@Ådd|! /6f#b1)pZ>؜9[#?4YwO0fHCnWI( =MP Ph&Êfa.)qɷș$.!-qԾ!@UL0CL`]*1ٟIp)'g%̄A,@ĿI4 qK&GA)hn&aGXH0ʃ ҢDp81jGtH _iͨ o^Z;Elg`jǦ Ҵji^џFF\V Ku/%Xp|3:MxB3j\7WGJ]n7(} iEK+uJ7&y@egҍ6"M1h& R ͱ^фmLE5\)c ܨ&P*a2C [=2i1\_u"\ V˿HQo 6 "t& 1!bC ćռX5=;#tLnh1BS`l}[12sB*OWHPNŻ\ ͬOkCN(-43:OiՇfU@0ވ0Cg2 dFmӇ.o`yx..ꛧ&˔G$RۈFqZ%įp~cO?, sBmTkcƿH?:z+[!&V_LH(d08㤅B~-{#i6EY޶R…zt#y*5E)[4 -F++<-;͕5^q֛X&|7ps^阨J%A,WJ¦60&L)w$YR)!%2HQ7@bY&ߞ$_$(u k7QsxEc6R#u| +8k wFr~h%Y^2M[֣u4ߘzpw{^d@Q߄&ƽ{ n*9FaDXy$ 9?,4MfXIu3 QN;0r/ZWK11@B!V\Į &0˖ &EOAyS,h-CЃy NOՕeQd1MZ0J,`(<!%y & YMUx Mt58c fؽtKypC:OHQLXUOx>am=ۦ3"+Cmd(Xu9!(i4maiC*36]Z@gl0M)!:@8K[[yvu3Q5m\'Od鼆I:5m)foPrh{lGE9-2 21ʴ(vx!`Mx, kHʫ(Q@-:CmTl˘^ષM\R+CJ P^Gc[2ȞoSs7 ?;1#8LiT(/yWAu1@(z;d 3:f0U'A 0TtUQ,sW< cش9Ff$:3 !!}J [U1fK \p1I\l؋Q}?4r!";km ̑UT+xVd2"a;EdR.rJ і5ms]*_E8?q$ΉΘS;ۤ!SSӨG໽)1ch$&wU 0!+) ϊ,*jxʚJ:-qqBԕi }Jr2QP=-%3 QmZfrALe*ց$myS PMvnCse5Ф(y-Б^̿˿h%9%"m=5 iw]qEmwEr60)=.@#Ehj-X`*mBk#>Ċ %F J1mTYtٯ-xҁِEyٴGD9 @lįu(E4J͉f/|iE (1k)Ǧ;6`.SthQ/C ^[*+nootS+1H CF\[mKLo aƚ½qIW:&#+oKzmSӦH'L^#]OmCL/`i0aW(5" t$*Gv2 =bTE_~$Ot:N?=蕧Ѳ:D(-Gb:5FƱDYYD-%76JA$Cpi~I*NQ骛;Lt`^)FV䐄O,w*&Tt M(p̃3cC]0J -?˵\0"(>|.6'`٨/2 atPԻު^_$ާ!(3fBdlמ.ΐZdoEdd͐Km"SyLQHMC((jW. ~g7AKA1#$:(hG# DdBtt49 nV q(C.*+5`$A&'Fn5dȅ&7b1<%Uќ)d[WV;]]4^mLqc?GcJKR;/죙z1!IU˔:.ʜ$SH@c@dgB% @R^5wIM2qZC@J&t*ɇtwكgUuǴKsLa֎æ8|TqegD`>ZG*8n3M1#f_&Ԣu\Pd@ )L9q1RJ.gDaKb:i*@ d[7izM<\:b/F(ή2 e VBBUrek&Ͽ媎']Ca`d8X@;]!k::WW% o<\hƧV)tD*&dǑr Ѽ־ȂqBaƣVVsh16ttJm$%R~!%)@bv{ĞQЖ22@j`xjS~=%}i=ٙnAv4Њ0h:"*z אfU 0Q& 6ا@;{*'ʠ,#np~;!`e6YH8m[Kq"ˆ}*5LkKGYow6V&Q69˕2Gw6\QnqȀ1SAnk#SflU?8Ɔ/`)=ƆT.$`))+ sRhD76q"&=>Rw16͖-f~犹qϯڱFX}_)F.sdӘ{+{kMP[/6&gk)Pnb4[}K(~6YuZŶpd 70S]!ϊ̞lO{T3M0t2D 2]A}m}zR}y[&jb DCп@|_dUӢ nU+,`\X*^Qcی2æ9W\wDܽ%:`PV9Z9o*V$ea5dF$M,n U-H1u t? DZFP@RV,CkVTL%jW:$UvUU!{3:R6G2bhs-nHaÒĶ0dv&CDaj)/wV&̔ D 1lqv wXER/Ȑa\nAt!ynFȆaV_$`~,V2)i(q b蘧k)G<{0#flG|=(ViTH a$0]i2`"uVCfҚOb6j(B>I :{YsOdY" Z/B#9/"F7#OڞB2Z1˜ʯ9Xyk{]GFĨMFۑU-jNF)[ eBM?M6:O*#d^}<`<}#) 3i(POқi6U1e%}0 ]ĝ^`]Kl10H*)-#/hlh2Y%G  eK FB ;nyģT]x %ILjT1׶_X$Cb !X˔mH[^eAnGDI PuBhIZ<%mhe5X\7iJ'"[ *Hxu#߇~X`%Ei(V6;QmLلq5"{o"̆PD4jxӝ>Qߢ%-!\ջ,Jln(2&faXoow4^ M G԰ ^/dLx$€r: 11]FZE/OU5[7#7@ 4nJQ$+6Z_ L^d4fyܻhAA`_䝭.^ K'4v*0pBEEg-*#h!7"t_/? +;ec}KUGCe#xi`rs# f*iAm&TnU-WE¢'lk@#Iݸ;]>x +ݵ\>{Z8=^nMv*S ^f}ЇZ_dD dWUS4۱?.C&EԦB z4. e;X;ڪ*}c!݀_64 !%"eI~EPP 6ik-i}`OcJ!+`e{ ɒ3>)@_o4jHNnw_0Ԙb4P I+:&nj$da>ml7 eG(ӯHEv`hF΋s4JS4.0O\j{qsCENi^p@ssc$i>6c2#o%.sJ`r J8$ }'i$܄Z4< (H1X0uD4uYfG0*IJDu[8(L\}jƦr0@*Q AXt7`BPuGzG&Pl۾yM+F/I$YV t|#BX5wEt>.ڈSэ/5UZ1$0/JI!v$N5C1tD$:#=IhZ~za0HϹM3~a#qƦ FQ<[_J*fi.hXt3ֱD1LJPvkG . &#XQ`)5FYE GG0dXQrI-2LO]rVKbXCj !}B(ܺnVu\Q]?rClLL¨x +4.[R Mv;E7p 5I6GR`ȿ-_P0ҤLj#&k=>S f?ZD @tA")j Es~K 3f7&:񠅸5qLvD'EӅIC b+¡ Iu\ ED…]zaH*MBJyOw*ߥL #_Gz $~.FetkTUtR!B٤ѡ`(0 M(wU1QcdbR09Ey䌝k?O SQ@Q\tot0|\XWRf(n< vyѿoz-KaPV(_[Wb̐"gdHTqX%:QH- bTLEAyo}ŀNSTeh}`x\,:B$Z'' VX>hFezh0ԏ~iJ(}&e=+WQ@ͿIkR`#ܩ:xh:;C->"'Ҵ! tx-?`șSH:&wx#B+n g[8/ NeZŧjl\`t) Bx&Cb‡8Tk}h^^Z9tYS-K=Y椳%S'{SwbB43h5Тf#ԴL|qȍx~-}nyIObȍCef,f,k:f\9R`2X^BDnJ>39 4I]Sp(@"Ε p>UĆFU5lHhR!4I{ P%l <2:C.*܎+4ܚ6^Rvpb20+a!нg֥= "X.)H,GA?u;BAXo"^R_^a?4;^0 #U_syMd߀OEݤ{x\Zj"gԩ"o8֢kN+hHf[JB++ }R\=ɨgKuWmޫ*s#"'hnտ.J='4$H\{M6Rw/!j  ʕaMN9 T<V(+#5.|22*u89҃;av *qMNAX<p9?iMkj1ǔP~H1a \љY#֋uQ!"9V&Tf]P'$nRY")5gfƨoe1L^w%vm4(ЊJɹ1h *fz)H0/`hz?* ߬?0e4< ˼!]4:mwT KܡmYx^~]l ='ܿ:n8)iwE YZCQw*r&m@1gPƗip > [89j\,܀jH,y:D}z2' E"&vHoHq/T&r&_y.} bSb]"P.4G;J<}_*KHI-]C؇ â%?0S%XV:7d*dt6Z^4>3-P%b tՑ&}cӕ Aa4Dw*qJ,pڔfa>nB Uta΢s4q|$u"+)j8擳2kvRá-lHD[ GGc+1IP0K;'n~}A F>A8 *bMAuxT1]W&n[Yԯh8Ry1RdDE2ZdSKG `qsdbz?\W߾ ygEOSf a9 ~#nZL!Co Ile ^4GyRpJה$ӡ:*w*O`Z, 9KHS21Eb#suYWXX GѥvbO,I+V{LFg%FؑSsdNP`8q/e6: eC߼TG9h͠uhaQv&h>@L1#( 4a̘HƯ4CX (h݇㌚\Mꩫ$l#FJ+fISyG=$9heb@B RcAVfs*4Vu 5u_iR՚0Uk#W{PZcG1WV95WQ LrEr7y,mpg6]k(XG*gN EC.nYF2ux`.4 a rJj7Rʻ|B*IMSa6[6a^p3nq)~{ђ]%7Jd*FF4+\Tlb-~:N\?EkǷ^Ru #*k~C)+1[#Mw1*2j3pbgE,o pb"s<!x( c0'^(j r!sjŦm$\ (i'4P,(쯛ZrQB[NVtLP@8મZwM腧ɡWcb(|L*R}1TZFp;+Q2w%N˔7͜Ic@Q >rBK굏/hdNW~s'nֺ/D{ \^M Sa3>X&q^.J¬Æ!6㓹 *#& 5m^Cpgk׿|,]VRWv2ݦ$&y.MH 4R t2Cuh׏~VNf#f"`̞9yZ 4v{q%K] C 4EXd~")tՌZVמ 7!KM`)/A,l)' ?ekU4 IX/d@؈zq]ZgZm"QLG};L:S"y"sFKAq[9Ǵq#1BluCq#"M۶LsG8ncNYT&cطSNF" ŠкF_eD}ABA!SL20ui<6ȇ &3ZO@,dE2;1``6D¤dsFE$`t7gԴ F t8oRVH )gXTWeuDg9J*eB@*B5NsEI$@5 lA*|H 7?Z+RfDDŨ!bfJd$xnO&[ț4}ˀ.ta "J4-%2ե&GhĿYaXCM{hPzd:jhvnj-%h^ GKt{-X鶐`GCGZ:I8[% (+R~ +It4 HKU14& J *:o;*iSvmh)/L~R5m4 %DwZQ&H^]ڨ/s8Mڼb[3*:O V^.\xWCTq7Xgʉn~X0`҇KAx2m k]Eak3>MQ*O(ǜb:8,)Kt3oٖY`(rQ5Éֺ$.,)A&~vJ -큞<-hw /lh[:ZșO\UaDM]2"Y,vB':˻ 71bDox&=l|s `2n8ZL@}z%|b@P[οz "@irG_肒5*k7ԪLDY--v5tP#<- Q^,0l*?jiZkk=ңYW9\EGnJq)SL}c4rWCgo'܁/b6]%2~pf죻}X N_LZaጄYGibW|ԃ\|`oЫ$de;p;kƀbcxM,%]OꁯSX]gx : qA UTAme? Q;>ړ%?#WQ.?6odG[x&tZl(IZ>mg9e`!y1N?lL}ʬڻ_>̬܎VVӢvn-71XsWaN776&"kUVצoޑ TMTS#boe4O۱F(kJ!LN[(X"UDL>& VK.Jp!ZR D%F-HL%j`e?:pIl@aMqxVua`!~~n_2=9B;) *Ř_=7惌ok7 Swj8Q:ukv T}m|Og@+L]ș)cTЯl /UYJv<(t@BX _S[ oaVI%ܑ @t) HŚ -1,s(Vkm%!g˜B$Qin}b!At0H2Axiw E9RD!'epb[)uI_FPԬA8't˅`S-zRubQ/xTLwN[ɥ<\;YQz ŗTVǛc5_6ZquoSHlqxtC3pK0""Vѽ4P> R}2OV @^bίއ*?4M(fԫZR9T1_եYVW LA鎛-vّ ߑ06<Hk StKް+.JmVÔ$.kGW.h~.w80+\:+bKObEFY@l|]+lQJ(hNn %ae70W {bZ=mAP/{VIʗȋ( 0DSFGN(SWDG)Y.HLF>Vf+Bu120bbϢiÁA F=#.&:`0ZtX5"X+6m/(8Bk#RФb1+4|R&ʀKplc:1b)wp5C`hL2k!H(CP_R3A @ rjGJj #?UtHa lIAdȄMg$KfB~HiӇ6-pY)EVyx#]c~ZL+էP[/GN0gnܱir\9&H wSѵU _)af2 ^x0r)`bFm@@ 2hTіt#3b{4ZW>~.zd[^%&r&Sas7IvD{ς8}1kh1#wҠJEІ7()CPE eLa؟4:o #g A0%Ȋqyٮak#5G$,Qq17+861Yވ84Wɪ1Njۅ./43SUk C _)y$uZk`}%eh1t )kŶFyR͋T`u$CӮyPV_k_/ Rt.W.\~}iC|hBd ztTv9%)WgƂkAh߅`A+<0/j"gYo,,:3_̉I_D1`B&JEqiV8jȂQZbBa,RZ6LٍV^\QPv^u$hcR/C3tNMg =}v#PEB`:ؼyGgM@1"TגAd<*|@E"[.-n* nenK'6z7;ڝɧW,L$n>;ɿ8+9u򿎞~^ ml2V'B$  he @IUu"(Hyjg문DmֿKҗ vKytW9w9[;:/đqG@M%T7GVمsn&/QL|Ά }eT/_ǁ׆"/h:ۋ; TՉ_Mq׊L_&z#5d6#D Qe͞zB}X!78z{S)hss]Vn[l)~}pO䇽!ח݇ŇCt)l+Omff"lMAE膔aD[&>#dl{^j底8A8X"9mJy}AQjKIBO/of/C Iq &¦oZ[IfA q%Uyq| . bHJddE 8"hm,!P) : A#tnRASXy'}I#e~ob;EǪx-OJ>͂WZ慏⦉vöLm]2̹pVkvRk"`I@7"2#tD`lЖ!K[c[, |;-Fk R}yxK-,'?'Rh#aQsNWf[o % -mMwL&[5IENDB`Dd $in   3 $A?BD21318_S"a!bhҫ`[ymy Wnhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`$$If!vh#v#v#v:V l4  @@@ tNyNyNy06555pNyNyNyytK'$$If!vh#v#v#v:V l4  ` t.t06+,555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+,555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+555p.tytK'$$If!vh#v#v#v:V l4  ` t.t06+555p.tytK'Dd p - s >A?Picture 1"b*+5nw﶑Dn*+5nw﶑PNG  IHDRssRGB;IDATx^՝uW˽ڧ{N X-k4@  !xBu,qwi/{Ut&{~sT}k/yy?V y rZW8rb& Cb!BcX)A_Z)U4-W_T)y ^xbX.x>~9U>~R3s3^RNB- ܪRb #~2T 9~U7‘|߯b>T,eO83 D!_ tP(pgd2 pjCnr?< 9=K0p?|CqQst=z,ղnK(=9 Gqb~/t({*Z5~ˍqQ ͽ~Ѣ(׭PA ֫ºxpz:CfpOZ|\YW^y{"[&BFOOBGkex CD<|$ z?07T)ESSFAn:m޾+ yKƣ|<~_P^RT*h?Ʃ8spp b6>ݙОg W*'RЂr~no xl x" %nn$ Ԕl *!qT R&ΜJЄ"Iۥ$_Ix:Ô%nQ^'&ސĒo$l*qaËff8A*K\.Ҥ)}tdaƑNM45#'u1DPìE/O`2?\L3Ovƃ)!c*,#*7戸K$ ћg&FvV%=bC\`!r':ZG"bt_,T)"y"Tޛ }Bv#8vZv{{P[ #\rIbk/1bɤU.,2XQxH,QO_Zv@feEq<,ԍKhjiP֯-[f糇#p.5jjn]]ݍ%z,b, '>,_TgYyN"syY)azzz$|g-psZ__[>*c0Ke lN˥KFZ.r~}8-͞&LӬMrc)"\t.7*4ǓTcrt657 uheItsi: omL$_%JKe$u ZA/G?q\([L wˇ!7$,90"Q'Ek!~^l@cOブ_> h; 3#A\!/i;o wbQ s_g1%",65EPQI6L$"bX%.^68Q^_\G,y u<\g4.ww#DpX ;P[g{HiFaj ȗPv QsKL(Jb8ˡTDAJ9:0rE #C0X#⯌1|d[4$|v;HùX,9M9=0P+F#%Xڬ̯ysټ l_ek&}0W[7"|&avC*bUӿ_> E,ϟI!f pȂ# f_`^g荧1?`OS y#&no@z2}mCCN˥|`!>`ܗMsM$S}TZN иQ QOs9dɔ]( }^ Tŋ{|Ȗ'܂n,$@H˲՜\W9<,;ugepT&oמ`JsMp!//8-l 8 g(HpN즆D/HbMl8x/gBDiD{}FITdtp0`2(8ev1rɪQ,*JGk^nMR0A4㳨בsߜ]WŌ?=S\MƢ74F-H2"*gvlA<нkkڅ;z:;g|{FB\vxKMw \៶CߝdVOWo]㇋6ϟ8098ClS*<}<~sC[.=o5?ɏ=v@#R;nu]Űb<(rGAxc9T$#Z xKB$AXAJ؉V4 #*n볋z-F) [ml8+RJIY遁|6xnܹoͶ斷[6;L$MTޝ"هϣiE9_~W9qόƎhsk7?nc[66D {*==@}O_eK-[u◾h,}UM-?'dT)Kf ţ{o!(FGQyΗ_;iL L{w D>jb"Sb W_O-8:܍u01͇Cĸ1c6߰efc?w_3fv->믏'Z~=@qFGq+2Yã~[?Ók{Ʒ7a=E1"ADʦ/\Ȃ+_@_v+0ӂ#Ͼ;v& fm=^I7$4$0pk)8KL6OO7PCK#l.%q(K|q%Hg(/!T@#?pcgΜd |Fwk m$SO;m΍6х yر#_|ai(~9\;3rHE$z۶l$>m @[!Jd$0MK Տmzړ& oЖ>9&u$j=qıS6GÉd9v. _wu_!\0sϻ_җӟtɣF?qٱ.T=P?E,0qo͠0 e$ ;M:"@ qoowZ|=z*Qٯnw:Fģ2,(IQ,?Ab61K֦x{s2q* 1\7$Kz}K1L&3߿qO< b5r)v䷸)'p)Hz衇֬Ysys1dɒ;2K_dB)pСyp׮]|\`Ҹ+;nxӏ~xN: =y/B^})ԏMrO-Wظok?Li2dK1b1:i'+t(f?hme1I."`W1e2L%!G`ŦI8p߰&V: ;.rjL\VD౵\N\$e2YˁK*p(SfRxcxOY+_#-^ BQvjkb$:)_qQpVryoalPQEP]y_͈k3x,)ϒ&m<@cAzn}#RJMMY,)U PE9pӜL[~qRH1 '82J`V*QE@3#w`h1 ۟T /aH,LYWd2 \w|ut&:Hm{~8gCܐWُ"Q-mF"m|U?׃ {r_)MUrvz < OeK8I)sS[Ň?smC!rO6f+ XU  ˸\*]B2n~d"6kxը \}MU1)7ֳ&(nt)&NW 9꣬Ey˪w9( %ǂ>WutGnFG=1aW7q/l QߚI=Dꃣ8ۮ` ik'@Ƭu!)VP2y~XσW.oAUiypwokws+U ]q)J^_Y{ņt6Ι41 )(O_EEVc#xk+kM]'Q$tD7BGm =K=GYtwck^+i錡(/xSAen]AtyRP7?]m۾PRn\u!9`$=ϟz7Zu+񝽹XYBj\7Nd6>%b;U``|AIw?ka0F:l Qh֩c e5N[X*]gKnF#:_C)f~QpxR?k|}EyjM_qT+)R$|U2Cw/Vs`)TɥJ{GDVG*ΜqUKzR3jM%{^yRلHffZisC^trĀH;Uݠ]k(eW^Ch r? ?;q0E;t?ԞK([F$WY(gZAx٣jSn@2a:q| bpՊU4eI!OTL&K%(nXbQ Kɏ01ȟ4nVq< v}k*X;ٺ: !0F<n $iuIC(pVsKkPhxyw'5^ /seuW/ڄ*6Mճ`zCRS:fr;%R %YQA^bʥ ѧTkф\[R~b0-Ŝ(Tq*b'Xn&|b ᩙ>:Z7ZcyuvhH \]OuPc괞]F5;&{Yj ոA)[W) b4d{^Ne ɈH gQqIARlNki͡C L41C UaWp3)@G{y.VCId{YXU *e$X+- XzYꟑcQ2l?q_K?70!rܱta(8WCM\@WGMhP8V-(L+S=|,'g'W/™C{{r~mo3, )?ȋXuEPic1jP=mm"-L]vjɓ;j840ŵGRz4$`$)(]ZS'RR9sF&֪i) |E^<lqmȡҭ$ {O%F~eg1D%+?szA^¥Ti#KD<^@ƢYr޴'G7Ŏ:ʳ8{yL4Ƌ%t,BE"Ij*dO=O?M=ɤB̥"-vq#{̘1ÚأbHuF bGT]u3kCGWšt<;6™3Щ{z&n`xuEa,Qۮh ڵx6RwޞH4ٻwΝ8@άY.b,8Jx⒡Nr h!HR}r[qBZ<4F jѢ,SC2I+eqz69'CDę#t/J./0k$kSHfعs/~7}Yg=;C8Cl!?0`d|?sSݑh+{(/'m==F&#eM< [gCxьݏ7K_g٬zc;v\wݵӦM7M8o̱_uk. vNE|~%jeCd膬 0g/Zxz{:R,ZtӁ L"SN# @ ~huwå)sF']P^4N͔6)B& M6سEæO$bt&Rv;oMe͚uhO?h Q%:ǼFOzCynPK1h>-U_ZޫE{#3:_Оh4b/}rFdݵsʔ) p&O% TJ$¶Pw2P#D;-{=rq_xHNȇUQS!:` }N+CnosE~},/CÇؿ7h9v>թ GG?>bWNc/W(<4suRk/D,KG}^:8Ԩc i#| 1HjF yP0[Z>5vv#74ɺEW !PjU,ך,KGSPfhhZڱ;yҤ!kXs?vȿc⢐C#ԭF*$*h{Y򢱠ѶNOϴbڧ| Iu]w*z$ј/袎&ܦ9ttx+/ѩΗO3A šȧ4wvj-_|ԍ ^; e|g1zˏR,  dE_tl c dKUÎ!x4Z<3r' jWw8xѨ?Qdjh GuڠwEdx=?M uχaY~UzY/܅)R½62ahbi0Rcsf~95g:j;Zj{ՎjsбMKoxsoer:<_xg#\(Dt4{?du֨?RvV8V ʆ {AhA_Rdc}칗^zi[G;%SyD[ ǻ:ˆCPsꢸTڬCea'}  Tu *'P"]0zhkdl4cr& vut2Vw\&.`Ќ9SwtVZԽJ`=4c.Tְ9}w;yRkvv]*1?Q iYƍsŗލ_r^uA*%=wr>gB.0/{ /|nT$ߝd>dYF'|\/B>Df#xx>E%Ok26-A0֙L%(ɠ.Kt~z˻w~'ɆCb'q_G . ?ٝfID9ڃwJ&)ȑ,LmY whOZ"eUis \u!anr1C]IAs8)@q;y|7.-_bGu䕟.׍LD<[ny$ECC?o{ٲeT0e♽XSLb+˅f>;%e.+O Od=g\Oh ai_6 )եCWSCm(5lZ,}+'MSy>}{^skX<4]I*IyN5xYXE 28V1(ݢ hajOu˯.}ˆhjHrO>M/*h\W !|ÍFH[SmzbKo"qkOvHt]!Q1m{&cݓm,he ɖ" .܆ \!O /OB^Yzg{tzkKssc+464\qU}.]c%n+jws׉Su35EE*DyҚHR]T>ԖuOk#Pʚ~vxR{٪9b.{svK_xa¸'t2Sb71| (d.y=STQ5ѯ໸9cA,0e JA4Flܺ[oT曩P%n0 ,PI{KWm5֦r=Mc΁uK%p*C 0:nIr<QߘK"'O? o?OL2%y|O$ИȖ_SWa4"55[.•[<iсXR>,;a/Ξ7wX{(%. IxҚ-In߲P MbK8}Jg@ŋnsIO5kL&O>amd*X,]ZS=Fb,Gp͍rX>/ ڲZ֡Zxʼn-'?zsw۱ke[ZfΜA)L[POWu j;q CƒDg)օ]L뮝;>`7@UVm[ۺ֬]v֭} AV._{X$LAB${b8*dB)U_!j560%a^ _Rpf1o߼u[z Tli5 }kxҽ0X}tc"`W|]x©+W2O ?<\QYMȼ۶,]C0#Tip^*%s=>a'ߐp')^X 9N6&gn>[z}/ ~ۯ9k_a~_l޾°0͏i_{lXsgI<ĢF˕1sĠb2ʨþg~G:x(PХA2I0`tnNcG:KAh])( %(f|९A3\wM;b{|pѢ3=o䘱y9"No So{h>]ے z>EBAԱ!b bւ[8s-ӝ<3A2G& rݺe;b_>`PPCr5]bՏR!G񗲼laR?N%Cb`+۷oC/ITv ~p.1I"rH::UѼ>ԧlXl=}}?/^15#zk7xhwZdq{{9$=.b2#T`DFHu=v~FhLta{&ѣG%ktfJARUդϫLOQVw9LgEq1-Up`?s‰bɄK- zɥ=aw"Xwx㦵1P ZUC.yILh5r: ('R KCC0WkGw8 'i ?yÆ(1 M$n}7mp 7w}Hn 2txY`<.8A5w#tu5 L'7GLF#29 &$Lڷg/sF>{w_uU'O^DVb޽~q}4JūN$N1 >] cp<oQFCef~3"fM両TQO?rҀh{dX#we$25Wwx*BFTiGM dQ⟢d8u ZZ?`{Tdv?óΙ7؅C7:5[n?/=P1;#yԎ(rU" 96v](]P0=?e~93‹%*43Jrt:XĽYy[Çy8&Hq}.Oj=Ȓj$U*² `#xE ӱQ$ԝxn=^Co1XȌ?n _΋՚!U@XSCӣ=GNIhcF [hSB! M[l&C:qr9Zz' ³=ZӮbGr*[ Pt?.1dIDpP7l}ʦHhYj#<Ə>SHhN50T _@_;\V,cs#VNwvFK o 䳢{3<#꺎vxSZCٜ2[%qb3< 5dqNCזùq7_` , 9/qb[R8yR<c݈6^+nm ]PAQHeA5GX(♛\?5SH#i m:B`{1b I#c|Հf3h)Sb‹%:Ll78X&V0yZJ?OѦL׽xSO?ϾKyRu!3)2_|tc,>[rE@eմZOƱ\>͘N@ {/rimfLʲ=\7o?Ƌ xCJ?Ȕ1lu:9szs[+[귾Ō"胉i抿oI]'?ysӝ$ϪM~CظbzruF.yIq!xQq!]>FGX,t"57ly?5v/K(P<W %z0"MEs w4@J b$}Zn?9 5PynhJMsЇ>"ޠnxf"ɣ*M{R(M3$KUmU'E}NAH!Ky9U$4B!>_əӦ:ԉ\Bykp x,Fl<+68^A_5XLh^"E˱!u10qw AlJ0):mݺu `.~G?Ɩf8N.‹kI4a7.@(bӳ wX >@.aM^-MGi@PŶ6ml/5%BǤs`8zIR!a,$?1䈝p1Ǿ5%Imָk.o D?An@Y~?} 8P%<q.N0ΊT|xeJbQ*||s]`RԆgɊ )1BYmmm[]sL43_<+Y P9K>O#{#+N&6ۨi8erC<2 /"Ƕƌ);F3MG+"烼Zm+KȖaaw@#Mo~3ڎw5p|gH.B %KӛQ~." 32.ds~:ڡs0OK0?Gd{'x"g)B/i=R(JnVr&7|ZIEas||+#sVؘLغ,+lrjBSEϡ0)j_o75|l ,On Ii(㴍JE ) B#s$ =a[_7~ Y?`p1-飱)5.4.Ov5X,mGL= 3?gl Ȱۓs\h)Hz!qލ 3g^W!VZbŪw+6_tW DĹDhhv qރƋup q;vwǩ)O~zr |e^T -UgT E:Z{K3wGb$xgNd|[Ŗ/6'f&[ ^ML`21\ 􁵉8F\D Ԡ$@`ǞpSJq5a,>#ߵGY%0eN,rb8}ݴѦ1Le.Oaq't:*_8wvv)DXL<wuZ's1׿*hOstLf{EzqCi>L6jpwA no䮆b]G7JU sSHHml&V8F4-6V.A.̝?7傌0MDFi/Le!#'`l jhE ?VZ?tI' I֗ɣ8Jz;,.U^dʞ;[ceOp@Xc CZ}`ǯ}klKu0VM#cerhC$߹*AE`ΆC#׿cF:Ξ=޻wOnk-E~(},7̳OzP&¹s\(v]rOG_p, A,/oŷl&E ѓ☌Wtܩ {y6?1X(yvf?|\}HMIY* D N&jsՋ\ro|둈0"Vӽַ:c\q u Mo??ۺonWu21TʘgfʱrI/*P`DM;Rҡ8Iwx9%خ@k 1*Yޛ7  AM _nK>89SyJ^+Cp&Wdri\wigv5^}͛at)KnD1Zy϶}}5XT זigB&#)^vB Grg!ۻuv92T'Xo_)O: j.wc3U^>Ïjl>`A?БumnIMkȑ#qh ً3DI)C|`vdIY~{K>?c Ih.!+!9sf]7M>HDbxH@]\Kq&AsAƟS=GKLFc ']*{[t^Z$g@3]/' 32CS8ac -70=ݽ\r5s ;c  vFL:&n.ԱrNB$>xЇ^΋ 쵿;trbK__Fa1F.@A:_sm݊˵I?ŝ'6Jo gI ז;-nZ=‹?ԐUX-OSYX}!X Cr6{uHgIz宝;绡i..Fa~D<<;IIr$ӢaYY, C /,e|i٪s 3mq<}'zρY)&S&"Mǻ4cLn1,FRgQ\~ )(cw9EBF獉H c]r3KC[_z"}[inj0;¢1dg׭yf[[֋`+t2_eω24i/EĢ޽ ;ozӛ0DZ_NEր'p-0sfzq}.|W)E4Q ТyoBPZ>ZF ܺ|XjW/ 1@~M"Sq $frKfJAsyF*${go]7YQD VXBXcwe83&Khܤim~Em *fK Q%ϳ$_[pD#qw64C$\u?Ͻ=NJ? o*D2^9`m փOYj-c_L/i9fd0/oSTdl PMBi ”iS״>?v'?)NMBU=`pD}ѹ"VԾt~Tck V[~I@zJ0lt$Șѣ!8+y==dTҙwtIxz2w<&+x3J=5ېk'gJAvB敭h/X${ YC>;W;_*c~1|yQo5%,yZ2Ƌ:>C`$H@l6K^3 B1Eb/v&ke ->QhGiK#裍$ܿv9j7ј|~›n,wea.qP'?hb3,.f #MꈃaBL(͞p}RY4Q$+g1y )"Zƫ h!,0OܐŒ+hx߉;U7P5FcCCBP`kFxCrqBd$-&mR:ZNF s~Zxo]qAL'e~5tzuw2}$2JFzUHkI:sIJdڮS*Z& DHeĹpEu2ʧSt%_H O % k'j}(|cc-# _3X9b|) f]RB"T|0m8D zR`=Sw~7Z >+:c(]W:*KBy ]ݶ?V `1 /Ι0 ^",TʋI Ekz)l bjeU%j*H$eRB(qx1e߯:/+|d?ht6y;6mN A_WDT' S6#0CqY&SXS1C\izk_d%z{PxlĉJ"~M^͍~bѼG~Ǭʟx̭-)RjK5/|tjG-Ks$rK]ƺ Y>h3^$ L#o[~׾ M0*Da3C%Ra8RT0}{ﲖO9s&H& t=hiA6c,H4."H`1 u~E-0(JJd:*3EQ(DRT! ~g?%ƃƀ- qi,uB">iN)A^"S'!PKQÂ~r_uD=srf4=ug}Ӡ 2Ax:x1C jl`ݟ{n"\Ë'W?xrmqEe'D92Jqf 1oGs7SI^f5zMd_|a#O>z֥{9DߩiwUnD%ۿqⓏ>Bjcҁ[,%w6&1r+qQ .D.0!=0@ H>kCiȀDN}m͍o"@ |>ҧ ݃+p`%8' Tb]=} M|@v%Ox@PPꉍh'1 äfߴsψhB r8?k矿W|s9SvU_zժH,|AӤs [ bT^f,Zg^X)O=kwnӭvh2xAc<]#!C!N-Nz׀P/֏A*HSUyo&-Wg٧˸q$k5a*GΝu֙}}wwn"Ь3@eC۾<9@#կ~p gF xbSVFpM"yx$.aUD靧q֝=5kȐ8sX3/VOѽ N"Owoz}rfh8R&ek>ג;ٯ#,Y+.'t⩧8:]#P3+emmBg}VG{fY@kV'E A"~|5ntnat( `ŊsSA g&1ߙZUBiU +^r-\Q Vҍ'R!MDؖ*k7nڼs'xc߲b鋏=wL4{'s 10)V,lP2;T&>wYz(H[(#^bq' (0`^:M'Jo/ܡ`-^_(?&%{\x۟8kxྕ+Vʫ;v/~2yz /w9vdFqtH,KuC2k#*3%>_59ZyAo'[-G3&d3p1/:]G̱>|`_Ke`&#lZw Io6UCEx1Ѥ.O%{#rv믑up*\ק"|D_'DHPȗ+|G{W/_ʑ.GDZ`мvg>N ' T})nٹcxK{ü Nh0MQU9KVqJ^., $0`(x~tPjZjCh`OT[<?/ux %v!T6ohDD8^zqyNsvlOfVRySGΜ([ )t䮭 v!d&Mof( o5>"[BnTۯyQD+l}4J׋b1t٦W{">1Zc%Nyդ胀H#HRﲿVbq8=#^ԆbjƈWcGRnPd"x!.ƼAQ[ ;V]b'y:O5`9T^\1-{пQ@E$)=U$L0f4nm&Vy(eط l 'L|ɥ9< \L צOLp'3{TIVd0éOe Ŭf=T&} F^/h}O<QG:&w{y@qBUI _5 Mr-0[!Cgf̙"6p!8zVn2ԀƋuh:Z:Ie5 F=c.yn!^6ɧc4 [[Q84` C_%<-V&!=fK&ËS}Y773O:8xdY-xѶ%1#OdU! 83(|$B1 cR}xxQ GlzFT#2˔d%< g&OJ3sK"b9DNI=j@\~}{mV %Pc=THŔA5?]`h?NK+О@.`[Il D s-y@6`1!{|(h1, qS)soy5''J.-RQ-IK슇[ώQNjD58}č7 5>M4j"FM5g1.y=Ӭ+G!!2k?Q ͑_җSӑnQ=OAT]6GL(Λⶁ F߳tk`3ܠ1cU gcP0SN;qZ1 .|E.:? *"Ja.MI !Q,`G D/Acǐ@Lrr:[RF,K% .2\y0.{ҍB7i91=H1ɞ=N7OH2=v (-?cvPI''(+lf4նkjnq݂!L՘th5^Ԑ"ǞLeU? '!yx3'L=SFs'˯o9X7L^I0~(IpIS@~,# aJbBy/bjjRbf6b_)l<38 𞱶UwNdҁv`bd[YZZYocGnK[J5?uEŽsןpʉtt!EHYw|wo|~77|'O~疿e`lI}桳&VFBe$m6:=0ECWKQjpBNA@iR3fCT9}N(X}X{w -dh6%\37"PCLFVy;{doȠcS}ù;>!W=Zh{kO-svaL^'_5~;BB,_>%5T_J =>&l17~+U!Q M`=.ni/K%J3!$-bV52G#̑,[ ^~.C$C DӦr4\ HULL;[`/֠|-rBM>E*ϣc* #7~ڴ)mLk'FI гiD>?3"YSN9ví1`ǪrC!9 8˜V~Ur2Nei cZսmf p E#G;0lr򾁁omA>C]my̍0\NG-^?O ؠ)l9ӮiWBHͲq#+ u4 "j1b cfLnؽm7l>Is 윧N jm\OԵPF9[=e"r(V B0$2Tɇwt}gٵ{(r'a-pe}LD*T5ۻo[i{{O1m*=d:.D,sz`0IjueiBqF#b;A007g\b)@sls +2|yAHo\X}?vyG"N.wYR$J7oJo}D<~S)r@:MY$\d9HIDA-+X|Np@ðaM0i9Sghnm*x+m[1q E%i+19]V=I oW? zןܬ]y1y!0yÓK;Xf"`oOj ]틲4.,vy! Aƚ=CX&epO~YgO9cxGN43vƍ0}`ʯh; 1LEB qڄI$c0St@ {醎]0 $妆"yu*?pX 6י F8z}c+CPXL^OC ‹>KBTY~n`$e#ոSN=M(3{ʉVMaÿn ˎ=t'9yiTzJG[S2vd ]O<s,lX^g hAn 2C\2{&-%1xiƸ1#Ο~JS>;SlH77  @$ 1nړ!|~!pY` VrC :Gc*>'0X4= A`n30x‡J>WN;.b35p.%p7]qO={2xҤ\ h#N-EQlz\C=߅yvK* u1.u0kRDL ]Elr phKd{@ǟÉ:|Tۈp<}-E3Dowb."=@FC-j1, uę y~\~Ct&\uTkƣjfI;WB0A :ƞp*,d %a|Irw8ych-%K\=3<0ƧE&Mvt[˃{YZF$ oo  5HApt(hBֺ{v@2׺C@3zrw'J3]"Sv7,۰i#~b͠;! 9< o߹4QOz г4'Nzy'vJpЗYrͺW>VYĈc&s f/a=1߉D$pP qgE#<¬c - { 1`30h:5q4 3Mfg@/r08H_DÆ pĄВcK c)hxx{#GCoʂp1D\y vá/Q]$h:xwQc!1.pTD]9l8NbbeG8͇+yHJ:{ޅO|ե쇾> 7kWib8‚КdK$IeXEln1(Wߝ"IAOʽ)=iN՜Tԝ ^(*i5Kk8^Ǜq\\6KBX$Pn F[=FOrްLc-+lݸ|N@4iX\rwh^e[C]h;5\"e /=cP`[FY 6U l r6|&S5x8 VaÁ][+_" uiFRh"\@%G.M^'']%C )~*ȐFw Ŵ*-2utwo};xE?ՀPsC3̜r\ڊj1`Rei#Sr0%İIJݷ{y֨Bu*Sn~zGZR= SIogn΃Ǒ蠧IdʫMmDt#eYk$Q&ՂGrWlRy)HKpp2@7GA"CUC}T9۵u'ٱjC+ѻmdmjC8DO M&o.Gv ǩBVT@(*9|7 @'0A*4.I-.AVA/?y !1}:M帠41t "@/޻w/PK?NJ~npH57md _zEP@C|@CU\/Z 609s==p_K}`:qIT׍1*ގVOK}A=].gY ֲsh| ڰv u^ZBaInE=6aӓU5Wa&WrR!hAh`:DDd?pSؽ?|t%Xadŗj -_M4-Wx+Nӆ7|gԸ%U~F32]i;7m_nj;}Df:LޘTKjކ{62[:){M?MW^l3=/e_\tE7,ćlW wT88w7Xlf|=Ī0QW3vpAX5L;vv= -$Г. P/ ͨ@7CHhh0q B[5wYnˮQS 2B!*Ƌ.ZFF%5jHz_\3Jۆ% Ie?ǟ/4%7mG?䵯 JZʹVjann>m7 Yc'L$|i/M yQO>DKY0aħD5)͛Y㓎?a9 nܵ|2xlWx}xpa+@t7N4ȑۍ8aڬ%]gη]s $1Sc/ `>ݻtutL4)j9EYvۮ#/3lFbħ CyQ\r9ef)b.X^m%tɗs]le* h- 6l(oC`?p"#qh\%_U#?DD>Gvغڜ?nR,acs,7E}`Dx!y^3H2_LOMՋছ֮Z-Equ-mzƍ?L7wcȊwq'@ p9WJ{a_xq]X"v/+$`pEk/_HEig~YM̈́I0FR3>ݔ2r߱cqa pX;rg.Xw}bW/_\ugW~:ѡrfIh'* ? `QGm5(w#vuݽ=LRyoYTDI!@1Rǿxq7^Ƴ^b2{k}yj&&@TZ,E j/3]E{!B$ ] G>lQAДQb<Rca]B~41=`@+am]ݏ= Ymd)>Y'W]Xzr=cE ?t)K.E3@wSirQ*^,GP^.&A5x•Z{5B\$"<jvtU[*2DqQXϐMARu^\=֘$5ׇ hDz[7mzF#N ! t}{CqsRYN;s_1J 9=ʫ5s&:R$!:w}I z>^&t+-%GBHB5T(6ܰfF1tG&TPYUB&Uf׾[uO mIS,]ےݐ'jx+ߵBNxg?|Th͕2{Ja:f/+GXϝj=wMOqbXzkߟ衠O=bfxQa,ċK&Y/z[}4,RMu8- ǞFة3g6,[}gQ' غϯݱ7W"MhCnE+YUI/xP '%m^ \&ݞY ȳ7^$F`{X&zGx̹&T#^p_7g͙E}*x.X@};bp8pފ+2xNpmx#F+`)r>Ow` vƼ4iʤyػjon4YKtzsK7[PXE--x9f >t2>۠b*&҉xǝ яNtW>81<}ƫ_w`'FSϒ|SR C[|)ysQM'՗r(a4|=},نk\>1&Фror>tfO#5;CPweF_-˔&d$,Kյ_Ū浻n[.&i?Gu&)x ?6d`iK(Yg0h-y9EV<5 1b ZVX +cx鐅,KF*";GPeFD G 0Sbq$30.5h3Ï6IOJ Ta&yC`΋gOB\ܛb Qջ@',i8y:ө{)J>BN dz3*2>=KN*Q=@ګZ5q^0]̔jsg_wZMo>;7nǟiM^yUO1w2'aEVn چRٮ'9GoCa4#x# w"x|gVAy#ZR7gCk#: ]ižxFN SDE_8i c\{7ވl}\>!q߿l3@V2ܻ\m 縆rQKK-]×v^GS+yYn`"zI{inq.Li_B:)X_ȵ@VLI"2}0G\;*f;BF? Qq #/-pWq@nETrҴ:3$7 oO \Nٯ}}r+-'zk~/}_nL]Bh}r]iO I 'Ec =R$R@YJ'Vw,,1b$1#54Z Ν}IS=|BZ"]2TJ0I0%L@c;7B;E@%^?mc*u$W'34U7+B> "7?r|1 ޯ~q V ~`i!ײI6Kr%ٛ7nALb9p 2;)òJECz#ф^L@ʭ\ia:NMs.yiF  4ub@#FhQ/hj5 J&&\a2^: 4etKGa3e(b$]So ĩ9g.(OK^:F$‹Ds/3klkWqfBN O_I:!ŖK& *hۢ FuJ(JHGxW˕d(E6޽ɮ>*(JL+fp{21A6<%!gOYsH!S0%50 !ƚN5Th.6 ?iWpXicL7bLI Mу]%GVr!Us9gcSY7ڵEaWd,:k&PuE: Apebv4zQ}%ob`9g;x"7A%bݶ}۶c 3ɒHy{Y_Wj9lj֭? d8+P uyBМl $O^ܴJ"X2\8-g|,p'"On-OqU$0 _'cCIyIe5h]4ތ0֊-۶lDԁ^eE(ХNgJkop#4&Hy˭ ?/buT0u?~O<h˦f&_* 7;^@.&^+' q0fˡ81 0ըQ#$\K5{nt1U$n)0\@Aӫ?v0A'z (wOOhs/\NKӽ/Ƌ ;jưƨb)³M*OQ$%yzz0'2pv {}B:aaa5Mr c3$]|T=oߴ@?G`a8F4_O8vET$c:n_B-:J7Q ©Z!*1 'hԉׄ3Pzɾd8 6K㐑{~()ԬE(Äjrdʒ%^qr?s2E/}c[h;~*W/>qwmB`4=`TV:Ї( f&6ǀeJl_XpuJ% q_}٥b?iU @O#c3)M?,tHuE dFނY~kz=L081hrl.UїotD[ߴ/`B@L`࣯zض@{CWԵÓ4֭?CG+66LqJ"Q(ny_@=Q&T*X|kT  br$EcI\V%g.7e!US,!ㅅ z]q]t%pRJ˕be,S ub?#4 GR@)&/ŷLB>@$H{Tu]49{F^s2 ۏ0E_ !EGoٶYc\`=x A0]A6I4gdTe2^tJOHX>He[pьgYEx8gM0q\ pE&K9%}xʳ// m$1P ( y_<̓ L‚Q@oƎoG|o{; nPA;}>{`+c|ޠ7R @ׄu&Gw;hjF}>wF1@5+4'gǀȄz;4}ť眉Нx"Pd_j zvk 5P dl!ĵ*y_16W[Nf 7 S<^okL$jN5=<ʎ% bwļahB@z~_y]+Zn~W_3ylkdHK4[ rۜs%p™e^J?wJ.CI?qܴvF[u46$~(6*dub@k̯-w 6'}"fA#b!3?L:y~=*>WHGeU : T.]ԛlg}&B:uO~J8F"~oQC2<3+o sc|Fb~C 6vԵ\6`X!v[M1+ⱒVBD E3Els{W{yh%"8[)0CJ0v؇>aYYHDQĽO,L寢=O:v(D*3S0gc\o8 4 4YnvMdMە%to -v=.t ]R)xr\t6&A%VqFw2TYq{wŅ{ŋMi=UtIrOtj\Vz~o[M?y{}ê(3jqgM7yB"Vn 1[(!c@ӝM,W]ڹ`YT:oR,F4BC٣cB [tf"8E4&@op8$5!q3Ry/Y]ݩ$?UfP2~VX syCzbXzW]7ݲuSB;ƌ2u"X #ߞGYGGqFrN-}q~wZ<9ě (݂Ĥ&:%kRͳ[(Re8w+/gAU;3b0؀f-l:ю6*.9uY`rQm2%er$Ȥ ^6nMg'8)f3uXx{)/b<" t'r\WoWY@؍gջ3ӗL):}̳z4R~֘+gyP)a#"o t %%Jm[@uۥkn9TҮm ߹A$(hG2׿ RA8W4O%"sRYGY(LO'eL!FCX &Ô5׀;U[*YF.:#1fX->{|)PQzBd ^޵{N,G[W cJ ;>p^YO@Qtf7%y?H>G%\en\p?p86N)lF!/b_,4b#DC 䆄}< o$IoݵGL$&XVlXzC[B)kU*}e5%U!m;aJp_je;cӭТ/oW6Bs HQȂe Q,80Pkfд4Edrv˯? BcEư:Ң.0zd4tM;H)s8QbZ#ߐl 5]SI#@4b 4HX( ?Uue?W'83= =ڶvöW]G 3F;_Fؠ M i 7.bb Dg= wPѣGRcraϟ3*@}+H4o$!$V %yNshCVf"< \KcpV,i w1Yc0SDJs> 2 aٵ TRW;a̤f9ޛ&D(H̛\U@@X#`+%nO$vڿxgwDR|h2qBagJyfCsR6oh8wVE^XQ\D9/ۀ8S ^L*&F =u;VEt1[WrQ;nXk¹rs%;yI:wzSxƐ#rԝ5Jw9ԔH*B7UpH4,uِP'oLX &|B )|h\qAж[u ctX;QgB "i}m6!`jRe Tf@0mDh#H&T+I& AC=c&Ʊ)yMѼy`^ 4&WuC ]$5y4k A lڰfݠ*tpP5fgՋ؜do޲1c:z!޽Nm[% yZ$w/4e>cXt_ơFv*NqslWeBGnX1S7. .n?G<:R̦_'<)@x'\ 5"p7\2Ĺ`i"h T, uלLv svBvo=~BDS $9 s \`{h)s׬`>gO &M ͣܺa?dZSFѣǏrr|:xwњ@vFFbnK??%TECDT '} D< 맀9׫MިR/ ")۪x}0Нmi5l3d{s94,iHD@Uخ%Q[O! Y*K-T9X6ým%0P9oJ#y#^LW(&#CU ]wݽg9PMͭ-DoO:d.(;$剧QefOw៾ VP_Lή_~Wm5lh99ڐ%"Ր7MȖ)ͫ vW96 e9uD Ե'Qv=~M/$_a(e,Y؎8%mnDn#&$'[gFt ;w2oN`^Y#I̡ƅ-m J{[fϚ-n x7761KMXg6rt˨ȒTD]ᖴWpqc=ù@6J{֯Zm۶uA 6]f{RΙ֘ dTh 7Dӊ:ԝ-p#.vsصV]M)&oiR)Q|g68-%Zn93gϺA@԰0֭]ǖc[J 5>Ĭc#R3oa MEqM0ȩWkCscQxip?]*Q+C1+KYy51Rv4R_؂Gŝ٨E8*B OĈmrsacJCI"eӈ&P^hѮݻi?}‰'M4M<3~Mo"sSy8.3,c (яZ-dh=s2k9]mf/GTWD<`44ji̞{0.ӻsߪF;UaVቓk%ZŚ#wc`W,0^v9xo59{c}̮ 9U^ Tz_ *̌r_t{є.E`=$WS؁6߷k3O< X$*ԗ9D۔LL7e'=S53_’%˗.X][gz= #U;wnA4Mm3]J:}DAI:x)⟴Ћ=٨zPiW Z?`5sv5hmX];w3fD 3Dz2(E09.焕cSa: (gtd[՟\Њ;^`U+G`yİ3'>ęg@n@FwV2.{ 5N8kR1F]EuuoL6u_uR3(#|f90pd1r5hio6vA68A% z(݌G{ܱ--%`Zvjkyq=p?OPICL@f}g {71wt@} #"!̴uk"~Uj1PTy*FA~Č9[pdZrpzv̜1E~?̇ ' M^*}7wǝ0wyo߶{ 1JC^Պѽ@Ht Ton 1̌׼7|ʙtkΝuO;nfyҬO6rUԵRe8eAø^f\{C'a&ψk[ذ./_?١@٪Wjn"RGdzۘ&ȬjT$0Hؐ%pB>TRszK<vl̩ 4,۱iMO^O-_|ˆ~Ly<  p)GUDZͦ3\4_CI裘SpP|OMD!F֔tL&( N*؂ji_| )xs}&@I\Yx FnFIRZKޅp*t" +_eU@NTaQ hgytXPqesܮCGvҨҽNDs^]9s"ӝ0-! &t$#ه)=@J--tSG3? -A );Gx|yd/ȯ*/6TMe S_se7%S}1!Svc?gg% Wnj;ygI$u:{طΈC!pR{G𣺊I.D…:5/^&;r](43]M:27|UoN4P!!_?=V|2@WH B ҇ #.}L$!UيCw7z! ~v}*"{,B-qwt !;vmJ#kcpt#LE3w8lu+6rc֬YdիW%N8#Gb\^۷۽`A*1'O1O i& F46,E@K4ܑ5Ps)H9*Cd.>dÚ(ea,< lA$X03CI9Ki4塮C֮ooVXc11*ʆD@Xj=VXd钍7-_lmÆxH$L3d"~m/#[k!n7|R=s]潽7;9K' L &,͸OLkcMcZ$-TRijlƧf!WV/PexBU=ÕKޤ` 9ť#hWK< |1TMr"uH]W;ŢyoNMo\|eeUKl=O`` 2<`$8q}#$d e]zvtHc$B꧀#}޹RE?Dlo<9aQBء!L[HZØ;˦nPu5Ut7h`y,K9\ TőswM_Ž[9~b je VܴK ZgV[ݳq3cN;mr _.HrQ:~\%-"X*!tve <1`N`:.Z'%:WXKvˑDN֗GVb9]¡ȄcϊE2i .`qBҐL+<;>gJЃ"Cp5Dg=YF: u*_D!ByMK 𛵧PEjACո1^mҾn%qcjF;Lj5[[C[ANr+Uӭ&Fȥ mO]c"4,Ƥʪ嚁HxCLryQ5Ě()G,R[e̩.Aye{،Z'\NX=x8(#T3k8F7sPȷfrT8Ғs <`h%HrP"{5qNc ~5 %L=b~ ]C 1QF3X=vd=8Z%seI3Te+$~UJ8CO\lmtBl, ea:LSakU.Aщ[-Xb /!GqV7*GOc\[{j1[:z 9? ݡeZD-kM/qA* o'Tƴ3 >4)inH Jgzh`4QIuV4pU )ۥBRVIU/I|:,JQ5 [K/g7Y$},jj88zǃ9nj.[1CCuv Yi[Kq:nbzyK:^g wR8B N7^ ꘓUkps!*҂R6sjдYLJξD9YqӶ`fA7;`y.G32򉽜M"mi+W50o]D¾$ ǤR,"sm9fdZvƻ1qVx 4:9@Eْ!?#/2OrvHX!QG&w*.k$ &Yfلm;gmk:[YSbaU:$K"][ps9hbw4nm' %ZQW @UJܙ]wV3^2k7& T;ɑXS턵2jvҰL.AOd xvm;>wjs=AIxw=;*,w7?)dlrQI#"dfwvWCUojRX&o ze/~y&IBAgCUj2̲{یND8yAhZ)(.6Ӌ H\om 9dk:n&䴝G2KìxFRf-5t_[P?[9.JBe)Uڍ܃(⪰^HmvuWrzfD{1wj,B#fl5P١ȧ{$4M1S>WDVw/k|)aN5 eb1VC jɎ#-$)/aey+8_[pg'܂3P{F0~^02吏T8?G"n)4S}eb1ODXYtSPA^+b𴭜|D** %kI65: d!NC kp lezk9FKgзbwPc kHb \@.1ġAxڃn~qE9T|媖[Yw2 1^$z_6ŇPsnUFƂqvOe&1FQp]|9e 1JGNS8"&ݫNj 'md.,@"P3vYeZF;G;[#Fh tS}=Tqx?Ea(VQ A}r7La{vjuևzR,KBMh`06= sKؿq.[W0%r+XAHq*YRY8"VX g'M*O0RkHP}y0 Yt(TF>uL6\^V]۝<ҊIlƀtۭDh }Nq pt2:ܡn53}FWFȔ]7O!54neۏRR.9貾]g$ưQFCa "RanBpW[ԩ** Eܫ'ÄK1?$XH(DZ>N Felh,SCΜi/9BVmh\Tں]~uiJheجXх<>m!Cr1*s)'{$,Ba5omKDl?[VZ;R -r5W^aN"KzdXY;hP t{Xٟn[p E|BQ5\NŘ)k89ҞV~n)D(gUm%c\B$'4[r@p& IENDB`$$IfJ!vh#v #vV:V lp05 5VaJytK'$$IfJ!vh#v #vV:V lh05 5VaJytK'$$IfJ!vh#v #vV:V lh05 5VaJytK'$$IfJ!vh#v #vV:V lh05 5VaJytK'$$If!vh#vo #v #v :V l t065x ytK'T$$If!vh#vo #v #v :V l t065x ytK'T$$If!vh#vo #v #v :V l t065x ytK'T$$If!vh#vo #v #v :V l t065x ytK'T$$If!vh#vo #v #v :V l t065x ytK'T$$If!vh#v #v^#v :V l4 t0e%65 5^5 ytK'T$$If!vh#v #v^#v :V l t0e%65 5^5 ytK'T$$If!vh#v #v^#v :V l t0e%65 5^5 ytK'T$$If!vh#v #v^#v :V l) t0e%65 5^5 ytK'T$$If!vh#vL #v/ #v :V l  t065 55 ytK'T$$If!vh#vL #v/ #v :V l  t065 55 ytK'T$$If!vh#vL #v/ #v :V l  t065 55 ytK'T$$If!vh#vL #v/ #v :V l  t065 55 ytK'T$$If!vh#vL #v/ #v :V l  t065 55 ytK'T$$If!vh#v#v~#v #vC#vl:V 4 t065/ /  / / 2-4 Bp2ytK'$$If!vh#v#v~#v #vC#vl:V  t065/ /  / 2-4 BytK'$$If!vh#v#v~#v #vC#vl:V  t065/ / 2-4 BytK'$$If!vh#v#v~#v #vC#vl:V  t065/ / 2-4 BytK'$$If!vh#v#v~#v #vC#vl:V  t065/ / 2-4 BytK'$$If!vh#v#v~#v #vC#vl:V  t065/ / 2-4 BytK'$$If!vh#v#v~#v #vC#vl:V  t065/ /  / 2-4 BytK'fDd \uqp . s >A?Picture 1""9fU2@Y!Gp"f@= fU2@Y!Gp"dihnex읋Eٍ#5`;bЅqV | b, 쀌++>zQ7DB| +1VzGaAA@={[ԩ{uOG:y9'Ω̼*.R}U//Y?k~VoKB#ߕ)_K_7n6^kf׵=_TOW><:t:t6H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $@b 1H $_j<`h>&@b 1H $@b 1X\(r}P+$$1H $@b 1H $;jţ244_|`BlF3g61H $@b 18Zb i>eʑūW=rG~hzz<vB^vЋԭ~>VS2FvhzկVeN 6)vO $@b 18xbPy;㷎oO*oyxl]y4jx$ʌuRo#]IY6AzRc=kH #%R0B[yz'ʹGdJvxS[yz=K/}rq_'LP/^~<=xȾǓ$ŏ{e{G1v:|wԞM|llҫϏǚ8u_)j)tw=1]N2Z^j}9dfmnG[-7Z䓼q,<_]d_S4^SQVGWo_ԇOSLrڃE*Z':zK&kK'nߚ|ҿ&ړz:޾]{j#6W<{ ݽ<ؼ5au[|tl~#Mq\_nَ4]mѾes6;ԍώgly n}a_e깆L/{kEN^?}? M'^2_?Qd'FMe Z Sz{d=vT=ϋPOi#~+ba Շ<՗h.ӗyю:$+u*F>%Ǜbہ^)m,FrxELK<臼Os /RP4J#h*mL=T2醬2주⻢ѳyȩ{M* mXY<)+ޘ̞Qcn8doǘW\cFo֛mӞM[vo[c*=/tWO%ב,@tQ/V;mO:Pv\jϮ {p|졲pо͎a\).ZrʖBcۻL2Yv-Cenxi|K:[K|3=u?bMGݻgZ׷)|eu,V_,&uεxb"8^n1Wlhαþ{kƣoux9?:()|uC&23MgaB9y~bM?].6U^nod[ ]Si[/}Kg ms.8uuXۦ)-?iߦyde4W8]β~ʘTvq)Sd52|p[';G~VxԸ3uճ 4_h2fivHMaqKe\?[ƾw%fY8݊ W13/cU-;yא2LV :tS_'? :|S93~RlN7wHZH ̏k}"8\JL-.ycfg|tzɥSk?>?m#b6gd{Q@-={:~۰ѼҫLkLǧK=8gxu~mA'0{ x7fy&㤓~ i a.aM ŕ5Z4ׇoܿ86g OX<lÖm獶(/ ysg/> ?W?ooc_]o|d{Gw5u=75Ooz׉=M-Z{}J.LZŢV<}PeOrU}lC+9+}sSK|S.}'A{xŨTuE,HFa3ʦ dU(4idsݫmeC]cC6V:AK=yO˸WHxl#XI?ʤ cU8GgCӽR#He {dAF}N.+]YBz׏aWPj1Ӻ!tx˩ŠzC[EMNԤ.Ϧ{}IwvUË2yDSK1,(~/yUdli SR$^uK쌯џw/i?vqw?_,q D',y9`mFS{o3?WhñGtS,nbﰹ?$swڜe |gߝڧxC<%w3ڦ6̃ WhzbVB61SbyQ\=ΙO'$OM⋽:=vޏMz`gPm2=]/+e^^W9܏Zߟ[2Ɍ߉OH|DŸ mU/z8lC&YW oT[s/%J.AL!#HWC9} MSP{~̣N^/u><|)z٘qžŽdRJ=IeY<$0(y!Z}$kV'ZSFWEc+Ֆ2d^xd_l-=eKxzz#[?×SrҖk2;R&lZ~}h>Rb-5^qBR8?Ÿ G>o6[Mn3_ksrޕa)F>;ag=72\ml1f%1rQkʐɟU~ģq>'ȟ$?W;ǭMN>{,6<5}ΐ2ߒ,!6͉v4hq1*R{ɠcXQm8nk6I*4>R7~&fx"cð'o yil9rA㙹r}ib[݄ ^_{hΟ[ukF쵒nfܟZlXԷmɧ7-LyY獔oomo%/Ab\1[.h oHz)1N1c)eKt5LNi{=jMg?f/w[sǚdY}?=(׺2l7aJ1>+;>_OiMb|pJwζύ.QԘyn|%73.ߗ|?ߓ8Lc dO'?h}2,Od_TqѓBOOG^~% *~/,U?EBC?$xJ>x{@X)/N}S{![2AI'7فʫO Vq>R%{[R'~G2?i7N=)<>NP>U>$v@gaK(6e#F}vZi|=D+ZŅTN*4AtT[DlJ~aCIeKC/eɌ54nQvW*(Ծϼp|q=ih}RΊx\(cC1P}wbq_dd=Mr߷yO_t/M1&8ÿ/ ZBGRm^g])V'I7/.VHeT*]m&*{=Q[%b -YGdn~)shOIN{@pf{)߰gK.M_ti; {]9;-M~1f ?8š$m8?C[|b1y:Zkⴡ{'lBݳweAWSdqY)n{QrH\~cmF/1ZC\7 dy֙`/lw Y;sj k/oWZocyZLzqP;/wY~'[RޏDf z4։'>#/?NmO;R@yɇ씑'^}^meKF!x2RhWQ1e{iL;@۲Тrg >҃1ہ54=?$ʹ^h:HՑvvt^>#(hb̲+eޮ~DvߥS#u-ٵNG~[J&zV̓XO]SdcD'3]\0vfC?m #}r3[7Bt<}|#n˾yĵP.O.*G&njk&(Ǟ}'6\.Xwoyie` }+n'Q㣳5kMvgM."Z$s7nً.l?׳e9ý6MqV΋ZRΝXrbmXguO7<6ť8d;>^񰕞/l~|uM2fka^kdG-|ܞi;_&FCe!tee7F1շcld6"fĹ}5lݟ3A1 zN#7ky!߄sORʦ5eO=}5uK6S}'} FWOv#=R?dٚcFG;>K01wd7$}gXGˬ߉}؉Zq%)1)Jh}/_K §[vu# xlZ?^eGcW 20F<\MGDrȵcqMy0a-Tc/yP_u柷g4x: ^4ū&ymD[ay!狽5;oJ<^zVo]^_‰{)YSdzŸdδ3~ټ}@,&?hƥt{|ĉ6YH{4f |M>g7Wkq)vs~j~}aۥ=|?zɭEːçC&_[9#v9#wvMXc-i'Wߜ1ĥN#Xgv`Ϙp}rY:(vzR=mXOc1! ?R?w\m{%+eO} ◲Il`v²～G}l+'{tp]e1۹o ? }Kclx×a=ҏ3X؅eb~}E6qύQG;|ѐ_cdShȱRa&ys5ыߠcI,?~n{#7g<1EZBvT"} Z#h~W_{ k~|57+M1 myx}XlsnyZ|/> $fكW//4O>JYH;_z?{AvX{*ֈ\wMy~1&s} Q9X^7|7}W2ڞϞ>>[o"zg<Ó=`Ϸ=`/bP5|muL2Yqo\g{gZ1hct'vI{%C>oO1n5f,d<t#m2r}rޕ,'_2 }kmu-m/_α־{W_C7ֶQ/Y1h~S|wbׯ_uV?ciC'*>='o}WZ4cHo=Ɠ3ǧs.{ <yt})NJgՑÞ.Ϸ>}f.|8(f{Qrǃs#i~>ἶ!z[y&4e,/o+f;hu.x\`m5~e{Y{yfӇn%u7~/o z_c񵑟u~lkM?H=dwFEOMLjQ*}cښ:xm#-Xc(z4^3`$CL3\:-Izam76_^:;W@3\FtpMŗ]t==MӦ@b 1H $@b 1H $@b 1H $@b 1H $@bi7 i@b 1H $@b 1H l, d, ZOlc=g99@b 1H $@b 1XIY:1rM&@b 1H $@b 1XXP'lzr_˜ڶ9{,'6yWs9tQjk>m0Tx9};6#?9|~<ˏct0ϻ3.RG?r/ɅX1~l)ό-Ғ'޸=gz8SF|"_xwSv6%盍S1s ﮔ5ch靖sn\scwt1ϻL6>1bR&؋vO 9w曕ĥ,aw~oG7RyfkȲaw1x w*km=qI'bN%gFO)+QO9eW^||۫hמ>wO٢cbB_񩕝(c'vd/C[Oq9E[}~'V;Mq)P\;EX|} \g,K{yv mI֦1"^ذ& .|jt=yO~Tŕُ"(+v퓶86()Q<ZKP/=#F~Qj|xK5`--Xr>7qn#HibMTsyCβF@?)inHH{IS;9hvęDq%ROxq/ݓj͖>+V2I[[[W @T؋q'_G>y)ypD;H9a"Ҟ^"V1HsF6F). ڨ(=~9G(>|Ͷ|heͲOۢc^Δij|je'ʘkzn֧F3.<7=oxb`m3ĘS-3Mȃ&A*ϹG1ϲF@wh2yOy6FăGum3$o ZJ9t!U>>hO[*kֱcu|cbR¹grr<@y{FHྉvs._3[D= =٠ s.kS c%{ߎ8Ki]Z+{TR/tۧob QN!Ex>Dli}l{?l֪Gb)6Fy7 o|AM'-Xr>|tKo 7bܩ_l‹<87xDAϹ|mm Y6$ t{h4\2nPe6FSʽ;#m6d tXzJt SC__Y&㷀3/C]=u1ik4SiNu!K9R>dfS&tϲfO ,L|s/]{ wK{\ڸpɻbfv|:2)9^zвӉ>q$m2h{]f!ΩGy|1m"5_ZKntk/uZȋ4:3y0;i}ɟo|hyk&NYx^S3e7_7,/O-Olʯ m~&5LWYyiAw)z[ɲ[7Q;vM )|. wr=~_qPWMUm?O{ j Cqlg͵|kzgY~'6+.vuS:;ي3V_sO|<,)o9\>5wk.qtfa"ӴF@{u˟=ߠ^A=iF@yĥѻDKE_=^_|7&7?6S\Q'Ɨg>6#9DKX3^qXs=FUΗ+AN!n?b2m~6iAϹxh].u%8Dyt.Gc>zNۦm@y󤸰-)'b\*ƌ߿M~XNS\6ڷ[=}?O衸κ)oS?˖%6gB3hq))s_5Ty: b}[S-{zjϲ q(>BkANYWߧnn>xgh/k2outK5Y}p$0ƿ/Ĺ:j4kkWTuj.G/\oz}3_v.iA@w[?4<wXM9O-@ӷL홉&:%$|Ti7{b7r>RĎ1@Ol˕W N=K1 dv٨ σ]`Uʗcub onq"H뢯im<"1P@SR.heUXNm1g`Wyb`u37ť(͗q>q)V>k2he9y!Җ~= 7H;4n)kۉM&\DzO}HY'cRt~1jzeY~'V;t-.ۑzL3kKW<êA9y!Җ~=Ĺ%;ﴵ"lֱ9:rZn"xї7Mx}nPSW+<1: |ޙgڱ&?R4_ƹ:|?{gsɒV纳= ;h2 011c{cu6=Y'*rܹs5HQ/xϕy}X{Vt]-⿽_m.oU9u>p_͹ ʁ]XϻwM|5y=+{ϊ׻,}?xru;c{BX_t8蜱~Kwz.Yzr(ʁr(ʁr } NǏ,a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝm-@ש}p,c9Ṕlrx?=+:q)a[r`t8z^/ˁ޳Sǝ3~_?/W/?w_ʫ` ޫԳZ_?]3שU|׵(ʁz~@9/V˾x?W|?;7Tq\ylܙ? G,׿ׯrZM8|_kZV8><_7ߟ3!&FrDl~SK[?o1g}/￿nn}~M웟~jtKiL%d7s}5q3~!'t%*Fcf3'J} 1@RK-HQ~pVxDwM?$ڈb.}h|8w3#~_}?^ERUrmWŶؖ@aa9P\+{ϊRGϷ71\{o\rΘm $My=kr{}я.:WҏuK۳ C'/m_Ԓ vD5}H'Ҽ/5pke 6~77c&':q̇:Ο9bolF=B'C{Ѷ^ΊO_r4yEqз&xmY`#δ1f ss;[9P_sט'Ť(ʁc9t{oi.ٙSb3rv76w)G<1|{edq=;8#2})s5K[%cŽ{0In0 "əciϼxvco|79A+ġssFqy1Zb,ǘ>2cy?I-:؁{ϯVnUdbqV-u9ssWW޳ss>78q3'[. m ijp'6p8 cvη>>όJ>m3'y[?oON^į8]i4G=ǣ_H>f g1Ϙp3 lI>|<2q1y}j 93ϔ`_$bFx80aL n|"o m 6ǾW@9́ؔ7Ŧ(ʁc8t~p=&s bm7|7Gcx )W8s`==sAo}\B=~z>@;0F?֦O$imK1|xc<쇼̛^{ks}3Ol'G8>g:iOh|sS {Y\Þ6s޸qKH}Sm[Gڐ26܃q=Sl~|rσ9bk]ARlUŶؖ1};@9p%=+:Wj>e [ ==sƸ–qF;AL~ow/g46?tAߌ󏭳%661OYҜ7P#'VBe!qOsX/!Zÿ>ʸIPS§uҏkMH'lr\2fk.u%A9+t=75?Xӏ.c؎r>[1u=*k{Z9PzMySlʁr8+{ϊN׫O9=9GgN[m繇u)|}KVhۭ98:=%ΞK8q5[rlpG##q{L-@9z^>$.ʁrX{VtƸ仚s/D!m||yنu)SoV{?#>oqyKש>KKu˗ry9yM(^+{ϊΫ u?P@ש?:V~@UU9P VWxVL Uݦ8rE7ZʃAS\]ϯ?};@9p5=+:WJ>zq!V\h±?1t%AiȟW_7olkd<}v̙'TG?'K8We{u^2߱cd|2Nș:)3mS/}ڧtLi?<1hov6􏾸7zc-'.|/^MnVg{^9P:WǁgEs{>΁#,.gE*$Y|cӟ|~Hi'q`<0?}m.t@COIc?9~韝w;We rg,eΞè~bG=؀_O8/8ǟ:r@>sjS#/E~kKl1ڼWb[<?||;p`eYyΪnk~g@g qO?L{|=o>=|oN)6E?9{@O{~4{=7<+bclusuÖ1g裋_28[Ҟ8zԗ16rL}Q1<[W с3+&$>d< ="g}EIXWk`9P[Ηs`eY\7G>y$oou8~i{療6d{_87QڟRC;}qn~ M|6o՛hs>yxbpY0]q+]sp>.E:cgA>z Q]Sf܉x^c.=66<2GJFtL#[%ub]鸽r999K(^+{ϊ+ctvmG6Z9=džw=[_)C676!mv܌}m dl :Y/q~hz'Ц6@dz /pB?|^=uƘ a[Y6~A+8~=12EmŽڑԅ=|Ї=:\f-).x7WbQ,ʁ@ן>ǝrx6=+:V+ q?廛>#9 s籡O|&f]͏oOtW&'q3OߞhO֤#29 W䁾gV x rX\G󲟼66ǹF'/u8731@#~hko>r_6S}/91!01Eg7jj5?ţx1};@9LX{VtWws׳ sV~@wJ_r^kOmg({d<~áq){<=cg9ܣ+:槽Sg%/!SOZg\}W_9&g}J|GF_D"̟>+cCmQeh}x{ZWʁr8|'x=+:}ϷH̭7>{=1M 9g%9&7чڌ90?uU3L E?k7=ڃ7Am8e񲍿^q1GL>fmbs#.ާ-,RUUjigŶؖρ?G}:G@9jX{Vt^ gQs.OyD\:2ք\G]Lw֗9gϨR[[/}lA/ϥ[GXrX@re++Wʁr`/=+:{S?_sQs 1YRyʅϪ==XM=?ӷ0soucs(@/}9P+VwuOYcgSϷO9<z—/rMM9P*VW*]͡<ŁS-~t(Áי>Wrx=+:3Q<#/Sy:U>$.ʁru](ʁgE_!GO _^pG?/o3xoYa-:w.^isDofc>l/~#}l]sMGlQ/1FX Xoֆ5038yv֎GkaޙrϘs~X/6?+Krͽq@9P],Y(ʁrX{Vt;{0og1{;<3.\C̅1˹[mg3\ǥ|).@9PǁgEst}+̱;wYq?/y~r9Ʒ<>\a<;ec5Y<̅Y\7MEN߶ϳ`;kG{63џgrcnpN|1?/ք%vË1fq$< ~++ޜۿm-ǁכ>gr:V?b79|Kp}7y~0Mߎ\ߧ;?OǑ*hygiG{55+Y3 2em{r猉9OQCzԋ"9c"ߴ 8g1l"gbmg|ԦϖX{VtW??1s6Ƿٸs,zlidz Erx֠3f~}1g%0qlWsqeiȱ}#fceީ֧9r~ \/ӏexmcs9C{UI=WͽyobZ\]ϯ;w};w|?ny]wkÞ)r`eY7Akc~;5Q-=qvb8J~{Rg?89w/ވ=!\:aYmxgʹa:9bT_I?qYxj%G=v֬]'c܏yjmƽr;rrz~yZĻ3U~fL5gE]{DݏArws~M9Jy+uh?pϚ8Ҷ_ߞ3p6ANo{3;7H[S/~\Oo` H6'?r`>gNfAqY>3ݜ>mٛ7qf}R3?o|'v>ϴ5\-Zg9mzmτwď9C|>#Ƽs q8[?\6'~u9}\|c㹊ag#3؍t +۷m-ˁם>wל;'}_<Ϻq滲*>P#'qYgh hL]mk;!<>4N=!2Y|hsS?:c<ʹSfNг&mF)}P+g ;k=#8ݫz59O#Ɯ>Z;-{6`5䈭5Y Ŕ~mR֙hw{B읷[98t=u潛gn|}+[{Vt:o?ؖp>8ű(@rlS|g?j ZO>g \{Vt:_?ؖp>8ű(@rlS|7.^Uk歷4ǯ+{ϊN+a[r`t8z^wϿuw}ʕgE$8l綋s9yty̝gbRGg6+g>wgp\勽].vs|26^ϸ2It\ӗE{'m~96K{oŠquyU\3csx ٹ"F1<љ̿ I>Ruqs\j\K6s6L^#}VIͷr^]za CH G7pW TSg6c,ygl =s96R,WirǞpJm_ #t9u7]HY}ǔ9r>)g>O}a3.>y@'S9>归~_We[ԏJ'gv \xY'>o_0ԓ{}闸8;lviG[G~a-Gٱ^yVt+7ß5 u/ЙB]f?fl36ڎ.\S]Ɩi\kwt}>e{}䥾[Oj>ۮ+{$~ďt2m.- S\lhbx:YG[(qHnn+C^3,3,-d<1 &C,c=ƺ[yoGxL G==3ρ+%~O-^n>y}Fmk̔银\*1smDxf ClG7sN|R<ʾq~KG&r1tmMqg5dr[7R ͑3ѷz 98ǷX&7Ѕ<{zk'Wt9A$N|7 s1x_9t\KKn;s/)~Y<78ʅ=~ꨣ=[>0w#b{$}s y+CxH/Gŧoe\[qm\3lzΏ׸99FĜz [low+r&{9Xyg }?Ͼ>w-\"Dz{/kOo_k{س/vc2#?svl8=Ķ:cw߹ߊ7V\kk++9~36h?&myg\ni>3Y2맏wƉg{yM[{rql~$v\q[vFg; yv5o 'Wo&}.8b:~p<> 27X+#YK>O\猓3U{9v˗:0f|A\81B<}8z5\BokW#飖'37ױ[97SC9Wr957?$>h|GB_?3~h}X8yyup,uG?/0e}G̏6넱܏FV}֖6>{mLɓgQY,6[u=cTflƌ}=@J^I,-s&N7~ -k@RpGϤJ<sN=_cEm=1~YYG'鸿>OO{4Gd}϶:3)gMś_#f|z ֿ>io}^ε$;泅16fܕF%1{X˶>7{{hF@qYOb f]++1O#?C $oG\lc.˹f. |>}9ok3=r?Zžܩ=}{їo0%.}>3;cYm䈮󣽹"ƚw?gۘJa<}6d7Pk=2J{m'cڏ/15ڎ6'#Ϧ 2rm>/?[ѹ㟟[NwX-k<_mةCLu؋Y}u-'W}c>|i͕1brON+r jc^})E?2/'#ϜW69im<+퍇.udތ+9 lfbO|7?c6:^ϑJ9RO-լ^m꼗#Q+J}jcD.\/b<+73^7{s.Ǵ㞶\s<\RWra3z39{zbO9vެ1qM k>L5cַ+]??ik|?1Ei[n ||:G\>7ϸ\XJcrvjd|6ϿK~;bK_n#e\ٖgɗz3Όpgܴyf3K\İ6푌s7½6֍mp!frϘh畾/s^}$l{tǵO(͸~惴O>xb`gMw]1Jmb`O5hzo䲧{걞SrOg?[ѹ- I^` 0.J5>~K]~[C=\|OE\2ocƟ,gq/bSǘGƢs?rqΈaqIF,1Ƴ[ﭼyk#9d7>kd.x>I~r|%h[+rK󼗋zHrߘ:<(~O9 rv'wWn3n^'9fc3ڦ.m f:9ړim]sF7W}vem`c=33{1?gtv>Y={>:ynglY#]oYCivw{| ⛃~<2tțulY#m$Ăیa| z)~7}@]ƽ9犸`KlI0O7\"QvH|$|a?r!cYN15gqFg;K8&v)o(b\ t>׾>VYJڒԣߙzbf=q},:9oJ葋J~1xߊ5].lB~lvؚ_}#kUmq@ʽc}韚;zү}˽{8Rk߂Iaܢc;k)^-Όp>r^[2/}ks 86`ig}hoٛoMf_lIܲzs-֩xY;fvhܰ.K⛜|#k9}dpU,ϽWt25ɾΚ Þ/^=cC,eڌNg|!O!;{C=`+S~zȉ~sş"[i-3N\EN%OuÅrc53f%zHDHC!1%mx`>6/zCfrg򀾜/6xVuuȸ6\úq㊉Iν}Jt#G=c/W򩟯9?k3k>|Wzbqu;~HktI\svM߶17AF7JlQI䗺ܻgފe2.f*#H`slllw7yo~}'5{{Rf x$'yeK19l =nytZitZU.QkŠYkYL⎟IE?%ELɟh^-*~[<Ö9yv.1gџ-]%GyeZMj5松ĩM]:Umt7u]gX#,ڠu/iߖy^3}-6c\#m=-]Yyqo2ħxYc_Zb㳧u)Ns)zWl͜Vsܴ~7fmUg38!9{KݶV|cIkuﻈ\Ӷ}bk}am3>pE~zڽ.ƶE|A~Wn'ဇn/ޣ:|A'Ę?=3mx/qx&u{cޗ=Lp<<*{3t_\7V8'dgg݃OkjqX?By*Nfh\g;2rgrv1wǽ⿳+;U|rWƾnn{V;yG/rMMqS5ʑgkgkא9]~>_9yto.;Wer5PT~]j5PywGw1ߡ̻gF];#>Qgs)ݪ<5Py\fo_9Ƶ7}k^ :3wόXF῞jjjjjjjjjjjjjjk`tD#Z)K{lT~> U5PennrqS+{쏌9$QkWcw\32wݰ9M᭺9Ꜫz;H푻mjƜֽT:>y/Y5#Oe3`*=^k·50G:f|g LGq5 \/ˈ!cN^*ϻ={$|9w]9߽!#ےͥgx> `+:C3Qv`Ys#l+|zgfƜֽT:><>[VgpYt^ym3uv ݿr} l2g|qb+~{]?X?꠽gP{|z\;W-Y5#n<3,_y~[4LasU~gL=.#32[Z^*Dp' >}Qݣ=ŘwR5w G=3z~=kF[,.G5p~[4?hv_W[{;{ -q.z/fr/eEܷoe_;kzmN{)u^C4Rwg}eW_9ز=kFs)x#ےͥK2G\1Tx#32[b\oh]x` ~a-,a˖g97XY>Kw{[pe1Y<KQ;km*m||P'kuبqw|y|o?CAzߖl.?SoG؜sl%>7sgȌ̖{v*<1O|sowQN[tzG:M_!#^kN+}7ݎ= [_wolYo/]Gc~UW_5Kqe{׌R5;êpoK6g䎰]QYk`flg׻'ymָq[a ~;Qg9w{)8;(}ܹQe~&Wg8z%|y\e͖“7G%K6g\w[o=2#hp!pm1fu>9 wԿ#g=K7A^ ?)=}z=~mpggyZ[؇zWjvj{So3u0#So8ng/dsi; `+Y=Gfd8o]ixgw8#ܚMiC\GqwV>ݹQ<$_G<ںw{)N:y*k =sޕ x*;T'Gm3asU~gLj`fl([96ƕY~ ?krW=A~%ߙ%G{)0qo5?:lgx=kFh~ߖl.?6g\w[fȌ̖XZ#asm\募;33tTsWlW=kFf+/7~cjdsiX9*3J· 50Gfdr-Xk,_ޙ1u/ήg>\32GpV6?Wsjsq~[4LasU~g;xfl([96ƕYy33cN^*O]]W|-+3fdl~:<>[VgpYt^ym3uvr/wȻ?͇?ټ߭V2|n>=g`FSRj"[ 9U5&9kpWozEGpw_fx֗_ߩ"ػ$l>-rv:rpq_5!8Ɓ:we̙c2cOGwF3zr̩:6f`Ffj:+88:ߪ{^z=}{wBdWRܥp (uO{o 1s <2} ctG^ooĀmBξ_}sANiW맻3>2Fqvg,?0ߵ%ZRgksKo\jsZn;{)z?В,w#ܓP[ʢ݋=^7wQܻ;g=7pw4=ևr/%"fֻ*c>G;9`ɝ1?|k3ό|]wv/* uT P3u0#_G_{bzsYs|G}Xh͑w( l{] lOb+?#p7]v1&Ѣ lD9ތ?)a8щXǖؽB?>6XCGyt_ΏS./%ފsYffdމc-k]sjnm 9U5fM=yKᮄ7ܛ=S]$ܩ` Yda{_]G?%;-wBGW`[cԍcG9t}bO gvBSE<1c;ɽ}MYG;|\~G93jQz+sWuWU SuNs}y>cpRm[$r˜F:^dXϘç,q_|۶vG>.h ~ZbW}pwmKz/I9UL,Y?_gVU@S[{~#܅x/;'<{#>csmїTqA't|K~cX,qŘm\3xieG@؈dM;Q.٫pACk|k,'.󕱹l,xoo̩xj=1=Gnr ϸ r{G?Cbbq~鸎6/}YYzV<'w^#3{3{ΜĽVs={ ~7 ѐa{{y`mv/3/7w 9.lэ2;T\36COKQ>ыq]~s"r7YxEqA:{Ѣ_?|?>oZ2^j?%N\3sp}S1ƸOK8gS|"Yε1b'pL\K-z{2ȴksTg=Zc~?r1kVL=_39rzpo:Z9͘.|ϰyb(:giNl{k̵v;-3r ƃh_r 2r O}9}s]/32K5.*=: j}Xy*ڳ͵`ws>YQ>a޴^bi{q;'}|.\a;ي瓳N]&5ǶWr-G͇m Xߌad6gpm۳yy5k*ȩ}:|O ~smnK˛cl~Em1mme g:9T6k'-/ͳ a5׭+񀏽 Fdm`}|DL>Ю[+]:r=ꋛ5C}tcmF(:ċq"'?' \_=-ob6cd7N+'Pީx3kֳ{qΜbx!䙋r֎X1GF~N#COxD<շ#Dcjf{0Gl }|G}9h956E7֥kOG ]+ƭ=s[=dzyo8g.$Fkl-aspXEscw ;<اFu,_O>C|>Y?}k1o״]dYnn,rf=2f=x?bo{5y6iǽLOgZ^ȵbkZuٮ;~$h+ӧuV߸-l۬;cmS칏c=vMv=͹q ^Zb?걎_}ވ.~x d838 5|;;FԳ\kqч[U}.[~o+gc;/%NxuǞq#ўƗ|6rl>zP[m}k[;A⤥X[;G&%?3IÇ8ݖ7?:a,-.aaO|Q{ϹV[c~܃1WIMaO݈AzzmmG0w:xn'.Zxlk9AZ[odh+Ȩ,v]SYbR̵ȩ?rm\Q~Q R Z.rb_;o!-!}@F.Xjgdtko?wl\S{b1|x~Z5vh܃l=[ɘywLQp1#=uc}9h幝c#`hu١.~/&Śgn/} kqgS_p-g0R@r,yFcǥ"Ǽyd3[|Q|җ?}dC/>yi}E?c|X16vm/^FztA?Q~/(#N9kQu3G#/YQ7?j͘u+8KW|pBӒ[R%WO}G9t r肕} 8;c^%9uXاV8'σ-ZĈ1f uenE=ng}iyN; X}[1;b&vbh{ЫQh,y4/Ȑh_٥^bh37pbɛ5><~@Yeֽb6=;bv]Έ}dZb-0,wQkY9iKsLĊ,ء=Cыv1žxY(C .|Fɺԗ^^9Ӓmp';bGl~>Ч&y5 6A3*ӏZ3ڢ ?. O~;oLq^!Ca9xq<GLO?<[';3?ꆚN׮{⫵kG%r>Ȃ;A Oi ṽ-甸Zi堝{]gl|wG=Ʃ,u@ !6]2#~N?11kEĚ` nb2Z vy= tg|֭"Xc=qNY }w>}9@.>+V{SqL;uEٶOɡЇVq/^h{__82?s<[x6OlӏQ>Ӯ]9FYbTp"ko5Zm sDH\ GF;}:k;HޑC:G6@>C90).6XsG]};a94>G'9dygkZ?7>W` m[9rL,qz`\j?]yĸOg֎X{)cѯmG/ s"W=<>?gNީa du9k`c~=plGі}u{ؤ7}e#ۧޣ(gG o./p+#w9K͚b,3m vسWz4-rrZՖqF=tuq=eb_qNi,ֺy6ǽLO.㟚.}[[\KGkei%</@ \O~iוCDZ8l1O|8[N.{'QԃvCX/F Aud:}8WOAb{_ױG1Ɵ5%v_{u wKs^{6\yњUސ]3û6m[pZO;ƬllwXǺ^2֙G޸#vk<é7cdvmZmޞpmA޾~l^ÖCѶsFe<+L''rSF~XmF&A9[(csLnN `Ů~o]֑u|q>9"~ -NS3 ȳB?[r{uON8ڎXV}u"%b=ila[`>z];SJ<'xg=7[;sr.u֤u.kӺB\72̓w#K X?1Zxg%^\裃z_cK}}uXx! _||m32=gD YuឲGi?XwjL=:s1Vyk@Ć#kzzX5(#zצ~Ł.SQvicc5['+ƋcKsj#O-1Rk1;k1|;f~aj?9tz#`Gnxb";/ub2ȕEᏱ|(x,E`sgdcbN'jg k?y`:i5|GdЇK[_di(}?0NI˺ش&y]؏zO>gŃ?t-7>1cR;#[M-Ϟb7Rۼ}\;}}Ǵ4m]W}l"FF11]8Lk_%~X\E9eϧ9ژ:2Gԅrcc"/-X#ۚ'dQžy'eQk{d6ϲc{(GG?e]|vz1`nj<#ضgZq>G}mcMtb}k /⤕~ϺXik+ڼ% py'^uN'q|r=::17Ŗuj5"F<6x)oXA'^E̳y30"]< ѳfŘm~q?>ŲgO^OtkxPa.ȵؕnEbpԂCcZ}rCc73{ .k&G>ćMs@>ԁG=G}1/ϱgGhŬMX_ڋ:քXЋrrƆmd&h辘Z?`sCS+n-s[<1ꀏ}lMk"0njcxj=xxwRD32QEE}V}T#;W_s깽DYZٚG,#wfpY|٣Fo2>]ۖulyZe+ևy8~'!#'1؊bn".u O죧ֆ#ٗ8`Nίm#7>'|zql⏭#wj[PE߬/-zv:soP?%GXZ[\-A\_(RZ /#<3ǘTQ}cZe^ZϞx)mc6?:sqCgw{ %[_3{IZ}ɸzDrx9q;yx:sw|jq>Wcc^1?T?uT-P3u0#N{Xګg\[[uNUͬw=R{.5_ZzFֽTՙuVgN0S32UST T T T T T T T T T T T T T b y$SGi6'Ikv|k;ã|Z?W/#GGy{ΑF =s5ǬHnOLf+KeqDώl[8-qs27S32bz5,φwv|ovǽ2~#X#^F\q3\G~eĻGYed6]Gٱo gw%x5Us-G{(;7;ί }H&Hף|܁ u?0>WǑ;pcG{=,uupvlg0nt{'^eh\fQ6<ʎ/͎5;+CGߟ85Re(w?Cݏx*q\F{G^Ff,j#KeqDpv[*މWsY5?r Oxc͎<ʐ'0dbTzq=P# su>f}˻RwYpQgv-㖸Jgw\Vee"X+.;2~ #X#^F\q3\G~eĻGYed6]Gٱo gw%x5Us-G{(;7;ί }H&Hף|܁ u?0>WǑ;pcG{=,uupvlk}՟?'_|/=~'6~s.F?$[dQ6<Oqev|mf;ƑLWף|۹e؛ϝh>9WcRwYpc[V?9?]Eom^|F/9lԽ(GQ<7kQwe#O6;Τ }H&Hף|܁ u?0>WǑ;pcG{=,uupvlkRޯ?5>V{sY59'$[i_ěkv|qW܏?q$kˈQ>Tx1룽XF˂:8;59c3>[?rL㌽]T\~j4MeQ6<^Ύ/͎5;+CGߟ85Re(w?Cݏx*q\F{G^Ff,j#KeqDKqo}{Kǿ}W=tu\wk9g8F6("X+.{fG2F\gO:ށˈwh>]md,8c[{7_}KY'69c.{5~Gmq~߽{9r6"X+.ϞL?CGߟ8dh(w9Cݏx*s:;p9>f}Ydf]Gٱg7^{)~7rѫ_Gmr.w7ѕgr_ěkv|ygG2ܸF\q38߁KՎ1룽^x~Wc[&!欽f|Ry33J溽j {=8>͞qyRnYkm_/G{b[k+v|ovǽ3~ #X#^F\q3\G~eĻGYedR6-\r*-8g}r\O^jNxzplx\wٹ̎/>;"YΝ'8ɴqx=5f(#>%\1룽LfƖ2a;ggv-|㖸JgxըwPu/O/IwNF_^^WǑ;pcG{=L5 ޵pvlg0nt{'^Rƿs /M3I;:lxZ>xc͎<]!O`s2z;G<8{.#=}h/#w2aٻΎl[-q~ī|T1ÿ1k?qWcx/t_&Q "X+.{eG2F\gO:ށˈwh>mdLXc;qK\;j.Feo{])֙cX|8K&6ZwNX3N*w~gޡ 9߳~^j\?fv= q H(7#v҇6m_.(t/cGϤ]ǴSv󙵎k:L:vwKj_W{h]jI=ٟk].%?>}nzq:oWVWF̯3mU_b<ZA#-gJѾ~gK>ۿKſe8|UNN̹quޮe%1G۽MpWGH=O?92L1YQ?gT{|SO}=|yo{y6ty箯]JZc6m T*hsoΉ@9J1G9JCXWiA\>c3) V*ܫUи5_;K-/zђ>SӳSfc̑````@{ ɏkdzq2RkW߿+?u[?Ńy9l.N`````X*ܫUrkQzvGng>uw'~Si[nܠ'00000g}~\h_QIg{.%_TT5)=W<<>Fa```@{ c~7gѾB]j{f['=;~v/^y.^ 0P^Fx㜹e.^o3PX_b9'7`````*h|1ǮSu˻11yy\Ka````*hz쏌T]O3SjM-sմG#k c½Z09Ɋ^>Kh}Ԟ՞yǷէG````pVA#g\o~}|~K߶:ӜsG{?׆-X@{ ap=Wn.KcmѶZȽs ca+2P^+h_S{_'mޯ{<<>^ @{ x b.QO}6g07*h$ȣVhEQ:[R,6qLo%:G+yhq䰂Q,uq ^F#ֳ<,f;^É9'-Y8zlGƯ ׌s}'y?}'/֪rS1:snzz/EZ~E1ka}/Y<*}qe;b=crYmFh5s2vtkq͸8gw^N17|'Q;)mkq>wN=+/禧]_]^]I6ַyţg>q ^F#ֳ<,f;^É9'-Y8zlGƯ ׌s}'|:izw8\w}QVw}xwC'iDFXKu ;pmG+xXXdz\VZ8xyessgl.;=՜Tj:LƬMdmd^gOhqQ,uƬMdmd^gOhqQ,uO~aBVnsPSb4uΞcukuׇܺC'i̍ɼQs3и9O+x9},u|~^=I6ό6qyţg>9^3uόcI,u 8V2屎g6#N9ic;5~Uиf\3;l/U*H{tjTgBMK_kڣznTwkuׇ}9>ƬMdmd^gOhqQ,uƬMdmd^gOhqQ,uۿIɏN\TZgsய]JZc^I1Qa hҜ =;vx{ =5kߒ?Ro>i[F}Oo7<⦧3z+yYIs+i#{kV` po΃؇}|{ץ[Ƚs4a @{ ~]|K$j-ZzTDӓZ}2;G] t! j4ﹺbt2_5~xLc5*y->kjjcwmNb0000P j4V7:h_ޏzKߞkRdοO}W|X@{ y]1:UGz7_ϗyԦ_Tw䦮{}zl~_5r98 pVA#yqXO1A[=3_߾w^Z^W;?pVA#ϪbĿA|j?1uG{6؄3*h3C#u)qg==m>5>fỞ ````` j4¶GD[{u' U>ckV##5x j4]+1}zϹ?:ckT#+; a```@{ cX?gkGzTiFרGjsq{1P^F^y{m]u^1;Ge````` j4³ga.xzZw5.{Ys ?'iڴ𹝕,b}ƬMdmd^gOhqQ,u 8V2屎g6#N9ic;5~Uиf\3;l/{Tzv9{ W*FgMO]>!4fm"#o%:G|B6zGgyY.-wsNZFp؎o_4N/on}ݿ^vVKlL]}yǸ,e=fbt=%WAov$Y%16:GU41Yxjs<+ؖXdwۗ˟vm]-S-mg?0:˽tww}Qo%Q㺻:1kӏyY<*x}3{[^,uǗG7=^wr9!4fm"#o%:G|B6zGgyY.-wsNZFpؖץ>?}gx^joq}v$YxɼQ3иo/Yxj3BĜ,=%źT[__iS]JςS Q[ҧ[ھ|ʅ| աm><?x?s1zݵ/u/{b?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GmI1!i]ر.ն\UKl\b{MZ~D[zPǕOYљ>pkuׇC'iڴ𹝕,b}oݍSƚy O+RQiS1ʮq9Cغ;"F楃I6u/:GU41ٜY.U8c;5Vиf\S81kzn=3>Mr$PN^=˶l[=Kw}=_z'ibq=':ǣks>eyv:lqs2vtkq͸8gw^1R{?ϏmaJ]j>:]_Vw}x}ugOҘcb}/Y<*}qe;b=crYmFh5s2vtkq͸8gw^>bT_^jL}ګ<hiMၛw}QVw}xwC'iDFXKu ;pmG+xXXdz\VZx '朴f*h\3.x0,%b䦧!w}QVw}xI6ַyţg>q ^F#ֳ<,f;^É9'-Y8zlGƯ ׌s}'[Mٳcp_/]Kϱ)]q/]fOҘ5:;^{3и ^ngy:zsNZFp؎o_4N<)FUg't7_'Nzgm֎*yYI[[#>4zB5 T592\9>s~,o}k_9>>K;?WzGW}6K73e%Gxt4g}B屮 ao9{WLHluXCQDmj'\>kZO%}jq'޸:oWV瘣& 0U#bT s^U}&1k$Z.5][}Zj{=T|@KO.:w}b``` ^=w.>>եڷYzM飿m-ԥea````F2Z41nY'h_OjuVO{חgws~\gUֵP7q `````@qT!u1ג⻐tQ>6^M]j_֙K``````$y=UAur]NՑ>ډh7w5^ռlO>R7q `````@qT!Gu%ݸO>e3>+YK EuU77=۷cJԾ3/ H*|*hU/賵-?=$uzÜG````` TTH7{RckMPSLbԽs @-*|*hZ܏z5wGN9.ߕ7f_|?3m}֮Vcyer`````d½ZGƌ1A(קm-zTk[uo_b0000f½ZyNե_zvӶRԥG=0000pG*|*h#;ݜ)F[}(ע۷e/yms;^]pa½Z.D9sICcZ; *h=1:U?˟ZR=o~ރ>u Qb 8V2屎g6#N9ic;5~Uиf\3;l/ջUo[׿קљcv{/u/.r}v$YxɼQ3иo/Yxj3BĜ,=[Wk9r-*&߾<^l/u/{b?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GUAqqθij¨բr[b/nz1zݵb?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GUAqqθij\߾ۏ1ڋ-7=8EZI|fm"#o%:oWa^Q~Vb?3crYmFhc愵>^Ƕ7K9Yzlߒ>u/>;?h˗K}/l?kR3wʙcb7Ƭ|2x?7;sGs屎g6GJN9iߣǶ.8fYнx]ں.S-m1bKcѧWe\S1:S3ڷռtЛ?Ic_,qྂO*>Vљx:,银ks2ǶvܶĨK˕d*Z~F僕Yљpkuׇ?1ka}/Y<*}qe;b=crYmFh5s2ǶvƬ{j=]TKԹKX^7.ܸMO'w}QVw}xI6ַyţg>q ^F#ֳ<,f;^É9'-Y8zlKu)=XҺktnDvwݽQb䦧aw}QVw}xI6ַyţg>q ^F#ֳ<,f;^É9'-Y8zlKku)բ~gs_^RJ-鳝3g7/kҘ>q_&;{MO?^w}QVw}xI6ַyţg>q ^F#ֳ<,f;^É9'-Y8zlKk٪=ſGRv\-S.m?:&\owUbKc>7.㚊љ^zݵb?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GmI>[m}]*>/zhoLKTK7]|^N1e ʍڎ ?x?S1z-/u/{b?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GmI>[q}]Jl~?oٵ8>{/y9hGj)/T\hsImC7^zݵsNgC'i,7ʼ⁷.!734j Utf~/9屎g6K?zlG ׌s<5qbՠK׏n9vq1:Kb[;~Kk4fmĈ1:>a;:YxjsnWߚ|q͸8gpS}ݿ^{ZYZۼm<֢cTǴhؾFk|k4fm m,|vྂO*>Vљx:,银X'朴f*h\3.y7TbQJZc>Z;&o_kϾTCMOԦuw}QVw}xwC'iDFXKu ;pmG+xXXdz\VZx '朴f*h\3.xsLSg|LIֱvs1ukuׇ}9>ƬMdmd^gOhqQ,u 8V2屎g6#N9ic;5~Uиf\3;l/atX79iyTS P?W#7=}zݵ/gOҘ,w> 8V2屎g6#N9ic;5~Uиf\3;l/o]CUGKљcv{/u/.r}v$YxɼQ3иo/Yxj3BĜ,=[Wk9r2ϖP ЛǪѱgqT7=z+yYIs+i#nΜ Le?s-S~εcI[u{^{u~k~}եT|kl?[QSϩ12cvuޮe%1Gu<0:1wK׈#xnG}եT'iھ Q͟jzTk?+uNy_)g@x_x;:;==f¼\A#|Mu_hhՠK=Wg[-h_>Ƚs.ssj TWZ;vzTұ ۏWz>JjPS^%|~=~' V*ܫUи5_;h_+߃~-z'j=gS|v?0000c½ZrcILhXR=ejOS虴/u{ܥ- >=4{}LJ3I|񏳿C:}jS=_}{~9V:;׸1,0qǑ ^F#ֳ<,f;^É9'-Y8zlGƯ ׌s}'ԥ;3q{/u/b?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GUAqqθijbե>7ۗE>pbt^zݵb?Ic&26^2xT߁'4n8[˨wz:ڌrk81e4 GUAqqθijbե~]l}gy즧]>!4fm"#o%:G|B6zGgyY.-wsNZFp؎o_4N<)F[͉Gbt&7nzz/EZ~sC'iDFXKu ;pmG+xXXdz\VZx '朴f*h\3.xSRTMO]>or}v$Yxɼo9f2YAW9Yxjob=[K4SRTdMO֨qKw}}LfOҘ,x{;yfyY.Ѻo|\ǶvR[ں[ҧ[ھiOmǧL^6{Gl۞jvЛ?Ic֦s.:GSUtf~/9屎g6Ky׉9'-9zlKkqԥS;~??(gTcڰ OS1:[7=^wr}l1kvV2xTOhr󸂗M,uoNr}v$YxɼQ3иo/Yxj3BĜ,=%źGZT~˧FmOoI:oisS9|c3r~,^wr!4fm"#o%:G|B6zGgyY.-wsNZFpؖR|='u)o]ii)O]i1z㾻-_UqT榧]_]^I6ַyţg>q ^F#ֳ<,f;^É9'-Y8zlKk~Ki[RzN{Jmߒ>9}z㾏rvE:j?n1|ܗɥpӏ]_]^78>ƬMdmd^gOhqQ,u}c/mh)ԶCcG3]{ 7=8EZ~C'iDFXKu ;pmG+xXXdz\VZx '朴f-g=ץڶӹji}9{/y9tR}璥{*F}#cwkuׇa\w}v$Y8&ַyţg>q ^F#ֳ<,f;^É9'-Y8zlKӽjM_mNZWc:G-鳝c}w ^riq6٧?kEM=~~ߙnzz/EFݎ^c7ƬM?.翯2o2xdsqͫ^fyY.U8c;5Vиf\ܿ*4hKW_RmҾ/>~z+HWKʿk4fmμⱇt~,u}WUS/[zbԷ9rMO?vw}QVw}丮?yZd  @m,%A Y+3Z+@/$!OꃤF"L D $CS#ęSSOWwuwuU?gѨ[U=U}5/95|_z~cf nJ\1=ē1>_S#p9/eljv~{o=լ0m&5]+u:m6{S;z/H}Gsomt~x{;>sߵߗXq~^J\1=ē1qw.#-uL}i-c['ek-[jcͼfk\Nie#ŷzx e|wz%|l{ÓΫw|oX{g.K6Q#ίK?Fݗx2u:eĻE/elr}lsk=^ _#`lwMz\OXB빵0m&ͥ5Η[:mdI7<)x{;>sՃKO`,D8N/%Kt_8;:-ѓz²Zϭx5|f^n5h.ѶƦo}kZf}D+_ k> }k_~|fGД1n-sFب\s_zimNKlk۩qϾ#׹9NxY?{4FrZhQtνK|>#a#a??F1̹XGܹfgnϹ~G{[v\,eŤ">A*֓m Og/H\g>o{P҆ %ά=6šqgh4|I/~წ?YS}e Xր5` Xր5` ܆x#`Cw=44mgq)~Ow8rB+~cJ|L)^k~kkk`FxVRmFPJْC>G'O~KbS*O[is95` Xր5` Xր5p 6FsZ?4Kk8c7zq^kkk8 5|{*64~{oЦRsggG~|ߧzKymo Xր5` Xր5` <Fh]=[q't}||*O{w) G8~_nMmKo Xր5` Xր50FxV6$4Ƒbґq)s/}/{ ̭kk 6rӾkkΣF5q5QK4G+{b+ϗŧ\.YncXր5` Xր5` Xk`g0ZkgR7;?UTty\j gGn{i Xր5` Xր5pYm!wB͉t-/H\g+j5p58kvm7v^/-4aH!KCkkkS3uO̻'z\OXB빵0m&5 uS1+;('w|oX{g.z} %u#߃K<:G~G2"_Zԗ26[`>z\OXB-ɓ\)3ezS;oɘje]S:.sfHĞ/i=y`J|Tjg} <?w;sysHm/&;E{;%𖞟XIU?}=fēˏܣq\[VZԗ266.Oߑr\j}~km|[GKws>g6K1W_}xQmTWE~j)[pn?k"{[z~c&o%Kt_5r;)uL}i-cǭIs=aZdR4Ƣ"|oɘ~k]g2ߵwʵ?+WGͫ7{QbQ1x^ʃ19\;_w\lyu#p?:5z :YVls[2bQ|{D9aŖ1fkv#ssbZo6Z]~ӉoJ=W{qNsk"{[z~c&K%Kt_5r;)uL}i-cǭIs=aZd<ť7rV .b^O1ޒ1cu5\NsyM^Ƶdy^5sM7kA[1浆R6-{k"{[z~c&U%Kt_5r;)uL}i-cǭIs=aZd<ťh7J{E<|Ri?N#֊?v`^}/|tq~6ڶv/p"G4f"ޱ/rI'0lyUA%^)#pb^{^Zԗ26kqj4znKS\9(ޗ?ڨ-Kk1bs5)ɷsڦ~=-=?dck6ui>7沎־+cKkָ=^Ƨx;[ϭxS~V7k]ӜFP>q^cSxs>ߣo߿xuҞo>|XSzF'0lzxJ\1{<0(8K|//cKk%c3eO i=5ƚyͳet.ru\jzхbIhF#Ƨr믧=w|ޱ/rI'0lyVA%^)#pb^{^Zԗ26kqj4znǫk5rGsӨRPkM6t=!.;RfzG n.c{}'cp\מ1Zھ'ek=[jcͼfk\45.xwś̵{WO{Bw|#aKxo %]J\1=ē1qw.#-uL}i-c['ek-[jcͼfk\4g?Η_~|w>xZv41. g[B3%#{G|ߗj6R#{k"{[z~c&_J\1=ē1k8v.SkKZf-[mߓz²Zϭx5|f^n5h.sU\:Q}x'޽NQ}:-,K͹Xctv w*3Wygim{;E.ɏw)g>??F1z\g4'n{’ڑ5%~Tkg[͑~ywy;=yPSSy9VS\껯(΄K#{7ˏ~?\z;ԧ#c` F=ül=qz~FX3/oj-őxg*#7} h#eӱRo_^^ރcL5-tY6`ǃ˞;1G{C2ϥyr~n=hq5rWht*D|ѣ_]ǧK _:L战Q1Y\y՜/GsZpٹ׺;+}uf[jk6 GqF;ǎȸcR_&S8!x}Fk_k~Ϩsu=wNg빵o#^ooFi%9#mr머cRĤGR}۾zkhxGXϷ1}}nLym3ZWFX3/f?G4Ƒ*ǕRJ|H,J9{Vȏ1?·9?mPq1l[q4x8/Ks-g빵F#`ۜgGiL$K_~ u鑶qxK=cP:ȕx\|=G;:zCscϬsk=^GX3/[=F8ҵ-{?xJ-Ӄ7b|خюcR}Ƥ=[Š;_UXf_[a4x۬ hԀ9H=znǫk6T1ޗTJ:!=3.T1q)ū}~w[cwwss?Ϭsk=^GX3/Y{ ΍)FƧ涷ݳxMR2p_/~wjܽw|5q׭}wny;~{f[j=ƚy:4z-^{<_/?{G e/}W_ǧ^KbK#&:xgX00^ck=_Wm_3c8=[ϭx5p5rsIinzg-H Yzf^ns}1ߡ#91ܑYu#}|8]w_N SKh?zܯٗ{Zpzf[jk69%_4RԗϏKޣYp}Q◵[ߗֻۻHw#X1{9wϬsk=^cͼܦd ?4w||7H^XҚQږ՞~:Tc=l>FGѧqξK!󹲮ՙznǫY#`ۜgoBkH5ݶÚ'O.|fq͏ۭGG]ǽn#`şߞ`!8Yzu3ƚyq{ܣѥ!~޽O_Mݺ}wl:v>]=>%x}{k3ZW0mk}ܸ/ߛvwr#?> αͩ~u|ud#`<҇o_ !}륍_άsk=^cͼܦ~тg4ߚ"6Q'[uqo1 ޛiMݛkTu:nqȍ10uYk~XYzݎf^ns}qˏ/{šx>1G>|bnhu#ckyc׹!ck[Yz0ƚyͶ‘|4z/OHv>'V>7%q&|~}{uZ10:v2ϼζٙznǫY#`l'%MIi\w(q}bOV}oYC\{[V׌/.>|kkkk8Ҹί=8>*:o{Mi^ǚf~'jk=w{Ͳ7mǚkּyKG{f?[j43ƚyy+4Z';}x>ȾSju9>>qON>칪Ǝ78g1N15nkSX\5s#gk^p5g ]ۦ5eg0ktBVek ~/8i랃4\if'-kA;iNKƋG:˷/xc58iT{E\79^XĨru.N9_|SOzlIb+x|yWwM.?٘?W-ec5O{v|am6wSG'}wQnx[tzCZ>*خ-pҏ`ep$^J}-}`z^Ymq/mԟH6+Kg<\i 1W_K<'W9L)ڥesϵwj^>Շb*1e'r.[*W py>]D_-5b}Dߠyx&Gc|":ALxPq^ibcT[jn}tfH/O OlUN~8}hkWqWb~Ľ)˧r6[Q\h?#a|yxا LJ{).żpk ﴇ?͉y؉_sٱ?!ݟd;'89[cϡ&ҚsNYꓔy2_uF]ӵ9;1c:c!?u Ís8۩?q9ةLy on\]ch@sMĩ>HiǏus^{{xr> lu|k&{ v?ڑWÇY<(v ePF_7}s9M|ԧ{3.2q=0▼+ߺsN-žԇ>7ilnh MrpݤL5dU=^{q$7>rsGpW] :-il9.H6==\Dű814n5ڃ^tmTtjn/:=jt 0?tāg\8$96c,SPO5,iØ6{(Fp/6_TsҽN;q8sƇȗPը%h{RQ;Ɵï禵ov7v{[QC/qo7ړFv69hm쩸*?jt?N\c~A76jO7g6iߔkO_mc*l<d[<8{:OEڱ?c/sXZ{}ml#]CcMaZR_ ~*r~iqr^FؗHĮ>=gP_ ͑9> S~ƩGE=08`?{U>LS}'ψwȃ)K>)͵g8n^ a"Fk0j-g>)=QjT9wsRr͚k_rvѤ:IJ|ƂGҷhYrq)_NUTi\b<VGQ{_x)Sq)H9t%JQgo.'XZgN뗜oݓP*8׺raճ/Q~YW{I ״Q9S`ѵ:4|r0m&b&&70Fۘ\́=[N|b?ا)Sh!9Jwg,ڧ.)—Mcgt"/NI׸VhwMe-r~m?T34'?kOr N~X:gLwĢiY7>G?:'T^XlcW̋C:дx՞I?1֠G?;/E8\cO1ܣ 51h5~78VOYLY8Wc\{I&oʾj8v联`n(co^2Q.nƣ}OɃK g?͗0= 7:. +kYuq>E>q Rc'[R0T@yRq"[/m,M5ZK<.>Jilqij|Ś`&Xk/ 4yMG6{wyq)IHsIvc|acJ1U?U)~4e]u0WI9>i+3=5n+a3WFڢy\ȫ%.I~y& ٪ok?Q}:TbY̫^}j,lkXO -OϱSoĠGĥX?ZCРJW{>=Nim~qҸb'zs1i],3ϻGS{"&oxq)8Ӹ yUٵ=.]`JUآTgzJۥ}q\Ե"6QZKXGmY{q3֑:>/{-KTuNJgXw-/,qJǹ3@Ӛ;i.84ϵ-Ukn:l5&s=ޛ5~3\eׄ8!U^\dz=Rs皭.RiI>o^sj~R8fVl}h|esx6M>"Q˜\\DR.SRqiW)6ZKukn҅H>zx6 eq?<]+[mr)=2z%/4XOM%yʸ'\hd *cPu{k=T<~L~́icL㭷>瀗R.T>jSN[$)E+i\ m_K`p3qz͕zxZ"OYCq,V\M_4\c67rk^D;q\OF8&b}̃qGsģ;={>#YJsڿCRAjK:<]c&yG?ѻ;Pmmb)soW-c㉿&*f4T1=Rxq"g\l8<-sSyEOhC\] (u@ylOuMu{+*(|b5>84`ae̚Q='Ɏty?6|.I#Ίc`cM)s c⸺?cCq0w*:gCC~Rơ,RԷH5/^y_dlpA=k >4wqp:'8C#¥>ᘶ)^cmumLaqD{{15w|xī. U^)X/\OXe?p^Mk,#>kʅ%m &ե`=iy EX{Ɖc1;폾gC#+/O5J9-6U?}>(STZ8Ֆ1q QRCei>wLb9X&q|h <<>c\7mCy*}A[q]sxGn nOc?qWXԱ-ک$q';>Ǽp1?\i|k?=^sCO4Oxt<[(Ki-5XsˆCͩ?{ÛSJӽ>[K 8.xՆ9m<{Y9b/;;u r>ڢߵ}hiǻP|67Rw%Sr.=%\_z]|70^5cטy[y'Hzׅ̮s͕ruUsm,s:cS^e9O}|}ĪX[~qf3]1txH<`xЖ\Ĺi?q39xAITzˏ7Ό^(eKl_||GLhMcM[D[5W_;7Qz_)# #{7q9{ܛv^[~G='˹k^*cS1.u {Uqn`e$mRz,/S~=e,F)[ro-9]ߺ1-ŧ|<(X'r+k-^'w4i'rAZϹkOD<$<[qn\[7E{?oee^u-sd?c?M܈#~+1m e2|q5~#Q3kuO\^G\#G"!{O/_q#Ğ5Asf㺦礼KDF:k{>|%M'Zߤ;1sFq>xpmtV@1ujC;lc`1ޟ{9~Nzӆ`֊?e:W?_R- x.?:.N8izP&jz6=ª>"p 6΍qSAuc C/`lƕҾc͸{(ß&R'_Gh;~yV?y_iO;٣5Ɣ-R|+71J\aGxZ{ε>\6壞%~*a?7?/{w'Co|oC=cSR?zRTw~d\WRu`yp:=Ik@ jG9</^^0!O }m8+W;c~۸ΰOυhi,=vv'01>dž>hO9y{W9eʫ=ªzpk~먧/i/;=1ټl\!1d'P A 6&Y1$GqBv@$c =)nwL+4xDf&cyҲ_隺ϭzsRuO:y/zFzQ|m/^LxW +eyKYcU>VV/4}Mx~xBbؒcJ \CtBK _ۍ(CʃF+geܒ-9|CyV$v]9 8x_s7qhyJܡwxx]SΡ5r^s^LƇx-M;<:P.C>vScô'.S:ʻ6(cP[%>kՐJ;D%/_Rs~km <CbǏ0fOq杹gǬƱ} tS:keicx÷twr/:P{7\t&%< c|Gs8=Dw zQOວWr"}6G8¯?җm;>M |i6ƃM vk3t/Wlem>]x\mg*^G ׺<(G9-ۥSgSF\dp{ͭc)?31'9.9J=>K#cߐ.=>/!(og ttJ8er4 *ρkk̫+8k:~- FS(67A;{mhHyׯfcВ)[`lw.ض'l UOU gO>K /△ aV ]jxhW`2uk0y&Q_XEGK쩍6ݳ)~uOM >O|j.u:ĎxGQ.>'rķ:D">upCGOᔴ!?gt%we +KM>G>dS%ߒ6 ʠDh;r]iw-vGDmb;uWPlLݛo~/x@1lݢsD[ozGKܓce>VK◾yd ىಞ6a-{-#6nت 2yJc\D($:gs-;'86fn_%~ >+u_XYFݠwzQGzuv `@/KA ld|}QWeӮ<̗,_lH{7 :i(yǗG  +2ǿnX yS߳2fnSL>چw/œ(G[o+ kEYs xiHRC9k`/:_Cߑ"'(rV?>I9sEw`ԧKڔoo;ZZ7ЙK'm9ww~a˾ 8v(.kW\!#<0WQH^tĖ5{k;lN{sgbi|Ofp qRSG2mzG>_āwy>n:_dP?0l%Ju.~d|D9,C;"><5ICKڑEz'}s^8^ #}!/ g~0QZl)uhi㘡q &tG<ԍxp,stL31EI S'b:ؐ9 ]C}ll%c9+uOmr-)mYZ ͡-))c=X!vG[;m3q{yo.Ou=Q<c~z-FW6޵ͳ|t4҇'=RQ|<ʿxI/cq:uZÞzw.}S7@~cױ8s.؏ m0 ;G+y7B/uvШPeJtdLKLVa4.8z š^Ʊ-x/myl/i?ⵜi= u|6t >GJ- {{xF\Ez#,dǩ~&3EcoA:_sĤ}1:cD>_S׎ȣoe?ʘ@>8izҷ'֣:?Fyo֣G>߲G{/L1OcPߝ9ucFDY;o%]x4C,_}N}rO:2`'숍%#}' #QFx+¶;Y~.xE~3q<|"_gjەnA bT^eg9m?7Mc~sW `Ĝx*pߡ#yaUۯ)rS7v.GORAkl"38+ Ozp.h?$KzA'mlxRg7x Qmw^ n;`\b ڵY 5ΎϲKoe:Z钾)Ͼ3jcmCXp96e -mc.Zy쭾'ٔ6|kC8O.CS5}A55`݋khLgh1c˵ʒ5+Zl m܋͝Jx8w?` ʘ:#{|KDYYMX#d!Ncb3s8ZG-u_C;qn:<a[ [yW1ᱎ< -x#]9ǶX'#e+1jlSG5P2'hK%SnQ!R_?;IQRj}.؃n*7Uޙ찣#{9ޢ/sgڥn[S̙3v!#O@:͕L:SMuDF['1@16zb-q fiS8J|_Gil-\tؗmˣk={ou#}7r2R˭~&G;s>u`+y^Fމs&y)>8s)oV8<1RM+gotܛRu±% +:QaY?1;;Nl=}4O&,6t, ߇H&mv RK.k\d/ƾgօIWr3R˭[3}c_jb: <6Ʋ?}si-F_ګ^Gg- 7ZBΈє}ν`RXmv,Jdq1.D'hMo;K/ϽwܓtW@կ|2O_~oSF\a?>j1j3GsZbSƑהc:r>]1c`<:g-ľ2ԁ+IkCO=Ɵvu(_I^?3:𹔯DD(:Ǿ`|uA}G8k_ʨR,\걝>St'p~ʫ,k#vּ˨GG%eY!s:˲~fl;֙'xqn&k-꼶(~[<:{:b;o}#^9?;?_Z@ak[RK׍G=쵹9:Er^߁|^<]t|`ȍ2Kξ_xy ?4;w<~~ppO_?sU(h|/rPLû:׿ݿrk3j]fS=%f *:.uJt*c>怭CX{siW^_asszB^{K([f RWy#lBW|u2%|'OWXBo^_ڷ&BNk'<3g?X# ny1v>ڮ,S55tSigu |k鷲˵^CGCvktZkgI; \h^={E9ChXoϭc[qǦuV1Wj1Z/7s3.ɧݿDw>ВCN+w]Z!5X H;Gx߾#F9{oL8GEޱx6ʈr2秞wh'sHoc,ky)rXЋ od <]\j#?6\bמ"&=x;&)|+"<+%SmѢ#x^o:2X7/@;:s u&їBGYk:x`GQ2'WfS4i-N5Mqx W>y!I M)ykˋ8mK,`R5]#-0hkt..Ǹ/g.s)yb{6+ix.kMq(:.].gǺscٿ8-i瞾D,~ڵZQO`%oq{"및8ʈxG?ּw +'K;w/q ;›w۴/Թ'e[ouos }=s_{6U}3gL1vM)tDsrJl-q^`9y6i\1(zB~tފzDہWQ<Sb[GxѩwN?QGa2W͙s2J{#(?翹3/%_K},K:4whCv@Igi;8|/z%>mKeeȾg b|}x1˻ğ/B_2>&chA <8S9̛g.Xc[Yy|P 6Pv3[Lٖ1MHl/}Nei?xG:+7 G;O:.3>6NJ~cOQ8[GEA?ƒvm%.b]͜[b?r)Z l;e|"PLD窣\zwb~ǽD%p}Ih9kK΁!?gK۫o}1tlѵG^+%xN3v[^-1:^|"5 h112E-Xݼ xIhlGZ?o\33s_'*\܇/F6m)AK)晀'xwvxXw=zEh_v+mrlj>t7/i }R}LFm3/jo||xF5ݡqs3=D.}WFmMq -: = Dyt7"z+~pJ(Kՙv^E،5xQNw6v+6<BǺҾ:0=O;ێʹ|(#P4}CgplRfzυG>t1klek85JX\=}S}Zp[qֱU9z?_O2x.5e =,#7=qJEtɾpfv`JqR6zʥG|Jawl #vx3׿<HwNs?=Sїy)9u.JޕGR~E?{Mq4sSeMqT];S¯-tDV)Bfc-u`s0sao;%zw_l~IDeQJC]\c]ȗziG(ѯ_SNP1zF~!^UvYB[AWr [;K\OķTO801Kq<.C)e52ģ 1X,E=KťO_{y,]Sɛ>:6ʶ/gxNѦ-sSʞ[]m:k %xN%o-_8&ʴ}MGeػjp ЖsmN?K[xd_ԍ@O5޶ 0yWwm<():&G;'В[R>yxSR3W2 u6ړR^}/xWWE9OMuLGt@&:0 xlhaka`=G^hc E)Ia1Qu ?r'>kȸd3d: ͅzN-R'o>4~ ڛvyLb+J~Qک&6{}SwyQ'yZ+Ҕu}ӎ.ȣ +}>W^skSo+Zx[e!>:֔'YK5!] vUwcE;";q^]+c^y Xyfo7܏^裏.>OF'5Z昷d:X|\ZY-_v}EK{h'/'3Y(sD'RrIl,i_ '=ᣍ|S;p\iw~phvMs3c8%sSeH?UrkV嘎8ZdiHO]{{jGc^<PAOu,ѯCo(GmjvBg続 t>}wY?D޶>C:)5TTt$*kr|SeFd/tw_>AMbC~S/}lhyU.^=|'-=.Ke'}$~-—3m%sQO-.um=lkm}ٳ{s?O\ |\]dzӽ7"6Sa m[[y}c54m6C걑ve( e?ݷ]sG~%W%>>Vy(c%*w9g\3l7fߣ猝h;rom6A#vsm'c z<]vs [}[[5wW|1O_z/\>'m11111110o yc,h\?.oa8txǃ8~>{5o^9#uHwm1Jfw|y4}C}9W-9c:RKqv -X<+i3.|1_73>>;UTm͟F;?/kQMF*s 駌ec 77111ȵ6Y3Np~3Zyo,qlߦGj܍[s,d?${Μ#0aۮFokyq<׊ױV\%c מ33wh gj;2S'z]>}|іYnzFoiK YN_/c c c-riӜ} eQ {pcVV5a[wִ嚲x͸>z19*c<g]4{ݩG}w'?yLyM<&1Ǔ7~q^8G飌[\{֍ir+-wb:x~ rT^7dku/9?ϓگTX+mio?yuկՋ䓿ş=;xc8ٞd s.kk [b4u,-9wB@Z1kz'+Ͻ-o mҰ6ښ<ۡ-Ӹ4W-kg\FyzZj<'uJ ۍҞ-mױI2f22@=Дᣖ5x5~ShkքԎtt]>[ɚ:?MK~F{S䥸E ˽4dcb0R犩w3g׌팁@=;SrRQ˙V)5~[V"ДJ^jowqOoj$i/9(T~~p_^%1~"3/uxy\><:fLf ~ ==;wdr$SbMlo93͔-_27wov-9)|mM%b̼Թb+s{y#yf e d @Ӄ۫ǭs^#'ŹkŭB[79-4ǽٳE-RSy?7{"J>R~7?r~>p 3/uy\{H~?@Ӄ{.D37{V)5~{ 9pGjU^ i;_˴=y)8%7ż拴4fã`;3Y{zp/S'U{ ׊;D_]G͖"/r|135/yOVݩ.m׬g1/)I8W |70X:'11e ==[iKK|kq^K}*M|[i8k4okҷmJ/1[Fs~m䷏ICi~8f/u,)/#c c`Y{zpu<5vo=O[K@o3wзuj;km#}Sz\w׳ur8^ζKmXZ"g@@1гݏq?\{D/g}>>`qX1蹮o5Rn^@51k&i2n22@Ӄ;Er'b;3gΥ7GqF-2ߛmgޝʵz2322zc 313ScgבΒKe^jZ7w[|ņc[$e^!c c c c5r+110W ==sw>|L:'R?[-8o ~q*z֞ܭ5yK]mmCjKz=|0wXkJ9kb #2>22w ]s e^*Rr{mJ!RoӼ>'c c c`>q>8[ ==l5us ʼTԷߘk؞71_=P@@o'w|7I?|>OG?=vkYOXScgמ׼+9qN+~W0k\*pwj8CrnY)'A{hgrU__hGY_֟-Mm?%N)c cbg%ž}W*v/ϭ9=7x;%c<7޾?O6Ď[='{[L^{|ۯчxOxʌ3".gP߳"IQ-={vM}ԗ9Bb7w޿w, yu捽>ߋ.ǹb/8o ==Skx}^5؞װK7GM>ҥԥyɓ/~Mhv}A~@{Rwy3϶o=ն=1H5޽$ǚq|v˹$eg\e d \̣-βؽE.x+VťgW!})b`귥Kq_nޝ:@~sq>8[ ==hG+x6\-Kҷ%N.oK1o"36;C^ ])eO IJLWf-vS,=铺+s@Ӄ{kķk.ŗl-Ђ*_3X2KqO,y)Io;'~7g^w.b0R(1ι}L=3.3n;z֞[lg->7E~ʧV9|y)Nz2ϔ{Z=6JursϣUμFe}&3//֪s.W)'*c cR ==dmO|=e|sQG`3奦Kqwޓ'?\%yݽdl?fiqkJNJW+c c={ܚ¶ _2ϴӘ.sJYKb]w?o3uϺ^cY7{q_Xyx:wC˿#=i)5 ݃'--4ym̱~Z'&&dsv ޫ_i3uV- }AN opۇQϟɏ_س\aC!^iuCƾ X  !E~!fh^ڍwCޑ&²~90SZm߃x_9|-voř淛[8]m={"ϒzysl8u͘Mf;ŹY9sv>/Aҧԙ J8АCB7x!w~M ,(GG'< t\ 0_Qw%?uOȍ798pɅ}q^K}I?~ʚF;lf55θokE>M:3fF|JmVhky/d 'mo,Ƿf;%:O04,6 2.8>s\ؾp]ξ} kY/)cݼֿۭ];VNiy@1piO\Fy?3<߆}|`l/K %ka%anʆW9y < LT}5H?h/}fμ9Gy[r<': W86Woy;֕Em7E^G plbeA;XXe=1jQn+Ͻ.v_[oن=?>~O'c c`9; k9EK^ \7{lyC ,Յw ޕ$;?Wx% >#Kh5B;OzhWn_ԃ@{cb~Gy9!snM)[ޕ<_["wy3u}>{~߼u8_sG%`<2#>5yȒGs'W?0aQ&axF(ҜL쏹"lO}H2 bEŸ85{0#T=E 8=)DJ?\IXcqb~G[.[Aݭg9=ߕbKݴ#٩c222@m]r/`k}W)};:롅|9e;UOsG=_#/C~~oU*;c%uE/d#4捀 Q%}߃Bg`Cu_Fy u Oq/0m5{?huFg?ApvF?ڑT< >VҫW椴9xjun+Ͻe^*@K缱ٮ?p=ss@10'Gݳ}[OļÐCĜ{hG<@/QIeIsl"|DMwu2RZ{M:)S޾Ry6}zNOO:cs}G}mˋn./'zm[B aiN[-.cR{ltGy݇yb`CxM#ϧ{G222gg\?.G飌ێVf3琬Kei(6ۻȏpgk+-ܭُ̫Wӿǎ33f_cgXYyKbKGW̚oie~ښMY_Ӈnj33V[@Ӄ{+1ٳ&/Rc~v;ORTq .#JEE (-4 ȡH"SA*+,0FpHlbc Zޣy;=ϳu5g֬YwfZ,UTa~篾z-5?e> m|_o,=oLoٜ}g^@b 1}ϦX\|/z8RWzou}|a1f|$1> {R LG[Y}=dh m%&wݡ>{U+ϲ=$qs,xnYZhb/z?WYg9{iX_y.Mby/πKƁ?G>}}@WuY 6D2,8ny.K{m^s`b>w9p}g-k@ ^lxz?%ǣ|oћ(^]6ISkR_X S߅=wI}Fۀ]/*qM X&b>d6.MG|:~׏;[ eYޯw-K{6{7ݞc;5v/},G{ɧO}h{AYh9A ߻w:=uO#ʸԹpn kCKW۵Ig+~<1)8_>YוBU:\G`KM_n.-{a5H%րÔa9-{T>DwɶĚ? />21+Ww9Ix֜ߔ2.Eʅ9{Ο. /]V>WLPf:R:byW~>DZ˸kP$ô׶5t.q[;FSi1ڲnkQ9G{W7~˿?׾u\"Ҭ/6FT\+ub(tDB-9ui95,lnI7{5N%]ܵ-{1~Ҿ,z"SO}zu}x,gY2FS ^~Y}bRq?cgd:_گ|θ`q/{NÌK]:WbwS9Z;e1]||iNwu8J-k@ ^t忢}}/\=?z}߻N|ݱ1mǦ/=Rov ה̗>>k8og?fyYǷ;=k*8\܃n)݌8__6^/ww-z Zրڽg ~PhùZ;a^ϔ]?GQm#VDL L7ypϝ}̗XS?_eڗm4HJK_uY^j\ͺuiI{ƫʝ8^۲li.qu ae h݋],9mxl K\!K)_/Z*&ŚfI|t/"6բ}8f^۲^֔]n/Xq5v/G_7EcuV {-a_n΄;^cx|I ]3Kǜ/}QǻCt=[zn%v[]Ik[Z|?W]\d}`e h >N34ol}Qɱt%>r6ԻcΗ%mȷj;ĎKCdL\[wY;:q}ݍ.#be hݓ.M!|]b^>e;}XY\kgzW\R:DkYC!0rÍ]D -k@ p1|`5djһb/(sa45- lIޣ>wdX#;ם8O%]ܵ-{>Gc}ߖڂ2F5njx81xpm s2e\ϳTi_aq*{{1cKߡ/mI $尛[N0вЮalcʰ9 >T5g%1|Gj+"6d{)C3>H $10pKyzK5v/qYEc}ǧDcpk<ݻwo->RT7_9|eXH $S6w]n7#`e hݣz#2&⋜s(:.SSQϼsܖV5ySsb`\̩%J=K ,ظkyWU(}9X|uy*bjw;c. 9u5usgN=]s_^үF^c[Bskz;Msɝ̷-{ >/+/gR99n1uh'5gxOK,/v"mS{quS?cw^!4?`ZpE ÛXX.yS3?嶗t10F葷4i_9 1(Fаدutstj}5:ޑ*Gc3SBīƴMgc8q#!߁MTFtnn򞿶swNG?u 2uK 9(W&>/\KKc,MY{0CJL?c'`Ɉ;dV^/.*MQg*K li8ȃ<}QO/q<9e%XȸgLT>g^i 9}">L|cn?U"Ļuē^ĹhE&mt&< y=7900q~Vy֣~0E?|#sB6w86{(3HWjw#q_k*c'G%"/R9wH͋wii/-un<E"7m)%Sȓq96!g"cn\k@M,;>>[GFc֎xf;\ƞ{tT丏I{osg؛ZGsGwd׭ť\1hyd~;'*#ψ3+:q %~mC4z˕C&0 rDZ}VyHG{2}ƺ2'g >ThS˲cS &̟J[hOr=95ާ6͖퐲g͚sM1qGDZ5g|Yψ÷[r~'yRb{ۙF-")d_ϩ^QZ uR/V-'Ͳ}⤶#1."VnT;_%sǙ+qd~vg?^w?s[8>>'7D*|3>(Ʀ8~}~;X.˹-ԏ/i*C:"˶y=kUI('Z׷.|@sܓ2t^Dt]im O87j]_l &NXBkzs}g O?o-6=߽Whs &|O܋"o {{>?bXewxA;| O-BSke`xj{E?\߅|l/#l2ZR{Xr?"^#V\'ι@ju/lƕ(}'ydrAk{uhڗtr9V$UWsv&>ǛL } P[)F}JͿozw(2RwγSϳ%389 V_ky2ҒuOS5za cm'1VG*arzx}hc{y2pk?b:hbҗ1ɻG~=uꛔ{iϩ/ǚ6-{JLdj_O˚־8 gB;ގ8e<{nΓ7IGK9۝{1ѧZ}|wӎ E^"cY-BSkZ6W?rm~=#ӗW3=Xzpj=:u1_Ή'm_q054MO=Tc>҃7xFlBGYEx3U^]1:N˴?3꒘ϵʹ~N}3?Nhg y1\s}yu>q#3]ɛ{cO,U)ۜs?W?ȶ6s|rE6 _)p'}i:1i=є2z;__d\oZϬ3ƉO޿o2V,&6bG\S͜2bTϙ mKsț"*.e|jyeՍY6W?cʼF^5=)#<㊘$My~D~Ж/|/ L%A Xr9A}CǦ(䕕/+/|nvKCtB;^h8g4K}G}e>J^3U^g}jC|5){W 7ewܽ'~]o)}^=x45'cΔqHۥZyO)+c}=evwyIS.=۞.oބM0 Kiw zW W Y>ߺ-[‹)z$_aʐ~Ӧ}X8ᅬS?calZc-TC)+7{h|T1.Qwƌno7ů\PFT^741^8|}R kWWHսket~Oy|(eR)EQ6-W15nĸ[i[؎{|&OUӨ#l~ 4>#:-cYyS<YLS#XbB],'S%nĩbMpѮ`׹ =23:H=rKK9mYCS~ʹ(k}-JÛ:׮ȇ~bmL r_Y,4c0вnIc:w|x+zD_>5^O|u9~gecyŶxF9Iw<+y<>?c{R>>q_VNȧLx4ǣ̼ݻSx}P~xWhJXNa2fcuЇvӷ:"֟cJ.ʺdK}6s8<)9sޓROz1.j`^rGY}@qs@frSq|'7g$iSbbh<<ătp\?컹eޑm s:#/+.W;^tee+B\y?U:W?Sɿ]zt/Ǽ$V\aޒr#O[d{s>hZ:Qr\veel%{Q^ʋ7T6z 1Ko^R'z17F-C퍆]Z{+皏 }xPZ r|揾rR|.axy6zq+I?1~h<9O;nPg}pNyC4=t!5ͳo|O u\ޛaaЕ2pORw` lB wthtۗmL3>SeB}6ʥ -^=ؗiY]C}rO?`{mZ"o(ewϛfW71/X*ίS s8 }[VŚֻFR_]ԓ-~eVs->Ikmz3]"uXφڪv(ϽMfoYֱ>G5 u?;0[~=Ͽ?sc+DY#r?/?JK=B?qi2c/e_.ʃO:S2ʛTbJ^^{SDb=y4Aw!Ečr\yCL#[@\;ȫC)'e5F9H)/3Ox,=,D9]8vR }1c/B<)/ЏrT~}/KuF\bR|5BZ꼉\ o @>y\Եӛ5<s3k[ӣsAYo(s03$]-u!o$24)>)C/y*rCA% sr{#?'OW>ЪW5E>2Hi}-J^kPW]#{٦c 6\Ye^?:}RR&?G[n _~6Vܾm)ms+[}YOE ]Kq?O{ȏ<%t%wMY~ ]3:.RA%0Jz| !h".X ^;C)##nvċX#K}w ^-i'V7ecO9h(s(󿻅.a}9 C'pd>N O;QwT t9b1ll|Flj.R%l=y/vQhIyqR.v=.B { kq$u(/}[>-/]\m6Nۤmu M P{ÏߜGe[DO|-h'E \n)q"r-~2Τȟ1zeO>'yNyIc :yџ;-Kq{36+!_hWQ^~ee7i{і{JC |9 42hŽ2Xg-SlG\\żx)b,9d_`eSqOGGY?yW7gcq-Co;v^:я~g| mkYMz2/em5ۡh7廁Td85iLKE^)%m#fk;)k 6[Fw,b=~Ρc,KѥG\qOXW,.U^(m{BQ>u*LoAGb`p=b!NCljϤSK{~%~dI[+/8Ӂ/3BR|VоNy4dH6|J(|!,{!c,lg"xγ_p |o!%. /ICL=b_敃4 ef}Kٌ_C-e6T/օ/BƔǘ9n[oNSڼ{?+Ǚ3c}s$[oR@Kw s3.UvȾo 7-nM;}aAsMyL;u"y~ר>څ{v_8_8^0^[ xnf &؊x믿{@b`Xj?Exťq~ I>CR}8#8mmΩۍ5#>|ȽF*10>O)}}6"hWG]{Yxv :!NC=XmR]үʱz,oW+f}S۰/-nm!i1{}?|Ʀ~e|G=/w]:sw{osT^.KwΩ)iFGu[,-qX6F9KqN*=+f,/ #KeKfׅ%txئJ[hϕ'۽5{ N)C7mspJ}/͛ԹXdo_H}$@m9Ɠs?eЌю qxq>+QO z}wRя2]}mf=XRٴO-n30֥w,`lƜ{yp3ל믯F[c{ο]okKͺUS/0еZS[I Jg~/n;swmX2}{ͳ,K%1pj9Nw SKdlSWG+о~o-nݲN&wJynnbRϵ6--ϞI\!fzѦ cٖ^cmȾs ,L<{Oϸ1]\{d۝3{О#K-zOͯ~|gkir%띷s8o5\M^hw)c> 3.ՍSmn7׆{ЦЧV9~muuiL?g[l;j#kg vw2uE ;NsudVHGL9{N)xqfL?osw1w[CKr>hozIs=ESt-?R9[0'ڭ=bػvُ%zOwY6cR|| ~>/}٩e9p^[Gq&%Kd)x^2ֶxc];:.۫k\Y~:x8Oo[[[h5=aq3&5l-/]Ox?kUxNLm/֖K_O=c;Nq#ZLxf\*׷`OWuq[h'd,ʘp5xcsn{\:5-u:wn]k3R%^h{5)eu71} <{Zhacl[{~}UƤcxؾZ}ZpS#=_{yDsH $mhyЦЧNL wluqp^3r M}$TδKbBU}Qe.kX2a,uy{ٜBL*˽eƔz9;Fb 1&Z=-0TƧ}]މDvI;V[ז|o}-cei``}Qtu#1H @˳6?LC4sy|*X;|ήsjʐgjҤ~sߙE'H -Ϟڣoq.wawK<ψ~ܹ8^vko~?|磜2O_źcuY]SΚ{ ;Ss~%`B6KTws6rׯ/p唭WGCo{O|ڌ~G{Z/}.M_Lf~V-cmseI3L]n K;7\{ߐvgO \swcүF. >Kͷ\Sq7c5܌1]$ɜߐzbRس:ۣ'ڕHϙ]z:s2s ]s|>[#gކe +!,84}0p3 g+fN>9m_/ejComs~2./cԜ>ENɑgO mq<;g- ʸ?x[VO<7=9A9>mI7^|O]Y~яbYIG~mj<(^?3 K+Ro/pȇq|?{'or/[P.-6 &ީC>Xmo={ú2%>"=mcWkEC~k;{/ㅎ,#vCLlY) %6J?/}m#ƎQ?`=rb_umGc#ޔ:m+W|1+bo)yyD{uuS2mbs22.VO9c\d!{{]ڥeSLK.SC1[kyC>{( 4%? <^Gޑ4\ ʶ}rtq5O/yLJ~xv2ROy]0V奝rDq 10∹fG{0輻`rS}l2.qLIC*߲=c,ʔb, o PIw[}zw9z=TkX .׌ ,m9e;}q)KT6/z{?PO>.>{/_N{F=:"88lG[u}k14|؞:e?bo 1ʳv<cPI\𥟯[nS3Ҷ5YqM{ȗ<8%6Ypۺ?7uX Ÿ1HtI;.“P_'SoĀ__yı :&?ܣG19wlcZƥȃ~Ꮽw>ۇz/ꡃ:iZc슶]2*)ؖzoϹ9m2=Nr<(gó [ԫ>g{>Cﳏ> >XO#9ʳ(m)wLf?/M3[:H _`le;>iG2ϵF+XlF3!L;ɻwMQ)p< [#Z>e`Fu>`muEc8\^ฮ3MOzЃ28roa[Z-%}~3?07VN^pwme'7Qy S9@Ws!à 'xnoώ!Ƅ2%x‏,A炷&s5'\`.9Gc/W:Og.ʓ(>J?m=qz_=n]%?o J;}{hh1Z]2\<ij/h8{SyBx مOJxKik.*okgR2wWX_N{o9bQ'%4V_zuu+Һ8ķ sv?ۊw%w ,yJWgs+вkVҊ]wv}!}x[_ 9#\Jrw?isg4Ķ%k~u)]Yg-%C~|͘'b/oߚ3ǑczztWy+FЇ;$s0.'!A)}pF:M[}}\nY}>1q/ʬ\eLwO9FA/tW=&k}š>i(_ZC//-݋g m0ixl}гP{7_.qhW#wv=Q޴C_娣ImCppI(C3 qY:Ǟs.G.Oޅ&,sW~y0֥;쓞\jmV0t1k y^Oxrǣ?C/g)O,飭Lmtl)MWheϺ4$ƐG\8.!0JHS7<w1<\K[K(r"Gvǂ>?/WǀXgb7~W/+A3}~|J7qiW-yN*G)I˴YZL_ۗYn(;.㏘h[3j OqSw=JΙu矸;2hWKY/uŸcʸ[+cjzS~gc`c~k9WFZ\y;xs~~e{V:ۼOAA˿w}#^~G?N+//NhMjx(ٷGaI꫌Q_< X|Y57v.o|Kܑ{[wdw/~m~SU'|^b?[b> ?'85C~}?{1?F<}S%cQ7f:9طXs7؏lyڍ)w|2g%Oǃ2IJ1E֚ก<'k{n9{S]{1^cu~}%{ {<9@eЮt)_<`yL8i{vK&SyUlp/t~ .wTޣ-ű7d\;y#b('>nQ`"xԽK6u G zGS:1 tN< Ƅx=7C#yqeKC`W˵A\x| 8ξli>)5^y={O}mo"?Ƿv C>#uLck%] ĚtP ipx5'SlM:xhr#1mj#O}헟:8wr=rS4ݚta 9S\Xp.L}ӄ_􁾹Td[ػƴ 9cxT葹*Zc On QO^pɲ1c.NG1|v}^;5<^x>ṃg h3{zyƺ4#or:y:xZΝkRNK~j>F\SzUh%>乻5Iy&mhqn."tGE[RQ8߷^[iG~?w#ݹ8}{ _5x_p wG 3ͼ!-a~{ZˡW{d;_ň^bzk1ȩb`޳T >Sߌu`1p{)xDZ෩Oa15kAq~S Ǟq2q5{?ru}{;b멧I_?Y{ݮ3i7h8w7&c110bc`޳vI:tx;[9}7l]rI.߬;uqAnEW?߃اo)\?nɦa˘#=>?kb` %t/2xF 10b`#F 10b`[l_;N=6bt1x*_o?F{s>"M=՚2Ώ1\soU_oU_[]-k|wJހ?u>kܓ-;-~yq;>"Y"]svk}zz߷ڒTmit]5S|gۈvNo=% kÇk’88}cx`.^[wF5֮W[Vq{kp皞޳n#Ɩ%|u9C{Ͻ>1i^c}|'w(dW:P{xt|}5c<k]uܶ}_l vS뷅1q =gF-K;w]w)nї-_z}|1d_ç%vyu1K]y}cw{}|kp8=gF|-Kws$7t))gϽ'uw{9}eG.wyd[dy A/ұe_9֮1fKwmgӊ5ܖ;,ۈ~q\|NYb\Cx^]sH?wgfGG'mm~W>sS?g ѿwざR,[j ;-9>Ň~v'c<5]ŕ(o7omlaiܼHXwzy蚳&??c1~:_3q݇c=ҒkTLwN^%k785/7ݛG pk'ImWR}GvRK8k6}zpCT~Ǻȃ^c=z'qE&}o)tY3x[{=zvX2/zi=Tf]Y{*{X:?o7hݚ5R:KGp^؝]p!Z[7ߖk^U?SQd.h>X cm^ʵEEIn'~0E}N3/#-v.XS㘮icO=gFLMԥ}Ӻ7[{G"=sc Hx G~ߋj&4աC{0cenUcaET|5ݚzַg[czt<88wޜy~CcWy[_y?ʳi<15/\=ڃNT:kZ5kt=gF\폫K~߹9;oNոط>z7'ϖs&%8OړON!/Og60"x1:pn#%;Umr_SFk=[{=<;,4Κߋ׬+kp{=v c 6[([6֗n׹e |B;ֳ$/EK%X/w|vh}փsǓeΊ:k"mqXK9Suޯߵ.eOV^ccogMb:s`ɼͦԧ]Vk|wQ޳n=}ԉ9~fϽ'u^>rΕ1,K٭Fܔc.0~sz>O~!_b ,Y^ M_?sS 7ψk|wKqֻ=gz-)%׭B=nsK s=Lc6?ws]ws!c?^=:Fc^<ǚg |9\z|ocϽ#)sXCbXSC|?h.ߖϱviV}UGS=VAҺѳ{mK1t-_o&]>{s~|{n{1}895Μz/)qx?/O3:ۜh)ީ-35} -(w9%?oU-Ձ-äL8xIs1\}Kc["c'}6ǣ;ln=붥1E]y:kx=uw{绽_<ZE~/|(A\ml.}}o þ7/xXj. ܺ/vʩ}k?t6/MQ}L O-5^ 1xۿpssPRS|2ƍgn? tx|/y)tQ/ĸ?g9p~K|0o#8-x lߊ=gݶ2ùzC/9[}ީ/1c:ԟ>c^|vq}?坜{+Os*n=/>>ݝ%Su__r5}sS='' r:_B> B3cM||Kg)cC/2ZU?Vϵ}imkp`Vt=붕U=o)'Uk{vhc}<{_[B1Ci':σvr)c,O7lwrn..ރ{.}Rg*cI_ڔ:iCzĞ]|[jV2^X33G+ݚԱeb=r,?aϱWZ;s7}U}7iRtVX/99ou-X+/WBOP1/o˗w@O?ރ+yq^iSQ׆ ﭭ{Fr3n5}FCƚqn<`\X&&W}kTŻv[}[)>O0g#ή[{_hi>dϽ'}}Oϑwy\l>W!c<~N; >k 0~C;:}#=wesi}ep'GO|{2g؂]GN :1 \?3~]xRqzu9rɹy cs1N–g R?b}G#߽_{:s5yQ[n k!l:v~ X"wӠ#1ᾟ;q̻Թ{~ɻ.Ꝝzp&$@G؉=]R[e?fLks^" 's{=\=ؕ1ݣ=S:L_+( -ܻ:'':ڽo,M߽w_Y}Es7-~ cϘsw|rwΥRݜ;,:s&ӟnݱ;~7g -`Sw?"92 9p1PbÇy໌ƅ}6Vq语)Ƙ,w)ρ7/~ш|t{yw?ΓNGop68;t'+???ͻ_yrnvV.spG|1KÝ{] }~]%T6e%KkW޹玎-䥦)kdܿ8}m|\e+^휾U䦎T'/z- ǎqj+k5=ٸu]ޚW-||OZ;gIz֧ /P)SNktONER)ZʚIyG|JھoٲA},+e0F;ڎG>oSrSf<3]:G#b;sw|;?o|x9eBK7ġD_ s0}b ޭgCe"^詮}T1<䩐lY堗t쟾k!n= S-{b6㴇:/!/{C&~ɸ!%-cf^J,K^{O=+\΍y-󸵆!|K߅ki@VG ({1~e?dh4)WA :@P>YzF/Y]i+znW}Sr83~ZyVOP?PsICyݗ|(Ӈ_%3<,[~?e',;uS#C}(ieK~oK9vdW98O|` -h3~]*cԳ$)[3³t,J9pїhc$%͜.RK=n}KYju8~ϧp\Tq8J/5uOǣ[ogo2>68ISKV%KќozϜ>6gKocVyaf?mx#\侀x,ZYgNdz et\\q(9 7ap'Y;EFm Cf-mvy3oٽ_=S঍ȕ).8<zFiUm]:cχ~Z*v+<ÏX\Tp_Q˖ޓ#I{kN~=5hEȏ~`Eꮎ髖?eud_;w}䧘ǭ}>Ϛ=#s}ޏ.qڏ!S2YgN>Щ*7g5@x',e2q <&EPW/I[e.`o?r9#GKeۦZO?ZR-4S_R=I2K%8.1j^׺ZL]ZAsTGxpOOZy >߲O1c"e=kp89)|4wk̻oyu~8/3yl?R2J?m,x~塳؂?u%w5,E0A^倧i~/'SxPG_)pt@(Ϻx9ovr2vjݸ#x=#?|w##ubx{l%t~r>ILZprMל6q{yk˭eU:ِ%g&.uyPYuMy!ћ2r߀zWm7y#ó/pK>DzYOKUڎE)_uK[z:%]3 oxPGƾz?>@>80:?뙺0K?mxoȏ9+%rs߲ުT/w#`Ե!uś~py'Gm+r)[1v%>R ]əUSx D~G4߷!B>{[iwpܼK?:pW)K^}p9'd-%:2!h&JIHA#/:f!W-OZ7eHK}E_]|yvqIX콎A?g僯ӏK/;5>>whNJC1\/<+k?8_p^\$|ҳEߺ{YEG!6~tzy&k~t-K 9Sg_ eyw/pͭk-S .s㬿&i8gGȯ-S%~>N?HƄ1m9[o|'M[{섿G9E3G[ltMi=Sv:o Oο.mr}K[㻥]sb0.ƷJ]s!}u޻S 柴 \<4YoۿlW_0zg>~N OߌiO~Gn4 zjB'rȏx_<ї9 qɓ us'XߢO~)s6]駟^*-9;HEN(a𬹆L(''mFS̷ _l16/}/݇G̸?qيOp+%>[-c9K8~ܭ>9ũx刮{q]gYggޏ=Ul{H<Գ(+g!snFi]=wf^#*򷟻-#G\缿sk%~[jܥ<y)}Glf97s'ּg]7OeBN{ʧ ?Y#z5:0u?yQ2'W+nw'~rNzPϺఆ,9^%_c婃%= ONuxW[>s&ϼr,ɑH+}Ӻ|r,ͻ xG[Zwr~ %}>o.H{ԓRK[п"=S}Y_1^WS ?=c:N)fQwMkO;% EOp;۽9E_yb]ǭ5sAy.g!M}p0sx ^ʠl^#܋ޭS>r'>*#u. ΄I^U7MUf^I?)R8݌m3&.tip}ʥrNQ1=)b|ekkPXcMxodُ,cЀvӗzcJO:L NC6PY'v_i{.7psR~gͩk>\QVqΓ,[tKϚSh#mJnRa}~eײ!ǁw3Qz8dۯԝ)\Sx/M3wcX/IVw U]iU{bSTPZFk_EՓ>韲ž)}Gwcw7S煱CCҶ྘n A9GhqBb0!A"?t-}Ǹ>10bX ,Y{;|[SF6K?}[c\IN.AR5\W69)mw୛{!~c;[ _٥Kg{{9;#>spjbK\ߔׂw|oI?jr߃o[mޫ[q=Sw 1Kpo6V쾇~A^2<\y=|nԷ͕lǥr=Oxvxj̐Wc5p\^礌?^s&t\=>ܙ|ޫ=Ӌ{L-/҇[{ԣo;t6'5ۛwf!&{N- ʭ99RN} ޺W-6t/mK>7ǯᗽzzc{L-/҇[{ԃw[<{{cdcc*3[}Zk͵W%%q YsW[Us5TBl.[M/}{бT~7{(%iu gIg;Y׎53zɵ;G؝>$cIgsWJR߃j+=AjЉ6''ȼQOMJ7/ivrRS׻Kp8օ[=n|V_(H8[?2ٹ~N sS㽽ysǻl5bx@;<.4̡R3e̥e>'^ڏ[?-:=A촥[9m^横 ;~<Z3GEֶު{{+{\/'Ε;g\k{L_~]/]=|&{б??#y)Ҟ9k{>9%7p楮Vjlbp\9'o_sJ 4⛋zէ޷8S|} ˃>ԋ1M ':s=xmm-k7jc 8{m<'3){yu:Fm/ޣ1pl\޻zݿs[b%sdy­}؃8,ys, #϶c=%tJwW9)x?ߜnV+&< 'Gx0/UqG;p6pZ[*l=s친CZsNngηϱZߊtܪ("jltlM~gfܓs=y@ߡ7w8[!ُ ɱqѻzݿs[b%sdy­}؃{K7/eY*xn!{-W>9czkt}^:W}y#dys87/uJyWlȹeSwr[Rd 95/>N|g۟..c\<.^,%]/c~v 7{81NzУW{{#<7t߭ߗ^ߋj#$ urSf[ZCsik2'uj?nn;|k`Y.ͦt{V{LcEn{te?-7xoo|̓17ߒ&{e^7W~k#Zrk|!e c:N~+׌ثr1?ecw'/ݓ zV쾇~A^uڟ6{9 2|=<7Ғ -)kmI˭K|zYC؃S |`u{^n`^w?@,K=R&>US\U`zOSWroӷjl^?(w+GOI|:ߙlnKpEAl;cg1ͭ#WW^Uy=ltM2~-~\}>n.COc4sNIw_Js.}3Sjd`bOlM=mN;xEOmZ>7y3?ed{_BK_:o@GpZm{-=}/:new*v`mBsp8 u.9gͱ%tsͥћ\A?.jߪ~s}h] SCv6e5׌Kƾs{L=}a.Z}O^??O_Q%cSLj{$._s:-:n=Gǹ2/; κ>SsſK7wb=81桸+a+Kz>Qr/ܾDZz/o͵yv^夰B JW{Yv8Wv8o#8=x 99Ƽ¼b9k-k]g{9Klnv=%"Evz"@?/#ҷstl;co:EjUإ}Лk,>}s#GjV?j[;6O>$lN}-~C{X3i\?SXvLG 5 /yZGW֙Py ,S=^Ce>icCss}F?^u>f ݜq 9ti38z>LŒgIk±ѩ{>oKzE1{Lӏg!g ܥ`CcۼzM)rOEO3:O/{~pll*ѱs 2Yo+.WŽKG%9Z77q⹖qVŸ6T퍾-Wһ\,K/l{$X6X3΁s.֎|uI_K+[q ͜3VY|*J?hm-YKlw-y-@r)9/^Kp '沍}̶Z_Cн=:/CƷN~g3#[^xN'<74&zC\إCҹPIB60?榀qȳS\kz Cz<-}nƵπ'go}ܣa/ׁ/٢l?!vS~{Ǟx̹Ϝ6IzS/2>@Η6q~ں•r2^܆%]oul O{r(~W;PbCt;PSv?ז-]ywRy.% ysZsm9_^B92cc;{g%<{&$6'tθl/9%KeSrR{UWRk᳝w=>pUóR~bOg r_ +c{vz;ɜzNʆb+{k[ gLxouEyO=sTcOƏ;e3,E9:&]kO}=O:|҇v&|H_>"q%69;y:禴6u.qK#:WYc~+ݦ1d^w+#nj^wĻV^5\_~~rׂO_sMv-v}v߿\s-{TӽgrhoF8꾬Vu]9ˡ'ttZc/NoNg5xl<b8r.n]:/bLESSOτ'}O~=GՏ>?c0㞺mcܿ:7k =Mɏ9s uCL<`%l:BȶOSs3:yqi#'ށzބg=]Ε_s }qɿԅ=іcoW5ppzl]KwzR'rO5ĜxavʹTL͑ny΅?}YgbNl\5q1J+~NDG_/T?)[KdدC93{ǎ }mܵ2LA-JuAWW'([BsxگC8xէG5rR坎Ĕc9S]?~w9>xoi'o:AXqf-S.heP#aOXKdT^MRVF_}Ƥ~Lot888ur])KR^TxÓ8q!,Awmli|&u2}Ӫ[ ~F LCSmwAx:|~-}3x_nףrNkiwy\7Zs1<\ҥVNE]8yOw?V.rkKֵY¬Wzk ^ځ 8}-ȫ}[z_n]ʽmKf[yfN-n{SmKSī͸/yC-h.m-yoƁR-sz,^WԲnǀ9#+S6a?yTcJd]:l%V/ǧ1w ^0"?zW?zd}$ތ3m*lҦY~GLjq@8 k"Otf|KS'F3Ή3Ni]Ybl] Kx/^-}V_K,9)%owKuAM{aW6dL٣{.S8At\K皒tqC[EXV`Fz#):|*{hi;CLq(N롺Rʻ N6aYOʢo7ihӡu,c-Niʭk78ʨ*U,?0m×kt:ˋ3-Å-:I}De}i]?9Y~{g%r)BF}Rf/FӺa":|2ԅ)=n⻗'-%|ý.>}_Vf[im=ZjM_|6(^2loUyJI\9v`-Lq/!{H snr`<\m{M <Џ~{/?[>޷JhK^[-Kg朋=q?gy>VrI)zGꞸ9GIPXr@+7S|>G<3e*j^w;e ľx&p'oûyCWt1̀ӎMg)G=Ļ:Ϙe|VowS긯 SQen._9T]x˃9{.+cf;B0ֲ\cąoAb ⃌ihS/lB,ptGp`kC7%}XKwqXR~;~—{xA@ N! <[ifO}|7c؄8:c9+czg->-k̜a*Nonv>uȺ΁ܷtI]=7K>*᢭ҋQVQGps/m|N=?Qem:/'LM0p8Rt֕YW|y؞EU101 Yɷ2[$SCN¹w=I4̑4 -e.׹ K>ֳ.kw: *={bxO\ʤ=ToɂU'oaGCEjbA3NK_d |K.W?ŽzOƌ<,+p5= 3>'N=GdN裾UeO[pwC*`s(:1/~ՊIKg%utZW]'X|#MˆgVW&0P3飴_!ef?xAn>Yxڳ8gUpY3t2l gb{e3m _-}NK/x!#/lZ~0&cY}^Ư5k,ࠃk4ԡ_T8WZx)OuL}^ISڽ?V͘qRd?1cx'yvϻ9:9)n.{"v_Kg/#gO1X #s9g`iS£%ZazO7'uoy/>9k{іwC_p9NI޷JppUz/N:<+No/gĽgjϤm.8ҁceQ+t8A>3uo8-`kӶ!.mƠxYQ7c|Cm^vWJ!YF!6WAo-9gc/eߕՖ<{ȳ>=`Ҕ{ƺwV.蘷K\Kxd@p(k7e^; SxXgEwj5F8|GGlRw['frjsCr52:o)^r_Oԋvx'>/z۸FԵl$"CY-vyxoNE]}ƖĀ|,޲EAt?enh{}=&S>"j1&hU]b0wv›r)ޕ{d:C=sdW[qL+v澥 {9'hCDvQ~kkms`+_Ci<~p?K6|>qYW p93tsRe]<γi=7ȺS%gk?%r&OUs K?j:8f<~@=rO\B ]Aphэ{SOݐ :@vx<`_CJ޷@.8.)S_tH\pRO…Uމs+lh(cy̯OrNVKګ ({ lA-S"79K|pL]Ӹ^W_rQo/-LSrs?gMKuE'$ .K;Vdw7տ0n2rOzM\b~֟ɓz][~POxe=y\ /0ⲥ<퓱տ+Tt¿-{ nS>" 5ޜZmɛzY):1H~JSaMl)Xu۲7Zy k弐uɼ>ܫ u.t^|: |W/pԱ:X#.V闲jɳS35ǘt\ci+CL؃K#{pŃ^}+rm+' YѺB 8pK(Һ8eU'Rlm CO`ɋz8s!?J`K; rዴmY:JhK}rHO>Zt]Ȗ?8 rs|l|zi_ CYu|j%0edK<.Ǧu}u q R{.u~̻9g=!wS؞jKz9g̀.MlOY"P2_ANݹ܋@Wi׎vqrOL֡~Rz7&RYikWuUrr ;~RVG4uɺ28x+p ,ϭ3R)'K K =UJ[0'&öؼC>OZcro,M@0 1,5&:!8<2 $%ķo剔iyL9(яg䪸|IOLm!up>v#~{wy%93u@oFO[;i}nslw1;={clJ:o0?dv܁8KU:s^JZm]Yķkz۞e{6vJBLihO^rG$L[|h/(- #-]X)'PC՟xmޡڈ~>%NȻb}16 :.2uK8|<(SmK:}vmŧ:pO-I:u1hKxK٦cZSI}29fଓ[7sԾT oؽ۶S|Lѱگ^KRk@lwPZq9V{ ݂#9CF^s͂Si$պ~wro 9gSZ^b ?MZnk9k-W{{cg^N{yfneO>XS욼{5XlC1嗴~zŷ]mrk5e9o./wsO=9#]oS/Rsġ[_ImُĻ7s}@m|9a;~ˈsl^6G?s1{~v*[.wE=[{KlV2rR_${Cb*.ew.׈a#F sRS ?C6C}9{歹'6ZϹk>%vzKi[7s/ie&G|c. 6c9NiQ610b`y10wgsk`#F 10b`#F 8'g2hWb̍>t#F 10b`#F  Fni96t#F 10b`#F 10b`8'2hwnhh#F 10b`#F 3F>.c\s\ 10b`#F 10b`1KeΏ6m }m׏WbRЋ?pҾ=:^˗?]/Ɩ]ԾMKǾs[2#F c?QOcz0^zEK=K9{%Kbh+5#'MV <{3>Q|أÇ#F -Ǩ/gj190x1to}ysbn.-9|4rRI5u;'zιq| 9ӿAp51ccX{q<|Կ񠿜y`>}:Cr;gW9v%y]k [ 3>f'cn10b`~ߎߢts|p֌ķ#F xCZ+ =ygr|؃Μ=~ ?'ӟW>{ݜS7|q{ю.ꭋ6 Sw}ܵx:>SZ莵~뾸.g-7͵:}AG$QNLފ&3xoo1g^dkKN곟ݯ=x>{}Ђ ]oU<^> dאE:{kw\o~޻^|Sx޴2?Ҏ=>7bp>s FSmMnu(Ѐ=ku 5ܵݒ}0J%Q_?M9.xooq8{7{I_?ŏ|ﾴκ`?[OA7>~җ%ZrNi;QE*.]_`{5ԸY@+||y"JdH=*%[޼U_0xI3ݰ݈|oNh_?ۻn|< stJT5?{k߷t?q6\p4!14$iЦ*#%h=m@%՜ڦRy{{9x֜s\ֺ\S*ïl~|lM?{9}t{s )yڗ|CJ[_?gz)c s-Kv^m7䥶Z|WB~5u2o/\ԬO]8d{o7<7Iw{[I'Zg~pN!>`kRr.?.ڇ>僚k˾2v}` <ǯ{[z.x^gYXX1bp?݃/~x;F{Q5Y.2xm%emv|GP۵}ɶ}{{.V,;3F=#>XOx[pzf+?W{_-?-?X1P V콮pVuj=rPd<>Kykݺߚ֖cۿ׉[.ڵ;gjNzFIg*G5~Oy(kҽtᓓi_Rz/u9 TczzwAN)x(/!> t--Lkcqg;gm-w՞{rѵFk[KӬ_}m%}_-9g干 C$9$R5V[?s{ssR^/zms+[7gVSWwlD_{$v%~ym-k߶b`ǽ|kslPrƺqO9%kNmp:÷HR'o'FrY[Kx,Kڲ^3xV`^[5ѥ^et E~^{I;dD?3X碵)Wbay1wG<і收Z7[ު>yJs/@m^*Y!صp/˟˟{O1N[I_hNrS[-WkWoʹf9S[n~M_[oEI?ܣ"{h߬X1bcੵz>M)e1xXOueRq{1{{91vK9K":?!אRװm\{+V xj>_>bˍScbzzۍmN-ƣ-r%)i|%|}+<־sCKC+V =ѿ7^6S{-/x_:Waod!nq>-R:>'2׾e֭%{o-[{䟶9ھly<6Fe׺WX17g-I/o>K{ns̳k}/Xbvbs\m5cc~]/.-/O{IZpSYXn-+V x,=_U߶rS׏Ccؘ񊁷s|ϭ񍨽w9[_x|t<5wG|{eӊ+\{|\Ω\ԤxQ~cK|iovvub,7[;g^{S{{[Y5^]+^V D ̵wΏxp>ˇˇ+n/y7N9'Gq޽w)K}oKo+V k^Wt銁ێ{^g=Ąy}k٬s߉%Sk].}m+X1p1wًw>x:/߯{[ѥߊї{{_g1',&,ݯ]W^;ך~Kt]b}޵g/ފ}ttƀԺùz'm]c mNo<s /cSݭs`o>T?wo抁{מx+V.+=ľ|ñzܛ]k7w~OV,X1b1wً|y8]>]1p1[<>CqK{sRr9[{f[{y'ցwˊ+V \/={X]~/˧+n/{͞x1'cr/rkl;~o]'{?;wcrٷbrk^3t銁ۊ{|w)۳cy,';''{l^-Zsiˊ+{מxk.?V~ֹgk>rRϕqk֞ z,xl|)>g,nf;ok}ZzZ1bػ{L{^,.?o+ޖV 5yPkNjZw4{׾}+n/={V \>/˧+n'n-psHr0mp9s/?<]kyV|-X1bػ[crl}|yn}+f ڻY6|[ir =9)^]{ر|v.Νbw1\k W ػŻ5oAu_8]:8t Y3 |nrvCWn[l{W־so%+W O ]{ع|,_ާ+NOW 5{e;%'%sK9ky[ɹn[lvlYη>x^:Y1bػ;GE{8eˊr15'Szߕk{On/w~zI/Y+V k ]{ݫi5}'ỿ~}+;p&Pj N>M_{hߟߧF4y[X1 VNj\8vkYj5:Ͻu|*ۼ{ K{Պ)={ޓoފ-/Ӝ<.$N'>ÂL\\|u_]1b5ΰo]yoϊgS[{{Zs/]ݹsrϽ?Oͽ?\3yƵ?[X+V \3={KSJ'u׾ItOrQ<++]h8.׽|1po{83=j2n_ϸ}nV[_rX/]k;oiOGG+V \*={.Y_w"{^9>HO_>J)UV/_,_޽}y5o-r{ΩK|ߞ?9%ڙ}?oJ4_CGnkb`׎k^k{LJ-sQ,UJ:5|Z'3?n[q,랾bx 󝮕:|[ʓ<c6=~o]9k]y;'w>%{~/\>[>[1b=޵g/{[ᚾ//%$R=%D0|A+ԳQpM[gW ~ xs{ӌI˻;|s5{^ .9ZEo/_w1X1b-޵g/[rMߗ+LGm߳TAEt\UWk,^X1 yrw9 ]Y}we[[;Kͧxk^1b`k޵g/5uW}yS|Kkt. wW ~ <>_}X^sRlĜ忷6sg|-^"^5+=Mxt|/y+fV 87={gcL_|;w\SStY/''f[>AR9)}k]#ro˯f_[K};s.}D +V T ]{⽔$g~)ޗ.ֹrLܛ͗IGܚ/ ϋyx%K߅_Z_j.,9+V x,={ۊo;3_<:sȇ-l8R߼t9st ])~/?憼g.G3{)seMş)6})/ܧgGG+V ػ{6޺Not]=έ}}X{9?O>|f/k}ߟ}}+77׹u<ě\smFNJַZTzL>zω)R˽uyRm\=1[_bi<ֲ'hշ9\I뷛?>oi?xV'tM::ổcӴ=~doy.zoF#_q7yLU?}||b{S6{?}-zTѤ gxCc<[Ӕ+qL-ٌͤc4liz!s`-[)x{έx|+79NчVfy);*Xt~n9lӿp}*O{~t{33_~crEsSC:3I3ڰ&1>[_;nqҗ~#bw{~+\kvr Ǿc6g5J9=Ϟ]{YNVơ_S966KQ?~h?x^2r%fWob 'hCߩ?i3)mޮd(w^EGwٔỶ2؁>mc_?6 {ދ9m]-'{ re# u ~֮ O`#kGnCz*[ V?}Mj';r<*`ַO6Dʩ!4eClp6 ~,ͱqVxfGMk|@6ߎ `z}xc8R_ǩoOLC:> 'O!Lɖc4SW|~g}/9,\ w_~OtEx:>yp^A=|oO>Cd(ɍ799O6gw'>Sfu#|чJ}~m|邯6MI?pM|"R/nO7/H[~hlXN{p]ϋ*))_O,{OЕ^l1^s_}Ѵe%tӸEtPNٌЫ(ݷLOrϿ;1Ÿ|2力k혱>߻Oi7~ϤE/~l|7/Uʕ>ͷr O~c%.X#W͹[  k{𣫶F?xqc\ml >闼i3};|?5|.c|dNPo>/=G&CInq/\-:D/Nl7>чӆl]㢣s]~@s:tCrKͲ>4^{MNe+wPNa__}bXQ7.(VŏvC|^.|mn짽ѳAo|O.O xgw{ΡPv*uG?zHNB8xp9|2-Ս5[_{(Ks >x _y>ֽ\×>K/]5.~io^ ?y;^RgN_*YoQ7F|J5,Os]q0+_-lk'݋&v™{xs|[9:!?{'1uo yO^tf_I1ه)>شs+SN"r }P~w~x3eqj׎F?U}n >98/ԗɘ|kwA/?eKiJsu$Mla4ᖛŏ3~KSgqK|p_FZzh`s3nw7crol{]K~~~g^XnЃxtӘk)Z4pD_nHz&xЂG;5tiͯ[CC;D`͏k~͵ܚ36c9kеvZ wi[K%/ ^`tij>uL<$?ѤJ4.m<pu&d''{f?O>{?;t>shpe[ez՞6 m|♮ƖMdIz}-&1lO.:>Ov1N֧,ւ>S[> G~\拭vN..u?L,6mtݞ϶ڕαxЃ< ~U{/ G|շ9y'ou.tQ6߂>u=ejo)5'VNBbfC1bULy#VSq]'.;s!٘_>\].oi,B|>o7oG.lx(/_,3 Ra|Q6}:pck[Pqzͧa7s#R=iq\>it+4|k[-[B)8NWv^Ÿ?YkV/+<8Dqmk2&qԆV?Zc~1~C.hS }8>ԋm{>lSҝ'>tC6?g>ȇlMx3e:]͵[CC;D`͉k~}bͱ1lڂSIkZi&dE7^M|Ѻv>uVyAx)ӕ][sƋGਃQßrgk/~|\_Y?][?F;ihx_:EN^ N{'/7~_%W |!閞hCݴ7}N;eo]<%]>u=~o/f3_>#yNxd>| yYyy3|0\|7B_^ALJ)\~wy˞9ye?Fcx{r®pgG\=?ҹ9-+/g䈑OxƏtK8hQ>/?m[;W.:>>SɯqO.SZb7Nz5ߋv=;måƊ5 oqlL|O2uOQ_1!{KKdm9xse3QWtș2oMvjwN\[{/1ǖx{x-5}:HuךbkTfM oWeuuTJ0Vme.ykX:*v.8~{N|4d)#ɛ\2e+ș;L|>OߩG.I^:`tKٖI~W]e~`˫?ӛxOׄx0ΟQϕMO:ߗO"UΑ6@/9.bfxxW1['<#[8{_iwʺtXL^ N}WAzlucV;ݛ_85{Wyq7.SNk ~ ]xb‚oD#蕓CvWj<\>0Z MLO oU;s9/wwFＪg᠝l&ESUoL l<#~Y1 /vgشe˖9C7hɣz~9$o<wnl흾kߕӾȖde³ek/) I9&'O>(ӏGN~ViמrSOF_o}3g?5u;>RiOJkȜU>G1ߔ:']^ϧp;o.-v 콷{m{ޣk= goYs}6['Su?gO{d<ҾƩ<ǧ{|ύy8}33ǹM ol;3[s =qǫ]K7ZtvRd>r,G^ٳ(̅ɷw{lcН\}_Wl9[9} p.9gSeCn9~9{Lc[x r/%M{cqO"~ ]9+pkP|YrVhdG֤;Үq\+^"\ձSpDAnyK䢦]'-?+1̞<79q4m0/=y|ۿMݷe+Zm6?Yy?kS׷;+V B X{osX?_+V xyyY x5Vmy;Wz]C[y&g;t &m^*]͹6v,Vmk^w<gx>w!}x>w>wuo%l>{ٛ؋^v-߿=5~^c1pk]<{F);`t,)yK{X^ mky>xa{k\T)DG.hf֓g&o 4FG7p1xe;98xЍf17෵w|%;_=8\l;^>$ەowh~Stq遧>tL\ dK(]|kb0[9dKJ(鬎6{җ> Vri wY}ON1Z%ދ|/M7|l/><'~}sྛ޹o{~\=>W< S-p\ gGo6>}9cRqY쉏bR_0c~rDV_=uƖ}?<0kyMN?N7i7tr \uS8xm>| |\'Mi,eeu5hGk>#;z9:n緧J <8w}7KѕйTtT3<vxj=if=3U=|iIf=+3{?D; ^9Wߡ1'{g%̖xilO%[^+ɦOLå^|-b:J}d͸e\8O|yo9+ᡡ 8I7%:)} WK?!>[Rng}~ΧNdK?yC_tިN>dnm'o6 o8f}0|'.1Ǔ W:4;7kY95ІJWm4m}p%ow>@qgiiVgY/[z?շ'/8Ldzxu^āk=uU}C`T& 7J4`Ѡo>~|.} R?S|4q~82~M0~<ϽzϿ.:s,[3|l<'`9^>\)v:W}lL|h+*[~g_ݫ\WJ  tVd/9m|OWA/׮+YVx|Jģ}zW{'ۓ^bvK<cQ%{iO|`lf`x[]m8OJ6{쁢 '?me7OɏF9xjp=衾8qYsL^c ~z>*6~k>UFs Ϝr뢏x4`t͉ա!9[X͡z8Uϳ{{JC->ݗ]ɘgshMX|]8g y)vO=;3Lj~|.dNVG%9W?$i׿k}[J:n wD^JOg5txй ^1$ ,9`[w4={3-s33X8λ;3vngֵ;#@^F=>[!33'\jW:oEx;-WesMo\GNʸb<*ҌI8{xG.fh%1fWl*/^wkƉ_0>?{k]ul@h7NEZ Ao؁P!$ej+A*.EJ, >xfY1ce5ךOy.g=?/s5s1/6N)kL|m2ϿSȅh7UoB}/S77Q fm3k*9svMn>>kJK|rU>wkdECٺma[[_ݼY+\u>C{n{ #n:W SQX[16k,ÆXġ^xhXⳛι|˜^mƯY~g:c q͇{v9S2ckOt|9ȦO^&8OdȦk,D?堼ЍW,tW6luXlW׬ g,vt5W2/^\ꏽt/[rvsC6L|ac{%[J7b|If̬|h|~7z\?-۰݆s'r_N 5Fժ9˜r,5YV{_ic{b\y_:Dh~u/Ngz󻘣ma9^>Dـؓ˥~򍑗ύK:[vrYY|FeS|%;2b 5dlUwr]4l㜻Z3/_[xs^g0'o~7'΢ɑi=Yu|}oOjY4m/:>3OO6{>[[ԨZ5o?jYl]o\]{o)ζ- 94SJf\u6H.?{5u?W1?;>n ?*=:^kxtbM3c,|ۧ~ejZkƘkCu&#ד7oL~([6lYTqFT[ÌuiNQ΢6;t^bl\JٺTgaͧ2Y׼Rͷ|y\?r٣ lM>tH[V: ҆_C:rM@&+*B]mɉ1l'\<}q˛1r֜_,+9j`y!؊E˝6_>9_d%Kr*)'狽MFI.o:$yט`fC|pX Sƚ?숣G?lz>闏r;Yy#Q:bAGgLk>K~>5/~|H_gtlZl+w1ὼ'r?ÉSmUwslmAKMү;.Ͻ^Ge,8L2[,[/) '_p[ljg0m?Ǜy. cRf7'k6O܋|kgOV~%i{Qaq[L-GO%Y_WیI|ʗj`ʱ_,xxq}d;mc'ӽ ~N&=yp=c/5#+_/k۫wً9"Gf=\0'9?\7xyx?hoIo;chBa?ѻ/|UyS7jemV;̱Z_~1tg̺Ew>)_˙7p|Ϣ7o v5!gdw5b?_}&N7JF-3n|#c_ Oj9\y_t×KyMi"+'™[[ Mj<;)vLsÉ{F%3⯆֚2ՠ!lX5)w&_Λ'4`ğwiKuy۾g.)[=͛1<67/jyL#o1W[+nIY-]V~Y-#yS|~ώ%X}&g?CFL噝[9;,r0ͺ1|AO|IK>2}1u ۓO~kp|iZo /bgcsJ-y<>&ҙ~kV_HQdrk\|C.`CDMXkNjm^=X'\}Ϗ0o)ݩ3eԨu&gN_ Ӽ{%b=x8|w߹xr(;0P [쒳 Km-p'Y|ɹ8߫iX1e_xɯOJ'{rCv15&ى[?0Ʋk:9tUk, l>ѯ0Ӿ-meff/G;7G#~Q[dooGƅ#?؃&kdf ݾX"_X&٫yꄅOǟQjW_6G54]NW=hՆ9:[+7\/;ckKN%xtr*WDl%t[L{g`Ùv:ꃽ.6ő?/#},kЁMƥ沅Θg,bJF 1ݿ7jhN~i˕UG-:7^ gG~pUr-3dzNbKd眴6O ^G60>ϹK]ݰkmup/ѹ,;j;| kTmy{o(Ks~X~8oÔ1&gmKO>)+nOkkw>D<^b5锏{N΢fܻ?c޵Εw9ҭgPW=v/S[:sE}x72|;gbwrk|c݋/r!^u1ObɏG]s\[V,Sggc+Yrm@e×''=+j <~]͡LY>>Y?SΚb3ڮ9^n|N$v{r;۵#^0yg pȷkOs caGO?_a#({YyvńG}~b3}/ghR-VG?_볹2aqg=k5֤Wr&FT>Q_6ϝY2ԚOsFe_w|7.I71)b>lșx:+)^0fL~9Shh9e81;ݟ?jP 򣮪=Ok=ꂜށ蓭>gѫΌUpo>P8t"KTTSOU?!bux{u.yٻ앻35s}kYg{{\~o坭ԃ3]>Y;hZL |h6{geCPWL /;  u.a⷟L.+J؛|%?s׺T~OnLNBxW;nGaY{fj揍%V%gĮr\9᳭GZO/*'|3-d໴#6g3#6|(R8^~Oį/>fz 3S~7:nf{m7ܫ%מڳo>T./}qT[x"0o|9Gx_7cy1|][18YuF!DNai!ð&u^ZzilXJ=ϭmo5/[qzؒ=xG~\R/u~[,{n9/oN^MNk='>z۳:6)gE{K{損tV:qɟlO鲹aL_ʁX읓gg/8 o ([p0ZWigd\Q~vI tTζW_^yujc)F3[X˽+/Yc3%c#2G鐛_}6Jxtמ:s*?/>sй wۿ~v|ށ_ɿnҙm\<4uïCu.8sy NӊLH}~`+:1uT mw[:w 5޿:%LJ7'99rrQo<{ļWn!s}v|g޼:'MZ.k)4%5s{^Y6;k>e|y&u۽co?e>k=?{pkspkԿ\V<|}ّx{W~Kv[#֣ݐ5K?26{7k}|~=wK]z\S $G 5p3rǼ=uz}:>;dt|๾~{;+~:ח^sJ}V5ɞ.9z [_߳cΎ8j.5c]|8t9a-c]d'Vsߑ3\tb;"~jbdcN<21M6Ne'^~O|7O~/JaɘrsbvO>w[7Mo5wߗ7w{NxhOݹK6(Sck _}2bٟzɡ'?̭\5w\S&?^KyF\CW|;|{cߩoL^gNoÐG״7W+~3QU#,'x%q<55kJ||{jh7?̹k灵{:ܚ9Fogu&׵Ƭ/5ٟ<k⊝tV_j{ƕ-S.Vdbě]m/jknNnlLV-3lg&]v\Y,G>jT [-X~Gh9Zu@qGYv^ޡO{|0d⑝WX|q9^=Ẋe-}ܺfJO5߬o},WX<5t>NǞu~9 ޺ ]~$?_1G<CVv)fWFgeLTL|]s~s|S/|~ #KdӷҞ{/K6(Sck ? -VvӉ7}NҗPU=?9CbkT 4gw{9hn*[WninV_~7w-3W-Ն5cҞ<sجV}5^N.}ydkiʇᝋ|475'%ޤtwla%6ֹHGծzۻfr^ȉ9>.{VaZK&,\ra#;ȠaSЙ^9:|ɶo~khϸXM}83rf9ˇ0L^_Na3>yx"?j>^*=ۃu\vr|jk͓gL]Ye ZQxt~k< xc/<k/;@S=#'LJ=kV~ ڲS>%d=#Nm2Ӧ6|0>/o%,%{*wpK^<[Z]/|woTx6G9w4d;Jm5ic \PXpox2ҞzCl{{|5?=|ȲSlG/w~ƎgŊ/{mcL.~G?P^7s/}gg_[5ά\+GgO5Sz >y5>JQ|ggibX<{ҟtq:pkgkڨ kfW=֊|L^L{Hcљx/ϵ|09JV{ycʇ!e6?x+]ȍzi|XklM+ڡzun9]s/Farjq:un='~~ƒߜo[qO?WlO{gCM[R^dw&2L{)/zn,x{3dF7 9`|ރNes?h 2ڳ>Ϟ~y,]bC;3Jf^hV^~x<_~Py_~o?6}l-;lZ]t塘&s7vE[S a^w/T[{{?yku=g n8dvϥ5p{8r[kb| +CHzX+o>KCOklESoCov g.tzyJ1Zq9ҟe$-;)50R. vJogk j&Ϝ6\T/tKWk0#(?[qOx{wWa2[4ֱ0B]?Ӂ5򍅗LW2Ǜ]_ =ۃu|fő'YuNy!v1޼KhNx2&?1ٟ|[SSϤsĝlb2E㡓MXNC/SN\oM>;0ny'+o'0>6|ƃ1/co<5o4lF^eń=q5io/wWm{|yE?\s`kGO[x)>?ŧ-}2Qh';-;'~OyJ?v|z%C;җ^N+b&ؤl5_ɽ8?S(b{]ӗ>aO7gFV_M6uϕ紫Wy6wk5wSs_}ww<#wdz6~f:h(}LyOvB/ў| +٭gYk|n?;r&`|ʮָ\h)>#Y\ V;] oW,ɪ!Gc Q6ܑ >[\b/7䋱{>/V/O߰9Ll6O_Oxʴs(rNob?W{Vu squ>s=^wڷ5l>{k- &,.2.ϯF ~,'}rM:|شa_eO=Zu5xmð|}>=\4ήkb!?{sɣwi,,9Ӗ7ؤژng٭vWWˤŐOr^Ӯ>`)~MY.qm9SW:wlKX4Oby"۵šqOmm#ӡ72闇9`9\/奷ųǽr{Y_^_yZg7v[]Y$k+TF$Nك8y1ߌgzo[3?Ʒrݕb>;6eqQny.:sH~$_^z.oU#r~Ȕxlo,=5@UmO:hzK}U{+g g|Z:+46鹱CPt;_g%jlfIE54sUy7sEG'ys^|j,_ 37+o/ͮZ}r?śzk>=꟢_Ƶ֊x֥9}tڢ5ɴkil 1*{ʗ)ۺ^ڹ Nt˟Z7`m*gM, ށ|8sp5w1o|[v<`W_5cԆ<tޓWm~sd;_{W.+dOs._<#y.z=75-N|tlgym\N~112󡼛Q}$,vf5ڗ=ۃu|^\N_s| c9{:Nxts}Vѝ9ag{^;;t„1g|Wkgq+q<3aO,-9[^o)c#ӊiW>ן)V6Ĝ}[g,[JX ~g>/"ge_u&`9BO,cݫ7Fo^'>C}6m+<:9g_<w~yO\4O{wexm9ֆO'OS7../s^:pzͅvz_ha/΁{^O3C<s51kM :|w6.Z7>lH|ħ_fS?&<ǁ72Q/lÌYt?w-z{WZ&?]Ӽ=fzlXǭm ls">R:SNÔblF%̴5'frspbM&ߧ1#Lzψ\c0tW*}+w|-wdzv믱锽b9U_xg3|:0޹E6Nf«xUM?T=tEƣa߆]>zn^Zc'<^4Lxٔ[bқ7FI\TΫZތ39|agkq9*^a{u.:Ros%TO~7̽llΥ{s3uW<}NϜ5wA:_;{Qk]Ϭu=J&'?~Vlk˛+vxa%e7ݭ#xYӖt`mϟ'=띩P[Xӧu>U'U[V˾+ ϿS|kWx\vQoqѹzu}q/'Qœ4տ·m>x/UmC擵aO._=9}2+y#vϼu\>S%3u'qTNaN[~gu^ydcj,-S9fߧ]ƦlyJg)7 OKs)~_ɥV9jX1~r`لԏ%K/; is>' c?w_T99Xx\ysOV>wߤ//pœԜ4_9;sp^"?ًfNf~^jsܳi֤)6-K%~Ys|ϭ9.km{Foܗ`ԾݪϞ-+ݑ#G 5|6z{SI]C_@[kͱ9֚}۟|.V\7x?9jਁ><g#w7c~#kWNk8r\Mg;R5vs)m5Rǜsvۭg{ZzZ:r9=QG k]guEI}}﫽ߨk]K_&|jK]]k]~&G 5Vk`^nj[QG 5pQG 5pQG 5pQG s"=rßuzx+礮9>~Ykc|&7x9jਁ>{~߇ǑCˁqQ~K} g羻wω>u:mcCݧɵn\~}cN9=jmwٽrG<|uzՀR~>s)S-~_5yzk; }]z\5Xv(c|UG 5p+w_Z>r^5pcրn֞3)9%t[vmk͵{b+\U뺆orgSU>+s^_ };jk#G 5|69~f89{;s\6}IS!W]k=zX )s߁u5k`W#ӣN5p%5`/~oJ_sN[ͩ2^r/=sЗܻ=^c{,ܧ8Cz ̧CWϻ_|>$S`S:lQ{rkyX^{5~-5i,.{k{NļקlgW\57G>wCP>?˙9wm1|uz[w=5='^wo.^}קּ8?K[7דDzw$UM#G~~Frqq SF&nj.s67H??OaUɓsy+V.xxtt\jbdV3(| ?j\ME_!Lq :v6dxÝX3NX Y9G_0[GNnKxkigNa6%C|L}Z{+Zq~ι8lsqQk <}ta9qs~R/uI-$ٷ:S'e3u?ھzdXϷȗ f$g?޹:p>:g[CvĀΗ`gwo9VnM3lyC|]3藏+s=})h5fI7=8[Xa&7νr)7/%#>QG l׀eeLoV7򜸶￭g2o7}kJ=zX=s>J'=D6_b&kw {{v:m΋u9:{c1p}|vfvx/,vA~c5puuLg8!Nr;yM?κ׸NMfb߬R }:oe{6%γc^guc=K)DGg?垫W^kAAƙ 0"̋cύHȘ00̼e!6*h;DǎMh/H"cNL {b _ovS眪SU|/kUS [y CUwV~Ϋ=*GQ=#Zj>|aֿ!bS~Zj87-WK2k\<8X}z2~`bx̂,6eMyneZ]vm߀Q[::o59|nعד ^߯k<["a=|Ow'xyW}XV_N:gb\Mk,Z9 zrsЬE0Ok5̧ȣ}h-BGh/~KŜ3|eç]3.f2lp.?S}W1͡Oy0N9d|䩭F2"/BUGE:kL]ElqG7>:|5c<w1Hט'1 1{c>UwL js<[ϥm _7~؝oE>oTkνeoH/υ< yD>L8KW~V_Ρ[>3bzcY!O߭qϹ1V$;CsD51`N8^}1lOK=Eg~X/r,cC>jyr 's'Įҍ#<EsDzm?3Vҙ:?tkN->a'_?u9֚L,_ygj 9`Ϊ;J lqЫ<ʵրzqeW_0Fs]Ü=RGBG7wnBVQqGoK1uG䕻v]jWbܳ9,*E9jR>n5-9TUX\nعדzy 1ϡ|XI\w\S79Zϩ}`X?V>1 6.k[;?Ok'煿ּ*|> ;|,.eb }^Bowsvx1K#.l𢡊{=^ρgBxga3$<1^-Д_S5'}.֛;ql.qNZ!sv eSLGLz5!>rtj:#o >,]ks([}tg,]90?,^W ׆[ ߵCk>Ru1 ;z2hfz5l|jLxfcS= cק|I짏ip%a`j|{g_7S\صckZcvd.{s=Z:c#gub`=/8G1 N` $ }R}_ji*[&MڵDsvH דͥwL OI]*(b(05{k>(ʱ؉\ \ּOC}o1͡%|_! ;z2ZH]:s`)6``kVb|Q֓S1`(l yγ~-qm+\?\{k%u޳ρ-[&GYWN䂝`:0}bK5|o~shkɵcR~7\{k!uػρ-[~&GYONP䃡`1}bkQL[\%[:a^O7s\/ԥzkwթ?9}&C=4K'G~/ әO0 L[ ߱[7[%cv{s[7>7'I՚VcoH<ϵa{| N0}bK;2~shM7o9u=Yr]b=kre}L``I qoU+X9Z5&ǻxɱs\` =SreK``I q4Əc9$ͷԩ [z"f `21gyM֟Q0 ,5 15?)S_c~7l)l` ֏s5[{|/y7Ͻ%_C f><Nݰ'kgB0 c<1y^vgl|$o0 k'^˸Z:3|r y?Mݰ' g `21{_҇iy_j~\rq'Ɖq0 lk'R4>Rר{=;SgM=,!',9{󫛧E|ak[O3@0p<z{u)Y4e}Lz9Bϟj>Oy'9iܣzPCүqjo~xnmrV?򹿼yǴL=|Мw7.U?w|m\C*jW '*-zq^շJo>]ڞdj W[VO'4w\͋DFߑ+YЉ?tоri=9ϵ|W`\!3?Ƶ>p#_=][<|1bښJ>TVc#/ܧCgq'y6u167Q"cѓcsON{n[Imu*[#ׂKxMI%}5&9}4ѯvsbGO񞼾yܔU}>srꡕVmGwKr)e{ 8^&us)_n/G9=Jg=iyf9sιOd}b-fs> ]u ~ ?ONxz/h >1^|6髣s/]c|Cs0WΡk}@/』0*\''U^Fy YyO 1o|]8WƶHޛ;cV[Gck\3s.Gj!CL3wƌmK'_@'<ew[㽰B>ڳmss!rZq+\`ÕoK ‹ :zv\]o.m=^[9 GK}ޗOs?FMqƩI(>Rwj+Ŕ:ݰcĠe$7\ok"ߌVsbCzq޻:?>i ?v}:yt+GGXKO'乵}>{+|V+c[_꼴XJ>Is!Z>?D^ߐF [;Μ*;5㿿#o`P9"/^ҿ?K<8ksf0xxm/GD=j?'8>R൯>ЪK9Y7]yh >|b,|fmZi0.cΙ9?εE5j gG1cm._m\=|ث1?ulIw__'䁦<-QP M/}>cݱ~ӯs&<t_W>w.뜳^!9s`bgTӾ;Nyle^ӯН+`X7N-:?wj u|ZWsI5JlT\5uȁ+x\ϰ ڷ՞;s%ꌽmJȵ=xILu%sos.LU?v0vjˍ9}E[e GlJة}jۓO^]^Kܽkĩ^p/?ȫS>uޕGcYRU.yZ:oegA7 VCk}G7_ٕwlT<{^[zYo<gy뿶wlWϐ-x2⥜:9H>k[x6jK>WrB&c>jwE5}:V=U%/dږȊ5ڡOd5) 6䜽:zm+= ^Z{3t ?^+9vKĜ[!2[LJ7eoln-\s>YotPCѩjYe!}kmk ?>⃲C-u"~MWu2֞CCqc >cB>o~u37ǴC'u sa ;ڒ8V[uȏ=}y7r7Oď1lgs'׾\bՍ1s82Qie:LXr|3c=2*{.uu>\XN+W!OH{3}ƽO:øt9mʶz{mmα{+|m7hC~д+5`?_{9*/9iڹڮtlacCW[uwΑgblZ/G+掵<2zB=GYXꞫ xz~AC7zW[0dz@sN?l1{FGw(L=_e~҇FL弪\;)x/uU}GrSIGN@WsN|x7c7$9o+=Σ^T:K9f óC?Z[m.%VG\o{;N)_#1Ω/XiǡsheX@NVRr pܶꄦۢ'v1hƈ b=!]iA׵ >+zYŕ_xᅻ"w1CΘК+}b Ux˫J}hP.{,{]O|`1uSPk~W-חq~_'wN_U/c,굌;/ǡX>G\ΧYcE  ]tbY/حW脧[eXsc<<#Εg==`>gч m^,rs+{扎>Ë 4 ѥos~U'}qGTlj[_t``}\@Ж< >֨G1n\9.[mw>g|.{*ϑ`[#p\sOK PGD1d<|ַ8|S{_J=k{R@5"kQέڲoZ/Vߗ2&ul~^s.DN͹{=x=ua]duI\Ɛg]e]V2Vq_߽vW[Ϝcͥ1.ØsкuѪ>LQ9Zjwm 8ƽgqFgt_*C]1[ }tq]icC˵,:.~x|.q &׶<Ҝ-K(z+֐.c86[_hXa_u^C#^I>Zxs#k!6tcKUGt^Wry/u\#+o2oA9[udE[2萖%Ǣ!x !1w(G+ҍuް.C9]w2 /yG]BCwۗG=?޿tٜc}r0}v<8yU싇̡գ=b>myb/|# ɼoh.ڡe>f{`^ ^h6$N{xtkCo/Z#ǘb[sюtZhۺ*_u:W_ҟ^"g0bw cgao{5'}h9צvq0nG9xUuWWG  槭^] Y^ls(mO~[[yv]a]'|Ȼ t>?}! <]yė9TqiRҚoc!L&+)wWaT^n V{_hYSCr^[d*4~eHcc:H\F]oӾA;H%sM[X*ӅnVU?11f!~{m>4PgB2=ԣEΣskǙSșܠcu צ OK<G֘q_ #C䨷ֶF\w+ɩ1ƾAKYZh ={8꽊Au]6ؿ~k߶w#Sc;yٳњPMӏ+r1NXV_3r?X &QŦ<`nhL>t]MZ '5Ln  qAM>5i}7Jo|Asc{F{c]A3Ƒvam>sV!_6:A[{k֎l`?~]kW\_sOz瀦 f|7ڙofMuNa+.@נ1.?-q_5nkCz/ƼlWkЯٞۢK?l CsAO}OO4#3u}V굅_=\O[}j?cJ .8|*Z?f[\b΅~kN{` ymHW׋Og~X]i/~sμ}Xİk>?cr4׸3h;1# [4Ч-{cݛO]?>kqc=Bsj[_s{rꑿCl׋<{rֹگ63&bz3T-q[+rk9Fg=ys98@*?}h[s<]?~-^s.*7k'XQV|6빜:MǼR UW+T:}B6w]jͧ]mRhuܾvGAc>*_}Ďy5*[oo沗ߩiॷV'x=:]}sUkG0H8u191&|/Cꚳ}9-E'N#_{V{Oggt| CMm2T ;;}u.8 34WU^^ma9wU}ǕrUV66Uʯ֦*cμe\iUw#|5W8k]zÖ4x|6\{s b>8^5Xr4KbZ0>Qߜ59tO??^OŴusk6x_/=@00z{(jՃZd/Gs!zϗ:0>?|''ޡy7l >^OZ'{l0 @o=={QrQ?N``Xz9,yXW^dM$߇廍?vZz=9e``=.xM.u\rkyH` X+'x?}>ic֊}~1sLg?NzondV2}8@o]JNa02FyWx$@0 @0 @0 10TOԟ|GuOU8&a0 \*';+|祗^}{o-\y#3qPJwѩv"?o7RD~7oMaLmo ͅ{1s i8;K's-@0^ PSo}w*us{Lr͟81``}lof@|:oɺ~/kwukd_Ϟ b})}>Q >G/G1O|` 'x75΍S<1v;)wܸ@0 \7z{6X%/%9H``-Xz]w;ASu Qs\2ՏkꃟwX@0 \z{OR/GFו#%1}oMg\z˼r*|rdyx.9^r-y+N|k@o.c-:nownkkh:/7>ִObY\zJoT~TZ.zs㥰e~n@y&c]}G{>ѥ1Oqb \ֶO7553Ga.|0s]`{D{~\;p[O]MUrl'uua-b-> WG \ֺO,3͹[3͹ΒXVIM7%#o/؞w?k />;b\$bXց^.:0<$0}blwG^?.ӟ_w{,K_bm׷vq_}7O}w3|^e|ԕ[/~hr|Β`_X.^.mO`  mz3JWճK/c̏~ZkTԫ:1XE5nmGjr5~ԟ]ez|?iS5ƽg>~bƮtsׅ{fisԺrQ+gG  jC皫FPK/c]Ω| :|k6|t9oRSS2f;:s` cX%t+).z-kZ֪C֩^/Ɠ䞽{m;算yH` X+Osvy.RhAҟ.bm{qu)w߫3v\-W}~ɵu0~MG&\<6vy `i 퐣N/G1N<` 2OK>sN|'3{{K:r¸ߗBq!Nk'~!lj]SV1msNˇq˷gM8@/cC_@;4(&c Ci3q3^G=Ruj,LЬG!k]w&GR֢}rLRkLY^>ͻSwR 7קoi/w_@;H}/G1O|` .ag|O/ ?3uo /Hk_{Sk>65ő:O.EkϘokV|ݩ'|`l?˘ < +<`.9'k K'noo'.Wzu(SNu]1ާ6t.,5CmѸA֥~ ɛvnǮxN_;u9!5]荱.Ɵkerys,h0 O;ŷM|.:9[}m_pMPg]og߭]cmA5>kQSĞw8jJiPmlzhys~a#O~˺k597{Z/>cO> i(1=-_ K'&E'>>7K/1klL*O/8*5*jS4W[]'5)b]mc 7x7k\|6mwԺrQu(H>``I \>SO}7Oy^Bva\=c;W~ԟ|u)bms?ĵ?Gc{N6Mz֥xo'ЯΡ1lޗ&.͟815a ~q[sekV.Q8&s?"Nj|Nk;߄ZI=s;xi'wS`wa]j JJŸx׽%N)1IL`Z1pMN9jko`k_98GET:w׺.oiS~$}ܖ:-^{֜R6bcuEn9M` ׶OC=sv5^~8%.5S6ug}_7XWsHs/R:Ob[W.#Bu5|)OKOU=/zm]wwߖSo[<(qO`  Os:dy}+Xk^8ւH-eME?η8}v=7rh^{u)l6jyW.])ZۭS6zw%z^z(9>wBOîhLΟ<10}bSikKaPk_}]kEj﫰;M[^+?kΚ<X[?uϏ81ezoޏz}ݫO=򹿼):P~9wHNk|oowhzYꕾ32 ieOV}m2uTmhy:yz -?_wd3'UsŃm^q36i51 }/>kg}'SOn;K&γm6V\oBC]o8_yͻC:-{/q^ʫWsiu:93?ŞOaȱc䅻uRy198A}qm|7CQemE{o^~ yۜ .?;sT'X#у̧|C8jܿCS}uت[ߤ3Zɘ}ty+6c15,s/F >Xu 70G3֮{#WEŽ2 d2es-͵]׶̧gk1^+ii.43l+]Ğ績cu~'!z2uR㞌kkkr]Sk NbS>k s_J﫱gyYgdSy>>} .-K>ouC1|/nIdvn^#1_`zN^d*k /i.ce%Zi68o hbz㮏C =X;Zz/z]8bz64cRǟ{TS\D1rqZg5z=-gN۶9b|?rۜs?]B<bKR#B~ :8*ۣK\CYtㇾA:`6pjlԛ6c1 *?x5.-a/Gq\vk]#1큗ޚ+]SF:hGsw5R= oBo}q L?yGZ=TƸ2ChS{׹26_ce1`ܱ\cx*KRX;8u::hN~;NxX㔯2Ы׹rP*Q>lWآ_~N#3& ߮L7s|.0 Zw` j U=j pZ5^~_[͵9I{/~XﵰQ M~KZmU9<;j3.ϩ+ Q#bú5##o0Zg ܨOC-WYGl#/KmΡU/ￕ7`!{ax\xZza9wC2ڶt~]>!XOo^Oc05Qec]ӟwtHS.YZ GN[}vMXwehƨ>T^=_)}{ϐMx^gy 5PuyjޮI/]:ӣ[j{Hksa]r^WoY3%)?QgG HQxF+d+ `K, B"&(ބ 2:\]b ;wnmϜ3s9_=N @gxf]ax|K-YXoz?sUGl]sN "`vRfo=ǸQGe撉}g&/!Gf y>zt|X >Meod\V6GۡT\Qǔ[:BWC\whBGk!u$&hz<"eЀ&>OL_ >lvaͳ6M1CCc/p#g{r›ӇlM8ɭ˅0g=zx /o/ݒ`K<s4~*8hK'P"M>︖Я㥿)ľ"W{vog8{fQG2PDašY߶Vn)d1 b$Zΰ>D9nY\s8?eO_Źh}rync ,c|GNj/Pd^ȕ=9r'^?:wXȝgd+O)qهsoLոk/~|/=s{dy{a[;5m>ꙸq $`H˸9۠)ڈ1;.Xݹ\G0>SD=}3}X|1Eʑm9xe,c[~Zc!|X){䴡p6'&>wc/ lAT`b=ebaT;П"<:`>OiRLYvr`"zuE(+N~5^qaξ'vzF<cڻkmŎSVVKGytD p}x黲Q&\;mH3:swCvɑuWpmHr\#ZLq\>z>\+ޢ셍4?rQ~ٷpxlNZSV(̱6ٖ)o>US>˹c3׺Nx=}_G`8״80U5pɐ1D޷.߅gֵeGjk6偽# `#gH B8x}_rm {,q~1oH=-Ի(ƍO"[HX ږsO/ئ~+%둹1$@9>"c<*_@m~l7gx1Gؿwן~RƮ':hMK{ɝ9_Yȭ Jxs|e}_)/xЍmpf mƆ hx39x]z`%W9_<1oY4Ƴ]/ŝ-i)x ;ED8xLn>??y%-abG9OvPOy ']pi}uБ7}"mo)cS7Nr \EO[7iGl.QgpK9iʣVg潲@d3vܵ5`ԑϳz[#-i={Μ0}[}RH;`Gee#kz `s<=@''~Sa|.m˔Qd\_ OZ^§VҖV̧h,юc[c_4[8CC׵GbFLq]T"~KQ>d^2gNneѧ818Z><~Di?8qMvp~j,>>{ywoYC9?34rθ_GZ4Of-Gz$eg*?R,{?|6]t9SrmP̝O A)Ӭm@ɳ9g[{ ʎ|[pyϳ\7LZt.nȜFo=OooOFw^O}qm3ӽl֞mK1ɘ%RxnRx/>/ Z'81Cq{|s(ѫ{cKώ#^:J(2^%s|uu %\V\j,jm6>Je@`9k^Ԙ={%&u/}b|P|R/{V̽uV_Kcʼ5.E^z;Z:*_/A@(6Pl81x6o?EY]j+^pC~ƥkc5p[ b}z)d^6lť˳-J%93{shK9ܴF#69-mh ~y ~w`k,I.QV=K󖎲y,>Jee{@cw9.Rߥ9:wöMK* ay"m(/yɼllRl։y[8%3x[w[̗u\wwG׵)W I[-yK׻:,/y@%@C>=hms:cM1橶=h.'no>!y,cx[_w~pca*{Zџc|Ϛ?7|'7zg[ ]Ms?Pr,9 \ :1Asy4xs~CfCX*5pŽ5z)ϯ{sczG,ُo^V\^}Kee@6C>=hiWk1o}.As)s<;Fk팘R9?'az93J_[}G:}YQT1w/O}Oo7GGwrM~hO^1mP6P6m։y{!C4_?y㍿|b39/QW~v.y2g%Kύy)!4ۧxFl&, тUw,w]51^z*O;=#~~P_>}~ͻĢ'g*}JȾ\r.(ubN{Mow{OGG>Gu_woߦ?QN0wmٔ<pw~n ]ñC2ϯї8uZF^w;މ^ᕎߪ㖎JNoSɤdR6P6pWm։y!C4ioťAlLSЉuGGZg:bM1E XIm?MĦ}S?}դ:iQ]oku-yDٌTiksxK 7Gϯח8/mtZb\]Km#%_g%y@6Pļ!/K1+I謵SW^>[Nq)bN (R1Eꝿm|j {Fm׾\FGZ=km>F5k7f;P]rRLKGl5ld].ub^=3G{NWLcĩGo})p?E)Ș>/Nьq)B"%<ܓ|߾Y>4u-gƵٖ\̗0KR߄Sgײ9R/O~K쁈O}b=~mgS:*o'eɲllm։y!9wHV쉦U%E*/qɬdV6P6p6PļMkn9q}4i Mn⻻sђ:[ MR伛-P“oxMm (\\>)߄Sg8 leD쳈Q{s%t vڎd9-˒Mɦllm։y!M~c> ;ĥkiƸN3;CɘsݩS4GM)!RߑSk{7k05,ᚿ}~7ʿǘN]}}~-wm:_[o1kvStt]_*^@!M~#.;zĥ(o|ijh22_y9I\ }=SĭHQuX)Dy./922.q޲.AMɝwi#ϻm~OK>L1o"d>[:*n'ߒeɲllm։y!MMMO^ XWm6?KRCS4KmscOƝ|ީkbRлwh5\_?GcśSMje]>}yo|.ssS}mQ/ gN뤇|zznmy4]-wR߿J_[$xR~ wʭ/;WE_Gv:gyV\j;fٮynh KG@V6Pļ-O[tz|1sө=h.wfNwέkKmM%s`Ǎiqn}%޸5;QyvQɼK%߲KZ'|zzki5'_yl։y#it{Wߙia4O_־ÇFR%.7N ;v|9~ {]?cp 4ir..j(۝]-(;b#01)^kKs?ujt_Zg(nTLģ➄w2~=oÖJʸY,(du]e^曭=A&/~[O\Ɵ亽p qoJ^|աukﱥ |cXKG[@KߥG@RulXo[21&:[׺s߸y~xC~Ƅf)[h%nTFШrWV6Ytj_ [:NlQ((6PDCCe]V^vكN>Aw ke,+_)Kʹcb⡤=;u<x]S\{ޥ΍K6{0~e\hKVi6A-|oɲdY6P6p6PD6%2~D:y^m|s(`ģ,˝#b>n?ću7"V" |A߀)ؔg9Kg->;C;׍|g[閸 b{̑592icpOD5U}h6XvQWWQ6P6 :Q6qn;=Ls ƥb|;Cn ͽ '7[8~?R b)w#})0.sƨ 'coZc͹OB"@c[8 }g\a!u˜ÇCBĻ'HenZg毾OIOxVF ʕM6)yV6[,#.sLz s02$cx$ ex\ʭ?m`K1F.OzhƾhVS~q#Yƴ|XzK.zM̛q) sswLJȶXr,(uxK;ݢq,9WrFdW19 .J˞77l掔"6A JËV+!kdG2T؟u洁4eⅴK/NI |@ipώ8PGSeSV֑7Q^)/! }6qջt#l^(K اre#=Wnrql+~7_r׾'?>({B7cqC2CXrO}V^Qlϼ"m> mr.L.j(a'^9;ypsFgv9<˙o2c//sRBwo)qso,LZshzEQ| G~)ehq-c]^󼢼ɕ+mߍ3Gw+"-o[G;I_`ԣe˳\!SЦ>|>uВ)pG20Yf茹G< m.lGq6^T=wk `߹Ryw.v%|rKGÞijrC{|]xri[iܵAC'叺q"?/ցi2mcE8m>7(mD.rP#ϭǓ|Aɯ7eS>ym`POC྇D0 kXƒO=2ТS:1|/9}'iR~ׇ;ّs[!Cv"oYC$>6t }Oai#=0c ㏹!;dō;7O|M(;Ol?ƥ PЀ},+'OO2ɘcE0KnZQ,c~[| >\LW(msmwu6|>?>-'itĺI=-[8E#ѭk4bN8}QmP&y.Xv: NC96$r)._ y@Ҍ‡g^Y)M훻x#Mȳȩ=t"]un+9W %ϒgbYa<+93s>Ǔ_|kH_=pIuDx>Ӆ7I1҂$/^x~zrl|WV!XO:2׏8=#~Ĺ/'yp :-hpfHYSΠ;#8hGhW}Gn#6Ϲ~mX3C4AmRI#9s9fn7akƹ'X|-u3k_1@L6/Y.ۗ1)8cHxuM?}R7 m G& p2t3OcʲcoZOQQf'<+ťz'le[ygMW{s՟1ڧ~_uqKGˑ5,j頵u%>{yl-Ӈm97]Cѯ|̳teWp'4gkq/PIW<?)o8.9όϙ8rڍOdl! @v?l/9M8sw?3!=s$v$9N*1l)03S/1,kڡM,KN[i>r=C:lX ϔōľaNG<}/OĒ'Om#:OXdJ xڣ]Rve̳}ŲF=Qc-3>#ޣL^{*3O[}q7G`_y_usKG?Lsa.]W^ȧhѦ.u=S-˄z7+s{j/2yy`}¯8a.#.դa_'^%<+|̏_vdY<-{h״`?S藄'P.I8ƾ'Zì/&|c~_దľ(iS7E/ukmCnq|O9xzoo!;3Ӊckp͙24ɡ{'o|65oyNO{&ȥ'K;OcL1sƺǶ8~`<8MFX}+G ~y&nc&amǦlQf<}o}펙>x6Vơ}Ų1.EƘQЇ'cWcx>k뜻SEs'WvQ>n?xcom2Fk.`MЗ6g l\\G8W;1tcNl>i.1m9dq(CS{Ɠwۑ}ظK<#ZG؃gSGsv"ʷ %ӒicYۂu3clK>Gg=DGݔ߉mƾA|ɿ"l.ksve' F1}xZ x%>Ŧ,gbܜ r=<2|tNf|>1-s=Be^нmAabئ# 2K9[96=xwk#w ӜSxTf0eab\:S$FH2Nmt99:ў+}h{-kKGy_ǽ#79DƝ=3}ZcVS/<}NcƳ oЄ}C6<3`i.nPv,Q!9iܲw]8#e[Gx(3hǤ"*o J%)`>l5pԵ`c1nD֢4 V1[]I?:_/4#WzCcb1&>d',sr?Јtڅ-3~cLT>칻48Ks7s:gx=M:摗{%KLRynO"Ex3'E$9u.>e1zGًg!/KrJ6Un0ΖZ<9>#.Va9πDYDUחnW7ǖ~_lLr\'%q@!L~?)SGr 6|%G๮IXOn-ҋc>>_.5.n8["=M T5= s6Q4O1Gx{b֞xz:i=n+ZeЌv:C5-3%tc߱Oj:ꕲS0[J?ףcKG}D}? pyn?䴷8x~D9eJ=> yw`=gshE径S&<ӟSG.xVϭ%ȍs90%w/_~􈜡nz7o(o֞M[6ȥ#q},)ab>ـ}698A+Xsŗ7iCt7[Wcٱc.o>;r˱2tcmg𭏹zi,x61<ӌ<)\~Z]'J_>}=hnz]~Fc$Krt~oؑ<27C{~C_{cP0J,_d _{5ih V/%ϒg@(6Pļ-O=,MOߨ0t2lF93E,G<|~'{QWw7hߵ%^t{z~4ywKcKG[-uW2. aNYG1GoS*nNJ<7=[$Z3G+3md9"sGLh|!6-k=UoAsk=]+^Ew/=O&Ǧ>?~/{얎J>S(Y uub~Oq1h gK:בJ⩣Q]5u aKV%9x/oO/qڋ>{NG%HɧS6P6pl։y;!4Gc^2>Zst2F+wZU7iDwi04GhފKqP}=ϯ~gQ97Ee2(bR{O|ۘ\95SƱQ훻|˥fٍ|4q67hεW}J/YZW\쥇~Z:W(} Z'm|Ѥ=U~#Fբ٢۞=~fK>#9ןoq/OOER#NFkcmܡKGcK{w(K7[fKv}ﾹ|vrWG'^u-~4}ij}c%^t3[7btLu/n~%sLɧS6P6p)6Z/=!9o }c_պ/#>S>Uuܘ3E3ƥxq|Ng/J/|y( Hrl.=~H<sS-KVУn zcDkt48: Z'C>s4=q)rb?܈$Qჿ1S4KGO^x{'﹛;ЬLMǝ{:[v?edl0A ᐙPQ4{+ІdZiEm6t+ieǟ_s۫:UuNSUkpدkZ)u5k 8ׯ[Is=Nɺ|sbkiiHs53.{Ϳ/dX*.5wOK\z}2*e>˒mS;{#~C]ߕ:V_S6n_~s@>a[C?S4{Tb+܏&{eAާ޵ө>_"MROR}?m\K~\o\[knڜ=n+5ǵ%]#V6|K=Qʻ|Kťy/H}?z-PY> sF6j}]}}|׉>~F41S|򜸔{8Ֆ;L$o^˘q_Ÿ=}wߺaMQ&nN?>{~Z?N$nB$!{Rݧwn1+=mҿf~KO$.WDOFĦ_A=}[ufUrKzb<8%kݖ /J׭N ;ҮGKzwϹvy 1XjF)vx^n\ju%ϵJt$?u ni~{z_O#84Ͻ\~j.wl{Ktǚ^Q|ǻĦ5e|t#=N`Oc@~֠qFנ9G ~t{:lE_ה}תOVz+Ý|T{y|s*\pOy$&V>kGs?8Ģׇ;kkt?gksG>>>a_C?kܻ5h#w_΍33нɵvYh䌼Oےm}We [/Mc4lɝ7h.%g KʶgĦ74ys xMN;=/>W?S6:^ck}}`+uﭡ5hn?s5h%?n\Sse3sg p=g3Qsus,ks'eL߻+pWy0ל4P?imiNFмFħ[n^wF^u.:ͶN9sm;oo n}Ƶ5{7wƑyooӼq6&s)Io˷I-kcS!ϕ<5vsqqUmU;oЬ<{kĽ5梁)~K׏g.ߒ{c/ӥl4wLizhܳ]kx\'sa/ zjL_2;?{;q|_?~h#sT~ĝ#yī[k%|'j-?rOۯ\b5fO {i^bqC};~?n#^/ku>>p/>D5~' 5dkx7~t3.wvĻ{Gma e\vd=vO$82|Ri^{,Sޑ-]Ǹf,u:oƜTu57._+.=l4aAu>>gusyKǣd`]/Ke\Kq?:!!Fu\ ܙBVR޳|v@νV̝5_x ;\S̹=wG?) S96jW}}}׉[=ʾo:[.|$Jk>ƙw=#L :R/^|܏~)96u4_B&5.??W>zBߜ#kɘ#(qnXZ-iK[}-KN9>pO \sg\uպjheuwϲ[X3|-fBLD3BK?y:z0&n5KC&rԸ2#sc?)nɘ߈1vEt{y[ąӹt-[żv'QqZ}xT~^'tB!1*`uswc{#$MY;~Ľה8 Q*MZ&ֺunk[?sةr0W)7isl:>MǭW@-@쿷"޾U\VKO%cR1-çmqޙSvRbTl[:Ϸe](e}gZ鹱 ߗT礜'?yJ3fE;eGߡJ:_&q[n>3M=^/m`ý3V@@|ubWdztYI[Nxc*>5d.sפίyn evf{5vmߝˏ۽׏sRܙz~􃑍y_oMj]@';7u̻Eⅼowsun n*.}p7r~hw7=T|ќ{F:ޣۙ{_g?ug +Yʷxwv{IKg-:^ҡ_ۇF袮ˮO:+N-0mTo+SVc~@@w[G}}J \C y[6VYC k[ΈmdJM?ߔ~7j ?lͪj:t,#:|h'5/<:|TWv'gdQK9.ͼQNyfusc=ܻ/?Fwg];؇Y}3ZgS#xoC\ Sq)tB8tHʺ>}!ĻZY#]~ JBGZؔ=x~Sy'. |K mr߹Co=),?X&ҧp6Kxx-ϔ:1c^XqMaeY;Y&Q.tK:B-}kno2NVf'Q:6~)Oyr8umzK=˺N?>l9 ŞG(#_7Y#F)}8˃_V:#6u;9K?SEVfˤ*̏hFJe[y(O;  @]+\ tIs~τ5o[e{~*/~|F.G݁i'W[P_YRc[i#Y,h\ft{;lG){Ž3ƩV_?@MS9'X8_T}PXCcŝG=u sȏ:fp KCCq)btGO^XqIW/GQmAWGJ/IeK}9'ĕ2vk Xǘ1f/8uLw 9_e`y\ {=?kgvhG8OwYG:9udDS|<±/N9{o=Me{uBGZ@^xPμuЅg6NdC ` | |δJ6yKCJߐ6iiEupsu`8g_/Cd[ZGCiN9l>zs9z˹չf~dGmO3JUeЉ}=PH71>0Y>{ެCOֳYLVi|W hL#F>S[FS7/:Q;wxL -o o> SR{"I\GyێSVI5Ct~}I=V?6>C~O̱ot2o}}'y|sg\T_yJ |3ثcG||C?+qͣd\Sh.a, =P oX؊}4InTH|xN9KWZ/uO;1t青rS!tw'ysbtZ<;#Şi `;(8wGtt@Ճ)q#m"$uT|Ҭ'&e (eWcVHrMIX:%v!'U]k't: -!N^OzSM6*5Ƽ8%),c&hV68OWCe[/kv)^u mׂi:$Gyx +8N簗eR'e| h?5E&.2g=y]‰~x&\C;JSy ZЭy`_?+rJ{d?~Іh4y%;!i"lăr*:A pwӞ#\>!;Т]πUw9Sh:f}U|55;ʗ#H~F2b%|8Έ[tH [;OWO{ȃo)8)\5-IS'0OӸWD䓟tFuSIX`g{ WZSGzDO;'lD%]QH&&#牑{7{>[;FO~K_ &e mC{ 77ϼ[c޹=#]nFsу}mi[yҡk \r?q9yyC~W=O,CSͧlRvhc~6䁖| YH\RWgh="g 8.MiRu ,tG0ЂMLuPϙ<.H?6} ʕO{W|j;iGKCGZ)S187y؊>1JHuT\Pnuz:Ա|#o:Cy`H)#$`~K_X8̋$]%ϭŧlw`8_T Z<ԑbR&e/c@l7 l~aI:`=ʝ1EWxӇF0#t,(>9't3quW>>\Sk4ޝsNl` ]lt.ؖ}?u'x'AR2Um)%^#){kGއu!OSEO.VЀ6plSt.~C+.ߤrRϞ:|Ǔ~G|h9w$~7N2g?u]Z 8iO6 5/m!RN"/)}^;0I:Խz޴lhأ.Rro9/Oz\2x)G_9vF)+4C'e9NXeEyʢ< -*\#S2_9/NW:e~c,S8\z>'>׎celgjO L>s+gX-晖3oG\tCcλHNF$o?+e`GmOyM!tcg^Ԧi,>~2,]SҮw} s?V%y|1)h:vS|8Aꖼ3eߘ˷*;59ope].Fdpg wm e= < 8G_*~Fx3///M*ɞ2U\O{˽me:g <=mpΜwqMՙL]ZVe\g9u*}XqSY>Oiv+HGXR6S2ɷecR$S c|W>y%/>SiPEl؎ҵ,>f Oa|V\RqLǼ}DRU֤ ::nܖ:q[:Sq[*VyQޑ p]ý#Og =5}h3g~6{\{mޛ?ms}׉s}nw8z뭷~wy0hxCvȯ͊;֝m>{bfGsUh Mc]~[^'׮k}A@@@}1xOo h;Zq}u^C-}%>FkOǥ>%%4F6^˾mG@>DХ>C'}Fw>bھӞ.񁥾}(-wј=ƥofWF]ߗHC#m:nzhܓ?,2G9ߞOC^7Gc{VrRw0YUF_}׉jj]{O3R}9[o1׎SZgã}}t\j_sFuNlh{\zh5[OG=w-;w7ݏ8gthqw3^q ߗZv|5ַEu>>Gur~2ݦ_|gyw6^xw=?]7|cR+ܕ1G.k*^yn;F=^>߶[Nނ᧷:x\nP;;ܹ.ꈱ}{c̉ӱR۠u:nhس:gln?oq>]s{H޼Clo=K_?^GsmǞ~o1|:mq}}`>D}h.P{帗8ͣqE=ל5ў窖m_h{ܿ:q6q6|QϦs;@|wK-3>WOY0=ƥOG}_jfd{u>>p+>Dj˹_νo鱷w 6=s(7o'wߍ=ƥHƇ0Zh.]=Zǭ@{ɖv}>#?碣;d;}j̤Ꮟ%ttE=Ɯ:.9ld=Q->vhx\uqmm|߸w޽o$/M\{>4yc=[}gwo}?zzP=W?#melzl=zhܳl執0y޹ooW{8'N8zwwGkxOOϷ~'bRҶs/rlt/}~Z>>>p:q[-'}F>~͙ovǤ^;>斎-]J־>pWCO[:Ĕz[ϭ@{іv|tI睏Sw{~oޘ4>&o!F=q'{1tOrM}u}}}|u|ݵߵ>{O<|s_ܯ[郘Z;oo\c6:n]׎w@Z>DZtϷDߖ׼:y݊/_]13i^z"vybkVo|F/[@Eŭ^>#?r]hcvK={ｷ9ckOIImt~Ѻhhh:IN='}Fwyoz:&ug{\{0$Cv=Q~>p>ڶm>Xˡ3U}"vwm_i~9?qռX+ڳ.ʻmts^jk=ulmW|gcΔ{:;t/Fku<=߬;ߌl:_Wo@-@-uOI+czcz}GMqx/z裵SpY#.e>>p>D=ui|gyg/^]E|2[~̛?鉻|kZkhZ>*Um{}׉}ۧO|`/I+װ;7-9;wbv|<ޫ==_Lmiݴߴn鷤C%|`η~3 =-asMQvq1k|}Ͼſ|Õlc[g>g/_ݏ|ﾏ#_¶yu^}׉^ylvߗ>#;CM1qo _Yh?=>W:ŻzW}Q~U~˿zn/9?V[Y>gx睟]頣scoNd ᷧ5dq|2E>#K5r6^Ǥ:&u0qWsԸOݟR9#1>[3{dS8a_V`[l(n!e7t#;EExSiGxr667t x]eʴ)Nk_SS_!c,g*A;et'eVŗ =M:ț*lK݁-]h*iVYh/y%-|YhWY{G䓦 O*S2 g k{3:Rl΄7737YGٲ}C])G2`o`iKU>#}]8Sh+,|Лh\%Ϙqb{Ҁ ~Rv3A]Ґ)Ukgq~毞|;X/eR)Um'I˼4I#%XQ^Ҹv}Ly/|zjzR鷜>_}D_<'?ODow^|?|/~-;@:xgy?xE_ }C*( >UZ|}'f1nj:OnAהqɺA]).tk?1H[seYwSFiR?'qFvIԟ|w4=R//q3>c1se[slUN{EO]SͧvM\ 009im#Wxr ;:LG{:>ȭQv,i:'!SkK[xRgzZ2h |tI lS'+<{a~(;#5)>>ɹ׏1/MRz~W-#jv㨎_u(LY-z%M<8*mfc~1O‘ʓE״SG? I8l)GٹЇ)4G8g3u(^!4rTBþxеϦ'(?,:N|ˤ֩;iҎ&o|O~Jc0OQϣe|v9vGQ\//Æ՞Ҁ\pEpC2sdТ\AzqHF6rsh_|5d΃~u11ռxS™wkyQS;S6SSμI:ׇ/䬺F4Rozl=p8ғT:Hn 䂯r ?#~SER)cG:Ѿ$lCeHK9-VڶAy:6t #=`ɧOYGzt14SGƨ#MrҐ'xT-"r$!o?k=e,.^9O#х&OfU>)N38ֽ@2?eǔ}$xtnp>ꂔ;@kp%l#aPOtiOӇg||X0DI)c$}Tx-,x[&%^u'a;;q*~SྫvN_c\yعnÚs s=pjJcGطOkc3_yijw NyX_x mIcpO+r&}p%~fymv ՎU>YSgiw}G|A;u^bņSyhGz[GRQ KY'u>AOЩJ:٦fSS:#N2'~ʍ[h%e' 5~l-aQa,R_񲍼L=ҥ.C]ۧhgiXI=І]e#bt&yxG2s2AZIG?{gzKV&4WsE&ȅ h$$1WɍtLDeZpheVΘF{gcێ_gYgU{ZߋbZZתzwUm8eO&Q2"SIkyX[ y"98dNqF#^ԑ0 ,0=Y~HC=SG1u!7ҳ=aycҋt{"h9:K;-q̓7fMyH;/xsxg-8xm Yv-)Sy\͎Aڞ'̋W|(2} ~+#{H> (O엲E}sC|<ҧϼq5`7hKZ,G=J{ݗj%=e-&cQ'!?[h{e;k?df_ҡU9R3.Fqp!pQL tH#oŧurɘҭ$ Ϛ8gɟse˜2@TXG~yK'q(|lE ҋxTH5:pͩ/crp#}QƌըW=bk^}taj9iWyi:6DGtnYOY?i/pPWY\Y1VG|wsf{/fms[jI֢c=:o%?ΑɹrMOg'5.0|0ڄ-^/~iC y|G3-y 9E)Jz+\9nmEWϑ7ݳJxO寜%=Yh,"q{֕;[ _*mHzT0u-)zȼ"r=p5ٯ=Gy+{ mӝe~f̿>ͽ{[~ʞ|eWR]>CE愃>ґo#3^3\!:~yK5/|b䅖kz2"2 z8k.)ZhEz.tзb53.osmm.sC+Zm -ir,A G~K˖y.hxϡ~-SOQLϰ4X90Cn}~9J_Xüv\?J[v펵"g)>;0V%~dJCe 6a9'H>.6AQOҨ;F+\l7ױ:Mt>#}M OgWsCzyp_=sL݇zAC5_ZQ;;sxemk-QfZ怍cԳ~y) 2>ikf\ko,1D;Ǿu1bsZ/xG< B>0u?ȋ7u[h9ڞ)>C|[G8 ncXq8Sw޽/Y_}2nӧ;udvnj6׮2Ϙk)/|+-y1|g;O_XZ}>7)gg?8Uq V#|&װ,r;`oڤ+>{이qp]"zaZ%=Zŵz1G&E Rf]eCA]10E|QkQ>O ]y+ YصI5E8`Xc\qփNr  l [ErW\փ\hR&iչq1`=W/ }Ky:G7r*zxs̱?K1}Um/eæqLzQ#?Ke-# }e;_a,򡏼)8; 1 Exie} 2y鉯]'"sG7:X~DlD^sZl /5=F9m<1mmcCx}C!ٖ>}EЕo [aijCޛrk- 89D_ |J1.c_>!~85GɃ8uO͕<ōcL]9L怶_ʩ}?chsc8d:Քƅ->K̍9$lIǚ'Ǔf-sO8a[LZGc2H0Fsh?}(҅kFњ9~ɺܻ+1Qfp0[&Uy 1mqD8"ps1Hǡ%=etb˼v5N#8{C敹]G/05XY>#kW`DصTޛٔͱkvq "2Jc5~lNNlez  tb1*.߃9Ç9ZǠ}h8o˺|9NG\ƅUEG$u :t]+@zv62"D(e 9`8 tƹ~ڙx[咧kw]y J)c@z-B) zs=q=J?>abڂ/}պԬp/Lx{=^'spm=sŝ=?xbLТw9{eeҤEQAg[^{3:kfkgl=l\Gh2/h;x`Eyy?Kqhg ?C+6<4"D)=ZYG>s86wj|'5¡#;F1,~?|X}N8~X?Ɵ,`c|ă<-R7[g7dM[w=vz\K5 <9\q_Cs>Eϼ|ma /ޟKOy_օQ73fuSy9FիGtܿ-p\H9ep2<>tm9 3xMc q+kSfan)J}ڎ f=%k,m r]\ʘe [_r S(Nv.Ø#u]ҧt ocg5Ccڠ2z(}C\c?}LMJ_$'fZΝ+[x\Q؅1u>'y2Bԭ:V 9sQvs^yN4m?0e_Eܹ[aH.|uYW c-z%|3{0 )񸏦n7{[ħｵ-Ѿc }NbLȅ| ,*w t8iQEo5_^c3elg5;3G>6iO P&^smO:z:&)74,}X#9[x7io?eگl-~?p>,8N?˷o#>Vڋj's13KS=@=oޖnO3mGƒ;nژTm ^{G1>V]&ol^Fשk@@>Dm~2鷭6ɒ>KP1Ԛ]}[v>F܂{cwk{O֥q5b&ڲ[#>>>%ZKk.x[CSj8OՁݻw):}FX%Vxt<}K=ujRiѹ>s$^N=17JXmՇ׶!1sŽ|Ǎg|~{噴'YޖgnmKytӏӏ[/+kKK'odL]SZ:1uMܸq mur9~} 'sk[8fե~c4q/~ܪn.VוrimC>~pų--81۬zm6oI}{~u]#?[J.cr= Qɜ[rI|_Lg z3n.|x [SwNJќu`(ih⶜u%b%iN˵מ[_KďG3H&'?Ӄ_ϻk;/m۶M}'oܬ҇-g;fݲO굛/AY3|]^o|;7慏y)co>*\#?o[X_XǏ~|;>w3Sϼ~̕~sk+yusv5p?txg<-}=8\n!3?y s~":cxm s{{}oN)6&nk7;{K`ʃ,#suen=W[/z~TokF^j{\C~<_im6Jޅ]?ֶm<oJsׇuP z[;n#Hw}%?SzWI=/~poO> j[||g^ JkeMZX;5&s+}|${'^.Syo9uIqq.׫3Sg7LsY5ci!:mG_< g?s* "ܾc5wKuu kgLK 9Պ)GE@[>|d>ou{s>';\'jeݠF:JoZS^{=5,uOGmhM[֚9s^Ӧ~k 'nωeHz=Vy+f‡}VjkV-=%< \B%Fzn[KdJ|+uR"-͇߯ZXT?L9#[Eʰ25iӴ\>|dst᭿;7Kz)O{ѹm4}^,<oVlG9έ{ai~whkoLm-2!NCKOZ%>üO~\6{J]KK؝*"W]?5kZ.[;dȱel{Mzr⵨=EL=٩sSz^{gsx1Ϗ}{ K~gU_+>rg|x~ruD-ĸ>ɳSs]?j?С]N.ө~ZΞ֒L|\שu)o.i9|u9l41ÏcoK}>tצw K97Ɔ3%?qItNj9{ZKt_CgSk GvIk'] \ۇQOלK?c3) z;ny-#6Dg{-wIE|ٞ3ޒV>So&Nu}>3J?w5?YKnk08֬KQK.~O^}nX2.s͂m?.K[u|p/#oa.^|Na{6LMZk'KOV~w8_ۇDZ*~FmT7L}e [*Y(p\L];r]r,O[?~}䷇r<лo"> ?_CGk*>w.ųF{Mehsbim;꧙kCk䱜 S罏}Ӊc#n;?>Ѷ}2~>=@wxo˺xQy}sYWǷlOSR{jYsk˺H޻VMߘ⹩֫~[]kp-ٶWڳ]{m6[@'oj?x8G:25-e[|e]9륵g}r;Ǯ[?-\?^S9Ћ?s+0R=@擺?Y=G6am~q,;z_k?kB/5lkcAѵ싯ԥ29:IkyEL-zƺ{} }$6Y&m>N4mW_U-|oRZBoE{%s~U难-^j)m ?.5WN"%{YGz%~L]ޞ9{`6JK+ޯvi%| i?YG~&-|6,MTj|g_wjJ-%C{L%nKR~Ӝ{懇X3\{zߚ#o[;i?{sG>70{spI|]K6uۣd>'k߸iݯZs 'K=)kK5[ZyeH?݃/2{\<>}BE-ȑ2NI]=Kgzz^kM}g{ɥZS־}5׾2LϲS1f|{9]^}sGyWV}}unsp q[>Ǽ>9mO/mx%i"J?TJ3 >3O ]G: {%}V*ْ栝z2gQ+_9H ~=O÷y7ox7Zp֥%u$}E_[=ʔG5mיO;Y:_s>|TeZʒlzzZOO$$u2d|/KI'})I@y`>{<Tދ_Il'ʳ=z?YR|-vvk2_SdهFY7U08 p\l?Dk\{-yu)j6mޞsֺK\[c"k68MnO=ZYKho*Q˧H'h 6#nK9^z##^]>RҚzέ-1e:+x[[_oowM|-WNPޗous*[;wn>4Mj,kYݵ]tyšE= {WuxMޜ:N?^0M4p}^آ2ٲELiV| Ib+x0uckQ&dcͷ=;;jϼofN} 4c| }d]j=z^xڒO?̮Ԥ>7-=Ӿׇdh[[Ge՚=S>E>P~^ֺO_jSϬWo>'/L|냲 shq*K ϳ655]#h3_BsH5^[J:KoFܖv=GCg` =.˙c}[uSk;<CǾ< QS+Ƙ&7cdoGM;+fK+Z:F |c1N!WI)_[?]~3rF9h9ZyZFv4šx12pj0Ш͉u[>냧K_nMMZ>)ߗp/sdq\ܒ6bhJ6^3XVlGMKJ3;7$tW?{~gJ}O0u:߇6/z_{\S{s֢s~q6pG|;pd 0G1y"+s8"Ƽ8H/S p-H`-GBCYCף-կk!hE>#GyzDG^i(u>kisSne!?35,Yg?sХ-s?W7\C0GSc^ښ|c>3OZڕkLI(p C ǵKY8я~SU[̝:ؠNtj7aM\65vCxz:Ow,'އRuj,q^;KQk/1}Iv_i1-QVeq+qQGQ4G)351ρNm׮̑#|ѳR#qy5+‰vwH֪l?xG;ӵC ρfɇ:p^P~}~Z r v8eu)_/+d ^?F`~zsܯjqž]o-ơEXv}1O/!r٢Hkh@[ 뼴llV<ۨshԁ덶N{>2m7y'G-Ӗ|B>%G<`sZÈ~03@.}F:!x}.fXl0Eg%M񸮈Wƃ>=?r𜐵Z'nØ>[9BrmGc=HcАm|6su)i 4>[̃CACڶy qKjW[Иk-4Ol4ăps?v7_Jءul^9q$uqSiO s#O<ʓo(h+< 16ڍʸ6sq=4O dy:yC=Υa+ jF! yMv&e65£s.Uc[і[˒Ӿ|B͈|?#y ,s}qȣ8[ 8N9!G;m߷+lG[;}~? o;<0=SuZmp,5kUԛE1o_ڶKZWǘvC!cC e:_Cұ?.1Om Z5y>; HigZjgMvmo>܇pL1hB9u{䜖F> Ok* fh-^Y 1/}=ý,=J9@xx3/FЌXa^:2(7G+}iB=Ѓmױؚ8.R։X"|G[n-KON[^-O)y4p#g.[;gt}?yhH csCCdZ O瞤c `˜|gA4=kfG<1-arc47Pr|9ka-#ǩuz:}Υiߴ>0&Rdc_r1{q 3>RW9scl){{-]5f^<o+|jm{rj4mhPSq:(ƬDX}i >em9g8LSr\\kLyIFS|xXS|c4_«{OӼu$6&ߐb _Fv| 4nu8Ro]tt}zm =Smg5,ǣxxC%%N~iwOtZ%?u4ďm%Mk\osr9}-tC.c𡍸fU'pAI9̿s_1m#'}ěXSg 'x:4Ń0cƃuxZ<֥Au(oBRNEٗ-3a 895}>4~ =|sS‡1ߘJ:F-' ouŖgxu>O`WBs~u^gGs?aohgœ Qƒ/'[id;Kl\rcҷOş yF%2Nq5Jt+Dyx##}aK160_ś ^kBr}sXz5]g/MӦs@-طj_b;?q=r~{`O{ɏ8U{S\C׍Q}{S>|^/'fT> Dm%W?|={֖.-͡'ʼt^s꯵u)cm*RO~ihiI};]S{-ח%}_}E$Q64QaG}5e<4kq˳P~Q{v ;~ϫ(7^6t~܆2i}55Ԯs~/zIC{3Ry ˯JL}r|MR>qKub~>7zгS|oS1|o8Ԭ'9~R8uK>SnZ2/mVȹ6P]ȋX휺 wщuU{=jTvXfK%2vJ^==%㨯8J{^Ogӌmlwvc}ԢȋXxo-x]Xë=_~;.򵚍|C!}`~SnZitd>I/ ;/'/ryq޽{0f HMmɺ8E=.ٯhI~I-=r֒^Sc} IX_Ia_[S nx}e NJ=֥>}޽_}_}.lS|`OuOk8i+Ng'gymój=gZy]7EpR̝:új6vY~q@>ܺd/iKu2qI #qש5M3yq ,o*e 'R_٨R$H{ʭ{ZK4?N}'Ss5㝭DWokXSp|wo_S\Ykm./l4ƶ ӆi6}`OuOkxi3^.c'cyms0|OT]"Om>;T{Kf7_ϚΡ82m6Hh[vb$mq|rvxܵF -cYsy>U{.uy^3l4'Ֆiu|`OuOkI_Sϩ!|19>?2u%j!Isz&;sQ3MFkN>?m6HX[e=zOWJ=AK-ZҜ:#/IFg.Umalq[k5;I@^}`OuOk٫2OW{V|7Y9^_}՛^]}06h%'U\W^ {ʭ{ZZO>k>KU'/-?Nūj{cS=ꥥ5lԒ|)K=rң/̙OҟKzOB (snŹi|li?n~==imB, '|`OuOkI?ǩ>$}jn+=4p0e]޽{7Ԫz yqKyǽ?;uj7_A[UZɡlԊ)G^Ǥ{ʭ{ZKO>fۣd>Iޣ_Ͻ&;uQkBsxWƆGf:h} C6j]/kZ==eI2]d>I??t6g-(ԟgzOwy|oE=ԛ>܃8dmjfcs$u:N[c+mط 3mG-eD|xq?~ZiH^lc;-cㅏu}>c:,CF{^om4u:NaۋrȘދ/:' ]PCk(|~?xȓi?EGoSu"|m=!Mif4R_)i-w o3SOͧ5Ηy7>Snϫ$ٕWZh/@ᕍfF $ \T 2ajK$Zyͧ72#"޸>'Ή^O\?ϥdO]|jM"/ݷ|q{&/[Ku;К{ knî#l=B޷ƳmD~P~WjjLjѩ~~cb`OuO:u_'i|zomA\ƭ_[WkZ<]cyW{xG9ǷG鶗[8Nn[bSnݓ.c;6 /c(;%|8]s ӵz[泦ϖzve?Mγn+z'}uՉ۷|AC_kqUO9 t*,"WBG2#+0ҧ?p=t^V;T^o_h|scKSלs }p q}q-&m/rUx<o~ݫ>O0c]۟~ kG 'cZxgpu=hi|\ r}0u?qoZ\ AYoq~-cb`*[E~Gk|J턦9XXr3<>cF^n=C ;>)#8kl/)!87| (Ҭtutsig VOh7ǯZzm/ `Vȣ'8NˡMПjk9[f\WNy㉑x2scb>ks,8'|kd]trUG_=ws'?l91o?SWKYyO{aPGlԋƾſpL:k-7~~?5xqƮkb610U{ {hfsh)qqHP>h`An+׳K_o_|yuڅwAM #=WFZ,kקѥכ:bobCyNA }xc?T{⪳~SN8Sc rGSq`η;{4=p/^RXypm=:j MÿO'T_UUS`ⷶ~rQ']zS-^Տ~3g_rPל~q>-cc`*Qo{ɷmOOɿ^7Xo9 F<-* s.cmϱu 0zvOT=vy;›SOe. ]h!UGS@h{Л|K͏`ʇuz}6ޣw_Uq2SCz>޳wYm8O''cVylX_ r~"XyO x@j uj~glqюt G\YwD]q=m:[agOɺ5%uʩ.eStRV>[Cº_Gѳ.0׉{v>$Cn7{q2׬>uGs ;SDmb>ٚWo16^zuwo=_қ7}N9X{wGoO}T=>qm~%aBϽgbE枏tQ?[K[!1r r+`J@jbOϩ|Jo\j~4%TWq)]ېۑ -eb:9 pԳ:J'{`shWI٣|RW]J7_AQCXsx\=y齶:;ksS׼*L_H $܊5j^>el̹c&qJk9P|x@uU `+{GSv[7]:NQ*OÛ!/4{jeaޥ}:qSR){Uœʋ= hysOi:㧮nŘK; q?'^A۟5ؕGu^s{^{[oGn>[ߧEr[ϟ?=ڟKóU~W%ߗZAQCXsx\=y)Ϳ?E{pϡ=dԽZrH  # ɟc~T>jG̻gtvuS ?qPS<B\ٳУp>8qVޕ6$2Kѓ!}N;GS72A:<}# ۵O^s^m9GO5؂Ɂӯ[Y\ąxGogٛ?x2q'w7m?Do>+csQkz8^o3Tk#:Ud'Nc`OuOnۇ'_ŋ2~OEfsDS=J⡸Nnf?nq=G-"<b`OuO$//4OCVЭ[OfmmYC2|rսԞמh>Z*7n|X.[Kb~mc91|8'{9ׇ~|X҇NgbwV}Ԟמh>5މy1ܺ']sҨXZ3߻r/b լ٣>aGM mR{_{Q 1H $@b 1H $=^WusXƞgb 1HH<)m9O_wSṳ63v<߶\/{MGѹ ^|H ]a[XҼNUѣ3ͣ)6ksjҏ ,z{[xOlu={wejzN|~髌Ub 1pZXB%h^ӗKɿSl K@bZXB%h^ZJb%dX):] hsv»ZkI)Nm?rN-GzdpkԞh>u}.AR/E,!4OR%EsKmkkպec.o͛MJNCwʶ Ԟh>:5g>>M $F^B}~}{K?KK=ij[B%hr/yhB;51w˻.:)׾6FKY^Qc׉91:L_jL]KМ9v e}ZzM;ff{'\#|_EF"`֞pkm/k^=@bXN}LJ77xrzΈugyO?q_FM{o_=|+O$:)t"=ֱ8~o?KV䯰EndB޿g3r:/-F0} vMu÷XVl#6aH5FZ1 KV@ebƽvMd'E߁~ʆ~SGlrat>s`<0dZ+oq.d~A>{*7F #kʈCQ=|8&"+eXxj=K0s!GEG265nzLC5>^x\[V~[ϭ=shۧ=F#_b41pXNǩA^{n_A/y=qGh#`^|F ι%|L8;,C 8#]QA^tV't5j/:GDN @[0uUhaj#Q4GShܶw'OO^wFqun u{QxMX"SH \+7;#ym{.wo}D*}{F>:S儏"ϼ=*O5rEg2ʹpUO`<#΁ǨRꤎU.zUa\c/<{~-|._:uEs*[橇{kž\_k;tkcp{yln VoY>|c`:A߂^ osYebw#c4w~uCp<š#m؇&vY|6c+۩c>=D Nsu4vͺ=9g}!^+2gp_DO~}pz2=gRƁ|g{OMS{d8^ۛT~e(T2mǦj]һ"/|lO?έ=s#~Mib 1XN;090G{4ݺ//':4?C}րڒ9@O`s>ju mtT\t +ҋGElq\z>kQ4GShVo9Fҥ2ݤ˳vSl֞psmu&oUlH c ,U'MO^ӳ70>Y^ܵc4;A*׹G\=Lo{؛wbOψL>qDFb@=kɵj:?޹(蜫GR#:WGXuw5.1?C/k̭ͭ=sᶢS5~ ,U'txC~Va8y>bhZ=~kn 7e߬cm{Չ%]5cg)ѥAj)}pߑ4;isd9gEsʘ:,yW+}T|{OT:tm'1~7۪̅,wlzlc`kub yy^Jb%dX):] hs,ヹjѣzcwynlo3N~-eb 1ZXB%h^3V)f yN.!(\j^9-^ZzM_NX2u1̅۫nWl| _b`1:Kмf/%RtO2,A.]BQ4GѹF_퉏.ԻZh =]csk\{ݵt/UW-b`kuy8naQ<4Gx.=+h9FEg~js\y 9F3n~}-.<w@v|*"fGE'XO ų?fgϞwv}ͭ=sf5۟%׌ԉ5-.7%I>ܿ#?3)ݕkh[3.~Mib 1HH<)m9OKΥ7u~osMm㚚[{ۏi46M $=stm<'ؿ}>(ߟzE^g5֞pkq2뿎c?1v Nl5@IqMY>GK˳Sx/#Oosk\zc6MƦb u"x.?OEOߟ~qY7̅/2oilH )R'{rxN>xU~{}<;:[{z ,q%{l',ko;".)͛<;oOͭ=sF\g~߷G=^^~V-zn/OIJ?'K{4.fܵg]t\;>!}5=6̅][>׿}/?]UFǟw6HHLлߘJ>__zs=ڥt*?z>:FO%E?/EO^~7̅y$1=d{{~6X ٙcc!j7!_s8w{闽1,v\Ύv[SpzxpM^/8GVKY^ -߫bW+z|ڵQ 2W;?|ԃϺ˿u#:VysFHWNt W`6lZi!C]]=Qc b rFjʹ'5y.~yw5dVN٩{Tgn[֞pSIovv9G o[ җy rq8B缽Ǥ}+yZOKֵ>tBVh!?4]cP}Эp^{ {kё{#[A/tQ {U&)8Uwx{Cnz#׎yn97x] 3V[y:oGdpQ4u Ճ+VsVNm)mVߓuy͋- pzx^i՜y#:# ϽEk9pdpM_[+]Uڕk}bMZʀ✹xuDs_Ks#Vo7ױ167Klc9tǑƐ#k\ڽ{^< WgW&ole~(?KϹVȢ!GWiW;/p=zAO7bV32Mpw8 v<>>|wcõux}s.1:?=wlOMb|O%}Y< y}Cxc<7Cjt:uMF:B->hakr#兎5Қ˹{/ TX.c;wX衋Z*+`C >^wkk6vXl]%GyCc:kЙ=|m<F2cb%בk^uTj00Vʓyũp k-J\ܼ]}p>%37Q<[5iXG4Qwźty +tqMs ɘ>Р@}畷vFʟ+ sxTAֿ~kU*;jwY©{k6z?O8X̘CNH#!~̽OCe%<9#L{dnE`j,k# veЀrp?-y9V@Ft`C>ЅUc_>VXCFAs#w~Ї.> L|`]y6{.E73gϞ=wt-]+ ͅ;F'g{`ͅC=CN6ok=&J܌<>p\/.#ts##Z\~Tڮ[Q?4ykm眷GY۩uG9c9; n%~wιwuݺ j:^74]gM=[?h?/Wlr6zy{pmMI0!F-F üA^=Z>^;ثv0ΧHmkӔ̬;c+5W|uz^k{ڠ#ع17~C2`EOED{:ZQ#e~+i>vk[tS|XZmMbI \̡9[{$ #2HuV~Azmd>ۋ5cnuRת.ڄsx  [ϑrXޱT|=],rx]=?@crzo&O;>uk?s1]#lO$WR;in0z| =x9ʼ\'shAmeIz4{k>?t5?ojS| w0M8sp+MuAl EhSis+ #1/Ic.>.>sW>sdbuAG*}2_b}' { 1sS 9V~'(`gF51BWYz ̭M(Z=mzmg l>:2ӓY;Ҁ6Ǻ/rnTGcKڊV/y2 [נG5gOZ+{x5х8`Ms̱k3z@KU׷6ꇞS-1b;+`ů1_?#C=K;ۑt xx"g-{:3kC{bВoՙyV p.;*C\ yaS*[KМ/ǡ,^+[|#KΥ7u~o^cS̅}z7/qCv,9/jyp<．x1"5Jǧ|p!ܿ5VxyPNVGIM8uQj>@u./>SεCt+<8gD*:C\cEv1#+Kc^ژ=WOz2ozg`:%)>11w: d\眻fqߺ!ɜYi:y]]3ߓYಏ9ށҗt9 \m4{~a ^W\ԏ9vV|POh}ΧS=<Ɏ]!%=kLڌ8t?$Ug k5ƍ\_o x΁fT=lUs2L{|W]=hsU{ۃ>`ip~(ؓ |ցAf qz 94a]_J~~oދ/]?]_K9s iٞY =]cƧБ"q5aź}yȳmmM'/IW]rcΨ^Kxg k娺Seb{CwJ/{q]|דՃg ؖ(tYk0^m^KuT`Z^S^zmcvsӓ5` ~/UNm <ɍm0UoW [Z2zU|=XaZ=!=i)6S6im&,4QUy[OvcX+5Y6ؖs2U?չ5*/s/5kUzu.>LzSi ,4y\ZծU趹 Zdd8a@ qҝ:צuۧvgS]|to+׷@[.:NÎ[dᐼsylz=ȡl>'FzXSP0gd\/lgͤ.֋J9u>߰|+Phḻ@94Qoku>K>z䫽0ں3G7xa*z@9|ā49VecԎ̥ulɿ8gK{U)zL([Zz}(ogmh˿廵stie֦ڳ\xΝqٗvdNqX{ 0QϨߐ31}.|z_\d7?kU^N>VY9<5Sȟ YUGϼT dQzOlH%|q|)[z*ET{0T?)ۓ#Mԣ XsƊΑյv=W~Y[EůQy0G =^/]F uV]=̥-~mW+s UO5!̥'6چD_ ^s]?Vv\\ns`C۱ü Qg[9ed>Ҫ:#rskKNU\U*/c+~ .ʅێ=ZãMLZҞ!DZ9he֦Xmp^IN b{ /Qpz/B\/:ʿ9~eM^cf//mГIGY[ױ0{~+0]OpֵKȢ\xHKT\x`9Ey?w޼yYŵ՞ szYwMl_b 1HH=ƣb}b 10'R''s$091|8'8y||w/Edž^_/sk\O$@b 1H $@b 1'A9pY/kl&{=9eں rjz<-fݾ]~ͭ=sb羝/Kl?ަ#Gb 1s؊n[ڱ]{ (ٷlQ6@?^s.{S|}{?֞pa~MG%4@b`-1:ݶ"cv),EYB4GҺ=#81pB%S]/bwn mG"oQ &1XC NlEyx].Kѽ}}$͑aHN .x/-{Sg>߹g.\ۏi46M ${[m+r^;Rta%dIs$k3M/!H#iͱG`R<;5?Gͪr}̭=sn3Of܄W&1p?1:q?^uo}~~sѽbs)}%dIs$9LWb`1ԛ7ofՌ{>֞pbk/W_3~+ NlE9*ԾWERygXIs$Q:6k_QVrͭ=snǞ7{N \{[m+rKủ9O_j^"VFIkTt<6cxg-S~=ͭ=s-=So!Σc<1p~ NlE9:/3Royf>=_=Н^]KH#i>.g})qܲ}n L7O s؊n[sd_^zT~kRxo,+#i5*Bxb-w={vNM-2έ=sny3{O \{[m+r|<yV Ǿ6c%be$͑#0/b |?O?yoz[{mX̱tw/K ${[m+rGz0;|M_x["VFI˸x<.bb޾իY8P߹g.t3˭8[&.c@b`1:ݶ"/;|ҽ1øD9V;@b|oo輻=k_\sk\ ێEl?ަ|:Mb 1s؊n[sT>>~ڒdG1x-1A, fhmmd L (Bv5.b"*(i(߽w>{YTDF"229_?;|~߾el/pcokp<$ ߏ<+~=/jק6wbB=o)#GzNTkΪYqGbu >FU穁3]tUngT8|/GAWx[,^fނy$-,|8_ y>oR?5:Y2c~_VmV5P5RjωGQ,[3#1ĺeU.'|пΪgϨ\>9UU^zN7{9=o xH{Ml淋sʌ_~WeGg2 ؗf~$XKx=WFkQ.WvwF8gT<=g\}YejkV 6_?7~QG肱ڣ,Og?9g.vgƵd,kџGbQ2U)-'[ϞQ{,ߟ+媁95pߥv÷&~go'C]9M!{g.eOW?Å] [:[r]j8O̸|υ3RZwX=5Xշ⾞ ZwnmjV K;|ܑgߥE뒟&6f-'.?_zkk\/כ{ é۬{|o?/+GO]|_USkj3*W9؟-Ί9󪁪G[='7Mğb,KsR,|'R~/}h*~޷'bq\_rYeU[W5P5pM ;s|縮%>{F^2b/kU[[U5psR=?C~{r0)9>hNw)ν? oV'^(?w~R5p5PsʡsoS~zo~[rϬ=eڟ+kbnaW UN+'e>wy_?kd^gϨ\\,qW׷߹Vom[ۼ{'嚟^xߥT=dvʟ1q~onsk_fὓ[VyMdnK=K=qgѼ>ׯOxM {=8Xշ|F/|\<{x?])agwDN9lF{v_Yܲ_Bj;CMY/5ύ>{FmrU/=R/ۜݚ9-mOG{1}Rٞב>8GVyۋ9ir;[81vAL\9COqIs>>#-2)s639?8z͘8`wsE~|BV_˘.cf,}kdĔdKy6%;Y,֧u;\q~=uj1\; 8MƘGw11g'YcԢ\ ʦ &))+vF!}>yA|$/p@%V?WGcg8ْ'@.Gs2&{u|Γ4dig-s෗[يJPOxK;;Gĥ,:|@9}OŦX)c}'O.|tvb[;1 $>׽>Xs`[+ʠ~$3m1,p{ŢM'61bGxܚS+u?OuV? f\|~.~^G`Sݿ-NӖ r#X%/O=X7^;sqm/ fcLxF>`c ?"3{Vh1d_VCY [^ܗ۸M9웩Cw~>>q#.Oz>/+qrghqr̾i9xE>I<ꋁ|9K8<"N#ͅ1\;=&SqZ/od\;;\Apևm=2G#cdNv3W䏜9^)OXZp<Ʊmؚ8\92V=TV,Ytr.uEy)Z9y[ڦ8{'j93y"&jOÞ888噄\a]i_Wd6}m66>ectX僖|LG1|E>wmh698]'Oz\BFR7'uhW9lL'<?37k_^v©yq^;z>rX{/Ӵx>`011ýs1ч+W+ .|7cߥsՋjĿϳ ]`rBsL%ZOZp1.cHCU^ ~K ZsHT<9$^[}Z,1366}"l#}9`KeV ]mGV6=2'7bf۶~7w0GL{쪟͖b~d_hs~Ƒ3-2MjqGY{(M-fs3ƅ-ڞ//x\Wl:F\s1N+V.uqu #|P|k[s3*Ss=n8vem{yk \=q} e}<#0۱{bwŞ6egbE{F|@9|4;I?/a ;pc6#-hG\$-K2}>gM˩vGQ+ؕjΙקI}G B^V,{bLdG|q-r^}qǽ>LYcX Y٧Fuj>>9Dr=\8Ou㸲ίu6=s'9f?}εb8Yz/.ϸ)#^=]@I=vꜥGpŞk}x/Gm=,FZ!>` [ټKy&89}gknK9u^;ĸO]S֑\hyc~j/?ϒFFJf_ָg q-ku˞<_*\˹_0~o[|f{혾s\;`1{}eB{ _rEK<}S,Z|{6qxӟG|:33\BϜ;>x^Dgs'y_!1aN \Zuӎ1}taܺ[ZpOp+wC'ǷC8G_i5x|Rs8a\n_ĤOUI3Ԯ1FneuBsug{p~Cf#8Xd iycQ:ENu+-܊g2vn/b0G?6Ɣ~]i!uo ~2>s e/O G`ӁK ':ujKnxΫCKnȁjO?uOVL2zo3B=Q;Ц>xR>Gsc><1mdb.}^RLDZ5m'q1}~G` Gw>\ĂoyHž>r,0vKlE^g9x5ƑIpFS}9xJھb#2d'Vo>hSy<)cYkߘ/>貿;Xu]ρuNY{){cs79Zu}Z aX7/m*s`/_".8xӺOʊܹc}ŽV?|mnqaL019 9l1gn3#f/Ѻe N~{C.o8P-/yI_z -2`ȋ~~ơꏶ&-xփ81k5DY\h9K~sP̏g]GZ$-mY ~御⫓zv[c}`ƚ?1r.\bg>}WV 0=Ϸ{z++V~|!ۋO ?W=qG?/~Ծy Who[jZ9o5vO9h]+o&\#>+I[5mui>}G֖r*pgb^@?;2+Kl8X }_OLb#>KCO1&7q'-\G}dB_;N7fta\s2=W>>b[?I˜R=p\3bc;7oѿ5,_bTYZilq5{ֽ"r}1\ {9F_\e{1>^V+{{n@{.'ϊ x޽{)sK\31s7wԆq*?bvÜ)v#Ӈ] 3nT=#WYȣ6#yfeNK>u{[P&mk >)z>Qc{O+0.6}76Y=z޼ +̽uTYql']l ~/1`MMr6> *-x^b.S'2x[_z=l {n7w*k3Sr&Z>[+?9%-y~ڤj7? ]9oe.`8`sYȀmb0h79S9ю6]qQgsL\ZzFF۶|ggFM~=}q=ޘ{]ઃ>{eۺ|GU{ʷvg -ϮA УO:MߕZ}C;%&cb̾oo<0|l[3sHZ&fZᖚGeXg!qOG^5.91{K&22bqծȟ)?{ "MrG&W[sۋK[ֱs=^bSRO(9딽U_9%\IrY7`-cȥ>OqiGt'mM[#>~u}駫?;:u?~^]<;7*|>3sw,8/>xx}}v{|ԇv?Cye{ƨI!~Żz1O>>X)m>>a<c/>b-Oɓ}֦Xmm`F)(Z|8oeZ]L^-xr8Yl_X\Wqn߽ Fʶʜ{49n/dmZȬuq!O>m~\}נK[,ѧ/.\1OYtani_[ߑ,'p_[jsX).|;{C!2qk9q^=r-k>cG'bKukMl24nǧΰo >.q~^.h\#:K>iw͖H}O^矟%x=GFlʍ`̾~_U_W@KzNTͿx|'󸭺-n~}oUy}UUqS=W,[ϵ{F*_ g]Ui17k{pϒ?qq̨yx)3ZϒZ`<kY%{g/.Z_sq暯*UUTϞQ{,~nܴu3u?jFnf`gj&&[Έ{-xToMٸ_oUU[50۲Wkrpϒ< m3]88g,f5{ ̽q=g`ނGܔ˞[V5P5UϞQ-{5&gq? ,9 ̳1uyjY7sψ{-yToMٸ_oUU[50۲Wkrpϒ< m3]88g,f5{ ̽q=g`ނGܔ˞[V5P5UϞQ-{5&gqwOo'z.-a}﯆}[¿qtQ\K\]&ykK=ⷿlanfK7OgOlcqu K}Ou v^$Σ&%LEޮV>_0Ƚ_~vK:=dk|8+ΪޯgϨ\q>r2c?=|smGOԟi9%̟6k jؖ&-L5^~o/[5Lޱ|^׸&%\K>} v)xWXo0w/֒5φ%k{qԑߥypzBjO(NӪ3gT [ oq9o5p=s} 93E1;Q$.pc[bh[}93/.=h󚶇O9g$g`).˛zyrhnSs y|z'q/[ ;ėWڇOdJdg11̇Xr9~}t'(0żh̋ye>y1"\^nžŘ{$C9DZŅL^) c>~>ico g l3v 9cucen+mv>i`7s$GI-;g1>!-9B5#ꂇ:3H- c|8k:E]0\_3!?]M_2KĽ ߨi8"VMI.r%~IM%u2srgszq_#=L\+A٣ɵ>/}na,jj@dT[c׭YܷG/FC{SsEs$:l =.Ŝ.a/tF-?=c=̖w6ˉg A^ ;ѢCn82nc}VՖ&uy!>QY[[pʽzȃ=)}}CNQu(0]-yw\޽}>B7Is}Y=\ĥ/-5s֪u,=l斸ƥn7[JL>CYdrG[{).E0^C|~p/|/m=L\g6}=_䀹R>GQ@@YQϷ^fqh߃8+g t<r쉼Pw <g|R_.yy9[t~S^< <#k̶(sJ7smϹpg3'bѫ/5\[*Gk[-[2{0'{|~ڤ˘m,ZE%9̋yо8kh!S[>گ%LxdN}vGr_m]geZ\>V컟17I[֢s3ޟM/O0.R?}kK?.ufwב9I3&qsYSzqgL{Qzuk9>'ޣ_PUUZϞQG}3g!ሳ)Iϡ)}HĻ~3lasNW߫3]Wd,3j3Ǯ0wdϖ<gb'6pgGi ; :铺ȘC"+Ц\/{\-Ɏa>gyd]x"rO.͇SnO1}g9rIп׋m 3y[.rȅ2F{r=~^*s?˽L5)9am2uO@[Z'2׸je/X{ׂs rě8a3VôŅwYlAsCȱ -8`sH=Lop侓@?|62G9ֹ=/*}Vn*7UUTϞQ{,⾇gw}8 y>cpf= 4e>4.G|]|=y>ܯ:k-ar~'N0=[cB. >+2 h>qЂ/xgy.|9Æ`"G p?ʛ>ʏma?'NhGZ9Eb\˗E=r9EK kۭ\&\)Yxsy#Ȑ0CypϜ`[3|b `3ƅmC?-xq!8-lp93~lGY wʃzgn&&3nYR.5i)^äsN m{Rчc+zǭF=rQz5<.g";99Y3sxw|P'|gpSCS[̃ =:rL8~y>cp`絴o\m ^;v&g}|7FfA;SKp`\& bcʀ=rڥsl1K\lma+2 1 iy}܁p\rfWtYyO{o_01;j_ȉV=\S/qO2)C-r>P9.l`taD.ٮ/O 1q.WK34%LkR\;Ͼ~-_֧z.}?K3uu qd|8o?ދSg⦸f >{Fo{_ù9!Xx']3s[-X/xڒvxo9P~b}r{_[pB>O'ץX4/FmsuIb=OYZ䉷kp^s@g08b*{vKc^¤ȋuǾ³ ;s3#Cn͗uh}C⾔G0._\cp#Ǭy5-jj,5lk2%\·8pA.)9t$ל]cDgϖ&nyw̖_y35[9G`}ɹZمS~wO7}lk\#=}0X'ȥ}xB m֐8mܩC۳:#dὯ)1`—u}΍ε9zyk=6IZ/G[@K>M?cX]fιΎq5Lj)1~_|1>dskq_&Yp}xm%.W5}qXV T T |]ϞQknbkxOnx9s~9F8W[T?Ty~Ƹ]K%L}˘9~߿{Z}A~whGOE`Gti~ ulvv%~yTY=jj`F >{Ff1gq? , ̳1uٳzFnf`5Zs) @{Ƽo;~`^[e{SV? ?MG|WGUwv_/i0-;ߊ>o!cpا{=K[ÕZ30p}Is3x+ުgϨ޻ϸ=eF?wm}i1el`|ɆXx|ob'z~k˟vߔ_Է瑐Qߑ81eooMGOQ|KK30/cΣ7Β3ArS5j`3*W5t| s:R>]2ϓxj,r7) ||_ygnϾc)GƱZ,Wt .R,b;̒圱oR)kr~/n1{\K,[1?3-潶pq_zqU\U T {F)G񵸯=QjZ)|k.9ßiI>i9z6IYZl_] }}C[=ļEomm ߍrRzq6[ģ2qz"g|E@@ùD^Gyz:)[s⮸x^~?✭w]7N9?x߶`lu.ǴE>)K;wYZϛ;#|>AH [I`lҕ\# }[f'":2/+2bW)ms®<<<{ _r.E\Nh܌ȘyPw*omi[[`5kU\V@1P w>*6X1kvڷm1P ǀg #!r"xg;iSg е5Ӷ|d9˚t[O:g92&Fb"Vz,}- _M}jfLUk[b(ngoΕz2kєڶ@1P )3<`=g^+mugߴ5ҌiÊΙ$&meS]>F=M"z{sț"0Ze~֦>8W<;{|^֣(b>})k]}}[ִ(cscgCJ9櫼'gN{%^߭w~W⢵(9V>7}o}xxߑ:K>{^IwK>3Gj~@1P @1P |w~W⢵19=To3 ;L1>C,>{<{z.HWgšr-m9B7J4Fy>CνwXǘXr>uRsb3&7os$&癇sYrM3☵ikr|.?{餑'td&܃{xLMxl_ ' `'/bogc_1SƼf;yb2.l smw!}ősKjU;=_Đ/cW2.BCR}okݱI |dukL1A5= 6 i[(T[IJ%~cbS3τi m ao^3r;[1"Mーa_W{=tci_N5~>ձ&)3m}ε1I6)#V;m0<.skҼGwqGPĉkܳnSsKN\Y/>c :#yq':xyψߣ?֗esָk*.G',fygY`ԇ6s>mNAMș4G*U#sk?5yo|;kѸ|a\C(s^5N?R6k}G]j{dg>+Yښj:Z?]z1{Ce߲؛=N̉5lUh;OLƳ[?CfdSzR3/}UFaUcz5Rz/Y# j94|``53{szk3s>Y38u Dvv}}M;إ.yd9'5͘43*}=B ]||b΅ R>w~/H|S bD3c Cg7=>A0~t>z7:w!.UՃ}`YʲNr>#LAQq)}6+o'MIۥ82F}Δ}9g5rY#tgr#Z;ka:kϝ\\KSU\|iѼZ>qO,8Kxƒ̑ smiGcL+|wjosÎ͘E?|&܅FNք;|6\"}:P7O,^zb0Y+jJIsh {Hߍ5}g=MFiӷxq֗d;9zc/5vm oϬES[}NYujI]x !H72j|99r9bsH/kyN2+<{k[Y8𙙹$_[|[ə{d} ?yM7i x?go늾vZC]|g4|!k\sGүMt~sw{#hUwzӆiG> Ɂ1S.<qHc k1/Hs\r26G@H<ztla\#y..ms$x˜ % 7 s,kQPwkO4{#J ,3s;g߼z[}zSg'k4bcw։Ȥ lsxrEc֞P~N1fV&\ǁA>GqX{G1w }ZC9G{-~{\ڵjć~K/w:G_޺&ٵoz;%.e>14wg;.&sbgz̑Y>WRrZθ{Ɖ]SMhy47?d7_ﱯ~-bNgXrGʿͳd#_S{lNY[q#42fii+*vyx9q5}+Gw-N;sOs'.U7I?<_C;FÚP0_}Nܺ|>Sl5lGF<|!9l#q\O_s4eg8&>[2Ǧ׊g(m]l[V`kM䤮~:Ƭ쇴G_w{?mSY _pmBJ[XG=AFGmBƐQ[}wYOXU>'SԊ9sW{ds<{,^kCra$^L-ȗ{f^6>66gƵ<ב6j1Aݩx`5ESj{ڇõP~bAmfа91mqO?rhwo8Ü8=C5>9ˈ6\9K~tS wXS ;BxɟrsW&Z`{U+saDOnƊ~ά'1㑗:~zo']"~0X?3Rl#%3|j~qYܣƣFƔϷw~gQyi|Cg r)7GxLzƙyu9{72l%XG7?zn\3k/𭑶K)o,4uvqv9f朸&jy><7k:άYSW;_?W`mg2Gҹ^XIla]g+i[ܟ{)s55FC5:Y|Av W}PYj?wrex<#|NpZk{|V){4J̑9˜Byx8by3è}%dSY.k__Y:^+ޑ)=50Vib|WȀEW?АWA|aC>S_~Gĵoz;/zx6.6^{k_,ϯ^c7S3[S5qܻn\ۣ/>9>ڇ(bx95l9h9L y6rsqrMY3U㸳-GCg-2"acT?e2H쿱w| xjo7=p<\dzcE/G{@1P @11#㻹sb}|>^ۣ{Ӛ@1P @10#ṹ@?{Oϻ(b(>Y7x_淺Val-b(b(b(a3wTgSpZ@1P @1P @1P aϘzyҞ'@1P @1P @1P 00BV=T\kZ@1P @1P @1P 9Ԥ}s(b(b(b(>29_~sj o3vq8}1P @1P @1P  ggo_{69gV/}w8|}1P @1P @1P gg0z־/b(b(bcb~޽t8/-Yq}\߫?g`ulb(b(b({?ǧ<~\z}\y Χ?_{^ @1P @1P [FߖB1^ӧ y+5cպ@1P @1P @1P |\ ݯѻÇmC/{vU3~sVoCiy޶@1P @1P @1P \ o|ݯѻOgSe ݺF*3~sV]k{{lpPZP @1P @1P m0+]=OfOo(Ic\:o3[8~ޭuw? 6?y?'fv)JͷۿOYggI1ٚ@1P @1P @1P \KΥu_׿{Ϧ3G{ޭu sXFvx6{ɹ/9S~_1P @1P @11H[a ^ڄ_>; J=|" }uG~Vlbt|N]굲w OmeX̥;b#՟qhQYƌ-u1O_̓o~I3l}Ɔ.?d)4F|gD ?W1&IǷ{9"IjŞr3isϬ ?hc.,?Wvc>Ƀ|*&lb_9=s`Mmiyhvsbn_ѝC71_&>q:#%N0O}ŗ123sŜxH #|@5'[АU?fm 9sw=sKs\.|X_Ng:zw8@Ŏ~?z Ѝ#s6>voOοkkZ@1P @1P o{̽ {d&{UQ`a?L7ڞ#{_ 볒K;Q:q@sH3iG=ul*>7cA?{L:bs ڱs.J?̩9k +SO/=kǽ5&b&][Y|KLC @4Em%W3/k󌁹_9xV}@'뤍H>sP5)c/{Uω?ϓ#MȞHϵ/b"xTdߐEv:~[֢(b(޳y?}˼_mOAsfOt.s>3Ц]ä71(7ǹyɔ],#VrVEܳ iGXKls6/{W5[zSbD8g)N}Ӿ5ܣgLfD%QyqY'|?r:O3bnm.)c6yYt/Ҟ>/qŃ:Y'mFbg9/sqM1*;?35YŘϒ\acNlY82ԟ8V~ޭw1P @1P oy{w=۫3\xdzG3'~dt|$=;&0G{|(|tu9 e^ʳ;t vɁbzk:xp\UtOĂ/d2os=c}g雘vqe ~kmp>@/qŃ?bB:Is\IOC[)[񵝲I[{Gd\g < ,C 񾟳o[ @1P 1/Wxf_;2ws/^Xwrid6{-Ǖ|Wܳg_PQ>ȤmbLE2n 1%/mW9 Y9~<3Yٙ4k|XmƲ>_յԏzwY.'^ԇz#\`еϜ>ZwCG'{N412h?-q˼́7C&k$kd^A<1'9 4W:$P#tݏ*iԅ|a戍YcX3>{Gu;'?cVRG_9 JϺ{}26HgY'q {U#ڄFСYS3foHy-s6ާ-h|Ńigkn|çN>r3{ QKF,H2>/6yq!k| y~ƫ|m][b(b({~ww3['ѽ+7˜;wF)s!ݣe}*>l3-Oiwe\!3q)3V1qp +O, / XGzvwT׸gݚ"˅9~z~ ]rcZ9+qalZSҝS@o=>gDfUOj`_z2N3z&gHv3d[?}?s[ַ(b(ǀ=ީspo{soL=H:s]ɟg^Lyl8ҶW&{Guw!;sF׌yR'y;g|iQ5qK˼8%_fn,Ok测3uOj8R9)y'O=VrfakB|_N]Ѓn=Iyx:as{sq˕|A[Q>zs>״̭F+{sֶ-b(b1ٽ gSg/7ld'uo݋b(b(b(b`7ly%T)yE1P @1P @1P @1P K0y.mw/[(b(b(b(bZ{/&b(b(b(b(v,+kh'Wz1T @1P @1P @1P @1Z "{kmW,b(b(b(bH ΢8ⷧSb(b(b(b(b,8)3=K1vc+vb(b(b(b`L?ݧEqFsbgҊb(b(b(bx ߝⷥK[Vub(b(b(b8w۽KCG*(b(b(b(`w9ZM[S?;Sb(b(b(b(ao{9nNd Ԁ=u)g=4cg-!I뼟@1P @1P @101ށߛ3|o͋ﱭ,1eW.ͱ:C%o7XkKc\A>sɤ@yku.:e/I?\ko>}oqu5/2N^~}ذ;՟ѯ61kE~w?GjXfmbعE-5kSV~M}5qD O'rszɼf*H6>ukZ @1P @1 ʞW9ٓjaKsl/N]{7#?y*Z\A&ɤ\^Jw"e+)=svWvw2;ؗ˛g9ȦeL\\̃jwʜ+g fi'e2^R<;{;zg=S_>cƖ景qWf}3c*{Ypų@msIX\Sw&Eq$7s1e2Ė1{m>Zֱ(b(b`b s?OSYh'{+}貇>푑x/ԧԗ>sydR/m2t>}(2?q=e?8+RYu6)WR_zQ.9LZr#9gƽ3GlgX2Խ YoGܙOҡwҘ{yn|~w}OM;H2՜U..N&cI%sx=8AkhΥvs/>1tKꢟv9N>CMI:!o :hۑ3Pl{If>\;򝙴82__K΂9{FhGhk/˳i{_,OsJyy$'`~ޭw1P @1P _|o޻HZ1Ƚnɽ{/zf_R/Ō2ү>.N&J%:@8s/͜e^'~cn,9L旱qʯ9i{ O]dUƜqyx3kG2I)dkoHlrX#m^ƛt䍋r#dٻܯ.˨?FϚҦ) J\'ϾҦ)zL\2klnb(b0{}@ҊŅ{kC+g>r~3&ڿv̺☶K:3ϥ},5Z.enR&5~3tg$ϼϫ3Ɯ}j\GZnھ4OGkl6Ͼ\!;gS6;ְ6?]>fz@1P @1>1Ka`߳z^} =ʽ%UOǢť=;?{_EuGKO[RE*j"H" jB)r W j E  xS[w!d5>ώwj}'y?l'X0߃ :l+e^k>\:Ck'8S }Q~zXG\7}s(gc 밴p,kt*ucPv3c KaZr~m8rڽ0=mcLU('[zdaL6Nd3^<;| o&sM d oq:7:9l|Vxfö2wϳ pWz,}9|aB1VGsϙ{!Oi$Za#,k0j Nub|[ȱ5nPls?3 2@ ou8o0|䆏pγ>ʖ'|v,-6{1w_üZ>ۘ:g0X'^'S[:e{vap|f+zp/NJ=+B7Oc(3~y{afrN΍1Y6[_=dLÿ8СeñV/WlX9Ua[We߅n5a$=0\"_KCOd}971O'  Y8qKpv//۳ 0[7x˰l/Zްog87Hzm Z _d{a\claa8 ӿl_7[WW\t,9a6^0u8\gLm C6m.PV>cs}V5C) 2@ d 䞁>ʖ'}bݕL:ov I't!h+y|lg%v/9S[IF :lˮlIQ^NΩ\[[U9emvFu$݆? /e,Lej/oxKʹZ_}U-kΙ\p6w21[=t|277[L!-wVخL}<ܡ9(k~y&d 2@@ۿ͓g>y([L¼ueEߎ$CUm¼l+m9#4~I W%IPor:uU85׳d_=d>c~cɼVo2힝3ee d[~KuvLCX>&4Lq9d 2@8L,|&#ޞ9̃X^eיZ~ ۰*tPwٽ\phĕ﫨pw([9@@[%vJ**||wYt•r@PչA: Eȫc2sFO@v3^p d 2@ d  |pQ;ٓfT3^VV<:G懪˔--\V/|\|vO^ }BZYi'[{|:sitC2Vݱx)|Fee{~aٚgs9%d 2@ d 2p`2~~EcԻ_)yo+FQl4w|e."g=CHHӘ)˷7_Fթe) 2@ d 2@j[WsMͺ bRnCi~)u/ĴG|sCpM3pi/=z2PRg>#Ce d 2@ d =UQϬfӉYQ^jרS=3eRc@[p=bSJc *Տh=am:(iT鵍 yoΝrxv8JKJbC>9d 2@ d 2@7Ug[6t;۔K|Z#euRO/. Q]i<ʊ y[tOmma/)2G ?Wrr~r8od 2@ d 2p0`G]?M{=jӧ;cɒw|˗-s$}tԭ[bz*Yh_fu7ߌ71:Vs9to-WJ d 2@ d ;*UU>ky{)]S~^%G~ڽ]ia¾c4x}ف6<7~8RF?uUuɧif͚diZ*FˮPԏڴ+g۷K?P/,,O' d 2@ d 8C\ploo/e^uIt~sqȐQYgyn ^ 1Os֭'do(ܹcT6͜|Ze^# )mOX }$YK'觲9CNxM d 2@ "R:&k 7]\W~F}Fo*s۷͞=uZ8Ky@=]/{wMsSw_[`A\WK+ lmߺu|V@nx\Ozgo1 d 2@ d 䒁KYpiX^kt/F|!@ G=|.*}d_E䬐̿{_Ѻ|/2vtz)uSB=.ߏ+Zin…[/7ïKl SϞD{CUu|xh!CӐ?*yNby1SBO2/̗-[EI9jigӦS/2^c5~>&ל2@ d 2@ Kx̤T6yop6KEN ^\Raa *Ӵˇ }|` {#erڎ3/e=/;֍1P8-?3qi>6ʼСC_rRy!d 2@ d 0Kpl܈}~Tuuʄ^m[_ gƌR.*INR}%mȐ1e~'楰왃9}<7kL>SQmu饗vx4_]a|M㿴pe ۤ߸^,!d 2@ d  |i9 k&C>cz=loxnJ4u|pD{}ʵ[Kד/%}5N 0)/ZowݽqW|K5ҍ5 8 |{KQȑ#|ޑnrƻ5;5rQ=Yܔ.O{|_ac=&_ꡒRpm d 2@ dPc \g|@OlJR~b"/ӳgt}K( p~ԋɓ>B2b?>7,\Sl{1R W\2@ d 2@T箶K]wsr;S{žORCN.<[cd^ G!kJKKӼɯ_V_AT7*iWM桗:X&d 2@ d  gR1Saj׮M݀\8 ׯ _=@g4fL9.D z[{conw?(IKڻށ}nР_ҏf;__+ߧGyştb{[<:Bw1ߌ륗Ϲ&d 2@ d \0`^ .ڃ ϵe襰~1LpIpF=$4Kbd_(ݗ}a-\a.U{=]{o}/~s.1O3ӯ2>Yr劘+4/^~eo}J6|$yV͛qDhvO~@Oǥ}~S/.vpg:r=sM d 2@ `G.w:>[7qv7oCGN»m*7^Pc{[BRzF=AՁs2[#N {Ql[W^yy\/ 'Z]ŋ% 8汗B߭Ri]ǧOc`0y<2@ d 2@@]2z(ʎ6\ |9/y/'N'h^Lx].T ''z$^K:>`quB~S^ HOR22ߏKW{:>_^xDtL:t/:Oq/"@ d 2@  7Nš>Q teNr5NcnE]uֹ#1ҟ}<ܥ>[GF  ϙ7orw߽q{w5zwx`:wNCԸSOm|ءO#6mڨ^~-ܑG=hsRxAJKK]?,f gsyz^l] d 2@ d 2P; E6XӫLd\9;[:A(sOeur7 eqH<0Tez:??c )QQ_%wx)r ĂP+ULՑ/KcRNSiߋ#+7 d 2@ d Ó78ۘs˗;F߹t˖-%>ʗy%_*yc 28R^8瞓楤/M͘߹ŋIy8 H~͚*k GٹC錄wޑv} ~Wz=4wܷdM߆>cSf|/Ós'd 2@ d 2@jرHl+fϞ{gw+\6q/8D}ᨗJn1JX?gk$^J:>[/eСCb$#ݳ x'[+ ^J~ٯ-nBcɒ%gqZ<| ^ FÆF#/=7fyy>0ss d 2@ d e^B ̙ωKq2˖"^ ^*< Ի˗)StO<1 k܍8|A'|B{#ϗX%8__(y/b."):h V\! kmv1ߌ׭]Rθ|Ȩׅ}? {?5jtbnZ4}Kl{g/,Ky#d 2@ d }3@/9 ,&βAw[˄ KֺɵGz=Ua'ZFl #k_s"?L |RwYP]qy8_B}h#/?3I?ミk;qǛ6Vj8h{Mn<2@ d 2@jg^·`/&[?+#?#nȯpQG xW\>K=)uP|t*=u;#ԉ,w->u˖-Ԛ5?a)86߲esڹs~d#.9d 2@ d 2@^ru|.bסC{9FY~1beݹ@<s=+СCr{O\|W{a,q=pMECoRgu>?rl܃?>cܸq[l/4`@ w1O/FFuկ%yڴ{uI!b}ߝܰy<2@ d 2@@m1@/RK^4~j==ycIHwRRC|MQh7BQaa(LS~}<5jz>[1T.V qVo彔6^zOiiV.>{G4ﯔ:QoӦ'K~ˋu76m5m3Ϲy&d 2@ d d^*7|k;;ok:ҵm~6ېv%SkqpK!}ñgRڸNngF8,Yq}ꪰ1Tȑ#UWBcظa/%{<=ܟ=k;ݷ*֭kB͕Y3wf=_pUyG_7x2%}溽x^/L d 2@jg^$ms9S:Mg;y{JY3y%;*]fȐQեK'^D[~Lԫa,7X{饗H_}|;={a9gԇFac}]:m۶JR6o⾴=>ጲbϲpS/cu|椬.^[3 2@ d 2@jz\㘗3[?%szI ,ϑ|pg=~ǽPv a^Ԙ1Eumi};A[+D1|#n ~ַ?l3WԵv6/W}2?^?gwuy<2@ d 2@Ȁ1@/;X0CpPGwvڵo|2y[Y׭[WIG'Nk^¾Oe; ~C;=s>ݻwP*J^,k -K*=~2~v :׭[+ީIF>}{Gʹ\2@ d 2@@m3@/ưw^췤ktߥKDwRVNTyBG^{K;=b|p{)OViՠ>%SSܗ2g ]5i8/?m-x)+ܓ ]]`.p9d 2@ d 2` K刅>ߘ>Խn{+.Fywk["fQTر7]<ϠA]AƇ=ƴ΢҇+h{"ԁ~-X{Rs+Z_s?4>ҿ}OԓO>}W|d}?wY[d׮x>l?.c1\s d 2@ d6_dN=[ܷ}uulp<z:X4swy {@,^ -ךVnVWc&O~L 7\{3K[JKuX\,.ľ:-[kb.us$ʏO>uC](qm[Uy:5jKY,a(*x)D2YT:.RG=j>(cOV?:%v}uq d 2@ dx]j_8\o2/H}Ắz c{=z۶mykb矹%KqK|;Ｍxu?裓9GswRw=x'8ƍ -$Q+_\~9gK~8V\)/]Go-]ԕ=|칕 ɋp\ d 2@ d  ^U* Uxt:> ~Ÿڵs뺸Ғ]>VhXٽξ^s73]a廡Cb=wo؇5rݻwS4Ν;EqOg'޳+/͛ިJ} YO#Ļ<]|ѸQψpN d 2@ d .pN2jobdo ݙg?˝u֙yܙ^ZCC^Jq;}ϯ?~0S/Nȧ]+^ʿsz|GvB}+_zu-0_JKoB1ɹܒ2@ d 2@@zI/\iRkJdRGݳ³;Z7T$^'T0彔K|7kLu[>^ ͕uZwCeGU~1Z _N &Y2@ d 2@?Oʴ/:9)Kɺ5wRg&O2xx#E!ڻ^qz)]Wz)}楴YK!?-K!z߾~]q1 d 2@ d C㷧y)|)UzB/u٥?q_֬Ykz}N?ZׯP|/\c]f?݈ñuV=xN<ӚP};'ߕzI5k}yx_⳼cz1hWb?yGUyߌǡ^*}83r>7 d 2@ d l 6*\X3Rym6'2$NȿD!bu{yEEbK ѣd_s8^*${&+5ƚ' ct[~YYZ1YS9<#sY̹'d 2@ d 2P i)95;UϤ27v SVT CΜy8ϡj׮M ^|䓿~4i?߯ݳnj)KRT(`w>u~}чnuraY'nZk;:v4Ѿ뺿EbxRj2wM|~eDc;唓͛S!^acbRK%G9 2@ d 2@V*/Cj8gfDKd￳rCU/%{l/e1M).sXC!>*|]ǧNϪE3cg~Z@޴i8,1x)Ps_ڗz{yGx|Uꈰz鶦M3gΔ:tD _w_J4^JxyNNS]/:㢼y M d 2@ uT;xTj)]LJ'SzwB۷5do|(8 &| * |% ))@BpeaDs'V='*dNPʦ6@Tult̳9>z{CpἫT*Y[tte¼S.k>_Oki{mx;vlO=ygZK%+WǷzL{h'ww{={vQ1/lpRWOSnKR+^*0R]8EoiQ|IkyTkk\4r vޕrK۾}[ֻs6ۭ9|u+R000000kZ#/zwS1=x`}=&sI1U1^J|9eFF>p}}||}}VqR }/e/%~R/Krf*v0f~ZɣieG}!``````@Ksz|3Rzq_>).EΝ9MEo#O9U)K:zRʋ9x=%sTʼŵIYߕ+_yKǢsjKRgx|TjN~a```````5Ƚڐb߶ݾ&TOwm>˫;thR䤎؟kt3g{y?F][RM)ˤ?9wX׮}v|='/kz|ƔSh{i{fO+D'j.``````^6tb/R1ٶWg^J< TKJNgtbKanE?MM}۵kz|6+5/ezNq0000000bֺ?ׯW}&mj|l&t)~I?{v"ju 7W/'Ӝ~uMK\;܍Z㥶M>ڽlpw=xb9 iv+ @pE&uTIT]ckjqg'7%jYy?7ϳ1UK*kn+,7rmeN{xq0OdkMػ(9$bZI+EooJV^ 4vF{s?[U./ksپ8xW0000000<0 S%~7Hn)=>V9l:ZM>*Ew8N.>ga``````Ecֻܑ&ϳ OX,]yjkܼE7eA?Picture 9"b ȗ6@7z  n ȗ6@7zPNG  IHDRsRGBIDATx^}HYWp^PȂBS ]a0U&oh%_h% Q0SD; lM/d5 i+ 40Aw617dЁR =X (L@aB~s,5Ws^:9oy&PY[o+~^8Pee@( :p'U@&S^ ԫjLVi_H@ T)_lC @(.&5@ @Z }Ukɓo@ @о˛ @ j%U%O!@ @*.oR @W< @KI  @Vh_Z @(.&5@ @Z }Ukɓo@ @о˛ @ j%U%O!@ @*.oR @W< @KI  @Vh_Z @(.&5@ @Z }Ukɓo@ @о˛ @ j%֛7o5 @(#KX)-X>xRyо*  @Z%о2Jj Chڅ_IJ^ /&/<@HMF#"}eTa @ @"$Ώd~.QG_hxܽ. ~"R~ }]t J@4sf}("Ay'rEPھ_=fH s^q"JK nh@0<S'Ml:m#%r!"dpc]i}<b"ǣ\!_2hiL`' ;DLO߅wS |1ܼ_r?y:'ss+r5_#ә5=x:X7nȷ@ >ꕒz37GB? ]kevSw!9ȯ"m'g!Kvћ<=pj9EeԲ@.P޸EH1/A}%H̋D@áum<> ZsߌK޹;|cxmo>cMNǞz/v|1_k"#Z7,lm_}l6> nZfWS\z>"ż)+/C$(nmi21!h$[ҋۣZF~v򃓚Şo&0xZ>4F{38yPVUg IlXȩ@ $U3; ILOpm_ }?wgv`l lhߗ漵Ch6 !i_s DCCCoߏ=yo#+!ܳphn׿>Dhߗ-Pe!l ٦t~F'abmkmOb5o@r?3.a }Mh@@`yE漲j(nK`R/|0rc$Nʵ+)-a^ *eH?jբoC2'֒T^"#Sv.D,홇oy&ǢH_ȅ@ [} ΅a!mP/j @ \:ӺAFՃiWzGɧZ~3{,bzwqs1}>!@"`oL>jrNΌuEկN; u4uO2eTU]k@"zFn__jNuлuWO:?Wս:^Lh_ŤMZ ! I0>9^u!W#TW'tERYm]M byuY;>X_! u.R4ջQuc4Wox<=73,B ` H!R4و9al:V\=D{.#tLݛCB0PCCu:UEw<áN*fU 5WP @r<ѐG|dү-iP2xm0!e̓_E\ :Xbc}S[U5rdN@9:U wpR$w݄u W @ hǗvj;. z0kmmGekьOF@ft~{i@iW3OC[]wl#F @:k[{,WJBهoPǵpqo"y %0p_ jyWҥ_ޙ/_+vEbݡFT ^3A^'Ŋ.GġŸlʷ*"9JIwJI!P ;[[ѯ:BC{K+e0 hdV[Cﺣ=]a5߼|Y{46 -^X')E& Bо ROP1@ &M5KS7[  @@zh_ @ @ w0U aI st}SbP/F2@܎+$.>!`o P jsb|h[KtIK`jΕ8d1baWo@ ڗ Q @Btn7ܿ].~[km9o*ż]}'B9!dA+ h T;O΅]<éյU]z;`rn~A+ x8bj'K!&UK @"PlVk-q^Hl}7SXnݒu /]?au6@I"LA L`#:JKMl#97xF=Zdr̮E45A>XX{R`щ@} = Cʘ@Mc?|EVGջk7>lav~AKM=0Yd%;PXо  dN`#lAb:?iO:ȯ##_\ׯ]ۗkr}ZW"1rzH0X-E# @m  @B? -~}_ދknG]qW>he~k%`~{NMؗqǥ˸h{/D_H@ sܶ93B@@ (kܶ\Ň n[哪 @@@&{ B)Btw-|o%nۓ赉˺.lzǃ4h^()|EWŁ0 x\:PF~:}\rolhB5z{x'Oa`m$BcGϗ 9̙ Th Bkw.\e4tf԰`ltNG?>xupé }\L͂*We/ FB/{t_wwvdj0yLyz+LOꦯ'傈KA "`.hyЍ̔sF`\n/Snnn^]]9]K;Ė_`{!2ag5zˊBȘW@@}'tQ;̛\ypƠЂñotWa]8Ű^}my@@%k B]:l.P֣wYdڒKl]_)]ZUoӾZ!׽kk6lu.]\_X(Yop۲oA PVm a!ܶD'mؾ @( `&@ @ $W~>8Y,N_%}:AK=<ʖQTj3 j b9f9}Vs, P5}Iï&0`7ECPB֜@t!Ώw%'GXBDYt7%!ppyoyyɯOZ}~y+,OIT%aDU"]@ &u⿮9>7?xtyMm^'v/c籘t3r_XG>_ƭS>=>inuú~x8{NwY Ϝ8XhGJ o{EbKC}{sI:%d`c l]/PZI%+Ds,edI)M#MzKD Tis>y:wuD.r2poVWWgNg 5s zolh4\o&a{Z&`;`F. ;z'nt}*kVPc㑻dлIɠ?/GḾaqHoVz_[[ELݟPTC$L6L꟎)16:XlQX2?'k76*O*uUTGB+NTXyk-j^,m$$`:LZzLܼnrO銳f X?/JD/C* @N?/i7|<~j҉G4+=zab,֗ZApiCᐰˢ7k,h +]뽘,\wgX'$}_ J =^\PZ 佝=ƒ%>SZ}XGRfv"ӓOB$O~pRJ3eONݼ7Y:ۮr$%m{Ӓ\ƁwHnEF>J7xv"*IlU(}a y" T#@-5?EΆńҚ4j.yTJ<ƧW_cRI9ݣPj k#\P&QrQP$ѻfUW`d/"@ʍ@1|sުЭDva  -v1.ߺګ7nh9=rͨW&CHKYCh#kC6+%nzK!G^@}UB)@@ ,/03%cnrIt"jO-t'=&FڝcPh u>Ő\:OuHv٣8wt?̐ *$Ծ޼yS' dGT{8>ћwm8dHd3)Şw\D&hmmKr㑖enrI^-8|pưo [n\:cȱ}E CzKbn]-s2wa>C)ܫz/D쉂 .ջ$:2~ѻ\ nf-Iӽ S ]JrY>I|^𥍋:`qX hXN'+Y^K yF.PmKr@}|#, K J 44{DN/-ΩXB. #EL>}kzzU>C]`FO;ҁ.=gt}?YߟYץ &NGo(-v˺+zgHcozmk+,|OS(1X; ǩY̢cda^  @\;^lpN8]% G}є!bnsVajd<Bk7;/_^C'[˜.#RSۍܮ\뽂|!6h_T@ ;'IڵshrΟk\|d`I~e#(ylޥ{eYqMͻ{R:Ns ݲ ǼlS6˸~z:8trڪ˾Y9/!lU @`/EwZ18,& A0iq3trEr#һ\Li[|6?-|m_>$d0)/љ)ckԖ cիPNVݦOU:8T~޸8+!1/[z41/ @Al̈́q,6:Ǟ}_ϝ&Kr>k{Zo7%l5шuLqٲcr=r,Z/#7G:.?ZXhN3iFJvÏo `m  @u?߮5xy0uTEֻ=Ի=R)Q"B }7y|7$/%&/j~T و \Z-/"GK >g@ QI,@ @G}$ @ #yԾ8@ @yԾ,N+ =;/c-Ǐtzbtxk˱o~gU2+9.8yDwK6L @C זgP/G. ; 9Ng . |;?rC za>lKN re޸ε~Brތ>y#).:I=t8 F'YOH$tA#Q%1 !8F]N=ʗOOzCXO$7F"?xy`[xl6{FwZpzkO^szfilhtz;7%{vqpzgvTaKTzwS'qniҊ~5&Vse|0=tuL6y#&w 6tmPx]2fJ@6 Qڲ}P]!$kNZ_7Veλkvx^9-nZ̭Ҏ6w.)0.Le#ysƿ3B5u#j~6r%rw*W7+Ș˸BCwǸ$]jԃl!tKnv1=X~G ڊv5#ٔobntq(1|Q P}mپ;;yܤ5,I$O1O9l3]oꡟ5^zeƐhiyΰ:!ſ:6hۆV촞hudvM#򛈛/VI+B\aV@ ÷Gn iEC 7kVgd2=XӃ8G>۲}% T0k]r"Y9UYiע)ps֬ ͶىW[Q9zu9/3˰㲹]Gz<r =@@}mZ]Vc fזؚ6ɬ'3fBᐳʄؾl cg7Kzhz9OЄu`^e zYBu…/JY-lS ?ۻv}iX9sڠ݈%`}iǔ6FT_ؽkVGSNfvX9=`[/fJe;zmItVvlLVi&\~jĬؾbddV2YM/Jf HĂӗֽ]|5Gt5oDo#n/)Br'G+i`eh什 3;>'_ۮ{ořuN567y0v&uz'"jW9hM< 뾻馤^OȯV,i\v՚S.:?2dќƔg۪Z#u\'{kʽ>ʝ@m0ӈK l?uc3YԖ0k<=,݅}8=X`K.(XW6{-LCY!ũ^T8}cX6hl{rk\I˫fiNA4K"Ow߻]e\.ѯet\]^uhe->:D̷݃& AE7oWӑFٯT&~B@k-\-Ԋ+_?%Fv@f ^xȱBFJbStr]! !!D۾I;%%Y8եm'^իjZ @@ Q*P#gC @^yԾwU @"G\,B#@ @yԾ5 @ !  @ h_fk1R HȀo[VH3d3ʊ;R –Eb A @(#yUFFT@ @&Ul@ T',wr @ W @ Pо5 @ Pl׾W{Nw;@ A8 @Owe_pK x#g@%%o' `@$}-<+IH@vF(@ /_m=~l?i5xu PS}vJJU /}6@'=C9woumq!j&@VͥO!l '#׮w|4=z{؇ÿW\j?);A 6+UT_ *Kڗc:N8N(XX{?i @ Ѓ0CI`ee9SqL}]߲zP[jo @ N+w@ @`h_3 @ /ss @  LʛU.*@,uKx]^"*$P«KզT4*dȑsb9Fcp?ȐcY^XyD@ @`h_Tl#HtwM?zo=~~'ta7bݗWlB'³9(֏~m(ũyw'ET'ۻ娶Q/^.eGz٧n_ú}青}z$K6|>>iIp}mpۡK\^ԯMޟtwԓ&x8^__oZMM6mо F`x~u1G ֘ю6|%tmdDߚ`u"PSkO["?+oۇ]{L5AקbΘbրpHIO|3&Gs?TDBھ: !3vfL@pH}t3ׯ :>?1RM"wN?c]~. }?,ԣ) v\ԳOgg#4М~4{c_>iHȽOb(ikeCc @vȯҤ^bmmEͪMqfjm=mݶ-4+K1vICG3ҢVa޳*W,ʆ˸c'Z##SMe`6zM⮽Zo#3fJr1OM`}#Yᛣcڈ9YU U5 '?h]}mf AjNl&f7 g\t:{Yފ36y"  Ge}bm[--#7GJKFR 31yzvE[c.2yPJJHφ\?zwC+X *9:C(Qk vCh^!"M׿j-pnvn~.0{ںm)Z1ToSYZpjkUT }][ybw'N.r{ӑ&꯳2f׏^쟚BMӽ"dzm)q-_'LӦžm(3pqX?˛8Y_[z<(>{ěnN^Z湧IɁ;Ԡ߶i[|8hfټ]ۗa-щLݟtGQ_jqL޹;ujܙntbXWݡ:n|o<?ؾ TD RHiZfM#{;Qߢ9O)ٸL_]]onnN549dwYyJr}wW>2zkԝAr5{KKg&n CPM?_kݽd* -kf֒e1v wUuUllYwAXU'LkVm$nh}ٞ&y'Kx,3kr?Тrךҋ%Uq-L7U/'Ohlzgv>js=6:9a7FF&J`]0m<6N+LᆼS.D/Gvge PڼYy4ss6 5̜,]$trYXW+}ׄH.mT2*5{w׏QŶ3,֧;/Bz5{By=khiR3\{tz&r+[6N$7+n'j[Ǿ݋T,S}cww&^>n %)vrymǞwp3Ee^QJBr}3YH:d޷Swr4|F@h;v֕ SRT-P;:N%FDj;%~mVm} ~L;;Lҧ`-y/a$/k_K3fgyUR\ˌf7-y6C/Z` 6 Ӄoũ/ZeCC׮(_7o=BP.DҗnM{|i7l5a7:/>}Yӛ^gB8?>ږV+`䓾g9c:y^WoשJ~.}A-:աb1oJwRJ[)kNFوݐ-͸ru_=촭[u,k`jX)6Y{ 5 3c}x'̔D>҇SGh;{N#?>_^]S[$ 1&1Ԛԃ9.K\zʑM@I(R2py.g@z ?}^JdPSkO`O;}MW ^~=l"틴p3vLRXyPg$:>hZuGvmݘЯ.K{¡+@<3WFilXӮ?z5$Isg{RY:6՞u[ƦV+V=LXj;ɃT'U|[(m˚X$^8C9TS2Qݱj`{i~7^?hHz0?6u}N;릕LÎ'=9I{4_(sYVᄵģ!޽ʬ? ͗h^Eu=w^vmrӷfYzrkKsW}bx)[a{TkKd:m Y=*6y"D4s4AۣMIm;ңj4 aT/2vܽwW-.ͪ-C' CɓN~myӸTYCeMEXF?7fÕe5kN{^ۗX^[n;2^)`Jbь=gi+!ݍSkyM~~X62rͬ7R,k._3cKYEK@I[fBU&cϷ afnu5akTmJF.H uLZج{>{)75_3\gJD!@tbpoAU$"7+/hyz?%͝1kjmJbtOJ~)&V m]宓euNJ3EQ^llo{J 9k{5vX'Şa11C+lYjje ӑZim˒|S3dV {XBhF"hF.?i 'JKTF _ejguꤎ9-\sK*Y]#ͺwLDBpܠә1![ w.4w mw^`e+%~iVoy$ώRVn?m3-O\)ymm{ꥶ] ͇19 Oݲ9WhvQ]:_ Ąh@/M 5O.bщY7O^׏׳[%#=%8"fE!yJ=< SJ*)38ZSе!KL\r'vؽ+zzB @:K"2 Mgے{U >D[=о MhJ}Z1xְ\[3katfjy/0v^Yr3ך&T튏Gnm;T^ Y"xR{׆6:zY/28Z4TJ>BN+\I4_U24ݣͯJgO܊*6,ltJi$q[e=Tv[1D^KL:5\]j@jޘRr7iV!YuɕGUQδT$HMݦrVVF՜DojomJȋ8Zux3Kfp5duyI"m$-@if;TڻrN6M|)W [BjB-e֫keĿ[{[t^ Dv~iȥe]ZW:^uM5;h[cߎ%;[w]Ի eת߷ZBʑdѕǍMRrGp$ܻKشh%Tq.黛wI6YRڙe̼mpU1CE[MF<5[8-(܊ jsM}L®lأ*؏aWm=gi 4Y3rRhk 7Νv/mXgyǞR iJR;QqaqaNyv 'hzW_F[dU3ӻ۬X^PD7mo$yܛa)-2jK. TmJӬUTo:TIɞO<}r:vsDǹ+~_M:ahǩMy-WO};Y^оʯj0JYIEM}*~| CUo3腕-M @*@~l_@ @8@s_[^}ejF"9@VI*Vf8IMP,H&]YVї*ץJ,&Q.UY/!"Wlۛ@5T*@ @ U ʤ@ @:@ @оA4 @ }Q @ W1( @ / @ b@*eҀ @ E @ P h_ŠL @о @AI @u @@1}2i@ @@@ @(bP& @ @h_@ @ U ʤ@ @:@ @оA4 @ }Q @ [o޼1#9@p@ @eG`rF2G{(U<@pR!,^V 4:rZJXI%!Of-%0f}0/ @> }-<+~8_͑ncS6B#[xM'I5[\ԻRrmy, z?+~7~*n9|3qM)wSzwe{]Ʀ$⑇m?{/8?ƭ7W=E/C7Fny4c]lֱOJK^=w1llzݖ ]mAg]5i(¸+ߛ_ݖ"w:rmlnKLrwEF1Ekȯ"ZQ^ϴѹ͏*-~~~$;2J&Fѿ_Fog66¼eυ,ie=jc3j:QsMAPwtg%?%i+[gV0ry>2Gz[e둋l pgX/d7Gv~R~d$uxxnV-_j ) }%}/N>ԧF= `X<W̓cESbS'5'O_3'W%lT`n~A>/H`k,=rww&7>l764\_;M6G/CCj49`|@7-'Z307pqg VYoO Goʧ\.CFuuuo׹]O?̈́X ~>yD]ǩGSDOOy>nȺ~ګl% eHǝʯf#0tT*I2 :ݣD.H䷽~-h>n[S]8´ z0i[~_M%m;fF57ߦiw苡3C7L^=*e[KN5:0z{ĴrYmM#/t/5ձQ}}*] ]3a~a~?/CU;}.(Ia෴YɽԾ 9=LTwfr~^_^>0(te8po?P܉knr䬣-fJv<[Yq:)Ĝ3r?%jCWibk^ v# M1P?nnuu~]DVԝbDqR~.bjMu82TI*׾V_FGo;TPI}Ц6w}Zrjy웱ދ_2vgLԉcz pcTN^5 ՛ԝ|{p}#I:)i8_6jvy{ZgtӄͅCa^6ſƂox`Fu2DD. rk(v:)B)9Db=H蝰F}Ԧ>Y,LvSq?+O;tL m֮BM~( d^RU؏1M| l~'L}qљ41ˎC|lYCkW_j$sKk_5y<'Z;](IFݜkMq(k :TEVL&-q5f XO~Ъ鍜5r_tJ.v$v֏ܼn%ta[MN7 iY濛VqMv"Ѱ+Nɼ3z'.2Oa?.})lr)\jEvMٹW+ROY/Fut8X{GΛW4nXYY)HSջV`&75΅l)j8fól1R33XlXʍ-Ȥ}p%~}ζ U-N8wǶ ƍ@׿H!Ɠ>ݴasiPޮ;URlt"YʾiT;Rrghf2uv ϒrO1~Zј>$\hlL~707ͷod s*ZB'UB~Ii]T|^#D[̔cnBVEmh{`z3 ?%Uu?+H)Qu) uS"vE$4|yúp6k"&k_I/>WUU.eW%S5_sp'Z&[ v?;`~ʟ3wnDpcP]PGKԵiL:>~Yeђ䜽33X5աشp]ƧKT 5'G=ŐW<.'oZ( Mܟ<)> }18x\>A|QV/3TP(L^忛s}^=l_vA46jЦ,:N=t ]=qu3oM!Ydְ8%G@VKl)a2b~Sg|EfWKIiA ]mA lIr^д mjji=Ԕo]EWs!0wkhuֵM|W^A9XBlɤpw-9JGݾ_'P,3[VP/|6y<5r+s)}==TK83E+]:,d0Wz?2|sxZʢh1jDEֈkz6쑛C9.//N.)٭򸋆>+5};?%:SKaKZ9|c~Vm KZ\(hwIzh"WU՝y<\}WENE5V?JAUZM-'KCd2ʆhR\y͝kՙI -uֻ9Ww-9mDF>k8ܨfӏXPzwX^+Y SlV+3mgi!-ͽ5kvmeoG!-" z-yqFTCΏ{n iYlsOԋ&CW_-~!&r{ӼV17].~e,[{V`^ֿ2_#Aǂ$3JN*iZ[[wZrrRZ4jIbzW}V}л93vŰE$ki'm..Jo-`onL+#ֶ-DzSKQ0rk4䔍Ԑ@JKɥhLCv>.{uT7`JOsl29ʶoݾ_j#7F?¦,_Kj&C)|1Ab$ט=*0;iSTkS糺jhB>0ؗ| =hNmɨpc?45\c̊%IShԤ毵3?NYLS*g5YK׶gӥq ' HFTgzN5 7X[KtzQL@/[÷G5sɡ A eC+ѵ^tGשpYT< }Z*kRlYhvi4FO#>qʬ+3uHXV'Gqѻf$z̟f>tMw},iwl<;ӕΰe?P~Ъ%v5/KY޳ݲKB;|ᕟVRUdsΓ"w:w>ѯǍxUTr,|.UB:-zeŲ xܪ}yRVЕY (ɕ!wRb,ŶݷW0bmO.lji[ƕ:ybRk3;ըGyN5m漭]o٫-xJҌ\aM[xҶܝasiX{fՁ/G4 5n dZ";MF;9@H{c*LN,pf 2KF/Khn̉}qQTQјOY_V>EeNfҠ> |Yb%>K[ۻHv$)I[yz/"hVZ;fs?z7ShfAnR\?ge$M,ߐ$Fz?^4rzMkZS,EVrvkO^ pr^q)2.Sil8V44rApw-uPcR^ܶD@ @  0B# @ 'PXk6lNhk]~..ޞv}z6DL^^C].j<:|Wڃ3[-(WI }ܛ~cD$]G/;H?D糙U%I|Do%?{:"F]v=tR׺sqyFo}ɶC6#>pq@ :B:a?VZ1ou({=3CV0^Q+Uo#:K~ٿ1nퟒ'S(?5u2HXF{{iOc~5kx /t2tsD 5gβoch;tɒg}Nj1 9n!yI#o/acQŞ.3ovfK^XP)3RA=.`k@RƕAӚ.]%Z;t_s.U G390!B ;fMj[GףaIpo͊zЭG]|t`{WLYfE֪Bg/ ͪb{b6i3-^:z~UK?l.QF^ *iu4ʚ058ocMIV3wÒRrwƲs\#km賢:-}N^Lm)=%^l,_:s eNsӆ'6}kj#2drMq普`t~KKJ_1覫wu)+n}oeO6 t`JkN)@تs涛c%BG:MZu D{aŶvP.*UVLl[J[xp(pss_坱Ӎ[ RwέjAw̝mΝ3vȶ*@_yQHO*֧;G V^9Mk/>#t5O#i7 )K*Ntcg|Y)fRy忯XB$o *~nUWm65=fjVt>.6/6/?:]^c9҆(RW2ZGgv«?kMIR'Jo+ /d~ LMdZl[e~~^g^sh^[y_KـͲSeYS96?w]g֢%w+G}p⵽,)m<;$wV 8eM("xIJx+؃I32Gh@DũeptVö́VI(s9jԯ"ۗ;c?WԼ"i߮y4܉nd!݉nUK%c׊Y hſ,Ώ{JZ{=MZ;?pyPٔBLL᯹^y+rvE<q&·6#nƢqVڿxfdڋnEe0 ]h;{7qy]d!цe\RƕA#{Lޯ_{We-;YNĚN~̞J޻Nw9+ <fL%L[RKkVHZWGr (kfצܾav#- [Z )Lr>l_= Uڃf9(s9jHaүb/;Gx6;9!y IRm۝͝J{o͹7Gҕ }'Ruɹư0pwوFo>wI"q?hGZ.!n.LjU^ZljOl$_'׭ie]a|Y<^3I6X~Xm,FS}+(홇Um?DhSލezҹ Yy*XɗfXm&xoѻSuGO~ЪJKQQf-@: O ێW>?uT'5By]l;AO2uCvdWiѾms5_Re0/GtHeJٴegѻʲJ WE뱯\Ҷ"~)Rfk"1UA הּVrW+n֩N`Lly6X]ؘlAnM[QZV2a--jH7oOd1着>3yByƒGyGDUIEL"@ Ia4kFQx @ PclF @Nھ}ejJNKtPxJIgb.R/n7i,{B[wVjN^) h_y!H F W O*‘c%S¤QL . )J~]blD@ @`h_T@ @ U ʤ@ @:@ @оA4 @ }Q @ W1( @ / @ bFy1<  ~ @ TiCdŒ4_웻l}# @ @J@ @(bP& @ @h_@ @ U ʤ@ @:@ @оA4 @ ͛)4i{1삷*.f)a$]ZStTP%S¤ 9JHIgJR)Uů~Y,ATǖ^,g$!p @@оG0@ @@!@ dI+Kp @ p @@оG0@ @@!@ dI+Kp @ l#M3J @*@P3 Wо @@X{X?xƲҾ6#׮2z @ @t6xf߬e}z?|49rsH} @ $:8P߅}3HN6} @ #X֘lkF?J Dv~Iw@ @HP}5pi`9FZ/=}o"&@ @I ^xŲQ^,e~׋`x\͘y9 p[l0_E лogeկK%Z論XD` :.W?7)wןGyq_n(:hƆUOYw0z'7QU҈J]uь)p_fZ7;;uٜ6w۸bP(9?} B]D"sgГ=jm=Z!A B:3`zR?N66jc؂~gN"Ʃ!o?...ʿFTS&>0ѵ+sߙO=zOj>4LA+/W{27`ְutߏ 9:BĽXlqѬc{cf S|bxݢ:v{T߉y9o ;c6TIuZo"oסk#׉=hs ;h&XCG>lm?)!5 1=XW )Yr{I~k[F:?<`2h.];Q~m ˯?mZnG h;|mHsuo7 ] RU MEYo+T]}EIIJ Vf_$clAQA#7Fz;V_KR<ԟW7btR߅>m蚙Q'K-li<ԘP&VVV낁;KWy( TБPuEWlDVeSSf@Y6z -~śetrbܶ;`4Sk ZM,Տ'K!~x1 vt؝KWJɽb7cVg݉YI]Jڲ1wh6]a{G^gZou=:ˢ8u"}оlQLY!T%4mjsto_VxFV| >l75J:j3f2d5kVblѯd/.ͬW d,Z]5K@kazfFA_eX)9_JCMeA^w@ѠNSҗ/[Kuޱ &r czqW$N>61(Ж `JW^R]V^YDcP/1k'hREl6C´덀ԖP%dy.һ >E?(~:9:hZ.'?h]\Y?$)ڗ W0cwd7K%_E  4k糵j೾Z^6bXdV+OǛoekUJ]:_88ilF`䬳p|br-ʯMNkHP,U'cUVC _16GSٴ:tGol~i:ER3Y_oQEtqhS1Y2|ˬ sx͕Z͍"oh.eiQ+K|[b[ھܕ]k*R췳 !,e,GÖw7H{3yxک32- H mj˚r?h2H+;]6zV5?(~Ŭ$ő[Q޹{>Q)}L׾Qfc6 *Pa#  e3ҪMP7?f&*Iδ2gֈ&%r~ }1hg]dd?fˇMk:oHW#&cw4$[#G0kU3րe$m7˿x잓`VHK-DeJRe 2Ə_bڿw=s >tFrO${mL U*C,#G;{d.\4|9aW 5tcH7܈& 7Kⲏv67;acP= ~/rpk浇mѠ,sc*Qn6EԆÍr~d&JwX U'm`RwY@eU3WOej۞,7fK?IGW}IaG=轻ꡆZnN_61.3 @'`pFZ- ^hYp8ql)ZwA%,:ʣg-_eOKF8PZң,P\Ǽǵi. ~fZٞpY3];Bᐍ$PsvViꯑ F N[)]P<"--R3!Kk~Yk*Jg1I%h9m3pZMvIV\oN8˓'ӳO \2GCKhIػӊ,lF;plb6!a9wlYQNܕR\ H(Cr;eA;ߡF4hڞXwc"vZ)ۣiR?M~e6 5hWAŘkuɄ6{/GVׯ" EOSdA 5esfêu9g~x͛79Ƥk1sdHp@(4~MrZ/Y\.Tʿ\`!' @ b@*&m҂ @W=9 @II ʏN0S9Ѹ'RVA_+W:˽fƐ=O7w mO/t=L%+\3%?ǓyLʵ~Ơ*&n޽'y@^աK:?6GJ耸ǓZܟ Z?;SȋlE"$1Jߚw{W@`z.n}S\2|kg4v&ȧmYrC{IleO ch9fN@Յ:!yMͬ%ՇU=eMN!@ cjSb 9g~;z~Ygջ" l.i<Us7օ6ݦ40??u]'㭾2#*]w{7=]{0tߴ)GQ])<׹ /~{Cڨ.#̻= bmpm;0p՜'ώ]:QwQAX?"mޒ{9a)kEo#v]leq.^6wuuѻuieN4._Al\'?LS%GL|7spƝ mDj :7U d|ڎBj/,xtꦻŤPl8x?ۼ+NIrPwQ1A: (A@5G5:Z]h1hZ~>X mtьT4ڔNs/E1Kg)' kj%7cĔWt ՓdX]&VSkFzJ~}|oni|0)IM]f5tN6__.ᵷ Kr.ʗ?˿9>K]*ais3E׈~ګz/yDbzá ]xxK0P3OJ`o% v'piͼ:ENIʉn7TVb4Mc(u7M >j-!DW$/f~e\2;ѪePS3Ec/k$޴ܛ,omXs'FG}/m󝺔xjw.G޿I}{x} Ptmjr_ө-³EE gb4_|V=j_d)Ϻ/J([T2ӯݓfKբH=m_jNwUGk#򘹶:%;DTwvra};@s+_Q5f󇹯N)};B@yRá)cߌiScv~.kԃ -Ķikz_\?Wyoha.WjiGnDZG>e Ғ6zYdvɝjԘiʅ+~>(Do&כQ$NB̡'O,ںN2Mۈ("g{QUMvr<8ھgN?('mcON@T~g"L  P5}e)J JX(%L dO IWgY0Y o @r">C @8  @ }儏 @H뀠@@&2EP,~O?5u @ ?.c|.{DXB:Y&=PjuC'O\2p/+W] JB$IJIlOlPcbc}Z)!m@h_USd6 ,,k>Ԯa@("@& @3~?6*⟚UҊ@ 䕀N6k,Kԇ,U\0\d @%/_ BA @G⊔ A @$bA(@ @͛3#D-Ǽ*V6,VåJ$-PŘ2r HN{/Ɩ&\ 6S=ۗo+ A 14،UtCEoOM@ʠ @ @ kh_Y#  @ }e  Pt2B @}]!0 D`j&ggESо|[I  B6PX/HD[>P ,/$ Tڙ3ɶS/JC4IJI`#88|ktp( X)˂!Tj*m @z`]z/ 7s" 0 "@*d %e@<|@Kr˖AnjjZvPU lV1H:#ԇ.< b%*@(/Fb?4e=S&r#sg\)&}GAJ@`0vHCGW-x @{@z@@uhE݉o"K'O>j[@(ұ'e@ @}USiW@@J']>G9^J—6)@ P,[_^K?5: @ @оA4 @ }Q @ W1( @ / @C?'Ur K/&͛stqr PPZ[!D-a҅NeYB)aҕQvE IdęE`'# @ }x @h_Sd @5/_A @Cb@ &x(@%@}2X h_I@:DbˑuddzU00Wtf9C*4jWV1@"Pw.X0:L~lO>Qr#!@}?5k9 LhasKKV,A|<3xuPX&טF8C>OM@NB@ގֻ>7>~JX!  P h_N PRuuu:y|i|b\oT *"UEMV!@ @*!| @W6Y T<lV"ԇ("韚U& @D?')$'OM@NB @(bP& @ @h_@ @ U ʤ@ @7oHAGg[y!8 T*~mY$ZKtI[D1e&>_-#t%L:#9}@mz/V @ ch#ԇ. 2矚A @@оFG@@ @@^!@ dM+kt @w w2!PPJ_)&}f  @SiϋEN G?{ Gb>8YUOʮi#H$y <@D %)_ّʌWB@?.5iz0X=Bb A(*@sP' /jj(`Udo }h  B C,7Nh@`#PT lV)D;ԇ.IR%&@(˯+ JغCu*B@Flx-CЖY h_eVur$pgGk՚iʑ'!@о  P 7h5[#@2U`{G_5A_~#"H[$V^Խ]W@cnt<\dQ<8a!@( P ڥ3N@Q ^EP7BA @ȌWf @ @ ;h_q# @ }e  @#7BAHdOqsH$6z{4ou\rE.;ȧjRXՋRI7#M3g\oׯ^0K%ȗ#{D Ik%wFhs;('FƯ,^KrV)2Wc # PtWOpC1}YHV rѻ\>|sx7Gmi7kC9=ݜ n#O"e'e+~%M1% rl#w+?+raϓ'rQ7~Yzd}+ii.vp@5ح/}67 aaqA mYrWl>3SZ??)گR!}uuUү ;EYE<=W&d{ZlwJ3-LQʔI7~{\Ƚj]}#l'o?("`|4D`%# #R`3%Sڳ?ʗ^OEkv*e٘P6]׿N֫8m(6 g_x@حիcqyx۸9}m}֏"ʿ7 ut2Kqvfzm"RZMfhm$N̯ tYe^̣$gfM=٨רs{5h_Ee ,Yc!V鿝]wG>i?O6 k/^?E5m[U~.'md$״jg1܃m-t;&QMPxIoV{ļS៺2>A-kwv;*=Y.nWgH;Z$'ҎP>U[)d-[ ;fmtrKA1+3,}3ysdk6V5jge˺h&ɃR&U,B<5W_x?eKk *F`}m]>fδhs%.c*bO>un$. ( $zsxoEGFԍd JQg!CԮ}4>FhhJŝzs$tt63VՕ՝yTj0;T'QwxrCzR|,1}9ݣ]{G3t$'2窍-'fg '-R1w SCE}s¬, cpv6Bd$_7dG1t]oh4 }ʿ]t ]5P4rg"^ oI;{$R^EF~Q  řN BOxȵ7ӎ$)hA4bƖ*]FtiH)*ǡCnjd8qo"nhь"% 7kۓf݃QrJM]iS>FHRven~vV,S~RZY~i>JgZ frA45f Ɠh_*$QZpr⴫@bmӬ{B|ׅ-6 5θy.]{kēã݉qaG=hc #)nςRޥ-/gu8*J掮lgv~ܞL[)7Vnza׈ 7́A!Pb?Į&.6PQ[j L>ֺo4 bh/L?ЪV?ںڝ~b۬UDlpmZlF9,uGAu,j3}yjӎxK7[}%۾vE;J6q;Яw]x|f5Vۼ9@xUOz4ΰ3w|4wD5;Rj~l~d'%"dmY@뒒Lc,rc|7ǚ4ra#^KS垒.6TsӜe8d0*~+C^\+|P4׫/ºl:譨Y 5odZ^1lڏkybZaIl?e%R 9S{IY. `a25,TDT&s%#Fb, J ?3Aa˧] cM)#1[JT{ʵ&˚RffKюbێX+OFoWvV7| h=M׌-ۗ׏ZOY]R.RݒUoangE*c9 ݱ41i+V*c:wZUmNϣѬzYAǎlUq]uojŒ۬7޾&#c7Mu#tEL$e\"d$kU gOJ9 r4ۚ{41)G'H<,=gg~w,qİǭH6;=;}"Iy&',yX3Vw3mvSs{d1S]BN;+c ,"/c mhc~"yҶ{L?sz4%/ړ߼kK+leRLf@`hkEڳ+RNƳrR*YkMД;8OYzJ*wy0n^l7b":* Aw,}9HW3:&=mY(RD9*pƵ#)arHeJV_W.bS()^a;B@jq8H ndM @*W, @E_4 @@@Ԓ%_ @}< @Th_Z  @/@ n(.\ } 羯} @JO6^z1 @m PѾ2MW-[|%?@gJ  8եa;B@jq8HY+!@ d@+Xx @ 5 @@о2W@ @Y@!@|M@"Zj%ckmmHSoj- @<8+)+\"IQIfWرÁ@|+F @ @L=:A|j_FU< @ t?%E)W2D]wQS1 @ QkJJE @y%Pͧ;d#r1 d;TB :@ @WH%RŨH}-ŗE @|I_[9suD6@ @bhpϙμi_u<}@Mm`yAZ@ @ 0xc]ph޴`0X[W;xyWBC8!@ {с˃C_ MJ$w|Q^8 @@|91zg/Uf?翛y4̾B @5"EW`#E%ҋҋe< @ȳrR*\)(M*yQ! @ 2%2$bC @(9@ @UA*LB @%'U"@@ ȳ BVs} @@TzłWt\о X @K@ @оA4 @ }Q @*@5ry͛79Mӑƥ9FR. ё4ʔL \ĦQRɽ0wr)լ,Zqd @2 ,B @ȚW@ @ h_+ @ }e @&C|-_ W咱5HSi` @ P\@Y.V)EiT2Ӿ/[S&b?IJM @ @ELЍ }yӾ5޽w7pbcFf @ dE`xGuoIQʛ ~vݣц Y F @ @E-ڢw/r>+}h9VYo3` @\Y.Ғ^,IK{n>/z'd @ Tz>F~ *\%IWʳu x @ }A @ 4@ @ȘW@ @ h_Y@# @@ȳʀ~"Vs}W;; @@yʳ@RWs}uEx@ @l}MQ!( @ Pоʺ @(h_eST @ j>!#PE\֛7ortqr0x_Bt$ 2%@/ӂ+`{pr0̝a!b\ A58VY$+b%  @ }e  @&5:B @ȀW @ @ kh_Y#  @ P_WUsd}Zk 55i:jB!@ʃ@Y]"eOVQ8̴WˡPhn~n\V @ @,//w햢4p5r<:yoҀ@ @YOݛl!o?;:#7Gb?IJ@ @*@m;ߗ7kn~va(s@`E#3 @"0951ni_mkWG_ e% @ P |^1fFEKWg.7PR|)H @ bȳiTd4sҋ%)Jml˛U z@ @K + @ P`h_L @h_T@ $P;T@QUs}U@&  @iTP\.h_P @ Pоʠ @h_Pd @(h_ePH@ T޼yc6thܳX0xpY_Bt$ 2%@/ӂ+`{pr0̈ap-[υU]J(D}Z" @@Na _Ws}Z1 @ / @ b@*eҀ @ E @L:23FʖWC IOwsըf8ckDSiꠟK @ H8CdI)J3gH$?{nc}YH@ @ u햢7+S<8wr0,f~H  @? _z]R]Cc޴Wɉ{23H@ @67Go]˛uc@M@닚 @@&tL8oEKˉĆ3kc/;T7|3uRbA @*t޿+\t*;7~о" @I"֫rA L @ȳ*\о*@ @ }A!!" @ Pо* @ Pоʠ @oy&l4i\zc$% ^ICL ˴El*%ܫ1 3bX4\EK(sq:~l amD0@  ;p5 ڗ&A @BRJ|@ @&A:@ @R}UJI@ t(H|H%c+eHԃ)$"A @%Pͧ;Tdihd{LZy2rshD"BE6@ @!p/z;xu0o@Mmݡ`M ^Z]q2I* @JO`#:k[ϛ~/~䉓 @ kWzC6 £Ge ,l" @ RܽswPˉپ`"'L"C @`W|EEs{_sߗJRG~.Qd @@EWZʛ ,@ @( }DD @ Pо* @ Pоʠ @ yCoy @C"OwRUҪG @@@& @@I }?C @UCjB @%%֛7or@=I %DG(S2-r GI'j Ì W(\h\2=Aۗo%A D,p5 WC @@:@ @(bP& @ @h_@ @ U ʤ@ P|:\2оV^4b?w5} @'PgSr$hIYl:Ҥ?ϧrPK1o l^)C77 @*ă:(r4(J7GsҾǗ5u/n1TX7?^$ @@ZݧGݕGʑT$)JfJJ 3@ @: lE$E)(c;H@ T J)I@ E Tsd}Zi 5~"Kӑ&'"A @@t?W+}g)TR,[WkeTLJ?+A @(,uHQrT ^/j_ ysxbü@ @N޻+EђsҾ7xޫ6 @QۗN*}%Cnھ\e9{@ @ 偛{9k_PCRw}_^? @1j>[r1*Ҧb)NRN @ _|9c*\"IQ j_% @ 825@ @ȊWV@ @ Ch_; @ }e@ @'PygrA:P @@ʮ \Uu\@ @~'B>@ @2}UF9 @ @zM2jܳX0xpY_Bt$ 2%@/ӂ+`{pr0̈ap-[υU]J(=lؾ|[-  @ '̰焯`\о V @ @@1}2i@ @@@ @(bP& @ БtO%P咁t)i^M? @(>j>[b啋T$)G" hIR9!vp&_1WϙC_ ;{ @ @L=:A%=Rs''+sFV py`Z/ɚLK/[\@ @E PyZ9#Q)(A*Ba @ $Êd@ @ W @ @Z@ P*t(j.ʨ @ @Pe\Uu\@ @~'B>@ @2}UF9 @ @о^B?+?P ($0GZ-\2^B#)̘)Lt }L t4؁ Z-1d29O! (LA}C=x~{v>g}@ W8R@ *Yj^^z1TӍcFR׫=eDGR*j6vHMb 3,F K1gɪ#}]@ @ X_9"( @ `}华!@ @+X @"ZSEr`}moojd,~FH % @.U3\u)H2a+V/}IWXkH|X_CtRsbM`@ @!0oge(? KjI^ADf>ilԙ{.@ @I|#JܽNoJoC @VϾ%CIv +#׏g}{/ܚ7.?^VN @|^ٮή'd5[ߗr]dGD^|fefx @fD7ܽ3 a}%|__.>Y{y\ @4CE0?3=КEssߚZ:3a0xXuouCUrՒ7@ %Qc"YW_oQMz|] Q?w~zO;! @@uO-uX_ydW @ @@ry3@ @ȋW^x  @@rFp@ *!٬z S @ T[/u\ @@" @@8`}) @ P^z1esˏcnjwiICJ ꫴ%!51 sbX2\%K(Wlb*v>X%6|_+d  @Xa?\U4"b@ @X_ @ R*eҀ @ @ @(RP& @ ЖtO$Pz5]\@{h○G% @JO+=S _8$ob\$[Ku75z} wllnd @D`7P5X 3ğ)j[EHdme.^jin ;@ @ {{enPҵhel%ek}yEvHdwogɡC猐 @BFHя&?z?}u޽٭;#  @@m0YY_Wzg]9Z_uDF^zxٸ @ Pyjyoʫ^d-YI#WF4=PdZk"2O7:YUK @j@ GU^qYIOuX_oJ@ @ryX " @ P E5R@ @ `}U|A@ ow0TK\/X_'d @ ·CA=Z @jWMT3 @NU@ @ UL!!@ *{@ @rŋcbl=ղt㘑jё4J+ZRS9 R yY#!|_yW+/B @ȁW @ @ oX_yE@ @9A!@ M+ot@ P)BEV3W|5&&92ݷjo  @hU/wE=^W/2YdM$P)[K1vEo+կc=hk;|ކ @ P͞{ %c%=^]^YFƏe}m=Hcc{ @ p<2ܽ#CXI'|D7{e}y/E?{if*oC @nD/]ZAv~Ŷڪ @/Zݡk5|bZ3mڋDkksK]  @H |;T <z1&}ſGr}?]b,.꾾>ܼ@ @ 4q2rB@ @(1'9@ @F `}hSl@ @J @JD |{\z*p= @@oo2,p\/X_& @ @ @JA4 @ ŋcRвDZcFR׻δUuˈ!PhUZqՒm쐚gXbP;ΒUu !@*:Z\- WJ= @a'ʬZʔIr@ Wj@ @I2\A @a#< @@-P2P|5l.׼n*j @@*W/2dyVҩVd%ek})3]m;ryh*j @ 79Jd4t9'H]dGDvv_nlli.@ @I wxfQ]3үl/ͽH _a7t҅j2 @ Dz?@!kք|jޝ8 @ %`)SL}YӟNڋDΧwF~8:y;s5C TZ[B c6W/D/GcPt+~[z*j @@zՋL$GG,CYI9 GS @ @%'Ur$@ $v @ Wɑ  @@Iow`#"*"\ @(#PFLb QA @Ge@ @JA4 @ `}! @JAI @jyw>Z^x=![O?8f$e|_Ft$ *%@Ҋl#`p/0<>b@jq:HWʋ @r ,B @țWx @@rEP@ @y/B T4mPr`}moojyElX  @hU/wE=^W/2dyVRlYg4_Z_:^E&wol`죱m@ @J`7P2V98z}XWO֟G" _$R_iii^@ `!s|Q#TdՑGB9f @jWm? @JETI @mX_] @ G]r`}C) @@*.Ybh @@ + @@ `}r) @ PA sX)ǬtiX\CZ=BPT!xs|ك#Tdաr]Æ+jE@ &qEV3WURO!@@ 02k2e\A @a#< @@ez!W @@`}F) @#P˻;T r`}MfT~Ukh_*j @@*CV/K^:mqG^R*|9qklĭ7>o%W-y @ P<.^fQu2e}5h|pYuWVV[+VWb @ P\}w7f#H2V2[IFx-z2ً4Dv";JFA @ @Oڦ~7%CI^/G2d(;pӉsoSDݯwnlķ7;;;X @ P&~31ͱWdDzGK:kё+##WG*Y @]^%ze)ydu!hʠ3e}ɡtc=t]A ,z YX3dl%e+4MA @ WY( @ Psj)0 @ PX_eN @@* @FloZ- WhĘ@ $zZЈ1 @*WEW @BC+4UIA @ &UC @&P˻; /rŋc"n=ղt㘑jё4J+ZRS9 R yY#!|_yW+/B @ȁW @ @ oX_yE@ @9A!@ M+ot@ P)BEV3W5h~ľ2Zm, T ޗj(ѐʟWZOPZg%E[dj'S͟{\!wڼ@ @ $5>~sKf:;hZ_-'Z\hinQ\M/7|xC’b@ @8W ouG"h wDm}:<ѵ͊o'SpT @ hIgF6}^l9 ;s)ݽӤ @"}1&nMj9ivy񵕕/ϾqVoF}! @K-*jBV/S4%P3]m%ړ~u_5J @ BS!HdWzrPeeFh*@ @( `'Q@ @`}\S`@ @,ʂD!@N d;Wz* @@i lw+bj\/X_E, @ B @ W)( @ /d @@)ŋcMKǎI_:V/#:@WiUKCj 8cİdJPNůU}J(D}UX1@ c`Xr- WĊ!@ `}! @JAI @2@ N!Rr`}U}@ ,\/9X_Sj=ժ_ʟWt:ڪJZ@ @xemq}6mNܚ?7qk,M[_/^I @@%A4񘌣w{DzO4>x@uvO}]}4d  @@,|No$v:x,뫾aEOFD~75reDF^JB @*@OڌetutN4{"ꯩ[S2dU2 @ PjyoJo&>9&UXWʣ]Z5`ȕ3\  @f z\!^& v?%'ӍཞTrՒ7@ @#`M$P *^v @@-vZ`A!@ W3 @ }X_H @@8 loTR- WhĘ@ $zZЈ1 @*WEW @BC+4UIA @ &ҋ/S-nj!@ @ii90WbX/6 Y9#9! {A-o9E@=>+X_t+]Oï -Yu*JT  @5M`ye-F@!jX_GWoXh[k'~3|;/_g?ҋg*CӿNď!_y7}0䈩7MJbAF @(:_Vb.՞wf>_^[s!Zv}ϐtH$>2!ГXK) \a2R1('ߚuEaiŅJI@'u4x<^_E"u uSL~4|ywww?'_]rܛb[7>}k^^YNO˥{U3&CkBȕ {%YA,kYKJuZ!j4,46v(EhCCE&z0Lwat>ޡ!l+>fScpnR_Qֹ5M5MzӋ.s0S܋fPJbfFqdq) gJs8 u8$3*CkΟv6hv~6g?=ښ\- ީ<0)ngJ޼ ^ 1C\q ŠAB`}]ob{;=ן?i>Zz$;%ԙx՟~4y{rumU,|Fq?)O'`yЊŞ— ׫*3Y0CqTzA PAd]97tyhъZZ7c7?J#j5Loy0S:RkrSX}ǜNE4{*zhzƆSPi<=W:,"WFRq.Kml= A9Tí *Ɋ8^q}TN*4"cZ:Ҍ'tyf?vSN$x~$_u}>Aw\omm>x2Ye:pJ`'?NfLa:bDK,)5t^zF=wco>()+)Z jzŤh.gI*o.JiB(iCk~lwɘCWL_h]B Wr$$o;w!xQps=I$Ǔ[|/~`59\nj@ǞܟfGgiO3.؞H0|v"(er(BIï.Yuuw383IDATuk'[ߗƥ&nݟ5ak\jiVVV4VrrX3 7TfGd[筞`5vkr4՛w17LrZPРl:4zKfq#Ѝ'+*ǮE_1#:ynN][=Ɵ---ȎƆC&5dըf+:遝1Jiʡ<C)I)=7kKP;ö{K.W~<%]ԠQX%{0 +L1;{fGLRTKBT2'lx|G1'93wr*+ 6=;#mo̭ gov{[,V`r^)$D"i_3no>l/}<\֯h&CwJa r뉆fBIu7\+lWߌq%+KNѻK+E3"ҷA֏>*UNmj`忹[5gGnd'0sLuׂv&hƵ7FS]gO?K2Eܺ,)ӄ?f{3|PT{Wۂq-ڥ%=_ 4d3VC݄m+ _~F95,~?wQߔVEdC6Cj|mK&w!*E\zڏ&~>um|1|JR 泫1?L;V?:8|H5+ `ߚ$ƒ1IIhFʕ ҅"6Fvڢj^6AR֗4bɭ&f2 SݸQ[ot9o0ݛSu5]h?>/ Җ.mSvYzz)yWRvd2Anj6?t7qs2ߦ:`տџTܻna\+ ׵_f]q y?p+zSV{wfvnrof[2(td(&+i1-x!c 4:pӉ&}&569H^ )hpöӃ >x@*FZJ0}N5g J_놃n {q._-[nf3=toš7{HZ(r#h/;_D|M-nO+۷"2g쓑K;R n2!e{=7ZѶzױjo~3}E<~a|toϿܶfҁd.ʤ裦JKUZ)r8T3S !,#7НBS6<(}L5ϼ%!. wnέmo&oLb3@߿iM'?l qtjdR']@,wcmi szNrg|%[KӬG+}4N3e2{مr2}ÿ}5Fu6.lwk桿¡Zm>iv7 ƶP雏tZ7ҵ1_MYI {OpCݧ,Q@q@bUM<`TwXvJJ[⑾JOoqfuuɽTD17kŨG7#ܾiqko% <~8ʴ.tk;100֤z3j~ӛuiJf!7@`p_;cZ%\k@ {3.NG&kvuߦ=U{WkބկW3-3[?ѾVD/}yb:jT=9gr۩r^>]\6;\LevBsMWz }kFv֡ݫK-4~t/݇G!_d8zcn^@^r~F1HRo,e5E7 Y3ź Q=n1tULr 0V3'e <nM %ju?:fW֯blWNZI)J?fW`9stj-ݛdxfZw\g΂JR:WM)\']˹R6)qz؛JҪUw &d :e!Cf-t\vix-މ,ZeWO$Y#UQ%݌ĔK`X-?ҊinĖTd{B YlUZՋ5a[ cf,=Kª#Wcu[v4]̓(*ʢ.2Ʉߦt[12r*xV2#bZ",Dzt;bNU˱QM!^rҝh&t%&d a\rG+kӽNgA&/c KqrϽҽun80tS|_m]8 !9oM}D"mPQI.=)Au.W]on%_n漿9g IXkhQsm 'uXQ3&Ӿ|fkOׁ63T'e>qsB:;N)=nަ6niX̖aX˛z]cj/2+FUp_!RN۟ +%&0ڋ@Ԧ ZrtLJ T, 󵊯al xUz)X45[E'絖):r2[[^r)_ԥ<%`unDwI9yfP.nV "qӼA)p {OdžUν&/GP};J,aM-1ipiҶ<\1F{{ OS: py+xe/7U3:ѥh8#%&.`mz% ^%Nr(6уvߚ_q"ɧ(Fh<^fo?hUaWL?y;K@[V-eh)ƻN6~Y۟U-gHȣ9pFTr&6tl qsjerZ\F JRv?o.Wdr]tDuR:Ӊdzn~6hRw-72~Lme(wIMQ1 {-p QeZvYc N 8`$pB jZ8.).,4=q[40kn]Y+ZhYiG׫I%&]>fWj1!@3dK#zepX *'ǒ%T9lb*v~Hq$w!@@ *S,B,l<\/٣U';, ,raA%#PR)YZU>x\!R%6 dIdՑGBX_Ui}e#v c\|%ȹ&۸屾rZ4@>UG 10z$$ @(.9׫e% WY!@Ccp`}N]SR@i\y(X_K @@k茓r5 c}-?Nh'uvj._ .`G},<,%!2Vεg\ը| bW髉!@ Z$UN!@YL~c{'mzOaJ+ W pxmU…s~E"{ǫ.O||CmܝфզM ߵ5/>^ӓO;#pխk營 @ X_9"( D mlWk">'_g.0hOX]Ǧ*L^泍wzeڍ\51w1W-qX`͉76 owf?+q^ @+X 6wI2uf-}fwɨy^-yξkO~*yyfuş翘GkuL\xLK&c7F~5٦zuK[ZYmNu&Dĸ:qklSot/|e-~F )])ѫ#ғv}5\X_y%@ȅ@Q/6pGCG.ܷmL&=V F,o>ۼэ&yN#zb>Z>Y9H~ex?xwVS_sQt~YgWJ='(i3d*'/z4rYydꪺ1w13Opk/x4{ׂ/ 鿥L44 F?deFC3z_V K09Ĭ7U(ݯw˹4K֚ @I҉DˍQDzيIe鯗.ecXCCÀ}+m7x3\D}#dc c^EAٮ#uDIoPł2d>Enb`%_'uMC.;o1и{ſoJZޖ ܏G3?]\RZ l*U鹖ϕTJP) -RL)BFĞj\E `~B*(s1NV_;$Z_Rt`!?@^\np@ܯP?I)E @/hjS?-9:;5դˍ;g7 Dݛ`،6kr-}x~Y45ōKlm;ȨReͰ܊ ~.O]p޼ ko d bPL_>=fPmtö cOB3޶ ΐ`ъi5XPHy9CϠ`z״DF~=DwL'ZV亀dB(>=@---S'+6B-LiЭLWSc/!W 5nt~4Z$'1qCu1=NtjH'FDҮ0.]tҽ'bG)J$.DN<ȭgq7b8}7 yqt,sYk_韦o' vFۤmޜwmq 4d_YiڣjtvWʡZm/qxt(Tw-H|W;-e*ݑ#ZV1EbK쫪@!S*%MU'T&o!]AF0ANL{ t2'1 hսu:aOw=+N^̔][ʕ5Jh]#2*7!B^h?@hrGlJA|4?M2b(%դn YߔL)FmWbdeI |`ZD<^yj`M'6JPG 7H߿iWeOab)7z7Rנ'_K#wC01+!PtZ']lc7{ͶkR[6+sve9 /~i;d)/GbHM7nsfri87"m'މsC ]|\+ΕCٶ>%Wܚ?%5!M2BLl*f,OZ"L=s &7$m\i70k7Re~U{~p25JQ5# pyP1˃'A9mK_I+3~dtʰ]x`%K-?Z;/pq_NR>@so~jc/[R(UrGcznWvl~~т4NO]Ϧ5 diTҽq/7t3[iSqZP6RB}ok5z/r{%'KUAbL.?ib`u/hMv ?z|r@҉xngϤRD/w:Ωz5vۯ[]Γreƃ"ϽyŢLUO,D-M?NZL*[5bh5. g^#'ۖ;.sI~8FW[{{f2ޮ^DZ@ζ|ݏ^4C&r[[d\1Eƒzoj*6o-A-(ۓ$_ UWMeCX=)L.BPAKkS 8-s^7+GlL\3kt~9-%Xqc`;ЖrH=;5ԛR^::"H4uB9o-OSҘெ]@(!p c23er?ok:fỳ_mr! ;”70}-Uv0I" ΌzYqJt)e@"iL5ݻє cUTdhg3jw>)ڗkJit7+ "2ym9)tSՖt鞴GJH)Q7کZn<[,IU\=MWnF@ pz9n 4L85-M12ȭE-u3{o5fҸ4-ScSC2C&63E,u "{fɁ-(Z/}gX~ohWJѶ+ReVsR)xp2O!{3nRUxnt|W'-tEzk^dwHwntlmh]'L,mZH5^O~zg귉Qbփ ԴeEM|tuveqt&(獧Z4 04H&G˚5T#E T;Zx|^nl>=ҽv̗,Ѥv+2Ϥ޺dkZO8Tʀ+9Ѫt'h|E( {IM,m]eMhTQcj߹Wv|+uBcz4OW'lW0?[Wܠڸ.%u@f{߽; X1m65vXjyh7eGe6k%kv> }ؓ&UHx-vɐuH4]~Z!;&VɊAR16 A*-Z%ԂoumYsF\eFvXJŶ=JS&&J̐m 6isS^OOFߚV{=񑪿d&Ox]E^CGF[J)єP|eEMte[%C o}i=&Z{諣2^U"1kvDܐ?צ\`ZoH>xz2`"|MhPe[oX"-=^N{iP9 VڹNa0[-^T_D8w{K߅ )$jf,'w*N95%%2oY&Rsw/-qVטvqEF"BV$p} ^;/_o/}{du^Y4ռOk @6'łD.A>~kk ii@[[7M]/|~jۉV`6IohiVEpmwP nVԦh0thrC.^)V m?W~@)E2*Z Zl&:*9Q6{=qdm~;'>Rݏ\5WB\oN.whz@ąTE!^xߛ[ZKT_ Ymt$A #i^UHA OG[?N塪&Fk_ G y框+g\ @ HMZT}M/7Mޞ׫rĿ7 X4UM2MD_J{Z&K!@&咜]f〽HScZZyɋ.X_U_ T+޷{[-N|Q%LG|C GX_9#8 @@^nEkXffgOyK>X_Wg PmCsHUR %UC @UMH6T5*40w';WUg}bzE0.o\tWOQk]+yH @Z rg^k+Immޘ~^s=1{ Eݞh߃@Zj&Eyŋ,&iu@'9$Sx .`G},_L`RZd a/XI0q.R < U(U UpyXa/$%A 4dO,c$A2V_*#CƘy=^BB @ȟWx @@gEH@ @ʟoB @ȞW @@=۠<T_ 9 T$ŀ TC53ūg[ZOG[Wşu'zC]o׳kY06SZr)2e!`ZΩo[|( @@ _.?]_xb:{;z_=oLnjwt2/E/ba+gn/ .{aҟ  @E'W*--HC]IZov؈ǝk J|y1,zIdl}ſk|Bc>@ dE.r.M2<^򌭬t۬ٹW{ 6hTȬ2@ @NQ֗mb|bkwkw@ @a%ypY 5pgudcY=:5ukjRggg$ ߗ/-SȰ2\U@ k(g'mi|F/wi*A!@(-6+-V=W,k^W4ŞWG5*l GBtL '(gKݹsoK=ohY$@RoETN!ɨSȮ2(zuPmj5!;}?Twʧ!cC+Jib}ſ|>:s(ⱏν}nC|ĭ1':a=S_(3c`>_;ywfjߍې^-zWYҽ1Iuqv+CPȶ3cfl5T1[]ӷthS_+*S[Wro5i{545ꁟ iElji뱩]G4 ?Ğgl3׻m _}p&/m67G|܆z̵}w@kFL7=9L0+Wm]?Ļ--WGѫc^dyO^»x\l)>>|eX=9]97ۦfUk_!$ SkW:_슭%.E2+ѻ$ c[jҁw]^N3Ep/S{kK߶U<*z2:`?vXXbUW)ϊMkiT}T,ӊNxJE[Rڋ;{)2KZզ8.Ԗ%_-J>O˕.=Y/Evww~>+n?܏`B;_]+f\گމcJ-KyJ[xSNͮlȩ[4H R6ZB(%Ԁ&|iot鹆~-JH߿k윸yC%hu֤"ы[?9~ovK=o*=IyIwjg:B&oۄ:;ξ޵0]ƺ3}ktn3)C6JV$#0 }j4d`۶k`RWBip{w4+K-#jkH} Ww GZ]4ŝ辆?>g:j@Ԥ IK8M6y*ks4*4t^>mݕRXbu*Hy6H@{F͐U@G4U)O?@3U9:Y4L.7JVKߖ{z{ÿ쯷^1}]>VV)&$~Yc=F_i A*.w1]׻ğ6ov9W}"k@yJwTkj'fwӆ 寉f+Vp`C'@᭯zuPܡG v}LO]H}iV)hPA{kS5Χw&>1c*>_o<%=X]@֎:C)fJZb)Zװm/=\נt kʻ,=jF|6͉)pԖÎ39>twm37~73J8E.hzTqU';bߓpwR\ƜYrQ#[93:4wo{WQ-']Υ4| S/QJa]vx8E Ruz k|u ͚R?4TSWhTxy#kV\4v$R}7YE-,vPw#u #/w9b,`:"fjTpOSeRqy(dh 6SN %NWi:w7U)LQTO[CPtf$WexŋI)9X;C!#eL:dHqBO*.o'x?M: :2I@ @AX_5X @(2@'I@ @ `}`Sd@ @ $!@ $UN!@ 2(̎e8IB @(+\w/keED@֗lwzg @ ٞ{"kY;X_ζ~;30bD @ {;K o}ɶӴáC]c!@ *Gzݸ~#R`gzݓW|XrF!@ g>\‘s_z1jYqHx%22&ʪP!&@c qVBJP$ywξ"eh!@ WA @BRj|@ @&t @@  @@ `}~) @ P)*& @ nX__J@ T œ8V)"@%:V.PƤ+ &@c9!A;<^t9WN @ @ OX_y5@ @9 !@ I+Op@ @ 'X_9"0 @ < `} @ D g+M5ztuhN @@{-gkvd/j_};B֗b? sRmR @?z5wotC=Osy @jYcseډyqnnmoo&eJ @ @@z/xQ`'{;3h.~ q@ @I`gw{m㱱 l}5h6.^y)d @[Nݷ]|K/^8&S-Op3 ^@C"5KRU_#`L*e!xaY F @W  @Wu @W  @Wu @W  @Wu @W  @@aN[K@ @#t# c}-?*!T3m躪52 @?3@j}1*@ @$zT @@!? @@8 `}^) @ Pi*F @ NX_WJ@ TX_[[ [}oln ^X^1tåΎ3z_o<`鿮{%1^w )ţDiz s 缷)rw`RLe=cp "P _NFӿ BW~BzPZ"|kKQ.'isNc+4Xb5~s,JkHQtq_Myj*1']{%(ŨuRZjݮ* 㔕ڑI; 1-) TbP{mY\MV)*] 9+o.UU|BkPG#{&N9-d?I&锂ó@ )‰gJif~kܽm-"^V]˪U5=]U&<#OikѮ2 vH@QϦvژL}2wȕFsUݷl_:"vNVʪ 3sϳy&o+GKsg:1.q]<ӓݽpOʉJ},+7>N,n2i/H^DQ=q )cS&10սS!8nt5BKm9uUw*4LERK򵜧s-Em襇KR_^Z)5ǣeh%濘zn̳[wNXDؙ=GxuZ[[-;mVjY<%eTEQIH}O >jlsi:-̲uxrnTn=@ɤhYCo]\<Šsi[cr8EqOyW-qRmҦ .SoN2Cp=tAfTA( 5%l9--oErYut'h!\Pt 5gCeRݮ 9-@:7[2E6zEUfکڎCZ<[[ J{'=納--Ӱ h*97sL쮽ݜZO*ԃ]'F=x:S4Ddt4{IO3)Jp-\%<)^C47I4e&%ʆEɤ}̽Eי:IKDԐ{=Q(k5)Sr71c'D.?;B^rWe% Px+}Fheٮ)a1TɎzactw >Ӓ;8$]af|n-dDoTpo &gT'5% s2;O`F+:9p1{=ԨF:a3gԛ`1S2 = ﲪ2nY&lfGp}9W 9s}T\YdzWV5 ޛiQs $ Pp)z-2 3hkiެkDԧVn3 9u'j5C,2TMڙ5^IFG{4kJQfӾ+]*'ʃ] hBiM4q Pv K9 ).MRrt_g$^)LDiDq0vTSii8OC5E EQ,~9j_1-ԬscWG>44W+uQ bzR2N$Ql34Ds߷2vBllڂj),"PxK)fr#}G x\&}}jTO\^\M/7v`*y4-UFqrЂM x\߂Oú6"cFKW5&HbنѠ-nV ^\M8FW?{4 %f"SNsf~?,WMg AEПf8ot9 ݯ{\xBZF:~VU:-SymNurn66>Yj$TtR8cuWUbnwԦL}[b~7SҽըI\#qZu--Z\pQ8O4HN~ItI%~V6fISz*֠Uv?A.i iis1*2i%i_뺒"rhrR]$I}TSRh(EXI+@PQH'U}դ[KRw~C]zV;|wSVJ(*)`#Mw F Qs 9v  6F jEU@) ŋczE>cF*F*EP. P_&3E}e0a @ n @ WГ0 @ PSj), @ P6X_eCO @@Mꦰ @@`} = C @5E0}2 @ @@r=0WRUNGU]a4IF JD@ W8RA @Fj@ @$zT @@!? @@8 i}Mft5M,T( @ Ŀjԑ/,, @ åH]dؑem6N#  @ 7vOa/k3vouq&X( @ p8Dؓ^dR/vzIɇ# @ P-u[_ֶ/|$>xeɇ*f @~>;/ҋ/ɬTӍcF*+AeO(#<~>XB @ P6 @ Pe. @ P6 @ Pe. @ P6 @ Pe. @ P6 @ Pe sXBȑ@י6t]Z!~H&t#'*rE`@ @yA @ȉWN @ @ OX_y5@ @9 !@ I+Op@ @ 'X_ZOG[{)1C @71gF[g^|H]d㱅?VbabGY @ dO`ѫE"u.R @ Pv";}\99y-'Zj1ņ @ {~瑗5B!} @jzE_v7ahQT@ @r6oK^Zr @j@NQWNj\[ݵIRC @>2|ݭmf"r @@ >jI[d/2^z׫5C @5M '(gD9q⥞{zi @a9G/x☬ӍcF*+AeO(#<~ξ2!@ T/;r@ Tj- @ T/;r@ Tj- @ T/;r@ Tj- @ T/;r@ Tœ\M%& @ A`FNZ~2ծ3mf1˘Clss;R777fdPXCd#K0d(_axRk9q̒!($WyFVWr̄a7+Eͥwdz^il,e+edXo!V_q"ZFYb^d6pmJ %R| bOX_Wf!|`8^(9}dɰ\9׆S!m0KŲvaN=kі+D1S}[S l}-_:18.ܟk%ԷQG2w*C H*¸sO}vc.]4W ajaž sr>Ł.55j,.ۓ0_ ]O,#156d Ž[>`ʎ!J)W\yb}eƙp_[C1} ^j>ha)f5 Ceׁ h>1N-x,H$# g::-niˆ71rZvP3kDZHe}[.I`fr/;G  j}}4y{]6}{JϾѵCIgזW N.~qm׍HC3"_; !}s>sGc3wg(5@;sW'?jlמoܥjv@;0 ;?VڪD{UJv{t sf5dWMUWw;2-B_VNqӆq_ GWб[m|?H:dVq`$}xp+,j ƾ󘎊m֍ \!PHKvki֖&"<^>VBc*X_"-$V.TghN[;*1L2lЀ~6@#lCdjHaQ;AH3#\N aʧ}=vR@˽Գ՞+c747mђ&"j=UЕM5hd̗8Ѹt 1&V9tĨnpZD%e'v|oەK6~pf&ل2KGe򲫏H2@ibj@:*C% Z–9֗7Uv<8qԖ‚MlnIdҡ"yk)w b=9g20s WۗM4d:dK~-34 F]v_'\r/$YiPc?'ʩ7)ƒr@ o>X+g񪞻R\-Rޮ\J8t\ yLz3Mg1<.+8h=@K̍;޾X!jD̋{eo揙H[΂Bf Y(e ,jq%F;ޝ9:vs\ òRd2&vbX_^vTn#dj .%ǖ[}b$dp9`.ӆĕj~K}e!Ga" XG]4?0'4jÅ!Q(jQ f}=]ɖ+ gӣtuvw]Ԓ$En I}.If>0xVc0]9\V|%2g*KEu  َb72U#َ5fWbH})a㸉9VHk(C yA2aZ4v;x+J9.Y_;~t%[~Բ{>o玛\7}/3$w:f"e]EJg"aِնM.l6HIgئsH^YPse$d2OzbsPsYlnhݴ eiCNw_Am0890!b7)G p,(cWс:mO <Ө}JM/ioO^l?Δnї%8٬R,q:,/bˍLRNK4n=iԖ^$/g9l_0m0U3pNl•}pUyb*n+ u!}YUGa,,2TjD#M||͌'Y MpDQ &Ag[>wc]pl5B) Q 0F%XB|_G׎ +iä%u'w mDsɶjƯlCi-0BXueQb?U H5~Aݨ>5&pe`֗g"]vÑ#W~mv٣6ƮO/eq/n~'35gf:TO)Uem[ҽs ^2 f$?yy)NY*/f]ebV g] DM/ `02oy"4Nط93CaXtƭ/ +̞g+%" CwdGdzPo+@A2a81YsVme-Г|D@ݦ@Rq닁 < W!KXi\fߗI~c$o:M5K %lNѥÂ"2`߆QT̙vEx3E3@[_@Q3{I0"n\Xu/K k dD22tm=pR%-/6Z` ' pjz4@pZ*+A[_V^=}Vzϡ}Z\n-=79gޛ,C {p.sig9uUK0^ 3]Cg88A%JE;Ґ-sOlz X^;f ,E~+15֬/ȇ@q W1*/S*!`ɢb,ځM5I1 aKSCAQxfcbX7{x!|wM/Lv)$ _'ѩۤ'gb;"fW|_"ޗ1H}<5[,:7ZYK-6i|$8_D00e2̼.[X^/c$ d/]ه32`#熡.2Mgr2ڗ8[)ku޵݋[h7A +<{m#y׎C'aŠ%n++RosEʊ j<ѬC޶iۛGT!ߠK>ʘ^Q@>r:y!  >{$iˍI'݅ ~ʡz;fkb;{U#ywx#Pc;A3{+c5|?Cߖ}˻[k| 9=Jmo09$i!H́OSͳi"fŴ|1x H[_O LK 3{̃0;S+^0NJ`by׮Ր]8ylv} pN_s0oi Ȧ9w>22޸.F* 4<arxa,yk(ʽi(șf`)};{Љ'72ȞT0pCM#yS:/Zt۵kqsɋCГBf8Z`Dϡͤ(+Lr늝ݥl? 4e 9OZF͛@[_ A cri2 /ɬf=!7f?,k+q9fK= n(xVâ'iT12ʺ-c5]<3,2rpNS!C0ؖ43S yq닁%ǬjHM Ol̲\4ΆQ?d_ b|ѢqLPN/!@8Fi5hӋu|+|n)U$%2 pOCGظgY3`^'PE4Jn@%eϞ" r 1fyxX\+іy6zw0죦g$ GDA:gܖ}\GWD}s ŋzeF88CLGgS3mˏcO6&K"-3!( Ci41V(r dٜ[a*e!I  @@%u405;BG:M6! Q<#SQWbHtiϦ㑜E.xeSƲ1,k5|¤6W`Wp*_ F$Q,*Kf G+K?5C뾎^޶geBJ01--p7J_LYe `XJcA01 ^1pZx`<(/Z_Go>X\K_5H1dR1;Go?]]r LGwgxk{k ` ^6mţ_C7#")zxb5H)Rۨ">mm=z:ڪ?ܿ?:j(}weЧB+}hoi>~wvwݭ ,] wWϗ.f\{YjI +{W]o5TEEq'^+A0ˏTBUFV/**ӓϧ}1PHW~޽VO*%1Jf-.?^z{νuvehRk;0F ž^K zh7zOn݇ P D}"no'.-\:TE^6UE5V>Xz__v퟼=9K]*NZHӟNww\~mSwi%9]BF~ȕg7>-7{E/듬woO/=\ҹ r/?ZR{Ү5+,4G]o!:}ho+s`e|3ffe3WhDU*k޼VxrM3[LU9ukO(zIl6PWQUXvxw~A«۝OVD٪h Zz*\΁tuv566¥@LUD4+ +jV\zzᶟ59"/Z_[_w}25F3f( / jJ]dyx"{;nKs{-'D&K y"=ΐ#\Ϸڢ++˝흝kkk>("v u$NPeDj*Ɯug+݋;Ѩ8(I]|^,|_E[hwvwoOq=]WO'~;xuxϾѵnG$CWc2zI:U*؞ω:+o׃{ ?q0Z_f$K/7lw5DyЯ\Bk>1z:Ԥn4̣ѵX[= `YK7xA$N܏&܏ M }.]>S+}$Leyyɻ;nu}$]& Y$}eY WUȱ5&bM7NE7AQto^m8)O~zg|L3 jM׬3chVrѠBX?L zX*U h}%|_%ՃG&niPol[Z{{0 ~gi}0K66lx9U*׻.}}-sIVqesҚ.lN˚{G 'x/BG:*޽zf-3ktָC7lཁx,>9_ RD*}i8n51wTr/GXo˰m2Iuk+,.,Uf>۪;C>6>8鸛O^iлFpe"ࣖlք&y{tRu@Uf[%NsDj]1rlps\Pfe}Z{zhӊZ_WNk}Ns0o2_n4++;sFeV%ͩ>io\~R;%TavT|=TJ|_O^u,-ӴCZYY=rR}Yf*sTzxW"El:Ѥ傚AP$+ruZB֤w"cZqFsᡰ~,aًg0Hi9 ugR?D!N̷諧b@ˍFnӻ4g󚨬]~7>y{ZOJ-Uz{{K b.j^Y]BcͨS}CL@+SUCaOt⫴W:^3zNg?pTMD o@k:]o756?swgν}ι/>;bjT1kyZ3ɬryiLdyW8j<0-x=RaH$%T;tuD$~QcKr* +[UFfո0ufvK#2zdm{vw?@s~mJ*igQ xj7RCv:.cA앮1񬂦ȬᕁY ,5ugvFj2{U^z13:l+1'^CZh`D#o&}^1;8~ T|7b;na* zsSѕWr4GTkW?G&=oq!QN%+,!,;C̺z_Z TʦZ] ﲝa$z,T3dU(R*?<E}<[̷**$bXnZǬ {,fyWTk@%(yCea97gxKvUi9녴 BXHT#Y+=˜^(Ϫ$nMΟ-ofC֗nVo6(S՗P*KWsB!vZ]^YS2h-1f֕Wh`OcU, EX(x0WhB dHn]WeprvbhѰwU^{=c7#  C $_UVg ^XZg쪚*3' l*N9]U^ѻMˏ/|u'zWa{K1tm\AP~'Gk A"ea߳.[ّښʴE@XW-2[h:VvUf=!08&}{=-!1~{M/,C(iX{t*#\p>|]n7a}_p@A^gnéNh)m7tyd斺nsd{}h?soγwBlS*s텨dTqzp@{Lim_9A_ݯ>^ug6ES$ǶX Am F,yf&ȯxk>|n9 7!F7x㰄 3Mo'9MRVoꃇjSc: D- c'Dl:e9p1rpe[ЌT}dVrrZcUWξQNi6~kFo||ckx]٧XuSLzs4.aX#}BiuA7a3bu)ٞKjPսS^^$z'~7 R>;T0A1dž8bx^rޭLñ͵ L8n_UsbA&[kWfS խQ?0$jd8]'vmJ_Ǧ%J h^)GG*b[i$,^x'-MvкEE(NWZ~[3{'Lwzs9{K?o9 wwvy$kמ|DOԀ7s:¬EOMNY3+O|<.tX7ojj<xO}4t`˒;Bb&Z5UKJZO5]ʙud׽+Qs^ST66lݩO|~=ǹ}UQ8];E3+p̗k O!Xt2J^al̆`(YLəvy[|onֱݩe(JGBWx'38oT$H X5aIϒzKr,i Zyc|:5S$.)՝j].%CBD|*<<e}1xC+*'{bRNFs딸q'r^bׯA!4Haڤzч^=,}r 醘 G|g/n!WZ[z+4,jUqİT}R9v:0UL%y!<}V-R),}80*0f#l%G0WIr @N /p.Cc4\ipC$.Z1ľ̈́]u_ @{o5_SP-X&Ú.uQݝ:3CUzL /<4O'4=wO\H=%ܓ`x5pG{&/>{8Ɯ.qs{]SzKg} XzL.?K1n0? * &]t@urI?UY Ow|N6`=}*`)1dWOHTs7%' _-)*?. r- _My.J&_ԱZj}PiꔕSSlM"؜S;˿2jN_3ݕ+"4O@:'-ܟ eWVAcPkXiSglYor$2gߋ%$/ Ȟ@Q{sծ7.*7ǯM9+FHe`26}onʐNѓID;?q6MHt|a]da]P=>@ᱏL2|κџoOſ}tl' +=c.uq|kksX,*w"c,ʥZ[L{/N}J* &3]ǪdK1*(|qסF# }0F I}㺩&迖ybrW:2ru׻|b1/y>5?7njߜyWquֹ*)>qɓ'eC)M;z}|rEC/]ɗkC"<>_~i5OtJamÏ4!~:+XRkΌ jq)+)LMy[ OBnRk~n]N|e;wo*ƍrSff+Q,=X?]~g:B Y|_?+V̲Xa- lnfA PCv7_->|) -&3ߋ4$No>h2n%|<ߋtu(&6ѫ2f/\PCY0+`ssTW○^'H˘K݋v{{SG _ԣ'Wg>WmᖓQeIVNV\\>%#~3)sd\( :_n)cc`?wꡲr=֓!QIOb5.ٖFuhʘ׻ՓVx/>\l{t\ɸjI[JY)+VrUhUe^dKZ^i>tykf=:t?+G ']=,tinm; I&t.mx-)}McRVNR\ ׼̡%}i]/^N|ex*]'[ Gy'Cp BPpThbY_I{_D|XெBh׻Ţ~ybj/`{yѷ?^oĿ~gow髥&'&Oȶo0Ql~?|uxW}zkmmm1L33fSw)g:uF/u(] 9orY2g*ʕܽK%#na7ը#cɘ+:ZJx>Wi0hZ{3?Ԅ濘 ufbj ~flz~|ve8퓔\}1̳sťk˼,_]cB&[Wski2㖖?.Vr9+|j{i'/5d5gwU~7ڜ Gꫧh+4T:ahΞ y|%2((`]Rh++*y+ODiQn.3}.GE N \O'Õ?1բG]X'@8b+:t(7 jKC%'P,keeG]ffg4P=J}[te,%I>_tnzNvkL-^o)B MsG_mlZًĭy2ԲFrl.6M5\{l?{ \iԹso޺%#P.Ц?쿛v7Hp\^.{aaѸ%$ 63&s7}˟|Gþ{OF>QΔ鞞9.Oyn4> ̳$,A׍}ý;{o]tĎjr/i>[i&]tddTwg<x]Cjs([O\ *jRzA * B4BTRFrIi Hd:vW'< T8rͤ9}՜q铌 JJi?).-ޅ&"TRhRk'' N6I]쪶d/YPZ6$Nozc1v5-IVY&_v'M!9eݏPT%9 UO@6Rѥ~{0c'39F[bx,w&=9zWL~\Jɧ?߈eh,o٦_3 eV% &L0vpie٭ZXsLnK1oYTr֠hU^Q R'mJgI6QKPX=iJ<1}ĺ Ӫ+{=_FFһ63ȯν )]Z!^c j.2ѯM+_k{>immmZ奿v٣2.͊FUDALf?3ڒD?Q)T?rrVe0 ǰY>MKsX~ʈ>L}'vtmlo5OjnrxF}>5?la6nYzh3x!%'f_C?Ҳ{W)u!zv-1*=m1ʄsUih&!Ord ;EE!5dYd);^GWBŒf|fd^!&=rŢL_Ճ"&u gfk1Q[?lmĵv^Kuxv+oQ{=W5tiMw2!ƿ{׶[|_5.@\P5媩(-WmUztoie9u{J~oս"i9'gߙwx`Ŀ{^Ts_]xMмMjȋncnL3#W]<럛tspViɨY9fN89^NҶz%@Hl0(O{r%e..b^W $v~> qPE\*-@✶\D@@v< :@w7xa6d5uѣnҗn*8Z6rNP**-?`̓מ+2;~Q.Rُ'-erAR̲ݫ Xg  ts#sר2D8]6n;{3ج_}W׮ڂТApE̔@f"44*6s=J v&G|]?N6{ɤ%.B铳ļ= wIA͹J![KMaDD5Nӄu'afZ`%p$,697SGLu( )NQGu;ލNI5X/*(Ej&@J% =o=_WFɓVpZS5޹?i}#.^1K̜e O>ͺFv o&yf#3@Ws?c1s0ܽx,&ւ- 6e~i*_UJL_wsibG-nѸ~=4#>ք XjM;'w]x<yƝFaCKJH%XGue:̭sd푨hP~zR2uF S7't~uM P: fJj8=~*5f{CmWp;++iuQھv|k/5,6,Ǫo0i{LmDVpEۢ;_VCe7I%k |>pIE˒Lxl׮v?3p1y80$eiDd~pH>vI#ZBL֌V'N5{#WK 6VBb}01/w' k,ks?\G|jm۷~W"!z+HVŪ/ElћbVT%{S'OeiJ7ԇe,[fms[ 70 *y9~ìФ#gkDM4R4ك9#qrЮ4Xp d?ut{uqa!|'2O;uM#51n5aVa*=8a{{P;v2ß~-z5_vg0#Hd?+|y@ֻV\rD^`3۸u j ?鉞#IIjǙZ(ߡ+C!4G~a*衄PЄ?̟#WUBa}a&f/sܰuHL| m`4xKU{Bh!!Amn1u;'1Q7Iěۮ$m>m^_qX?4V e&AmL{k2kgr[Ƅ4XlmM[ҽ5YRtTꂛPEL?*|3(mkK&\ԞkioGGY[khk8͘Q~;~ތv2cӽo]5ު85_ 0yHē^moeb#c5 %#SԧDHR"H3/XZ5_[!kl`bd18N|Nr*˟ ge֞ڟNOIbWsMaf|i_}OJWiku<̨P1)ެc 48 fn f̔gusF%VrBV޶טu#S'2(0$_z\z椘N[·BӖsEe9#Ak&hB <-Wpr  T:[UY͏@a5ߛwϗ_[3}0VV.~X*o&| HrvQ'ֻ0@ /D c؋ĿMb.=\ڈG |9tuDX]7>]">}[=HW!PP{IJேO'}pYϗW:|:Otmoư菣Wj2@E`wo7Rݙ_#ݽm(P۽uz[l.2H' olomomnnXѫN+Ό- `}!  O^#KѕG+:71|^hWO"].T'ϒU7-6,/{ykkױ._ [D%W@@H— K:3Ϸ/<ݟDgÛs'ϒUoh5傞kʊtieuM]W_j tdX_H, $2ү^f'oOk[ӟLy[kW޺}զTv=WAߗ֚\vyMKٍ67WepsU:  *&E_u7MݽHݮD?f4PaoO޽xta_/bd=dē>9QrӒkcJQ /xQI՚M αDƃ0B+IPūzb"tUVEe5UQ5Hf @  mR0@ @`}UTu@ @ B[  @(X_Ud @-V- @*@av"@@E͹,+0 P.jxrLM%o u-gqB os.q4lZ~+iՐIhx:k{ti/qUQ( ۸dGC`xCZ)յѯC$f"b޽\3('c7M]דz2?Xn SYR~ݭg:;4` m+9UpAlHVTf?Edܰ6y  l l lH}S؍F Vʋ,XX]$h@, ys.i||$;#4{:͙?3g ld7OB3n1d*_n$_&aPFT0\j˯tH aW3x>HQ:SwQ<+0?[}*!-Z^,w)]F' <—Ao>o):T҇v]+#l8~nJ@W6e[.ݦ7oxW1 @ *Tǩãׇi;;zccPmpXEq9~?LOqs֣2?#G16>;  pc\^tcoKސ+s\.J2Et6V>GK}*c*f)2-=\憻ڴ%~ViJ|"X\X^|=z#"9];:z)+T)Ov3k۴\fn3i3яG1#p^aVDmT K:Nd3|b3pEo+ 홗)ZѦ^jn++:OwˋW^]Yn4l|{R = IR؝>O:%t2w}EcstzE;ޢݦSK/ 8"!俀GIF[D¼i$-}nM?60N@s)fxg1_`f?ުCc>|㭽z.UpTj`⇵ȓJ'>g/ttސa[ BI~)\T bKJ'Zm#{3L2WHS<+j+mܰ䣆M驭-[,1H䋤5?_96m.("mTmټO,FnsuM϶oI$Qdȓ)#qkۇhac]mFѾh;]5Keo8=[hiZvJ9Ba x&FDXϹw,faj,H+V_lX=(:ȿh %_DΫՅE*pqw75Vֆ7k_{.>30\ G22m肛Ï~D>OJ!<͉fn;|ǙH<?$ nT+q0 6I|'#`uHJd6Vκ ~L?0ysQ%MIGJ]hz$=a575YG; }Ԗas =F_ yVL5ۛ!㎐Cb^T4[,[yVr.ӳCqWJ4|j[[t)Dj{:_:%A,/}uxݳE KϦEGhw*Z)ZqAt_֏Fێoi6 ;j,HU_lX=(neCr{ E2S kq”$,?$O~W9~D"{<16-o ?qGYcΊ'y"Cr 1 Y.,36jM<Őz&L/u]³纫VM6hD$"QLz$q~e(:"C6|.цIB0)C^7eOA+haqaN͏3\Ū-fݗԃ e1kug.qeH (8o)V]r9ߋj{:_[,/}l绹^Qב@O0]S=aZҏF:]t_n3b~HꋀrEa5?n侞wM-I^$Kp| KE٬갬Һ.hbǦ'ge# qPeμ}HoenX/P%n P+(0%Í`jZ䫤JaobZvcEͥÎʨ1eUWQ38зdo֗vFPAo4Ӿk>+G64HkΨ/eIk2"8;N8SYp#k |p^疾niaiR?]\Z<kUutʪmZ*m<8^ra /zoS7h_dp{n3PŢ\d5,$۩;M360EG:wwfkl91=0# w 7FR9faYjt LGB4f1|֞vBSX ΆD$BUr%QHV_JfJra_TŅ~ۃ{d{W$HN@biz;G>u%. F;Py#Eٳ+M&ym+a.*= ~XbfꋙO)mdHS툐$>=O٬E/cnkmc7`]!f. V+0f2$ږx>8Ӆt K&ҍslXLx=)W cXFafb5xiPr*lJ ?~U 9vk`T p'TR^˯ʿI4$5?U~As_o}E@x] 1|A}F3բlhw:t5rxRidO6g)tw}4h0 θ9|,16s'&VK%5L>-PXdzDtcг:GPc#9%daT*-P Y4`ՎP-dNw 4ce"e5CLjEČ9,yR0͊ٛ7ob 5$ 油m*d; LG2'Z/ySꩾzڢ?,?^& /-XCx wѯg',>`Wi~dďqL?*6\Ѐ悘ġ{s=Ϻ!BC0(HwٴK* @廪40 g-?^8 qfQU+fڞoh<)P,z0.\C3 R8!m}0ZAyڥ}4Af6K>h% T'H/A mrNA޼0T6l c8^| Y:0#qX/!ׁ%ɍsg%+j:wU"_2@C0>DeYkdBql2[ Mq`>$[{Ɩ$UFR6vЁ֞)%muP! 6`0(48 8+hRqrW* R*mex;eB)-,%ͲN̽ɹXQG'Mkp3~rzVG~Gj]q2 '_&~6 k_GWc(lrV DaĘlۑ  +=[4B;(`x_%_@h r=XO+Ve>,Gaծ)+@C6xv4|1нB(Jejah2zc/Vjr>'_ JEl;h.cN4`H pҼ_DfaAZNK f%DqYGWdIX,uN`UvQ{gʵ[Mq&1]@=H_ݝXԈq(6¼f8@7ecOB!QZBn-X܌͵ar;QtϴJ-e}Nn''{1 v/:&hq;X䖟ȴc,P67qdTY*;N871`4%,3 DzE*֢ {0(>bw~SaNDzSXy8asy0! ;^a#\l΂ /pT#V`̊n2b({§xږyqhoť@<Ձm :. ɳiIm npσCǔe绝 v:k˵O5n}"7S-=f!>zs O?6Գ8'ƏΖBL[6pkLbw ;豸zЍ#^*}㢪s(tC;õotCzsQNw6I;#t09WG[BS$bjIX f^nsrTnu:bKf0P&IS}nle x:ۅ)pl˙ռOZ;Ob~-HlxϷC:|X z0y=N~T瓩0VYqynxm=81çc~ŞX&^KVζGQ%쐡9T]?c[|AwWC"`6(6vUW忭5m!e$PگR3Τ@=H_'s; o;F9%(/\ZQo}j:sitb(,ŘG[[t_~6.6 ";tYXۃF nô@8THʆGffb4TG[,Rȓp:cȫb%;C_ݣ.z:G8w F`z^XIʒY;ykU|[\ -~ z`j台6#NÈcGeÒGsD&9=9NS54` b ^$80nYo}UNu_hZcIiY19wVƃ;)¸CZ?kM/8l\ ]Ylo}by)eeUv]D;1TX)=YT21asyGo BWgWaUث7l?_aR$ Joh,z`j u,_ Gp|aXI8ej؛͊ B6zMN4<m/,MM#X"p->\D g3΢T1]/uxя}zZVl*WAX7|`dC*;j[9 ɾo=FeC Xl~ ͡f+(\5j6X17l=wpzRu8x=7z*y+Hw$P˱6T+ ϗZ 4K_X\zl}\uD1!.,iE4ՊrrTUiU%f-0JLR,\$z<<$>^{ʸˀSZ JƆy:+QjHHJD fE 8 @k4aH$@o'4~S}{92,Gᔤq'$sFк?kC`V=uQ[99@ˡamU1sK$@$@$@$@$P(}j1$@$@$@$@$@EWmsK$@$@$@$@$P(}j1$@$@$@$@$@EWmsK$@$@$@$@$P(}j1$@$@$@$@$@EWmsK$@$@E 2)gia^Evgao?7=8T]Ebn}N>[8ڹnh/*~m<,Y(}e @u:HX? k7DzWћuY͑pۚl={$ 3Z&'ZZb}ΗdepUjX[[|Vğ _/#< wۉ掑J_P, Tn۴& ޺3?b,dz/z/{s7mY^$PM O:gmT .;N͑3](J7ȼT W'  &bj?%Ѩg?myy>WG&ngy@5*F0jMsnw> V`,9ۃCW BYQMc^*OW9   %P8ChLߝ = @+,H..,:]*/u_[sihb|ˬZy$>B0 .!|w&m)pd,$@$@$И,3oc~n~Yt:ws[k(}FU1[LuPse}VjAӵluڼlju_]Õs@$@$@KX+t{foPJO$`y0SSK-[3,/&hhisɌO;Z0DD^}:=9 c1/'7o20uq ]!Ɲ06Bҵ>+tUUG e-_fHHHHH PcIHHHHj,fHHHHH PcIHHHHj,fHHHHH f 와r|m@IWz]$yS;Ea!H G][ٕ0F}qIC:VKq;wIY: #~(},@8 Qq0ԲUS̕L,}E*R>ӹa(EToȳxi>*m#DK[G%ĴH$^&OO˔zmOgX{g:d%v{*$ @ P*!LFEF`7M{?*Y VQ(:-gZ֖E`G"W͑z lڽ.IH(}8#"JG[Ss:=߻bݶi7q;N9-B$gۉc-]̬ @j$HH(}8#"0 H\\M`f\ ͘s*2J$~aIJGWX2&;ݩ-¼'J=+`VyuwwF1*Uaz=XaHb  ?^ MF@\c&U^SÉ-xk 9v{ bXufY\F@a%(#0=d' #3ڝW`| wLc g_qa ~ۗ'G{N%]9ڸ(Dm!*kr\Jt:[SCGC:ɩ{uj2wwpދT$2F6 EgCb!w&p$> Z[[מa:3j۴&ZbmԫTu+L#[OvsCK_Kl~N$7FE2?-׆#x| .ܾ"R/(kA'0} ek~#шyGčl\ |n'E>U) #E<⎤r02ts<4@d6XO)?s|r ;KEFV#җ$qiUh$Cb agh#S^G"}}饅yY,zn CmPnS֫90%jG!d[Bx,Kث-42|y=:M[<Ǹf諷~3  ^J\Xb~wl|ϩg0=l'ŅG ?ų@㓍XQ-9"_YD E|}LWw4d7m(;-*&e8~ȹ ^H`q!8|m@vv =!QYwOqu K<H_. `˃/hwuz&u|)gnPKV~~/^-נ>]H[o0 R)Bja i  F%k xι" @[9l6cɦ__G'Z1!i^ Yj3\abn 6x1BT :t_ TvL0汍XhFm9]X,+U?2nUC,sm?,K_B|HJ+OW03?ig[gYt_YR$(%0[<0U9ߋ'??/ww_4cgz4ag @%cWN89$'  F#5em|DߏonٞK6۱>߭DZjTimQ* E(zfzݸA7__b<s= W uRY6bC5H-hoďq=ym})ul Mh/X@C[[nK)x2  h9M-l:C,b0k8]}_E=|Ƨ_ a0x!xVL`b:{pf>|4 UK,tPϦ0 WY[ \ܛZ{ K{K /KAGeˮhS#0vΜ@饯m06h0ꃁzt:} 4:6 ?$%١@o Fď)3B9c͆װ3r+B!ǑOG2RK'DŽ4 4i|ՖFw>fɗil 7}wwm0e(r/[ p5\ .Fi̔XV%/1l绝S21OTFM#5*+ƟXj8Ye/`aďsw mwϛ-..ߕ2:elӅ: g?{͞~ұW2*>N$P RòsPPelansYgQ%hSX5T}k~`9qp7 :69 `hveXa_Ώ1'b۰\X0;B{;ap.%O,^nKWi!vX:=ЦU bZ$PЕ`#2,cXS.].rJ>c:rtP0;#o1Ҕ[(H`qNX.<7֊ ~YU[=AHH(}'##&]|.8@A$@`obQI*fjv=l i ؅@V. rgz$PÿK㘇z-)E$'Pm5I$@&@ę ꚪ-|A$P;(}N]1$@$@$P]kE!hq7^$@A`J} (99,?-MZ 1 K@5lӳpzŲaC$@6m]v隺;|I% 4 M[3$H$FoB ˼ ]{ź{ӱp/?^55'n;0X&im&dJ } #L&3rst>X,ƈA8]Pt&IIh<[u8oYFH@v3kk炷>`&&ez/{/{Bcˋ@a{i)҂ΤS64`>9u }#K Pp0y6wqwOX ] ؛/ FO}oC!TGe/*K@ڳvteboЪuz܏?㫇+^5ѠZlzUm5@$w4GK5[ fH` g BLt~1p g|XGo*ch8bҞ v 'fڶ2}F ƅʤ 눫棧UU@'*cW2_\1$@GM2ӏ{3rd%kj󙂛 TB͕Y6Ze,}QyAjkSƼPZaH Sv=Ţ0$@!&޽0U iSvȸ¢<<<Wcر`?)1, =&fQy[YՁl\05S!?{!CFI^ȳxi>*U%edlob_uhdn/Uyr*|C$@$@$@$@$@A$@$@$@$@$@ @ Pb      rULHHHHH(} @9f,#LH,%&B$P{uH~O*THdpx[.a%f}` W-U|>TI(h1neKuw,(iyX bZ$@$@$@$@5MRk3Bϐ 4$pސДYz    }(Kp(}5\$@$@$@$@%P*ëPj*gIHHHJsJ_l$@$@$@$@$G}'@-HHHHH@"Ѱ} w8xDEn_]~,p'S%1Q.Y  (? :]z6~ֵ.>J ? gwe;" n yJH*tO S=_+}~َ_S/S_=yfNC6YGȳUG~)aD4J3fQpGĝ \k9+,r?2lU'b@ K3v{ cϧx~ .,Fy|fN\o?0?=->Z,,q9 7zk)}5F**¢6 |اW$X^xwpzb}#+^kT P |]P;ms#ׂ$1#u?~"o@^Ed˸I|9tגd{E$80zT*vqc+Τ_Fnr9'#7F_65Yem[nᆏnf7fg1d=;r!>9i"SR{YyeH@ᣚeCդ7Js;_55$ !0?7S_Ly~!# !}W,]Jjs` gkMxU -y a+%h.ŔkUMjVދ9< Z7ayO?A K9uǦ 'FnL3{'<ә!n(f/*Jfi"4OI%/lh}5wemKBB㟍6<yɷs˼SdaH\=[0i 2}6u_Sfe'' &aic(9D/^j!(WVXe\Cf6m>Q;̅BZd,d-оBk5o}ݝRYDg_ ]/(}KM$Pim'cZw`IJ;LtZ(ݗŅqs>/:Ow \.ܞXf@Bkɛ#nc߸Ne?_N2~{|rB>.Wb*g\=f}5[}bԳ]gBJ ^|"iJц 8zLٛ7oY 1C~H8 @8q0a^9aG=R ]p`Y` z=FW[Yr,m#DKXAoz+U     !`^ux76J_ W,0 A w,UgƳeޕ/6 X}kmqK/#"bD*;ͱLU{;zst-99{/X󄳊Ȭ5g[ m-s=>Ɉnh狏depU - >OVbcɗI1YN5;uo(}C @:hWٛ:'; @=7ٍ mWp.8~i ɤFA TiSnPm>kKRMJ|lji3]QE%dV*MWk@HJa_ w;AWT,Ao!7_h6}c(Ցlb}/"ҞfeH[x\;N9vC&z Е!7PVFTQ* @ *Y >[D#fVYx;™04ޝ ? 0,*űOǶVy Tibv" ˬ!#XiYp:q12䛾3PUEYYUL@ haw1>9 ձ,L$o~rF30;-(-٦ޚKdq()B͕Y6Zd Sw,[U^}B02J_uX, T@Bh^weϋHk@w/oX9瑢? -*CgTAx\lHM,Uk7.w::Num>_O1f ͛7LCFI^ȳxi>*U%edlob_uhdn/Uyr*|C$@$@$@$@$@A$@$@$@$@$@ @ Pb      rULHHHHH(} @9fri @5[% T)XxzR/SRDo{pwQ3l6;-?aG<ÏDTӟOK| nO wׇu&-!>z *S{lR"%_.<~>k~StȏDbf{1́LWlh!,̫< GYul2Xߢ5ht \s I݊dl ÆVpIx_l4,\^bAs:*sk~q$!X&N-!7ssCTwѺ62Gn|Ym^^^=A]agOWXҝZ|Mby͸;g991sSw666n-'&_$71swj <-%wUBx~ă0!N/Rpb9FzL;k3X[:rՄ=aQ0* K7!-Ul4$J <2WD['pGFT~lj$$HĿhkt~E#g F M/֍^pj-_jKXXGwYz_޷D"X7ݺc0:B 6TZް9#.Z0J뱟AY<]5IPve #+k FVP-2Ϝ|QX5RvAs,7S9h?Vs#OG`lw^ v˘X8[U#G@p٦%; o$E;|PǒMw GzeYr.ya7hxmE}w, l?KmM-n{S#:lk3}sK>?7~8h=wNُ}UȓZ{H.*7W9uK{WYd"7'gq~ WYF 8s 5Gh*vUp8r|}9lA/qLߝFlN3HDW- ^DKӭJ'E i;Hvw%G!L"饇!i{g_g]jKS;8oF{#P$PDra5ۚ67~zOw'3.BM"LBoPʨ{VZ7G'T_-erݩ{!}BJ672BPcb;CŇR>A54MsZIyw-G!E)Q]1*om#ZPCg!+)_@ :UXq>GMR&ăk0B:3-[ްm>-X JgG4ɽ&ĭOo-Um9ٹ},o>>xZ ]Fhxxŷ,mS7QӹwR_x )Rv;l9 sajCo f{sw%Yq#/LNgb8q0J³%HTk1?,& AΗwO+U|G'DHs'87ZBH4~oo U?(@Ημ @l3$PLBF^Rc,/@?%+VSw裗|:0gs a[zN9o;N9voA7mFWR6mms 1HZ-c>YZJ`ѧCclGvヂ.H/{~-0}rS>*|_."[mM3BJ"{ z sU,&zŒ1te(:]^\;\#B30'4paїF(߱=E]fP[_vR s.b=/qqG̶>4*ސ"Q옓M ϶ܝ}&C 5CNtUEG,Uŷt2ܫ{j]BRX@v%.z{J?swbOPD 7G$ c_$mPjD$:rF:rKrS>M b$@bv; _4m65*47Tj6NwH$B4ÂT+-6/TDxR|JhEgnH>#ȃDbο)OhAQ[Q@=ya;M kv>Em~RdK:Qi_ܱ#D|AKO1‡Iו"_x!1@.CtTE)UrI᳌R3:/Š3ؠ_̥TPQݓv3lw֢_&ˀvwa,`Oμeв;[9FSDֻSobGz)`~H_ X&܊ X. 苿WX|J} |B4i!dZ޺%7ְ .maSCOD" (27 -?VK )o+ $Kr_c yOLͯmUe=P&s3_pp: YeT6Z{IkKﰏ IDATm>*=6ܒV-jˏC4Ѣ] |?@H$޼юvBɻ=&ycCTp-],?/i-魒N}GfX{c[8qA4ߏk,xG7e 7+,q |*֌̽&Ren*9'EfM0U[LJj]]om<&ѹ5TEKFt2tH EC/Bm]%5į=ɈA61:5D3B=&ucMp\🞜FY#ďIzt!c$̻.dd< Uvb ]6l'?ə}P0Յ0vvv\t'"I@S ^y{.4]x\OL8!pGwՇ&HծrZvF۞.fE%!ȑZ-@$P)˴ M]Xk(^wot~f㕔YG̠GzCswn}o#}NEj1X0\G#gBBb* ϓDa5{w Y8n"?C 65!e!_0)M1:휚_1tVLF\I\Vt2E #$2 Q-iU2aV~%3EK;1p<` TSaug'e_.flwAQc"NW j4פۍ@O[+;[&_zm§MW7(*Y拾^7xޗ$@$P'd$taMTcK/LbstX\a88Ęz9(6sL"_εD ,>Oh F$HH<2U gȼ>dO}>IY<ؐJݑqF2L]0/ -C wg!naj/uj7~66}:He#?)r"ga?$a6 zgىY`_fl!E]Nazn~KA`g%hlw/3g1HkPguz~1cr1DeViba@i1_`u5K&c 1`kKt\0Q-Kq S)fV ` IHu_UV! xWE\Vΐn:izb8rz'HtX !*58>S tPX|CD"c*?XhjU )+GB'M "rKXq3u"6c"  VD @$@5LPW|w8W愫:I'BͲ DZ2j+wPDB|P@a+78b :7Y W]- X[bIX.,ٿNܲsJ'uP)IStb)׈l YԀb(;:N7%‹='˜#6e$c= N$@$/6 sXm:b9(D CKNJe1e](_mXӅeTcu_t_'QCZh/mۏWm.6[2@!zaR'b0\tX= a8 X%ce ӕC`h TԐ!IG2E$@$P(}_D$@$PD#!E4&L@L'l.uZ1eKHh#1>܀Li6y/ oXެ?_ p$wAaCT=l@x0zŎ6RE Z " @>QQ:?,RC(,KO`P%+ - AdxZBe;aF r B*8SJ{}E6D5j*LCp8aXȉ'mP +J_Z, lBFX:vcLqiݗ>zVIN}/~{;;{jRObK*z6k5.)Z5[aqYEPCXamLjBn "+s m"A 70gP%+"9epڅ=KmV9~xѢH;l+JdfS8a"c>u |$24{9K$@LW=.F$@j6HMX[Xu_qZW,;dx ։ArP( Cx,Mΰ ˾V8CR| rX}Vz3Q7)!VayԾ96tuޟXXL%b0|?SJ۷pJ,aΗŞĪRNf7؎;cWXNM*BdR|C {nۥbgFكa}Hqpr"ixzRI 0g% c ,*CrHHH(}% #bR2?uW, @% P$}M$@$@$@$@$8F5KJ$@$@$@$@$PI*Ii 4J_S,) @% P$}M$@$@$@$@$8?{ IENDB`DyK yK https://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f1/s0/t0/pw_038000.htm&na=edi_ct&rootLevel=0&label=EDIyX;H,]ą'c$$If!vh#v8#v#vT#v~ #v :V lX t0$5855T5~ 5 9Bap2yto$$If!vh#v8#v#vT#v~ #v :V l t0$5855T5~ 5 9Bap2yto$$If!vh#v8#v#vT#v~ #v :V l t0$5855T5~ 5 9ap2ytoDyK FrC:\Users\AD43469\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.Outlook\02UATIHE\www.anthem.comDd $in   3 $A?BD21318_S"a!bhҫ`[ymy  nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`$$If!vh#v #vP:V l4  t0&65 5P/  / /  / pyttT$$If!vh#v #vP:V l  t0&65 5P/  /  /  / yttT$$If!vh#v #vP:V l  t0&65 5P/  /  / /  yttT$$If!vh#v #vP:V l  t0&65 5P/  /  / /  yttT$$If!vh#v #vP:V l4  t0D%65 5P/  / /  / pyttT$$If!vh#v #vP:V l  t0D%65 5P/  /  /  / yttT$$If!vh#v #vP:V l  t0D%65 5P/  /  / /  yttT$$If!vh#v #vP:V l  t0D%65 5P/  /  / /  yttT$$If!vh#v #vP:V l  t0D%65 5P/  /  / /  yttTDd $in   3 $A?BD21318_S"a!bhҫ`[ymy & nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`DyK F"CT 2019 Provider Manual-Final.docDd $ih   3 $A?BD21318_C"a!bhҫ`[ymy ) nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy * nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy , nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy C. nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`q$$If!vh#v:V l405yt`Tr$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`Tn$$If!vh#v:V l05yt`T$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v#v:V l t0655pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#v2#v:V l t06525pyt1r$$If!vh#vK#vM:V l t065K5Mpyt1r$$If!vh#vK#vM:V l t065K5Mpyt1r$$If!vh#vK#vM:V l t065K5Mpyt1r$$If!vh#vK#vM:V l t065K5Mpyt1r$$If!vh#vK#vM:V l t065K5Mpyt1rDd $in  3 $A?BD21318_S"a!bhҫ`[ymy lH nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy *J nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!bhҫ`[ymy K nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $ih  3 $A?BD21318_C"a! bhҫ`[ymy M nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in  3 $A?BD21318_S"a!!bhҫ`[ymy ^O nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $ih   3 $A?BD21318_C"a!"bhҫ`[ymy Q nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in ! 3 $A?BD21318_S"a!#bhҫ`[ymy R nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in " 3 $A?BD21318_S"a!$bhҫ`[ymy T nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in # 3 $A?BD21318_S"a!%bhҫ`[ymy PV nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`$$If!vh#v":V l t0    65$/ ytgT$$If!vh#vN#vc#v:V l t0    6555h/ /  ytgT$$If!vh#vN#vc#v:V l t0    6555h/  ytgT$$If!vh#vN#vc#v:V l t0    6555hytgT$$If!vh#vN#vc#v:V l t0    6555hytgT$$If!vh#vN#vc#v:V l t0    6555hytgT$$If!vh#vN#vc#v:V l t0    6555hytgT$$If!vh#vN#vc#v:V l t0    6555hytgT$$If!vh#vN#vc#v:V l t0    6555hytgT$$If!vh#v":V l t0    65$/ ytgT$$If!vh#vS#vd#v:V l t0    6555m/ /  ytgT$$If!vh#vS#vd#v:V l t0    6555m/  ytgT$$If!vh#vS#vd#v:V l t0    6555mytgT$$If!vh#vS#vd#v:V l t0    6555mytgT$$If!vh#vS#vd#v:V l t0    6555mytgT$$If!vh#vS#vd#v:V l t0    6555mytgTDd $in $ 3 $A?BD21318_S"a!&bhҫ`[ymy a nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`\$$If!vh#v#v!:V 6,55L'34 ytSATT$$If!vh#v#v!:V 6,534 ytSATDd $in % 3 $A?BD21318_S"a!'bhҫ`[ymy d nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`s$$If!vh#v:V l t065ytrs$$If!vh#v:V l t065ytrs$$If!vh#v:V l t065ytrs$$If!vh#v:V l t065ytrs$$If!vh#v:V l t065ytrDd $in & 3 $A?BD21318_S"a!(bhҫ`[ymy h nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $i8h ' 3 $A?BD21318_C"Pj!)bhҫ`[ymy i nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in ( 3 $A?BD21318_S"a!*bhҫ`[ymy k nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in ) 3 $A?BD21318_S"a!+bhҫ`[ymy Cm nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in * 3 $A?BD21318_S"a!,bhҫ`[ymy o nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in + 3 $A?BD21318_S"a!-bhҫ`[ymy p nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`Dd $in , 3 $A?BD21318_S"a!.bhҫ`[ymy }r nhҫ`[ymyPNG  IHDRo PLTEf3\HbKGDH cmPPJCmp0712Om=IDATHc0>0 0`р#0(r( 0rC*>6A*m@zm\Y\IENDB`sppppppppp000008000002&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XVx 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@_HmH nH sH tH L`L [TNormal$CJOJQJ^J_HaJmH sH tH V@V ^c Heading 1$H*$1$@&a$5@^JaJT@T cG Heading 2$<@&56CJ\]^JaJN@N xu ' Heading 3$<@&5CJ\^JaJV@V P< Heading 4$<@&5CJOJQJ\^JaJNN G Heading 5 <@&56CJ\]aJTT  Heading 6 <@&5CJOJQJ\^JaJNN 4 Heading 7 <@&CJOJQJ^JaJH H  Heading 9 <1$@& CJ^JaJDA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List @/@ 2PM1"6>*B*CJOJQJ]^Jph6U`6 20 Hyperlink >*B*phVoV c0Default 7$8$H$!B*CJ_HaJmH phsH tH R/!R c Default Char!B*CJ_HaJmH phsH tH D>@2D |B!TitleH*$a$5@^JaJVB@BV `u( Body Text 0*$1$a$ @^JaJ0^@R0 jNormal (Web),Normal (Web) Char1,Normal (Web) Char Char,Normal (Web) Char1 Char Char,Normal (Web) Char Char Char Char,Normal (Web) Char2 Char Char Char Char,Normal (Web) Char1 Char Char1 Char Char Char,Normal (Web) Char Char Char Char1 Char Char Chardd[$\$CJOJQJ^JaJ@J@b@ bG SubtitleCJOJQJ^JaJPSrP G Body Text Indent 3 x^hCJaJ*W`* "}Strong5\>@> eO7Header!1$^JaJL/L eO7 Header Char1CJOJQJ_HmH sH tH NRN Body Text Indent 2dx^hFQF s Body Text 3 x1$ CJ^JaJjj E Table Grid7:V0\!\ EHeader2*$@& a$56@CJ\]aJX/X E Header2 Char(@CJOJQJ^J_HaJmH sH tH DC@D aKBody Text Indent x^hPNP KBody Text First Indent 2!`H6@"H K List Bullet 2 " & F1$^JaJ>72> K List Bullet 3 # & FD0BD jp List Bullet $ & F1$^JaJD+RD ~#G Endnote Text%1$ CJ^JaJF@bF ~NP0 Footnote Text&1$ CJ^JaJ,/r, List '^h`<P@< V{ Body Text 2 (dxLL t40 Balloon Text)1$CJOJ QJ ^J aJNN | SingleSpaced*$a$CJOJ QJ ^JaJDZD eJ90 Plain Text+CJOJ QJ ^JaJXOX + Blockquote,dd]h^hCJOJQJ^JaJhHOH +antiqua-B*CJOJ QJ ^JaJphVOV +Antiqua no indent.1$CJOJ QJ ^JaJTOT +antiqua indent /1$^hCJOJ QJ ^JaJLOL + A BLOCK PARA01$CJOJ QJ ^JaJTOT +Antiqua Indent 11$^hCJOJ QJ ^JaJ6O"6 + Antiqua122^hCJRO2R +Antiqua 3dB*CJOJ QJ ^JaJph02B0 ?List 2 4^`\/Q\ ? bodyblackb1.57>*B*CJOJ QJ S*Y(\aJo(phDbD *7+Inside Address61$^JaJVV *7+Definition Term71$CJOJQJ^JaJhB'`B ,0Comment ReferenceCJaJH@H S,0 Comment Text9CJOJQJ^JaJXX ` Number Bullet:$ & FCJOJQJ^JaJ4 @4 l+i0Footer ;!.). +i Page NumberLjL kz6z0Comment Subject=5OJQJ\^JhOh #(Style Justified Left: 0" Hanging: 0.5"DoD #Style Arial 9 pt CJOJQJVYV ~ Document Map@M CJOJ QJ ^J aJP/P | tableheader1 B*CJOJQJ^JaJo(phHH )=Pa16Bd7$8$H$CJOJQJ^JaJFV 1F v0FollowedHyperlink >*B* ph^/A^ + EmailStyle681+567>*B* CJOJQJ\]aJphVrV Definition ListE^hCJOJQJ^JaJht At Yep TOC Heading$F$dH*$1$@& a$ @B*CJOJQJ\aJph6_R@Rm@pTOC 1G ! dhx5CJaJmHnHu.@. pTOC 2H^5J/J .W Header CharCJOJQJ_HmH sH tH @@@ n  List Paragraph J^m$J/J =~bodyKd5$7$8$9DH$_HmH sH tH \/\ FA- EmailStyle76+567>*B* CJOJQJ\]aJph^/^ -Y EmailStyle771+567>*B* CJOJQJ\]aJph\/\ F] EmailStyle78+567>*B* CJOJQJ\]aJph^/^ Kr EmailStyle791+567>*B* CJOJQJ\]aJphP Pp 0RevisionP$CJOJQJ^J_HaJmH sH tH LL VdefaultQdd[$\$CJOJQJ^JaJ! Vc2:1: 9z@0Comment Text Char:X A: R~Emphasis5CJOJQJ]H/QH VI&Answer Body Char@OJQJ^JTObT UI& Answer BodyVdG$^h@CJ^JaJL/qL XI&Answer Bullet Char@OJQJ^JXOX WI& Answer BulletX & Fd<@CJ^JaJO k0Subsection Heading for TOCYd 7$8$9DH$5B*CJPJ\^JaJphHoH k0 Subheadings5CJOJQJ\^JaJfOf k0Body$[d<x*$7$8$9DH$^h5B*CJPJ\^JaJph6o6 k0Body1CJOJQJ^JaJBOB k0 Bulleted List]^8`H/H %kHeading 1 Char5@CJOJQJ\/\ z EmailStyle95+567>*B* CJOJQJ\]aJphD/D *#Body Text Char@CJOJQJV/V *#Body Text Indent CharCJOJQJ^JaJ6/!6 *# Subtitle CharCJT/1T OAHeading 2 Char 56CJOJQJ\]^JaJ8/A8 !; Style Black B*ph>/Q> +!;0Plain Text CharOJ QJ fObf GV0Manual Sub Headersf$ & FCJOJPJQJ^JaJLOrL q footnotetex0gCJOJ PJQJ ^J aJVoV F Subhead NUhd5@OJQJ_HmH sH tH joj FBullet indent NUi & F!d @OJQJ^J_HmH sH tH o FBullet 2nd level indent NU)j & F" (d^`( @OJQJ^J_HmH sH tH R/R =5}0Comment Subject Char5OJQJ\^JB/B ;5}0 Footer CharCJOJQJ^JaJT`T K$ No Spacingm$CJOJPJQJ_HaJmH sH tH R/R JBd List Paragraph CharCJOJQJ^JaJfOf' WLP Body copy oxx(B*CJOJQJ^JaJmHnHphuxOx ' WLP Bullets)p & F' hExx^`EB*CJOJQJ^JaJphhOh OCBullet10q & F0 dx^`CJPJ^JaJpO"p OCQuestion&r$ & F1 x^5B*CJPJ\^JaJphJO2J OCNotessd^@6CJPJ]^JaJN/AN )W0Balloon Text CharCJOJ QJ ^J aJH"@H WCaption u7$8$H$CJOJQJ^JaJhObh W Bullet Text 1#v & FL a88^8`CJPJ^JaJTOT W TOA Heading1 w$@CJOJQJ^JaJN/N WHeading 3 Char5CJOJQJ\^JaJNN W bt-blocktexty7$8$ CJ^JaJ^/^ {W Callout bodyzd#5CJOJQJ_HaJmH sH tH N/N zWCallout body Char5CJOJQJaJ@/@ W Title Char5@CJOJQJ"o" H@mysubH/H &g 0Footnote Text Char CJOJQJT/T g Block Text CharB*CJOJQJ^JaJphFT@F g Block TextB*CJ^JaJph@&`@ g 0Footnote ReferenceH*0/!0$ Bullet-Do F.. 1pTOC 3 d^hLL @pTOC 4dd^CJOJPJQJ^JaJLL @pTOC 5dd^pCJOJPJQJ^JaJLL @pTOC 6dd^LCJOJPJQJ^JaJLL @pTOC 7dd^(CJOJPJQJ^JaJLL @pTOC 8dd^CJOJPJQJ^JaJLL @pTOC 9dd^CJOJPJQJ^JaJH!H {PIntense Emphasis6B*]phLOL ]Bullet 1 & FCJOJPJQJ^JaJF/F ] Bullet 1 CharCJOJPJQJaJdOdHeading 1 Text x#CJOJPJQJ^JaJmHnHuPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vc:E3v@P~Ds |w<v azz{jaj2  36E 5 I  !s=[&>7z O%|= Q!!"#$6%%n&&'((-))W**j++,}-g.l0n749j:<>II8`[kn$ EPXşpryTqV7Ҿ lKLac[ek IL$).25#89<DORU0X\hlLordt5}/!Peqf`2[t%7q  @@ @$,',04J7];MCGOT[HbgWijqnuoJsx {~\ĈlvUn s 6 _M`oPO|6 ,h{'-07):DPW)\_oio/xz~c؏!ǦѧtN3-< ,qndm<0Z`ip{VmvΐÑ 1       "%&'(*+,-/2578:<>?@BCEFGHIKLNOPRSUVWYZ[^_acdfhjkmnx~    !"#%&()+,./1246789;<@BKSU[_d~   @ZV&A.^.Z9>HI RF\zcgmnznj*>{ |*xK}Q~?6H)( k  ###$$%%'+!,, ...1d122344a5g555 66A6O66677"86:=CKSZVX\e5i+pw|282l zG  ")(28L<}DJR?[WinyG٩SJ.Y=0bW3#z,6@LToyL<~ž.hџ-uLUɢ"yԣJ~;!,k(C5CLT\[8hk;ll_mmn5ooop]pqgqqMrcs z- ҏuȰ /Je^$E O'>GXZk|ͅ_ 1 !#$).013469;=ADJMQTX\]`begilopqrstuvwyz{|}  $'*-035:=>?ACDEFGHIJLMNOPQRTVWXYZ\]^`abcefghijklmnopqrstuvwxyz{|}  c{|1346Uj<WYZ\{6d &)*,KE`cdf#?Z]^` Ut (<WZ[]|8 S V W Y x    0 \ w z { }  4 7 8 : Y m  + F I J L k  ! $ % ' F ` { ~  9<=?^x"=@ACb6^y|}C^abd<^y|}  &5PSTVu&=X[\^}   +=X[\^}=Zuxy{#>ABDc+./1P)DGHJi}9TWXZy )Hcfgi7:;=\}/JMNPo5p  / 2 3 5 T h !,!G!J!K!M!l!!!!!!!!!!!!"="X"["\"^"}"""""""## #!###B#P#k#n#o#q########%$@$C$D$F$e$l$$$$$$$$$$$%$%?%C%D%F%f%|%% &&2&6&7&9&h&&&G(k(z(---1%141B444)666X~|~~V<qdpvK`ȊjFjy2I(.ǏQ:@ڑOx~IOɓ&10/SbЦߦѶ۷!RIfm<H01)1gggj&j5jcjjj'xfxx{|)|/|Y|u|~~G*9f3(.c{? %&&QS"S3SCTbTwTUUUVVWXVpVVVvV|T3-Ji(Vlg   z{r"""##$$V$$',,,, ---..ђo(Ȕ!/Td"hޛbƜϝs֥%IX1-9دL' Clqqr<ӂ\we.P]yˆކDfs‡Շ,MÊ-aҍkj X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%XX%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%XX%̕XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX! ,?"$s:x/%g=42 b$jf[%"QwO>q b$ɼl/ti@g7ABR # @H 0(  L + (  d ( dGi:$?`8c?"Right Arrow 1C"ð?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!>Ddrs/e2oDoc.xmlTn1}G,݄MVTUJR87kM"gg̙9\]&{ A9餤DZۆ~~$Dfʆ>@/_\39-$}C}]wҰ0q^Zt h¶zD7E;!Im%6HtC['sby-0)>`0e EFv2 LVq{nn:eiL{ Jv%vLӄzj |z XI&W/~KHFT?8l]֡q 5y&{tKC!όr 1 #65u3M%wp3{3:c LVbl7+ ^ `J8Ӗ SǘUs "VTg$֊#Szc8"'Qpr2sDIc@R[Tʹ&e_Ѐs,G *YfRhUL&UW5׹~,PK!=a drs/downrev.xmlLOMO0 #"#qciѡtR@\ƤS5ZNp>zq1tRMGVD= J]?+hP(6ơ24-:V~@ߗ G+ͨgw̒$Nw滞c:lzoVۛe"pѡLG? gq3IS:ˑv* /PK-!8[Content_Types].xmlPK-!8! /_rels/.relsPK-!>D.drs/e2oDoc.xmlPK-!=a drs/downrev.xmlPK + tA?. "Picture 39v`TT`TTvv#" ? ) rA?. "Picture 4`T~T`T~T3"? * rA?. "Picture 6`T~T`T~TC"?B S  ?,&,,j(xPt+&, @** @)[*@f _Hlt11930146 _Hlt11930147 _Hlt11930148 _Hlt11930149 _Hlt11930150 _Hlt11930151 _Hlt11930152 _Hlt11930153 _Hlt11930170 _Hlt11930183 _Hlt11930193 _Hlt11930396 _Hlt11930216 _Hlt11930231 _Hlt11930244 _Hlt11930837 _Hlt11930320 _Hlt11930624 _Hlt11930659 _Hlt11930680 _Hlt11930735 _Hlt11930794 _Hlt11931555 _Hlt11931593 _Hlt11931612 _Hlt11931691 _Hlt11931656 _Hlt11931674 _Hlt11932146 _Hlt11931953 _Hlt11931738 _Hlt11931899 _Hlt11931759 _Hlt11931784 _Hlt11931799 _Hlt11931843 _Hlt11931862 _Hlt11932199 _Hlt11932234 _Hlt11932255 _Hlt11936072 _Hlt11935843 _Hlt11935891 _Hlt11935857 _Hlt11936073 _Hlt11936100 _Hlt11936193 _Hlt11936167 _Hlt11936250 _Hlt11936266 _Hlt11936282 _Hlt11936318 _Hlt11936410 _Hlt11936473P32_1761intro_Introduction_and_Guide _Toc282603652 _Toc291241734 _Toc11930046purpose _Toc11930047 _Toc282603653 information _Toc11930048_Legal_and_Administrative _Toc282603654 _Toc291241768legal _Toc11930049insurancerequirements _Toc11930050 _Toc11930051 _Toc11930052 Misrouted _Toc11930053Risk _Toc11930054_Directory_of_Services _Toc282603655 directory _Toc11930055 secureemail networkupdatequick whoishere _Toc11930056_Provider_Web_Sitesproviderwebsites _Toc11930057 anthemcom _Toc11930058 _Toc282603657 aopsheaderavaility _Toc11930059 _Eligibility _Toc282603658 eligibility _Toc11930060 _Toc11930061idcardmemberid _Hlt11748519 _Hlt11748520_Claims_Submission _Toc282603659claimssubmission _Toc11930062 _Toc282603660cselecdatainterchange _Toc11930063csfrequencycodes csurgentcarepaecsfacilitycharge _Hlt11851829 _Toc11930064 _Toc11930065 reimbursement_Reimbursement_and_Billing _Toc11930066csemergentnextdaycsemergeroomguideCMSHospacquired_Medical_Policies_and#medicalpoliciesclinicalumguidelines _Toc282603692 _Toc11930067 _Hlt7509543 _Hlt7509651 _Hlt7509564 _Hlt7509686 _Hlt7509687 _Hlt7509553 _Hlt7509554 _Hlt7509558contactusmedpol _Toc282603693umheader _Toc11930068_Utilization_Management_ProgramUM_DefinitionsProgram_Overview _Toc11930070 Preservice_Continued_Stay_Review _Toc11757879 _Toc11930071 _Toc11930072 _Toc11930073 _Toc11930074 _Toc11757883 _Toc11930075 Retrospective _Toc11757884 _Toc11930076 _Toc11757885 _Toc11930077Failure_to_Comply _Toc11930079 _Toc11930080 _Toc536440423 _Toc11930081 _Toc11930082Peer_to_Peer_Review _Toc11930083 _Toc11930084 _Toc11930085 mcgmilliman _Toc11930086priorauthguidelines _Toc11930087 _Hlt7512761respforpriorauth _Toc11930088balancebilling _Toc11930089 emergencyadm _Toc11930090servicesrequiringumonsitecontinuedstayreviewumbalancebilling umurgentcare _Toc11930091umbehvaioralhealthbehavioralhealth _Toc11930092mentalhealthparity _Toc11930093 umdecisions _Toc11930094aim physician _Toc11930095participatingphysicianumtransitionalcareparticipationconfirmationdefiningsolovsgroupchangingyourpracticenotifyingcoveredindividuals openpracticeaddingnewproviders%participationthroughprovidersponsoredwhentosubmitanagreementhowtocompleteanagreementnotificationofchangesphysicianproviderhmoaccessgoalscalendaraccessrequirements afterhourstwentyfoursevenhospitalistprograms locumtenensproviderterminationwithoutcause credentialing _Toc11930096 _Toc11930097 _Toc11930098 _Toc11930099 _Toc11930100 _Toc11930101 _Toc11930102 _Toc11930103 _Toc11930104_Nondiscrimination_Policy credcommittee initialcredrecredhealthdeliveryorgongoingsanctionanthemcredprogstandardsqualityimprovementprogram _Toc11930105 _Toc517101229 _Toc517101593 _Toc517101758 _Toc517101841 _Toc11757915 _Toc11930106 _Toc11757916 _Toc11930107continuityandcoordinationofcare _Toc67741204 _Toc285113128 _Toc321406179QualityManagemenProgramheadermemberbillofrights _Toc11930108 _Toc11930109 continuityofcaretransitionofcare _Toc11930110 _Toc271806655 _Toc271806656qualityinsights _Toc11930111qualityinsightspcpanthemqualityinsightsforpcp _Toc11930112performancedata _Toc11930113hedis _Toc11930114 _Hlt11853445 _Hlt11853446 _Hlt6484177 _Hlt6484178cahps _Toc11930115 _Hlt7086871clinicalpractice _Toc11930116preventivehealth _Toc11930117medicalrecords _Toc11930118culturaldiversitymulticulturalhealth _Toc11930119centersofmedicalexcellence _Toc11930120 anthemcentersofmedicalexcellencebluedistinction$bluedistinctioncentersfortransplantsnondescriminationpolicy(participatingproviderappealsofauditdecis _Recredentialing_Appeals_Processmemberqualityofcarecoveredindivqoc _Toc11930121 _Toc11930122 _Toc11930123 _Toc11930124 _Toc11930125 _Toc11930126 TopOfPageprovidercomplaintappealprocess _Toc282603723 _Toc11930127mediblueappeals _Toc11930128 _Toc11930129_Product_Summary _Toc282603724ProductSummary _Toc11930130 _Toc11930131 _Toc282603725_Federal_Employee_Program _Toc282603656federalemployeeprogram _Toc11930132 _Toc11930133ProductSummaryMedicareAdvantage _Toc11930134 _Hlt7446173 _Hlt7446174"ProductSummaryMedicareSupplemental _Toc11930135ProductSummaryLumenos _Toc11930136fepprogramrequirementsempire _Toc11930137plans#eligibilityandclaimsstatusinquiriespriorauthorizationempire_New_England_Health _Toc282603727NewEnglandHealthPlansheader _Toc11930138NewEnglandHealthPlansumNewEnglandBenefitPrograms!NewEnglandHealthHMOBlueNewEngland"NewEnglandBluChoiceNewEnglandPointNewEnglandAccessBlueNEnglandNewEnglandBehavioralHealthCare _Taft_Hartley _Toc282603728 tafthartley _Toc11930139$federalemployeehealthbenefitsprogram _Toc282603731 AUDITHEADER _Toc11930140healthinsurancemarketplace _Toc11930141audit _Toc11930142fraudwasteabuse _Toc11930143 _Toc123715982 _Toc11930144 pharmacyhome usefullinks _Toc11930145_Federal_Employee_Program_1 _Toc282603736 _Hlt11757701 _Hlt11757702bt%,3 L   W pAI/PX#r%s%h&h&h&&&&&&000666667>XX]c]c\f\f } } } }!"Ɨ{{{ǾǾǾǾm15uddeϺMdhw &&kkk  ?-##$$&)()(,,//88888@@@eEeE|J|JNwdwdddsfhknops,t\z}1SŴŴ%|XL%%%%ΡΡu!"PP;;"#fg$$QQQQQQQQQ+R^_aOhoooo pwSSST!!ܜܜNOȦȦɦ5fffh  gef4P5PVPor``̇̇k@@@@@@@@@ @ @ @ @ @@@@@@@@@@@@@@@@@@@ @!@"@#@$@%@&@'@(@)@*@+@,@-@.@/@0@1@2@3@4@5@:;6789=<>@?ABCEDIFGHKJMLNOQPRSTUVWYXZ[^_]\`acbdefg@h@ijkluvmnpoqr@stwxyz{|}~@@@@@@@@@@@@@   @  $ !"#%(&')*+,-0./123546879@:@<;>=?A@BCDEFHGIJKLMNOPQRTWYSVUZX\[]^_a`bcd@e@cu&-4 M   X qBJ0QY$s%t%h&&&&&&&&00067777>7XX\ccclfmf }"}"}8"{bþþǾҾҾӾ1au``ddeix,#iik>>?E $"$$$&O(O(,,9/;/88888 88@@@EEJJOwdddsfhknops,t\z}1SҴ=nr#IIIIllOOPPPPPPwx56$QQQQQQQ)R*R3R7^_akhoo p p p p,xUSl34ݜݜstȦ5f='R _UPzozoo+r`x͇͇k5566h8m8::C;I;XX"|U\ي ǬϬ;CZb4<˷ӷ Ϻ׺w#+9A=E<?PQ!&& )%)++==CC\\idqd%e-efgngvvwwx xgxoxxxpyxy}}#OV@N$$]$e$ 0(088+838BBQQi]w]]]^^W_^_r_y_u`|`````BaJaaa!b(bddAP@N$3,;)&&BBreuezz'~1~ގrv&DLT\ OO7O>Os{՞ܞOVu|աܡ ߤץޥĦ{ӱ۱ƴδط Ӽۼɿ ΆֆgsÇՇ܇hk(z(**++++Y.k.u0017777<<AAZByBCZEYF^FGG)H4HIIJJ KLNNOOQ8R;RSSSGTlVVVYYZv[[[S^b^bccc}ddPe[ef ghhjkYmemPnZn#sBsssst vLvww!x'xxx5zQz||}~R^VYruɉ҉5<  װ۰UY&(ؿ 9Hy  [h{#$$ -6^g&jq >INU",;?7Xgn!!#*###&&H(V(();,>,,,Z2264:4V4Z46666.7=7R9c9t::==??B.BYBBC*CFFdGpGHH7JDJMNENVNNNRRXX[[[7\\\__{aabbddff ggiikkkpxp|}"o +R|%Jԑђϔ̖2DWϜۜ ע~)ҫ٫#DGlp&2Ϸ߷DLYc5V*r*r\htFO"+;M8H@[ j   tvKbk! CT!!#!P!\!"")#8#&&))(*7*+,--..//Z0m011R3[3445566::/?4?=@L@@A9CCCCCDD#H7HIILLPQS_U_bbbbccccd eSgeggQhhh&i/iZihiiikkprrssuuvv$($%".9D(6(P`Ѣܢ3BئipYh&vˮخ;KG_ #j|`n*}"BckWb-N>*1AJ]BO$K X  t 12.fjxamO##%%4&?&&&T)U)++../(/// 0011113344>5M555}77:;t=}=r>}>@@CC2EAEEE_GVI!J$JLNPQQQXXY ZR\_\\\\\[`h`?dPddd3gDg3iCikk ll=lSlTl`loorrBsRsssvvy"yCyYyZyfyK|L|}} $@Nڎ[e4A+ uW˟ݢdf+-ϬM`lϮDckL[#1PSJS;MU.=ix&+MQt<=C;G#gi$ gvdn\]bz  !!""##b%n%% &''C)L)))++,&,r//4 5::@AB,B/E?EEEI&IK"KLLMMOOOPFTRThTTTULVVVWWXX0Y7YYY[[B\W\^^``aa;dJdddeeffllpm|m7nCnaoqo pp(q,qqqrrssttGvVvvv`ww#y1yzzz){ ||||l}|}V~l~(+>@E͉y_kΞ./CLIVWZqxզަ02ִܴԹns0<$=N*7<%6[g)9z@M! a   LTxAK6E2V!a!)"/"$.%,,/-8-..B/M/0033(515[5e555C6O658o888??@@AAB+ByDDhR}RS;SlUnUYYZZ[[]]__?aKa.Xlo][@yw-{NlNP7B}@;saeB2P2H !Ƙ;iCpD}r jB|^ Pa/du @Web ` p5k z TB# 2)) #g1 -A Tʩ@l ķJ&Ơ9ZI+rRpVVCn""~dc!64n< 'mRM*JSX_[Rf!"0P.R|o-V<X5@B,?`H؀6hc28vҙ~T`fYqiF8R rr^0|dDtsR0`qG94($? hr&K~ rA!N);W),eaY*nH9we+Hy+@+VV+,M&B-`Zm-:,9`9/fsB30FX50xPv0j*NnW-0v;\.1#<6a1.;1nX`10/I@1.nP2u3'3xm\!>3\ }Wu3XN*UN46r$X5Tn\ x5Be5= 3M7W8$q7658zgzu9+?279+hqd;2w|X:BF>[?}?zvA栘\8B1Bj}BYfAC L DaKBDD?L2E?8ucFFHnd5++VI'I`p(;JXd~i(JNa %Kǘj.sBKL R{LVhL.}M\Uz)NwZ sOL@JhOX@ O usXPYYPj]P'`Rf^ RKd RɨFlRq{Rpk>Rl5S>XBMHVKPVfx=Vd CWN{{KXF<=jjdYRx:Z:\Zdu[fqus\Ԧhvz\&!]FtU]REm]`wF]^nq_</D_ ^x '`6όEb<Z`b&h=b vcb:'1cDa7dcLDBc9T{cFdRfc.'-c6OOxd!/d0uueV'[ez)/e|H f&nfxflHZ`Ggf֪yGiFp[jDjbj<6D%kb%ak*b['kq,lFH6BczF~fdu[\ uk>RsF]m-9Z\ x5ucF"~d$q7;1 rR T` sa5!>we+W-0B DqUv CW(;J {KX;1 `RD/D_;.sBK a %K -({cr$X5 w<}?i f 'k r )) y@=7dc3UmW"nq_eaY*kqtOs!"0y+yGi W! ! u3g1 xdH !EpYfACdO$@l '[e5S(Jh=bNkw<]P*rOK{)/e%\=R0o-L,!]A %-Q<a1Lhq sOVbjFlR,ls!X5m6t%akj%z& ++VIe};W)}Wu3I@1:ZA!ANV#^ R],?`8v D-t58Pt R{L/3rDjLTne5Em]B# {B7lnmteb Qyhvz\Kd R0sYP$? Sh'DU]^NP7fcdYKBD3M7;\.1{|#k" 3PV9`9/\Z`&MHV}M`1+Lqus\}giv\!>3H f[@ygzu9z)Nz& '+%-6#n)D'Ir M*|w&B- OL2E5k nP2wRb"B30vA =N)/du ' fue~q{R5uue-cYqiBALtPB|^ v0279$Z`busXP`Ggd;@+ '`[?=V8Bp[jP2UN4~ 9 ~ Ys|X_*=D%kJhO~/'i fX50zidt'1c{NEb-A5TX`  CD%%F%+t                   8x@                  .m                                   8x@        r~         yB                 h                          8=                                                     @]q                                                                                                                                               f`^{                /                                           F        d                                   kV1l-қR$(* * δ7Y<        k.        2                                   lD        ^=tt.URxfB=xn+  r1zC~V<,.nE                           jr                                             Ƽ*                                                                                                                   @.                                                                                                                     @]q       :                          Z|طNB [œ̘(W(:P r| -        ٖ         `̈                                                              z         Ƽ*                         ؟Piєd"hLܵVnVYb                           2(         @]q                                  z*|*Y|*d 6} 6%dSg -j8Mg-mn 6%mn0b-52|*H-TJ 6HM}CH*|*w|*v |*G>-=)-Y|*H/ 6cR|*z 1{2&@g -}VR->-d|*lB 6'|*G-5M}C'JOd-XNn 67s 6) 6P|** 6?/X -@ 6?Q -y1 6s 6 |*y 6;C !cu*S `0k |*,\ - |* 6 6k ( 4CR -3$ -k |*y#i -A  - -X|*~v_NM}C9 6i M}CnlQ |*:r|tYG| 6L |*T-Aqj?Aq)U 4C-7 6=HWU|*>- 6 |*3{ 6On|*~{2&Y0SQ|*1- R."{2&]w 6at 6 -]|*4 ) 68^M}C_- m%y-|*O-d6|*tx 61|*]!|*{m  6{( 6uP 6  6/S{2&*=|*Q`|*x 60-Y 6ST, {2&zG{2&]" 68(|*3-9L|*-4ng -}V2-t 6%e{2&5"-l3/ 6tB9`SnQ0 |*n SO=_ 8, 6cYL 6=ka+!e|*{2g -}VRg -j`0SQ/=-3'r|*)|*~WTG- %|*K?*-"3{2&[waAqog- 6a$ SQ4T |*E &*xi &*x.! 6j! 6f'!-&^}!}}!SQ.!w!-w"M}C*r""r"AqO"-2#e8##- #-'#|*)#$=Es# 6'oD$$=Y$|*w$|*D<$ 6g$ 6R+$ 6LW$-${2&s$|*q{%-,yc%-+d%|*,&{2&tz!&ka{2&/r&\& 6%'E%4' 6Og'9G(-m(|**h(|* L)-,W) 6C[)|*Ysf)-'`)HW9) l)i) 67)|*!B4*g -j|*~V6v#*4C=3;+ 6 [+|*+~+{2&M[+ 6| ,|*F,|*A,!cug -&%- 6Od-X^T-JYS9- 6 - 6 e. 6E. 6/.X.|*.].{2& .AqM.|*.6$=, 6L6|*:6|*,E6 6]~V6.077|*d.8!cu08B;19 6nU9J9|*B9X):08:M}C)\:|*S+:|*e; 6W;|*f;|*a; 6W%<|*&|<M< 6M$=|*9Q=ka$=-$=~v0"= 6)= 6=-SO=(M l>1> 6:F> 6qK>-|jq_>|*;d> 6l">{2&7V>- >|*N> 6oH?{2&US?-iY?|*8 g?-!?SQ\?|*?-B? 6|@{2&W@&*x%@-sI@Aq @ 6&@{2&1I A 6,RA|*enAvASQ[A`B{2&YeB2B 6B-4CS ?CM}CidC-PCOg'0aC 6MLD$=sDD 6aD--E|*#E'rbE|*joE-vE|*6E-+FkaOjF-Mn;G|*s+G 6MG|*[{H 6uH-,H!cu_[H-*H|*g#I{2&PUI|* I-$2I|*mUnI~I5nISQ!I|*a1J|*^7kJ|*/nJ-J|*N J-Z]JSQvJ1TK 6m+XKn @=\KIK|*n{K 61 &Lg -}ViPL-|}`[)_L 6&cM&*x$M-(MA MeN%/W&NSQ2;N 6 2N-),N|*pN|*,zNCO&*xKO-VO|*dxO|*f=!PHW_"P-1NP 6. XP|*({yP4C~*P 6AP 60P4CiQ|*mG%QPCQ%QI*Q4Co-Q|*nlQ f0nQSQ5w0iXQ|*d|*LATd 6\Xd-ud 6Ed|*Z*e-X8e&^}!0!e 6Ufwof|*_2f ff|*bf{2&#7f|*7g-"&dg7g 6HAg|*pSg|*kg|*^RXhCdh|*p 66UpSQ ppAq5\q|*JLq|*$q 6q|*Iq 6gnq 6fq-"q|*8rAVr-r:Qs gs-1-At|*'t|*Ut|** t 6$u 6!cu m%0fu4C Pu 6>u 68uv&*xb vgv&*xqv!cu?v-v--wv uw|*r[wAq5w3wowka&*x?)0 3x-A8xX8eLwx 6x 6SWy|*OEZy 6V4y 6B;y|*.y-Rwz-^IzAq?z|*lz-|bz-Vz-'{|*z {K|{|*r{j{|*|-1|-\||* 6|-lk|ka-|"L} 6g'~|*F~ 6F~B9` ~|*~ 6I 6\.-TE 6_7U 6RSQp|*@J 6o!cu?)  Sa"&&' 5CKYY`(fuu|~ *#&(*-.l?not{6EI~L P$QTV^g_h !M!$'5+I:[[nt9!Woe.'j-1zS7`dklv|,T2;<EGO(VWY[7b<y*252FK]twy,J M#N\PY]mcvF |6 ? @ oA T a b p z    j+ , D M W d l v Yx    ( + Z/ 0 #> G 4L cU V b] d s D$ % \, Q R \ !x   & ^' <* + 8 I mL O R V c g m Tw >$%:2,@STUZl&k"$+~. /3==?DLL^PSUZfj*8<6GNHWRXehoqw$3.88^UYeBmuy q  =|SUhn{r{0~GR"}\#d%5#689>FMiN:ZssyKe&(,,;8ST{_lo|,#:EYMMSU Y [ga$j[ot{'j4D7Jjim&(4fm g)*:?h\e^D_M_b_c R S=? -5.6M]w$&o()AD[F^Kcnink E {9f t *z9V`Rf:gpN`^V 3AFJOYY;^fyG H G V" 9& 4 C 0E F W j m ~ {!"!!B ! ! !!B!O!d!k!m!y!{!u"" """$"(")"7"G;"I"L"RR"sU"pX"]"_"d"2v"I{"}"Y #S #6#1#3#B#6I#1O#y#~#$$$-$(8$bA$DE$H$L$S$y\$ki$Bo$Ar$Z%>%@"%+%,%VD%W% &&#&*&-&U2&5&A&aB&E&I&#c&e&Hm&''K'u 'D/'/P'/Z'.g'x'z'$}'u(wF(dJ(?L(L(,P(k(|(}())&)*),)/)E)G)EM)W)a)p)p)*** **#+*F*U*V* X*o*+7*+4+*7+T<+H+;J+(t+w+w+^~+[ ,A ,,,k&,5,K8,]8,u=,_[, ],a,b,{,w~, ,K - %-w(-\)-6-'A-FA- O-S-SV-_-d-9g-sv-y-z-i..&. .&.[/.:.%<.D.VQ.Z.].g.k.o.u.x. /?//8/2>/g/sm/m/p/]z/?|/<000h%0R1060E01@11111sG1N1aS1LU1u1~12-,2Z1272Y29k2qv23q 3k 33!3&373n?3!N3>d3Yg3r3{3444 4#4#4B4D4H4L4O4Y4 f4s4A555&"505G15o45c?5A5R5S5}T5X5Y5%^5a5 k5m5vr5t5z56|5}66(6BU6Z6_6m67a77O 7'7=7>7/C7eO7T7U7_7g7w7+8-818M8O8a8i8.q8(u8v8x8199J9c 99B9K9@b9g9t9:4!:o!:8:C:_:i:1u:y:|;{ ;6;;N;; ;!;&;=/;B;EQ;8R;n;u;;<<L<M<Sb< t<u<=d=^ =)==(=[=Jd=$j=}=>>#>#>Y'>)(>!2>+2>4>:> J>J>2]>b>Ej>g ?*???xJ?x?{?.@z@$@ @1@@6@$B@E@H@O@g@v@.x@W~@ A_ A AAFA Ab.AOARAXAg]AhAxABBlBIBBB6BFB+IBSBTB[BYlB`nB!~B CMC,C3C OCHDuDDDD*D>DDD![DagDosDEGEEEE$E~(EMEHQEXEbEgEsE${E{EFF_ F FhFF[F3F>FDFUFYFsbF0eF GjGGG<"G~#G&$G%G&0G9GFGPGcGjGnGrG8H]:HUAHFHHHMH8]H]H`HdHpH{HZ~HII1 I-I I1IGIJITIbIdI!rI]uIJEJ\JJ/J4J!eJsJ8,K?K@KUK9iKqKwK&~KL LL<$L-L.L2L3L?LELILLrSL.]L8bLcLU'M,Mv-MQ}HQNQYQZQ[Q9rQ5RR RRvR"RE3RDRXRSSSfSS\SSA/Sl:S=ASHSWS\SmSTc-TCTCdTsjT^wT"zT|T~TFTXUr!U%U1UIU KUZU}}U VV V<VV-V4V7VD>VTV&xVxVk|V|VWWW#W^3W5W9W$;WDBW|WXXvX,Xm5X7X+;XCXdGXHXj\X\X]XeXvXZxXYyYT0Y8Y;?YFYPY]UYafYlvY(}Y+ZZ^ZCZ1Z 6Z5RZ*XZ^ZZ]ZyZ|ZuZ[}[d[:![L&[2[7[=S[b[~m[p[ou[\\\\,\!\0\2\3\/=\|M\R\e\h\v\w\] ] ]]-]F]J]bK]M]N]NP]IT]V]Y]a]3w]\7^GN^T^&s^:t^_>_ _p_$_D*_/_2_6_6_7_s__`$```)`0`<`@`Q`X`Z`o`a)BaEMaWdaja)kaOtaa%b"b2b2IbMbRbYb_b}b~bcHccctc~1c>cBcTBcEFcLcdcBkcId3ddd!dM,dG5d6d=>d?dBdNd-RdkSd7WdWdYd Zd_dadddkd=odBudzd~d1e!eK5eT=e?eKePexTepe{eZfO f f2"f?fCf}bfsf?vfS~f*g3g!g#gCg1Egfgjgxghl hh_6hk{p{s{t{|{ |)|}=|jS|#U| g|h|q|-x|[}p}j }"},}e0}5}gE}T}k}p}8t}w}}}~~~T~(~y6~=~NI~R~X~u~z~8Y%12O2d{P"P&,oDdJqqt+`e&1I(QXTY_qWwZ : 0/17q;AyEJS U%Zm~k!)%,&8FKC_Loz u,4;8YN/r!;@XX%[]O^f#j %&+35ER0ay{{Wq#,$,7>SR7^ x!5r8C`HOSVTY\Rhh(A+is\ 7VWGdddwy}U*XI$Z[gl $%+2D>Pf}ijw'R%EHMkm|n*/s2<=BNP0U`ov.+2K"ZolRmw/$-.q4G?DQ.TV`)lrz,zDLn{zxK));++=">?EFJLNhU ,/ //96KzZioo58 f!#%''1;MY]avabqtUGVqross$;>SAH=KANg[\`i{ ]=BStZ[=];^o!E|HWmz{#%.->OS7[ikBw $ 8K*m5:E.TyW\l!,1s8\@CtNVloopLqos.&x*+30J1@CIkU?W^]jwV,2AjCK.Q&bbf) ~05q72C] 8:LR[ftv}Di 59{AI,Q@YKfiii|#03@rHI4WXbZeZcf+Rx\oqh@&@V^cvexz* J!Y:&RFZ` )/F4@@CUic]jooy<5G( *.8:GMEa1@H-T1cblv &R+4afkn]swv% -q:\;;UphOl1wxx} 7+5268^KrZ.4HRRx.02CLV6^u w/r3 8<QpZGb *->ELNP]~!,3\V_!gjUZ4'DFVSGdg|hisyT  ![45OQ`d0q2z UC1:::P;Z8ddz_(!*U0)24=UYinxxxNc s#_0Osktw06?O3QRSW`|gx%&+':]?\_bg7qN"i#T%w%)PEHW/[T`9a.bbN{|bJ h?::zBUcwC{ki "7,//a7:SAAxSUUpVrcx*#$L%&4>bIKbRUL_,kw||= ]"*?GH/ORrTV+Z\dpI##%2X22_8>@KCO^fXgs,fv08 Y?Zwacz89HHR[\Rb^oq(tutuf22 ;ACckouuu C*.k3E6Ut|K$N`t' YX41=H?EvQ-Y[d{GHXS`a g#s0 +!*0|@cBF3Xe jF!178kBBCAFG7JUs}:gyj%'[B9EJL*TaUfpixzz|~~~:},47@`K Ypwp d,l.PuQ9UU Ygnv{VM7;AC;Nmgnkx0q%/-1GuLiNO6fggYljrw}}t)].CBN\XXI^Ik g |"D.WNY\glr|eEZTqwV{f G*N W~`hc "&P+7<M6Un\fvS +.FfOo.p2w| P26$CLWPr9ww/1?7[jIj =!)/2j7m@HdJ{UXD_clprt?W & 42',2JKO3`mne `*68@ABFJJ~L`4f m z:eA5KuLGMNRLVJ\`Aae]oo"#BCH LSS@eit.x}qap"Q+3n=A}t.#:PSYZZscdVqv}m 7[%BMOP8gTpi$%+22=Y3bgj+u2xpy %>%&h,,G//3@FSWp+q V/@ ?!<oNQn M2vEScet,&*8@5GO0\sc\ez3u%'.,1@IS[T^hym!!3}5&?Kacswyz$=CMWAX ]_Wecu~4@EQ.WahlEk Y1 !*@aIUV]m/wy~~0nIY!ow|t?w?|F Na:jz0|c )??oMNZ`]^p_ago1@KLT[``[cx*017=CyFMeniuy  +#2HE GS]oW&9=@BPWuXky$69C;.<Q>[CKS@UiZ/eCo;u/&)6C7u=L\o{~[=1@JQiVY]_cyzC #",0AABcRYehp{d K >eA4Q[xC}+J-j=@{AFQNdnvyyMO )*Z*5+-JQbb7mtgy$1X3tIiOZj1rrv!%2 !\P<@NMS7`Yd5yy sP527T<w?Vpq!;=EGsHbdWr?uz atM*l/Gc|_AMO_XmlVersionEmpty@4aj@@`@UnknownSchoenberg, Beth A.G.[x Times New Roman5Symbol3. .Cx Arial7.*{$ Calibri;. .Cx Helvetica9. . Segoe UI5+mn-ea9GaramondS  Myriad ProMyriad Pro5. .[`)TahomaMCentury Schoolbook?= .Cx Courier NewABook Antiqua7. [ @VerdanaS  TV Nord EFTV Nord EF=Calisto MT7@CambriaA. Arial NarrowS.Arial Rounded MT Bold;Wingdings?Wingdings 23.[x TimesA$BCambria Math"1h̃y'̃y'Hvgbl bl !0##NQHP  ?p2!xxC Dan Schwandner Adams, Helen                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~   Oh+'0|   , 8 D P\dltDan Schwandner Normal.dotmAdams, Helen2Microsoft Office Word@F#@3&@l@llb ՜.+,D՜.+,< hp  WellPoint, Inc. #  Title(X` _PID_HLINKS_NewReviewCycleAL`9http://www.anthem.com/wps/portal/ahpmedicare?content_path=shared/noapplication/f2/s2/t4/pw_ad090993.htm&label=Anthem%20Provider%20ServicesG]http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a084753.htm&state=ct&rootLevel=3&label=Provider%20Appeals%20and%20Billing%20Disputes0bhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003150.htm&state=ct&rootLevel=0&label=Medical%20Policies%20and%20Clinical%20UM%20Guidelines|Yhttp://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f3/s1/t0/pw_038045.htm&na=edi_ct&rootLevel=2&label=HIPAA%20Companion%20Guide7http://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f2/s2/t0/pw_039731.htm&na=edi_ct&rootLevel=1&label=EDI%20Registration%20FormsPQhttp://www.anthem.com/ediNThttp://www.nubc.org/Q]http://www.availity.com/L"http://www.fepblue.org/index.htmlNEhttp://www.bcbs.com/91http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_036846.htm&state=ct&rootLevel=4&label=What%20is%20the%20BlueCard%20ProgramW[http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&state=ct&rootLevel=0&label=Quick%20Reference%20Guides!qhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&rootLevel=4&label=Phone%20Numbers55http://www.anthem.com/LMJhttps://www.anthem.com/health-insurance/provider-directory/searchcriteriaM)https://messageinsite.com/networkeupdate~Uhttp://www.anthem.com/provider/ct/f4/s6/t0/pw_e225397.pdf?refer=ahpprovider&state=ct{`http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_036845.htm&state=ct&rootLevel=4&label=The%20BlueCard%20ProgramNhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_ad085407.htm&label=Empire%20Blue%20Cross%20and%20Blue%20Shield%20Plan%20Information&state=ct&rootLevel=055http://www.anthem.com/f^Uhttp://www.anthem.com/provider/ct/f3/s10/t0/pw_003460.pdf?refer=ahpprovider&state=ct"thttp://www.anthem.com/wps/portal/ahpprovider?content_path=shared/ct/f3/s2/t0/pw_002632.htm&state=ct&rootLevel=2&label=Medicare%20SupplementalkVhttp://www.anthem.com/shared/noapplication/f0/s0/t0/pw_ad094474.pdf?refer=ahpmedicare>/'http://www.anthem.com/medicareprovider'MUhttps://www.anthem.com/provider/me/f5/s2/t0/pw_036843.pdf?refer=ahpprovider&state=ct~<{http://www.fepblue.org/i$xLhttp://www.anthem.com/wps/portal/disclaimerlink?uri=http://www.fepblue.org/55uhttp://www.anthem.com/Nrhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&label=Quick%20Reference%20Guides&state=ct&rootLevel=0lhohttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f3/s0/t0/pw_ad076839.htm&label=Plans%20and%20Benefits&rootLevel=2&state=ct&label=Plans%20%5e%20Benefits Zlhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/noapplication/f2/s3/t0/pw_ad094863.htm&rootLevel=1&state=ct&label=Centers%20of%20Medical%20Excellence55ihttp://www.anthem.com/}-fhttp://www.anthem.com/wps/portal/ahpmember?content_path=provider/noapplication/f2/s3/t0/pw_ad094863.htm&label=Centers%20of%20Medical%20Excellence&state=oh&rootLevel=1RJcBhttps://www.cdc.gov/cdcgrandrounds/archives/2017/february2017.htmRJ`Bhttps://www.cdc.gov/cdcgrandrounds/archives/2017/february2017.htm3l]https://mydiversepatients.com/jfZ0http://www.mydiversepatients.com/le-asthma.htmlXW"http://www.mydiversepatients.com/jfT0http://www.mydiversepatients.com/le-asthma.htmlXQ"http://www.mydiversepatients.com/XN"http://www.mydiversepatients.com/XK"http://www.mydiversepatients.com/XH"http://www.mydiversepatients.com/phE7https://www.thinkculturalhealth.hhs.gov/clas/standards55Bhttp://www.anthem.com/OD?http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_003161.htm&label=Clinical%20Practice,%20Preventive%20Health,%20and%20Behavioral%20Health%20Guidelines&rootLevel=1&state=ct&label=Practice%20Guidelines%20OD<http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s2/t0/pw_003161.htm&label=Clinical%20Practice,%20Preventive%20Health,%20and%20Behavioral%20Health%20Guidelines&rootLevel=1&state=ct&label=Practice%20Guidelines%20_9https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003096.htm&state=ct&rootLevel=4&label=Provider%20Newsletters]\6http://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f2/s4/t0/pw_003178.htm&state=ct&rootLevel=1&label=Quality%20Improvement%20and%20Standards.%20tt3https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f2/s4/t0/pw_003178.htm&label=QUALITY%20IMPROVEMENT%20AND%20STANDARDS&rootLevel=1&state=ct&label=Quality%20Improvement%20and%20Standards%20}x08https://www.aacn.org/certification/verify-certification T-http://oncc.org/yy*4http://www.pncb.org/ptistore/control/exams/ac/progs"7'http://www.nccwebsite.org/[$"http://www.aanpcertification.org/s !6http://www.nursingcertification.org/exam_programs.htm&2#http://www.nursecredentialing.org/*'Ljavascript:openWin('http://www.CAQH.org', 'mainWin', 1, 1, 1, 1, 700, 500);55http://www.anthem.com/:,zhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&label=Contact%20Ushttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f6/s0/t0/pw_e229315.htm&rootLevel=5&state=ct&label=Join%20Our%20NetworksQ]http://www.availity.com/;5 http://www.providerportal.com/Q] http://www.availity.com/;5http://www.providerportal.com/,9+http://www.aimproviders.com/rehabilitation42/http://www.aimproviders.com/surgicalprocedureshttps://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_msk&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=EkSgHW1NQslQ9wvcvlamIxH27SunJ636fzwTVZ_9UNk&e=<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_specialtyrx&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=T-yEdBwsSk6dL4FpuZeDJbQfjTcg9dm0IwbUKOEON9A&e=7t https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimspecialtyhealth.com_gowebsleep&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=1DHpJRhJYuVJZ3siYFYXW6nU6DdvQO1dId_Pny7GX5M&e='Mhttps://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_genetictesting&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=ZZnnHJYURIdOBlJW5N0E6gpEadhw5I8PtaDyOnwDTd4&e=yZhttps://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_radoncology&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=Ycr8WDlpD1-9fgXwbv3ELmuX7vn8eFIzsNV8IxoZcUI&e=g%https://urldefense.proofpoint.com/v2/url?u=http-3A__www.cancercarequalityprogram.com&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=5oV7aK5iynovoZm3r_3UAIAQWz4yge5_TPbCTdKiuT4&e=k0https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_cardiology&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=HzSY0MjsKCiU2RePm2xJQkZ6FrBvOugXrZ-12bXU_dY&e= Xhttps://urldefense.proofpoint.com/v2/url?u=http-3A__www.aimprovider.com_radiology&d=DwMFAg&c=A-GX6P9ovB1qTBp7iQve2Q&r=SM4oB330QPybQBJs_IU6n4wJdrqXgQ0zV8q2U58lV0w&m=tkQ3HASWEVm08iqSJ4u7cmmqKwuKxIxLZ3mZc_xgoxw&s=GtHgD0w8hhDFhG0V6Eh1_4U0UobZykFoT8dO-tWI3Lk&e=yahttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_ad078024.htm&label=Precertification%20(Prior%20Authorization)%20Guidelines&state=ct&rootLevel=0~?,https://www11.anthem.com/vaprovider/router/https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003150.htm&label=Medical%20Policies%20and%20Clinical%20UM%20Guidelines&cnslocale=en_US_ct&state=ctC"CT 2019 Provider Manual-Final.dochttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_b142511.htm&label=Administrative,%20Billing%20and%20Reimbursement%20Policies&state=ct&rootLevel=0}U https://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_g328372.htm&state=ct&rootLevel=3&label=Reimbursement%20Policies%20 %20ProfessionalOrC:\Users\AD43469\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.Outlook\02UATIHE\www.anthem.com(https://www.anthem.com/wps/portal/ahpculdesac?content_path=edi/noapplication/f1/s0/t0/pw_038000.htm&na=edi_ct&rootLevel=0&label=EDIXhttp://www.anthem.com/edi andy#https://solutions.caqh.org/y#https://solutions.caqh.org/1f'https://apps.availity.com/web/welcome//ediZZ6http://aimspecialtyhealth.com/ClinicalGuidelines.html55http://www.anthem.com/Q]http://www.availity.com/PQhttp://www.anthem.com/ediPQhttp://www.anthem.com/edi|*http://www.cms.gov/nchttps://www11.anthem.com/provider/noapplication/f1/s0/t0/pw_g279544.pdf?refer=ahpprovider&state=ct`$mailto:edihelpdesk-ne@wellpoint.comPQhttp://www.anthem.com/edi:,zhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&label=Contact%20Us{t8http://www.availity.com/providers/registration-details/Q]http://www.availity.com/55http://www.anthem.com/55http://www.anthem.com/55http://www.anthem.com/5sLhttps://central.provider.anthem.com/mwpmf/entpmf/landingpage?brand=ctabcbs:l5http://anthem.com/F=`http://www.anthem.com/provider/noapplication/f4/s0/t0/pw_e184316.pdf?refer=ahpprovider&state=ctF>`http://www.anthem.com/provider/noapplication/f4/s0/t0/pw_e184315.pdf?refer=ahpprovider&state=ctpUhttp://www.anthem.com/provider/ct/f4/s0/t0/pw_a034842.pdf?refer=ahpprovider&state=ctpUhttp://www.anthem.com/provider/ct/f4/s0/t0/pw_a034841.pdf?refer=ahpprovider&state=ctpUhttp://www.anthem.com/provider/ct/f4/s0/t0/pw_a034840.pdf?refer=ahpprovider&state=cttUhttp://www.anthem.com/provider/ct/f4/s6/t0/pw_a031254.pdf?refer=ahpprovider&state=ctw|Uhttp://www.anthem.com/provider/ct/f4/s0/t0/pw_a035022.pdf?refer=ahpprovider&state=ctG6y`http://www.anthem.com/provider/noapplication/f4/s0/t0/pw_b153377.pdf?refer=ahpprovider&state=ctW_vhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f4/s0/t0/pw_a034845.htm&state=ct&rootLevel=4&label=Quick%20Reference%20Guides55shttp://www.anthem.com/m9phttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f1/s0/t0/pw_ad076835.htm&rootLevel=0&state=ct&label=Provider%20Home55mhttp://www.anthem.com/Gjhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003096.htm&state=ct&rootLevel=4&label=Provider%20Newsletters -g,http://userawareness.zixcorp.com/wellpoint/ -d,http://userawareness.zixcorp.com/wellpoint//ga(https://messages.anthemsecureemail.com/:,^zhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s5/t1/pw_m010364.htm&state=ct&label=Contact%20Us55[http://www.anthem.com/onXhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f1/s0/t0/pw_040291.htm&label=Network%20eUPDATE&state=ct&rootLevel=0GUhttp://www.anthem.com/wps/portal/ahpprovider?content_path=provider/ct/f5/s1/t0/pw_003096.htm&state=ct&rootLevel=4&label=Provider%20Newsletters55Rhttp://www.anthem.com/55Ohttp://www.anthem.com/55Lhttp://www.anthem.com/I Introduction<B _Toc11930145? pharmacyhome<9 _Toc11930144<3 _Toc11930143<- _Toc11930142<' _Toc11930141<! _Toc11930140; _Toc11930139; _Toc11930138; _Toc11930137;  _Toc11930136; _Toc11930135; _Toc11930134; _Toc11930133; _Toc11930132; _Toc11930131; _Toc11930130: _Toc11930129: _Toc11930128: _Toc11930127: _Toc11930126: _Toc11930125: _Toc11930124: _Toc11930123: _Toc11930122: _Toc11930121: _Toc119301209 _Toc119301199 _Toc119301189 _Toc119301179 _Toc119301169 _Toc119301159 _Toc119301149 _Toc119301139y _Toc119301129s _Toc119301119m _Toc119301108g _Toc119301098a _Toc119301088[ _Toc119301058U _Toc119301048O _Toc119301038I _Toc119301028C _Toc119301018= _Toc1193010017 _Toc1193009911 _Toc119300981+ _Toc119300971% _Toc119300961 _Toc11930095aiaim1 _Toc119300941 _Toc119300931  _Toc119300921 _Toc119300911 _Toc119300900 _Toc119300890 _Toc119300880 _Toc119300870 _Toc119300860 _Toc119300850 _Toc119300840 _Toc119300830 _Toc119300820 _Toc119300810 _Toc11930080? _Toc11930079? _Toc11930077? _Toc11930076? _Toc11930074? _Toc11930073? _Toc11930072? _Toc11930071? _Toc11930070> _Toc11930069> _Toc11930068> _Toc11930067>z _Toc11930066>t _Toc11930065>n _Toc11930064>h _Toc11930063>b _Toc11930062>\ _Toc11930061>V _Toc11930060=P _Toc11930059=J _Toc11930058=D _Toc11930057=> _Toc11930056=8 _Toc11930055=2 _Toc11930054=, _Toc11930053=& _Toc11930052=  _Toc11930051= _Toc11930050< _Toc11930049< _Toc11930048< _Toc11930047< _Toc11930046  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] z { | } ~  Root Entry FA>l Data s 1TableR sWordDocument/ SummaryInformation( DocumentSummaryInformation8 ȒMsoDataStore ;lA>lXDMLAM2Q==2;lA>lItem  PropertiesU0YNYHNG0DAKUGBA==2 ;lA>lItem  PropertiesUK3VOX2RJFFHA==2;lA>lItem PropertiesUT5RDCU0DO0Q==2 ;lA>lItem Properties"UC2BMOH4N4==2;lA>lItem (Properties,UFCNTMJ1OUKH21IP==2;lA>lItem 2Properties7USK4WT5EVRW2Q==2;lA>lItem =PropertiesBU   !#$%&')*+-./01345689:;<>?@ACDEFGI CompObjHr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q